10-K

0001071739-16-000192.txt : 20160222 0001071739-16-000192.hdr.sgml : 20160222 20160222103051 ACCESSION NUMBER: 0001071739-16-000192 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 124 CONFORMED PERIOD OF REPORT: 20151231 FILED AS OF DATE: 20160222 DATE AS OF CHANGE: 20160222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CENTENE CORP CENTRAL INDEX KEY: 0001071739 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 041406317 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31826 FILM NUMBER: 161443916 BUSINESS ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3147254477 MAIL ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 10-K 1 form10k.htm FORM 10-K 10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-K

(Mark One)


x	ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2015

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


	For the transition period from to

Commission file number: 001-31826

Centene Corporation

(Exact name of registrant as specified in its charter)



Delaware		42-1406317
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification Number)

7700 Forsyth Boulevard
St. Louis, Missouri		63105
(Address of principal executive offices)		(Zip Code)

Registrant's telephone number, including area code: (314) 725-4477

Securities registered pursuant to Section 12(b) of the Act:



Common Stock, $0.001 Par Value		New York Stock Exchange
Title of Each Class		Name of Each Exchange on Which Registered

Securities registered pursuant to Section 12(g) of the Act:

None

(Title of Each Class)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes x No o

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes o No x

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was require to submit and post such files). Yes x No o

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer” and “small reporting company” in Rule 12b-2 of the Exchange Act.

x Large accelerated filer o Accelerated filer

o Non-accelerated filer (do not check if a smaller reporting company) o Smaller reporting company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes o No x

The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant, based upon the last reported sale price of the common stock on the New York Stock Exchange on June 30, 2015, was $9.6 billion.

As of February 17, 2016, the registrant had 121,654,923 shares of common stock issued and outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the Proxy Statement for the registrant's 2016 annual meeting of stockholders are incorporated by reference in Part III, Items 10, 11, 12, 13 and 14.

CENTENE CORPORATION

ANNUAL REPORT ON FORM 10-K

TABLE OF CONTENTS



		PAGE
Part I
Item 1.	Business	1
Item 1A.	Risk Factors	20
Item 1B.	Unresolved Staff Comments	32
Item 2.	Properties	32
Item 3.	Legal Proceedings	33
Item 4.	Mine Safety Disclosures	33
Part II
Item 5.	Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	34
Item 6.	Selected Financial Data	36
Item 7.	Management's Discussion and Analysis of Financial Condition and Results of Operations	38
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	59
Item 8.	Financial Statements and Supplementary Data	60
Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	96
Item 9A.	Controls and Procedures	96
Item 9B.	Other Information	97
Part III
Item 10.	Directors, Executive Officers and Corporate Governance	98
Item 11.	Executive Compensation	98
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	98
Item 13.	Certain Relationships and Related Transactions, and Director Independence	98
Item 14.	Principal Accountant Fees and Services	98
Part IV
Item 15.	Exhibits and Financial Statement Schedules	100
Signatures		104

Table of Contents

CAUTIONARY STATEMENT ON FORWARD-LOOKING STATEMENTS

All statements, other than statements of current or historical fact, contained in this filing are forward-looking statements. We have attempted to identify these statements by terminology including “believe,” “anticipate,” “plan,” “expect,” “estimate,” “intend,” “seek,” “target,” “goal,” “may,” “will,” “would,” “could,” “should,” “can,” “continue” and other similar words or expressions in connection with, among other things, any discussion of future operating or financial performance. In particular, these statements include statements about our market opportunity, our growth strategy, competition, expected activities and future acquisitions, including our proposed merger with Health Net, Inc. (Health Net) (Proposed Merger), investments and the adequacy of our available cash resources. These statements may be found in the various sections of this filing, including those entitled “Management's Discussion and Analysis of Financial Condition and Results of Operations,” Part II, Item 1A. “Risk Factors,” and Part II, Item 1 “Legal Proceedings.” Readers are cautioned that matters subject to forward-looking statements involve known and unknown risks and uncertainties, including economic, regulatory, competitive and other factors that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions.

All forward-looking statements included in this filing are based on information available to us on the date of this filing and we undertake no obligation to update or revise the forward-looking statements included in this filing, whether as a result of new information, future events or otherwise, after the date of this filing. Actual results may differ from projections or estimates due to a variety of important factors applicable to both us and Health Net, including but not limited to:


•	our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves;


•	competition;


•	membership and revenue projections;


•	timing of regulatory contract approval;


•	changes in healthcare practices;


•	changes in federal or state laws or regulations, including the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act and any regulations enacted thereunder;


•	changes in expected contract start dates;


•	changes in expected closing dates, estimated purchase price and accretion for acquisitions;


•	inflation;


•	foreign currency fluctuations;


•	provider and state contract changes;


•	new technologies;


•	advances in medicine;


•	reduction in provider payments by governmental payors;


•	major epidemics;


•	disasters and numerous other factors affecting the delivery and cost of healthcare;


•	the expiration, cancellation or suspension of our or Health Net's managed care contracts by federal or state governments (including but not limited to Medicare and Medicaid);


•	the outcome of our or Health Net's pending legal proceedings;


•	availability of debt and equity financing, on terms that are favorable to us;


•	our ability to adequately price products on federally-facilitated and state-based Health Insurance Marketplaces;


•	changes in economic, political and market conditions;


•	the ultimate closing date of the Proposed Merger;


•	the possibility that the expected synergies and value creation from the Proposed Merger will not be realized, or will not be realized within the expected time period;


•	the risk that acquired businesses will not be integrated successfully;


•	disruption from the Proposed Merger making it more difficult to maintain business and operational relationships;


•	the risk that unexpected costs related to the Proposed Merger will be incurred; and


•	the possibility that the Proposed Merger does not close, including, but not limited to, due to the failure to satisfy the closing conditions thereto.

Item 1A “Risk Factors” of Part I of this filing contains a further discussion of these and other important factors that could cause actual results to differ from expectations. We disclaim any current intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Due to these important factors and risks, we cannot give assurances with respect to our future premium levels or our ability to control our future medical costs.

Table of Contents

Non-GAAP Financial Presentation

The Company is providing certain non-GAAP financial measures in this report as the Company believes that these figures are helpful in allowing individuals to more accurately assess the ongoing nature of the Company's operations and measure the Company's performance more consistently. The Company uses the presented non-GAAP financial measures internally to allow management to focus on period-to-period changes in the Company's core business operations. Therefore, the Company believes that this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.

Table of Contents

PART I

ITEM 1. Business

OVERVIEW

We are a diversified, multi-national healthcare enterprise that provides programs and services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. We provide member-focused services through locally based staff by assisting in accessing care, coordinating referrals to related health and social services and addressing member concerns and questions. We also provide education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. We believe our local approach, including member and provider services, enables us to provide accessible, quality, culturally-sensitive healthcare coverage to our communities. Our health management, educational and other initiatives are designed to help members best utilize the healthcare system to ensure they receive appropriate, medically necessary services and effective management of routine, severe and chronic health problems, resulting in better health outcomes. We combine our decentralized local approach for care with a centralized infrastructure of support functions such as finance, information systems and claims processing.

On July 2, 2015, we announced that we had entered into a definitive merger agreement with Health Net, Inc. (Health Net) under which we will acquire all of the issued and outstanding shares of Health Net. Under the terms of the agreement, at the closing of the transaction, Health Net stockholders (with limited exceptions) would receive 0.622 of a validly issued, fully paid, non-assessable share of Centene common stock and $28.25 in cash for each share of Health Net common stock. The transaction is valued at approximately $5.5 billion (based on the Centene closing stock price on February 17, 2016), including the assumption of debt. The Company expects to fund the cash portion of the acquisition through a combination of the debt financing completed in February 2016, borrowings on the Company's revolving credit facility and existing cash on hand. The transaction is expected to close in early 2016 and is subject to approvals by relevant state insurance and healthcare regulators and other customary closing conditions.

We operate in two segments: Managed Care and Specialty Services. Our Managed Care segment provides health plan coverage to individuals through government subsidized programs, including Medicaid, the State Children's Health Insurance Program (CHIP), Long Term Care (LTC), Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program, or collectively ABD. Beginning in 2014, our Managed Care segment also provides health plan coverage to individuals covered through federally-facilitated and state-based Health Insurance Marketplaces (HIM). Our Specialty Services segment consists of our specialty companies offering diversified healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups and other commercial organizations, as well as to our own subsidiaries. For the year ended December 31, 2015, our Managed Care and Specialty Services segments accounted for 90% and 10%, respectively, of our total external premium and service revenues.

Our managed care membership totaled 5.1 million as of December 31, 2015. For the year ended December 31, 2015, our premium and service revenues and net earnings from continuing operations attributable to Centene were $21.3 billion and $356 million, respectively, and our total cash flow from operations was $658 million.

On February 2, 2015, the Board of Directors declared a two-for-one split of Centene's common stock in the form of a 100% stock dividend distributed February 19, 2015 to stockholders of record on February 12, 2015. All share, per share and stock price information presented in this Form 10-K has been adjusted for the two-for-one stock split.

Our subsidiary, Kentucky Spirit Health Plan (KSHP), ceased serving members in Kentucky as of July 6, 2013. Accordingly, the results of operations for KSHP are classified as discontinued operations for all periods presented in our consolidated financial statements. The following discussion and analysis, with the exception of cash flow information, is presented in the context of continuing operations unless otherwise identified.

Our initial health plan commenced operations in Wisconsin in 1984. We were organized in Wisconsin in 1993 as a holding company for our initial health plan and reincorporated in Delaware in 2001. Our corporate office is located at 7700 Forsyth Boulevard, St. Louis, Missouri 63105, and our telephone number is (314) 725-4477. Our stock is publicly traded on the New York Stock Exchange under the ticker symbol “CNC.”

Table of Contents

INDUSTRY

We provide our services primarily through Medicaid, CHIP, LTC, Foster Care, ABD, Medicare and other state and federal programs for the uninsured. The federal Centers for Medicare and Medicaid Services, or CMS, estimated the total Medicaid and CHIP market was approximately $449 billion in 2013, and estimate the market will grow to $890 billion by 2024. According to the most recent information provided by the Kaiser Commission on Medicaid and the Uninsured, Medicaid spending increased by 13.9% in fiscal 2015 and states appropriated an increase of 6.9% for Medicaid in fiscal 2016 budgets.

Established in 1965, Medicaid is the largest publicly funded program in the United States, and provides health insurance to low-income families and individuals with disabilities. Authorized by Title XIX of the Social Security Act, Medicaid is an entitlement program funded jointly by the federal and state governments and administered by the states. The majority of funding is provided at the federal level. Each state establishes its own eligibility standards, benefit packages, payment rates and program administration within federal standards. As a result, there are 56 Medicaid programs - one for each U.S. state, each U.S. territory and the District of Columbia. Eligibility is based on a combination of household income and assets, often determined by an income level relative to the federal poverty level. Historically, children have represented the largest eligibility group. Many states have selected Medicaid managed care as a means of delivering quality healthcare and controlling costs. We refer to these states as mandated managed care states.

Established in 1972, and authorized by Title XVI of the Social Security Act, ABD covers low-income persons with chronic physical disabilities or behavioral health impairments. ABD beneficiaries represent a growing portion of all Medicaid recipients. In addition, ABD recipients typically utilize more services because of their critical health issues.

The Balanced Budget Act of 1997 created CHIP to help states expand coverage primarily to children whose families earned too much to qualify for Medicaid, yet not enough to afford private health insurance. Some states include the parents of these children in their CHIP programs. Costs related to the largest eligibility group, children, are primarily composed of pediatrics and family care. These costs tend to be more predictable than those associated with other healthcare issues which predominantly affect the adult population.

A portion of Medicaid beneficiaries are dual-eligible, low-income seniors and people with disabilities who are enrolled in both Medicaid and Medicare. According to the Kaiser Commission on Medicaid and the Uninsured, there were approximately 9.6 million dual-eligible enrollees in 2015. These dual-eligible members may receive assistance from Medicaid for Medicaid benefits, such as nursing home care and/or assistance with Medicare premiums and cost sharing. Dual-eligibles also use more services due to their tendency to have more chronic health issues. We serve dual-eligibles through our ABD, LTC and MMP programs and through Medicare Special Needs Plans.

While Medicaid programs have directed funds to many individuals who cannot afford or otherwise maintain health insurance coverage, they did not initially address the inefficient and costly manner in which the Medicaid population tends to access healthcare. Medicaid recipients in non-managed care programs typically have not sought preventive care or routine treatment for chronic conditions, such as asthma and diabetes. Rather, they have sought healthcare in hospital emergency rooms, which tends to be more expensive. As a result, many states have found that the costs of providing Medicaid benefits have increased while the medical outcomes for the recipients remained unsatisfactory.

We believe recognition of the value of managed care as a means of delivering improved health outcomes for Medicaid beneficiaries and effectively controlling costs will continue to strengthen. A growing number of states have mandated that their Medicaid recipients enroll in managed care plans. Other states are considering moving to a mandated managed care approach. As a result, we believe a significant market opportunity exists for managed care organizations with operations and programs focused on the distinct socio-economic, cultural and healthcare needs of the uninsured population and the Medicaid, CHIP, LTC, Foster Care and ABD populations.

In 2010, the Patient Protection and Affordable Care Act and the accompanying Health Care and Education Affordability Reconciliation Act collectively referred to as the Affordable Care Act (ACA), were enacted. While the constitutionality of the ACA was subsequently challenged in a number of legal actions, in June 2012, the Supreme Court upheld the constitutionality of the ACA, with one limited exception relating to the Medicaid expansion provision. The Supreme Court held that states could not be required to expand Medicaid and risk losing all federal money for their existing Medicaid programs. Under the ACA, Medicaid coverage was expanded to all individuals under age 65 with incomes up to 138% of the federal poverty level beginning January 1, 2014, subject to the states' elections. The federal government will pay the entire costs for Medicaid expansion coverage for newly eligible beneficiaries for three years, from 2014 through 2016. In 2017, the federal share declines to 95%; in 2018 it is 94%; in 2019 it is 93%; and it will be 90% in 2020 and subsequent years.

Table of Contents

Health Insurance Marketplaces are a key component of the ACA and provide an opportunity for individuals and small businesses to obtain health insurance. States have the option of operating their own Marketplace or partnering with the federal government. States choosing neither option will default to a federally-facilitated Marketplace. Premium and cost-sharing subsidies are available to make coverage more affordable and access to Marketplaces is limited to U.S. citizens and legal immigrants. Insurers are required to offer a minimum level of benefits with three levels of coverage that vary based on premiums and out-of-pocket costs. Premium subsidies are provided to families without access to other coverage and with incomes between 100-400% of the federal poverty level to help them purchase insurance through the Marketplaces. These subsidies are offered on a sliding scale basis.

OUR COMPETITIVE STRENGTHS

Our multi-national managed care approach is based on the following key attributes:


•	Strong Historic Operating Performance. We have increased revenues as we have grown in existing markets, expanded into new markets and broadened our product offerings. We entered the Wisconsin market in 1984 as a single health plan and have grown to serve 23 states. Our operating performance has been demonstrated by the following:



	2015		2014		% Change 2014 - 2015
Total membership (in millions)	5.1		4.1		26%
Premium and service revenues ($ in billions)	$	21.3	$	15.7	36%
Net earnings from continuing operations attributable to Centene Corporation	$	356	$	268	33%
Diluted earnings per share (EPS)	$	2.89	$	2.23	30%
Diluted EPS (excluding Health Net merger related expenses)	$	3.03	$	2.23	36%
Adjusted EBITDA¹	$	948	$	636	49%

¹Adjusted EBITDA represents net earnings attributable to Centene Corporation excluding income tax expense, interest expense, depreciation, amortization (excluding senior note premium amortization), stock compensation expense, and Health Net merger related expenses. A reconciliation of this non-GAAP measure follows ($ in millions):



	2015		2014
Net earnings from continuing operations attributable to Centene Corporation	$	356	$	268
Income tax expense	339		196
Interest expense	43		35
Depreciation and amortization	112		89
Non-cash stock compensation expense	71		48
Health Net merger related expenses	27		—
Adjusted EBITDA	$	948	$	636

For the year ended December 31, 2015, premium and service revenues of $21.3 billion have produced a five year Compound Annual Growth Rate (CAGR) of 38% and diluted earnings per share of $2.89 has produced a five year CAGR of 26%.

•

Innovative Technology and Scalable Systems. The ability to access data and translate it into meaningful information is essential to operating across a multi-state service area in a cost-effective manner. Our centralized information systems support our core processing functions under a set of integrated databases and are designed to be both replicable and scalable to accommodate organic growth and growth from acquisitions. We continue to enhance our systems in order to leverage the platform we have developed for our existing states for configuration into new states or health plan acquisitions. Our predictive modeling technology enables our medical management operations to proactively case and disease manage specific high risk members. It can recommend medical care opportunities using a mix of company defined algorithms and evidence based medical guidelines. Interventions are determined by the clinical indicators, the ability to improve health outcomes, and the risk profile of members. Our integrated approach helps to assure that consistent sources of claim and member information are provided across all of our health plans. Our membership and claims processing system is capable of expanding to support additional members in an efficient manner.


•	Expertise in Government Sponsored Programs. For more than 30 years, we have developed a specialized government services expertise that has helped us establish and maintain relationships with members, providers and state

Table of Contents

governments. We have implemented programs developed to achieve savings for state governments and improve medical outcomes for members by reducing inappropriate emergency room use, inpatient days and high cost interventions, as well as by managing care of chronic illnesses. We work with state agencies in order to maximize the effectiveness of their programs. Our approach is to accomplish this while maintaining adequate levels of provider compensation and protecting our profitability.

•

Diversified Business Lines. We continue to broaden our service offerings to address areas that we believe have been traditionally under-served by Medicaid managed care organizations. In addition to our Medicaid and Medicaid-related managed care services, our service offerings include behavioral health management, care management software, correctional healthcare services, dental benefits management, HIM, in-home health services, life and health management, managed vision, pharmacy benefits management, specialty pharmacy and telehealth services. We expect to further broaden our service offerings in 2016 through the acquisition of Health Net, which will add government-sponsored care under its federal contracts with the Department of Defense and the U.S. Department of Veterans Affairs (VA), as well as Medicare Advantage. Through the utilization of a multi-business line approach, we are able to improve the quality of care, improve outcomes, diversify our revenues and help control our medical costs.

•

Localized Approach with Centralized Support Infrastructure. We take a localized approach to managing our subsidiaries, including provider and member services. This approach enables us to facilitate access by our members to high quality, culturally sensitive healthcare services. Our systems and procedures have been designed to address these community-specific challenges through outreach, education, transportation and other member support activities. For example, our community outreach programs work with our members and their communities to promote health and self-improvement through education on how best to access care. We complement this localized approach with a centralized infrastructure of support functions such as finance, information systems and claims processing, which allows us to minimize general and administrative expenses and to integrate and realize synergies from acquisitions. We believe this combined approach allows us to efficiently integrate new business opportunities in both Medicaid and specialty services while maintaining our local accountability and improved access.

•

Quality and Innovation. Our innovative medical management programs focus on improving quality of care in areas that have the greatest impact on our members. We concentrate on serving the whole person to impact outcomes and costs. We recognize the importance of member-focused delivery of quality managed care services and have developed award winning education and outreach programs including the CentAccount program, Start Smart For Your Baby, and MemberConnections.

OUR BUSINESS STRATEGY

Our objective is to become the leading multi-national healthcare enterprise focusing on the uninsured and under-insured population through government sponsored healthcare initiatives. We intend to achieve this objective by implementing the following key components of our strategy:

•

Increase Penetration of Existing State Markets. We seek to continue to increase our Medicaid membership in states in which we currently operate through alliances with key providers, outreach efforts, development and implementation of community-specific products and acquisitions. For example, in 2015, we began operating under a contract with the Arizona Department of Health Services/Division of Behavioral Health Services to be the Regional Behavioral Health Authority for the new southern geographic service area.

•

Diversify Business Lines. We seek to broaden our business lines into areas that complement our existing business to enable us to grow and diversify our revenue. In 2015, we served managed care members in 23 states through over 200 product solutions. We are constantly evaluating new opportunities for expansion both domestically and abroad. For example, in 2015, we announced that we had entered into a definitive merger agreement with Health Net under which we will acquire all of the issued and outstanding shares of Health Net. In 2014, we acquired U.S. Medical Management, a management services organization and provider of in-home health services for high acuity populations. We employ a disciplined acquisition strategy that is based on defined criteria including internal rate of return, accretion to earnings per share, market leadership and compatibility with our information systems. We engage our executives in the relevant operational units or functional areas to ensure consistency between the diligence and integration process.


•	Address Emerging State Needs. We work to assist the states in which we operate in addressing the operating challenges they face. We seek to assist the states in balancing premium rates, benefit levels, member eligibility,

Table of Contents

policies and practices, provider compensation and minimizing fraud, waste, and abuse. By helping states structure an appropriate level and range of Medicaid, CHIP and specialty services, we seek to ensure that we are able to continue to provide those services on terms that achieve targeted gross margins, provide an acceptable return and grow our business.

•

Develop and Acquire Additional Markets. We continue to leverage our experience to identify and develop new domestic and international markets by seeking both to acquire existing business and to build our own operations. Domestically, we focus expansion in states where Medicaid recipients are mandated to enroll in managed care organizations because we believe member enrollment levels are more predictable in these states. In addition, we focus on states where managed care programs can help address states' financial needs. In 2014, we entered the international market with our investment in Ribera Salud, a Spanish health management group. In 2015, we began managing care for Medicaid members in Oregon and also began managing care for members who are dually eligible for Medicare and Medicaid in Michigan.

•

Leverage Established Infrastructure to Enhance Operating Efficiencies. We intend to continue to invest in infrastructure to further drive efficiencies in operations and to add functionality to improve the service provided to members and other organizations at a low cost. Information technology, or IT, investments complement our overall efficiency goals by increasing the automated processing of transactions and growing the base of decision-making analytical tools. Our centralized functions and common systems enable us to add members and markets quickly and economically.

•

Maintain Operational Discipline. We seek to operate in markets that allow us to meet our internal metrics including membership growth, plan size, market leadership and operating efficiency. We use multiple techniques to monitor and reduce our medical costs, including on-site hospital review by staff nurses and involvement of medical management in significant cases. Our executive dashboard is utilized to quickly identify cost drivers and medical trends. Our management team regularly evaluates the financial impact of proposed changes in provider relationships, contracts, changes in membership and mix of members, potential state rate changes and cost reduction initiatives. We may divest contracts or health plans in markets where the state's Medicaid environment, over a long term basis, does not allow us to meet our targeted performance levels. For example, as a result of lower than anticipated financial performance, in July 2013, we terminated our Kentucky Medicaid managed care contract with the Commonwealth of Kentucky.

Table of Contents

We have subsidiaries offering healthcare services in each state we serve. The table below provides summary data for the state markets we currently serve¹:



State	Primary Local Plan Name	First Year of Operations Under Centene	Managed Care Membership at December 31, 2015
Arizona	Bridgeway Health Solutions	2006	6,900
Arizona	Cenpatico Integrated Care	2005	434,000
Arkansas	Arkansas Health and Wellness Solutions	2014	41,900
California	California Health and Wellness	2013	186,000
Florida	Sunshine State Health Plan	2009	510,400
Georgia	Peach State Health Plan	2006	408,600
Illinois	IlliniCare Health	2011	207,500
Indiana	Managed Health Services	1995	282,100
Kansas	Sunflower Health Plan	2013	141,000
Louisiana	Louisiana Healthcare Connections	2012	381,900
Massachusetts	CeltiCare Health	2009	51,300
Massachusetts	Massachusetts Partnership for Correctional Healthcare	2013	10,200
Michigan	Fidelis SecureCare of Michigan	2015	4,800
Minnesota	Centurion of Minnesota	2014	9,600
Mississippi	Magnolia Health	2011	284,400
Mississippi	Centurion of Mississippi	2015	17,800
Missouri	Home State Health	2012	95,100
New Hampshire	New Hampshire Healthy Families	2013	71,400
Ohio	Buckeye Health Plan	2004	302,700
Oregon	Trillium Community Health Plan	2015	98,700
South Carolina	Absolute Total Care	2007	104,000
Tennessee	Centurion of Tennessee	2013	20,000
Texas	Superior HealthPlan	1999	983,100
Vermont	Centurion of Vermont	2015	1,700
Washington	Coordinated Care	2012	209,400
Wisconsin	MHS Health Wisconsin	1984	77,100
Total at-risk membership			4,941,600
Non-risk membership			166,300
Total			5,107,900

¹Table includes members served in each our states through our government sponsored programs, Health Insurance Marketplaces, and

correctional healthcare services.

Substantially all of our revenue is derived from operations within the United States and its territories, and all of the Company's long lived assets are based in the United States and its territories. We generally receive a fixed premium per member per month pursuant to our state contracts. Our medical costs have a seasonality component due to cyclical illness, for example cold and flu season, resulting in higher medical expenses beginning in the fourth quarter and continuing throughout the first quarter of the following year. Our managed care subsidiaries in Texas and Florida had revenues from their respective state governments that each exceeded 10% of our consolidated total revenues in 2015.

Table of Contents

MANAGED CARE

Benefits to States

Our ability to establish and maintain a leadership position in the markets we serve results primarily from our demonstrated success in providing quality care while reducing and managing costs, and from our specialized programs in working with state governments. Among the benefits we are able to provide to the states with which we contract are:

•

Significant cost savings and budget predictability compared to state paid reimbursement for services. We bring experience relating to quality of care improvement methods, utilization management procedures, an efficient claims payment system, and provider performance reporting, as well as managers and staff experienced in using these key elements to improve the quality of and access to care. We generally receive a contracted premium on a per member basis and are responsible for the medical costs and as a result, provide budget predictability.

•

Data-driven approaches to balance cost and verify eligibility. We seek to ensure effective outreach procedures for new members, then educate them and ensure they receive needed services as quickly as possible. Our IT department has created mapping/translation programs for loading membership and linking membership eligibility status to all of Centene's subsystems. We utilize predictive modeling technology to proactively case and disease manage specific high risk members. In addition, we have developed Centelligence, our enterprise data warehouse system to provide a seamless flow of data across our organization, enabling providers and case managers to access information, apply analytical insight and make informed decisions.


•	Establishment of realistic and meaningful expectations for quality deliverables. We have collaborated with state agencies in redefining benefits, eligibility requirements and provider fee schedules with the goal of maximizing the number of individuals covered through Medicaid.

•

Managed care expertise in government subsidized programs. Our expertise in Medicaid has helped us establish and maintain strong relationships with our constituent communities of members, providers and state governments. We provide access to services through local providers and staff that focus on the cultural norms of their individual communities. To that end, systems and procedures have been designed to address community-specific challenges through outreach, education, transportation and other member support activities.


•	Improved quality and medical outcomes. We have implemented programs developed to improve the quality of healthcare delivered to our members including Start Smart for your Baby, Living Well With Sickle Cell and The CentAccount Program.


•	Timely payment of provider claims. We are committed to ensuring that our information systems and claims payment systems meet or exceed state requirements. We continuously endeavor to update our systems and processes to improve the timeliness of our provider payments.

•

Provider outreach and programs. Our health plans have adopted a physician-driven approach where network providers are actively engaged in developing and implementing healthcare delivery policies and strategies. We prepare provider comparisons on a severity adjusted basis. This approach is designed to eliminate unnecessary costs, improve services to members and simplify the administrative burdens placed on providers.

•

Care management for complex populations. Through our experience with Medicaid populations and long-time presence in states with experience in long term care for children and adolescents in the foster care system, we have developed care management, service coordination and crisis prevention/response programs that increase opportunities for successful outcomes for members. This experience has led to partnerships with specialized networks and community advocates as states transition to managed care programs for vulnerable and complex populations.

•

Responsible collection and dissemination of utilization data. We gather utilization data from multiple sources, allowing for an integrated view of our members' utilization of services. These sources include medical, vision and behavioral health claims and encounter data, pharmacy data, dental vendor claims and authorization data from the authorization and case management system utilized by us to coordinate care.

Table of Contents


•	Timely and accurate reporting. Our information systems have reporting capabilities which have been instrumental in identifying the need for new and/or improved healthcare and specialty programs. For state agencies, our reporting capability is important in demonstrating an auditable program.


•	Fraud, waste and abuse prevention. We have several systems in place to help identify, detect and investigate potential waste, abuse and fraud including pre and post payment review software. We collaborate with state and federal agencies and assist with investigation requests. We use nationally recognized standards to benchmark our processes.

Member Programs and Services

We recognize the importance of member-focused delivery of quality managed care services. Our locally-based staff assists members in accessing care, coordinating referrals to related health and social services and addressing member concerns and questions. While covered healthcare benefits vary from state to state, our health plans generally provide the following services:


•	primary and specialty physician care


•	inpatient and outpatient hospital care


•	emergency and urgent care


•	prenatal care


•	laboratory and x-ray services


•	home health and durable medical equipment


•	behavioral health and substance abuse services


•	24-hour nurse advice line


•	transportation assistance


•	vision care


•	dental care


•	immunizations


•	prescriptions and limited over-the-counter drugs


•	specialty pharmacy


•	therapies


•	social work services


•	care coordination

We also provide the following education and outreach programs to inform, assist and incentivize members in accessing quality, appropriate healthcare services in an efficient manner. Many of these programs have been recognized with awards for their excellence in education, outreach and/or case management techniques including Case In Point, Hermes Awards, U.S. Environmental Protection Agency and National Health Information Awards.

•

Start Smart For Your Baby, or Start Smart, is our award winning prenatal and infant health program designed to increase the percentage of pregnant women receiving early prenatal care, reduce the incidence of low birth weight babies, identify high-risk pregnancies, increase participation in the federal Women, Infant and Children program, prevent hospital admissions in the first year of life and increase well-child visits.


•	Connections Plus is a cell phone program developed for high-risk members who have limited or no access to a safe, reliable telephone. This program seeks to eliminate lack of safe, reliable access to a telephone as a barrier to coordinating care, thus reducing avoidable adverse events such as inappropriate emergency room utilization, hospital admissions and premature birth.


•	MemberConnections is a community face-to-face outreach and education program designed to create a link between the member and the provider and help identify potential challenges or risk elements to a member's health, such as nutritional challenges and health education shortcomings.

•

The ScriptAssist for Hepatitis C Adherence Program seeks to empower patients towards Hepatitis C virus treatment success through a series of telephonic interventions. Goals of the program include preventing premature treatment discontinuation due to medication side effects and access to therapy. NurseWise clinicians and AcariaHealth patient care coordinators collaborate throughout a patient’s treatment course to ensure appropriate therapy management and regimen access.


•	Health Initiatives for Children is aimed at educating child members on a variety of health topics. In order to empower and educate children, we have partnered with a nationally recognized children's author to develop our own children's book series on topics such as obesity prevention and healthy eating, asthma, diabetes, foster care, the ills of smoking, anti-bullying and heart health.


•	Health Initiatives for Teens is aimed at empowering, educating and reinforcing life skills with our teenage members. We have developed an educational series that addresses health issues, dealing with chronic diseases including diabetes and asthma, as well as teen pregnancy.

Table of Contents


•	Living Well with Sickle Cell is our innovative program that assists with coordination of care for our sickle cell members. Our program ensures that sickle cell members have established a medical home and work on strategies to reduce unnecessary emergency room visits through proper treatment to control symptoms and chronic complications, as well as promote self-management.


•	My Route for Health is our adult educational series used with our case management and disease management programs. The topics of this series include how to manage asthma, COPD, diabetes, heart disease and HIV.


•	Diabetes Program is an innovative program that is a collaboration with our life and health management subsidiary and our health plans that targets diabetic patients and educates them on their disease state.

•

Community Health Record, our patient-centric electronic database, collects patient demographic data, clinician visit records, dispensed medications, vital sign history, lab results, allergy charts, and immunization data. Providers can directly input additional or updated patient data and documentation into the database. All information is accessible anywhere, anytime to all authorized users, including health plan staff, greatly facilitating coordinated care among providers.


•	The CentAccount Program offers members financial incentives for performing certain healthy behaviors. The incentives are delivered through a restricted-use prepaid debit card. This incentive-based approach effectively increases the utilization of preventive services while strengthening the relationships between members and their primary care providers.

•

The Asthma Management Program integrates a hands-on approach with a flexible outreach methodology that can be customized to suit different age groups and populations affected by asthma. We provide proactive identification of members, stratification into appropriate levels of intervention including home visits, culturally sensitive education, and robust outcome reporting. The program also includes aggressive care coordination to ensure patients have basic services such as transportation to the doctor, electricity to power the nebulizer, and a clean, safe home environment.


•	Fluvention is an outreach program aimed at educating members on preventing the transmission of the influenza virus by encouraging members to get the seasonal influenza vaccines and take everyday precautions to prevent illness.


•	Preventive Care Programs are designed to educate our members on the benefits of Early and Periodic Screening, Diagnosis and Treatment, or EPSDT, services. We have a systematic program of communicating, tracking, outreach, reporting and follow-through that promotes state EPSDT programs.

Providers

For each of our service areas, we establish a provider network consisting of primary and specialty care physicians, hospitals and ancillary providers. Our network of primary care physicians is a critical component in care delivery, management of costs and the attraction and retention of new members. Primary care physicians include family and general practitioners, pediatricians, internal medicine physicians and obstetricians and gynecologists. Specialty care physicians provide medical care to members generally upon referral by the primary care physicians. Specialty care physicians include, but are not limited to, orthopedic surgeons, cardiologists and otolaryngologists. We also provide education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services.

Our health plans facilitate access to healthcare services for our members primarily through contracts with our providers. Our contracts with primary and specialty care physicians and hospitals usually are for one to two-year periods and renew automatically for successive one-year terms, but generally are subject to termination by either party upon 90 to 120 days prior written notice. In the absence of a contract, we typically pay providers at state Medicaid reimbursement levels. We pay hospitals under a variety of methods, including fee-for-service, capitation arrangements, per diems, diagnostic related grouping and case rates. We pay physicians under a fee-for-service, capitation arrangement, or risk-sharing performance-based arrangement. In addition, we are governed by state prompt payment policies.

•

Under our fee-for-service contracts with physicians, particularly specialty care physicians, we pay a negotiated fee for covered services. This model is characterized as having no financial risk for the physician. In addition, this model requires management oversight because our total cost may increase as the units of services increase or as more expensive services replace less expensive services. We have prior authorization procedures in place that are intended to make sure that certain high cost diagnostic and other services are medically appropriate.

Table of Contents

•

Under our capitated contracts, primary care physicians are paid a monthly fee for each of our members assigned to his or her practice for all ambulatory care. In return for this payment, these physicians provide all primary care and preventive services, including primary care office visits and EPSDT services, and are at risk for all costs associated with such services. If these physicians also provide non-capitated services to their assigned members, they may receive payment under fee-for-service arrangements at standard Medicaid rates.


•	Under risk-sharing performance-based arrangements, physicians are paid under a capitated or fee-for-service arrangement. The arrangement, however, contains provisions for additional bonus to the physicians or reimbursement from the physicians based upon cost and quality measures.

We work with physicians to help them operate efficiently by providing financial and utilization information, physician and patient educational programs and disease and medical management programs. Our programs are also designed to help the physicians coordinate care outside of their offices.

We believe our local and collaborative approach with physicians and other providers gives us a competitive advantage in entering new markets. Our physicians serve on local committees that assist us in implementing preventive care programs, managing costs and improving the overall quality of care delivered to our members, while also simplifying the administrative burdens on our providers. This approach has enabled us to strengthen our provider networks through improved physician recruitment and retention that, in turn, have helped to increase our membership base. The following are among the services we provide to support physicians:

•

Customized Utilization Reports provide certain of our contracted physicians with information that enables them to run their practices more efficiently and focuses them on specific patient needs. For example, quarterly detail reports update physicians on their status within their risk pools. Equivalency reports provide physicians with financial comparisons of capitated versus fee-for-service arrangements.


•	Case Management Support helps the physician coordinate specialty care and ancillary services for patients with complex conditions and direct members to appropriate community resources to address both their health and socio-economic needs.


•	Web-based Claims and Eligibility Resources have been implemented to provide physicians with on-line access to perform claims and eligibility inquiries.

Our contracted physicians also benefit from several of the services offered to our members, including the MemberConnections, EPSDT case management and health management programs. For example, the MemberConnections staff facilitates doctor/patient relationships by connecting members with physicians, the EPSDT programs encourage routine checkups for children with their physicians and the health management programs assist physicians in managing their patients with chronic disease.

Where appropriate, our health plans contract with our specialty services organizations to provide services and programs such as behavioral health management, care management software, dental benefits management, in-home health services, life and health management, managed vision, pharmacy benefits management, specialty pharmacy and telehealth services. When necessary, we also contract with third-party providers on a negotiated fee arrangement for physical therapy, home healthcare, dental, diagnostic laboratory tests, x-ray examinations, transportation, ambulance services and durable medical equipment.

Quality Management

Our medical management programs focus on improving quality of care in areas that have the greatest impact on our members. We employ strategies, including health management and complex case management, that are adjusted for implementation in our individual markets by a system of physician committees chaired by local physician leaders. This process promotes physician participation and support, both critical factors in the success of any clinical quality improvement program.

We have implemented specialized information systems to support our medical quality management activities. Information is drawn from our data warehouse, clinical databases and our membership and claims processing system to identify opportunities to improve care and to track the outcomes of the interventions implemented to achieve those improvements. Some examples of these intervention programs include:


•	appropriate leveling of care for neonatal intensive care unit hospital admissions, other inpatient hospital admissions, and observation admissions, in accordance with Interqual criteria

Table of Contents


•	tightening of our pre-authorization list and more stringent review of durable medical equipment and injectibles


•	Emergency room program designed to collaboratively work with hospitals to steer non-emergency care away from the costly emergency room setting (through patient education, on-site alternative urgent care settings, etc.)


•	increase emphasis on case management and clinical rounding where case managers are nurses or social workers who are employed by the health plan to assist selected members with the coordination of healthcare services in order to meet a member's specific healthcare needs


•	incorporation of disease management, which is a comprehensive, multidisciplinary, collaborative approach to chronic illnesses such as asthma and diabetes


•	Start Smart For Your Baby, a prenatal case management program aimed at helping women with high-risk pregnancies deliver full-term, healthy infants


•	Pharmacy treatment compliance programs are driven by clinical policy and focus on identifying the appropriate medication in the correct dose, delivered in an efficient format and utilized for the correct duration.

We provide reporting on a regular basis using our data warehouse. State and Health Employer Data and Information Set, or HEDIS, reporting constitutes the core of the information base that drives our clinical quality performance efforts. This reporting is monitored by Plan Quality Improvement Committees and our corporate medical management team.

In an effort to ensure the quality of our provider networks, we undertake to verify the credentials and background of our providers using standards that are supported by the National Committee for Quality Assurance, or NCQA.

It is our objective to provide access to the highest quality of care for our members. As a validation of that objective, we often pursue accreditation by independent organizations that have been established to promote healthcare quality. The NCQA Health Plan Accreditation and URAC Health Plan Accreditation programs provide unbiased, third party reviews to verify and publicly report results on specific quality care metrics. While we have achieved or are pursuing accreditation for all of our plans, accreditation is only one measure of our ability to provide access to quality care for our members. We currently have 17 of 19 eligible health plans with NCQA accreditation.

SPECIALTY SERVICES

Our specialty services are a key component of our healthcare strategy and complement our core Managed Care business. Specialty services diversify our revenue stream, provide higher quality health outcomes to our membership and others, and assist in controlling costs. Our specialty services are provided primarily through the following businesses:

•

Pharmacy Solutions. US Script is rebranding and will be transitioning to Envolve Pharmacy Solutions. Envolve Pharmacy Solutions will utilize innovative, flexible solutions and customized care management. Under the new brand, we will continue to offer traditional pharmacy benefits management as well as comprehensive specialized pharmacy benefit services through our specialty pharmacy, AcariaHealth. Our traditional pharmacy benefits management program offers progressive pharmacy benefits management services that are specifically designed to improve quality of care while containing costs. This is achieved through a low cost strategy that helps optimize clients' pharmacy benefits. Services include claims processing, pharmacy network management, benefit design consultation, drug utilization review, formulary and rebate management, online drug management tools, mail order pharmacy services, home delivery services, analytics and clinical consulting and patient and physician intervention. AcariaHealth offers specialized care management services for complex diseases and enhances the patient care offering through collaboration with providers and the capture of relevant data to measure patient outcomes.

Table of Contents

•

Health, Triage, Wellness, and Disease Management Services companies are rebranding and will transition to Envolve PeopleCare. Envolve PeopleCare will bring together our behavioral health, nurse advice, telehealth, and health, wellness and disease guidance programs, allowing for a focus on individual health management through education and empowerment. Our networks feature a full range of services and levels of care to help people with mental illness reach their recovery and wellness goals. Our life and health management programs specialize in encouraging healthy behaviors, promote healthier workplaces, improve workforce and societal productivity and reduce healthcare costs. Health risk appraisals, biometric screenings, interactive wellness programs, disease management and work-life/employee assistance services are areas of focus. We utilize telephonic health and work/life balance coaching, in-home and online interaction and informatics processes to deliver effective clinical outcomes, enhanced patient-provider satisfaction and lower overall healthcare cost. We offer telehealth services where members reach bilingual customer service representatives and nursing staff who provide health education, triage advice and offer continuous access to health plan functions. Our staff can arrange for urgent pharmacy refills, transportation and qualified behavioral health professionals for crisis stabilization assessments.


•	Vision Services. Opticare Managed Vision is rebranding and will transition to Envolve Vision. Under the new name, we will continue to coordinate benefits beyond traditional medical benefits to offer fully integrated vision health services. Our vision benefit administers routine and medical surgical eye care benefits via a contracted national network of eye care providers.


•	Dental Services. Dental Health & Wellness is rebranding and will transition to Envolve Dental. We will continue to coordinate benefits beyond traditional medical benefits to offer fully integrated dental health services. Through the dental benefit, we are dedicated to improving oral health through a contracted network of dental healthcare providers.


•	Care Management Software. Casenet is a software provider of innovative care management solutions that automate the clinical, administrative and technical components of care management programs, which is available for sale to third parties and used by our health plans.


•	Correctional Healthcare Services. Centurion, our joint venture subsidiary with MHM Services Inc., provides comprehensive healthcare services to individuals incarcerated in Massachusetts, Minnesota, Mississippi, Tennessee and Vermont state correctional facilities. In 2016, we expect to begin providing healthcare services to individuals incarcerated in Florida.


•	In-Home Health Services. U.S. Medical Management, our majority owned subsidiary acquired in January 2014, provides in-home health services for high acuity populations.


•	Integrated Long-Term Care. LifeShare provides home and community-based support for people with developmental disabilities, children in the child welfare system and people of all ages and abilities, with a focus on those that are often marginalized by society. In addition, LifeShare operates school-based programs that focus on students with special needs.

The NCQA and URAC also provide accreditation and certification for our specialty companies. We currently have four specialty companies with NCQA accreditation or certification and five specialty companies with URAC accreditation.

CORPORATE COMPLIANCE

Our Corporate Ethics and Compliance Program provides controls by which we assure that our values are reflected in everything we do, further enhancing operations, improving access to quality care and safeguarding against fraud, waste and abuse.

Three standards by which corporate compliance programs in the healthcare industry are measured are the Federal Organizational Sentencing Guidelines, the Centers for Medicare and Medicaid Services Chapter Guidance and Compliance Program Guidance series issued by the Department of Health and Human Services' Office of the Inspector General, or OIG. Our program contains each of the seven elements suggested by the Sentencing Guidelines and the OIG guidance. These key components are:


•	written standards of conduct


•	designation of a corporate compliance officer and compliance committee


•	effective training and education

Table of Contents


•	effective lines for reporting and communication


•	enforcement of standards through well publicized disciplinary guidelines and actions


•	internal monitoring and auditing


•	prompt response to detected offenses and development of corrective action plans

The goal of the program is to build a culture of ethics and compliance, which is assessed periodically using a diagnostic survey to measure the integrity of the organization. Our internal Corporate Compliance intranet site, accessible to all employees, contains our Business Ethics and Conduct Policy (Code of Conduct), Compliance Program description and resources for employees to report concerns or ask questions. If needed, employees have access to the contact information for the members of our Board of Directors' Audit Committee to report concerns. Our Ethics and Compliance Helpline is a toll-free number and web-based reporting tool operated by a third party independent of the Company and allows employees or other persons to report suspected incidents of misconduct, fraud, waste, abuse or other compliance violations anonymously. Furthermore, the Board of Directors reviews an ethics and compliance report on a quarterly basis.

COMPETITION

We continue to face varying and increasing levels of competition as we expand in our existing service areas or enter new markets. Federal regulations require at least two competitors in each service area. Healthcare reform may cause a number of commercial managed care organizations to decide to enter or exit the various managed care markets.

In our business, our principal competitors for state contracts, members and providers consist of the following types of organizations:


•	Medicaid Managed Care Organizations focus on providing healthcare services to Medicaid recipients. These organizations consist of national and regional organizations, as well as not-for-profits and smaller organizations that operate in one city or state and are owned by providers, primarily hospitals.


•	National and Regional Commercial Managed Care Organizations have Medicaid members in addition to members in private commercial plans. Some of these organizations offer a range of specialty services including pharmacy benefits management, behavioral health management, health management, and nurse triage call support centers.


•	Primary Care Case Management Programs are programs established by the states through contracts with primary care providers. Under these programs, physicians provide primary care services to Medicaid recipients, as well as limited medical management oversight.


•	Accountable Care Organizations are groups of doctors, hospitals, and other health care providers, who come together to give coordinated high quality care to their patients.

We compete with other managed care organizations and specialty companies for state contracts. In order to grant a contract, state governments consider many factors. These factors include quality of care, financial requirements, an ability to deliver services and establish provider networks and infrastructure. In addition, our specialty companies also compete with other providers, such as disease management companies, individual health insurance companies, and pharmacy benefits managers for non-governmental contracts.

We also compete to enroll new members and retain existing members. People who wish to enroll in a managed healthcare plan or to change healthcare plans typically choose a plan based on the quality of care and services offered, ease of access to services, a specific provider being part of the network and the availability of supplemental benefits.

We also compete with other managed care organizations to enter into contracts with physicians, physician groups and other providers. We believe the factors that providers consider in deciding whether to contract with us include existing and potential member volume, reimbursement rates, medical management programs, speed of reimbursement and administrative service capabilities. See “Risk Factors - Competition may limit our ability to increase penetration of the markets that we serve.”

REGULATION

Our operations are regulated at both state and federal levels. Government regulation of the provision of healthcare products and services is a changing area of law that varies from jurisdiction to jurisdiction. Regulatory agencies generally have discretion to issue regulations and interpret and enforce laws and rules. Changes in applicable laws and rules also may occur periodically.

Table of Contents

Our regulated subsidiaries are licensed to operate as health maintenance organizations (HMOs), third party administrators, utilization review organizations, pharmacies, direct care providers and/or insurance companies in their respective states. In each of the jurisdictions in which we operate, we are regulated by the relevant insurance, health and/or human services departments, departments of insurance, boards of pharmacy and other health care providers, and departments of health that oversee the activities of managed care organizations providing or arranging to provide services to Medicaid, Medicare and Health Insurance Marketplace commercial enrollees.

The process for obtaining authorization to operate as a managed care organization and provider organizations is complex and requires us to demonstrate to the regulators the adequacy of the health plan's organizational structure, financial resources, utilization review, quality assurance programs, complaint procedures, provider network and procedures for covering emergency medical conditions. Under both state managed care organization statutes and insurance laws, our health plan subsidiaries, as well as our applicable specialty companies, must comply with minimum statutory capital and other financial solvency requirements, such as deposit and surplus requirements. Insurance regulations may also require prior state approval of acquisitions of other managed care organization businesses and the payment of dividends, as well as notice for loans or the transfer of funds. Our subsidiaries are also subject to periodic state and federal reporting requirements. In addition, each health plan and individual health care provider must meet criteria to secure the approval of state regulatory authorities before implementing operational changes, including the development of new product offerings and, in some states, the expansion of service areas.

States have adopted a number of regulations that may affect our business and results of operations. These regulations in certain states include:


•	premium taxes or similar assessments


•	stringent prompt payment laws


•	disclosure requirements regarding provider fee schedules and coding procedures


•	programs to monitor and supervise the activities and financial solvency of provider groups

We are regulated as an insurance holding company and are subject to the insurance holding company acts of the states in which our insurance company and HMO subsidiaries are domiciled. These acts contain certain reporting requirements as well as restrictions on transactions between an insurer or HMO and its affiliates. These holding company laws and regulations generally require insurance companies and HMOs within an insurance holding company system to register with the insurance department of each state where they are domiciled and to file with those states' insurance departments reports describing capital structure, ownership, financial condition, intercompany transactions and general business operations. In addition, depending on the size and nature of the transaction, there are various notice and reporting requirements that generally apply to transactions between insurance companies and HMOs and their affiliates within an insurance holding company structure. Some insurance holding company laws and regulations require prior regulatory approval or, in certain circumstances, prior notice of certain material intercompany transfers of assets as well as certain transactions between insurance companies, HMOs, their parent holding companies and affiliates. Among other provisions, state insurance and HMO laws may restrict the ability of our regulated subsidiaries to pay dividends.

Additionally, the holding company acts of the states in which our subsidiaries are domiciled restrict the ability of any person to obtain control of an insurance company or HMO without prior regulatory approval. Under those statutes, without such approval or an exemption, no person may acquire any voting security of an insurance holding company, which controls an insurance company or HMO, or merge with such a holding company, if as a result of such transaction such person would “control” the insurance holding company. “Control” is generally defined as the direct or indirect power to direct or cause the direction of the management and policies of a company and is presumed to exist if a person directly or indirectly owns or controls 10% or more of the voting securities of a company.

Our pharmacies must be licensed to do business as pharmacies in the states in which they are located. Our pharmacies must also register with the U.S. Drug Enforcement Administration and individual state controlled substance authorities to dispense controlled substances. In many of the states where our pharmacies deliver pharmaceuticals, there are laws and regulations that require out-of-state mail order pharmacies to register with that state’s board of pharmacy or similar regulatory body. These states generally permit the pharmacy to follow the laws of the state in which the mail order pharmacy is located, although some states require that we also comply with certain laws in that state.

Table of Contents

Our health care providers must be licensed to practice medicine and do business as care providers in the state in which they are located. In addition, they must be in good standing with the applicable medical board, board of nursing or other applicable entity. Furthermore, they cannot be excluded from participation at both the state and federal levels. Our facilities are periodically reviewed by state departments of health and other regulatory agencies to ensure the environment is safe to provide care.

State and Federal Contracts

In addition to being a licensed insurance company or HMO, in order to be a Medicaid managed care organization in each of the states in which we operate, we must operate under a contract with the state's Medicaid agency. States generally use either a formal proposal process, reviewing a number of bidders, or award individual contracts to qualified applicants that apply for entry to the program. We receive monthly payments based on specified capitation rates determined on an actuarial basis. These rates differ by membership category and by state depending on the specific benefits and policies adopted by each state. In addition, several of our Medicaid contracts require us to maintain Medicare Advantage special needs plans, which are regulated by CMS, for dual eligible individuals. We also contract with states to provide healthcare services to correctional facilities.

Our state and federal contracts and the regulatory provisions applicable to us generally set forth the requirements for operating in the Medicaid and Medicare sectors, including provisions relating to:


•	eligibility, enrollment and dis-enrollment processes


•	covered services


•	eligible providers


•	subcontractors


•	record-keeping and record retention


•	periodic financial and informational reporting


•	quality assurance


•	accreditation


•	health education and wellness and prevention programs


•	timeliness of claims payment


•	financial standards


•	safeguarding of member information


•	fraud, waste and abuse detection and reporting


•	grievance procedures


•	organization and administrative systems

A health plan or individual health insurance provider's compliance with these requirements is subject to monitoring by state regulators and by CMS. A health plan is also subject to periodic comprehensive quality assurance evaluations by a third-party reviewing organization and generally by the insurance department of the jurisdiction that licenses the health plan. A health plan or individual health insurance provider must also submit reports to various regulatory agencies, including quarterly and annual statutory financial statements and utilization reports.

The table below sets forth the terms of our contracts and provides details regarding related renewal or extension and termination provisions. The contracts are subject to termination for cause, an event of default or lack of funding.



Contract	Expiration Date	Renewal or Extension

Arizona - Behavioral Health	September 30, 2018	Renewable for two additional two-year terms.
Arizona - LTC	September 30, 2016	Renewable for one additional one-year term.
Arizona - Special Needs Plan (Medicare)	December 31, 2016	Renewable annually for successive 12-month periods.
Arkansas - Medicaid Expansion	December 31, 2016	Renewable annually for successive 12-month periods.
California - Medicaid & ABD	October 31, 2018	Renewable up to three additional one-year terms.
Florida - Medicaid, ABD, LTC & Foster Care	December 31, 2018	Renewable through the state's recertification process.
Florida - CHIP	September 30, 2017	May be extended for two additional one-year terms.

Table of Contents



Florida - Special Needs Plan (Medicare)	December 31, 2016	Renewable annually for successive 12-month periods.
Florida - Special Needs Plan (Medicaid)	December 31, 2017	Renewable through the state's recertification process.
Georgia - Medicaid & CHIP	June 30, 2016	RFP awarded for an initial one-year term to begin July 1, 2016 and renewable for five additional one-year terms. The expiration date of the current contract may be extended for up to two six-month periods, subject to CMS approval.
Georgia - Special Needs Plan (Medicare)	December 31, 2016	Renewable annually for successive 12-month periods.
Illinois - ABD & LTC	April 30, 2016	May be extended for up to five additional years.
Illinois - Duals	December 31, 2016	Renewable for one additional one-year term.
Illinois - Medicaid	June 30, 2019	May be extended for up to five additional years.
Indiana - ABD	March 31, 2019	May be extended for two additional one-year terms.
Indiana - Medicaid, CHIP & Hybrid (Healthy Indiana Plan)	December 31, 2016	Renewable for one additional one-year term.
Kansas - Medicaid, ABD, CHIP, LTC & Foster Care	December 31, 2017	Renewable through the state's reprocurement process.
Louisiana - Medicaid, CHIP, ABD, Foster Care & Behavioral Health	January 31, 2018	May be extended for up to two additional one-year terms.
Massachusetts - Correctional Healthcare Services	June 30, 2018	Renewable for two additional two-year terms.
Massachusetts - Medicaid	September 30, 2016	May be extended for five additional one-year terms.
Michigan - Duals	December 31, 2017	Renewable through the state's reprocurement process.
Minnesota - Correctional Healthcare Services	June 30, 2018	Renewable through the state's reprocurement process.
Mississippi - Medicaid, ABD & Foster Care	June 30, 2017	May be extended for up to two additional one-year terms.
Mississippi - CHIP	June 30, 2017	May be extended for up to two additional one-year terms.
Mississippi - Correctional Healthcare Services	June 30, 2016	Renewable through the state's reprocurement process.
Missouri - Medicaid, CHIP & Foster Care	June 30, 2016	Renewable for two additional one-year terms.
New Hampshire - Medicaid, CHIP, Foster Care & ABD	June 30, 2016	Renewable for one additional two-year term.
New Hampshire - Medicaid Expansion	December 31, 2016	Program is expected to end on December 31, 2016. The majority of members converted to Health Insurance Marketplace effective January 1, 2016.
Ohio - Duals	December 31, 2016	Renewable for one additional one-year term.

Table of Contents



Ohio - Medicaid, CHIP & ABD	June 30, 2016	Renewable annually for successive 12-month periods.
Ohio - Special Needs Plan (Medicare)	December 31, 2016	Renewable annually for successive 12-month periods.
Oregon - Medicaid, Medicaid Expansion, ABD, CHIP & Foster Care	December 31, 2018	Renewable through the state's reprocurement process.
Oregon - Medicare Advantage HMO (Includes Special Needs Plan)	December 31, 2016	Renewable annually for successive 12-month periods.
Oregon - Medicare Advantage PPO	December 31, 2016	Renewable annually for successive 12-month periods.
South Carolina - Medicaid & ABD	June 30, 2016	Renewable through the state's recertification process.
South Carolina - Duals	December 31, 2016	Renewable for one additional one-year term.
Tennessee - Correctional Healthcare Services	August 31, 2016	Renewable through the state's reprocurement process.
Texas - ABD Dallas Expansion	August 31, 2018	Renewable through the state's reprocurement process.
Texas - ABD MRSA	August 31, 2017	May be extended for up to five additional years.
Texas - CHIP Rural Service Area	August 31, 2018	Renewable through the state's reprocurement process.
Texas - Foster Care	August 31, 2018	May be extended for up to five additional years.
Texas - Medicaid, CHIP & ABD	August 31, 2018	May be extended for up to one and a half additional years.
Texas - Duals	December 31, 2016	Renewable for two additional one-year terms.
Texas - Special Needs Plan (Medicare)	December 31, 2016	Renewable annually for successive 12-month periods.
Vermont - Correctional Healthcare Services	January 31, 2018	May be extended for up to two additional one-year terms.
Washington - Medicaid, CHIP, Foster Care & ABD	December 31, 2016	Renewable through the state's recertification process.
Wisconsin - Medicaid, CHIP & ABD	December 31, 2017	Renewable through the state's recertification process every two years.
Wisconsin - Network Health Plan Subcontract	December 31, 2017	Renews automatically for successive three-year terms.
Wisconsin - Special Needs Plan (Medicare)	December 31, 2016	Renewable annually for successive 12-month periods.

Marketplace Contracts

We operate under federally facilitated and state-based Marketplace contracts in 12 states with CMS that expire annually. In 2016, we began operating in a federally facilitated Marketplace in New Hampshire.

Table of Contents

We operate under a contract with the Arkansas Department of Human Services Division of Medical Services and the Arkansas Insurance Department to participate in the Medicaid expansion model that Arkansas has adopted (referred to as the "private option"). This contract expires December 31, 2016 and may be extended for subsequent and consecutive one-year terms. In 2016, we started operating under a contract with the New Hampshire Department of Health and Human Services to participate in the Medicaid expansion model that New Hampshire has adopted (referred to as the “premium assistance program”). This contract expires December 31, 2016 and may be extended for subsequent and consecutive one-year terms.

The Health Insurance Portability and Accountability Act (HIPAA)

In 1996, Congress enacted the Health Insurance Portability and Accountability Act, or HIPAA. We are subject to various federal and state laws and rules regarding the use and disclosure of confidential information, including HIPAA and the Gramm-Leach-Bliley Act. HIPAA is designed to improve the portability and continuity of health insurance coverage, simplify the administration of health insurance through standard transactions and ensure the privacy and security of individual health information. Among the requirements of HIPAA are the Administrative Simplification provisions which include: standards for processing health insurance claims and related transactions (Transactions Standards); requirements for protecting the privacy and limiting the use and disclosure of medical records and other personal health information (Privacy Rule); and standards and specifications for safeguarding personal health information which is maintained, stored or transmitted in electronic format (Security Rule). The Health Information Technology for Economic and Clinical Health (HITECH) Act amended certain provisions of HIPAA and enhanced data security obligations for covered entities and their business associates. HITECH also mandated individual notifications in instances of a data breach, provided enhanced penalties for HIPAA violations, and granted enforcement authority to states' Attorneys Generals in addition to the HHS Office for Civil Rights. The HIPAA Omnibus Rule further enhanced the changes under the HITECH Acts and the Genetic Information Nondiscrimination Act of 2008 (GINA) which clarified that genetic information is protected under HIPAA and prohibits most health plans from using or disclosing genetic information for underwriting purposes. This Omnibus rule enhances the privacy protections and strengthens the government's ability to enforce the law. The preemption provisions of HIPAA provide that the federal standards will not preempt state laws that are more stringent than the related federal requirements.

The Privacy and Security Rules and HITECH/Omnibus enhancements established requirements to protect the privacy of medical records and safeguard personal health information maintained and used by healthcare providers, health plans, healthcare clearinghouses, and their business associates.

The Security Rule requires healthcare providers, health plans, healthcare clearinghouses, and their business associates to implement administrative, physical and technical safeguards to ensure the privacy and confidentiality of health information electronically stored, maintained or transmitted. The HITECH Act and Omnibus Rule enhanced a federal requirement for notification when the security of protected health information is breached. In addition, there are state laws that have been adopted to provide for, among other things, private rights of action for breaches of data security and mandatory notification to persons whose identifiable information is obtained without authorization.

The requirements of the Transactions Standards apply to certain healthcare related transactions conducted using "electronic media." Since "electronic media" is defined broadly to include "transmissions that are physically moved from one location to another using portable data, magnetic tape, disk or compact disk media," many communications are considered to be electronically transmitted. Under HIPAA, health plans and providers are required to have the capacity to accept and send all covered transactions in a standardized electronic format. Penalties can be imposed for failure to comply with these requirements. The transaction standards were modified on October 1, 2015 with the implementation of the ICD-10 coding system.

We have implemented processes, policies and procedures to comply with HIPAA, HITECH and the Omnibus Rule, including administrative, technical and physical safeguards to prevent against an electronic data breach. We provide education and training for employees specifically designed to help prevent any unauthorized use or access to health information and enhance the reporting of suspected breaches. In addition, our corporate privacy officer and subsidiary privacy officials handle complaints and serve as resources to employees to address questions or concerns they may have. We periodically review our privacy and security procedures and conduct risk assessments to ensure we promptly identify and address gaps in our processes.

Table of Contents

Other Fraud, Waste and Abuse Laws

Investigating and prosecuting healthcare fraud, waste and abuse continues to be a top priority for state and federal law enforcement entities. The focus of these efforts has been directed at participants in public government healthcare programs such as Medicare and Medicaid. The fraud, waste and abuse laws include the federal False Claims Act, which prohibits the known filing of a false claim or the known use of false statements to obtain payment from the federal government. Many states have false claim act statutes that closely resemble the federal False Claims Act. The laws and regulations relating to fraud, waste and abuse and the requirements applicable to health plans and providers participating in these programs are complex and change regularly. Compliance with these laws may require substantial resources. We are constantly looking for ways to improve our waste, fraud and abuse detection methods. While we have both prospective and retrospective processes to identify abusive patterns and fraudulent billing, we continue to increase our capabilities to proactively detect inappropriate billing prior to payment.

EMPLOYEES

As of December 31, 2015, we had approximately 18,200 employees. None of our employees are represented by a union. We believe our relationships with our employees are positive.

EXECUTIVE OFFICERS OF THE REGISTRANT

The following table sets forth information regarding our executive officers, including their ages, at February 17, 2016:



Name	Age	Position
Michael F. Neidorff	73	Chairman, President and Chief Executive Officer
K. Rone Baldwin	57	Executive Vice President, Markets
Cynthia J. Brinkley	56	Executive Vice President, Global Corporate Development
Carol E. Goldman	58	Executive Vice President and Chief Administrative Officer
Jesse N. Hunter	40	Executive Vice President, Products
William N. Scheffel	62	Executive Vice President, Chief Financial Officer and Treasurer
Jeffrey A. Schwaneke	40	Senior Vice President, Corporate Controller and Chief Accounting Officer
Keith H. Williamson	63	Executive Vice President, General Counsel and Secretary

Michael F. Neidorff. Mr. Neidorff has served as our Chairman and Chief Executive Officer since May 2004. From May 1996 to May 2004, Mr. Neidorff served as President, Chief Executive Officer and as a member of our Board of Directors.

K. Rone Baldwin. Mr. Baldwin has served as our Executive Vice President, Markets since January 2016. From December 2012 to January 2016, he served as our Executive Vice President, Insurance Group Business Unit. Prior to joining Centene, he served as Executive Vice President and Business Leader of Group Insurance Business, which included both group health and ancillary product lines, for Guardian Life Insurance Company, which he joined in 2006.

Cynthia J. Brinkley. Ms. Brinkley has served as our Executive Vice President, Global Corporate Development since January 2016. From November 2014 to January 2016, she served as Executive Vice President, International Operations and Business Integration. Prior to joining Centene, she served as Vice President of Global Human Resources at General Motors from 2011 to 2014. She previously held various positions of increasing responsibility at AT&T including Senior Vice President of Talent Development/Chief Diversity Officer and President of AT&T's operations in both Missouri and Arkansas.

Carol E. Goldman. Ms. Goldman is our Executive Vice President and Chief Administrative Officer and has served in that capacity since June 2007.

Jesse N. Hunter. Mr. Hunter has served as our Executive Vice President, Products since January 2016. From December 2012 to January 2016, he serviced as Executive Vice President, Chief Business Development Officer. From February 2012 to December 2012, he served as our Executive Vice President, Operations. He previously served as our Executive Vice President, Corporate Development from April 2008 to February 2012.

William N. Scheffel. Mr. Scheffel is our Executive Vice President, Chief Financial Officer and Treasurer and has served in that capacity since May 2009. Mr. Scheffel is expected to retire in early 2016.

Table of Contents

Jeffrey A. Schwaneke. Mr. Schwaneke is our Senior Vice President, Corporate Controller and has served in that capacity since July 2008 and has been our Chief Accounting Officer since September 2008. Mr. Schwaneke will assume the role of Executive Vice President, Chief Financial Officer and Treasurer upon Mr. Scheffel's retirement in early 2016.

Keith H. Williamson. Mr. Williamson has served as our Executive Vice President, General Counsel and Secretary since November 2012. He served as Senior Vice President and General Counsel from November 2006 to November 2012.

Available Information

We are subject to the reporting and information requirements of the Securities Exchange Act of 1934, as amended (Exchange Act) and, as a result, we file periodic reports and other information with the Securities and Exchange Commission, or SEC. We make these filings available on our website free of charge, the URL of which is http://www.centene.com, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The SEC maintains a website (http://www.sec.gov) that contains our annual, quarterly and current reports and other information we file electronically with the SEC. You can read and copy any materials we file with the SEC at the SEC's Public Reference Room at 100 F Street, N.E., Room 1850, Washington, D.C. 20549. You may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. Information on our website does not constitute part of this Annual Report on Form 10-K.

ITEM 1A. Risk Factors

FACTORS THAT MAY AFFECT FUTURE RESULTS AND THE

TRADING PRICE OF OUR COMMON STOCK

You should carefully consider the risks described below before making an investment decision. The trading price of our common stock could decline due to any of these risks, in which case you could lose all or part of your investment. You should also refer to the other information in this filing, including our consolidated financial statements and related notes. The risks and uncertainties described below are those that we currently believe may materially affect our Company. Additional risks and uncertainties that we are unaware of or that we currently deem immaterial also may become important factors that affect our Company.

Reductions in funding or changes to eligibility requirements for government sponsored healthcare programs in which we participate could substantially affect our financial position, results of operations and cash flows.

The majority of our revenues come from government subsidized healthcare programs including Medicaid, Medicare, CHIP, LTC, ABD, Foster Care and Health Insurance Marketplace premiums. The base premium rate paid for each program differs, depending on a combination of factors such as defined upper payment limits, a member’s health status, age, gender, county or region and benefit mix. Since Medicaid was created in 1965, the federal government and the states have shared the costs, with the federal share currently averaging around 57%.

Future levels of funding and premium rates may be affected by continuing government efforts to contain healthcare costs and may further be affected by state and federal budgetary constraints. Governments periodically consider reducing or reallocating the amount of money they spend for Medicaid, Medicare, CHIP, LTC, ABD and Foster Care. Adverse economic conditions may continue to put pressures on state budgets as tax and other state revenues decrease while the population that is eligible to participate in these programs increases, creating more need for funding. We anticipate this will require government agencies to find funding alternatives, which may result in reductions in funding for programs, contraction of covered benefits, and limited or no premium rate increases or premium rate decreases. A reduction (or less than expected increase), a protracted delay, or a change in allocation methodology in government funding for these programs, as well as termination of the contract for the convenience of the government, may materially and adversely affect our results of operations, financial position and cash flows.

Additionally, changes in these programs could reduce the number of persons enrolled in or eligible for these programs or increase our administrative or healthcare costs under these programs. Recent legislation generally requires that eligibility levels be maintained, but this could cause states to reduce reimbursement or reduce benefits in order for states to afford to maintain eligibility levels. If any state in which we operate were to decrease premiums paid to us or pay us less than the amount necessary to keep pace with our cost trends, it could have a material adverse effect on our results of operations, financial position and cash flows.

Table of Contents

Lastly, if a federal government shutdown were to occur for a prolonged period of time, federal government payment obligations, including its obligations under Medicaid, Medicare, CHIP, LTC, ABD, Foster Care and the new Health Insurance Marketplaces, may be delayed. Similarly, if state government shutdowns were to occur, state payment obligations may be delayed. If the federal or state governments fail to make payments under these programs on a timely basis, our business could suffer, and our financial position, results of operations or cash flows may be materially affected.

Failure to accurately estimate and price our medical expenses or effectively manage our medical costs or related administrative costs could negatively affect our financial position, results of operations or cash flows.

Our profitability, to a significant degree, depends on our ability to estimate and effectively manage expenses related to health benefits through our ability to contract favorably with hospitals, physicians and other healthcare providers. For example, our Medicaid revenue is often based on bids submitted before the start of the initial contract year. If our actual medical expense exceeds our estimates, our health benefits ratio, or our expenses related to medical services as a percentage of premium revenue, would increase and our profits would decline. Because of the narrow margins of our health plan business, relatively small changes in our health benefits ratio can create significant changes in our financial results. Changes in healthcare regulations and practices, the level of utilization of healthcare services, hospital and pharmaceutical costs, major epidemics or pandemics, new medical technologies, pharmaceutical compounds and other external factors, including general economic conditions such as inflation and unemployment levels, are beyond our control and could reduce our ability to accurately predict and effectively control the costs of providing health benefits.

Our medical expense includes claims reported but not paid, estimates for claims incurred but not reported, and estimates for the costs necessary to process unpaid claims at the end of each period. Our development of the medical claims liability estimate is a continuous process which we monitor and refine on a monthly basis as claims receipts and payment information as well as inpatient acuity information becomes available. As more complete information becomes available, we adjust the amount of the estimate, and include the changes in estimates in medical expense in the period in which the changes are identified. However, we still cannot be sure that our medical claims liability estimate is adequate or that adjustments to the estimate will not unfavorably impact our results of operations.

Additionally, when we commence operations in a new state, region or product, we have limited information with which to estimate our medical claims liability. For a period of time after the inception of the new business, we base our estimates on state-provided historical actuarial data and limited actual incurred and received claims and inpatient acuity information. The addition of new categories of individuals who are eligible under new legislation may pose the same difficulty in estimating our medical claims liability. Similarly, we may face difficulty in estimating our medical claims liability in 2016 for the relatively new and evolving Health Insurance Marketplaces.

From time to time in the past, our actual results have varied from our estimates, particularly in times of significant changes in the number of our members. If it is determined that our estimates are significantly different than actual results, our results of operations and financial position could be adversely affected. In addition, if there is a significant delay in our receipt of premiums, our business operations, cash flows, or earnings could be negatively impacted.

The implementation of the Health Reform Legislation and other reforms could materially and adversely affect our results of operations, financial position and cash flows.

In March 2010, the Patient Protection and Affordable Care Act and the accompanying Health Care and Education Affordability Reconciliation Act, collectively referred to as the Affordable Care Act (ACA), were enacted. While the constitutionality of the ACA was generally upheld by the Supreme Court in 2012, the Court determined that states could not be required to expand Medicaid and risk losing all federal money for their existing Medicaid programs.

Under the ACA, Medicaid coverage was expanded to all individuals under age 65 with incomes up to 138% of the federal poverty level beginning January 1, 2014, subject to each states' election. The federal government will pay the entire costs for Medicaid coverage for newly eligible beneficiaries for three years (2014 through 2016). Beginning in 2017, the federal share begins to decline, ending at 90% for 2020 and subsequent years. As of December 31, 2015, 31 states and the District of Columbia have expanded Medicaid eligibility, and additional states continue to discuss expansion. The ACA also maintained CHIP eligibility standards through September 2019.

The ACA required the establishment of Health Insurance Marketplaces for individuals and small employers to purchase health insurance coverage commencing in January 2014. The ACA required insurers participating on the Health Insurance Marketplaces to offer a minimum level of benefits and included guidelines on setting premium rates and coverage limitations.

Table of Contents

Our ability to adequately price products offered in the Health Insurance Marketplaces may have a negative impact on our results of operations, financial position and cash flow. We may be adversely selected by individuals who will have a higher acuity level than the anticipated pool of participants. In addition, the risk corridor, reinsurance and risk adjustment ("three Rs") provisions of the ACA established to reduce risk for insurers may not be effective in appropriately mitigating the financial risks related to the Marketplace product. Further, the reinsurance and risk corridor components may not be adequately funded. Any variation from our expectations regarding acuity, enrollment levels, adverse selection, the three Rs, or other assumptions utilized in setting adequate premium rates could have a material adverse effect on our results of operations, financial position and cash flows.

The U.S. Department of Health and Human Services (HHS) has stated that it will consider a limited number of premium assistance demonstration proposals from States that want to privatize Medicaid expansion. States must provide a choice between at least two qualified health plans and offer very similar benefits as those available in the newly created Health Insurance Marketplaces. Arkansas became the first state to obtain federal approval to use Medicaid funding to purchase private insurance for low-income residents and we began operations under the program beginning January 1, 2014.

The ACA imposes an annual insurance industry assessment of $8.0 billion starting in 2014, and $11.3 billion in each of 2015 and 2016, with increasing annual amounts thereafter. Such assessments are not deductible for federal and most state income tax purposes. The fee will be allocated based on health insurers' premium revenues in the previous year. Each health insurer's fee is calculated by multiplying its market share by the annual fee. Market share is based on commercial, Medicare, and Medicaid premium revenue. Not-for-profit insurers may have a competitive advantage since they are exempt from paying the fee if they receive at least 80% of their premium revenue from Medicare, Medicaid, and CHIP, and other not-for-profit insurers are allowed to exclude 50% of their premium revenue from the fee calculation. If we are not reimbursed by the states for the cost of the federal premium assessment (including the associated tax impact), or if we are unable to otherwise adjust our business model to address this new assessment, our results of operations, financial position and cash flows may be materially adversely affected.

There are numerous steps required to implement the legislation, including the promulgation of a substantial number of new and potentially more onerous federal regulations. Further, various health insurance reform proposals are also emerging at the state level. Because of the unsettled nature of these reforms and numerous steps required to implement them, we cannot predict what additional health insurance requirements will be implemented at the federal or state level, or the effect that any future legislation or regulation will have on our business or our growth opportunities. Although we believe the legislation may provide us with significant opportunities to grow our business, the enacted reforms, as well as future regulations and legislative changes, may in fact have a material adverse effect on our results of operations, financial position or liquidity. If we fail to effectively implement our operational and strategic initiatives with respect to the implementation of healthcare reform, or do not do so as effectively as our competitors, our results of operations may be materially adversely affected.

Our business activities are highly regulated and new laws or regulations or changes in existing laws or regulations or their enforcement or application could force us to change how we operate and could harm our business.

Our business is extensively regulated by the states in which we operate and by the federal government. In addition, the managed care industry has received negative publicity that has led to increased legislation, regulation, review of industry practices and private litigation in the commercial sector. In each of the jurisdictions in which we operate, we are regulated by the relevant insurance, health and/or human services departments that oversee the activities of managed care organizations providing or arranging to provide services to Medicaid, Medicare and Health Insurance Marketplace enrollees. For example, our health plan subsidiaries, as well as our applicable specialty companies, must comply with minimum statutory capital and other financial solvency requirements, such as deposit and surplus requirements.

The frequent enactment of, changes to, or interpretations of laws and regulations could, among other things: force us to restructure our relationships with providers within our network; require us to implement additional or different programs and systems; restrict revenue and enrollment growth; increase our healthcare and administrative costs; impose additional capital and surplus requirements; and increase or change our liability to members in the event of malpractice by our contracted providers. In addition, changes in political party or administrations at the state, federal or country level may change the attitude towards healthcare programs.

Additionally, the taxes and fees paid to federal, state and local governments may increase due to several factors, including: enactment of, changes to, or interpretations of tax laws and regulations, audits by governmental authorities, geographic expansions into higher taxing jurisdictions and the effect of expansions into international markets.

Table of Contents

Our contracts with states may require us to maintain a minimum health benefits ratio (HBR) or may require us to share profits in excess of certain levels. In certain circumstances, our plans may be required to return premium back to the state in the event profits exceed established levels or HBR does not meet the minimum requirement. Other states may require us to meet certain performance and quality metrics in order to maintain our contract or receive additional or full contractual revenue.

The governmental healthcare programs in which we participate are subject to the satisfaction of certain regulations and performance standards. For example, under Health Reform Legislation, Congress authorized CMS and the states to implement managed care demonstration programs to serve dually eligible beneficiaries to improve the coordination of their care. Participation in these demonstration programs is subject to CMS approval and the satisfaction of conditions to participation, including meeting certain performance requirements. Our inability to improve or maintain adequate quality scores and star ratings to meet government performance requirements or to match the performance of our competitors could result in limitations to our participation in or exclusion from these or other government programs. Specifically, several of our Medicaid contracts require us to maintain a Medicare health plan. Although we strive to comply with all existing regulations and to meet performance standards applicable to our business, failure to meet these requirements could result in financial fines and penalties. Also, states may not allow us to continue to participate in their government programs, or we may fail to win procurements to participate in such programs which could materially and adversely affect our results of operations, financial position and cash flows.

In addition, as a result of the expansion of our businesses and operations conducted in foreign countries, we face political, economic, legal, compliance, regulatory, operational and other risks and exposures that are unique and vary by jurisdiction. These foreign regulatory requirements with respect to, among other items, environmental, tax, licensing, intellectual property, privacy, data protection, investment, capital, management control, labor relations, and fraud and corruption regulations are different than those faced by our domestic businesses. In addition, we are subject to U.S. laws that regulate the conduct and activities of U.S.-based businesses operating abroad, such as the Foreign Corrupt Practices Act. Our failure to comply with laws and regulations governing our conduct outside the United States or to successfully navigate international regulatory regimes that apply to us could adversely affect our ability to market our products and services, which may have a material adverse effect on our business, financial condition and results of operations.

Our businesses providing pharmacy benefit management (PBM) and specialty pharmacy services face regulatory and other risks and uncertainties which could materially and adversely affect our results of operations, financial position and cash flows.

We provide PBM and specialty pharmacy services through our Envolve Pharmacy Solutions product. Each business is subject to federal and state laws that govern the relationships of the business with pharmaceutical manufacturers, physicians, pharmacies, customers and consumers. They also conduct business as a mail order pharmacy and specialty pharmacy, which subjects them to extensive federal, state and local laws and regulations. In addition, federal and state legislatures regularly consider new regulations for the industry that could materially and adversely affect current industry practices, including the receipt or disclosure of rebates from pharmaceutical companies, the development and use of formularies, and the use of average wholesale prices.

Our PBM and specialty pharmacy businesses would be materially and adversely affected by an inability to contract on favorable terms with pharmaceutical manufacturers and other suppliers, including with respect to the pricing of new specialty and generic drugs. In addition, our PBM and specialty pharmacy businesses could face potential claims in connection with purported errors by our mail order or specialty pharmacies, including in connection with the risks inherent in the authorization, compounding, packaging and distribution of pharmaceuticals and other healthcare products. Disruptions at any of our mail order or specialty pharmacies due to an event that is beyond our control could affect our ability to process and dispense prescriptions in a timely manner and could materially and adversely affect our results of operations, financial position and cash flows.

Table of Contents

If any of our government contracts are terminated or are not renewed or we receive an adverse review, audit or investigation, our business will suffer.

We provide managed care programs and selected services to individuals receiving benefits under governmental assistance programs. We provide those healthcare services under contracts with regulatory entities in the areas in which we operate. Our government contracts are generally intended to run for three years and may be extended for additional years if the contracting entity or its agent elects to do so. When our contracts expire, they may be opened for bidding by competing healthcare providers, and there is no guarantee that our contracts will be renewed or extended. Competitors may buy their way into the market by submitting bids with lower pricing. Even if our responsive bids are successful, the bids may be based upon assumptions or other factors which could result in the contracts being less profitable than we had anticipated. Further, our government contracts contain certain provisions regarding eligibility, enrollment and dis-enrollment processes for covered services, eligible providers, periodic financial and informational reporting, quality assurance, timeliness of claims payment and agreement to maintain a Medicare plan in the state and financial standards and are subject to cancellation if we fail to perform in accordance with the standards set by regulatory agencies.

We are also subject to various reviews, audits and investigations to verify our compliance with the terms of our contracts with various governmental agencies and applicable laws and regulations. Any adverse review, audit or investigation could result in: cancellation of our contracts; refunding of amounts we have been paid pursuant to our contracts; imposition of fines, penalties and other sanctions on us; loss of our right to participate in various programs; increased difficulty in selling our products and services; or loss of one or more of our licenses.

If any of our government contracts are terminated, not renewed, renewed on less favorable terms, or not renewed on a timely basis, or we have an adverse review, audit or investigation, our business will suffer, our goodwill could be impaired and our financial position, results of operations or cash flows may be materially affected.

Ineffectiveness of state-operated systems and subcontractors could adversely affect our business.

Our health plans rely on other state-operated systems or subcontractors to qualify, solicit, educate and assign eligible members into managed care plans. The effectiveness of these state operations and subcontractors can have a material effect on a health plan’s enrollment in a particular month or over an extended period. When a state implements new programs to determine eligibility, new processes to assign or enroll eligible members into health plans, or chooses new subcontractors, there is an increased potential for an unanticipated impact on the overall number of members assigned to managed care plans.

Our investment portfolio may suffer losses which could materially and adversely affect our results of operations or liquidity.

We maintain a significant investment portfolio of cash equivalents and short term and long term investments in a variety of securities, which are subject to general credit, liquidity, market and interest rate risks and will decline in value if interest rates increase or one of the issuers’ credit ratings is reduced. As a result, we may experience a reduction in value or loss of our investments, which may have a negative adverse effect on our results of operations, liquidity and financial condition.

Execution of our growth strategy may increase costs or liabilities, or create disruptions in our business.

Our growth strategy includes the acquisition of health plans participating in government sponsored healthcare programs and specialty services businesses, contract rights and related assets of other health plans both in our existing service areas and in new markets and start-up operations in new markets or new products in existing markets. Although we review the records of companies or businesses we plan to acquire, it is possible that we could assume unanticipated liabilities or adverse operating conditions, or an acquisition may not perform as well as expected or may not achieve timely profitability. We also face the risk that we will not be able to effectively integrate acquisitions into our existing operations effectively without substantial expense, delay or other operational or financial problems and we may need to divert more management resources to integration than we planned.

In connection with start-up operations, we may incur significant expenses prior to commencement of operations and the receipt of revenue. For example, in order to obtain a certificate of authority in most jurisdictions, we must first establish a provider network, have systems in place and demonstrate our ability to administer a state contract and process claims. We may experience delays in operational start dates. As a result of these factors, start-up operations may decrease our profitability. In addition, we are planning to expand our business internationally and we will be subject to additional risks, including, but not limited to, political risk, an unfamiliar regulatory regime, currency exchange risk and exchange controls, cultural and language differences, foreign tax issues, and different labor laws and practices.

Table of Contents

If we are unable to effectively execute our growth strategy, our future growth will suffer and our results of operations could be harmed.

If competing managed care programs are unwilling to purchase specialty services from us, we may not be able to successfully implement our strategy of diversifying our business lines.

We are seeking to diversify our business lines into areas that complement our government sponsored health plan business in order to grow our revenue stream and balance our dependence on risk reimbursement. In order to diversify our business, we must succeed in selling the services of our specialty subsidiaries not only to our managed care plans, but to programs operated by third-parties. Some of these third-party programs may compete with us in some markets, and they therefore may be unwilling to purchase specialty services from us. In any event, the offering of these services will require marketing activities that differ significantly from the manner in which we seek to increase revenues from our government sponsored programs. Our ineffectiveness in marketing specialty services to third-parties may impair our ability to execute our business strategy.

Adverse credit market conditions may have a material adverse effect on our liquidity or our ability to obtain credit on acceptable terms.

The securities and credit markets have been experiencing extreme volatility and disruption over the past several years. The availability of credit, from virtually all types of lenders, has at times been restricted. In the event we need access to additional capital to pay our operating expenses, fund subsidiary surplus requirements, make payments on or refinance our indebtedness, pay capital expenditures, or fund acquisitions, our ability to obtain such capital may be limited and the cost of any such capital may be significant, particularly if we are unable to access our existing credit facility.

Our access to additional financing will depend on a variety of factors such as prevailing economic and credit market conditions, the general availability of credit, the overall availability of credit to our industry, our credit ratings and credit capacity, and perceptions of our financial prospects. Similarly, our access to funds may be impaired if regulatory authorities or rating agencies take negative actions against us. If a combination of these factors were to occur, our internal sources of liquidity may prove to be insufficient, and in such case, we may not be able to successfully obtain additional financing on favorable terms or at all.

If state regulators do not approve payments of dividends and distributions by our subsidiaries to us, we may not have sufficient funds to implement our business strategy.

We principally operate through our health plan subsidiaries. As part of normal operations, we may make requests for dividends and distributions from our subsidiaries to fund our operations. These subsidiaries are subject to regulations that limit the amount of dividends and distributions that can be paid to us without prior approval of, or notification to, state regulators. If these regulators were to deny our subsidiaries’ request to pay dividends, the funds available to us would be limited, which could harm our ability to implement our business strategy.

We derive a majority of our premium revenues from operations in a limited number of states, and our financial position, results of operations or cash flows would be materially affected by a decrease in premium revenues or profitability in any one of those states.

Operations in a limited number of states have accounted for most of our premium revenues to date. If we were unable to continue to operate in any of our current states or if our current operations in any portion of one of those states were significantly curtailed, our revenues could decrease materially. Our reliance on operations in a limited number of states could cause our revenue and profitability to change suddenly and unexpectedly depending on legislative or other governmental or regulatory actions and decisions, economic conditions and similar factors in those states. For example, states we currently serve may bid out their Medicaid program through a request for proposal process. Our inability to continue to operate in any of the states in which we operate could harm our business.

Competition may limit our ability to increase penetration of the markets that we serve.

We compete for members principally on the basis of size and quality of provider networks, benefits provided and quality of service. We compete with numerous types of competitors, including other health plans and traditional state Medicaid programs that reimburse providers as care is provided. In addition, the impact of healthcare reform legislation and potential growth in our segment may attract new competitors.

Table of Contents

Some of the health plans with which we compete have greater financial and other resources and offer a broader scope of products than we do. In addition, significant merger and acquisition activity has occurred in the managed care industry, as well as complementary industries, such as the hospital, physician, pharmaceutical, medical device and health information systems businesses. To the extent that competition intensifies in any market that we serve, as a result of industry consolidation or otherwise, our ability to retain or increase members and providers, or maintain or increase our revenue growth, pricing flexibility and control over medical cost trends may be adversely affected.

If we are unable to maintain relationships with our provider networks, our profitability may be harmed.

Our profitability depends, in large part, upon our ability to contract at competitive prices with hospitals, physicians and other healthcare providers. Our provider arrangements with our primary care physicians, specialists and hospitals generally may be canceled by either party without cause upon 90 to 120 days prior written notice. We cannot provide any assurance that we will be able to continue to renew our existing contracts or enter into new contracts on a timely basis or under favorable terms enabling us to service our members profitably. Healthcare providers with whom we contract may not properly manage the costs of services, maintain financial solvency or avoid disputes with other providers. Any of these events could have a material adverse effect on the provision of services to our members and our operations.

In any particular market, physicians and other healthcare providers could refuse to contract, demand higher payments, or take other actions that could result in higher medical costs or difficulty in meeting regulatory or accreditation requirements. In some markets, certain healthcare providers, particularly hospitals, physician/hospital organizations or multi-specialty physician groups, may have significant market positions or near monopolies that could result in diminished bargaining power on our part. In addition, accountable care organizations, practice management companies, which aggregate physician practices for administrative efficiency and marketing leverage, and other organizational structures that physicians, hospitals and other healthcare providers choose may change the way in which these providers interact with us and may change the competitive landscape. Such organizations or groups of healthcare providers may compete directly with us, which could adversely affect our operations, and our results of operations, financial position and cash flows by impacting our relationships with these providers or affecting the way that we price our products and estimate our costs, which might require us to incur costs to change our operations. Provider networks may consolidate, resulting in a reduction in the competitive environment. In addition, if these providers refuse to contract with us, use their market position to negotiate contracts unfavorable to us or place us at a competitive disadvantage, our ability to market products or to be profitable in those areas could be materially and adversely affected.

From time to time healthcare providers assert or threaten to assert claims seeking to terminate non-cancelable agreements due to alleged actions or inactions by us. In addition, we are aware that other managed care organizations have been subject to class action lawsuits by healthcare providers with respect to claim payment procedures, and we may be subject to similar lawsuits. Regardless of whether any lawsuits brought against us are successful or have merit, they will still be time-consuming and costly and could distract our management’s attention. As a result, we may incur significant expenses and may be unable to operate our business effectively. If we are unable to retain our current provider contract terms or enter into new provider contracts timely or on favorable terms, our profitability may be harmed.

We may be unable to attract, retain or effectively manage the succession of key personnel.

We are highly dependent on our ability to attract and retain qualified personnel to operate and expand our business. We would be adversely impacted if we are unable to adequately plan for the succession of our executives and senior management. While we have succession plans in place for members of our executive and senior management team, these plans do not guarantee that the services of our executive and senior management team will continue to be available to us. Our ability to replace any departed members of our executive and senior management or other key employees may be difficult and may take an extended period of time because of the limited number of individuals in the managed care and specialty services industry with the breadth of skills and experience required to operate and successfully expand a business such as ours. Competition to hire from this limited pool is intense, and we may be unable to hire, train, retain or motivate these personnel. If we are unable to attract, retain and effectively manage the succession plans for key personnel, executives and senior management, our business and financial position, results of operations or cash flows could be harmed.

Table of Contents

If we are unable to integrate and manage our information systems effectively, our operations could be disrupted.

Our operations depend significantly on effective information systems. The information gathered and processed by our information systems assists us in, among other things, monitoring utilization and other cost factors, processing provider claims, and providing data to our regulators. Our healthcare providers also depend upon our information systems for membership verifications, claims status and other information. Our information systems and applications require continual maintenance, upgrading and enhancement to meet our operational needs and regulatory requirements. We regularly upgrade and expand our information systems’ capabilities. If we experience difficulties with the transition to or from information systems or are unable to properly maintain or expand our information systems, we could suffer, among other things, operational disruptions, loss of existing members and difficulty in attracting new members, regulatory problems and increases in administrative expenses. In addition, our ability to integrate and manage our information systems may be impaired as the result of events outside our control, including acts of nature, such as earthquakes or fires, or acts of terrorists.

From time to time, we may become involved in costly and time-consuming litigation and other regulatory proceedings, which require significant attention from our management.

We are a defendant from time to time in lawsuits and regulatory actions relating to our business, including, without limitation, medical malpractice claims. Due to the inherent uncertainties of litigation and regulatory proceedings, we cannot accurately predict the ultimate outcome of any such proceedings. An unfavorable outcome could have a material adverse impact on our business and financial position, results of operations or cash flows. In addition, regardless of the outcome of any litigation or regulatory proceedings, such proceedings are costly and time consuming and require significant attention from our management, and could therefore harm our business and financial position, results of operations or cash flows.

An impairment charge with respect to our recorded goodwill and intangible assets could have a material impact on our results of operations.

We periodically evaluate our goodwill and other intangible assets to determine whether all or a portion of their carrying values may be impaired, in which case a charge to earnings may be necessary. Changes in business strategy, government regulations or economic or market conditions have resulted and may result in impairments of our goodwill and other intangible assets at any time in the future. Our judgments regarding the existence of impairment indicators are based on, among other things, legal factors, market conditions, and operational performance. For example, the non-renewal of our health plan contracts with the state in which they operate may be an indicator of impairment. If an event or events occur that would cause us to revise our estimates and assumptions used in analyzing the value of our goodwill and other intangible assets, such revision could result in a non-cash impairment charge that could have a material impact on our results of operations in the period in which the impairment occurs.

If we fail to comply with applicable privacy, security, and data laws, regulations and standards, including with respect to third-party service providers that utilize sensitive personal information on our behalf, our business, reputation, results of operations, financial position and cash flows could be materially and adversely affected.

As part of our normal operations, we collect, process and retain confidential member information. We are subject to various federal and state laws and rules regarding the use and disclosure of confidential member information, including the Health Insurance Portability and Accountability Act (HIPAA) and the Health Information Technology for Economic and Clinical Health (HITECH) Act and the Gramm-Leach-Bliley Act, which require us to protect the privacy of medical records and safeguard personal health information we maintain and use. Certain of our businesses are also subject to the Payment Card Industry Data Security Standard, which is a multifaceted security standard that is designed to protect credit card account data as mandated by payment card industry entities. Despite our best attempts to maintain adherence to information privacy and security best practices as well as compliance with applicable laws and rules, our facilities and systems, and those of our third party service providers, may be vulnerable to privacy or security breaches, acts of vandalism or theft, malware, misplaced or lost data including paper or electronic media, programming and/or human errors or other similar events. In the past, we have had data breaches resulting in disclosure of confidential or protected health information that have not resulted in any material financial loss or penalty to date. However, future data breaches could require us to expend significant resources to remediate any damage, interrupt our operations and damage our reputation, subject us to state or federal agency review and could also result in enforcement actions, material fines and penalties, litigation or other actions which could have a material adverse effect on our business, reputation and results of operations, financial position and cash flows.

Table of Contents

In addition, HIPAA broadened the scope of fraud and abuse laws applicable to healthcare companies. HIPAA created civil penalties for, among other things, billing for medically unnecessary goods or services. HIPAA established new enforcement mechanisms to combat fraud and abuse, including civil and, in some instances, criminal penalties for failure to comply with specific standards relating to the privacy, security and electronic transmission of protected health information. The HITECH Act expanded the scope of these provisions by mandating individual notification in instances of breaches of protected health information, providing enhanced penalties for HIPAA violations, and granting enforcement authority to states’ Attorneys General in addition to the HHS Office for Civil Rights. It is possible that Congress may enact additional legislation in the future to increase penalties and to create a private right of action under HIPAA, which could entitle patients to seek monetary damages for violations of the privacy rules. In addition, HHS has announced that it will continue its audit program to assess HIPAA compliance efforts by covered entities with a focus on security risk assessments. Although we are not aware of HHS plans to audit any of our covered entities, an audit resulting in findings or allegations of noncompliance could have a material adverse effect on our results of operations, financial position and cash flows.

Under HIPAA, health plans are required to have the capacity to accept and send all covered transactions in a standardized electronic format. Penalties can be imposed for failure to comply with these requirements. The transaction standards were modified to version 5010 prior to the implementation of the ICD-10 coding system. While we transitioned to the ICD-10 coding system in October 2015, if unforeseen circumstances arise, it is possible that we could be exposed to investigations and allegations of noncompliance. In addition, if some providers continue to use ICD-9 codes on claims after October 1, 2015, we may have to reject such claims, which may lead to claim resubmissions, increased call volume and provider and customer dissatisfaction. Further, providers may use ICD-10 codes differently than they used ICD-9 codes in the past, which could result in higher costs and reimbursement levels, or lost revenues under risk adjustment. As a result, the changes and complications associated with the transition to ICD-10 may have a material adverse effect on our results of operations, financial position and cash flows.

If we fail to comply with the extensive federal and state fraud and abuse laws, our business, reputation, results of operations, financial position and cash flows could be materially and adversely affected.

Companies involved in public health care programs are often the subject of fraud and abuse investigations. The regulations and contractual requirements applicable to participants in these public sector programs are complex and subject to change. Violations of fraud and abuse laws applicable to us could result in civil monetary penalties, criminal fines and imprisonment, and/or exclusion from participation in Medicaid, Medicare, other federal health care programs and federally funded state health programs. Fraud and abuse prohibitions encompass a wide range of activities, including kickbacks for referral of members, billing for unnecessary medical services, improper marketing and violations of patient privacy rights. These fraud and abuse laws include the federal False Claims Act, which prohibits the known filing of a false claim or the known use of false statements to obtain payment from the federal government. Many states have false claim act statutes that closely resemble the federal False Claims Act. In addition, the Deficit Reduction Act of 2005 encourages states to enact state-versions of the federal False Claims Act that establish liability to the state for false and fraudulent Medicaid claims and that provide for, among other things, claims to be filed by qui tam relators. Federal and state governments have made investigating and prosecuting health care fraud and abuse a priority. In the event we fail to comply with the extensive federal and state fraud and abuse laws, our business, reputation, results of operations, financial position and cash flows could be materially and adversely affected.

A failure in or breach of our operational or security systems or infrastructure, or those of third parties with which we do business, including as a result of cyber attacks, could have an adverse effect on our business.

Information security risks have significantly increased in recent years in part because of the proliferation of new technologies, the use of the internet and telecommunications technologies to conduct our operations, and the increased sophistication and activities of organized crime, hackers, terrorists and other external parties, including foreign state agents. Our operations rely on the secure processing, transmission and storage of confidential, proprietary and other information in our computer systems and networks.

Table of Contents

Security breaches may arise from external or internal threats. External breaches include hacking personal information for financial gain, attempting to cause harm to our operations, or intending to obtain competitive information. We experience attempted external hacking or malicious attacks on a regular basis. We maintain a rigorous system of preventive and detective controls through our security programs; however, our prevention and detection controls may not prevent or identify all such attacks. Internal breaches may result from inappropriate security access to confidential information by rogue employees, consultants or third party service providers. Any security breach involving the misappropriation, loss or other unauthorized disclosure or use of confidential member information, financial data, competitively sensitive information, or other proprietary data, whether by us or a third party, could have a material adverse effect on our business reputation, financial condition, cash flows, or results of operations.

Consummation of the merger with Health Net is subject to receipt of regulatory approvals and certain other conditions and we cannot predict when or if such conditions will be satisfied or waived or if, in connection with the receipt of necessary approvals, regulators will impose conditions on us that have an adverse effect on our business.

Consummation of the merger with Health Net is subject to receipt of certain remaining regulatory approvals and certain other conditions, including, among others:


•	certain filings or consents required for the consummation of the Merger and the other transactions under applicable state and foreign insurance and health care regulatory laws having been made or obtained; and


•	certain other customary conditions.

We cannot provide any assurance that the merger will be completed, that there will not be a delay in the completion of the merger or that all or any of the anticipated benefits of the merger will be realized. Any delay could also, among other things, result in additional transaction costs, loss of revenue or other negative effects associated with uncertainty about completion of the merger. In the event the merger agreement is terminated or the transaction is materially delayed for any reason, the price of our common stock may be impacted. Regulatory authorities reviewing the merger may refuse to permit the merger or may impose restrictions or conditions on the merger that may adversely affect the Company if the merger is completed.

We may be unable to successfully integrate our business with Health Net and realize the anticipated benefits of the merger.

The success of the merger will depend, in part, on our ability to successfully combine the businesses of the Company and Health Net, which currently operate as independent public companies, and realize the anticipated benefits, including synergies, cost savings, innovation and operational efficiencies, from the combination. If we are unable to achieve these objectives within the anticipated time frame, or at all, the anticipated benefits may not be realized fully or at all, or may take longer to realize than expected and the value of our common stock may be harmed.

The merger involves the integration of Health Net’s business with our existing business, which is a complex, costly and time-consuming process. We have not previously completed a transaction comparable in size or scope to the proposed merger. The integration of the two companies may result in material challenges, including, without limitation:


•	the diversion of management’s attention from ongoing business concerns and performance shortfalls at one or both of the companies as a result of the devotion of management’s attention to the merger;


•	managing a larger combined company;


•	maintaining employee morale and retaining key management and other employees;


•	the possibility of faulty assumptions underlying expectations regarding the integration process;


•	retaining existing business and operational relationships and attracting new business and operational relationships;


•	consolidating corporate and administrative infrastructures and eliminating duplicative operations;


•	coordinating geographically separate organizations;


•	unanticipated issues in integrating information technology, communications and other systems;


•	unanticipated changes in federal or state laws or regulations, including the ACA and the Health Care Education Affordability Reconciliation Act and any regulations enacted thereunder; and


•	unforeseen expenses or delays associated with the merger.

Many of these factors will be outside of our control and any one of them could result in delays, increased costs, decreases in the amount of expected revenues and diversion of management’s time and energy, which could materially affect our financial position, results of operations and cash flows.

Table of Contents

We and Health Net are currently permitted to conduct only limited planning for the integration of the two companies following the merger and have not yet fully determined the exact nature of how the businesses and operations of the two companies will be combined after the merger. The actual integration may result in additional and unforeseen expenses, and the anticipated benefits of the integration plan may not be realized.

Our financial results after the merger will depend on our ability to maintain our and Health Net’s business and operational relationships.

A substantial portion of each of our and Health Net’s revenues are received under contracts with states. Our success following the merger will depend in part on our ability to maintain these state contracts and other business and operational relationships, including those of Health Net. Health Net’s state contracts and other business and operational relationships may have termination or other rights that may be triggered by the merger, or the states or other business and operational relationships may decide not to renew their existing relationships with Health Net or, after the merger, with us. If Health Net (prior to the completion of the merger) and we (after the completion of the merger) are unable to maintain these contracts and other business and operational relationships, our financial position, results of operations or cash flows could be materially affected.

We are expected to incur substantial expenses related to the completion of the merger and the integration of Health Net.

We are expected to incur substantial expenses in connection with the completion of the merger and the integration of Health Net. There are a large number of processes, policies, procedures, operations, technologies and systems that must be integrated, including purchasing, accounting and finance, sales, payroll, pricing, revenue management, marketing and benefits. In addition, the businesses of Centene and Health Net will continue to maintain a presence in St. Louis, Missouri and Woodland Hills, California, respectively. The substantial majority of these costs will be non-recurring expenses related to the merger (including financing of the merger), facilities and systems consolidation costs. We may incur additional costs to maintain employee morale and to retain key employees. We will also incur transaction fees and costs related to formulating integration plans for the combined business, and the execution of these plans may lead to additional unanticipated costs. Additionally, as a result of the merger, rating agencies may take negative actions with regard to our credit ratings. This may increase our costs in connection with the financing of the merger. These incremental transaction and merger-related costs may exceed the savings the combined company expects to achieve from the elimination of duplicative costs and the realization of other efficiencies related to the integration of the businesses, particularly in the near term and in the event there are material unanticipated costs.

Failure to complete the merger could impact our stock price and our future business and financial position, results of operations and cash flows.

If the merger is not completed or our financing for the transaction becomes unavailable, our ongoing business and financial position, results of operations and cash flows may be materially affected and we will be subject to a number of risks, including the following:


•	depending on the reasons leading to such termination we could be liable to Health Net for termination fees in connection with the termination of the merger agreement;


•	we could be responsible for the transaction costs relating to the merger, whether or not the merger is completed;


•	while the merger agreement is in force, we are subject to certain restrictions on the conduct of our business, which may adversely affect our ability to execute certain of our business strategies;


•	the market price of our common stock could decline to the extent that the current market price reflects, and is positively affected by, a market assumption that the transactions contemplated by the merger will be completed; and


•	matters relating to the merger (including integration planning) may require substantial commitments of time and resources by our management, whether or not the merger is completed, which could otherwise have been devoted to other opportunities that may have been beneficial to us.

In addition, if the merger is not completed, we may experience negative reactions from the financial markets and from our providers, members and employees. We may also be subject to litigation related to any failure to complete the merger or to enforcement proceedings commenced against us to perform our obligations under the merger agreement. If the merger is not completed, these risks may materialize and may materially affect our financial position, results of operations and cash flows, as well as the price of our common stock.

Table of Contents

The market price of our common stock may decline as a result of the merger with Health Net.

The market price of the common stock of our company may decline as a result of the merger if, among other things, we are unable to achieve the expected growth in earnings, or if the operational cost savings estimates in connection with the integration of Health Net’s business with ours are not realized, or if the transaction costs related to the merger are greater than expected, or if the financing related to the transaction is on unfavorable terms. The market price also may decline if we do not achieve the perceived benefits of the merger as rapidly or to the extent anticipated by financial or industry analysts or if the effect of the merger on our financial position, results of operations or cash flows is not consistent with the expectations of financial or industry analysts.

The merger will substantially reduce the percentage ownership interests of our current stockholders; it may not be accretive and may cause dilution to our earnings per share, which may negatively affect the market price of our common stock.

Our stockholders have the right to vote in the election of our Board of Directors and on certain other matters affecting the Company. If the merger is completed we will pay approximately $5.5 billion and Health Net’s stockholders are expected to hold approximately 29% of the common stock of the Company after the merger. As a result, if the merger is completed, our pre-merger stockholders will own a smaller proportion of our outstanding common stock than the proportion of our outstanding common stock they owned before the merger and, as a result, they will have less influence on our management and policies following the merger than they now have on our management and policies. We currently anticipate that the merger will be accretive to our earnings per share. This expectation is based on preliminary estimates which may materially change. We could also encounter additional transaction and integration-related costs or other factors such as the failure to realize all of the benefits anticipated in the merger, or unforeseen liabilities or other issues existing or arising with the business of Health Net or otherwise resulting from the merger. All of these factors could cause dilution to our earnings per share or decrease or delay the expected accretive effect of the merger and cause a decrease in the price of our common stock.

Uncertainties associated with the merger may cause a loss of management personnel and other key employees which could adversely affect the future business and operations of the combined company.

Centene and Health Net are dependent on the experience and industry knowledge of their officers and other key employees to execute their business plans. The combined company’s success after the completion of the merger will depend in part upon the ability of Centene and Health Net to retain key management personnel and other key employees. Prior to completion of the merger, current and prospective employees of Centene and Health Net may experience uncertainty about their roles within the combined company following the completion of the merger, which may have an adverse effect on the ability of each of Centene and Health Net to attract or retain key management and other key personnel. In addition, no assurance can be given that the combined company will be able to attract or retain key management personnel and other key employees of Centene and Health Net to the same extent that Centene and Health Net have previously been able to attract or retain their own employees.

The future results of the combined company may be adversely impacted if the combined company does not effectively manage its expanded operations following the completion of the merger.

Following the completion of the merger, the size of the combined company’s business will be significantly larger than the current size of either Centene’s or Health Net’s respective businesses. The combined company’s ability to successfully manage this expanded business will depend, in part, upon management’s ability to design and implement strategic initiatives that address not only the integration of two discrete companies, but also the increased scale and scope of the combined business with its associated increased costs and complexity. There can be no assurances that the combined company will be successful or that it will realize the expected operating efficiencies, cost savings and other benefits currently anticipated from the merger.

The combined company will be significantly more leveraged than Centene is currently.

Upon completion of the merger, the combined company expects to incur approximately $2,382 million in additional indebtedness. The combined company will have consolidated indebtedness of approximately $4,136 million, which is greater than the current indebtedness of Centene prior to the merger. The increased indebtedness and higher debt-to-equity ratio of the combined company in comparison to that of Centene on a historical basis will have the effect, among other things, of reducing the flexibility of Centene to respond to changing business and economic conditions and increasing borrowing costs.

Table of Contents

Item 1B. Unresolved Staff Comments

None.

Item 2. Properties

We own our corporate office headquarters buildings and land located in St. Louis, Missouri. We generally lease space in the states where our health plans, specialty companies and claims processing facilities operate. We are required by various insurance and regulatory authorities to have offices in the service areas where we provide benefits. We believe our current facilities are adequate to meet our operational needs for the foreseeable future.

Table of Contents

Item 3. Legal Proceedings

On February 6, 2015, the Kentucky Court of Appeals affirmed a Franklin Circuit Court ruling that Kentucky Spirit does not have a contractual right to terminate the contract early. The Court of Appeals also found that the contract’s liquidated damages provision “is applicable in the event of a premature termination of the Contract term.” On September 8, 2015, Kentucky Spirit filed a motion for discretionary review seeking Kentucky Supreme Court review of the finding that Kentucky Spirit's departure constituted a breach of contract. On October 9, 2015, the Commonwealth filed a response opposing discretionary review.

On May 26, 2015, the Commonwealth issued a demand for indemnification to its actuarial firm for "all defense costs, and any resultant monetary awards in favor of Kentucky Spirit, arising from or related to Kentucky Spirit's claims which are predicated upon the alleged omissions and errors in the Data Book and the certified actuarially sound rates." On August 19, 2015, the actuarial firm moved to intervene in the litigation. The Franklin Circuit Court granted the actuarial firm's motion on September 8, 2015 and ordered a forty-five day stay of all pretrial proceedings in order for the firm to review the record. Also, on August 19, 2015, the actuarial firm filed a petition seeking a declaratory judgment that it is not liable to the Commonwealth for indemnification related to the claims asserted by Kentucky Spirit against the Commonwealth. On October 5, 2015, the Commonwealth filed an answer to the actuarial firm's petition and asserted counterclaims/cross-claims against the firm.

On March 9, 2015, the Secretary of the Kentucky Cabinet for Health and Family Services (CHFS) issued a determination letter finding that Kentucky Spirit owed the Commonwealth $40 million in actual damages plus prejudgment interest at 8 percent. On March 18, 2015, in a letter to the Kentucky Finance and Administration Cabinet (FAC), Kentucky Spirit contested CHFS' jurisdiction to make such a determination. The FAC did not issue a decision within the required 120 days. On August 13, 2015, Kentucky Spirit filed a declaratory judgment action against the Commonwealth in Franklin Circuit Court seeking a declaration that the Commonwealth may not purport to issue a decision against Kentucky Spirit awarding damages to itself when the matter is already before the Kentucky courts, and that the Commonwealth has waived its claims against Kentucky Spirit for damages arising out of the contract. The Commonwealth filed counterclaims seeking a Declaration of Rights and Entry of Judgment on its determination letter. On December 1, 2015, the Franklin Circuit Court consolidated this declaratory judgment action with Kentucky Spirit's other litigation claims against the Commonwealth. On December 15, 2015, the Franklin Circuit Court denied Kentucky Spirit's motion to dismiss the Commonwealth's counterclaim for Declaration of Rights and Entry of Judgment. Discovery is proceeding in the consolidated litigation matters.

The resolution of the Kentucky litigation matters may result in a range of possible outcomes. If Kentucky Spirit prevails on its claims, it would be entitled to damages. If the Commonwealth prevails, a liability to the Commonwealth could be recorded. The Company is unable to estimate the ultimate outcome resulting from the Kentucky litigation. As a result, the Company has not recorded any receivable or any liability for potential damages under the contract as of December 31, 2015. While uncertain, the ultimate resolution of the pending litigation could have a material effect on the financial position, cash flow or results of operations of the Company in the period it is resolved or becomes known.

Excluding the Kentucky matters discussed above, the Company is also routinely subjected to legal proceedings in the normal course of business. While the ultimate resolution of such matters in the normal course of business is uncertain, the Company does not expect the results of any of these matters individually, or in the aggregate, to have a material effect on its financial position, results of operations or cash flows.

Item 4. Mine Safety Disclosures

Not applicable.

Table of Contents

PART II

Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Market for Common Stock; Dividends

Our common stock has been traded and quoted on the New York Stock Exchange under the symbol “CNC” since October 16, 2003. On February 2, 2015, the Board of Directors declared a two-for-one split of Centene's common stock in the form of a 100% stock dividend distributed February 19, 2015 to stockholders of record on February 12, 2015. All share, per share and stock price information presented in this Form 10-K has been adjusted for the two-for-one stock split. The high and low prices, as reported by the NYSE, are set forth below for the periods indicated.



	2016 Stock Price (through February 17, 2016)				2015 Stock Price				2014 Stock Price
	High		Low		High		Low		High		Low
First Quarter	$	68.42	$	47.36	$	71.66	$	51.73	$	33.18	$	28.44
Second Quarter					82.18		61.85		38.84		27.56
Third Quarter					83.00		50.93		41.99		35.49
Fourth Quarter					67.53		51.75		54.24		37.53

As of February 17, 2016, there were 322 holders of record of our common stock.

We have never declared any cash dividends on our capital stock and currently anticipate that we will retain any future earnings for the development, operation and expansion of our business.

Issuer Purchases of Equity Securities

In 2009, the Company's Board of Directors extended the Company's stock repurchase program. The program authorizes the repurchase of up to 8,000,000 shares of the Company's common stock from time to time on the open market or through privately negotiated transactions. We have 3,335,448 available shares remaining under the program for repurchases as of December 31, 2015. No duration has been placed on the repurchase program. The Company reserves the right to discontinue the repurchase program at any time. During the year ended December 31, 2015, we did not repurchase any shares through this publicly announced program.



Issuer Purchases of Equity Securities Fourth Quarter 2015
Period	Total Number of Shares Purchased¹	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs²
October 1 – October 31, 2015	8,959	$	57.77	—	3,335,448
November 1 – November 30, 2015	10,759	59.95		—	3,335,448
December 1 – December 31, 2015	754,235	57.46		—	3,335,448
Total	773,953	$	57.50	—	3,335,448

⁽¹⁾ Shares acquired represent shares relinquished to the Company by certain employees for payment of taxes or option cost upon vesting of restricted stock units or option exercise. ⁽²⁾ Our Board of Directors adopted a stock repurchase program which allows for repurchases of up to a remaining amount of 3,335,448 shares. No duration has been placed on the repurchase program.

Table of Contents

Stock Performance Graph

The graph below compares the cumulative total stockholder return on our common stock for the period from December 31, 2010 to December 31, 2015 with the cumulative total return of the New York Stock Exchange Composite Index and the Standard & Poor's Supercomposite Managed Healthcare Index over the same period. The graph assumes an investment of $100 on December 31, 2010 in our common stock (at the last reported sale price on such day), the New York Stock Exchange Composite Index and the Standard & Poor's Supercomposite Managed Healthcare Index and assumes the reinvestment of any dividends.



	December 31,
	2010			2011			2012			2013			2014			2015
Centene Corporation	$	100.00		$	156.27		$	161.80		$	232.68		$	409.87		$	519.42
New York Stock Exchange Composite Index	100.00			93.89			106.02			130.59			136.10			127.37
S&P Supercomposite Managed Healthcare Index	100.00			133.96			140.46			203.83			271.09			325.43

Centene Corporation closing stock price	$	12.67		$	19.80		$	20.50		$	29.48		$	51.93		$	65.81
Centene Corporation annual shareholder return	19.6		%	56.3		%	3.5		%	43.8		%	76.2		%	26.7		%

In accordance with the rules of the SEC, the information contained in the Stock Performance Graph on this page shall not be deemed to be “soliciting material,” or to be “filed” with the SEC or subject to the SEC’s Regulation 14A, or to the liabilities of Section 18 of the Exchange Act, except to the extent that Centene specifically requests that the information be treated as soliciting material or specifically incorporates it by reference into a document filed under the Securities Act, or the Exchange Act.

Table of Contents

Item 6. Selected Financial Data

The following selected consolidated financial data should be read in conjunction with the consolidated financial statements and related notes and “Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations” included in our Annual Report on Form 10-K. The assets, liabilities and results of operations of Kentucky Spirit Health Plan have been classified as discontinued operations for all periods presented.



	Year Ended December 31,
	2015			2014			2013			2012			2011
	(In millions, except share data)
Revenues:
Premium	$	19,389		$	14,198		$	10,153		$	7,569		$	4,948
Service	1,876			1,469			373			113			104
Premium and service revenues	21,265			15,667			10,526			7,682			5,052
Premium tax and health insurer fee	1,495			893			337			428			159
Total revenues	22,760			16,560			10,863			8,110			5,211
Expenses:
Medical costs	17,242			12,678			8,995			6,781			4,191
Cost of services	1,621			1,280			327			88			78
General and administrative expenses	1,826			1,314			931			705			578
Premium tax expense	1,151			698			333			428			161
Health insurer fee expense	215			126			—			—			—
Total operating expenses	22,055			16,096			10,586			8,002			5,008
Earnings from operations	705			464			277			108			203
Other income (expense):
Investment and other income	35			28			19			35			13
Debt extinguishment costs	—			—			—			—			(8		)
Interest expense	(43		)	(35		)	(27		)	(20		)	(20		)
Earnings from continuing operations, before income tax expense	697			457			269			123			188
Income tax expense	339			196			107			47			71
Earnings from continuing operations, net of income tax expense	358			261			162			76			117
Discontinued operations, net of income tax expense (benefit) of $(1), $1, $2, $(48), and ($4), respectively	(1		)	3			4			(87		)	(9		)
Net earnings (loss)	357			264			166			(11		)	108
(Earnings) loss attributable to noncontrolling interests	(2		)	7			(1		)	13			3
Net earnings attributable to Centene Corporation	$	355		$	271		$	165		$	2		$	111

Amounts attributable to Centene Corporation common shareholders:
Earnings from continuing operations, net of income tax expense	$	356		$	268		$	161		$	89		$	120
Discontinued operations, net of income tax expense (benefit)	(1		)	3			4			(87		)	(9		)
Net earnings	$	355		$	271		$	165		$	2		$	111

Net earnings (loss) per common share attributable to Centene Corporation:
Basic:
Continuing operations	$	2.99		$	2.30		$	1.49		$	0.86		$	1.20
Discontinued operations	(0.01		)	0.03			0.03			(0.84		)	(0.09		)
Basic earnings per common share	$	2.98		$	2.33		$	1.52		$	0.02		$	1.11

Diluted:
Continuing operations	$	2.89		$	2.23		$	1.43		$	0.83		$	1.15
Discontinued operations	(0.01		)	0.02			0.04			(0.81		)	(0.09		)
Diluted earnings per common share	$	2.88		$	2.25		$	1.47		$	0.02		$	1.06

Weighted average number of common shares outstanding:
Basic	119,100,744			116,345,764			108,253,090			103,018,732			100,397,908
Diluted	123,066,370			120,360,212			112,494,346			107,428,750			104,948,476

Table of Contents



	December 31,
	2015		2014		2013		2012		2011
	(In millions)
Consolidated Balance Sheet Data:
Cash and cash equivalents ¹	$	1,760	$	1,610	$	974	$	746	$	494
Investments and restricted deposits ¹	2,218		1,557		941		727		653
Total assets	7,339		5,824		3,519		2,764		2,182
Medical claims liability ¹	2,298		1,723		1,112		815		519
Long term debt ¹	1,216		874		655		526		341
Total stockholders' equity	2,168		1,743		1,243		954		936

__________________________

¹ From continuing operations.

Table of Contents

ITEM 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the related notes included elsewhere in this filing. The discussion contains forward-looking statements that involve known and unknown risks and uncertainties, including those set forth under Part I, Item 1A.“Risk Factors” of this Form 10-K.

OVERVIEW

In 2013, we classified the operations for Kentucky Spirit Health Plan (KSHP) as discontinued operations for all periods presented in our consolidated financial statements. The following discussion and analysis, with the exception of cash flow information, is presented in the context of continuing operations unless otherwise identified.

Our financial performance for 2015 is summarized as follows:


•	Year-end managed care membership of 5.1 million, an increase of over 1.0 million members, or 26% over 2014.


•	Premium and service revenues of $21.3 billion, representing 36% growth year over year.


•	Health Benefits Ratio of 88.9%, compared to 89.3% in 2014.


•	General and Administrative expense ratio of 8.6%, compared to 8.4% in 2014.


•	Total operating cash flows of $658 million, or 1.8 times net earnings.


•	Diluted net earnings per share of $2.89, or $3.03 excluding $0.14 of diluted EPS of Health Net merger related expenses, compared to $2.23 in 2014.

The following items contributed to our revenue and membership growth over the last two years:


•	Arizona. In October 2015, our subsidiary, Cenpatico Integrated Care, in partnership with University of Arizona Health Plan, began operating under a contract with the Arizona Department of Health Services/Division of Behavioral Health Services to be the Regional Behavioral Health Authority for the new southern geographic service area.


•	California. In January 2014, California Health and Wellness (CHW), began serving members under the state's Medicaid expansion program. In December 2014, the ABD membership of CHW increased as a result of the mandatory transition of the ABD population to managed care. The enrollment of this population to managed care was previously voluntary.

•

Centurion. In January 2014, Centurion began operating under a new agreement with the Minnesota Department of Corrections to provide healthcare services to offenders in the state's correctional facilities. In February 2015, Centurion also began operating under a new contract with the State of Vermont Department of Corrections. In July 2015, Centurion began operating under a new contract with the Mississippi Department of Corrections.

•

Florida. In March 2014, our Florida subsidiary, Sunshine Health, completed the implementation of 10 regions under the state's new Medicaid managed care Long Term Care program. In May 2014, Sunshine Health began operating under a new contract in 9 of 11 regions of the Managed Medical Assistance (MMA) program. The MMA program includes TANF recipients as well as ABD and dual-eligible members. In addition, we began operating as the sole provider under a new statewide contract for the Child Welfare Specialty Plan (Foster Care). Enrollment for both the MMA program and Foster Care began in May 2014 and was implemented by region through August 2014.

In October 2015, Sunshine Health began operating under a two-year, statewide contract with the Florida Healthy Kids Corporation to manage healthcare services for children ages five through 18 in all 11 regions of Florida.


•	Health Insurance Marketplaces (HIM). In January 2014, we began serving members enrolled in Health Insurance Marketplaces in certain regions of nine states. In 2015, we expanded our participation in Health Insurance Marketplaces to include members in certain regions of 3 additional states.

Table of Contents


•	Illinois. In March 2014, our Illinois subsidiary, IlliniCare Health, began operating under a new contract as part of the Illinois Medicare-Medicaid Alignment Initiative serving dual-eligible members in Cook, DuPage, Lake, Kane, Kankakee and Will counties (Greater Chicago region).

In July 2014, IlliniCare Health began operating under a new contract with the Cook County Health and Hospitals System to perform third party administrative services to members enrolled in the CountyCare program, as well as care coordination, behavioral health, vision care and pharmacy benefit management services.

In September 2014, IlliniCare Health began serving additional Medicaid members under the state's Medicaid and Medicaid expansion programs.


•	Indiana. In February 2015, our Indiana subsidiary, Managed Health Services, began operating under an expanded contract with the Indiana Family & Social Services Administration to provide Medicaid services under the state's Healthy Indiana Plan 2.0 (HIP 2.0) program.

In April 2015, Managed Health Services began operating under an expanded contract with the Indiana Family & Social Services Administration to provide services to its ABD Medicaid enrollees who qualify for the new Hoosier Care Connect Program.


•	Louisiana. In July 2014, we completed the transaction whereby Community Health Solutions of America, Inc. assigned its contract with the Louisiana Department of Health and Hospitals under the Bayou Health Shared Savings Program to our subsidiary, Louisiana Healthcare Connections (LHC).

In February 2015, LHC began operating under a new contract with the Louisiana Department of Health and Hospitals to serve Bayou Health (Medicaid) beneficiaries. Members previously served under the shared savings program were transitioned to the at-risk program on February 1, 2015.

In December 2015, Louisiana Healthcare Connections began operating under an expanded contract to include behavioral health benefits.


•	Massachusetts. In January 2014, our CeltiCare Health subsidiary began operating under a new contract with the Massachusetts Executive Office of Health and Human Services to participate in the Medicaid expansion MassHealth CarePlus program in all five regions.

•

Michigan. In May 2015, we completed the acquisition of Fidelis SecureCare of Michigan, Inc. (Fidelis). Fidelis began operating under a new contract with the Michigan Department of Community Health and the Centers for Medicare and Medicaid Services to provide integrated healthcare services to members who are dually eligible for Medicare and Medicaid in Macomb and Wayne counties in May 2015. Passive enrollment began in July 2015.


•	Mississippi. In July 2014, our Mississippi subsidiary, Magnolia Health, began operating as one of two contractors under a new statewide managed care contract serving members enrolled in the Mississippi Coordinated Access Network program. Program expansion began in December 2014 and continued through July 2015.

In January 2015, Magnolia Health began operating under a new temporary six-month contract with the State of Mississippi to provide services under the Children's Health Insurance Program (CHIP). In July 2015, Magnolia Health began operating under a two-year CHIP contract with the State of Mississippi. In December 2015, Magnolia Health began operating under an expanded contract to include the inpatient benefit for Medicaid and ABD members.


•	New Hampshire. In September 2014, our New Hampshire subsidiary, New Hampshire Healthy Families, began serving members under the state's Medicaid expansion program.

•

Ohio. In January 2014, our Ohio Subsidiary, Buckeye Health Plan (Buckeye), began serving members under the state's Medicaid expansion program. In May 2014, Buckeye began operating under a new contract with the Ohio Department of Medicaid and the Centers for Medicare and Medicaid Services to serve Medicaid members in a dual-eligible demonstration program in three of seven regions: Northeast (Cleveland), Northwest (Toledo) and West Central (Dayton). This three-year program, which is part of the Integrated Care Delivery System expansion, serves those who have both Medicare and Medicaid eligibility. Passive enrollment for Medicaid began in May 2014 and implementation was completed in July 2014. Passive enrollment for Medicare began in January 2015.

Table of Contents


•	Oregon. In September 2015, we completed the acquisition of Agate Resources, Inc., a diversified holding company that offers primarily Medicaid and other healthcare products and services to Oregon residents through Trillium Community Health Plan.


•	South Carolina. In February 2015, our South Carolina subsidiary, Absolute Total Care, began operating under a new contract with the South Carolina Department of Health and Human Services and the Centers for Medicare and Medicaid Services to serve dual-eligible members as part of the state's dual demonstration program.

•

Texas. In September 2014, we began operating under a new contract with the Texas Health and Human Services Commission (HHSC) to expand our operations and serve STAR+PLUS members in two Medicaid Rural Service Areas. We also began providing expanded coverage in September 2014 under our STAR+PLUS contracts to provide acute care services for intellectually and developmentally disabled members. In March 2015, we began operating under an expanded STAR+PLUS contract with the Texas HHSC to include nursing facility benefits.

In March 2015, we also began operating under a new contract with the Texas HHSC and the Centers for Medicare and Medicaid Services to serve dual-eligible members in three counties as part of the state's dual demonstration program.


•	U.S. Medical Management. In January 2014, we acquired a majority interest in U.S. Medical Management, LLC, a management services organization and provider of in-home health services for high acuity populations.


•	Washington. In January 2014, our subsidiary, Coordinated Care, began serving additional Medicaid members under the state's Medicaid expansion program.

In addition, in July 2014, we completed an investment accounted for under the equity method for the purchase of a noncontrolling interest in Ribera Salud S.A. (Ribera Salud), a Spanish health management group. Centene is a joint shareholder with Ribera Salud's remaining investor, Banco Sabadell S.A.

We expect the following items to contribute to our future growth potential:


•	We expect to realize the full year benefit in 2016 of business commenced during 2015 in Arizona, Florida, Illinois, Indiana, Louisiana, Michigan, Mississippi, Oregon, South Carolina, Texas and Vermont as discussed above.


•	In February 2016, our Nebraska subsidiary, Nebraska Total Care, was recommended by the Nebraska Department of Health and Human Services’ Division of Medicaid and Long-Term Care as one of three managed care organizations to administer its new Heritage Health program for Medicaid and CHIP enrollees. The contract is expected to commence in the first quarter of 2017, pending regulatory approvals.


•	In February 2016, Centurion of Florida, LLC reached a formal agreement to provide correctional healthcare services for the Florida Department of Corrections in Regions 1, 2 and 3. The contract is expected to commence in the second quarter of 2016.


•	In January 2016, the governor of Louisiana signed an executive order to expand Medicaid coverage under the Affordable Care Act (ACA) by July 1, 2016.


•	In October 2015, our subsidiary, Superior HealthPlan, Inc., was awarded a contract by the Texas HHSC to serve seven delivery areas for STAR Kids Medicaid recipients. The new contract is expected to commence in the second half of 2016.

•

In September 2015, our subsidiary, Peach State Health Plan, was one of the Care Management Organizations selected to serve Medicaid recipients enrolled in the Georgia Families, PeachCare for Kids and Planning for Healthy Babies programs. The contract renewal is expected to commence in July 2016, pending regulatory approval. However, the expiration date of the current contract may be extended for up to two six-month periods.


•	In August 2015, our subsidiary, Coordinated Care of Washington, was selected by the Washington State Health Care Authority as the sole provider for the Apple Health Foster Care contract. The new contract is expected to commence in April of 2016, pending regulatory approvals.

Table of Contents


•	In July 2015, we entered into a definitive merger agreement with Health Net, Inc. (Health Net) under which we will acquire all of the issued and outstanding shares of Health Net. The transaction is valued at approximately $5.5 billion (based on Centene's closing stock price on February 17, 2016), including the assumption of debt. The transaction is expected to close in early 2016.

MEMBERSHIP

From December 31, 2013 to December 31, 2015, we increased our managed care membership by 2.2 million, or 77%. The following table sets forth our membership by state:



	December 31,
	2015	2014	2013
Arizona	440,900	204,000	163,700
Arkansas	41,900	38,400	—
California	186,000	163,900	97,200
Florida	510,400	425,700	222,000
Georgia	408,600	389,100	318,700
Illinois	207,500	87,800	22,300
Indiana	282,100	197,700	195,500
Kansas	141,000	143,300	139,900
Louisiana	381,900	152,900	152,300
Massachusetts	61,500	48,400	22,600
Michigan	4,800	—	—
Minnesota	9,600	9,500	—
Mississippi	302,200	108,700	78,300
Missouri	95,100	71,000	59,200
New Hampshire	71,400	62,700	33,600
Ohio	302,700	280,100	173,200
Oregon	98,700	—	—
South Carolina	104,000	109,700	91,900
Tennessee	20,000	21,000	20,700
Texas	983,100	971,000	935,100
Vermont	1,700	—	—
Washington	209,400	194,400	82,100
Wisconsin	77,100	83,200	71,500
Total at-risk membership	4,941,600	3,762,500	2,879,800
Non-risk membership	166,300	298,400	—
Total	5,107,900	4,060,900	2,879,800

At December 31, 2015, we served 449,000 members in Medicaid expansion programs in eight states compared to 201,300 members at December 31, 2014 in six states, included in the table above.

The following table sets forth our membership by line of business:

Table of Contents



	December 31,
	2015	2014	2013
Medicaid	3,497,500	2,754,900	2,054,700
CHIP & Foster Care	260,900	222,700	275,100
ABD, Medicare & Duals	446,000	392,700	305,300
Health Insurance Marketplaces	146,100	74,500	—
Hybrid Programs	—	18,900	19,000
LTC	75,000	60,800	37,800
Behavioral Health	456,800	197,000	156,600
Correctional Healthcare Services	59,300	41,000	31,300
Total at-risk membership	4,941,600	3,762,500	2,879,800
Non-risk membership	166,300	298,400	—
Total	5,107,900	4,060,900	2,879,800

The following table identifies the Company's dual-eligible membership by line of business. The membership tables above include these members.



	December 31,
	2015	2014	2013
ABD	112,300	118,300	71,700
LTC	55,100	35,900	28,800
Medicare	11,100	7,200	6,500
Medicaid / Medicare Duals	26,300	3,200	—
Total	204,800	164,600	107,000

The reduction in ABD is the result of members transitioning to Medicaid / Medicare Duals.

From December 31, 2014 to December 31, 2015, our membership increased as a result of:


•	product and geographic expansions in Arizona, Florida, Louisiana, Mississippi, South Carolina, and Texas;


•	the acquisition of Agate Resources, Inc., our Oregon subsidiary;


•	the commencement of HIP 2.0 program in Indiana;


•	the commencement of Health Insurance Marketplaces in certain regions of Illinois, Oregon and Wisconsin;


•	organic growth in Illinois; and


•	the commencement of correctional healthcare service contracts in Mississippi and Vermont.

From December 31, 2013 to December 31, 2014, our membership increased as a result of:


•	product and geographic expansions in Florida and Illinois;


•	the assignment of members in Louisiana under the CHS transaction;


•	the commencement of Medicaid expansion programs in California, Illinois, Massachusetts, New Hampshire, Ohio, and Washington;


•	the commencement of Health Insurance Marketplaces in certain regions of nine states: Arkansas, Florida, Georgia, Indiana, Massachusetts, Mississippi, Ohio, Texas and Washington;


•	product expansions in Mississippi and Texas;


•	organic growth in South Carolina; and


•	the commencement of a correctional healthcare service contract in Minnesota.

Table of Contents

RESULTS OF OPERATIONS

The following discussion and analysis is based on our consolidated statements of operations, which reflect our results of operations for each of the three years ended December 31, 2015, prepared in accordance with generally accepted accounting principles in the United States ($ in millions, except per share data):



	2015			2014			2013			% Change 2014-2015		% Change 2013-2014
Premium	$	19,389		$	14,198		$	10,153		37	%	40	%
Service	1,876			1,469			373			28	%	294	%
Premium and service revenues	21,265			15,667			10,526			36	%	49	%
Premium tax and health insurer fee	1,495			893			337			67	%	165	%
Total revenues	22,760			16,560			10,863			37	%	52	%
Medical costs	17,242			12,678			8,995			36	%	41	%
Cost of services	1,621			1,280			327			27	%	291	%
General and administrative expenses	1,826			1,314			931			39	%	41	%
Premium tax expense	1,151			698			333			65	%	110	%
Health insurer fee expense	215			126			—			71	%	n.a.
Earnings from operations	705			464			277			52	%	68	%
Investment and other income, net	(8		)	(7		)	(8		)	(14	)%	13	%
Earnings from continuing operations, before income tax expense	697			457			269			53	%	70	%
Income tax expense	339			196			107			73	%	83	%
Earnings from continuing operations, net of income tax	358			261			162			37	%	61	%
Discontinued operations, net of income tax expense (benefit) of $(1), $1, and $2, respectively	(1		)	3			4			(133	)%	(25	)%
Net earnings	357			264			166			35	%	59	%
(Earnings) loss attributable to noncontrolling interests	(2		)	7			(1		)	129	%	n.m.
Net earnings attributable to Centene Corporation	$	355		$	271		$	165		31	%	64	%

Amounts attributable to Centene Corporation common shareholders:
Earnings from continuing operations, net of income tax expense	$	356		$	268		$	161		33	%	66	%
Discontinued operations, net of income tax expense (benefit)	(1		)	3			4			(133	)%	(25	)%
Net earnings	$	355		$	271		$	165		31	%	64	%

Diluted earnings (loss) per common share attributable to Centene Corporation:
Continuing operations	$	2.89		$	2.23		$	1.43		30	%	56	%
Discontinued operations	(0.01		)	0.02			0.04			(150	)%	(50	)%
Total diluted earnings per common share	$	2.88		$	2.25		$	1.47		28	%	53	%

n.a.: not applicable

n.m.: not meaningful

Table of Contents

Revenues and Revenue Recognition

Our health plans generate revenues primarily from premiums we receive from the states in which we operate. We generally receive a fixed premium per member per month pursuant to our state contracts. We generally receive premium payments and recognize premium revenue during the month in which we are obligated to provide services to our members. In some instances, our base premiums are subject to an adjustment, or risk score, based on the acuity of our membership. Generally, the risk score is determined by the state analyzing submissions of processed claims data to determine the acuity of our membership relative to the entire state's membership. Some contracts allow for additional premiums associated with certain supplemental services provided such as maternity deliveries.

Our contracts with states may require us to maintain a minimum health benefits ratio or may require us to share profits in excess of certain levels. In certain circumstances, our plans may be required to return premium to the state in the event profits exceed established levels. We recognize reductions in revenue in the current period for these programs. Other states may require us to meet certain performance and quality metrics in order to receive additional or full contractual revenue. For performance-based contracts, we do not recognize revenue subject to refund until data is sufficient to measure performance.

Revenues are recorded based on membership and eligibility data provided by the states, which is adjusted on a monthly basis by the states for retroactive additions or deletions to membership data. These eligibility adjustments are estimated monthly and subsequently adjusted in the period known. We continuously review and update those estimates as new information becomes available. It is possible that new information could require us to make additional adjustments, which could be significant, to these estimates.

Our specialty services generate revenues under contracts with state programs, healthcare organizations, and other commercial organizations, as well as from our own subsidiaries. Revenues are recognized when the related services are provided or as ratably earned over the covered period of services.

Premium and service revenues collected in advance are recorded as unearned revenue. Premium and service revenues due to us are recorded as premium and related receivables and are recorded net of an allowance based on historical trends and our management's judgment of the collectibility of these accounts. As we generally receive payments during the month in which services are provided, the allowance is typically not significant in comparison to total revenues and does not have a material impact on the presentation of our financial condition or results of operations.

Some states enact premium taxes, similar assessments and provider and hospital pass-through payments, collectively, premium taxes, and these taxes are recorded as a component of revenues as well as operating expenses. Additionally, our insurance subsidiaries are subject to the Affordable Care Act annual Health Insurer Fee (HIF). The Company recognizes revenue associated with the HIF on a straight line basis when we have binding agreements for the reimbursement of the fee, including the “gross-up” to reflect the HIFs non-tax deductible nature. We exclude the HIF and premium taxes from our key ratios as we believe they are a pass-through of costs and not indicative of our operating performance. Collectively, this revenue is recorded as Premium Tax and HIF revenue in the consolidated statement of operations.

The Centers for Medicare and Medicaid Services (CMS) deploys a risk adjustment model that retroactively apportions Medicare premiums paid according to health severity and certain demographic factors. The model pays more for members whose medical history indicates they have certain medical conditions. Under this risk adjustment methodology, CMS calculates the risk adjusted premium payment using diagnosis data from hospital inpatient, hospital outpatient, physician treatment settings as well as prescription drug events. The Company estimates the amount of risk adjustment based upon the diagnosis and pharmacy data submitted and expected to be submitted to CMS and records revenues on a risk adjusted basis.

Operating Expenses

Medical Costs

Medical costs include payments to physicians, hospitals, and other providers for healthcare and specialty services claims. Medical costs also include estimates of medical expenses incurred but not yet reported, or IBNR, and estimates of the cost to process unpaid claims. We use our judgment to determine the assumptions to be used in the calculation of the required IBNR estimate. The assumptions we consider include, without limitation, claims receipt and payment experience (and variations in that experience), changes in membership, provider billing practices, healthcare service utilization trends, cost trends, product mix, seasonality, prior authorization of medical services, benefit changes, known outbreaks of disease or increased incidence of illness such as influenza, provider contract changes, changes to Medicaid fee schedules, and the incidence of high dollar or catastrophic claims.

Table of Contents

Our development of the IBNR estimate is a continuous process which we monitor and refine on a monthly basis as claims receipts and payment information becomes available. As more complete information becomes available, we adjust the amount of the estimate, and include the changes in estimates in medical expense in the period in which the changes are identified.

Additionally, we contract with independent actuaries to review our estimates on a quarterly basis. The independent actuaries provide us with a review letter that includes the results of their analysis of our medical claims liability. We do not solely rely on their report to adjust our claims liability. We utilize their calculation of our claims liability only as additional information, together with management's judgment, to determine the assumptions to be used in the calculation of our liability for medical costs.

While we believe our IBNR estimate is appropriate, it is possible future events could require us to make significant adjustments for revisions to these estimates. Accordingly, we cannot assure you that medical costs will not materially differ from our estimates.

Results of operations depend on our ability to manage expenses associated with health benefits and to accurately estimate costs incurred. The Health Benefits Ratio, or HBR, represents medical costs as a percentage of premium revenues (excluding Premium Tax and Health Insurer Fee revenues) and reflects the direct relationship between the premium received and the medical services provided.

Cost of Services

Cost of services expense includes the pharmaceutical costs associated with our pharmacy benefit manager and specialty pharmacy's external revenues and certain direct costs to support the functions responsible for generation of our service revenues. These expenses consist of the salaries and wages of the professionals who provide the services and associated expenses.

General and Administrative Expenses

General and administrative expenses, or G&A, primarily reflect wages and benefits, including stock compensation expense, and other administrative costs associated with our health plans, specialty companies and centralized functions that support all of our business units. Our major centralized functions are finance, information systems and claims processing. G&A expenses also include business expansion costs, such as wages and benefits for administrative personnel, contracting costs, and information technology buildouts, incurred prior to the commencement of a new contract or health plan.

The G&A expense ratio represents G&A expenses as a percentage of premium and service revenues, and reflects the relationship between revenues earned and the costs necessary to earn those revenues.

Health Insurer Fee

The Health Insurer Fee reflects the annual fee mandated by the ACA to health insurers. The fee is determined based on our premium revenues in the previous year. Each health insurer's fee is calculated by multiplying its market share by the annual fee. Market share is based on commercial, Medicare, and Medicaid premium revenue.

Other Income (Expense)

Other income (expense) consists principally of investment income from cash and investments, earnings in equity method investments, and interest expense on debt.

Discontinued Operations

Our subsidiary, Kentucky Spirit Health Plan (KSHP), ceased serving Medicaid members in Kentucky as of July 6, 2013. Accordingly, the results of operations for KSHP are classified as discontinued operations for all periods presented in our consolidated financial statements. The following discussion and analysis is presented primarily in the context of continuing operations unless otherwise identified.

Table of Contents

Year Ended December 31, 2015 Compared to Year Ended December 31, 2014

Premium and Service Revenues

Premium and service revenues increased 36% in the year ended December 31, 2015 over the corresponding period in 2014 primarily as a result of the impact from expansions or new programs in many of our states, particularly, Florida, Illinois, Indiana, Louisiana, Mississippi, Ohio and Texas. During the year ended December 31, 2015, we received premium rate adjustments which yielded a net 1% composite change across all of our markets.

Operating Expenses

Medical Costs



	2015		2014
Medicaid, CHIP, Foster Care & HIM	86.0	%	86.3	%
ABD, LTC and Medicare	92.9		93.5
Specialty Services	85.8		85.5
Total	88.9		89.3

The consolidated HBR for the year ended December 31, 2015 of 88.9% was a decrease of 40 basis points over the comparable period in 2014. The decrease compared to last year is primarily attributable to improvement in medical expense in the high acuity populations (LTC/MMP) and membership growth in Medicaid expansion programs and Health Insurance Marketplace, which operate at a lower HBR than traditional Medicaid businesses.

Cost of Services

Cost of services increased by $341 million in the year ended December 31, 2015, compared to the corresponding period in 2014. This was primarily due to growth in the AcariaHealth business. The cost of service ratio for the year ended December 31, 2015, was 86.4% compared to 87.1% in 2014.

General and Administrative Expenses

General and administrative expenses, or G&A, increased by $512 million in the year ended December 31, 2015, compared to the corresponding period in 2014. This was primarily due to expenses for additional staff and facilities to support our membership growth. During the year ended December 31, 2015, we recorded approximately $27 million of Health Net merger related expenses, which reduced our diluted earnings per share by $0.14.

During the first quarter of 2015, we recorded a gain of $10 million on the settlement of contingent consideration related to the CHS transaction. We also recorded expense of $10 million for a contribution to our charitable foundation during the first quarter of 2015.

Also during 2015, we experienced higher than anticipated opt-out rates and member attrition in the new Michigan dual demonstration program, resulting in lower than expected membership and lower blended premium rates. As a result, the fair value of estimated contingent consideration was reduced from $50 million to $16 million, and we recorded a gain of $34 million in general and administrative expenses. In connection with the lower membership and revenue outlook, we conducted an impairment analysis of the identifiable intangible assets and goodwill, resulting in a reduction of goodwill and intangible assets of $38 million which was recorded in general and administrative expenses. The Company's initial allocation of fair value resulted in goodwill and intangible assets of $52 million. At December 31, 2015, the Company had goodwill of $11 million and other identifiable intangible assets of $1 million, net of $2 million of amortization, remaining on the balance sheet.

Table of Contents

The consolidated G&A expense ratio for the years ended December 31, 2015 and 2014 was 8.6% and 8.4%, respectively. The G&A ratio for the year ended December 31, 2015 was 8.5% excluding the impact of the Health Net merger related expenses. The increase over prior year is primarily related to the expansion of our Health Insurance Marketplace business which operates at a higher G&A ratio and incurred higher open enrollment costs in the fourth quarter of the current year.

Health Insurer Fee

During the year ended December 31, 2015, we recorded $215 million of non-deductible expense for the Affordable Care Act (ACA) annual health insurer fee, compared to $126 million for the year ended December 31, 2014. As of December 31, 2015, we recorded $344 million in Premium Tax and Health Insurer Fee revenue associated with the accrual for the reimbursement of the fee, compared to $195 million in 2014.

Other Income (Expense)

The following table summarizes the components of other income (expense) for the year ended December 31, ($ in millions):



	2015			2014
Investment income	$	27		$	22
Earnings from equity method investments	8			6
Interest expense	(43		)	(35		)
Other income (expense), net	$	(8	)	$	(7	)

The increase in investment income in 2015 reflects an increase in investment balances over 2014 and improved performance of certain equity investments. Interest expense increased during the year ended December 31, 2015 by $8 million primarily reflecting the issuance of $300 million of Senior Notes in April 2014 and the issuance of an additional $200 million in Senior Notes in January 2015.

Income Tax Expense

Our effective tax rate for the year ended December 31, 2015 was 48.6% compared to 42.9% in 2014. The effective tax rate is higher than the applicable statutory rate primarily as a result of the non-deductibility of the health insurer fee expense.

Segment Results

The following table summarizes our consolidated operating results by segment for the year ended December 31, ($ in millions):



	2015			2014			% Change 2014-2015
Premium and Service Revenues
Managed Care	$	19,154		$	13,946		37	%
Specialty Services	7,075			4,800			47	%
Eliminations	(4,964		)	(3,079		)	(61	)%
Consolidated Total	$	21,265		$	15,667		36	%
Earnings from Operations
Managed Care	$	513		$	353		45	%
Specialty Services	192			111			73	%
Consolidated Total	$	705		$	464		52	%

Table of Contents

Managed Care

Premium and service revenues increased 37% in the year ended December 31, 2015, primarily as a result of expansions or new programs in many of our states, particularly Florida, Illinois, Indiana, Louisiana, Mississippi, Ohio and Texas. Earnings from operations increased $160 million between years primarily reflecting growth in the business.

Specialty Services

Premium and service revenues increased 47% in the year ended December 31, 2015, resulting primarily from increased service associated with membership growth in the Managed Care segment and growth in our pharmacy businesses. Earnings from operations increased $81 million in the year ended December 31, 2015, primarily reflecting growth in the specialty services provided to our increased Managed Care membership.

Year Ended December 31, 2014 Compared to Year Ended December 31, 2013

Premium and Service Revenues

Premium and service revenues increased 49% in the year ended December 31, 2014 over the corresponding period in 2013 as a result of expansions in Florida, Ohio, Washington, Texas and Illinois, growth in the AcariaHealth business, the addition of the California and New Hampshire operations and our participation in the Health Insurance Marketplaces. During the year ended December 31, 2014 we received premium rate adjustments which yielded an approximate net 1% composite increase across all of our markets.

Operating Expenses

Medical Costs

The table below depicts the HBR for our membership by member category for the year ended December 31,:



	2014		2013
Medicaid, CHIP, Foster Care & HIM	86.3	%	87.5	%
ABD, LTC and Medicare	93.5		90.4
Specialty Services	85.5		85.4
Total	89.3		88.6

The consolidated HBR for the year ended December 31, 2014, of 89.3% was an increase of 70 basis points over the comparable period in 2013. The increase compared to last year is primarily attributable to an increase in complex care membership over the prior year.

Cost of Services

Cost of services increased by $953 million in the year ended December 31, 2014, compared to the corresponding period in 2013. This was primarily due to the acquisition of and growth in our AcariaHealth business as well as the acquisition of U.S. Medical Management. The cost of service ratio for the year ended December 31, 2014, was 87.1% compared to 87.7% in 2013.

General and Administrative Expenses

General and administrative expenses, or G&A, increased by $383 million in the year ended December 31, 2014, compared to the corresponding period in 2013. This was primarily due to expenses for additional staff and facilities to support our membership growth.

The consolidated G&A expense ratio for the years ended December 31, 2014 and 2013 was 8.4% and 8.8%, respectively. The year over year decrease in the G&A ratio reflects the leveraging of expenses over higher revenues in 2014, offset by the acquisition of U.S. Medical Management and start up of Health Insurance Marketplaces which operate at higher G&A ratios.

Table of Contents

Health Insurer Fee

During the year ended December 31, 2014, we recorded $126 million of non-deductible expense for the Affordable Care Act (ACA) annual health insurer fee. As of December 31, 2014, we had received signed agreements representing virtually all of the total revenue associated with the reimbursement of the ACA insurer fee including the related gross-up for the associated income tax effects. As a result, we recorded $195 million in Premium Tax and Health Insurer Fee revenue associated with the reimbursement of the fee.

Other Income (Expense)

The following table summarizes the components of other income (expense) for the year ended December 31, ($ in millions):



	2014			2013
Investment income	$	22		$	18
Earnings from equity method investments	6			1
Interest expense	(35		)	(27		)
Other income (expense), net	$	(7	)	$	(8	)

The increase in investment income in 2014 reflects an increase in investment balances over 2013 and improved performance of certain equity investments. Interest expense increased during the year ended December 31, 2014 by $8 million reflecting the issuance of an additional $300 million in Senior Notes in April 2014 and a higher level of borrowings under our revolving credit agreement.

Income Tax Expense

Our effective tax rate for the year ended December 31, 2014 was 42.9% compared to 39.8% in 2013. The increase is due to the non-deductibility of the health insurer fee which increased our effective tax rate. This was partially offset by a reduction of tax expense associated with the compensation deduction limitation. During 2014, the IRS issued final regulations related to the compensation deduction limitation applicable to certain health insurance providers. Accordingly, we reversed previously recorded tax expense of $14 million for prior years resulting in a decrease in the effective tax rate which offset the health insurer fee impact. As a result, we no longer believe the deduction limitation applies.

Segment Results

The following table summarizes our consolidated operating results by segment for the year ended December 31, ($ in millions):



	2014			2013			% Change 2013-2014
Premium and Service Revenues
Managed Care	$	13,946		$	9,782		43	%
Specialty Services	4,800			2,932			64	%
Eliminations	(3,079		)	(2,188		)	(41	)%
Consolidated Total	$	15,667		$	10,526		49	%
Earnings from Operations
Managed Care	$	353		$	198		78	%
Specialty Services	111			79			41	%
Consolidated Total	$	464		$	277		68	%

Managed Care

Premium and service revenues increased 43% in the year ended December 31, 2014, primarily as a result of expansions in Florida, Ohio, Washington, Mississippi, Texas and Illinois, the addition of the California and New Hampshire operations and our participation in the Health Insurance Marketplaces. Earnings from operations increased $155 million in the year ended December 31, 2014, primarily reflecting growth in the business.

Table of Contents

Specialty Services

Premium and service revenues increased 64% in the year ended December 31, 2014, resulting from growth in our AcariaHealth business, increased services associated with membership growth in the Managed Care segment, the addition of three Centurion contracts and the acquisition of U.S. Medical Management. Earnings from operations increased $32 million in the year ended December 31, 2014, primarily reflecting growth in the AcariaHealth business as well as favorable performance in our legacy individual health business.

Table of Contents

LIQUIDITY AND CAPITAL RESOURCES

Shown below is a condensed schedule of cash flows for the years ended December 31, 2015, 2014 and 2013, used in the discussion of liquidity and capital resources ($ in millions).



	Year Ended December 31,
	2015			2014			2013
Net cash provided by operating activities	$	658		$	1,223		$	382
Net cash used in investing activities	(813		)	(848		)	(342		)
Net cash provided by financing activities	305			198			154
Effect of exchange rate changes on cash and cash equivalents	—			(1		)	—
Net increase in cash and cash equivalents	$	150		$	572		$	194

Cash Flows Provided by Operating Activities

Normal operations are funded primarily through operating cash flows and borrowings under our revolving credit facility. Cash flows from operating activities for 2015 were $658 million, 1.8 times net earnings, compared to $1,223 million in 2014. The cash provided by operations in 2015 and 2014 was primarily related to net earnings and an increase in medical claims liabilities resulting from growth in the business, partially offset by increases in premium and related receivables.

Cash flows from operating activities for 2014 increased to $1,223 million, compared to $382 million in 2013. Operating cash flows in 2014 significantly benefited from the 49% premium and service revenue growth, which resulted in increased medical claims liabilities. In addition, 2014 uniquely benefited from an increase in payables associated with various programs requiring a return of premium to state customers. Cash flows from operating activities benefited in 2013 due to an increase in net earnings and growth in our business.

Cash flows from operations in each year were impacted by the timing of payments we received from our states. States may prepay the following month premium payment, which we record as unearned revenue, or they may delay our premium payment, which we record as a receivable. We typically receive capitation payments monthly, however the states in which we operate may decide to adjust their payment schedules which could positively or negatively impact our reported cash flows from operating activities in any given period.

The reimbursement of the HIF from our state customers may be settled as a separate payment or monthly in combination with our other premium payments. The vast majority of our state customers are settling the reimbursement through a separate payment after verification of each state's portion of our HIF, resulting in an increase in Premium and Related Receivables at December 31, 2015. During 2015, we paid the 2015 annual HIF totaling $220 million. This negatively impacted our cash flows as we have not been reimbursed from the majority of our state customers. Similarly, during 2014, we paid the 2014 annual HIF invoice totaling $126 million. The table below details the impact to cash flows from operations from the timing of payments from our states ($ in millions).



	Year Ended December 31,
	2015			2014			2013
(Increase) in premium and related receivables	$	(360	)	$	(463	)	$	(143	)
Increase (decrease) in unearned revenue	(27		)	129			3
Net (decrease) in operating cash flow	$	(387	)	$	(334	)	$	(140	)

Cash Flows Used in Investing Activities

Investing activities used cash of $813 million for the year ended December 31, 2015, and $848 million in the comparable period in 2014. Cash flows used in investing activities in 2015 primarily consisted of additions to the investment portfolio of our regulated subsidiaries, including transfers from cash and cash equivalents to long term investments and capital expenditures.

In January 2015, we sold a 25% ownership interest in Celtic Insurance Company. No gain or loss was recognized on the sale of the ownership interest. Celtic Insurance Company is included in the Managed Care segment. Under the terms of the agreement, we entered into a put agreement with the noncontrolling interest holder to purchase the noncontrolling interest at a later date.

Table of Contents

Cash flows used in investing activities in 2014 primarily consisted of additions to the investment portfolio of our regulated subsidiaries, including transfers from cash and cash equivalents to long term investments, the acquisition of U.S. Medical Management and CHS, an equity investment in Ribera Salud and capital expenditures. We completed the acquisition of U.S. Medical Management for $213 million in total consideration. The transaction was financed through a combination of Centene common stock as well as $80 million of cash. We also completed a transaction with CHS for initial cash consideration of $56 million as well as common stock. Additionally, we purchased a noncontrolling interest in Ribera Salud, S.A. (Ribera Salud), a Spanish health management group for $17 million. During 2013, our investing activities primarily related to additions to the investment portfolio of our regulated subsidiaries, including transfers from cash and cash equivalents to long term investments, the acquisition of AcariaHealth and capital expenditures. We completed the acquisition of AcariaHealth for $142 million in total consideration. The transaction was financed through a combination of Centene common stock as well as $67 million of cash.

Our investment policies are designed to provide liquidity, preserve capital and maximize total return on invested assets within our guidelines. Net cash provided by and used in investing activities will fluctuate from year to year due to the timing of investment purchases, sales and maturities. As of December 31, 2015, our investment portfolio consisted primarily of fixed-income securities with an average duration of 2.9 years. These securities generally are actively traded in secondary markets and the reported fair market value is determined based on recent trading activity, recent trading activity in similar securities and other observable inputs. Our investment guidelines comply with the regulatory restrictions enacted in each state. We had unregulated cash and investments of $78 million at December 31, 2015, compared to $85 million at December 31, 2014.

We spent $150 million, $103 million and $68 million in 2015, 2014 and 2013, respectively, on capital expenditures for system enhancements and market expansions.

Cash Flows Provided by Financing Activities

Our financing activities provided cash of $305 million, $198 million and $154 million in 2015, 2014 and 2013, respectively. Financing activities in 2015, 2014 and 2013 are discussed below.

2015

During 2015, our financing activities primarily related to the proceeds from the issuance of Senior Debt and an additional $150 million of borrowings on our revolving credit facility. In January 2015, we issued an additional $200 million of 4.75% Senior Notes due May 15, 2022 at par (Add on Notes). In connection with the January 2015 issuance, we entered into interest rate swap agreements for a notional amount of $200 million (2015 Swap Agreements) that are scheduled to expire on May 15, 2022. Under the 2015 Swap Agreements, we receive a fixed rate of 4.75% and pay a variable rate of LIBOR plus a spread adjusted quarterly, which allows us to adjust the $200 million Notes to a floating rate. We do not hold or issue any derivative instrument for trading or speculative purposes.

2014

In April 2014, pursuant to a shelf registration statement, we issued $300 million 4.75% Senior Notes due May 15, 2022 at par. Interest is paid semi-annually in May and November. In connection with the issuance, we entered into $300 million notional amount of interest rate swap agreements (2014 Swap Agreements) that are scheduled to expire May 15, 2022. Under the 2014 Swap Agreements, we receive a fixed rate of 4.75% and pay a variable rate of LIBOR plus a spread adjusted quarterly, which allows us to adjust the $300 million Notes to a floating rate. We do not hold or issue any derivative instrument for trading or speculative purposes.

2013

During 2013, our financing activities primarily related to borrowings under our revolving credit facility, the sale of $15 million of common stock to fund the escrow account for the acquisition of AcariaHealth and the repayment of a mortgage note.

In May 2013, we entered into a new unsecured $500 million revolving credit facility and terminated our previous $350 million revolving credit facility. Borrowings under the agreement bear interest based upon LIBOR rates, the Federal Funds Rate or the Prime Rate. The agreement has a maturity date of June 1, 2018, provided it will mature 90 days prior to the maturity date of the 5.75% Senior Notes due 2017 if such notes are not refinanced (or extended) or certain financial conditions are not met, including carrying $100 million of unrestricted cash on deposit.

Table of Contents

Liquidity Metrics

The $500 million revolving credit agreement contains non-financial and financial covenants, including requirements of minimum fixed charge coverage ratios, maximum debt-to-EBITDA ratios and minimum tangible net worth. We are required not to exceed a maximum debt-to-EBITDA ratio of 3.0 to 1.0. As of December 31, 2015, we had $225 million in borrowings outstanding under our revolving credit facility, and we were in compliance with all covenants. As of December 31, 2015, there were no limitations on the availability under the revolving credit agreement as a result of the debt-to-EBITDA ratio.

We had outstanding letters of credit of $47 million as of December 31, 2015, which were not part of our revolving credit facility. We also had letters of credit for $50 million (valued at the December 31, 2015 conversion rate), or €46 million, representing our proportional share of the letters of credit issued to support Ribera Salud's outstanding debt which are a part of the revolving credit facility. Collectively, the letters of credit bore interest at 1.55% as of December 31, 2015. In addition, we had outstanding surety bonds of $305 million as of December 31, 2015.

The indenture governing our Senior Notes contains non-financial and financial covenants, including requirements of a minimum fixed charge coverage ratio.

At December 31, 2015, we had working capital, defined as current assets less current liabilities, of negative $24 million, compared to $51 million at December 31, 2014. We manage our short term and long term investments with the goal of ensuring that a sufficient portion is held in investments that are highly liquid and can be sold to fund short term requirements as needed.

At December 31, 2015, our debt to capital ratio, defined as total debt divided by the sum of total debt and total equity, was 36.0%, compared to 33.5% at December 31, 2014. Excluding the $67 million non-recourse mortgage note, our debt to capital ratio was 34.7% as of December 31, 2015, compared to 31.7% at December 31, 2014. We utilize the debt to capital ratio as a measure, among others, of our leverage and financial flexibility.

We have a stock repurchase program authorizing us to repurchase up to 8 million shares of common stock from time to time on the open market or through privately negotiated transactions. We have 3 million available shares remaining under the program for repurchases as of December 31, 2015. No duration has been placed on the repurchase program. We reserve the right to discontinue the repurchase program at any time. We did not make any repurchases under this plan during 2015, 2014 or 2013.

During the year ended December 31, 2015, 2014 and 2013, we received dividends of $11 million, $50 million, and $18 million, respectively, from our regulated subsidiaries.

2016 Expectations

In early 2016, we expect to complete the merger with Health Net, a publicly traded managed care organization that delivers health care services through health plans and government-sponsored managed care plans, for approximately $5.5 billion. In connection with the upcoming closing of the merger, in February 2016, our wholly owned unrestricted subsidiary (Escrow Issuers) issued approximately $1.4 billion 5.625% Senior Notes due 2021 at par and $1.0 billion 6.125% Senior Notes due 2024 at par. The transaction will be financed through a combination of borrowings on our revolving credit facility, existing cash on hand, the $2.4 billion February debt issuance, and approximately $2.8 billion in shares of Centene common stock. The proceeds of the debt issuance will be held in escrow until the closing of the Health Net merger. If the Health Net merger is not consummated, the Escrow Issuer will be required to redeem each series of Notes at a redemption price equal to 100% of the principal amount of such series of Notes, plus accrued and unpaid interest to the redemption date.

Upon execution of the merger agreement, the Company negotiated the terms of a new unsecured $1,000 million revolving credit facility with its banking syndicate. The new $1,000 million revolving credit facility is effective upon the closing of the merger and the existing $500 million unsecured revolving credit facility will be terminated simultaneously.

Including the effects of potential contributions and expenditures related to Health Net, we expect to make net capital contributions to our insurance subsidiaries of approximately $250 million during 2016 associated with our growth and spend approximately $330 million in additional capital expenditures primarily associated with system enhancements, integration, and market expansions. These capital contributions are expected to be funded by unregulated cash flow generation in 2016 and borrowings on our revolving credit facility.

Table of Contents

In January 2016, the Company announced an ongoing comprehensive internal search for six hard drives that were unaccounted for in its inventory of approximately 26,000 information technology (IT) devices. This incident resulted from an employee not following established procedures on storing IT hardware. In the process of completing its investigation, in February 2016, the Company received an admission from an employee to placing the six hard drives in a locked receptacle for secure destruction. As a result, the Company satisfied itself and concluded its investigation.

Based on our operating plan, we expect that our available cash, cash equivalents and investments, cash from our operations and cash available under our credit facility will be sufficient to finance our general operations and capital expenditures for at least 12 months from the date of this filing.

CONTRACTUAL OBLIGATIONS

The following table summarizes future contractual obligations. These obligations contain estimates and are subject to revision under a number of circumstances. Our debt consists of borrowings from our senior notes, credit facility, mortgages and capital leases. The purchase obligations consist primarily of software purchases and maintenance contracts. The contractual obligations and estimated period of payment over the next five years and beyond are as follows (in millions):



	Payments Due by Period
	Total		Less Than 1 Year		1-3 Years		3-5 Years		More Than 5 Years
Medical claims liability	$	2,298	$	2,298	$	—	$	—	$	—
Debt and interest	1,454		56		722		61		615
Redeemable Noncontrolling Interest	156		—		156		—		—
Operating lease obligations	315		58		109		78		70
Purchase obligations	79		31		43		5		—
Other long term liabilities ¹	—		—		—		—		—
Total	$	4,302	$	2,443	$	1,030	$	144	$	685

^{________________________________}

¹ Our Consolidated Balance Sheet as of December 31, 2015, includes $170 million of other long term liabilities. This consists primarily of long term deferred income taxes, liabilities under our deferred compensation plan, and reserves for uncertain tax positions. These liabilities have been excluded from the table above as the timing and/or amount of any cash payment is uncertain.

REGULATORY CAPITAL AND DIVIDEND RESTRICTIONS

Our operations are conducted through our subsidiaries. As managed care organizations, these subsidiaries are subject to state regulations that, among other things, require the maintenance of minimum levels of statutory capital, as defined by each state, and restrict the timing, payment and amount of dividends and other distributions that may be paid to us. Generally, the amount of dividend distributions that may be paid by a regulated subsidiary without prior approval by state regulatory authorities is limited based on the entity’s level of statutory net income and statutory capital and surplus.

Our subsidiaries are required to maintain minimum capital requirements prescribed by various regulatory authorities in each of the states in which we operate. As of December 31, 2015, our subsidiaries had aggregate statutory capital and surplus of $2,284 million, compared with the required minimum aggregate statutory capital and surplus requirements of $1,195 million. During the year ended December 31, 2015, we contributed $643 million of statutory capital to our subsidiaries. We estimate our Risk Based Capital, or RBC, percentage (including KSHP) to be in excess of 350% of the Authorized Control Level.

The National Association of Insurance Commissioners has adopted rules which set minimum risk-based capital requirements for insurance companies, managed care organizations and other entities bearing risk for healthcare coverage. As of December 31, 2015, each of our health plans was in compliance with the risk-based capital requirements enacted in those states.

RECENT ACCOUNTING PRONOUNCEMENTS

For this information, refer to Note 2, Summary of Significant Accounting Policies, in the Notes to the Consolidated Financial Statements, included herein.

Table of Contents

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Our discussion and analysis of our results of operations and liquidity and capital resources are based on our consolidated financial statements which have been prepared in accordance with GAAP. Our significant accounting policies are more fully described in Note 2, Summary of Significant Accounting Policies, to our consolidated financial statements included elsewhere herein. Our accounting policies regarding medical claims liability and intangible assets are particularly important to the portrayal of our financial position and results of operations and require the application of significant judgment by our management. As a result, they are subject to an inherent degree of uncertainty. We have reviewed these critical accounting policies and related disclosures with the Audit Committee of our Board of Directors.

Medical Claims Liability

Our medical claims liability includes claims reported but not yet paid, or inventory, estimates for claims incurred but not reported, or IBNR, and estimates for the costs necessary to process unpaid claims at the end of each period. We estimate our medical claims liability using actuarial methods that are commonly used by health insurance actuaries and meet Actuarial Standards of Practice. These actuarial methods consider factors such as historical data for payment patterns, cost trends, product mix, seasonality, utilization of healthcare services and other relevant factors.

Actuarial Standards of Practice generally require that the medical claims liability estimates be adequate to cover obligations under moderately adverse conditions. Moderately adverse conditions are situations in which the actual claims are expected to be higher than the otherwise estimated value of such claims at the time of estimate. In many situations, the claims amounts ultimately settled will be different than the estimate that satisfies the Actuarial Standards of Practice. We include in our IBNR an estimate for medical claims liability under moderately adverse conditions which represents the risk of adverse deviation of the estimates in our actuarial method of reserving.

We use our judgment to determine the assumptions to be used in the calculation of the required estimates. The assumptions we consider when estimating IBNR include, without limitation, claims receipt and payment experience (and variations in that experience), changes in membership, provider billing practices, healthcare service utilization trends, cost trends, product mix, seasonality, prior authorization of medical services, benefit changes, known outbreaks of disease or increased incidence of illness such as influenza, provider contract changes, changes to fee schedules, and the incidence of high dollar or catastrophic claims.

We apply various estimation methods depending on the claim type and the period for which claims are being estimated. For more recent periods, incurred non-inpatient claims are estimated based on historical per member per month claims experience adjusted for known factors. Incurred hospital inpatient claims are estimated based on known inpatient utilization data and prior claims experience adjusted for known factors. For older periods, we utilize an estimated completion factor based on our historical experience to develop IBNR estimates. The completion factor is an actuarial estimate of the percentage of claims incurred during a given period that have been received or adjudicated as of the reporting period to the estimate of the total ultimate incurred costs. When we commence operations in a new state or region, we have limited information with which to estimate our medical claims liability. See “Risk Factors - Failure to accurately predict our medical expenses could negatively affect our financial position, results of operations or cash flows.” These approaches are consistently applied to each period presented.

Our development of the medical claims liability estimate is a continuous process which we monitor and refine on a monthly basis as additional claims receipts and payment information becomes available. As more complete claims information becomes available, we adjust the amount of the estimates, and include the changes in estimates in medical costs in the period in which the changes are identified. In every reporting period, our operating results include the effects of more completely developed medical claims liability estimates associated with previously reported periods. We consistently apply our reserving methodology from period to period. As additional information becomes known to us, we adjust our actuarial models accordingly to establish medical claims liability estimates.

Table of Contents

The paid and received completion factors, claims per member per month and per diem cost trend factors are the most significant factors affecting the IBNR estimate. The following table illustrates the sensitivity of these factors and the estimated potential impact on our operating results caused by changes in these factors based on December 31, 2015 data:



Completion Factors: ⁽¹⁾					Cost Trend Factors: ⁽²⁾
(Decrease) Increase in Factors		Increase (Decrease) in Medical Claims Liabilities			(Decrease) Increase in Factors		Increase (Decrease) in Medical Claims Liabilities
		(in millions)					(in millions)
(2.0	)%	$	264		(2.0	)%	$	(72	)
(1.5	)	197			(1.5	)	(54		)
(1.0	)	131			(1.0	)	(36		)
(0.5	)	65			(0.5	)	(18		)
0.5		(64		)	0.5		18
1.0		(128		)	1.0		36
1.5		(191		)	1.5		55
2.0		(253		)	2.0		73



(1)	Reflects estimated potential changes in medical claims liability caused by changes in completion factors.
(2)	Reflects estimated potential changes in medical claims liability caused by changes in cost trend factors for the most recent periods.

While we believe our estimates are appropriate, it is possible future events could require us to make significant adjustments for revisions to these estimates. For example, a 1% increase or decrease in our estimated medical claims liability would have affected net earnings by $14 million for the year ended December 31, 2015, excluding the effect of any return of premium, risk corridor, or minimum medical loss ratio programs. The estimates are based on our historical experience, terms of existing contracts, our observance of trends in the industry, information provided by our providers and information available from other outside sources.

The change in medical claims liability is summarized as follows (in millions):



	Year Ended December 31,
	2015			2014			2013
Balance, January 1,	$	1,723		$	1,112		$	815
Acquisitions	79			—			—
Incurred related to:
Current year	17,471			12,820			9,073
Prior years	(229		)	(142		)	(78		)
Total incurred	17,242			12,678			8,995

Paid related to:
Current year	15,279			11,122			7,975
Prior years	1,467			945			723
Total paid	16,746			12,067			8,698

Balance, December 31,	$	2,298		$	1,723		$	1,112

Days in claims payable ¹	44.3			44.2			42.4

________________________


¹	Days in claims payable is a calculation of medical claims liability at the end of the period divided by average expense per calendar day for the fourth quarter of each year.

Table of Contents

Medical claims are usually paid within a few months of the member receiving service from the physician or other healthcare provider. As a result, the liability generally is described as having a “short-tail,” which causes less than 5% of our medical claims liability as of the end of any given year to be outstanding the following year. We believe that substantially all the development of the estimate of medical claims liability as of December 31, 2015 will be known by the end of 2016.

Changes in estimates of incurred claims for prior years are primarily attributable to reserving under moderately adverse conditions. Additionally, as a result of minimum HBR and other return of premium programs, approximately $47 million, $26 million and $0 million of the “Incurred related to: Prior period” was recorded as a reduction to premium revenues in 2015, 2014 and 2013, respectively. Further, claims processing initiatives yielded increased claim payment recoveries and coordination of benefits related to prior year dates of service. Changes in medical utilization and cost trends and the effect of medical management initiatives may also contribute to changes in medical claim liability estimates. While we have evidence that medical management initiatives are effective on a case by case basis, medical management initiatives primarily focus on events and behaviors prior to the incurrence of the medical event and generation of a claim. Accordingly, any change in behavior, leveling of care, or coordination of treatment occurs prior to claim generation and as a result, the costs prior to the medical management initiative are not known by us. Additionally, certain medical management initiatives are focused on member and provider education with the intent of influencing behavior to appropriately align the medical services provided with the member's acuity. In these cases, determining whether the medical management initiative changed the behavior cannot be determined. Because of the complexity of our business, the number of states in which we operate, and the volume of claims that we process, we are unable to practically quantify the impact of these initiatives on our changes in estimates of IBNR.

The following are examples of medical management initiatives that may have contributed to the favorable development through lower medical utilization and cost trends:


•	Appropriate leveling of care for neonatal intensive care unit hospital admissions, other inpatient hospital admissions, and observation admissions, in accordance with Interqual or other criteria.


•	Management of our pre-authorization list and more stringent review of durable medical equipment and injectibles.


•	Emergency room program designed to collaboratively work with hospitals to steer non-emergency care away from the costly emergency room setting (through patient education, on-site alternative urgent care settings, etc.)


•	Increase emphasis on case management and clinical rounding where case managers are nurses or social workers who are employed by the health plan to assist selected patients with the coordination of healthcare services in order to meet a patient's specific healthcare needs.


•	Incorporation of disease management which is a comprehensive, multidisciplinary, collaborative approach to chronic illnesses such as asthma.


•	Prenatal and infant health programs utilized in our Start Smart For Your Baby outreach service.

Goodwill and Intangible Assets

We have made several acquisitions that have resulted in our recording of intangible assets. These intangible assets primarily consist of customer relationships, purchased contract rights, provider contracts, trade names and goodwill. At December 31, 2015, we had $842 million of goodwill and $155 million of other intangible assets.

Intangible assets are amortized using the straight-line method over the following periods:



Intangible Asset		Amortization Period
Purchased contract rights		5 - 15 years
Provider contracts		4 - 15 years
Customer relationships		3 - 15 years
Trade names		7 - 20 years
Developed technology		5 years

Table of Contents

Our management evaluates whether events or circumstances have occurred that may affect the estimated useful life or the recoverability of the remaining balance of goodwill and other identifiable intangible assets. If the events or circumstances indicate that the remaining balance of the intangible asset or goodwill may be impaired, the potential impairment will be measured based upon the difference between the carrying amount of the intangible asset or goodwill and the fair value of such asset. Our management must make assumptions and estimates, such as the discount factor, future utility and other internal and external factors, in determining the estimated fair values. While we believe these assumptions and estimates are appropriate, other assumptions and estimates could be applied and might produce significantly different results.

Goodwill is reviewed annually during the fourth quarter for impairment. In addition, an impairment analysis of intangible assets would be performed based on other factors. These factors include significant changes in membership, state funding, medical contracts and provider networks and contracts.

Table of Contents

We first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. We generally do not calculate the fair value of a reporting unit unless we determine, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. However, in certain circumstances, such as recent acquisitions, we may elect to perform a quantitative assessment without first assessing qualitative factors. The fair value of all reporting units with material amounts of goodwill was substantially in excess of the carrying value as of our annual impairment testing date, with the exception of reporting units that were recently acquired without excess fair value on the acquisition date.

ITEM 7A. Quantitative and Qualitative Disclosures About Market Risk

INVESTMENTS AND DEBT

As of December 31, 2015, we had short term investments of $176 million and long term investments of $2,042 million, including restricted deposits of $115 million. The short term investments generally consist of highly liquid securities with maturities between three and 12 months. The long term investments consist of municipal, corporate and U.S. Treasury securities, government sponsored obligations, life insurance contracts, asset backed securities and equity securities and have maturities greater than one year. Restricted deposits consist of investments required by various state statutes to be deposited or pledged to state agencies. Due to the nature of the states’ requirements, these investments are classified as long term regardless of the contractual maturity date. Substantially all of our investments are subject to interest rate risk and will decrease in value if market rates increase. Assuming a hypothetical and immediate 1% increase in market interest rates at December 31, 2015, the fair value of our fixed income investments would decrease by approximately $55 million. Declines in interest rates over time will reduce our investment income.

We have interest rate swap agreements for a notional amount of $750 million with creditworthy financial institutions to manage the impact of market interest rates on interest expense. Our swap agreements convert a portion of our interest expense from fixed to variable rates to better match the impact of changes in market rates on our variable rate cash equivalent investments. As a result, the fair value of $750 million of our long term debt varies with market interest rates. Assuming a hypothetical and immediate 1% increase in market interest rates at December 31, 2015, the fair value of our debt would decrease by approximately $31 million. An increase in interest rates decreases the fair value of the debt and conversely, a decrease in interest rates increases the value.

For a discussion of the interest rate risk that our investments are subject to, see "Risk Factors–Risks Related to Our Business–Our investment portfolio may suffer losses from reductions in market interest rates and changes in market conditions which could materially and adversely affect our results of operations or liquidity.”

INFLATION

The inflation rate for medical care costs has been higher than the inflation rate for all items. We use various strategies to mitigate the negative effects of healthcare cost inflation. Specifically, our health plans try to control medical and hospital costs through our state savings initiatives and contracts with independent providers of healthcare services. Through these contracted care providers, our health plans emphasize preventive healthcare and appropriate use of specialty and hospital services. Additionally, our contracts with states require actuarially sound premiums that include healthcare cost trend.

While we currently believe our strategies to mitigate healthcare cost inflation will continue to be successful, competitive pressures, new healthcare and pharmaceutical product introductions, demands from healthcare providers and customers, applicable regulations or other factors may affect our ability to control the impact of healthcare cost increases.

Table of Contents

Item 8. Financial Statements and Supplementary Data

Report of Independent Registered Public Accounting Firm

The Board of Directors and Stockholders

Centene Corporation:

We have audited the accompanying consolidated balance sheets of Centene Corporation and subsidiaries as of December 31, 2015 and 2014, and the related consolidated statements of operations, comprehensive earnings, stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2015. These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Centene Corporation and subsidiaries as of December 31, 2015 and 2014, and the results of their operations and their cash flows for each of the years in the three-year period ended December 31, 2015, in conformity with U.S. generally accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), Centene Corporation’s internal control over financial reporting as of December 31, 2015, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), and our report dated February 22, 2016 expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting.

/s/ KPMG LLP

St. Louis, Missouri

February 22, 2016

Table of Contents

CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In millions, except share data)



	December 31, 2015			December 31, 2014
ASSETS
Current assets:
Cash and cash equivalents	$	1,760		$	1,610
Premium and related receivables	1,279			912
Short term investments	176			177
Other current assets	390			252
Total current assets	3,605			2,951
Long term investments	1,927			1,280
Restricted deposits	115			100
Property, software and equipment, net	518			445
Goodwill	842			754
Intangible assets, net	155			120
Other long term assets	177			174
Total assets	$	7,339		$	5,824
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Medical claims liability	$	2,298		$	1,723
Accounts payable and accrued expenses	976			768
Return of premium payable	207			236
Unearned revenue	143			168
Current portion of long term debt	5			5
Total current liabilities	3,629			2,900
Long term debt	1,216			874
Other long term liabilities	170			159
Total liabilities	5,015			3,933
Commitments and contingencies
Redeemable noncontrolling interest	156			148
Stockholders’ equity:
Preferred stock, $0.001 par value; authorized 10,000,000 shares; no shares issued or outstanding at December 31, 2015 and December 31, 2014	—			—
Common stock, $.001 par value; authorized 400,000,000 shares; 126,855,477 issued and 120,342,981 outstanding at December 31, 2015, and 124,274,864 issued and 118,433,416 outstanding at December 31, 2014	—			—
Additional paid-in capital	956			840
Accumulated other comprehensive loss	(10		)	(1		)
Retained earnings	1,358			1,003
Treasury stock, at cost (6,512,496 and 5,841,448 shares, respectively)	(147		)	(98		)
Total Centene stockholders’ equity	2,157			1,744
Noncontrolling interest	11			(1		)
Total stockholders’ equity	2,168			1,743
Total liabilities and stockholders’ equity	$	7,339		$	5,824

The accompanying notes to the consolidated financial statements are an integral part of these statements.

Table of Contents

CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(In millions, except share data)



	Year Ended December 31,
	2015			2014			2013
Revenues:
Premium	$	19,389		$	14,198		$	10,153
Service	1,876			1,469			373
Premium and service revenues	21,265			15,667			10,526
Premium tax and health insurer fee	1,495			893			337
Total revenues	22,760			16,560			10,863
Expenses:
Medical costs	17,242			12,678			8,995
Cost of services	1,621			1,280			327
General and administrative expenses	1,826			1,314			931
Premium tax expense	1,151			698			333
Health insurer fee expense	215			126			—
Total operating expenses	22,055			16,096			10,586
Earnings from operations	705			464			277
Other income (expense):
Investment and other income	35			28			19
Interest expense	(43		)	(35		)	(27		)
Earnings from continuing operations, before income tax expense	697			457			269
Income tax expense	339			196			107
Earnings from continuing operations, net of income tax expense	358			261			162
Discontinued operations, net of income tax expense (benefit) of $(1), $1, and $2, respectively	(1		)	3			4
Net earnings	357			264			166
(Earnings) loss attributable to noncontrolling interests	(2		)	7			(1		)
Net earnings attributable to Centene Corporation	$	355		$	271		$	165

Amounts attributable to Centene Corporation common shareholders:
Earnings from continuing operations, net of income tax expense	$	356		$	268		$	161
Discontinued operations, net of income tax expense (benefit)	(1		)	3			4
Net earnings	$	355		$	271		$	165

Net earnings (loss) per common share attributable to Centene Corporation:
Basic:
Continuing operations	$	2.99		$	2.30		$	1.49
Discontinued operations	(0.01		)	0.03			0.03
Basic earnings per common share	$	2.98		$	2.33		$	1.52

Diluted:
Continuing operations	$	2.89		$	2.23		$	1.43
Discontinued operations	(0.01		)	0.02			0.04
Diluted earnings per common share	$	2.88		$	2.25		$	1.47

Weighted average number of common shares outstanding:
Basic	119,100,744			116,345,764			108,253,090
Diluted	123,066,370			120,360,212			112,494,346

The accompanying notes to the consolidated financial statements are an integral part of these statements.

Table of Contents

CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS

(In millions)



	Year Ended December 31,
	2015			2014			2013
Net earnings	$	357		$	264		$	166
Reclassification adjustment, net of tax	—			—			(1		)
Change in unrealized gain (loss) on investments, net of tax	(4		)	3			(7		)
Foreign currency translation adjustments, net of tax	(5		)	(1		)	—
Other comprehensive earnings (loss)	(9		)	2			(8		)
Comprehensive earnings	348			266			158
Comprehensive (earnings) loss attributable to the noncontrolling interest	(2		)	7			(1		)
Comprehensive earnings attributable to Centene Corporation	$	346		$	273		$	157

The accompanying notes to the consolidated financial statements are an integral part of this statement.

Table of Contents

CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(In millions, except share data)



	Centene Stockholders’ Equity
	Common Stock										Treasury Stock
	$.001 Par Value Shares	Amt		Additional Paid-in Capital		Accumulated Other Comprehensive Income (Loss)			Retained Earnings		$.001 Par Value Shares		Amt			Non controlling Interest			Total
Balance, December 31, 2012	110,678,320	$	—	$	451	$	5		$	567	6,019,824		$	(70	)	$	1		$	954
Net earnings	—	—		—		—			165		—		—			1			166
Other comprehensive earnings (loss), net of $(4) tax	—	—		—		(8		)	—		—		—			—			(8		)
Common stock issued for acquisition	3,433,380	—		75		—			—		—		—			—			75
Common stock issued for stock offering	685,280	—		15		—			—		—		—			—			15
Common stock issued for employee benefit plans	2,549,450	—		10		—			—		—		—			—			10
Common stock repurchases	—	—		—		—			—		688,128		(19		)	—			(19		)
Stock compensation expense	—	—		37		—			—		—		—			—			37
Excess tax benefits from stock compensation	—	—		6		—			—		—		—			—			6
Contribution from noncontrolling interest	—	—		—		—			—		—		—			7			7
Balance, December 31, 2013	117,346,430	$	—	$	594	$	(3	)	$	732	6,707,952		$	(89	)	$	9		$	1,243
Net earnings (loss)	—	—		—		—			271		—		—			(1		)	270
Other comprehensive earnings, net of $1 tax	—	—		—		2			—		—		—			—			2
Common stock issued for acquisitions	4,486,434	—		170		—			—		(1,492,738	)	20			—			190
Common stock issued for employee benefit plans	2,442,000	—		9		—			—		—		—			—			9
Common stock repurchases	—	—		—		—			—		626,234		(29		)	—			(29		)
Stock compensation expense	—	—		48		—			—		—		—			—			48
Excess tax benefits from stock compensation	—	—		19		—			—		—		—			—			19
Reclassification to redeemable noncontrolling interest	—	—		—		—			—		—		—			(9		)	(9		)
Balance, December 31, 2014	124,274,864	$	—	$	840	$	(1	)	$	1,003	5,841,448		$	(98	)	$	(1	)	$	1,743
Net earnings	—	—		—		—			355		—		—			—			355
Other comprehensive earnings (loss), net of $3 tax	—	—		—		(9		)	—		—		—			—			(9		)
Common stock issued for acquisitions	—	—		8		—			—		(247,580	)	4			—			12
Common stock issued for employee benefit plans	2,580,613	—		12		—			—		—		—			—			12
Common stock repurchases	—	—		—		—			—		918,628		(53		)	—			(53		)
Stock compensation expense	—	—		71		—			—		—		—			—			71
Excess tax benefits from stock compensation	—	—		25		—			—		—		—			—			25
Contribution from noncontrolling interest	—	—		—		—			—		—		—			11			11
Reclassification to redeemable noncontrolling interest	—	—		—		—			—		—		—			1			1
Balance, December 31, 2015	126,855,477	$	—	$	956	$	(10	)	$	1,358	6,512,496		$	(147	)	$	11		$	2,168

The accompanying notes to the consolidated financial statements are an integral part of this statement.

Table of Contents

CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In millions)



	Year Ended December 31,
	2015			2014			2013
Cash flows from operating activities:
Net earnings	$	357		$	264		$	166
Adjustments to reconcile net earnings to net cash provided by operating activities
Depreciation and amortization	111			89			67
Stock compensation expense	71			48			37
Deferred income taxes	(17		)	(42		)	(2		)
Gain on contingent consideration	(44		)	—			—
Goodwill and intangible adjustment	38			—			—
Changes in assets and liabilities
Premium and related receivables	(360		)	(463		)	(143		)
Other current assets	(96		)	(5		)	(80		)
Other assets	(9		)	(8		)	(1		)
Medical claims liabilities	536			609			172
Unearned revenue	(27		)	129			3
Accounts payable and accrued expenses	39			506			152
Other long term liabilities	51			89			8
Other operating activities	8			7			3
Net cash provided by operating activities	658			1,223			382
Cash flows from investing activities:
Capital expenditures	(150		)	(103		)	(68		)
Purchases of investments	(1,321		)	(1,015		)	(790		)
Sales and maturities of investments	669			406			579
Proceeds from asset sale	7			—			—
Investments in acquisitions, net of cash acquired	(18		)	(136		)	(63		)
Net cash used in investing activities	(813		)	(848		)	(342		)
Cash flows from financing activities:
Proceeds from exercise of stock options	13			8			9
Proceeds from borrowings	1,925			1,875			180
Proceeds from stock offering	—			—			15
Payment of long term debt	(1,583		)	(1,674		)	(41		)
Excess tax benefits from stock compensation	25			19			6
Common stock repurchases	(53		)	(29		)	(19		)
Contribution from noncontrolling interest	11			6			8
Debt issue costs	(4		)	(7		)	(4		)
Payment of contingent consideration obligation	(29		)	—			—
Net cash provided by financing activities	305			198			154
Effect of exchange rate changes on cash and cash equivalents	—			(1		)	—
Net increase in cash and cash equivalents	150			572			194
Cash and cash equivalents, beginning of period	1,610			1,038			844
Cash and cash equivalents, end of period	$	1,760		$	1,610		$	1,038
Supplemental disclosures of cash flow information:
Interest paid	$	55		$	40		$	30
Income taxes paid	$	328		$	237		$	85
Equity issued in connection with acquisitions	$	12		$	190		$	75

The accompanying notes to the consolidated financial statements are an integral part of these statements.

Table of Contents

CENTENE CORPORATION AND SUBSIDIARIES

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

1. Organization and Operations

Centene Corporation, or the Company, is a diversified, multi-national healthcare enterprise operating in two segments: Managed Care and Specialty Services. The Managed Care segment provides Medicaid and Medicaid-related health plan coverage to individuals through the government subsidized programs, including Medicaid, the State Children's Health Insurance Program (CHIP), Long Term Care (LTC), Foster Care, dual-eligible individuals (Duals) in Medicare Special Needs Plans and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program, or collectively ABD and the Health Insurance Marketplace. The Specialty Services segment consists of our specialty companies offering auxiliary healthcare services and products to state programs, healthcare organizations, employer groups and other commercial organizations, as well as to our own subsidiaries.

On February 2, 2015, the Board of Directors declared a two-for-one split of Centene's common stock in the form of a 100% stock dividend distributed February 19, 2015 to stockholders of record on February 12, 2015. All share and per share information presented in this Form 10-K has been adjusted for the two-for-one stock split.

2. Summary of Significant Accounting Policies

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of Centene Corporation and all majority owned subsidiaries and subsidiaries over which the Company exercises the power and control to direct activities significantly impacting financial performance. All material intercompany balances and transactions have been eliminated. The assets, liabilities and results of operations of Kentucky Spirit Health Plan are classified as discontinued operations for all periods presented.

Certain amounts in the consolidated financial statements have been reclassified to conform to the 2015 presentation. These reclassifications have no effect on net earnings or stockholders' equity as previously reported.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles in the United States, or GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Future events and their effects cannot be predicted with certainty; accordingly, the accounting estimates require the exercise of judgment. The accounting estimates used in the preparation of the consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the operating environment changes. The Company evaluates and updates its assumptions and estimates on an ongoing basis and may employ outside experts to assist in our evaluation, as considered necessary. Actual results could differ from those estimates.

Cash and Cash Equivalents

Investments with original maturities of three months or less are considered to be cash equivalents. Cash equivalents consist of money market funds and bank certificates of deposit and savings accounts.

The Company maintains amounts on deposit with various financial institutions, which may exceed federally insured limits. However, management periodically evaluates the credit-worthiness of those institutions, and the Company has not experienced any losses on such deposits.

Investments

Short term investments include securities with maturities greater than three months to one year. Long term investments include securities with maturities greater than one year.

Table of Contents

Short term and long term investments are generally classified as available for sale and are carried at fair value. Certain equity investments are recorded using the cost or equity method. Unrealized gains and losses on investments available for sale are excluded from earnings and reported in accumulated other comprehensive income, a separate component of stockholders' equity, net of income tax effects. Premiums and discounts are amortized or accreted over the life of the related security using the effective interest method. The Company monitors the difference between the cost and fair value of investments. Investments that experience a decline in value that is judged to be other than temporary are written down to fair value and a realized loss is recorded in investment and other income. To calculate realized gains and losses on the sale of investments, the Company uses the specific amortized cost of each investment sold. Realized gains and losses are recorded in investment and other income.

The Company uses the equity method to account for its investments in entities that it does not control but has the ability to exercise significant influence over operating and financial policies. These investments are recorded at the lower of their cost or fair value adjusted for the Company's proportionate share of earnings or losses.

Restricted Deposits

Restricted deposits consist of investments required by various state statutes to be deposited or pledged to state agencies. These investments are classified as long term, regardless of the contractual maturity date, due to the nature of the states' requirements. The Company is required to annually adjust the amount of the deposit pledged to certain states.

Fair Value Measurements

In the normal course of business, the Company invests in various financial assets and incurs various financial liabilities. Fair values are disclosed for all financial instruments, whether or not such values are recognized in the Consolidated Balance Sheets. Management obtains quoted market prices and other observable inputs for these disclosures. The carrying amounts reported in the Consolidated Balance Sheets for cash and cash equivalents, premium and related receivables, unearned revenue, accounts payable and accrued expenses, and certain other current liabilities are carried at cost, which approximates fair value because of their short term nature.

The following methods and assumptions were used to estimate the fair value of each financial instrument:


•	Available for sale investments and restricted deposits: The carrying amount is stated at fair value, based on quoted market prices, where available. For securities not actively traded, fair values were estimated using values obtained from independent pricing services or quoted market prices of comparable instruments.


•	Senior unsecured notes: Estimated based on third-party quoted market prices for the same or similar issues.


•	Variable rate debt: The carrying amount of our floating rate debt approximates fair value since the interest rates adjust based on market rate adjustments.


•	Interest rate swap: Estimated based on third-party market prices based on the forward 3-month LIBOR curve.


•	Contingent consideration: Estimate based on expected membership retained at contract commencement and per member purchase price in the acquisition agreement.

Property, Software and Equipment

Property, software and equipment are stated at cost less accumulated depreciation. Capitalized software includes certain costs incurred in the development of internal-use software, including external direct costs of materials and services and payroll costs of employees devoted to specific software development. Depreciation is calculated principally by the straight-line method over estimated useful lives. Leasehold improvements are depreciated using the straight-line method over the shorter of the expected useful life or the remaining term of the lease. Property, software and equipment are depreciated over the following periods:



Fixed Asset		Depreciation Period
Buildings and land improvements		3 - 40 years
Computer hardware and software		2 - 7 years
Furniture and equipment		3 - 10 years
Leasehold improvements		1 - 20 years

Table of Contents

The carrying amounts of all long-lived assets are evaluated to determine if adjustment to the depreciation and amortization period or to the unamortized balance is warranted. Such evaluation is based principally on the expected utilization of the long-lived assets.

The Company retains fully depreciated assets in property and accumulated depreciation accounts until it removes them from service. In the case of sale, retirement, or disposal, the asset cost and related accumulated depreciation balance is removed from the respective account, and the resulting net amount, less any proceeds, is included as a component of earnings from operations in the consolidated statements of operations.

Goodwill and Intangible Assets

Intangible assets represent assets acquired in purchase transactions and consist primarily of customer relationships, purchased contract rights, provider contracts, trade names and goodwill. Intangible assets are amortized using the straight-line method over the following periods:



Intangible Asset		Amortization Period
Purchased contract rights		5 - 15 years
Provider contracts		4 - 15 years
Customer relationships		3 - 15 years
Trade names		7 - 20 years
Developed technology		5 years

The Company tests for impairment of intangible assets as well as long-lived assets whenever events or changes in circumstances indicate that the carrying value of an asset or asset group (hereinafter referred to as “asset group”) may not be recoverable by comparing the sum of the estimated undiscounted future cash flows expected to result from use of the asset group and its eventual disposition to the carrying value. Such factors include, but are not limited to, significant changes in membership, state funding, state contracts and provider networks and contracts. If the sum of the estimated undiscounted future cash flows is less than the carrying value, an impairment determination is required. The amount of impairment is calculated by subtracting the fair value of the asset group from the carrying value of the asset group. An impairment charge, if any, is recognized within earnings from operations.

The Company tests goodwill for impairment using a fair value approach. The Company is required to test for impairment at least annually, absent a triggering event including a significant decline in operating performance that would require an impairment assessment. Absent any impairment indicators, the Company performs its goodwill impairment testing during the fourth quarter of each year. The Company recognizes an impairment charge for any amount by which the carrying amount of goodwill exceeds its implied fair value.

The Company first assesses qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. The Company generally does not calculate the fair value of a reporting unit unless it determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. However, in certain circumstances, such as recent acquisitions, the Company may elect to perform a quantitative assessment without first assessing qualitative factors.

If the two-step quantitative test is deemed necessary, the Company determines an appropriate valuation technique to estimate a reporting unit's fair value as of the testing date. The Company utilizes either the income approach or the market approach, whichever is most appropriate for the respective reporting unit. The income approach is based on an internally developed discounted cash flow model that includes many assumptions related to future growth rates, discount factors, future tax rates, etc. The market approach is based on financial multiples of comparable companies derived from current market data. Changes in economic and operating conditions impacting assumptions used in our analyses could result in goodwill impairment in future periods.

Table of Contents

Medical Claims Liability

Medical claims liability includes claims reported but not yet paid, or inventory, estimates for claims incurred but not reported, or IBNR, and estimates for the costs necessary to process unpaid claims at the end of each period. The Company estimates its medical claims liability using actuarial methods that are commonly used by health insurance actuaries and meet Actuarial Standards of Practice. These actuarial methods consider factors such as historical data for payment patterns, cost trends, product mix, seasonality, utilization of healthcare services and other relevant factors.

Actuarial Standards of Practice generally require that the medical claims liability estimates be adequate to cover obligations under moderately adverse conditions. Moderately adverse conditions are situations in which the actual claims are expected to be higher than the otherwise estimated value of such claims at the time of estimate. In many situations, the claims amounts ultimately settled will be different than the estimate that satisfies the Actuarial Standards of Practice. The Company includes in its IBNR an estimate for medical claims liability under moderately adverse conditions which represents the risk of adverse deviation of the estimates in its actuarial method of reserving.

The Company uses its judgment to determine the assumptions to be used in the calculation of the required estimates. The assumptions it considers when estimating IBNR include, without limitation, claims receipt and payment experience (and variations in that experience), changes in membership, provider billing practices, healthcare service utilization trends, cost trends, product mix, seasonality, prior authorization of medical services, benefit changes, known outbreaks of disease or increased incidence of illness such as influenza, provider contract changes, changes to fee schedules, and the incidence of high dollar or catastrophic claims.

The Company's development of the medical claims liability estimate is a continuous process which it monitors and refines on a monthly basis as additional claims receipts and payment information becomes available. As more complete claims information becomes available, the Company adjusts the amount of the estimates, and includes the changes in estimates in medical costs in the period in which the changes are identified. In every reporting period, the operating results include the effects of more completely developed medical claims liability estimates associated with previously reported periods. The Company consistently applies its reserving methodology from period to period. As additional information becomes known, it adjusts the actuarial model accordingly to establish medical claims liability estimates.

The Company periodically reviews actual and anticipated experience compared to the assumptions used to establish medical costs. The Company establishes premium deficiency reserves if actual and anticipated experience indicates that existing policy liabilities together with the present value of future gross premiums will not be sufficient to cover the present value of future benefits, settlement and maintenance costs.

Revenue Recognition

The Company's health plans generate revenues primarily from premiums received from the states in which it operates health plans. The Company receives a fixed premium per member per month pursuant to its state contracts. The Company generally receives premium payments during the month it provides services and recognizes premium revenue during the period in which it is obligated to provide services to its members. In some instances, the Company's base premiums are subject to an adjustment, or risk score, based on the acuity of its membership. Generally, the risk score is determined by the State analyzing submissions of processed claims data to determine the acuity of the Company's membership relative to the entire state's Medicaid membership. Some states enact premium taxes, similar assessments and provider pass-through payments, collectively premium taxes, and these taxes are recorded as a separate component of both revenues and operating expenses. Some contracts allow for additional premiums related to certain supplemental services provided such as maternity deliveries.

Revenues are recorded based on membership and eligibility data provided by the states, which is adjusted on a monthly basis by the states for retroactive additions or deletions to membership data. These eligibility adjustments are estimated monthly and subsequent adjustments are made in the period known. We continuously review and update those estimates as new information becomes available. It is possible that new information could require us to make additional adjustments, which could be significant, to these estimates.

The Company's specialty companies generate revenues under contracts with state programs, individuals, healthcare organizations and other commercial organizations, as well as from the Company's own subsidiaries. Revenues are recognized when the related services are provided or as ratably earned over the covered period of service.

Table of Contents

Health Insurance Marketplace

Risk Adjustment

The permanent risk adjustment program established by the ACA transfers funds from qualified individual and small group insurance plans with below average risk scores to those plans with above average risk scores within each state. The Company estimates the receivable or payable under the risk adjustment program based on its estimated risk score compared to the state average risk score. The Company may record a receivable or payable as an adjustment to Premium revenue to reflect the year to date impact of the risk adjustment based on its best estimate. The Company expects to refine its estimate as new information becomes available. As of December 31, 2015, the Company recorded a payable of $108 million associated with risk adjustment, and $44 million at December 31, 2014.

Reinsurance

The ACA established a transitional three-year reinsurance program whereby the Company’s claims costs incurred for qualified members will be reimbursed when they exceed a specific threshold. For the 2015 benefit year, qualified member claims that exceeded $45,000 entitled the Company to reimbursement from the programs at 50% coinsurance. The Company accounts for reinsurance recoveries as a reduction of Medical Costs based on each individual case that exceeds the reinsurance threshold established by the program. As of December 31, 2015, the Company recorded a receivable of $24 million associated with reinsurance, and $11 million at December 31, 2014.

Risk Corridor

The temporary, three-year risk corridor program established by the ACA applies to qualified individual and small group health plans operating both inside and outside of the Health Insurance Marketplace. The risk corridor program limits the Company’s gains and losses in the Health Insurance Marketplace by comparing certain medical and administrative costs to a target amount and sharing the risk for allowable costs with the federal government. Allowable medical costs are adjusted for risk adjustment settlements, transitional reinsurance recoveries, and cost sharing reductions received from the federal government. The Company records a risk corridor receivable or payable as an adjustment to Premium Revenue on a year to date basis based on where its estimated annual costs fall within the risk corridor range. As of December 31, 2015, the Company recorded a payable of $4 million associated with risk corridor, and $9 million at December 31, 2014.

Minimum Medical Loss Ratio

Additionally, the ACA established a minimum annual medical loss ratio for the Health Insurance Marketplace. Each of the three R programs described above are taken into consideration to determine if the Company’s estimated annual medical costs are less than the minimum loss ratio and require an adjustment to Premium revenue to meet the minimum medical loss ratio. As of December 31, 2015, the Company recorded a payable of $15 million associated with minimum medical loss ratio, and $6 million at December 31, 2014.

Table of Contents

Premium and Related Receivables and Unearned Revenue

Premium and service revenues collected in advance are recorded as unearned revenue. For performance-based contracts the Company does not recognize revenue subject to refund until data is sufficient to measure performance. Premiums and service revenues due to the Company are recorded as premium and related receivables and are recorded net of an allowance based on historical trends and management's judgment on the collectibility of these accounts. As the Company generally receives payments during the month in which services are provided, the allowance is typically not significant in comparison to total revenues and does not have a material impact on the presentation of the financial condition or results of operations. Activity in the allowance for uncollectible accounts for the years ended December 31, is summarized below ($ in millions):



	2015			2014			2013
Allowances, beginning of year	$	5		$	1		$	1
Amounts charged to expense	12			8			3
Write-offs of uncollectible receivables	(7		)	(4		)	(3		)
Allowances, end of year	$	10		$	5		$	1

Significant Customers

Centene receives the majority of its revenues under contracts or subcontracts with state Medicaid managed care programs. The current contracts expire on various dates between April 30, 2016 and June 30, 2019. States where the aggregate annual contract value exceeded 10% of total annual revenues included Texas, where the percentage of the Company's total revenue was 22%, 25% and 37% for the years ended December 31, 2015, 2014, and 2013, respectively, and Florida where the percentage of the Company's total revenue was 14% for the years ended December 31, 2015 and 2014.

Other Income (Expense)

Other income (expense) consists principally of investment income, interest expense and equity method earnings from investments. Investment income is derived from the Company's cash, cash equivalents, restricted deposits and investments. Interest expense relates to borrowings under the senior notes, interest rate swap, credit facilities, interest on capital leases and credit facility fees.

Income Taxes

Deferred tax assets and liabilities are recorded for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax law or tax rates is recognized in income in the period that includes the enactment date.

Valuation allowances are provided when it is considered more likely than not that deferred tax assets will not be realized. In determining if a deductible temporary difference or net operating loss can be realized, the Company considers future reversals of existing taxable temporary differences, future taxable income, taxable income in prior carryback periods and tax planning strategies.

Contingencies

The Company accrues for loss contingencies associated with outstanding litigation, claims and assessments for which it has determined it is probable that a loss contingency exists and the amount of loss can be reasonably estimated. The Company expenses professional fees associated with litigation claims and assessments as incurred.

Stock Based Compensation

The fair value of the Company's employee share options and similar instruments are estimated using the Black-Scholes option-pricing model. That cost is recognized over the period during which an employee is required to provide service in exchange for the award. Excess tax benefits related to stock compensation are presented as a cash inflow from financing activities.

Table of Contents

Foreign Currency Translation

The Company is exposed to foreign currency exchange risk through its equity method investment in Ribera Salud S.A. (Ribera Salud), a Spanish health management group whose functional currency is the Euro. The assets and liabilities of the Company's investment are translated into United States dollars at the balance sheet date. The Company translates its proportionate share of earnings using average rates during the year. The resulting foreign currency translation adjustments are recorded as a separate component of accumulated other comprehensive income.

Recent Accounting Pronouncements

In November 2015, the Financial Accounting Standards Board (FASB) issued an Accounting Standards Update (ASU) which requires entities to present deferred tax assets and deferred tax liabilities as noncurrent in a classified balance sheet. The new standards simplifies the current guidance, which requires entities to separately present deferred tax assets and deferred tax liabilities as current and noncurrent in a classified balance sheet. It is effective for annual and interim periods beginning after December 15, 2016. Early adoption is permitted. The Company elected to adopt this guidance in the current fiscal year and applied the new standard retrospectively to all prior periods. The reclassification of deferred tax assets and deferred tax liabilities impacted the Consolidated Balance Sheets by decreasing Other Current Assets and increasing Other Long Term Assets by $102 million and $83 million at December 31, 2015 and December 31, 2014. These reclassifications have no effect on net earnings or stockholders' equity as previously reported.

In September 2015, the FASB issued an ASU which simplifies the accounting for measurement-period adjustments in business combinations. The new standard eliminates the requirement for an acquirer in a business combination to account for measurement-period adjustments retrospectively. Instead, acquirers must recognize measurement-period adjustments during the period in which they determine the amounts, including any amounts they would have recorded in previous periods if the accounting had been completed at the acquisition date. Additionally, the acquirer must disclose the portion of the amount that would have been recorded in previous reporting periods. It is effective for annual and interim periods beginning after December 15, 2016. Early adoption is permitted. The Company elected to adopt this guidance in the current fiscal year.

In May 2015, the FASB issued an ASU which expands the disclosure requirements for insurance companies that issue short-duration contracts. The new standard will increase the level of disclosure around the Company's Medical Claims Liability to include the following: claims development by year; claim frequency; a rollforward of the claims liability; and a description of methods and assumptions used for determining the liability. It is effective for annual periods beginning after December 15, 2015 and interim periods beginning after December 15, 2016. Early adoption is permitted. The Company is currently evaluating the effect of the new disclosure requirements.

In April 2015, the FASB issued an ASU which changes the presentation of debt issuance costs in financial statements. Under the new standard, debt issuance costs are presented in the balance sheet as a direct deduction of the related debt liability rather than as an asset. Amortization of the cost is reported as interest expense. The new standard is effective for annual and interim periods beginning after December 15, 2015 and early adoption is permitted. The Company elected to adopt this guidance beginning in the first quarter of 2015 and has applied the new standard retrospectively to all prior periods. The reclassification of debt issuance costs impacted the Consolidated Balance Sheets by decreasing both Other Long Term Assets and Long Term Debt by $14 million at December 31, 2015 and December 31, 2014. These reclassifications have no effect on net earnings or stockholders' equity as previously reported.

In May 2014, the FASB issued an ASU which supersedes existing revenue recognition standards with a single model unless those contracts are within the scope of other standards (e.g., an insurance entity's insurance contracts). Under the new standard, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. In addition, the standard requires disclosure of the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The new effective date is for annual and interim periods beginning after December 15, 2017. Early adoption is permitted. The Company is currently evaluating the effect of the new revenue recognition guidance.

The Company has determined that there are no other recently issued accounting pronouncements that will have a material impact on its consolidated financial position, results of operations and cash flows.

Table of Contents

3. Health Net Merger

On July 2, 2015, the Company announced that the Company and two direct, newly formed subsidiaries of the Company had entered into a definitive merger agreement with Health Net, Inc. (Health Net) under which the Company will acquire all of the issued and outstanding shares of Health Net. Under the terms of the agreement, at the closing of the transaction, Health Net stockholders (with limited exceptions) would receive 0.622 of a validly issued, fully paid, non-assessable share of Centene common stock and $28.25 in cash for each share of Health Net common stock. The transaction is valued at approximately $5.5 billion (based on the Centene closing stock price on February 17, 2016), including the assumption of debt.

The transaction is expected to close in early 2016 and is subject to approvals by relevant state insurance and healthcare regulators and other customary closing conditions. In August 2015, the Company announced the early termination of the waiting period required under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended. In October 2015, the Company and Health Net announced the transaction was approved by both the Centene and Health Net stockholders. The Company expects to fund the cash portion of the acquisition through a combination of the debt financing completed in February 2016, borrowings on the Company's revolving credit facility and existing cash on hand.

4. Acquisitions and Noncontrolling Interest

Acquisitions

Agate Resources, Inc. In September 2015, the Company completed the acquisition of Agate Resources, Inc. (Agate) for $109 million. Agate is a diversified holding company that offers primarily Medicaid and other healthcare products and services to Oregon residents. The fair value of consideration of $109 million consists of initial cash consideration of $93 million, the present value of future cash payments of $7 million to be paid out over a three year period, and the fair value of estimated contingent consideration of $9 million. A portion of the contingent consideration is based on the achievement of underwriting targets and will be paid in cash over a three year period; the remainder is based on the net proceeds of a retrospective rate adjustment to be settled in 2016.

The Company's preliminary allocation of fair value resulted in goodwill of $48 million and other identifiable intangible assets of $39 million. The Company has not finalized the allocation of the fair value of assets and liabilities. The goodwill is not deductible for income tax purposes. The acquisition is recorded in the Managed Care segment.

Community Health Solutions of America, Inc. In July 2014, the Company completed a transaction whereby Community Health Solutions of America, Inc. assigned its contract with the Louisiana Department of Health and Hospitals under the Bayou Health Shared Savings Program to the Company's subsidiary, Louisiana Healthcare Connections (LHC). The fair value of consideration transferred included the present value of the estimated contingent consideration, subject to membership retained by LHC in the first quarter of 2015. The fair value of contingent consideration was $18 million at December 31, 2014. During the first quarter of 2015, the Company determined the amount of the actual contingent consideration to be $8 million. A gain of $10 million related to the settlement of the obligation was recorded in General and Administrative expense.

Fidelis SecureCare of Michigan, Inc. In May 2015, the Company acquired 100% of Fidelis SecureCare of Michigan, Inc. (Fidelis) a subsidiary of Concerto Healthcare. Fidelis was previously selected by the Michigan Department of Community Health to provide integrated healthcare services to members who are dually eligible for Medicare and Medicaid in Macomb and Wayne counties. The fair value of consideration of $57 million consisted of initial cash consideration of $7 million and the fair value of estimated contingent consideration of $50 million. The contingent consideration is based on duals membership and revenue per member during the first year of the contract (July 2015 - June 2016), including reconciliation payments settled over a two year period. The contingent consideration fair value is estimated based on expected membership during the first year of the contract as well as estimated revenue per member reflecting both member mix and risk adjustment. The Company's allocation of fair value resulted in goodwill of $29 million and other identifiable intangible assets of $23 million. 100% of the goodwill is deductible for income tax purposes. The acquisition is recorded in the Managed Care segment.

During 2015, the Company experienced higher than anticipated opt-out rates and member attrition in the dual demonstration program, resulting in lower than expected membership and lower blended premium rates. As a result, the fair value of estimated contingent consideration was reduced from $50 million to $16 million, and the Company recorded a gain of $34 million in general and administrative expenses. In connection with the lower membership and revenue outlook, the Company conducted an impairment analysis of the identifiable intangible assets and goodwill, resulting in a reduction of goodwill and intangible assets of $38 million which was recorded in general and administrative expenses. At December 31, 2015, the Company had goodwill of $11 million and other identifiable intangible assets of $1 million, net of $2 million of amortization, remaining on the balance sheet.

Table of Contents

LiveHealthier, Inc. In January 2015, the Company acquired the remaining 79% of LiveHealthier, Inc. (LiveHealthier) for $28 million , bringing its total ownership to 100%. LiveHealthier is a provider of technology and service-based health management solutions. The fair value of consideration of $28 million consists of cash paid of $11 million, Centene common stock issued at closing of $13 million, and the fair value of estimated contingent consideration of $4 million to be paid in cash over a three year period. The contingent consideration will not exceed $9 million.

The Company's allocation of fair value resulted in goodwill of $26 million and other identifiable intangible assets of $15 million. The goodwill is not deductible for income tax purposes. The acquisition is recorded in the Managed Care segment.

Ribera Salud, S.A. In July 2014, the Company purchased a noncontrolling interest in Ribera Salud S.A. (Ribera Salud), a Spanish health management group for $17 million. Centene is a 50% joint shareholder with Ribera Salud's remaining investor, Banco Sabadell S.A. The Company is accounting for its investment using the equity method of accounting. Any basis difference between the Company's share of underlying net assets and the purchase price will be attributable to certain intangible assets and will be accreted into earnings over their useful lives.

Upon closing, the Company executed letters of credit for $52 million (valued at the December 31, 2015 conversion rate), or €48 million, representing its proportional share of the letters of credit issued to support Ribera Salud’s outstanding debt. Refer to Note 11, Debt for outstanding balance as of December 31, 2015.

U.S. Medical Management. In January 2014, the Company acquired 68% of U.S. Medical Management, LLC (USMM), a management services organization and provider of in-home health services for high acuity populations, for $213 million in total consideration. The transaction consideration consisted of $133 million of Centene common stock and $80 million of cash.

The total fair value of 100% of USMM on the date of acquisition was $352 million ($213 million for the Company's interest and $139 million for the redeemable noncontrolling interest). The Company's allocation of fair value resulted in goodwill of $280 million and other identifiable intangible assets of $78 million. Approximately 45% of the goodwill is deductible for income tax purposes. The acquisition is recorded in the Specialty Services segment.

In connection with the acquisition, the Company entered into call and put agreements with the noncontrolling interest holder to purchase the noncontrolling interest at a later date. Under these agreements, the Company may purchase or be required to purchase up to the total remaining interests in USMM over a period beginning in 2015 and continuing through 2017. Under certain circumstances, the agreements may be extended through 2020. At the Company’s sole option, up to 50% of the consideration to be issued for the purchase of the additional interests under these agreements may be funded with shares of the Company's common stock.

Noncontrolling Interest

The Company has consolidated subsidiaries where it maintains less than 100% ownership. The Company’s ownership interest for each subsidiary as of December 31, are as follows:



	2015		2014		2013
Celtic Insurance Company	75	%	100	%	100	%
Centurion	51	%	51	%	51	%
Home State Health Plan	95	%	95	%	95	%
U.S. Medical Management	68	%	68	%	—

Table of Contents

Net income attributable to Centene Corporation and transfers from (to) noncontrolling interest entities are as follows ($ in millions):



	Year Ended December 31,
	2015		2014			2013
Net earnings attributable to Centene Corporation	$	356	$	268		$	161
Transfers from (to) the noncontrolling interest:
Increase in equity for distributions from and consolidation of noncontrolling interest	11		—			7
Reclassification to redeemable noncontrolling interest	1		(9		)	—
Net transfers from (to) noncontrolling interest	12		(9		)	7
Changes from net earnings attributable to Centene Corporation and net transfers from (to) the noncontrolling interest	$	368	$	259		$	168

Redeemable Noncontrolling Interest

As a result of put option agreements, noncontrolling interest is considered redeemable and is classified in the Redeemable Noncontrolling Interest section of the consolidated balance sheets. Noncontrolling interest is initially measured at fair value using the binomial lattice model as of the acquisition date. The Company has elected to accrete changes in the redemption value through additional paid-in capital over the period from the date of issuance to the earliest redemption date following the effective interest method.

A reconciliation of the changes in the Redeemable Noncontrolling Interest is as follows ($ in millions):



Balance, December 31, 2014	$	148
Fair value of noncontrolling interest sold	7
Reclassification to redeemable noncontrolling interest	(1		)
Net earnings attributable to noncontrolling interest	2
Balance, December 31, 2015	$	156

Ownership changes are described in more detail below.

Celtic Insurance Company In January 2015, the Company sold 25% of its ownership in Celtic Insurance Company for $7 million. No gain or loss was recognized on the sale of the ownership interest. Celtic Insurance Company is included in the Managed Care segment. In connection with the sale of the ownership interest, the Company entered into a put agreement with the noncontrolling interest holder, allowing the noncontrolling interest holder to put its interest back to the Company beginning in 2022. As a result of put option agreements, the noncontrolling interest is considered redeemable and is classified in the Redeemable Noncontrolling Interest section of the consolidated balance sheets.

Pro forma disclosures related to the acquisitions have been excluded as immaterial.

Table of Contents

5. Short term and Long term Investments, Restricted Deposits

Short term and long term investments and restricted deposits by investment type consist of the following ($ in millions):



	December 31, 2015									December 31, 2014
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value		Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
U.S. Treasury securities and obligations of U.S. government corporations and agencies	$	431	$	—	$	(2	)	$	429	$	393	$	1	$	(2	)	$	392
Corporate securities	859		2		(8		)	853		556		2		(2		)	556
Restricted certificates of deposit	5		—		—			5		6		—		—			6
Restricted cash equivalents	78		—		—			78		79		—		—			79
Municipal securities	496		2		(1		)	497		174		1		—			175
Asset backed securities	163		—		(1		)	162		180		—		—			180
Residential mortgage backed securities	66		1		—			67		84		1		—			85
Commercial mortgage backed securities	40		—		—			40		—		—		—			—
Cost and equity method investments	71		—		—			71		68		—		—			68
Life insurance contracts	16		—		—			16		16		—		—			16
Total	$	2,225	$	5	$	(12	)	$	2,218	$	1,556	$	5	$	(4	)	$	1,557

The Company’s investments are classified as available-for-sale with the exception of life insurance contracts and certain cost and equity method investments. The Company’s investment policies are designed to provide liquidity, preserve capital and maximize total return on invested assets with the focus on high credit quality securities. The Company limits the size of investment in any single issuer other than U.S. treasury securities and obligations of U.S. government corporations and agencies. The Company's mortgage backed securities are issued by the Federal National Mortgage Association and carry guarantees by the U.S. government. As of December 31, 2015, 99% of the Company’s investments in rated securities carry an investment grade rating by S&P or Moody’s. At December 31, 2015, the Company held certificates of deposit, life insurance contracts and cost and equity method investments which did not carry a credit rating.

Table of Contents

The fair value of available-for-sale investments with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):



	December 31, 2015										December 31, 2014
	Less Than 12 Months					12 Months or More					Less Than 12 Months					12 Months or More
	Unrealized Losses			Fair Value		Unrealized Losses			Fair Value		Unrealized Losses			Fair Value		Unrealized Losses			Fair Value
U.S. Treasury securities and obligations of U.S. government corporations and agencies	$	(2	)	$	294	$	—		$	14	$	—		$	72	$	(2	)	$	180
Corporate securities	(6		)	561		(2		)	41		(2		)	311		—			1
Municipal securities	(1		)	208		—			5		—			20		—			7
Asset backed securities	(1		)	121		—			8		—			70		—			10
Residential Mortgage backed securities	—			30		—			—		—			18		—			—
Commercial mortgage backed securities	—			34		—			—		—			—		—			—
Total	$	(10	)	$	1,248	$	(2	)	$	68	$	(2	)	$	491	$	(2	)	$	198

As of December 31, 2015, the gross unrealized losses were generated from 429 positions out of a total of 733 positions. The change in fair value of fixed income securities is a result of movement in interest rates subsequent to the purchase of the security.

For each security in an unrealized loss position, the Company assesses whether it intends to sell the security or if it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual or regulatory purposes. If the security meets this criterion, the decline in fair value is other-than-temporary and is recorded in earnings. The Company does not intend to sell these securities prior to maturity and it is not likely that the Company will be required to sell these securities prior to maturity; therefore, there is no indication of other than temporary impairment for these securities.

During the year ended December 31, 2015, the company recognized $8 million of income from equity method investments.

The contractual maturities of short term and long term investments and restricted deposits are as follows ($ in millions):



	December 31, 2015								December 31, 2014
	Investments				Restricted Deposits				Investments				Restricted Deposits
	Amortized Cost		Fair Value		Amortized Cost		Fair Value		Amortized Cost		Fair Value		Amortized Cost		Fair Value
One year or less	$	176	$	176	$	93	$	93	$	176	$	177	$	92	$	92
One year through five years	1,662		1,654		22		22		1,121		1,121		8		8
Five years through ten years	267		268		—		—		121		120		—		—
Greater than ten years	5		5		—		—		38		39		—		—
Total	$	2,110	$	2,103	$	115	$	115	$	1,456	$	1,457	$	100	$	100

Actual maturities may differ from contractual maturities due to call or prepayment options. Asset backed and mortgage backed securities are included in the one year through five years category, while cost and equity method investments and life insurance contracts are included in the five years through ten years category. The Company has an option to redeem at amortized cost substantially all of the securities included in the greater than ten years category listed above.

Table of Contents

The Company continuously monitors investments for other-than-temporary impairment. Certain investments have experienced a decline in fair value due to changes in credit quality, market interest rates and/or general economic conditions. The Company recognizes an impairment loss for cost and equity method investments when evidence demonstrates that it is other-than-temporarily impaired. Evidence of a loss in value that is other than temporary may include the absence of an ability to recover the carrying amount of the investment or the inability of the investee to sustain a level of earnings that would justify the carrying amount of the investment.

6. Fair Value Measurements

Assets and liabilities recorded at fair value in the consolidated balance sheets are categorized based upon observable or unobservable inputs used to estimate the fair value. Level inputs are as follows:



Level Input:		Input Definition:
Level I		Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.

Level II		Inputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.

Level III		Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.

The following table summarizes fair value measurements by level at December 31, 2015, for assets and liabilities measured at fair value on a recurring basis ($ in millions):



	Level I		Level II		Level III		Total
Assets
Cash and cash equivalents	$	1,760	$	—	$	—	$	1,760
Investments available for sale:
U.S. Treasury securities and obligations of U.S. government corporations and agencies	$	325	$	72	$	—	$	397
Corporate securities	—		853		—		853
Municipal securities	—		497		—		497
Asset backed securities	—		162		—		162
Residential mortgage backed securities	—		67		—		67
Commercial mortgage backed securities	—		40		—		40
Total investments	$	325	$	1,691	$	—	$	2,016
Restricted deposits available for sale:
Cash and cash equivalents	$	78	$	—	$	—	$	78
Certificates of deposit	5		—		—		5
U.S. Treasury securities and obligations of U.S. government corporations and agencies	32		—		—		32
Total restricted deposits	$	115	$	—	$	—	$	115
Other long term assets:
Interest rate swap agreements	$	—	$	11	$	—	$	11
Total assets at fair value	$	2,200	$	1,702	$	—	$	3,902

Liabilities
Other long term liabilities:
Interest rate swap agreements	$	—	$	2	$	—	$	2
Total liabilities at fair value	$	—	$	2	$	—	$	2

Table of Contents

The following table summarizes fair value measurements by level at December 31, 2014, for assets and liabilities measured at fair value on a recurring basis ($ in millions):



	Level I		Level II		Level III		Total
Assets
Cash and cash equivalents	$	1,610	$	—	$	—	$	1,610
Investments available for sale:
U.S. Treasury securities and obligations of U.S. government corporations and agencies	$	360	$	17	$	—	$	377
Corporate securities	—		556		—		556
Municipal securities	—		175		—		175
Asset backed securities	—		180		—		180
Residential mortgage backed securities	—		85		—		85
Commercial mortgage backed securities	—		—		—		—
Total investments	$	360	$	1,013	$	—	$	1,373
Restricted deposits available for sale:
Cash and cash equivalents	$	79	$	—	$	—	$	79
Certificates of deposit	6		—		—		6
U.S. Treasury securities and obligations of U.S. government corporations and agencies	15		—		—		15
Total restricted deposits	$	100	$	—	$	—	$	100
Other long term assets:
Interest rate swap agreements	$	—	$	11	$	—	$	11
Total assets at fair value	$	2,070	$	1,024	$	—	$	3,094

The Company periodically transfers U.S. Treasury securities and obligations of U.S. government corporations and agencies between Level I and Level II fair value measurements dependent upon the level of trading activity for the specific securities at the measurement date. The Company’s policy regarding the timing of transfers between Level I and Level II is to measure and record the transfers at the end of the reporting period. At December 31, 2015, there were $53 million of transfers from Level I to Level II and no transfers from Level II to Level I. The Company utilizes matrix pricing services to estimate fair value for securities which are not actively traded on the measurement date. The Company designates these securities as Level II fair value measurements. The aggregate carrying amount of the Company’s life insurance contracts and other non-majority owned investments, which approximates fair value, was $87 million and $84 million as of December 31, 2015 and December 31, 2014, respectively.

7. Property, Software and Equipment

Property, software and equipment consist of the following as of December 31 ($ in millions):



	2015			2014
Computer software	$	237		$	198
Building	223			208
Land	104			87
Computer hardware	105			88
Furniture and office equipment	92			70
Leasehold improvements	108			82
	869			733
Less accumulated depreciation	(351		)	(288		)
Property, software and equipment, net	$	518		$	445

Table of Contents

As of December 31, 2015 and 2014, the Company had assets acquired under capital leases included above of $6 million and $7 million, net of accumulated amortization of $4 million and $3 million, respectively. Amortization on assets under capital leases charged to expense is included in depreciation expense. Depreciation expense for the years ended December 31, 2015, 2014 and 2013 was $78 million, $65 million and $52 million, respectively.

8. Goodwill and Intangible Assets

The following table summarizes the changes in goodwill by operating segment ($ in millions):



	Managed Care			Specialty Services		Total
Balance as of December 31, 2013	$	151		$	197	$	348
Acquisition	125			281		406
Balance as of December 31, 2014	276			478		754
Acquisition	103			3		106
Impairment	(18		)	—		(18		)
Balance as of December 31, 2015	$	361		$	481	$	842

Goodwill acquisitions were related to the acquisitions and finalization of fair value allocations discussed in Note 4, Acquisitions and Noncontrolling Interest.

Intangible assets at December 31, consist of the following ($ in millions):



							Weighted Average Life in Years
	2015			2014			2015	2014
Purchased contract rights	$	71		$	28		8.8	7.5
Provider contracts	103			103			11.1	11.1
Customer relationships	26			15			8.1	7.1
Trade names	12			17			7.3	13.1
Developed technology	5			—			5.0	—
Intangible assets	217			163			9.8	10.3
Less accumulated amortization:
Purchased contract rights	(21		)	(14		)
Provider contracts	(24		)	(14		)
Customer relationships	(14		)	(12		)
Trade names	(2		)	(3		)
Developed technology	(1		)	—
Total accumulated amortization	(62		)	(43		)
Intangible assets, net	$	155		$	120

Amortization expense was $24 million, $16 million and $6 million for the years ended December 31, 2015, 2014 and 2013, respectively. Estimated total amortization expense related to intangible assets for each of the five succeeding fiscal years is as follows ($ in millions):



Year	Expense
2016	$	22
2017	19
2018	18
2019	18
2020	16

Table of Contents

9. Medical Claims Liability

The change in medical claims liability is summarized as follows ($ in millions):



	Year Ended December 31,
	2015			2014			2013
Balance, January 1,	$	1,723		$	1,112		$	815
Acquisitions	79			—			—
Incurred related to:
Current year	17,471			12,820			9,073
Prior years	(229		)	(142		)	(78		)
Total incurred	17,242			12,678			8,995

Paid related to:
Current year	15,279			11,122			7,975
Prior years	1,467			945			723
Total paid	16,746			12,067			8,698

Balance, December 31,	$	2,298		$	1,723		$	1,112

Changes in estimates of incurred claims for prior years are primarily attributable to reserving under moderately adverse conditions. Additionally, as a result of minimum HBR and other return of premium programs, approximately $47 million, $26 million, and $0 million of the “Incurred related to: Prior period” was recorded as a reduction to premium revenues in 2015, 2014 and 2013, respectively. Further, claims processing initiatives yielded increased claim payment recoveries and coordination of benefits related to prior year dates of service. Changes in medical utilization and cost trends and the effect of medical management initiatives may also contribute to changes in medical claim liability estimates. While the Company has evidence that medical management initiatives are effective on a case by case basis, medical management initiatives primarily focus on events and behaviors prior to the incurrence of the medical event and generation of a claim. Accordingly, any change in behavior, leveling of care, or coordination of treatment occurs prior to claim generation and as a result, the costs prior to the medical management initiative are not known by the Company. Additionally, certain medical management initiatives are focused on member and provider education with the intent of influencing behavior to appropriately align the medical services provided with the member's acuity. In these cases, determining whether the medical management initiative changed the behavior cannot be determined. Because of the complexity of its business, the number of states in which it operates, and the volume of claims that it processes, the Company is unable to practically quantify the impact of these initiatives on its changes in estimates of IBNR.

The Company had reinsurance recoverables related to medical claims liability of $31 million and $22 million at December 31, 2015 and 2014, respectively, included in premium and related receivables.

10. Health Insurance Marketplace

The Affordable Care Act (ACA) established risk spreading premium stabilization programs effective January 1, 2014 for the Health Insurance Marketplace product. These programs, commonly referred to as the “three Rs,” include a permanent risk adjustment program, a transitional reinsurance program, and a temporary risk corridor program. Additionally, the ACA established a minimum annual medical loss ratio for the Health Insurance Marketplace. Each of the three R programs are taken into consideration to determine if the Company’s estimated annual medical costs are less than the minimum loss ratio and require an adjustment to Premium revenue to meet the minimum medical loss ratio.

In June 2015, CMS released final results on reinsurance and risk-adjustment for the 2014 plan year. In September 2015, the results on risk corridor and the minimum medical loss ratio were finalized for the 2014 plan year. These final results had an insignificant impact to the Company for the 2014 plan year.

Table of Contents

The Company's receivables (payables) for each of these programs are as follows at each year ended ($ in millions):



	December 31, 2015			December 31, 2014
Risk adjustment	$	(108	)	$	(44	)
Reinsurance	24			11
Risk corridor	(4		)	(9		)
Minimum medical loss ratio	(15		)	(6		)

11. Debt

Debt consists of the following ($ in millions):



	December 31, 2015			December 31, 2014
$425 million 5.75% Senior notes, due June 1, 2017	$	428		$	429
$500 million 4.75% Senior notes, due May 15, 2022	500			300
Fair value of interest rate swap agreements	9			11
Senior notes	937			740
Revolving credit agreement	225			75
Mortgage notes payable	67			70
Capital leases	6			8
Debt issuance costs	(14		)	(14		)
Total debt	1,221			879
Less current portion	(5		)	(5		)
Long term debt	$	1,216		$	874

Senior Notes

In January 2015, the Company issued an additional $200 million of 4.75% Senior Notes ($200 Million Add-on Notes) at par. The $200 Million Add-on Notes were offered as additional debt securities under the indenture governing the $300 million of 4.75% Senior Notes issued in April 2014. In connection with the January 2015 issuance, the Company entered into interest rate swap agreements for a notional amount of $200 million at a floating rate of interest based on the three month LIBOR plus 2.88%. Gains and losses due to changes in the fair value of the interest rate swap completely offset changes in the fair value of the hedged portion of the underlying debt and are recorded as an adjustment to the $200 Million Add-on Notes.

In April 2014, the Company issued $300 million of 4.75% Senior Notes due May 15, 2022 ($300 Million Notes) at par. In connection with the April 2014 issuance, the Company entered into interest rate swap agreements for a notional amount of $300 million. Gains and losses due to changes in the fair value of the interest rate swap agreements offset changes in the fair value of the hedged portion of the underlying debt and are recorded as an adjustment to the $300 Million Notes.

The indentures governing both the $425 million and the $500 million notes contain non-financial and financial covenants, including requirements of a minimum fixed charge coverage ratio.

Interest Rate Swaps

The Company uses interest rate swap agreements to convert a portion of its interest rate exposure from fixed rates to floating rates to more closely align interest expense with interest income received on its cash equivalent and variable rate investment balances. The Company has $750 million of notional amount of interest rate swap agreements consisting of $250 million which are scheduled to expire on June 1, 2017 and $500 million that are scheduled to expire May 15, 2022. Under the Swap Agreements, the Company receives a fixed rate of interest and pays a variable rate of the three month LIBOR plus an average 2.85% adjusted quarterly. At December 31, 2015, the weighted average rate was 3.22%.

Table of Contents

The Swap Agreements are formally designated and qualify as fair value hedges and are recorded at fair value in the Consolidated Balance Sheet in other assets or other liabilities. Gains and losses due to changes in fair value of the interest rate swap agreements completely offset changes in the fair value of the hedged portion of the underlying debt. Therefore, no gain or loss has been recognized due to hedge ineffectiveness. Offsetting changes in fair value of both the interest rate swaps and the hedged portion of the underlying debt both were recognized in interest expense in the Consolidated Statement of Operations. The Company does not hold or issue any derivative instrument for trading or speculative purposes.

The fair values of the Swap Agreements as of December 31, 2015 were assets of $11 million and liabilities of $2 million, and are included in other long term assets and other long term liabilities, respectively in the Consolidated Balance Sheet. The fair value of the Swap Agreements as of December 31, 2014 were assets of $11 million and are included in other long term assets in the Consolidated Balance Sheet. The fair value of the Swap Agreements excludes accrued interest and takes into consideration current interest rates and current likelihood of the swap counterparties' compliance with its contractual obligations.

Revolving Credit Agreement

The Company has an unsecured $500 million revolving credit facility. Borrowings under the agreement bear interest based upon LIBOR rates, the Federal Funds Rate or the Prime Rate. The agreement has a maturity date of June 1, 2018, provided it will mature 90 days prior to the maturity date of the Company's 5.75% Senior Notes due 2017 if such notes are not refinanced (or extended), certain financial conditions are not met, or the Company does not carry $100 million of unrestricted cash. As of December 31, 2015, the Company had $225 million of borrowings outstanding under the agreement with a weighted average interest rate of 2.05%.

The agreement contains non-financial and financial covenants, including requirements of minimum fixed charge coverage ratios, maximum debt-to-EBITDA ratios and minimum tangible net worth. The Company is required to not exceed a maximum debt-to-EBITDA ratio of 3.0 to 1.0. As of December 31, 2015, there were no limitations on the availability under the revolving credit agreement as a result of the debt-to-EBITDA ratio.

Mortgage Notes Payable

The Company has a non-recourse mortgage note of $67 million at December 31, 2015 collateralized by its corporate headquarters building. The mortgage note is due January 1, 2021 and bears a 5.14% interest rate. The collateralized property had a net book value of $151 million at December 31, 2015.

Letters of Credit & Surety Bonds

The Company had outstanding letters of credit of $47 million as of December 31, 2015, which were not part of the revolving credit facility. As discussed in Note 4, Acquisitions and Noncontrolling Interest, the Company also had letters of credit for $50 million (valued at December 31, 2015 conversion rate), or €46 million, representing its proportional share of the letters of credit issued to support Ribera Salud's outstanding debt which are a part of the revolving credit facility. Collectively, the letters of credit bore interest at 1.55% as of December 31, 2015. The Company had outstanding surety bonds of $305 million as of December 31, 2015.

Aggregate maturities for the Company's debt are as follows ($ in millions):



2016	$	5
2017	429
2018	228
2019	4
2020	4
Thereafter	553
Total	$	1,223

The fair value of outstanding debt was approximately $1,239 million and $901 million at December 31, 2015 and 2014, respectively.

Table of Contents

12. Stockholders' Equity

The Company has 10,000,000 authorized shares of preferred stock at $.001 par value. At December 31, 2015, there were no preferred shares outstanding.

The Company's Board of Directors has authorized a stock repurchase program for up to 8,000,000 shares of the Company's common stock from time to time on the open market or through privately negotiated transactions. No duration has been placed on the repurchase program. The Company has 3,335,448 available shares remaining under the program for repurchases as of December 31, 2015. The Company reserves the right to discontinue the repurchase program at any time. During the year ended December 31, 2015, the Company did not repurchase any shares through this publicly announced program.

As a component of the employee stock compensation plan, employees can use shares of stock which have vested to satisfy minimum statutory tax withholding obligations. As part of this plan, the Company repurchased 918,628 shares at an aggregate cost of $53 million in 2015 and 626,234 shares at an aggregate cost of $29 million in 2014. These shares are included in the Company's treasury stock.

In January 2014, the Company completed the acquisition of 68% of USMM and as a result, issued 4,486,434 shares of Centene common stock to the selling stockholders. Additionally, in July 2014, the Company completed a transaction whereby CHS assigned its contract with the Louisiana Department of Health and Hospitals to Centene's wholly owned subsidiary, LHC. The closing resulted in the issuance of 1,492,738 shares of Centene common stock.

13. Statutory Capital Requirements and Dividend Restrictions

Various state laws require Centene's regulated subsidiaries to maintain minimum capital levels specified by each state and restrict the amount of dividends that may be paid without prior regulatory approval. At December 31, 2015 and 2014, Centene's subsidiaries, including Kentucky Spirit Health Plan, had aggregate statutory capital and surplus of $2,284 million and $1,699 million, respectively, compared with the required minimum aggregate statutory capital and surplus of $1,195 million and $851 million, respectively.

14. Income Taxes

The consolidated income tax expense consists of the following for the years ended December 31 ($ in millions):



	2015			2014			2013
Current provision:
Federal	$	332		$	225		$	121
State and local	26			13			6
Total current provision	358			238			127
Deferred provision	(19		)	(42		)	(20		)
Total provision for income taxes	$	339		$	196		$	107

Table of Contents

The reconciliation of the tax provision at the U.S. Federal Statutory Rate to the provision for income taxes for the years ended December 31 is as follows ($ in millions):



	2015		2014			2013
Earnings from continuing operations, before income tax expense	$	697	$	457		$	269
(Earnings) loss attributable to flow through noncontrolling interest	1		4			(1		)
Earnings from continuing operations, less noncontrolling interest, before income tax expense	698		461			268

Tax provision at the U.S. federal statutory rate	244		162			94
State income taxes, net of federal income tax benefit	15		6			3
Nondeductible compensation	2		1			12
Benefit from reversal of prior years impact of 162(m)(6) regulations	—		(14		)	—
ACA Health Insurer Fee	75		44			—
Other, net	3		(3		)	(2		)
Income tax expense	$	339	$	196		$	107

The tax effects of temporary differences which give rise to deferred tax assets and liabilities are presented below for the years ended December 31 ($ in millions):



	2015			2014
Deferred tax assets:
Medical claims liability	$	27		$	27
Accrued expenses	9			11
Net operating loss carryforward	20			21
Compensation accruals	73			53
Acquisition costs	10			—
Premium and related receivables	34			35
Other	18			9
Deferred tax assets	191			156
Valuation allowance	(11		)	(12		)
Net deferred tax assets	$	180		$	144

Deferred tax liabilities:
Intangible assets	$	46		$	25
Prepaid assets	8			6
Depreciation and amortization	31			26
Investments in partnerships	7			—
Other	1			4
Deferred tax liabilities	93			61

Net deferred tax assets	$	87		$	83

Table of Contents

The Company's deferred tax assets include federal and state net operating losses, or NOLs. Accordingly, the total and annual deduction for those NOLs is limited by tax law. Federal and State NOLs of $6 million were all acquired in business combinations. The Company's federal NOLs expire between the years 2020 and 2033 and the state NOLs expire between the years 2016 and 2035. Valuation allowances are recorded for those NOLs the Company believes are more likely than not to expire unused. During 2015 and 2014, the Company recorded valuation allowance additions in the tax provision of $1 million and $5 million, respectively. The Company recorded valuation allowance reductions of $2 million and $1 million during the years ended December 31, 2015 and 2014.

As of December 31, 2015 and 2014, the Company maintained reserves for uncertain tax positions that may be challenged by a tax authority of $4 million. The unrecognized federal tax benefits are related to returns open from 2012 to 2015. The Company files in numerous state jurisdictions with varying statutes of limitation. The unrecognized state tax benefits are related to returns open from 2010 to 2015.

In September 2014, the Internal Revenue Service issued final regulations related to the compensation deduction limitation applicable to certain health insurance issuers. The new regulations provided additional information regarding the definition of a health insurance issuer. Based on the final regulations, the Company believes it is not subject to the compensation deduction limitation. As a result of this change in regulation, tax benefits of $14 million related to 2013 were recorded during the 2014 period.

As of December 31, 2015, the Company had $8 million of undistributed earnings from non-U.S. subsidiaries that are intended to be reinvested in non-U.S. operations. Because these earnings are considered permanently reinvested, no U.S. tax provision has been accrued related to the repatriation of these earnings. The amount of U.S. tax that would be payable on the eventual remittance of such earnings is not material to the Company’s financial statements.

15. Stock Incentive Plans

The Company's stock incentive plans allow for the granting of restricted stock or restricted stock unit awards and options to purchase common stock. Both incentive stock options and nonqualified stock options can be awarded under the plans. No option will be exercisable for longer than ten years after the date of grant. The plans have 2,528,371 shares available for future awards. Compensation expense for stock options and restricted stock unit awards is recognized on a straight-line basis over the vesting period, generally three to five years for stock options and 1 to 10 years for restricted stock or restricted stock unit awards. Certain restricted stock unit awards contain performance-based as well as service-based provisions. Certain awards provide for accelerated vesting if there is a change in control as defined in the plans. The total compensation cost that has been charged against income for the stock incentive plans was $71 million, $48 million and $36 million for the years ended December 31, 2015, 2014 and 2013, respectively. The total income tax benefit recognized in the income statement for stock-based compensation arrangements was $24 million, $17 million and $8 million for the years ended December 31, 2015, 2014 and 2013, respectively.

Option activity for the year ended December 31, 2015 is summarized below:



	Shares		Weighted Average Exercise Price		Aggregate Intrinsic Value ($ in millions)		Weighted Average Remaining Contractual Term
Outstanding as of December 31, 2014	1,267,066		$	12.18
Granted	—		—
Exercised	(588,658	)	12.52
Forfeited	(1,000	)	12.39
Outstanding as of December 31, 2015	677,408		$	11.88	$	37	2.0

Exercisable as of December 31, 2015	670,740		$	11.78	$	36	2.0

The fair value of each option grant is estimated on the date of the grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:

Table of Contents



	Year Ended December 31,
	2015 ⁽¹⁾	2014 ⁽¹⁾	2013
Expected life (in years)	—	—	5.1
Risk-free interest rate	—	—	0.8%
Expected volatility	—	—	48.1%
Expected dividend yield	—	—	—

(1) No options were awarded in the years ended December 31, 2015 and 2014.

For the year ended December 31, 2013, the Company used a projected expected life for each award granted based on historical experience of employees' exercise behavior. The expected volatility is primarily based on historical volatility levels. The risk-free interest rates are based on the implied yield currently available on U.S. Treasury instruments with a remaining term equal to the expected life.

Other information pertaining to option activity is as follows:



	Year Ended December 31,
	2015 ⁽¹⁾		2014 ⁽¹⁾		2013
Weighted-average fair value of options granted	$	—	$	—	$	9.52
Total intrinsic value of stock options exercised ($ in millions)	$	28	$	17	$	13

(1) No options were awarded in the years ended December 31, 2015 and 2014.

A summary of the Company's non-vested restricted stock and restricted stock unit shares as of December 31, 2015, and changes during the year ended December 31, 2015, is presented below:



	Shares		Weighted Average Grant Date Fair Value
Non-vested balance as of December 31, 2014	4,350,014		$	36.86
Granted	1,795,359		58.38
Vested	(1,906,900	)	31.81
Forfeited	(116,470	)	34.10
Non-vested balance as of December 31, 2015	4,122,003		$	48.65

The total fair value of restricted stock and restricted stock units vested during the years ended December 31, 2015, 2014 and 2013, was $112 million, $82 million and $49 million, respectively.

As of December 31, 2015, there was $191 million of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the plans; that cost is expected to be recognized over a weighted-average period of 1.3 years.

The Company maintains an employee stock purchase plan and has issued 86,819 shares, 76,088 shares, and 84,168 shares in 2015, 2014 and 2013, respectively.

16. Retirement Plan

Centene has a defined contribution plan which covers substantially all employees who are at least twenty-one years of age. Under the plan, eligible employees may contribute a percentage of their base salary, subject to certain limitations. Centene may elect to match a portion of the employee's contribution. Company expense related to matching contributions to the plan was $19 million, $12 million and $9 million during the years ended December 31, 2015, 2014 and 2013, respectively.

Table of Contents

17. Commitments

Centene and its subsidiaries lease office facilities and various equipment under non-cancelable operating leases which may contain escalation provisions. The rental expense related to these leases is recorded on a straight-line basis over the lease term, including rent holidays. Tenant improvement allowances are recorded as a liability and amortized against rent expense over the term of the lease. Rent expense was $64 million, $46 million and $31 million for the years ended December 31, 2015, 2014 and 2013, respectively. Annual non-cancelable minimum lease payments over the next five years and thereafter are as follows ($ in millions):



2016	$	58
2017	59
2018	50
2019	45
2020	33
Thereafter	70
	$	315

18. Contingencies

On May 26, 2015, the Commonwealth issued a demand for indemnification to its actuarial firm, for "all defense costs, and any resultant monetary awards in favor of Kentucky Spirit, arising from or related to Kentucky Spirit's claims which are predicated upon the alleged omissions and errors in the Data Book and the certified actuarially sound rates." On August 19, 2015, the actuarial firm moved to intervene in the litigation. The Franklin Circuit Court granted the actuarial firm's motion on September 8, 2015 and ordered a forty-five day stay of all pretrial proceedings in order for the firm to review the record. Also, on August 19, 2015, the actuarial firm filed a petition seeking a declaratory judgment that it is not liable to the Commonwealth for indemnification related to the claims asserted by Kentucky Spirit against the Commonwealth. On October 5, 2015, the Commonwealth filed an answer to the actuarial firm's petition and asserted counterclaims/cross-claims against the firm.

On March 9, 2015, the Secretary of the Kentucky Cabinet for Health and Family Services (CHFS) issued a determination letter finding that Kentucky Spirit owed the Commonwealth $40 million in actual damages plus prejudgment interest at 8 percent. On March 18, 2015, in a letter to the Kentucky Finance and Administration Cabinet (FAC), Kentucky Spirit contested CHFS' jurisdiction to make such a determination. The FAC did not issue a decision within the required 120 days. On August 13, 2015, Kentucky Spirit filed a declaratory judgment action against the Commonwealth in Franklin Circuit Court seeking a declaration that the Commonwealth may not purport to issue a decision against Kentucky Spirit awarding damages to itself when the matter is already before the Kentucky courts, and that the Commonwealth has waived its claims against Kentucky Spirit for damages arising out of the contract. The Commonwealth filed counterclaims seeking a Declaration of Rights and Entry of Judgment on its determination letter. On December 1, 2015 the Franklin Circuit Court consolidated this declaratory judgment action with Kentucky Spirit’s other litigation claims against the Commonwealth. On December 15, 2015, the Franklin Circuit Court denied Kentucky Spirit’s motion to dismiss the Commonwealth’s counterclaim for Declaration of Rights and Entry of Judgment. Discovery is proceeding in the consolidated litigation matters.

Table of Contents

19. Earnings Per Share

The following table sets forth the calculation of basic and diluted net earnings per common share for the years ended December 31 ($ in millions, except per share data):



	2015			2014		2013
Earnings attributable to Centene Corporation:
Earnings from continuing operations, net of tax	$	356		$	268	$	161
Discontinued operations, net of tax	(1		)	3		4
Net earnings	$	355		$	271	$	165

Shares used in computing per share amounts:
Weighted average number of common shares outstanding	119,100,744			116,345,764		108,253,090
Common stock equivalents (as determined by applying the treasury stock method)	3,965,626			4,014,448		4,241,256
Weighted average number of common shares and potential dilutive common shares outstanding	123,066,370			120,360,212		112,494,346

Net earnings per common share attributable to Centene Corporation:
Basic:
Continuing operations	$	2.99		$	2.30	$	1.49
Discontinued operations	(0.01		)	0.03		0.03
Basic earnings per common share	$	2.98		$	2.33	$	1.52

Diluted:
Continuing operations	$	2.89		$	2.23	$	1.43
Discontinued operations	(0.01		)	0.02		0.04
Diluted earnings per common share	$	2.88		$	2.25	$	1.47

The calculation of diluted earnings per common share for 2015, 2014 and 2013 excludes the impact of 7,247 shares, 207,980 shares and 187,078 shares, respectively, related to anti-dilutive stock options, restricted stock and restricted stock units.

20. Segment Information

Centene operates in two segments: Managed Care and Specialty Services. The Managed Care segment consists of Centene’s health plans including all of the functions needed to operate them. The Specialty Services segment consists of Centene’s specialty companies offering auxiliary healthcare services and products.

Factors used in determining the reportable business segments include the nature of operating activities, existence of separate senior management teams, and the type of information presented to the Company's chief operating decision maker to evaluate all results of operations.

Table of Contents

Segment information as of and for the year ended December 31, 2015, follows ($ in millions):



	Managed Care		Specialty Services		Eliminations			Consolidated Total
Premium and service revenues from external customers	$	19,054	$	2,211	$	—		$	21,265
Premium and service revenues from internal customers	100		4,864		(4,964		)	—
Total premium and service revenues	19,154		7,075		(4,964		)	21,265
Earnings from operations	513		192		—			705
Total assets	6,202		1,137		—			7,339

Segment information as of and for the year ended December 31, 2014, follows ($ in millions):



	Managed Care		Specialty Services		Eliminations			Consolidated Total
Premium and service revenues from external customers	$	13,886	$	1,781	$	—		$	15,667
Premium and service revenues from internal customers	60		3,019		(3,079		)	—
Total premium and service revenues	13,946		4,800		(3,079		)	15,667
Earnings from operations	353		111		—			464
Total assets	4,706		1,118		—			5,824

Segment information as of and for the year ended December 31, 2013, follows ($ in millions):



	Managed Care		Specialty Services		Eliminations			Consolidated Total
Premium and service revenues from external customers	$	9,741	$	785	$	—		$	10,526
Premium and service revenues from internal customers	41		2,147		(2,188		)	—
Total premium and service revenues	9,782		2,932		(2,188		)	10,526
Earnings from operations	198		79		—			277
Total assets	2,921		598		—			3,519

21. Quarterly Selected Financial Information

(In millions, except share data)

(Unaudited)



	For the Quarter Ended
	March 31, 2015			June 30, 2015		September 30, 2015		December 31, 2015
Total revenues	$	5,131		$	5,506	$	5,821	$	6,302
Amounts attributable to Centene Corporation common shareholders:
Earnings from continuing operations, net of income tax expense	$	64		$	88	$	92	$	112
Discontinued operations, net of income tax expense (benefit)	(1		)	—		1		(1		)
Net earnings	$	63		$	88	$	93	$	111

Net earnings (loss) per common share attributable to Centene Corporation:
Basic:
Continuing operations	$	0.54		$	0.74	$	0.77	$	0.94
Discontinued operations	(0.01		)	—		0.01		(0.01		)
Basic earnings per common share	$	0.53		$	0.74	$	0.78	$	0.93

Diluted:
Continuing operations	$	0.52		$	0.72	$	0.75	$	0.91
Discontinued operations	(0.01		)	—		0.01		(0.01		)
Diluted earnings per common share	$	0.51		$	0.72	$	0.76	$	0.90

Table of Contents



	For the Quarter Ended
	March 31, 2014			June 30, 2014		September 30, 2014		December 31, 2014
Total revenues	$	3,460		$	4,023	$	4,352	$	4,725
Amounts attributable to Centene Corporation common shareholders:
Earnings from continuing operations, net of income tax expense	$	34		$	47	$	81	$	106
Discontinued operations, net of income tax expense (benefit)	(1		)	2		1		1
Net earnings	$	33		$	49	$	82	$	107

Net earnings (loss) per common share attributable to Centene Corporation:
Basic:
Continuing operations	$	0.30		$	0.41	$	0.69	$	0.90
Discontinued operations	(0.01		)	0.01		0.01		0.01
Basic earnings per common share	$	0.29		$	0.42	$	0.70	$	0.91

Diluted:
Continuing operations	$	0.29		$	0.39	$	0.67	$	0.87
Discontinued operations	(0.01		)	0.02		0.01		0.01
Diluted earnings per common share	$	0.28		$	0.41	$	0.68	$	0.88

Table of Contents

22. Condensed Financial Information of Registrant

Centene Corporation (Parent Company Only)

Condensed Balance Sheets

(In millions, except share data)



	December 31,
	2015			2014
ASSETS
Current assets:
Cash and cash equivalents	$	4		$	3
Short term investments, at fair value (amortized cost $5 and $8, respectively)	5			8
Other current assets	711			378
Total current assets	720			389
Long term investments, at fair value (amortized cost $6 and $10, respectively)	6			10
Investment in subsidiaries	2,749			2,296
Other long term assets	35			38
Total assets	$	3,510		$	2,733

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities	$	13		$	24
Long term debt	1,147			815
Other long term liabilities	26			3
Total liabilities	1,186			842

Redeemable noncontrolling interest	156			148

Stockholders' equity:
Common stock, $.001 par value; authorized 400,000,000 shares; 126,855,477 issued and 120,342,981 outstanding at December 31, 2015, and 124,274,864 issued and 118,433,416 outstanding at December 31, 2014	—			—
Additional paid-in capital	956			840
Accumulated other comprehensive loss	(10		)	(1		)
Retained earnings	1,358			1,003
Treasury stock, at cost (6,512,496 and 5,841,448 shares, respectively)	(147		)	(98		)
Total Centene stockholders' equity	2,157			1,744
Noncontrolling interest	11			(1		)
Total stockholders' equity	2,168			1,743
Total liabilities and stockholders' equity	$	3,510		$	2,733

See notes to condensed financial information of registrant.

Table of Contents

Centene Corporation (Parent Company Only)

Condensed Statements of Operations

(In millions, except share data)



	Year Ended December 31,
	2015			2014			2013
Expenses:
General and administrative expenses	$	9		$	3		$	4
Gain on contingent consideration	(44		)	—			—
Other income (expense):
Investment and other income	(5		)	1			1
Interest expense	(39		)	(30		)	(23		)
Earnings (loss) before income taxes	(9		)	(32		)	(26		)
Income tax benefit	(26		)	(8		)	(15		)
Net earnings (loss) before equity in subsidiaries	17			(24		)	(11		)
Equity in earnings from subsidiaries	341			285			173
Net earnings	358			261			162
(Earnings) loss attributable to noncontrolling interests	(2		)	7			(1		)
Net earnings attributable to Centene	$	356		$	268		$	161

Net earnings per share from continuing operations:
Basic earnings per common share	$	2.99		$	2.30		$	1.49
Diluted earnings per common share	$	2.89		$	2.23		$	1.43
Weighted average number of shares outstanding:
Basic	119,100,744			116,345,764			108,253,090
Diluted	123,066,370			120,360,212			112,494,346

See notes to condensed financial information of registrant.

Table of Contents

Centene Corporation (Parent Company Only)

Condensed Statements of Cash Flows

(In millions)



	Year Ended December 31,
	2015			2014			2013
Cash flows from operating activities:
Cash provided by operating activities	$	462		$	317		$	302
Cash flows from investing activities:
Net dividends from and capital contributions to subsidiaries	(660		)	(384		)	(417		)
Purchase of investments	(17		)	(32		)	(12		)
Sales and maturities of investments	9			14			10
Proceeds from asset sale	7			—			—
Acquisitions	(113		)	(137		)	(67		)
Net cash used in investing activities	(774		)	(539		)	(486		)
Cash flows from financing activities:
Proceeds from borrowings	1,925			1,875			180
Payment of long term debt	(1,575		)	(1,650		)	(30		)
Proceeds from exercise of stock options	13			8			9
Proceeds from stock offering	—			—			15
Common stock repurchases	(53		)	(29		)	(20		)
Debt issue costs	(4		)	(7		)	(3		)
Payment of contingent consideration obligation	(29		)	—			—
Contributions from noncontrolling interest	11			6			8
Excess tax benefits from stock compensation	25			19			6
Net cash provided by financing activities	313			222			165
Net increase (decrease) in cash and cash equivalents	1			—			(19		)
Cash and cash equivalents, beginning of period	3			3			22
Cash and cash equivalents, end of period	$	4		$	3		$	3

See notes to condensed financial information of registrant.

Notes to Condensed Financial Information of Registrant

Note A - Basis of Presentation and Significant Accounting Policies

The parent company only financial statements should be read in conjunction with Centene Corporation's audited consolidated financial statements and the notes to consolidated financial statements included in this Form 10-K.

The parent company's investment in subsidiaries is stated at cost plus equity in undistributed earnings of the subsidiaries. The parent company's share of net income of its unconsolidated subsidiaries is included in income using the equity method of accounting. Certain unrestricted subsidiaries receive monthly management fees from our restricted subsidiaries. The management and service fees received by our unrestricted subsidiaries are associated with all of the functions required to manage the restricted subsidiaries including but not limited to salaries and wages for all personnel, rent, utilities, medical management, provider contracting, compliance, member services, claims processing, information technology, cash management, finance and accounting, and other services. The management fees are based on a percentage of the restricted subsidiaries revenue.

Table of Contents

Due to our centralized cash management function, all cash flows generated by our unrestricted subsidiaries, including management fees, are transferred to the parent company, primarily to repay borrowings on the parent company's revolving credit facility. The parent company may also utilize the cash flow to make acquisitions, fund capital contributions to subsidiaries and fund its operations. During the years ended December 31, 2015, 2014 and 2013, cash flows received by the parent from unrestricted subsidiaries was $445 million, $341 million, and $313 million and was included in cash flows from operating activities.

Certain amounts presented in the parent company only financial statements are eliminated in the consolidated financial statements of Centene Corporation.

Note B - Dividends

During 2015, 2014 and 2013, the Registrant received dividends from its subsidiaries totaling $14 million, $54 million and $21 million, respectively.

Note C - Other Current Assets

The parent company's other current assets include $686 million and $359 million of federal and state income tax receivables as of December 31, 2015 and 2014, respectively, primarily due to tax sharing agreements with its subsidiaries.

23. Subsequent Events

In January 2016, the Company completed an approximate 19% investment in a data analytics business and as a result, issued 1.1 million shares of Centene common stock to the selling stockholders. The investment will be accounted for using the equity method of accounting.

In February 2016, a wholly owned unrestricted subsidiary of the Company (Escrow Issuer) issued $1,400 million of 5.625% Senior Notes ($1,400 million Notes) at par due 2021 and $1,000 million of 6.125% Senior Notes ($1,000 million Notes) at par due 2024. The Company intends to use the net proceeds of the offering, together with borrowings under the Company's $1,000 million revolving credit facility and cash on hand, to fund the cash consideration for the Health Net merger, to pay merger and offering related fees and expenses, and for general corporate purposes. The proceeds of the debt issuance will be held in escrow until the closing of the Health Net merger. If the Health Net merger is not consummated, the Escrow Issuer will be required to redeem each series of Notes at a redemption price equal to 100% of the principal amount of such series of Notes, plus accrued and unpaid interest to the redemption date.

Table of Contents

Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

None.

Item 9A. Controls and Procedures

Evaluation of Disclosure Controls and Procedures - Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2015. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company's management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of December 31, 2015, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

Management's Report on Internal Control Over Financial Reporting - Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on our evaluation under the framework in Internal Control - Integrated Framework (2013), our management concluded that our internal control over financial reporting was effective at the reasonable assurance level as of December 31, 2015. Our management's assessment of the effectiveness of our internal control over financial reporting as of December 31, 2015 has been audited by KPMG LLP, an independent registered public accounting firm, as stated in their report which is included herein.

Changes in Internal Control Over Financial Reporting - No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the year ended December 31, 2015 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

Report of Independent Registered Public Accounting Firm

The Board of Directors and Stockholders

Centene Corporation:

We have audited Centene Corporation’s internal control over financial reporting as of December 31, 2015, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Centene Corporation’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit.

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, Centene Corporation maintained, in all material respects, effective internal control over financial reporting as of December 31, 2015, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Centene Corporation and subsidiaries as of December 31, 2015 and 2014, and the related consolidated statements of operations, comprehensive earnings, stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2015, and our report dated February 22, 2016 expressed an unqualified opinion on those consolidated financial statements.

/s/ KPMG LLP

St. Louis, Missouri

February 22, 2016

Table of Contents

Item 9B. Other Information

None.

PART III

Item 10. Directors, Executive Officers and Corporate Governance

(a) Directors of the Registrant

Information concerning our directors will appear in our Proxy Statement for our 2016 annual meeting of stockholders under “Proposal One: Election of Directors”. This portion of the Proxy Statement is incorporated herein by reference.

(b) Executive Officers of the Registrant

Pursuant to General Instruction G(3) to Form 10-K and Instruction 3 to Item 401(b) of Regulation S-K, information regarding our executive officers is provided in Item 1 of Part I of this Annual Report on Form 10-K under the caption “Executive Officers of the Registrant.”

Information concerning our executive officers' compliance with Section 16(a) of the Exchange Act will appear in our Proxy Statement for our 2016 annual meeting of stockholders under “Section 16(a) Beneficial Ownership Reporting Compliance.” Information concerning our audit committee financial expert and identification of our audit committee will appear in our Proxy Statement for our 2016 annual meeting of stockholders under “Board of Directors Committees.” Information concerning our code of ethics will appear in our Proxy Statement for our 2016 annual meeting of stockholders under “Corporate Governance and Risk Management.” These portions of our Proxy Statement are incorporated herein by reference.

Information concerning certain corporate governance matters will appear in our Proxy Statement for our 2016 annual meeting of stockholders under “Corporate Governance and Risk Management.” These portions of our Proxy Statement are incorporated herein by reference.

Item 11. Executive Compensation

Information concerning executive compensation will appear in our Proxy Statement for our 2016 Annual Meeting of Stockholders under “Information About Executive Compensation.” Information concerning Compensation Committee interlocks and insider participation will appear in the Proxy Statement for our 2016 Annual Meeting of Stockholders under “Compensation Committee Interlocks and Insider Participation.” These portions of the Proxy Statement are incorporated herein by reference.

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Information concerning the security ownership of certain beneficial owners and management and our equity compensation plans will appear in our Proxy Statement for our 2016 annual meeting of stockholders under “Information About Stock Ownership” and “Equity Compensation Plan Information.” These portions of the Proxy Statement are incorporated herein by reference.

Item 13. Certain Relationships and Related Transactions, and Director Independence

Information concerning director independence, certain relationships and related transactions will appear in our Proxy Statement for our 2016 annual meeting of stockholders under “Corporate Governance and Risk Management” and “Related Party Transactions.” These portions of our Proxy Statement are incorporated herein by reference.

Item 14. Principal Accountant Fees and Services

Information concerning principal accountant fees and services will appear in our Proxy Statement for our 2016 annual meeting of stockholders under “Proposal Two: Ratification of Appointment of Independent Registered Public Accounting Firm.” This portion of our Proxy Statement is incorporated herein by reference.

Table of Contents

PART IV

Item 15. Exhibits and Financial Statement Schedules


(a)	Financial Statements and Schedules

The following documents are filed under Item 8 of this report:


1.	Financial Statements:

Report of Independent Registered Public Accounting Firm

Consolidated Balance Sheets as of December 31, 2015 and 2014

Consolidated Statements of Operations for the years ended December 31, 2015, 2014 and 2013

Consolidated Statements of Comprehensive Earnings for the years ended December 31, 2015, 2014 and 2013

Consolidated Statements of Stockholders' Equity for the years ended December 31, 2015, 2014 and 2013

Consolidated Statements of Cash Flows for the years ended December 31, 2015, 2014 and 2013

Notes to Consolidated Financial Statements


2.	Financial Statement Schedules:

None.


3.	The exhibits listed in the accompanying Exhibit Index are filed or incorporated by reference as part of this filing.

Table of Contents

EXHIBIT INDEX



				INCORPORATED BY REFERENCE ¹
EXHIBIT NUMBER		DESCRIPTION	FILED WITH THIS FORM 10-K	FORM	FILING DATE WITH SEC	EXHIBIT NUMBER
2.1		Agreement and Plan of Merger, dated as of July 2, 2015, by and among Centene Corporation, Health Net, Inc. Chopin Merger Sub I, Inc., and Chopin Merger Sub II, Inc.		8-K	July 7, 2015	2.1

3.1		Certificate of Incorporation of Centene Corporation		S-1	October 9, 2001	3.2

3.1a		Certificate of Amendment to Certificate of Incorporation of Centene Corporation, dated November 8, 2001		S-1/A	November 13, 2001	3.2a

3.1b		Certificate of Amendment to Certificate of Incorporation of Centene Corporation as filed with the Secretary of State of the State of Delaware		10-Q	July 26, 2004	3.1b

3.1c		Certificate of Amendment to Certificate of Incorporation of Centene Corporation as filed with the Secretary of State of the State of Delaware		S-3ASR	May 16, 2014	3.1c

3.1d		Certificate of Amendment to Certificate of Incorporation of Centene Corporation as filed with the Secretary of State of the State of Delaware		8-K	October 26, 2015	3.1

3.2		By-laws of Centene Corporation, as amended effective as of February 2, 2015		10-K	February 23, 2015	3.2

4.1		Indenture, dated May 27, 2011, among the Company and The Bank of New York Mellon Trust Company, N.A., relating to the Company's 5.75% Senior Notes due 2017 (including Form of Global Note as Exhibit A thereto)		8-K	May 27, 2011	4.1

4.2		Indenture, dated April 29, 2014, among the Company and The Bank of New York Mellon Trust Company, N.A., relating to the Company’s 4.75% Senior Notes due 2022 (including Form of Global Note as Exhibit A thereto)		8-K	April 29, 2014	4.1

4.3		Indenture, dated February 11, 2016, among Centene Escrow Corporation and The Bank of New York Mellon Trust Company, N.A., relating to the Company’s 5.625% Senior Notes due 2021 (including Form of Global Note as Exhibit A thereto)		8-K	February 11, 2016	4.1

4.4		Indenture, dated February 11, 2016, among Centene Escrow Corporation and The Bank of New York Mellon Trust Company, N.A., relating to the Company’s 6.125% Senior Notes due 2024 (including Form of Global Note as Exhibit A thereto)		8-K	February 11, 2016	4.2

10.1	*	1998 Stock Plan of Centene Corporation		S-1	October 9, 2001	10.10

10.2	*	1999 Stock Plan of Centene Corporation		S-1	October 9, 2001	10.11

10.3	*	2000 Stock Plan of Centene Corporation		S-1	October 9, 2001	10.12

10.4	*	2002 Employee Stock Purchase Plan, As Amended and Restated	X

10.5	*	Centene Corporation Amended and Restated 2003 Stock Incentive Plan		8-K	April 30, 2010	10.1

100

Table of Contents



10.6	*	Amended and Restated 2012 Stock Incentive Plan		8-K	April 22, 2014	10.1

10.7	*	Amended and Restated Non-Employee Directors Deferred Stock Compensation Plan		10-Q	July 28, 2015	10.1

10.8	*	Centene Corporation Employee Deferred Compensation Plan		10-K	February 22, 2010	10.10

10.9	*	Centene Corporation 2007 Long-Term Incentive Plan		8-K	April 26, 2007	10.2

10.10	*	Centene Corporation Short-Term Executive Compensation Plan		10-K	February 22, 2011	10.12

10.11	*	Executive Employment Agreement between Centene Corporation and Michael F. Neidorff, dated November 8, 2004		8-K	November 9, 2004	10.1

10.11a	*	Amendment No. 1 to Executive Employment Agreement between Centene Corporation and Michael F. Neidorff		10-Q	October 28, 2008	10.2

10.11b	*	Amendment No. 2 to Executive Employment Agreement between Centene Corporation and Michael F. Neidorff		10-Q	April 28, 2009	10.2

10.11c	*	Amendment No. 3 to Executive Employment Agreement between Centene Corporation and Michael F. Neidorff		10-Q	October 23, 2012	10.2

10.11d	*	Amendment No. 4 to Executive Employment Agreement between Centene Corporation and Michael F. Neidorff		8-K	May 16, 2013	10.1

10.12	*	Form of Executive Severance and Change in Control Agreement		10-Q	October 28, 2008	10.3

10.12a	*	Amendment No. 1 to Form of Executive Severance and Change in Control Agreement		10-Q	October 23, 2012	10.3

10.12b	*	Amendment No. 2 to Form of Executive Severance and Change in Control Agreement		10-Q	April 28, 2015	10.1

10.13	*	Form of Restricted Stock Unit Agreement	X

10.14	*	Form of Non-statutory Stock Option Agreement (Non-Employees)		8-K	July 28, 2005	10.3

10.15	*	Form of Non-statutory Stock Option Agreement (Employees)		10-Q	October 28, 2008	10.5

10.16	*	Form of Non-statutory Stock Option Agreement (Directors)		10-K	February 23, 2009	10.18

10.17	*	Form of Incentive Stock Option Agreement		10-Q	October 28, 2008	10.6

10.18	*	Form of Stock Appreciation Right Agreement		8-K	July 28, 2005	10.6

10.19	*	Form of Restricted Stock Agreement		10-Q	October 25, 2005	10.8

10.20	*	Form of Performance Based Restricted Stock Unit Agreement #1	X

10.21	*	Form of Performance Based Restricted Stock Unit Agreement #2	X

10.22	*	Form of Long-Term Incentive Plan Agreement		8-K	February 7, 2008	10.1

10.23		Credit Agreement dated as of May 21, 2013 among Centene Corporation, the various financial institutions party hereto and Barclays Bank PLC		8-K	May 22, 2013	10.1

101

Table of Contents



10.23a	Amended No. 1 to Amended and Restated Credit Agreement dated as of July 15, 2014 among Centene Corporation, the various financial institutions party hereto and Barclays Bank PLC		10-Q	October 28, 2014	10.3

10.23b	Amended No. 2 to Amended and Restated Credit Agreement dated as of July 20, 2015 among Centene Corporation, the various financial institutions party hereto and Barclays Bank PLC	X

10.24	Voting Agreement, dated as of July 2, 2015, by and between Centene Corporation and Jay M. Gellert		8-K	July 7, 2015	10.1

10.25	Registration Rights Agreement, dated February 11, 2016, by and among Centene Escrow Corporation, Wells Fargo Securities, LLC, Barclays Capital Inc., Citigroup Global Markets Inc., and SunTrust Robinson Humphrey, Inc., as representatives of the initial purchasers, relating to the Company’s 5.625% Senior Notes due 2021		8-K	February 11, 2016	10.1

10.26	Registration Rights Agreement, dated February 11, 2016, by and among Centene Escrow Corporation, Wells Fargo Securities, LLC, Barclays Capital Inc., Citigroup Global Markets Inc., and SunTrust Robinson Humphrey, Inc., as representatives of the initial purchasers, relating to the Company’s 6.125% Senior Notes due 2024		8-K	February 11, 2016	10.2

12.1	Computation of ratio of earnings to fixed charges	X

21	List of subsidiaries	X

23	Consent of Independent Registered Public Accounting Firm incorporated by reference in each prospectus constituting part of the Registration Statements on Form S-3 (File Numbers 333-197213, 333-196037, 333-193205, 333-187741, 333-187652 and 333-209252) and on Form S-8 (File Numbers 333-197737, 333-180976, 333-108467, 333-90976, 333-83190)	X

31.1	Certification Pursuant to Rule 13a-14(a) and 15d-14(a) of the Exchange Act, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Chief Executive Officer)	X

31.2	Certification Pursuant to Rule 13a-14(a) and 15d-14(a) of the Exchange Act, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Chief Financial Officer)	X

32.1	Certification Pursuant to 18 U.S.C. Section 1350 (Chief Executive Officer)	X

32.2	Certification Pursuant to 18 U.S.C. Section 1350 (Chief Financial Officer)	X

101.1	XBRL Taxonomy Instance Document	X

101.2	XBRL Taxonomy Extension Schema Document	X

101.3	XBRL Taxonomy Extension Calculation Linkbase Document	X

101.4	XBRL Taxonomy Extension Definition Linkbase Document	X

101.5	XBRL Taxonomy Extension Label Linkbase Document	X

102

Table of Contents



101.6	XBRL Taxonomy Extension Presentation Linkbase Document	X

¹ SEC File No. 001-31826 (for filings prior to October 14, 2003, the Registrant's SEC File No. was 000-33395). * Indicates a management contract or compensatory plan or arrangement.

103

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, as of February 22, 2016.



CENTENE CORPORATION

By:		/s/ Michael F. Neidorff
		Michael F. Neidorff Chairman and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities as indicated, as of February 22, 2016.



Signature		Title

/s/ Michael F. Neidorff		Chairman and Chief Executive Officer (principal executive officer)
Michael F. Neidorff

/s/ William N. Scheffel		Executive Vice President and Chief Financial Officer (principal financial officer)
William N. Scheffel

/s/ Jeffrey A. Schwaneke		Senior Vice President, Corporate Controller and Chief Accounting Officer (principal accounting officer)
Jeffrey A. Schwaneke

/s/ Orlando Ayala		Director
Orlando Ayala

/s/ Robert K. Ditmore		Director
Robert K. Ditmore

/s/ Fred H. Eppinger		Director
Fred H. Eppinger

/s/ Richard A. Gephardt		Director
Richard A. Gephardt

/s/ Pamela A. Joseph		Director
Pamela A. Joseph

/s/ John R. Roberts		Director
John R. Roberts

/s/ David L. Steward		Director
David L. Steward

/s/ Tommy G. Thompson		Director
Tommy G. Thompson

104

EX-10.4 2 exhibit104.htm EMPLOYEE STOCK PURCHASE PLAN Exhibit

Exhibit 10.4

2002 EMPLOYEE STOCK PURCHASE PLAN,

As Amended and Restated

The purpose of this Plan is to provide eligible employees of Centene Corporation (the "Company") and certain of its subsidiaries with opportunities to purchase shares of the Company's common stock, $.001 par value (the "Common Stock"), commencing on July 1, 2002. An aggregate of 1,800,000 shares of Common Stock has been approved for this purpose. This Plan is intended to qualify as an "employee stock purchase plan" as defined in Section 423 of the Internal Revenue Code of 1986, as amended (the "Code"), and the regulations promulgated thereunder, and shall be interpreted consistently therewith. The Plan is hereby amended and restated effective October 1, 2015.

1.Administration. The Plan will be administered by the Company's Board of Directors (the "Board") or by a Committee appointed by the Board (the "Committee"). The Board or the Committee has authority to make rules and regulations for the administration of the Plan and its interpretation and decisions with regard thereto shall be final and conclusive.

2.Eligibility. All employees of the Company, including directors who are employees, and all employees of any subsidiary of the Company (as defined in Section 424(f) of the Code) designated by the Board or the Committee from time to time (a "Designated Subsidiary"), are eligible to participate in any one or more of the offerings of Options (as defined in Section 9) to purchase Common Stock under the Plan provided that:

(a)they have been employed by the Company or a Designated Subsidiary for at least ninety days prior to enrolling in the Plan;

(b)they are employees of the Company or a Designated Subsidiary on the first day of the applicable Plan Period (as defined below); and

(c)they are not an intern, per diem, or a project based employee.

No employee may be granted an option hereunder if such employee, immediately after the option is granted, owns five percent or more of the total combined voting power or value of the stock of the Company or any subsidiary. For purposes of the preceding sentence, the attribution rules of Section 424(d) of the Code shall apply in determining the stock ownership of an employee, and all stock that the employee has a contractual right to purchase shall be treated as stock owned by the employee.

3.Offerings. The Company will make one or more offerings ("Offerings") to employees to purchase stock under this Plan. Offerings will begin each January 1, April 1, July 1 and October 1, or the first business day thereafter (the "Offering Commencement Dates"). Each Offering Commencement Date will begin a three-month period (a "Plan Period") during which payroll deductions will be made and held for the purchase of Common Stock at the end of the Plan Period. The Board or the Committee may, at its discretion, choose a different Plan Period of twelve months or less for subsequent Offerings.

4.Participation. An employee eligible during the Open Enrollment window may participate in such Offering by electronically enrolling on the Company’s stock plan administrator’s website. The electronic enrollment will authorize a regular payroll deduction from the Compensation received by the employee during the Plan Period. Unless an employee updates their electronic enrollment during the Open Enrollment window or withdraws from the Plan, the employee's deductions and purchases will continue at the same rate for future Offerings under the Plan as long as the Plan remains in effect. The term "Compensation" means the amount of money reportable on the employee's Federal Income Tax Withholding Statement, excluding incentive or bonus awards, allowances and reimbursements for expenses such as relocation allowances for travel expenses, income or gains on the exercise of Company stock options or stock appreciation rights, and similar items, whether or not shown on the employee's Federal Income Tax Withholding Statement.

5.Deductions. The Company will maintain payroll deduction accounts for all participating employees. With respect to any Offering made under this Plan, an employee may authorize a payroll deduction in any dollar amount equal to:

(a)from a minimum of 1.0% to a maximum of 10.0% as specified by the employee, multiplied by;

(b)the amount of Compensation the employee receives during the Plan Period (or such short period during which deductions from payroll are made), up to a maximum of $8,333.33 of Compensation per month.

6.Deduction Changes. An employee may decrease or discontinue the employee's payroll deduction once during any Plan Period, by updating their enrollment election on the stock plan administrator’s website at least seven calendar days prior to the last day of such Plan Period. An employee may not, however, increase the employee's payroll deduction during a Plan Period. If an employee elects to discontinue the employee's payroll deductions during a Plan Period, but does not elect to withdraw the employee's funds pursuant to Section 8 hereof, funds deducted prior to the employee's election to discontinue will be applied to the purchase of Common Stock on the Exercise Date (as defined below).

7.Interest. Interest will not be paid on any employee accounts, except to the extent that the Board or the Committee, in its sole discretion, elects to credit employee accounts with interest at such per annum rate as it may from time to time determine.

8.Withdrawal of Funds. An employee may at any time at least seven calendar days prior to the close of business on the last business day in a Plan Period and for any reason permanently draw out the balance accumulated in the employee's account and thereby withdraw from participation in an Offering. Partial withdrawals are not permitted. The employee may not begin participation again during the remainder of the Plan Period. If an employee withdraws from participation in an Offering, he or she may participate in the immediately following Offering and any Offering thereafter in accordance with terms and conditions established by the Board or the Committee.

If an employee makes a hardship withdrawal from any plan with a cash or deferred arrangement qualified under Section 401(k) of the Code, which plan is sponsored by or otherwise in which the Company or Designated Subsidiary participates, such employee shall be suspended from making payroll deductions under the Plan for a period of six months. Such employee may resume payroll deductions by filing a new payroll authorization form after the expiration of such period of suspension, subject to and otherwise in accordance with the terms of the Plan. In the event of any such hardship withdrawal from any such 401(k) plan, such employee shall receive a withdrawal hereunder coincident with or as soon as administratively feasible after such payroll deductions are suspended.

9.Purchase of Shares. On the Offering Commencement Date of each Plan Period, the Company will grant to each eligible employee who is then a participant in the Plan an option (“Option”) to purchase on the last business day of such Plan Period (the “Exercise Date”), at the Option Price hereinafter provided for, the largest number of whole and fractional shares of Common Stock of the Company as does not exceed the number of shares determined by multiplying $2,083 by the number of full months in the Offering Period and dividing the result by the closing price (as defined below) on the Offering Commencement Date of such Plan Period.

Notwithstanding the above, no employee may be granted an Option (as defined in Section 9) that permits the employee’s rights to purchase Common Stock under this Plan and any other employee stock purchase plan (as defined in Section 423(b) of the Code) of the Company and its subsidiaries, to accrue at a rate that exceeds $25,000 of the fair market value of such Common Stock (determined at the Offering Commencement Date of the Plan Period) for each calendar year in which the Option is outstanding at any time.

The purchase price for each share purchased will be 95% of the closing price of the Common Stock on the Exercise Date. Such closing price shall be (a) the closing price on any national securities exchange on which the Common Stock is listed, (b) the closing price of the Common Stock on the New York Stock Exchange or (c) the average of the closing bid and asked prices in the over-the-counter-market, whichever is applicable, as published in The Wall Street Journal. If no sales of Common Stock were made on such a day, the price of the Common Stock for purposes of clauses (a) and (b) above shall be the reported price for the next preceding day on which sales were made.

Each employee who continues to be a participant in the Plan on the Exercise Date shall be deemed to have exercised the employee’s Option at the Option Price on such date and shall be deemed to have purchased from the Company the number of full and fractional shares of Common Stock reserved for the purpose of the Plan that the employee’s accumulated payroll deductions on such date will pay for, but not in excess of the maximum number determined in the manner set forth above.

Any balance remaining in an employee’s payroll deduction account at the end of a Plan Period will be automatically refunded to the employee.

10.Issuance of Certificates. Certificates representing shares of Common Stock purchased under the Plan may be issued only in the name of the employee, in the name of the employee and another person of legal age as joint tenants with rights of survivorship, or (in the Company's sole discretion) in the name of a brokerage firm, bank or other nominee holder designated by the employee. The Company may, in its sole discretion and in compliance with applicable laws, authorize the use of book entry registration of shares in lieu of issuing stock certificates.

11.Rights on Retirement, Death or Termination of Employment. In the event of a participating employee's termination of employment prior to the last business day of a Plan Period, no payroll deduction shall be taken from any pay due and owing to an employee and the balance in the employee's account shall be paid to the employee or, in the event of the employee's death, (a) to a beneficiary previously designated in a revocable notice signed by the employee (with any spousal consent required under state law), (b) in the absence of such a designated beneficiary, to the executor or administrator of the employee's estate, or (c) if no such executor or administrator has been appointed to the knowledge of the Company, to such other person or persons as the Company may, in its discretion, designate. If, prior to the last business day of the Plan Period, the Designated Subsidiary by which an employee is employed shall cease to be a subsidiary of the Company, or if the employee is transferred to a subsidiary of the Company that is not a Designated Subsidiary, the employee shall be deemed to have terminated employment for the purposes of this Plan.

12.Optionees Not Stockholders. Neither the granting of an Option to an employee nor the deductions from the employee's pay shall constitute such employee a stockholder of the shares of Common Stock covered by an Option under this Plan until such shares have been purchased by and issued to him.

13.Rights Not Transferable. Rights under this Plan are not transferable by a participating employee other than by will or the laws of descent and distribution, and are exercisable during the employee's lifetime only by the employee.

14.Application of Funds. All funds received or held by the Company under this Plan may be combined with other corporate funds and may be used for any corporate purpose.

15.Adjustment in Case of Changes Affecting Common Stock. In the event of a subdivision of outstanding shares of Common Stock, or the payment of a dividend in Common Stock, the number of shares approved for this Plan, and the share limitation set forth in Section 9, shall be increased proportionately, and such other adjustment shall be made as may be deemed equitable by the Board or the Committee. In the event of any other change affecting the Common Stock, such adjustment shall be made as may be deemed equitable by the Board or the Committee to give proper effect to such event.

16.Holding Period. By purchasing shares hereunder, absent written consent from the Company to the contrary, the employee agrees not to sell, contract to sell, make any short sale of, grant any option for the purchase of or otherwise dispose of any of said shares during the 90 day period following the Exercise Date of the Plan Period pursuant to which the shares were purchased.

17.Merger. If the Company shall at any time merge or consolidate with another corporation and the holders of the capital stock of the Company immediately prior to such merger or consolidation continue to hold at least 80% by voting power of the capital stock of the surviving corporation ("Continuity of Control"), the holder of each Option then outstanding will thereafter be entitled to receive at the next Exercise Date upon the exercise of such Option for each share as to which such Option shall be exercised the securities or property that a holder of one share of the Common Stock was entitled to upon and at the time of such merger or consolidation, and the Board or the Committee shall take such steps in connection with such merger or consolidation as the Board or the Committee shall deem necessary to assure that the provisions of Section 15 shall thereafter be applicable, as nearly as reasonably may be, in relation to the said securities or property as to which such holder of such Option might thereafter be entitled to receive thereunder.

In the event of a merger or consolidation of the Company with or into another corporation that does not involve Continuity of Control, or of a sale of all or substantially all of the assets of the Company while unexercised Options remain outstanding under the Plan: (a) subject to the provisions of clauses (b) and (c), after the effective date of such transaction, each holder of an outstanding Option shall be entitled, upon exercise of such Option, to receive in lieu of shares of Common Stock, shares of such stock or other securities as the holders of shares of Common Stock received pursuant to the terms of such transaction; (b) all outstanding Options may be cancelled by the Board or the Committee as of a date prior to the effective date of any such transaction and all payroll deductions shall be paid out to the participating employees; or (c) all outstanding Options may be cancelled by the Board or the Committee as of the effective date of any such transaction, provided that notice of such cancellation shall be given to each holder of an Option, and each holder of an Option shall have the right to exercise such Option in full based on payroll deductions then credited to the employee's account as of a date determined by the Board or the Committee, which date shall not be less than ten days preceding the effective date of such transaction.

18.Amendment of the Plan. The Board may at any time, and from time to time, amend this Plan in any respect, except that (a) if the approval of any such amendment by the stockholders of the Company is required by Section 423 of the Code, such amendment shall not be effected without such approval, and (b) in no event may any amendment be made that would cause the Plan to fail to comply with Section 423 of the Code.

19.Insufficient Shares. In the event that the total number of shares of Common Stock specified in elections to be purchased under any Offering plus the number of shares purchased under previous Offerings under this Plan exceeds the maximum number of shares issuable under this Plan, the Board or the Committee will allot the shares then available on a pro rata basis.

20.Termination of the Plan. This Plan may be terminated at any time by the Board. Upon termination of this Plan all amounts in the accounts of participating employees shall be promptly refunded.

21.Governmental Regulations. The Company's obligation to sell and deliver Common Stock under this Plan is subject to listing on a national stock exchange or quotation on The New York Stock Exchange (to the extent the Common Stock is then so listed or quoted) and the approval of all governmental authorities required in connection with the authorization, issuance or sale of such stock.

22.Governing Law. The Plan shall be governed by Missouri law except to the extent that such law is preempted by federal law.

23.Issuance of Shares. Shares may be issued upon exercise of an Option from authorized but unissued Common Stock, from shares held in the treasury of the Company, or from any other proper source.

24.Notification upon Sale of Shares. Each employee agrees, by entering the Plan, to promptly give the Company notice of any disposition of shares purchased under the Plan where such disposition occurs within two years after the date of grant of the Option pursuant to which such shares were purchased.

25.Withholding. Each employee shall, no later than the date of the event creating the tax liability, make provision satisfactory to the Board for payment of any taxes required by law to be withheld in connection with any transaction related to Options granted to or shares acquired by such employee pursuant to the Plan. The Company may, to the extent permitted by law, deduct any such taxes from any payment of any kind otherwise due to an employee.

26. Effective Date and Approval of Stockholders. The Plan took effect on April 24, 2002, and was approved by the stockholders of the Company as required by Section 423 of the Code, which approval occurred within twelve months of the adoption of the Plan by the Board. The Plan is amended by this restatement effective October 1, 2015.

EX-10.13 3 exhibit1013.htm FORM OF RESTRICTED STOCK UNIT AGREEMENT Exhibit

Exhibit 10.13

CENTENE CORPORATION

Restricted Stock Unit Agreement Granted Under

2012 Stock Incentive Plan

THIS AGREEMENT is entered into by Centene Corporation, a Delaware corporation (hereinafter the “Company”), and the undersigned employee of the Company (hereinafter the “Participant”).

WHEREAS, the Participant renders important services to the Company and acquires access to Confidential Information (as defined below) of the Company in connection with the Participant’s relationship with the Company; and

WHEREAS, the Company desires to align the long-term interests of its valued employees with those of the Company by providing the ownership interest granted herein and to prevent former employees whose interest may become adverse to the Company from maintaining an ownership interest in the Company;

NOW, THEREFORE, in consideration of the foregoing and the mutual agreements herein contained, the parties hereto hereby agree as follows:


1.	Grant of RSUs.

This Agreement evidences the grant by the Company on the Issue Date (or the “Grant Date”) to the Participant of restricted stock units (each an “RSU,” and collectively the “RSUs”) pursuant to the Company’s 2012 Stock Incentive Plan (the “Plan”). Each RSU represents the right to receive one share of the common stock, $.001 par value per share, of the Company (“Common Stock”) as provided in this Agreement. The shares of Common Stock that are issuable upon vesting of the RSUs are referred to in this Agreement as “Shares.”


2.	Vesting.

(a)Subject to Section 3 of this Agreement, the RSUs shall vest as to _____% of the original number of RSUs on the _____ anniversary of the Grant Date and as to an additional _____% of the original number of RSUs at the end of each successive _____ period following the _____ anniversary of the Grant Date until the _____ anniversary of the Grant Date. The Participant must hold vested shares for one year from the vesting date, less shares valued at an amount equivalent to the Participant’s tax liability applicable to the vested shares at the Participant’s marginal tax rate. The Participant’s tax liability may exceed the minimum statutory withholding.

3.Reorganization Event.

Upon the occurrence of a “Change in Control,” all of the RSUs that (but for the application of this clause) are not vested at the time of the occurrence of such Change in Control event shall vest. A “Change in Control” shall be deemed to have occurred if any of the events set forth in any one of the following clauses shall occur: (i) any Person (as defined in section 3(a)(9) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and as such term is modified in sections 13(d) and 14(d) of the Exchange Act), excluding a group of persons including the Participant, is or becomes the “beneficial owner” (as defined in Rule 13(d)(3) under the Exchange Act), directly or indirectly, of securities of the Company representing forty percent or more of the combined voting power of the Company’s then-outstanding securities; (ii) individuals who, as of the Grant Date, constitute the Board of Directors of the Company (the “Incumbent Board”), cease for any reason to constitute a majority thereof (provided, however, that an individual becoming a director subsequent to the Grant Date whose election, or nomination for election by the Company’s stockholders, was approved by at least a majority of the directors then comprising the Incumbent Board shall be included within the definition of Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of either an actual election contest (or such terms used in Rule 14a-11 of Regulation 14A promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board of Directors of the Company); or (iii) the stockholders of the Company consummate a merger or consolidation of the Company with any other corporation, other than a merger or consolidation that would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) at least fifty percent of the combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation.


4.	Distribution of Shares.

(a) Timing of Distribution. The Company will distribute to the Participant (or to the Participant’s estate in the event of the death of the Participant occurring after a vesting date but before distribution of the corresponding Shares), as soon as administratively practicable after each vesting date, the Shares represented by RSUs that vested on such vesting date.

(b) No Fractional Shares. No fractional Shares shall be issuable pursuant to any RSU. In lieu of any fractional shares to which the Participant would otherwise be entitled, the Company shall pay cash in an amount equal to such fraction multiplied by the Fair Market Value (as defined in the Plan) of a share of Common Stock.

(c) Termination of Employment. In the event that the Participant’s employment with the Company (and any parent or subsidiary thereof) is terminated for any reason by the Company or by the Participant other than by reason of death or disability (within the meaning of Section 22(e)(3) of the Internal Revenue Code of 1986, as amended (the “Code”)), the RSUs shall cease vesting as of the date of termination. In the event the Participant’s employment with the Company (and any parent or subsidiary thereof) is terminated by reason of death or disability (as defined previously in this Section 4.(c)), the pro-rata amount of RSUs attributable to the time elapsed between the grant date and the termination date shall immediately vest, and fractional shares will be rounded down to the nearest full share and will not be distributed or paid in cash.

(d) Compliance Restrictions. The Company shall not be obligated to issue to the Participant the Shares upon the vesting of any RSU (or otherwise) unless (i) the Participant has complied with covenants set forth in Section 10 of this Agreement and (ii) the issuance and delivery of such Shares shall comply with all relevant provisions of law and other legal requirements including any applicable federal or state securities laws and the requirements of any stock exchange or quotation system upon which Common Stock may then be listed or quoted.

5.Restrictions on Transfer.

The RSUs may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either voluntarily or by operation of law, except by will or the laws of descent and distribution.


6.	No Rights as Stockholder.

Except as set forth in the Plan, neither the Participant nor any person claiming under or through the Participant shall be, or shall have any rights or privileges of, a stockholder of the Company in respect of any Share issuable pursuant to the RSUs granted hereunder until such Share has been delivered to the Participant.


7.	Withholding Taxes; Section 83(b) Election.

(a) No Shares will be delivered pursuant to the vesting of an RSU unless and until the Participant pays to the Company, or makes provision satisfactory to the Company for payment of, the amount (with respect to such vesting, the “Withholding Amount”) of the Company’s minimum statutory withholding obligations with respect to the income recognized by the Participant upon such vesting, based on minimum statutory withholding rates for all tax purposes, including payroll and social security taxes, that are applicable to such income.

(b) The Participant acknowledges that no election under Section 83(b) of the Code may be filed with respect to the RSUs.

8.Automatic Sale Upon Vesting.

(a) Upon any vesting of RSUs pursuant to Section 2 hereof, the Company may sell, or arrange for the sale of, such number of the Shares issuable pursuant to such vested RSU under Section 2 as is sufficient to generate net proceeds to satisfy the Company’s minimum statutory withholding obligations with respect to the income recognized by the Participant upon vesting (based on minimum statutory withholding rates for all tax purposes, including payroll and social security taxes, that are applicable to such income), and the Company shall retain such net proceeds in satisfaction of such tax withholding obligations.

(b) The Participant hereby appoints the Company’s Secretary as his or her attorney-in-fact to sell the Shares in accordance with this Section 8. The Participant agrees to execute and deliver such documents, instruments and certificates as may reasonably be required in connection with the sale of the Shares pursuant to this Section 8.

(c) It is understood that the Participant and the Company may agree from time to time, subject to compliance with applicable laws, to procedures to be implemented, in lieu of the procedures set forth in paragraphs (a) and (b) of this Section 8, to fund the Withholding Amount.

9.Provisions of the Plan.

The RSUs are subject to the provisions of the Plan, a copy of which is being furnished to the Participant with this Agreement.


10.	Participant’s Covenants.

For and in consideration of the delivery of this Agreement, the Participant agrees to the provisions of this Section 10.

(a) Confidential Information. As used in this Agreement, “Confidential Information” shall mean the Company’s trade secrets and other non-public proprietary information relating to the Company or the business of the Company, including information relating to financial statements, customer lists and identities, potential customers, customer contacts, employee skills and compensation, employee data, suppliers, acquisition targets, servicing methods, equipment, programs, strategies and information, analyses, marketing plans and strategies, profit margins, financial, promotional, marketing, training or operational information, and other information developed or used by the Company that is not known generally to the public or the industry. Confidential Information shall not include any information that is in the public domain or becomes known in the public domain through no wrongful act on the part of the Participant.

(b) Non-Disclosure. The Participant agrees that the Confidential Information is a valuable, special and unique asset of the Company’s business, that such Confidential Information is important to the Company and the effective operation of the Company’s business, and that during employment with the Company and at all times thereafter, the Participant shall not, directly or indirectly, disclose to any competitor or other person or entity (other than current employees of the Company) any Confidential Information that the Participant obtains while performing services for the Company, except as may be required in the Participant’s reasonable judgment to fulfill his duties hereunder or to comply with any applicable legal obligation.

(i)

During Participant’s employment with the Company and for the period of six (6) months immediately after the termination of Participant’s employment with the Company (including any parent, subsidiary, affiliate or division of the Company) for any reason whatsoever, and whether voluntary or involuntary, Participant shall not invest in (other than in a publicly traded company with a maximum investment of no more than 1% of outstanding shares), counsel, advise, consult, be employed or otherwise engaged by or with any entity or enterprise (“Competitor”) that competes with (A) the Company’s business of providing Medicaid managed care services, Medicaid-related services, behavioral health, nurse triage or pharmacy compliance specialty services or (B) any other business in which, after the date of this Agreement, the Company (or any parent, subsidiary, affiliate or division of the Company) becomes engaged (or has taken substantial steps in which to become engaged) on or prior to the date of termination of Participant’s employment. For purposes of paragraph 10, Participant agrees that this agreement not to compete applies to any Competitor that does business within the state of Missouri or and any other state in which Centene does business, and that such geographical limitation is reasonable.

(ii)

During the Participant’s employment with the Company (or any parent, subsidiary, affiliate or division of the Company) and for the period of twelve months immediately after the termination of the Participant’s employment with the Company (or any parent, subsidiary, affiliate or division of the Company) for any cause whatsoever, and whether voluntary or involuntary (“Restricted Period”), the Participant will not, either directly or indirectly, either for himself or for any other person, firm, company or corporation, call upon, solicit, divert, or take away, or attempt to solicit, divert or take away any of the customers, prospective customers, business, vendors or suppliers of the Company that the Participant had dealings with, or responsibility for, or as to which the Participant had access to confidential information.

(iii)

The Participant shall not, at any time during the Restricted Period, without the prior written consent of the Company, (i) directly or indirectly, solicit, recruit or employ (whether as an employee, officer, director, agent, consultant or independent contractor) any person who was or is at any time during the previous six months an employee, representative, officer or director of the Company (or any parent, subsidiary, affiliate or division of the Company); or (ii) take any action to encourage or induce any employee, representative, officer or director of the Company (or any parent, subsidiary, affiliate or division of the Company) to cease their relationship with the Company (or any parent, subsidiary, affiliate or division of the Company) for any reason.


(iv)	This Section 10(c) shall not apply if a "Change in Control" (as defined in Section 3) occurs.

(d) Enforcement. If any of the provisions or subparts of this Section 10 shall be held to be invalid or unenforceable by a court of competent jurisdiction, the remaining provisions or subparts thereof shall nevertheless continue to be valid and enforceable according to their terms. Further, if any restriction contained in the provisions or subparts of this Section 10 is held to be overbroad or unreasonable as written, the parties agree that the applicable provision should be considered to be amended to reflect the maximum period, scope or geographical area deemed reasonable and enforceable by the court and enforced as amended.

(e) Remedy for Breach.

(i)Because the Participant’s services are unique and because the Participant has access to the Company’s Confidential Information, the parties agree that any breach or threatened breach of this Section 10 will cause irreparable harm to the Company and that money damages alone would be an inadequate remedy. The parties therefore agree that, in the event of any breach or threatened breach of this Section 10, and in addition to all other rights and remedies available to it, the Company may apply to any court of competent jurisdiction for specific performance and/or injunctive or other relief, without a bond, in order to enforce or prevent any violations of the provisions of this Section 10.

(ii)The Participant shall immediately repay to the Company a cash sum in the principal amount equal to all gross proceeds (before-tax) realized by Participant upon the sale or other disposition of the Shares occurring at any time during the period commencing on the date that is three years before the date of termination of the Participant’s employment with the Company and all Subsidiaries of the Company and ending on the date of the Participant’s breach or threatened breach of this Section 10 (the “Refund Period”), together with interest accrued thereon, from the date of such breach or threatened breach, at the prime rate (compounded calendar monthly) as published from time to time in The Wall Street Journal, electronic edition (“Interest”); and

(iii)The Participant shall repay to the Company a cash sum equal to the fair market value of all of the Shares transferred by the Participant as a gift or gifts at any time during the Refund Period, together with Interest, and for which purpose, “fair market value” shall be the Fair Market Value of one share of Common Stock on the date such gift occurs.

(iv)The Participant acknowledges and agrees that nothing contained herein shall be construed to be an excessive remedy to prohibit the Company from pursuing any other remedies available to it for such actual or threatened breach, including the recovery of money damages, proximately caused by the Participant’s breach of this Section 10.

(f) Survival. The provisions of this Section 10 shall survive and continue in full force in accordance with their terms notwithstanding any forfeiture, termination or expiration of this Agreement in accordance with its terms or any termination of the Participant’s employment for any reason (whether voluntary or involuntary).


11.	Miscellaneous.

(a) Severability. The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, and each other provision of this Agreement shall be severable and enforceable to the extent permitted by law.

(b) Waiver. Any provision for the benefit of the Company contained in this Agreement may be waived, either generally or in any particular instance, by the Board of Directors of the Company.

(c) Binding Effect. This Agreement shall be binding upon and inure to the benefit of the Company and the Participant and their respective heirs, executors, administrators, legal representatives, successors and assigns, subject to the restrictions on transfer set forth in Section 5 of this Agreement.

(d) Notice. All notices required or permitted hereunder shall be in writing and deemed effectively given upon personal delivery or five days after delivery to a United States Post Office, by registered or certified mail, postage prepaid, addressed to the other party hereto at the address shown beneath his or its respective signature to this Agreement, or at such other address or addresses as either party shall designate to the other in accordance with this paragraph (d).

(e) Entire Agreement. This Agreement and the Plan constitute the entire agreement between the parties, and supersede all prior agreements and understandings, relating to the RSUs.

(f) Participant’s Acknowledgments. The Participant acknowledges that he or she: (i) has read this Agreement; (ii) has been represented in the preparation, negotiation, and execution of this Agreement by legal counsel of the Participant’s own choice or has voluntarily declined to seek such counsel; (iii) understands the terms and consequences of this Agreement; (iv) is fully aware of the legal and binding effect of this Agreement; and (v) understands that the law firm of Bryan Cave LLP, is acting as counsel to the Company in connection with the transactions contemplated by the agreement, and is not acting as counsel for the Participant.

(g) Unfunded Rights. The right of the Participant to receive Common Stock pursuant to this Agreement is an unfunded and unsecured obligation of the Company. The Participant shall have no rights under this Agreement other than those of an unsecured general creditor of the Company.

(h) Deferral. Neither the Company nor the Participant may defer delivery of any Shares issuable under unvested RSUs except to the extent that such deferral complies with the provisions of Section 409A of the Code.

IN WITNESS WHEREOF, the parties hereto have executed this Agreement.

CENTENE CORPORATION

Michael F. Neidorff

Chairman, President and CEO

EX-10.20 4 exhibit1020.htm FORM OF PERFORMANCE BASED RESTRICTED STOCK UNIT AGREEMENT Exhibit

Exhibit 10.20

CENTENE CORPORATION

Restricted Stock Unit Agreement Granted Under

2012 Stock Incentive Plan

THIS AGREEMENT is entered into by Centene Corporation, a Delaware corporation (hereinafter the “Company”), and the undersigned employee of the Company (hereinafter the “Participant”).

NOW, THEREFORE, in consideration of the foregoing and the mutual agreements herein contained, the parties hereto hereby agree as follows:


1.	Grant of RSUs.


2.	Performance Condition and Vesting.

(a) The grant of RSUs provided for in Section 1 shall be contingent on the Company meeting its Annual Operating Plan target for diluted earnings per share (EPS) for the ___ fiscal year of ___. If the target is not achieved, the percentage of RSUs that vest will correlate directly to the percentage of the EPS target achieved, provided that the EPS achieved is 80% or more of the EPS target of ___. If the EPS achieved is less than 80% of the target, all performance based RSUs will be forfeited.

(b) If the requirements of paragraph (a) are satisfied, then the RSUs shall vest as to 33.3% of the number of shares granted on the first trading day following the ____ year end earnings release and as to an additional 33.3% of the number of shares granted on each anniversary of the initial vesting date until the third anniversary of the initial vesting date. The Participant must hold vested shares for one year from the vesting date, less shares valued at an amount equivalent to the Participant’s tax liability applicable to the vested shares at the Participant’s marginal tax rate. The Participant’s tax liability may exceed the minimum statutory withholding.

3.Reorganization Event.


4.	Distribution of Shares.

5.Restrictions on Transfer.

The RSUs may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either voluntarily or by operation of law, except by will or the laws of descent and distribution.


6.	No Rights as Stockholder.


7.	Withholding Taxes; Section 83(b) Election.

(b) The Participant acknowledges that no election under Section 83(b) of the Code may be filed with respect to the RSUs.

8.Automatic Sale Upon Vesting.

9.Provisions of the Plan.

The RSUs are subject to the provisions of the Plan, a copy of which is being furnished to the Participant with this Agreement.

10.Participant’s Covenants.

For and in consideration of the delivery of this Agreement, the Participant agrees to the provisions of this Section 10.

(i)

(ii)

(iii)


(iv)	This Section 10(c) shall not apply if a "Change in Control" (as defined in Section 3) occurs.

(e) Remedy for Breach.

11.Miscellaneous.

(b) Waiver. Any provision for the benefit of the Company contained in this Agreement may be waived, either generally or in any particular instance, by the Board of Directors of the Company.

(e) Entire Agreement. This Agreement and the Plan constitute the entire agreement between the parties, and supersede all prior agreements and understandings, relating to the RSUs.

IN WITNESS WHEREOF, the parties hereto have executed this Agreement.

CENTENE CORPORATION

Michael F. Neidorff

Chairman, President and CEO

EX-10.21 5 exhibit1021.htm FORM OF PERFORMANCE BASED RESTRICTED STOCK UNIT AGREEMENT Exhibit

Exhibit 10.21

CENTENE CORPORATION

Restricted Stock Unit Agreement Granted Under

2012 Stock Incentive Plan

THIS AGREEMENT is entered into by Centene Corporation, a Delaware corporation (hereinafter the “Company”), and the undersigned employee of the Company (hereinafter the “Participant”).

NOW, THEREFORE, in consideration of the foregoing and the mutual agreements herein contained, the parties hereto hereby agree as follows:


1.	Grant of RSUs.


2.	Performance Condition and Vesting.

(a) The grant of RSUs provided for in Section 1 shall be contingent on the Company meeting a cumulative three year pre-tax margin target of ___ and a three year annualized compounded revenue growth rate (excluding GAAP premium tax revenue and health insurer fee revenue) of ____. The number of RSUs may be increased or decreased based on the Company’s performance compared to these metrics as described in Exhibit A.

(b) If the requirements of paragraph (a) are satisfied in accordance with the terms of Exhibit A, then the RSUs shall vest as to 100% of the number of shares granted on the first trading day following the ____ year end earnings release. The Participant must hold vested shares for one year from the vesting date, less shares valued at an amount equivalent to the Participant’s tax liability applicable to the vested shares at the Participant’s marginal tax rate. The Participant’s tax liability may exceed the minimum statutory withholding.

3.Reorganization Event.


4.	Distribution of Shares.

(a) Timing of Distribution. The Company will distribute to the Participant (or to the Participant’s estate in the event of the death of the Participant occurring after a vesting date but before distribution of the corresponding Shares), as soon as administratively practicable after the vesting date, the Shares represented by RSUs that vested on such vesting date.

5.Restrictions on Transfer.

The RSUs may not be sold, assigned, transferred, pledged or otherwise encumbered by the Participant, either voluntarily or by operation of law, except by will or the laws of descent and distribution.


6.	No Rights as Stockholder.


7.	Withholding Taxes; Section 83(b) Election.

(b) The Participant acknowledges that no election under Section 83(b) of the Code may be filed with respect to the RSUs.

8.Automatic Sale Upon Vesting.

9.Provisions of the Plan.

The RSUs are subject to the provisions of the Plan, a copy of which is being furnished to the Participant with this Agreement.


10.	Participant’s Covenants.

For and in consideration of the delivery of this Agreement, the Participant agrees to the provisions of this Section 10.

(i)

(ii)

(iii)


(iv)	This Section 10(c) shall not apply if a "Change in Control" (as defined in Section 3) occurs.

(e) Remedy for Breach.

11.Miscellaneous.

(b) Waiver. Any provision for the benefit of the Company contained in this Agreement may be waived, either generally or in any particular instance, by the Board of Directors of the Company.

(e) Entire Agreement. This Agreement and the Plan constitute the entire agreement between the parties, and supersede all prior agreements and understandings, relating to the RSUs.

IN WITNESS WHEREOF, the parties hereto have executed this Agreement.

CENTENE CORPORATION

Michael F. Neidorff

Chairman, President and CEO

EX-10.23B 6 exhibit1023b.htm CONTRACT AMENDMENT Exhibit

Exhibit 10.23b

AMENDMENT NO. 2

TO AMENDED AND RESTATED CREDIT AGREEMENT

This AMENDMENT NO. 2 dated as of July 20, 2015 (this “Amendment”), is made to the Amended and Restated Credit Agreement dated as of May 21, 2013 (as heretofore amended, supplemented or otherwise modified, including pursuant to Amendment No. 1 dated as of July 15, 2014, the “Credit Agreement”), among CENTENE CORPORATION (the “Company”), the financial institutions from time to time party thereto (the “Lenders”) and BARCLAYS BANK PLC, as administrative agent for the Lenders (in such capacity, the “Administrative Agent”).

WHEREAS, the Lenders have agreed to extend credit to the Company under the Credit Agreement on the terms and subject to the conditions set forth therein.

WHEREAS, the Company has notified the Lenders and the Administrative Agent that it has entered into the HN Acquisition Agreement (as defined below) and intends to consummate the HN Acquisition (as defined below).

WHEREAS, the Company has requested that the Lenders and the Administrative Agent consent to amend certain provisions of the Credit Agreement to permit the HN Escrow Transactions (as defined below).

WHEREAS, the Lenders whose signatures appear below, constituting the Required Lenders, and the Administrative Agent have agreed to so amend the Credit Agreement on the terms and subject to the conditions set forth herein.

NOW, THEREFORE, in consideration of the mutual agreements herein contained and other good and valuable consideration, the sufficiency and receipt of which are hereby acknowledged, the parties hereto hereby agree as follows:

1. Definitions. Capitalized terms used in this Amendment and not otherwise defined are used herein as defined in the Credit Agreement.

2. Amendment of Credit Agreement. Effective as of the Amendment Effective Date (as defined below), the Credit Agreement shall be amended as follows:

(a) Section 1.1 of the Credit Agreement is amended by inserting the following definitions in proper alphabetical order:

“HN” means Health Net, Inc., a Delaware corporation.

“HN Acquisition” means the acquisition by the Company of all of the issued and outstanding equity interests of HN pursuant to the HN Acquisition Agreement.

“HN Acquisition Agreement” means the Agreement and Plan of Merger, dated as of July 2, 2015, by and among the Company, Chopin Merger Sub I, Inc., Chopin Merger Sub II, Inc. and HN.

“HN Closing Date” means the date on which the HN Acquisition is consummated.

“HN Escrow Transactions” means, collectively, the issuance and sale by a Permitted Escrow Subsidiary of one or more series of HN Acquisition Notes in a public offering or in a Rule 144A or other private placement on or before the HN Closing Date and the Permitted Escrow Transactions, and all activities incidental thereto.

“HN Acquisition Notes” means senior unsecured (except as contemplated by the definition of “Permitted Escrow Transactions”) notes of a Permitted Escrow Subsidiary in an aggregate principal amount not to exceed $2,670,000,000 issued and sold to (a) provide a portion of the cash consideration payable for the HN Acquisition and to consummate the other transactions contemplated by the HN Acquisition Agreement, (b) finance consent fees, if any, in connection with a consent solicitation with respect to HN’s 6.375% Senior Notes due 2017 and the related indenture to obtain from the requisite holders thereof an agreement that the change of control repurchase rights shall not apply with respect to the HN Acquisition contained therein (the “Change of Control Waiver”), (c) prepay all of the existing and outstanding indebtedness of HN and its subsidiaries outstanding under the Credit Agreement dated as of October 24, 2011 (as amended prior to the date hereof, the “Acquired Company Credit Agreement”), among HN, the lenders party thereto and Bank of America, N.A., as administrative agent and terminate the Acquired Company Credit Agreement, (d) repurchase HN’s 6.375% Senior Notes due 2017 pursuant to the required change of control offer if the Change of Control Waiver is not obtained, (e) pay fees, commissions and expenses in connection with the foregoing and (f) finance ongoing working capital requirements and other general corporate purposes.

“Permitted Escrow Funds” means, with respect to any HN Acquisition Notes issued prior to the HN Closing Date, the sum of (a) the aggregate cash proceeds received by a Permitted Escrow Subsidiary from the issuance and sale of such HN Acquisition Notes, plus (b) cash and cash equivalents (including U.S. government securities) deposited to prefund interest accruing on such HN Acquisition Notes for the escrow period provided in the escrow agreement applicable to such HN Acquisition Notes, plus, (c) all premium, fees, expenses or other amounts payable in connection with the HN Escrow Transactions, plus, in each case, any interest or other earnings thereon and all proceeds or products of the foregoing.

“Permitted Escrow Subsidiary” means a wholly-owned limited purpose Subsidiary of the Company formed solely for the purposes of, and that solely engages in, the HN Escrow Transactions; provided that such Permitted Escrow Subsidiary (a) has no assets or liabilities other than (i) cash and cash equivalents (including U.S. government securities) constituting Permitted Escrow Funds and (ii) obligations under the HN Acquisition Notes or otherwise arising out of the Permitted Escrow Transactions and (b) is merged into or consolidated with the Company (with the Company as the surviving Person) substantially contemporaneously with the consummation of the HN Acquisition, with the Company assuming (including by operation of law) such Permitted Escrow Subsidiary’s obligations under the HN Acquisition Notes upon consummation of such merger or consolidation.

“Permitted Escrow Transactions” means, with respect to any HN Acquisition Notes issued prior to the HN Closing Date, (a) the establishment by a Permitted Escrow Subsidiary of a segregated escrow account under the sole control of the trustee for such HN Acquisition Notes or other escrow agent reasonably acceptable to the Administrative Agent pursuant to a customary escrow agreement, which shall provide for the termination of such escrow and the discharge and release of the related Liens permitted by clause (c) below upon satisfaction of certain conditions or the occurrence of certain events, (b) the depositing of the Permitted Escrow Funds with respect to the HN Acquisition Notes into such escrow account substantially contemporaneously with the issuance of such HN Acquisition Notes and (c) the granting by the Permitted Escrow Subsidiary of a Lien on such escrow account and the Permitted Escrow Funds in favor of the trustee for such HN Acquisition Notes, for the ratable benefit of the holders of such HN Acquisition Notes and, if applicable, the initial purchasers or underwriters thereof, and all activities incidental thereto.

(b) Section 1.1 of the Credit Agreement is hereby amended by restating in its entirety each of the following definitions therein to read as set forth below for such definition:

“Funded Debt” means all Debt of the Company and its Subsidiaries, determined on a consolidated basis, that matures more than one year from the date of its creation (or is renewable or extendible, at the option of such Person, to a date more than one year from such date), but excluding Debt of any Permitted Escrow Subsidiaries.

“Interest Expense” means for any period the consolidated interest expense of the Company and its Subsidiaries for such period (including all imputed interest on Capital Leases), but excluding interest expense of any Permitted Escrow Subsidiaries.

“Loan Party” means the Company and each of its Subsidiaries (direct or indirect, whether now existing or hereafter created) separately, excluding any Dormant Subsidiary or Permitted Escrow Subsidiary so long as such Subsidiary qualifies as a Dormant Subsidiary or Permitted Escrow Subsidiary, respectively, hereunder, and excluding the Centene Plaza Subsidiary and the Centene Plaza Phase II Subsidiary, but specifically including those listed on Schedule 1.1(b); provided that (a) the Centene Plaza Subsidiary may become a Loan Party after the repayment in full of the NML Loan and (b) the Centene Plaza Phase II Subsidiary may become a Loan Party after the repayment in full of the Centene Plaza Phase II Debt. The Company agrees that any Subsidiary which is a Dormant Subsidiary or Permitted Escrow Subsidiary will automatically become a Loan Party hereunder without any further action if at any time such Subsidiary ceases to be a Dormant Subsidiary or Permitted Escrow Subsidiary, respectively.

“Total Debt” means all Debt of the Company and its Subsidiaries, determined on a consolidated basis, excluding (a) contingent obligations in respect of Indirect Obligations (except to the extent constituting Indirect Obligations in respect of Debt of a Person other than any Loan Party), (b) Hedging Obligations, (c) Debt of the Company to Loan Parties and Debt of Loan Parties to the Company or to other Loan Parties, (d) contingent obligations in respect of undrawn letters of credit and (e) Debt of any Permitted Escrow Subsidiaries.

(c) Section 11.14 of the Credit Agreement is amended by inserting "(other than a Permitted Escrow Subsidiary)" immediately after "its Subsidiaries".

(d) Section 13.1(b) of the Credit Agreement is amended by inserting "(other than the HN Acquisition Notes issued by a Permitted Escrow Subsidiary)" immediately after "any Debt of the Company or any of its Subsidiaries".

3. Representations and Warranties. The Company hereby represents and warrants to each Lender and the Administrative Agent that:

(a) The execution, delivery and performance by the Company of this Amendment is within the Company’s corporate powers and has been duly authorized by all necessary corporate and, if required, stockholder action. This Amendment has been duly executed and delivered by the Company and constitutes a legal, valid and binding obligation of the Company, enforceable in accordance with its terms, subject to applicable bankruptcy, insolvency, reorganization, moratorium or other laws affecting creditors’ rights generally and subject to general principles of equity regardless of whether considered in a proceeding in equity or at law.

(b) No consent or approval of any Governmental Authority or any other Person is required for the Company to execute, deliver and perform this Amendment (other than any consent or approval which has been obtained, which is in full force and effect).

(c) Each of the representations and warranties made by the Company or any Loan Party in the Credit Agreement or any Loan Document, as applicable, are true and correct in all material respects (or, in the case of any representation or warranty qualified by materiality, in all respects) on and as of the Amendment Effective Date as if made on and as of such date (except for those which expressly relate to an earlier date which shall be true as of such earlier date).

(d) No Unmatured Event of Default or Event of Default has occurred and is continuing on the Amendment Effective Date.

4. Confirmation of Loan Documents. The Company confirms and ratifies all of its obligations under the Credit Agreement and each Loan Document to which it is a party.

5. Conditions Precedent to Effectiveness. This Amendment shall become effective as of the date (the “Amendment Effective Date”) on which the Administrative Agent (or its counsel) shall have received counterparts of this Amendment (which may include facsimile transmission or other electronic transmission of a signed counterpart) duly executed by the Company, the Required Lenders and the Administrative Agent.

6. Effect of Amendment. Except as expressly set forth herein, this Amendment shall not by implication or otherwise limit, impair, constitute a waiver of or otherwise affect the rights and remedies of the Lenders or the Administrative Agent under the Credit Agreement or any other Loan Document, and shall not alter, modify, amend or in any way affect any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or any other provision of the Credit Agreement or any other Loan Document, all of which are ratified and affirmed in all respects and shall continue in full force and effect. On and after the Amendment Effective Date, references in the Credit Agreement (including references to the Credit Agreement as amended hereby) to “this Agreement” and “this Credit Agreement” (and indirect references such as “hereunder,” “hereby,” “herein,” and “hereof”) shall be deemed to be references to the Credit Agreement as amended hereby. This Amendment is deemed to be a “Loan Document” for the purposes of the Credit Agreement.

7. Miscellaneous. The jurisdiction and waiver of right to trial by jury provisions in Sections 15.18 and 15.19 of the Credit Agreement are incorporated herein by reference mutatis mutandis. This Amendment may be executed in any number of counterparts, all of which taken together shall constitute one and the same agreement and any of the parties hereto may execute this Amendment by signing any such counterpart. Delivery of an executed signature page of this Amendment by facsimile or other electronic transmission (including “.pdf”, “.tif” or similar format) shall be effective as delivery of a manually executed counterpart hereof. This Amendment shall be governed by, and construed in accordance with, the laws of the State of New York.

[Remainder of page intentionally left blank]

IN WITNESS WHEREOF, the parties hereto have duly executed this Amendment as of the day and year first above written.

CENTENE CORPORATION,

/s/ William N. Scheffel

Name: William N. Scheffel

Title: EVP & CFO

BARCLAYS BANK PLC,

as Administrative Agent and Lender,

/s/ Ronnie Glenn

Name: Ronnie Glenn

Title: Vice President

LENDER SIGNATURE PAGE TO

AMENDMENT NO. 2 TO

CENTENE CORPORATION CREDIT AGREEMENT

Lender: CITIBANK, N.A.

/s/ Rosanna Valenzuela

Name: Rosanna Valenzuela

Title: Vice President

For any Lender requiring a second signature

line:

Name:

Title:

LENDER SIGNATURE PAGE TO

AMENDMENT NO. 2 TO

CENTENE CORPORATION CREDIT AGREEMENT

FIFTH THIRD BANK,

/s/ Nathaniel E. Sher

Name: Nathaniel E. Sher

Title: Vice President

For any Lender requiring a second signature

line:

Name:

Title:

LENDER SIGNATURE PAGE TO

AMENDMENT NO. 2 TO

CENTENE CORPORATION CREDIT AGREEMENT

Lender: MUFG UNION BANK, N.A.

/s/ Teuta Ghilaga

Name: Teuta Ghilaga

Title: Director

LENDER SIGNATURE PAGE TO

AMENDMENT NO. 2 TO

CENTENE CORPORATION CREDIT AGREEMENT

Lender: REGIONS BANK,

/s/ Joseph A. Miller

Name: Joseph A. Miller

Title: Managing Director

For any Lender requiring a second signature

line:

Name:

Title:

LENDER SIGNATURE PAGE TO

AMENDMENT NO. 2 TO

CENTENE CORPORATION CREDIT AGREEMENT

Lender: SUNTRUST BANK,

/s/ Mary E. Coke

Name: Mary E. Coke

Title: Vice President

For any Lender requiring a second signature

line:

Name:

Title:

LENDER SIGNATURE PAGE TO

AMENDMENT NO. 2 TO

CENTENE CORPORATION CREDIT AGREEMENT

Lender: U.S. BANK NATIONAL

ASSOCIATION,

/s/ David C. Mruk

Name: David C. Mruk

Title: Senior Vice President

LENDER SIGNATURE PAGE TO

AMENDMENT NO. 2 TO

CENTENE CORPORATION CREDIT AGREEMENT

Lender: WELLS FARGO BANK, NATIONAL

ASSOCIATION,

/s/ Wallace Saunders

Name: Wallace Saunders

Title: Managing Director

For any Lender requiring a second signature

line:

Name:

Title:

EX-12.1 7 exhibit121.htm RATIO OF EARNINGS TO FIXED CHARGES Exhibit

Exhibit 12.1

Centene Corporation

Computation of ratio of earnings to fixed charges

($ in millions)



	Year Ended December 31,
	2015			2014		2013			2012		2011
Earnings:
Pre-tax earnings from continuing operations	$	697		$	457	$	269		$	123	$	188
Addback:
Fixed charges	65			50		37			29		28
Subtract:
Noncontrolling interest	(2		)	7		(1		)	13		3
Interest capitalized	—			—		—			—		—
Total earnings	$	760		$	514	$	305		$	165	$	219

Fixed Charges:
Interest expensed and capitalized	$	43		$	35	$	27		$	20	$	20
Interest component of rental payments (1)	22			15		10			9		8
Total fixed charges	$	65		$	50	$	37		$	29	$	28

Ratio of earnings to fixed charges	11.7			10.3		8.2			5.7		7.8


(1) Estimated at 33% of rental expense as a reasonable approximation of the interest factor.

EX-21 8 exhibit21.htm LIST OF SUBSIDIARIES Exhibit

Exhibit 21

List of Subsidiaries

Absolute Total Care, Inc., a South Carolina corporation

AcariaHealth Pharmacy #11, Inc., a Texas corporation

AcariaHealth Pharmacy #12, Inc., a New York corporation

AcariaHealth Pharmacy #13, Inc., a California corporation

AcariaHealth Pharmacy #14, Inc., a California corporation

AcariaHealth Pharmacy, Inc., a California corporation

AcariaHealth, Inc., a Delaware corporation

Access Health Solutions, LLC, a Florida LLC

AECC Total Vision Health Plan of Texas, Inc., a Texas corporation

Agate Resources, Inc., an Oregon corporation

Ambetter of Magnolia, Inc., a Mississippi corporation

Ambetter of Peach State Inc., a Georgia corporation

ANJ, LLC, a Texas LLC

Bankers Reserve Life Insurance Company of Wisconsin, a Wisconsin corporation

Bridgeway Health Solutions of Arizona, Inc., an Arizona corporation

Buckeye Community Health Plan, Inc., an Ohio corporation

California Health and Wellness Plan, a California corporation

Cantina Laredo Clayton, LP, a Delaware limited partnership

Casenet S.R.O., a Czech Republic S.R.O.

Casenet, LLC, a Delaware LLC

CBHSP Arizona, Inc., an Arizona corporation

Celtic Group, Inc., a Delaware corporation

Celtic Insurance Company, an Illinois corporation

CeltiCare Health Plan of Massachusetts, Inc., a Massachusetts corporation

CenCorp Health Solutions, Inc., a Delaware corporation

Cenpatico Behavioral Health of Arizona, LLC, an Arizona LLC

Cenpatico Behavioral Health of Texas, Inc., a Texas corporation

Cenpatico Behavioral Health, LLC, a California LLC

Cenpatico of Arizona Inc., an Arizona corporation

Cenpatico of Louisiana, Inc., a Louisiana corporation

Centene Center II, LLC, a Delaware LLC

Centene Center, LLC, a Delaware LLC

Centene Company of Texas, LP, a Texas limited partnership

Centene Corporation, a Delaware corporation

Centene Health Systems Group of New York Inc., a New York corporation

Centene Management Company, LLC, a Wisconsin LLC

Centurion Group, Inc., a Delaware corporation

Centurion of Florida, LLC, a Florida LLC

Centurion of Minnesota, LLC, a Minnesota LLC

Centurion of Mississippi, LLC, a Mississippi LLC

Centurion of Tennessee, LLC, a Tennessee LLC

Centurion of Vermont, LLC, a Vermont LLC

Centurion, LLC, a Delaware LLC

Chopin Merger Sub I, Inc., a Delaware corporation

Chopin Merger Sub II, Inc., a Delaware corporation

Clayton Property Investment, LLC, a Delaware LLC

CMC Hanley, LLC, a Missouri LLC

CMC Real Estate Company, LLC, a Delaware LLC

Comfort Hospice of Missouri, LLC, a Michigan LLC

Comfort Hospice of Texas, LLC, a Michigan LLC

ComfortBrook Hospice, LLC, an Ohio LLC

Coordinated Care Corporation, an Indiana corporation

Coordinated Care of Washington, Inc., a Washington corporation

Country Style Health Care, LLC, a Texas LLC

Dental Health & Wellness, Inc., a Delaware corporation

Envolve Benefit Options, Inc., a Delaware corporation

Envolve Total Vision, Inc., a Delaware corporation

Family Nurse Care II, LLC, a Michigan LLC

Family Nurse Care of Ohio, LLC, a Michigan LLC

Family Nurse Care, LLC, a Michigan LLC

Fidelis SecureCare of Michigan, Inc., a Michigan corporation

GPT Acquisition, LLC, a Delaware LLC

Grace Hospice of Austin, LLC, a Michigan LLC

Grace Hospice of Colorado, LLC, a Michigan LLC

Grace Hospice of Grand Rapids, LLC, a Michigan LLC

Grace Hospice of Indiana, LLC, a Michigan LLC

Grace Hospice of San Antonio, LLC, a Michigan LLC

Grace Hospice of Virginia, LLC, a Michigan LLC

Grace Hospice of Wisconsin, LLC, a Michigan LLC

Granite State Health Plan, Inc., a New Hampshire corporation

Hallmark Life Insurance Company, an Arizona corporation

Health Care Enterprises, LLC, a Delaware LLC

Health Plan Real Estate Holdings, Inc., a Missouri corporation

Healthy Louisiana Holdings, LLC, a Delaware LLC

Healthy Missouri Holdings, Inc., a Missouri corporation

Heritage Home Hospice, LLC, a Michigan LLC

Home State Health Plan, Inc., a Missouri corporation

HomeScripts.com, LLC, a Michigan LLC

Hospice DME Company, LLC, a Michigan LLC

IAH of Florida, LLC, a Florida LLC

IlliniCare Health Plan, Inc., an Illinois corporation

Independent Professional Services, LLC, an Oregon LLC

Integrated Mental Health Services, a Texas corporation

Kentucky Spirit Health Plan, Inc., a Kentucky corporation

Lane Individual Practice Association, Inc., an Oregon corporation

LBB Industries, Inc., a Texas corporation

LifeShare Management Group, LLC, a New Hampshire LLC

LiveHealthier, Inc., a Delaware corporation

Louisiana Healthcare Connections, Inc., a Louisiana corporation

LSM Holdco, Inc., a Delaware corporation

Magnolia Health Plan, Inc., a Mississippi corporation

Managed Health Services Insurance Corporation, a Wisconsin corporation

Massachusetts Partnership of Correctional Healthcare, LLC, a Massachusetts LLC

MHS Consulting International, Inc., a Delaware corporation

MHS Travel & Charter, Inc., a Wisconsin corporation

Nebraska Total Care, Inc., a Nebraska corporation

North Florida Health Services, Inc., a Florida corporation

Novasys Health, Inc., a Delaware corporation

Nurse Response, Inc., a Delaware corporation

NurseWise, LP, a Delaware limited partnership

Nurtur Health, Inc., a Delaware corporation

OcuCare Systems, Inc., a Florida corporation

OptiCare Vision Company, Inc., a Delaware corporation

OptiCare Vision Insurance Company, Inc., a South Carolina corporation

Peach State Health Plan, Inc., a Georgia corporation

Phoenix Home Health Care, LLC, a Delaware LLC

Pinnacle Home Care, LLC, a Texas LLC

Pinnacle Senior Care of Kalamazoo, LLC, a Michigan LLC

Pinnacle Senior Care of Missouri, LLC, a Michigan LLC

Pinnacle Senior Care of Wisconsin, LLC, a Wisconsin LLC

PrimeroSalud, S.L., a Spanish Sociedad Limitada

R&C Healthcare, LLC, a Texas LLC

Rapid Respiratory Services, LLC, a Delaware LLC

RMED, LLC, a Florida LLC

RX Direct, Inc., a Texas corporation

Seniorcorps Penninsula, LLC, a Virginia LLC

Specialty Therapeutic Care Holdings, LLC, a Delaware LLC

Specialty Therapeutic Care, GP, LLC, a Texas LLC

Specialty Therapeutic Care, LP, a Texas limited partnership

Sunflower State Health Plan, Inc., a Kansas corporation

Sunshine Health Holding, LLC, a Florida LLC

Sunshine State Health Plan, Inc., a Florida corporation

Superior HealthPlan, Inc., a Texas corporation

Traditional Home Health Services, LLC, a Texas LLC

Trillium Community Health Plan, Inc., an Oregon corporation

U.S. Medical Management Holdings, Inc., a Delaware corporation

U.S. Medical Management, LLC, a Delaware LLC

U.S. Script IPA, LLC, a New York LLC

U.S. Script, Inc., a Delaware corporation

USMM Accountable Care Network, LLC, a Delaware LLC

USMM Accountable Care Partners, LLC, a Delaware LLC

USMM Accountable Care Solutions, LLC, a Delaware LLC

EX-23 9 exhibit23.htm CONSENT Exhibit

Exhibit 23

Consent of Independent Registered Public Accounting Firm

The Board of Directors

Centene Corporation:

We consent to the incorporation by reference in the registration statements on Form S‑8 (Nos. 333‑197737, 333‑180976, 333-108467, 333‑90976, and 333‑83190) and in the registration statements on Form S‑3 (Nos. 333‑197213, 333-196037, 333-193205, 333-187741, 333-187652, and 333-209252) of Centene Corporation of our reports, dated February 22, 2016, with respect to the consolidated balance sheets of Centene Corporation and subsidiaries as of December 31, 2015 and 2014, and the related consolidated statements of operations, comprehensive earnings, stockholders’ equity, and cash flows for each of the years in the three‑year period ended December 31, 2015, and the effectiveness of internal control over financial reporting as of December 31, 2015, which reports appear in the December 31, 2015 annual report on Form 10‑K of Centene Corporation.

/s/ KPMG LLP

St. Louis, Missouri

February 22, 2016

EX-31.1 10 exhibit311.htm CERTIFICATION Exhibit

EXHIBIT 31.1

CERTIFICATION

I, Michael F. Neidorff, certify that:


1.	I have reviewed this Annual Report on Form 10-K of Centene Corporation;


2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):


a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



Dated:	February 22, 2016	/s/ MICHAEL F. NEIDORFF
		Chairman, President and Chief Executive Officer (principal executive officer)

EX-31.2 11 exhibit312.htm CERTIFICATION Exhibit

EXHIBIT 31.2

CERTIFICATION

I, William N. Scheffel, certify that:


1.	I have reviewed this Annual Report on Form 10-K of Centene Corporation;


2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;


5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):


a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



Dated:	February 22, 2016	/s/ WILLIAM N. SCHEFFEL
		Executive Vice President and Chief Financial Officer (principal financial officer)

EX-32.1 12 exhibit321.htm CERTIFICATION Exhibit

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of Centene Corporation (the Company) for the period ended December 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, Michael F. Neidorff, Chairman, President and Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:


(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Dated:	February 22, 2016	/s/ MICHAEL F. NEIDORFF
		Chairman, President and Chief Executive Officer (principal executive officer)

EX-32.2 13 exhibit322.htm CERTIFICATION Exhibit

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of Centene Corporation (the Company) for the period ended December 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, William N. Scheffel, Executive Vice President and Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:


(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Dated:	February 22, 2016	/s/ WILLIAM N. SCHEFFEL
		Executive Vice President and Chief Financial Officer (principal financial officer)

EX-101.INS 14 cnc-20151231.xml XBRL INSTANCE DOCUMENT 0001071739 2015-01-01 2015-12-31 0001071739 2016-02-17 0001071739 2015-06-30 0001071739 2014-12-31 0001071739 2015-12-31 0001071739 2013-01-01 2013-12-31 0001071739 2014-01-01 2014-12-31 0001071739 us-gaap:TreasuryStockMember 2013-01-01 2013-12-31 0001071739 us-gaap:NoncontrollingInterestMember 2014-01-01 2014-12-31 0001071739 us-gaap:RetainedEarningsMember 2015-12-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2014-01-01 2014-12-31 0001071739 us-gaap:NoncontrollingInterestMember 2012-12-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-12-31 0001071739 us-gaap:TreasuryStockMember 2013-12-31 0001071739 us-gaap:TreasuryStockMember 2014-12-31 0001071739 us-gaap:TreasuryStockMember 2014-01-01 2014-12-31 0001071739 us-gaap:TreasuryStockMember 2012-12-31 0001071739 us-gaap:CommonStockMember 2013-01-01 2013-12-31 0001071739 us-gaap:RetainedEarningsMember 2014-01-01 2014-12-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-01-01 2015-12-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-12-31 0001071739 us-gaap:CommonStockMember 2014-12-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-01-01 2013-12-31 0001071739 us-gaap:NoncontrollingInterestMember 2013-01-01 2013-12-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2013-01-01 2013-12-31 0001071739 us-gaap:RetainedEarningsMember 2012-12-31 0001071739 us-gaap:TreasuryStockMember 2015-01-01 2015-12-31 0001071739 us-gaap:NoncontrollingInterestMember 2015-01-01 2015-12-31 0001071739 us-gaap:RetainedEarningsMember 2013-12-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2012-12-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2015-12-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-12-31 0001071739 us-gaap:CommonStockMember 2014-01-01 2014-12-31 0001071739 us-gaap:CommonStockMember 2015-01-01 2015-12-31 0001071739 us-gaap:CommonStockMember 2013-12-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2015-01-01 2015-12-31 0001071739 2012-12-31 0001071739 us-gaap:NoncontrollingInterestMember 2014-12-31 0001071739 us-gaap:RetainedEarningsMember 2014-12-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-12-31 0001071739 us-gaap:NoncontrollingInterestMember 2013-12-31 0001071739 us-gaap:RetainedEarningsMember 2015-01-01 2015-12-31 0001071739 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-01-01 2014-12-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2014-12-31 0001071739 us-gaap:CommonStockMember 2012-12-31 0001071739 us-gaap:CommonStockMember 2015-12-31 0001071739 us-gaap:RetainedEarningsMember 2013-01-01 2013-12-31 0001071739 2013-12-31 0001071739 us-gaap:TreasuryStockMember 2015-12-31 0001071739 us-gaap:NoncontrollingInterestMember 2015-12-31 0001071739 us-gaap:AdditionalPaidInCapitalMember 2013-12-31 0001071739 2015-02-02 2015-02-02 0001071739 stpr:TX 2013-01-01 2013-12-31 0001071739 stpr:TX 2014-01-01 2014-12-31 0001071739 cnc:ASUASUonpresentationofdeferredtaxassetsandliabilitiesasnoncurrentMember us-gaap:NewAccountingPronouncementEarlyAdoptionEffectMember 2015-12-31 0001071739 stpr:FL 2015-01-01 2015-12-31 0001071739 cnc:ASUonclassificationofdebtissuancecostsMember us-gaap:NewAccountingPronouncementEarlyAdoptionEffectMember 2015-12-31 0001071739 cnc:ASUASUonpresentationofdeferredtaxassetsandliabilitiesasnoncurrentMember us-gaap:NewAccountingPronouncementEarlyAdoptionEffectMember 2014-12-31 0001071739 stpr:TX 2015-01-01 2015-12-31 0001071739 us-gaap:TradeNamesMember us-gaap:MinimumMember 2015-01-01 2015-12-31 0001071739 us-gaap:ContractualRightsMember us-gaap:MinimumMember 2015-01-01 2015-12-31 0001071739 cnc:ProviderContractsMember us-gaap:MaximumMember 2015-01-01 2015-12-31 0001071739 cnc:ProviderContractsMember us-gaap:MinimumMember 2015-01-01 2015-12-31 0001071739 us-gaap:DevelopedTechnologyRightsMember 2015-01-01 2015-12-31 0001071739 us-gaap:TradeNamesMember us-gaap:MaximumMember 2015-01-01 2015-12-31 0001071739 us-gaap:CustomerRelationshipsMember us-gaap:MaximumMember 2015-01-01 2015-12-31 0001071739 us-gaap:CustomerRelationshipsMember us-gaap:MinimumMember 2015-01-01 2015-12-31 0001071739 us-gaap:ContractualRightsMember us-gaap:MaximumMember 2015-01-01 2015-12-31 0001071739 cnc:ASUonclassificationofdebtissuancecostsMember us-gaap:NewAccountingPronouncementEarlyAdoptionEffectMember 2014-12-31 0001071739 stpr:FL 2014-01-01 2014-12-31 0001071739 us-gaap:LeaseholdImprovementsMember us-gaap:MaximumMember 2015-01-01 2015-12-31 0001071739 us-gaap:FurnitureAndFixturesMember us-gaap:MinimumMember 2015-01-01 2015-12-31 0001071739 us-gaap:FurnitureAndFixturesMember us-gaap:MaximumMember 2015-01-01 2015-12-31 0001071739 us-gaap:ComputerEquipmentMember us-gaap:MinimumMember 2015-01-01 2015-12-31 0001071739 us-gaap:LeaseholdImprovementsMember us-gaap:MinimumMember 2015-01-01 2015-12-31 0001071739 us-gaap:ComputerEquipmentMember us-gaap:MaximumMember 2015-01-01 2015-12-31 0001071739 us-gaap:LandBuildingsAndImprovementsMember us-gaap:MinimumMember 2015-01-01 2015-12-31 0001071739 us-gaap:LandBuildingsAndImprovementsMember us-gaap:MaximumMember 2015-01-01 2015-12-31 0001071739 2015-07-02 0001071739 2015-07-02 2015-07-02 0001071739 cnc:LiveHealthierInc.Member cnc:ManagedCareMember 2015-01-31 0001071739 cnc:FidelisMember us-gaap:GeneralAndAdministrativeExpenseMember cnc:ManagedCareMember 2015-01-01 2015-12-31 0001071739 cnc:U.S.MedicalManagementMember cnc:SpecialtyServicesMember 2014-01-01 2014-01-31 0001071739 cnc:AgateResourcesInc.Member cnc:ManagedCareMember 2015-09-01 2015-09-30 0001071739 cnc:FidelisMember cnc:ManagedCareMember 2015-05-31 0001071739 cnc:FidelisMember cnc:ManagedCareMember 2015-05-01 2015-05-31 0001071739 cnc:LiveHealthierInc.Member cnc:ManagedCareMember 2015-01-01 2015-01-31 0001071739 cnc:RiberaSaludMember 2014-07-01 0001071739 cnc:CommunityHealthSolutionsMember 2015-01-01 2015-03-31 0001071739 cnc:U.S.MedicalManagementMember cnc:SpecialtyServicesMember 2014-01-31 0001071739 cnc:AgateResourcesInc.Member cnc:ManagedCareMember 2015-09-30 0001071739 cnc:FidelisMember cnc:ManagedCareMember 2015-12-31 0001071739 cnc:CommunityHealthSolutionsMember 2014-12-31 0001071739 cnc:RiberaSaludMember 2014-07-01 2014-07-31 0001071739 cnc:CelticInsuranceCompanyMember 2015-01-01 2015-01-31 0001071739 cnc:CelticInsuranceCompanyMember 2015-01-31 0001071739 cnc:RiberaSaludMember 2014-07-31 0001071739 cnc:U.S.MedicalManagementMember 2013-12-31 0001071739 cnc:CelticInsuranceCompanyMember 2014-12-31 0001071739 cnc:HomeStateHealthPlanMember 2014-12-31 0001071739 cnc:CelticInsuranceCompanyMember 2015-12-31 0001071739 cnc:HomeStateHealthPlanMember 2015-12-31 0001071739 cnc:U.S.MedicalManagementMember 2014-12-31 0001071739 cnc:U.S.MedicalManagementMember 2015-12-31 0001071739 cnc:CenturionMember 2014-12-31 0001071739 cnc:CenturionMember 2013-12-31 0001071739 cnc:CenturionMember 2015-12-31 0001071739 cnc:HomeStateHealthPlanMember 2013-12-31 0001071739 cnc:CelticInsuranceCompanyMember 2013-12-31 0001071739 cnc:U.S.MedicalManagementMember 2015-12-31 0001071739 cnc:U.S.MedicalManagementMember 2015-01-01 2015-12-31 0001071739 cnc:FidelisMember cnc:ManagedCareMember 2015-01-01 2015-12-31 0001071739 cnc:LifeInsuranceContractsMember 2015-12-31 0001071739 cnc:RestrictedCertificatesOfDepositMember 2015-12-31 0001071739 cnc:RestrictedCertificatesOfDepositMember 2014-12-31 0001071739 cnc:RestrictedCashEquivalentsMember 2014-12-31 0001071739 us-gaap:CorporateDebtSecuritiesMember 2015-12-31 0001071739 cnc:RestrictedCashEquivalentsMember 2015-12-31 0001071739 cnc:CostMethodInvestmentsAndEquityMethodSecuritiesMember 2014-12-31 0001071739 us-gaap:MunicipalBondsMember 2014-12-31 0001071739 us-gaap:CommercialMortgageBackedSecuritiesMember 2015-12-31 0001071739 us-gaap:USTreasuryAndGovernmentMember 2015-12-31 0001071739 us-gaap:MunicipalBondsMember 2015-12-31 0001071739 us-gaap:USTreasuryAndGovernmentMember 2014-12-31 0001071739 us-gaap:ResidentialMortgageBackedSecuritiesMember 2014-12-31 0001071739 us-gaap:CommercialMortgageBackedSecuritiesMember 2014-12-31 0001071739 us-gaap:AssetBackedSecuritiesMember 2014-12-31 0001071739 us-gaap:AssetBackedSecuritiesMember 2015-12-31 0001071739 cnc:LifeInsuranceContractsMember 2014-12-31 0001071739 us-gaap:ResidentialMortgageBackedSecuritiesMember 2015-12-31 0001071739 us-gaap:CorporateDebtSecuritiesMember 2014-12-31 0001071739 cnc:CostMethodInvestmentsAndEquityMethodSecuritiesMember 2015-12-31 0001071739 us-gaap:InvestmentsMember 2014-12-31 0001071739 us-gaap:InvestmentsMember 2015-12-31 0001071739 us-gaap:DepositsMember 2015-12-31 0001071739 us-gaap:DepositsMember 2014-12-31 0001071739 us-gaap:FairValueInputsLevel1Member 2014-12-31 0001071739 us-gaap:FairValueInputsLevel1Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2014-12-31 0001071739 us-gaap:FairValueInputsLevel2Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2014-12-31 0001071739 us-gaap:FairValueInputsLevel2Member 2014-12-31 0001071739 us-gaap:FairValueInputsLevel3Member 2014-12-31 0001071739 us-gaap:FairValueInputsLevel3Member us-gaap:CommercialMortgageBackedSecuritiesMember 2014-12-31 0001071739 us-gaap:FairValueInputsLevel2Member us-gaap:CommercialMortgageBackedSecuritiesMember 2014-12-31 0001071739 us-gaap:FairValueInputsLevel3Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2014-12-31 0001071739 us-gaap:FairValueInputsLevel3Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2015-12-31 0001071739 us-gaap:FairValueInputsLevel2Member 2015-12-31 0001071739 us-gaap:FairValueInputsLevel3Member 2015-12-31 0001071739 us-gaap:FairValueInputsLevel1Member 2015-12-31 0001071739 us-gaap:FairValueInputsLevel2Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2015-12-31 0001071739 us-gaap:FairValueInputsLevel3Member us-gaap:CommercialMortgageBackedSecuritiesMember 2015-12-31 0001071739 us-gaap:FairValueInputsLevel1Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2015-12-31 0001071739 us-gaap:FairValueInputsLevel2Member us-gaap:CommercialMortgageBackedSecuritiesMember 2015-12-31 0001071739 us-gaap:FairValueInputsLevel1Member us-gaap:CommercialMortgageBackedSecuritiesMember 2015-12-31 0001071739 us-gaap:LandMember 2014-12-31 0001071739 us-gaap:BuildingMember 2015-12-31 0001071739 cnc:ComputerHardwareMember 2015-12-31 0001071739 us-gaap:ComputerSoftwareIntangibleAssetMember 2015-12-31 0001071739 us-gaap:BuildingMember 2014-12-31 0001071739 cnc:FurnitureAndOfficeEquipmentMember 2015-12-31 0001071739 cnc:ComputerHardwareMember 2014-12-31 0001071739 cnc:FurnitureAndOfficeEquipmentMember 2014-12-31 0001071739 us-gaap:LeaseholdImprovementsMember 2015-12-31 0001071739 us-gaap:LandMember 2015-12-31 0001071739 us-gaap:LeaseholdImprovementsMember 2014-12-31 0001071739 us-gaap:ComputerSoftwareIntangibleAssetMember 2014-12-31 0001071739 us-gaap:AssetsHeldUnderCapitalLeasesMember 2014-12-31 0001071739 us-gaap:AssetsHeldUnderCapitalLeasesMember 2015-12-31 0001071739 cnc:SpecialtyServicesMember 2014-01-01 2014-12-31 0001071739 cnc:ManagedCareMember 2015-01-01 2015-12-31 0001071739 cnc:SpecialtyServicesMember 2013-12-31 0001071739 cnc:ManagedCareMember 2013-12-31 0001071739 cnc:ManagedCareMember 2014-01-01 2014-12-31 0001071739 cnc:SpecialtyServicesMember 2015-12-31 0001071739 cnc:SpecialtyServicesMember 2015-01-01 2015-12-31 0001071739 cnc:ManagedCareMember 2015-12-31 0001071739 cnc:SpecialtyServicesMember 2014-12-31 0001071739 cnc:ManagedCareMember 2014-12-31 0001071739 us-gaap:ContractualRightsMember 2014-12-31 0001071739 cnc:ProviderContractsMember 2015-12-31 0001071739 us-gaap:ContractualRightsMember 2015-12-31 0001071739 us-gaap:DevelopedTechnologyRightsMember 2014-12-31 0001071739 us-gaap:CustomerRelationshipsMember 2015-12-31 0001071739 us-gaap:CustomerRelationshipsMember 2014-12-31 0001071739 cnc:ProviderContractsMember 2014-12-31 0001071739 us-gaap:CustomerRelationshipsMember 2015-01-01 2015-12-31 0001071739 cnc:ProviderContractsMember 2015-01-01 2015-12-31 0001071739 cnc:ProviderContractsMember 2014-01-01 2014-12-31 0001071739 us-gaap:TradeNamesMember 2015-12-31 0001071739 us-gaap:TradeNamesMember 2014-12-31 0001071739 us-gaap:ContractualRightsMember 2015-01-01 2015-12-31 0001071739 us-gaap:CustomerRelationshipsMember 2014-01-01 2014-12-31 0001071739 us-gaap:TradeNamesMember 2015-01-01 2015-12-31 0001071739 us-gaap:DevelopedTechnologyRightsMember 2015-12-31 0001071739 us-gaap:ContractualRightsMember 2014-01-01 2014-12-31 0001071739 us-gaap:TradeNamesMember 2014-01-01 2014-12-31 0001071739 cnc:MedicaidPremiumRevenueMember 2014-01-01 2014-12-31 0001071739 cnc:MedicaidPremiumRevenueMember 2013-01-01 2013-12-31 0001071739 cnc:MedicaidPremiumRevenueMember 2015-01-01 2015-12-31 0001071739 cnc:FourPointSevenFivePercentSeniorNotesDueonMayFifteenTwentyTwentyTwoMember us-gaap:SeniorNotesMember 2014-12-31 0001071739 cnc:FivePointSevenFivePercentSeniorNotesDueJuneFirstTwentySeventeenMember us-gaap:SeniorNotesMember 2014-12-31 0001071739 cnc:FourPointSevenFivePercentSeniorNotesDueonMayFifteenTwentyTwentyTwoMember us-gaap:SeniorNotesMember 2015-12-31 0001071739 cnc:FivePointSevenFivePercentSeniorNotesDueJuneFirstTwentySeventeenMember us-gaap:SeniorNotesMember 2015-12-31 0001071739 cnc:FourPointSevenFivePercentSeniorNotesDueonMayFifteenTwentyTwentyTwoMember 2015-01-31 0001071739 us-gaap:InterestRateSwapMember 2015-12-31 0001071739 cnc:FivePointSevenFivePercentSeniorNotesDueJuneFirstTwentySeventeenMember 2015-12-31 0001071739 cnc:NonRevolverLetterofCreditMember 2015-12-31 0001071739 cnc:NonRecourseMortgageNoteDueJanuary12021Member 2015-12-31 0001071739 cnc:June12017ExpirationMember us-gaap:InterestRateSwapMember 2015-12-31 0001071739 2015-01-31 0001071739 cnc:NonRecourseMortgageNoteDueJanuary12021Member 2015-01-01 2015-12-31 0001071739 cnc:FourPointSevenFivePercentSeniorNotesDueonMayFifteenTwentyTwentyTwoMember 2014-04-30 0001071739 cnc:RiberaSaludMember 2015-12-31 0001071739 cnc:FourPointSevenFivePercentSeniorNotesDueonMayFifteenTwentyTwentyTwoMember 2015-01-01 2015-12-31 0001071739 cnc:May152022ExpirationMember us-gaap:InterestRateSwapMember 2015-12-31 0001071739 us-gaap:InterestRateSwapMember cnc:FourPointSevenFivePercentSeniorNotesDueonMayFifteenTwentyTwentyTwoMember 2014-04-30 0001071739 cnc:A200MillionInterestRateSwapMember 2015-12-31 0001071739 cnc:FivePointSevenFivePercentSeniorNotesDueJuneFirstTwentySeventeenMember 2015-01-01 2015-12-31 0001071739 cnc:FourPointSevenFivePercentSeniorNotesDueonMayFifteenTwentyTwentyTwoMember 2015-12-31 0001071739 cnc:FourPointSevenFivePercentSeniorNotesDueonMayFifteenTwentyTwentyTwoMember 2014-12-31 0001071739 cnc:FivePointSevenFivePercentSeniorNotesDueJuneFirstTwentySeventeenMember 2014-12-31 0001071739 cnc:FivePointSevenFivePercentSeniorNotesDueJuneFirstTwentySeventeenMember 2015-12-31 0001071739 cnc:CommunityHealthSolutionsMember 2014-07-01 2014-07-31 0001071739 cnc:U.S.MedicalManagementMember 2014-01-01 2014-01-31 0001071739 us-gaap:MaximumMember 2015-01-01 2015-12-31 0001071739 us-gaap:MinimumMember 2015-01-01 2015-12-31 0001071739 us-gaap:RestrictedStockUnitsRSUMember us-gaap:MaximumMember 2015-01-01 2015-12-31 0001071739 us-gaap:RestrictedStockUnitsRSUMember us-gaap:MinimumMember 2015-01-01 2015-12-31 0001071739 us-gaap:EmployeeStockOptionMember us-gaap:MinimumMember 2015-01-01 2015-12-31 0001071739 us-gaap:EmployeeStockOptionMember us-gaap:MaximumMember 2015-01-01 2015-12-31 0001071739 2015-03-09 0001071739 us-gaap:IntersegmentEliminationMember 2014-01-01 2014-12-31 0001071739 us-gaap:OperatingSegmentsMember cnc:SpecialtyServicesMember 2014-01-01 2014-12-31 0001071739 us-gaap:IntersegmentEliminationMember cnc:ManagedCareMember 2014-01-01 2014-12-31 0001071739 us-gaap:OperatingSegmentsMember cnc:ManagedCareMember 2014-12-31 0001071739 us-gaap:IntersegmentEliminationMember cnc:SpecialtyServicesMember 2014-01-01 2014-12-31 0001071739 us-gaap:IntersegmentEliminationMember 2014-12-31 0001071739 us-gaap:OperatingSegmentsMember cnc:ManagedCareMember 2014-01-01 2014-12-31 0001071739 us-gaap:OperatingSegmentsMember cnc:SpecialtyServicesMember 2014-12-31 0001071739 us-gaap:IntersegmentEliminationMember cnc:SpecialtyServicesMember 2015-01-01 2015-12-31 0001071739 us-gaap:OperatingSegmentsMember cnc:SpecialtyServicesMember 2015-01-01 2015-12-31 0001071739 us-gaap:IntersegmentEliminationMember 2015-01-01 2015-12-31 0001071739 us-gaap:IntersegmentEliminationMember cnc:ManagedCareMember 2015-01-01 2015-12-31 0001071739 us-gaap:OperatingSegmentsMember cnc:ManagedCareMember 2015-12-31 0001071739 us-gaap:OperatingSegmentsMember cnc:SpecialtyServicesMember 2015-12-31 0001071739 us-gaap:OperatingSegmentsMember cnc:ManagedCareMember 2015-01-01 2015-12-31 0001071739 us-gaap:IntersegmentEliminationMember 2015-12-31 0001071739 us-gaap:OperatingSegmentsMember cnc:ManagedCareMember 2013-01-01 2013-12-31 0001071739 us-gaap:OperatingSegmentsMember cnc:SpecialtyServicesMember 2013-12-31 0001071739 us-gaap:OperatingSegmentsMember cnc:SpecialtyServicesMember 2013-01-01 2013-12-31 0001071739 cnc:ManagedCareMember 2013-01-01 2013-12-31 0001071739 us-gaap:IntersegmentEliminationMember cnc:SpecialtyServicesMember 2013-01-01 2013-12-31 0001071739 cnc:SpecialtyServicesMember 2013-01-01 2013-12-31 0001071739 us-gaap:IntersegmentEliminationMember 2013-01-01 2013-12-31 0001071739 us-gaap:OperatingSegmentsMember cnc:ManagedCareMember 2013-12-31 0001071739 us-gaap:IntersegmentEliminationMember 2013-12-31 0001071739 us-gaap:IntersegmentEliminationMember cnc:ManagedCareMember 2013-01-01 2013-12-31 0001071739 2015-10-01 2015-12-31 0001071739 2015-01-01 2015-03-31 0001071739 2015-07-01 2015-09-30 0001071739 2015-04-01 2015-06-30 0001071739 2014-01-01 2014-03-31 0001071739 2014-10-01 2014-12-31 0001071739 2014-04-01 2014-06-30 0001071739 2014-07-01 2014-09-30 0001071739 us-gaap:ParentCompanyMember 2015-12-31 0001071739 us-gaap:ParentCompanyMember 2014-12-31 0001071739 us-gaap:ParentCompanyMember 2013-01-01 2013-12-31 0001071739 us-gaap:ParentCompanyMember 2015-01-01 2015-12-31 0001071739 us-gaap:ParentCompanyMember 2014-01-01 2014-12-31 0001071739 us-gaap:ParentCompanyMember 2013-12-31 0001071739 us-gaap:ParentCompanyMember 2012-12-31 0001071739 cnc:SixPointOneTwoFivePercentSeniorNotesDueinTwentyTwentyFourMember us-gaap:SubsequentEventMember 2016-02-19 0001071739 us-gaap:SubsequentEventMember 2016-01-01 2016-01-31 0001071739 us-gaap:SubsequentEventMember 2016-01-31 0001071739 cnc:FivePointSixTwoFivePercentSeniorNotesDueinTwentyTwentyOneMember us-gaap:SubsequentEventMember 2016-02-19 cnc:subsidiary cnc:position iso4217:USD xbrli:shares iso4217:EUR iso4217:USD cnc:segment xbrli:shares xbrli:pure 0 44000000 75000000 180000000 0 180000000 0 162000000 0 162000000 0 0 -14000000 0 0 0 0 0 8000000 29000000 29000000 7000000 P3Y P3Y P3Y 1.00 0.622 352000000 79000000 79000000 0 0 78000000 78000000 0 0 313000000 341000000 445000000 6000000 6000000 0 0 5000000 5000000 0 0 134000000 92000000 40000000 28000000 P2Y 556000000 0 556000000 0 853000000 0 853000000 0 0 10000000 26000000 31000000 0 7000000 6000000 8000000 2033 2020 6000000 15000000 11000000 24000000 44000000 108000000 9000000 4000000 0 126000000 215000000 268000000 461000000 698000000 0 121000000 0 267000000 0 120000000 0 268000000 8000000 1121000000 22000000 1662000000 8000000 1121000000 22000000 1654000000 0 38000000 0 5000000 0 39000000 0 5000000 100000000 1456000000 115000000 2110000000 100000000 1457000000 115000000 2103000000 92000000 176000000 93000000 176000000 92000000 177000000 93000000 176000000 25000000 1000000 -4000000 -1000000 84000000 87000000 3.0 100000000 10000000 6000000 175000000 0 175000000 0 497000000 0 497000000 0 151000000 -417000000 -384000000 -660000000 6000000 -11000000 -24000000 17000000 2 0.25 0.37 0.14 0.25 0.14 0.22 0.99 0.50 0.45 429 10526000000 -2188000000 41000000 2147000000 9782000000 2932000000 9741000000 785000000 15667000000 -3079000000 60000000 3019000000 13946000000 4800000000 13886000000 1781000000 21265000000 -4964000000 100000000 4864000000 19154000000 7075000000 19054000000 2211000000 333000000 698000000 1151000000 337000000 893000000 1495000000 35000000 34000000 0 9000000 9000000 -1000000 -1000000 $45,000 entitled the Company to reimbursement from the programs at 50% coinsurance 236000000 207000000 40000000 0.08 300000000 500000000 425000000 300000000 200000000 740000000 937000000 8000000 5000000 2035 2016 14000000 100000000 100000000 0 0 115000000 115000000 0 0 733 377000000 360000000 17000000 0 397000000 325000000 72000000 0 15000000 15000000 0 0 32000000 32000000 0 0 5000000 1000000 1000000 2000000 0.0322 false --12-31 FY 2015 2015-12-31 10-K 0001071739 121654923 Yes Large Accelerated Filer 9600000000 CENTENE CORP No Yes 250000000 500000000 750000000 300000000 200000000

768000000

976000000

288000000

3000000

351000000

4000000

-1000000

-10000000

840000000

956000000

37000000

48000000

71000000

6000000

19000000

25000000

3000000

7000000

8000000

36000000

48000000

71000000

6000000

16000000

24000000

187078

207980

7247

3519000000

2921000000

598000000

5824000000

2733000000

4706000000

1118000000

7339000000

3510000000

6202000000

1137000000

2951000000

389000000

3605000000

720000000

3094000000

2070000000

1024000000

3902000000

2200000000

1702000000

1557000000

68000000

16000000

79000000

6000000

180000000

556000000

175000000

85000000

392000000

2218000000

71000000

16000000

78000000

5000000

162000000

40000000

853000000

497000000

67000000

429000000

5000000

2000000

1000000

5000000

2000000

1000000

4000000

2000000

12000000

1000000

8000000

1000000

2000000

1556000000

68000000

16000000

79000000

6000000

180000000

556000000

174000000

84000000

393000000

2225000000

71000000

16000000

78000000

5000000

163000000

40000000

859000000

496000000

66000000

431000000

2000000

10000000

1000000

6000000

1000000

2000000

491000000

70000000

311000000

20000000

18000000

72000000

1248000000

121000000

34000000

561000000

208000000

30000000

294000000

198000000

10000000

1000000

7000000

180000000

68000000

8000000

41000000

5000000

14000000

0.68

0.79

1.00

0.19

28.25

213000000

28000000

57000000

109000000

5513000000

133000000

13000000

-10000000

-44000000

-34000000

duals membership and revenue per member during the first year of the contract (July 2015 - June 2016), including reconciliation payments settled over a two year period

A portion of the contingent consideration is based on the achievement of underwriting targets and will be paid in cash over a three year period; the remainder is based on the net proceeds of a retrospective rate adjustment to be settled in 2016.

9000000

18000000

9000000

16000000

4000000

50000000

39000000

78000000

15000000

23000000

8000000

6000000

1610000000

3000000

1760000000

4000000

844000000

22000000

1038000000

3000000

1610000000

3000000

1760000000

4000000

1610000000

1760000000

194000000

-19000000

572000000

150000000

1000000

21000000

54000000

14000000

0.001

200000000

400000000

124274864

126855477

110678320

6019824

117346430

6707952

118433416

124274864

5841448

120342981

126855477

6512496

157000000

273000000

346000000

1000000

-7000000

2000000

158000000

266000000

348000000

168000000

259000000

368000000

7000000

-9000000

12000000

327000000

1280000000

1621000000

10586000000

16096000000

22055000000

121000000

225000000

332000000

127000000

238000000

358000000

6000000

13000000

26000000

879000000

1221000000

425000000

500000000

425000000

500000000

1400000000

1000000000

0.0155

0.0575

0.0475

0.0575

0.0475

0.05625

0.06125

2017-06-01

2022-05-15

2021-01-01

0.0205

-2000000

-42000000

-17000000

61000000

93000000

-20000000

-42000000

-19000000

168000000

143000000

156000000

191000000

83000000

87000000

144000000

180000000

21000000

20000000

9000000

18000000

53000000

73000000

11000000

9000000

27000000

12000000

11000000

25000000

46000000

4000000

1000000

9000000

12000000

19000000

52000000

65000000

78000000

67000000

89000000

111000000

0.0285

0.0288

2000000

1000000

-1000000

1.52

1.49

0.29

0.42

0.70

0.91

2.33

2.30

0.53

0.74

0.78

0.93

2.98

2.99

1.47

1.43

0.28

0.41

0.68

0.88

2.25

2.23

0.51

0.72

0.76

0.90

2.88

2.89

-1000000

191000000

P1Y3M

8000000

17000000

24000000

0.50

6000000

19000000

25000000

53000000

P10Y3M

P11Y1M

P7Y6M

P7Y1M

P13Y1M

P9Y9M

P11Y1M

P15Y

P4Y

P8Y9M

P15Y

P5Y

P8Y1M

P15Y

P3Y

P5Y0M

P7Y4M

P20Y

P7Y

43000000

14000000

12000000

3000000

62000000

2000000

24000000

21000000

14000000

1000000

2000000

22000000

16000000

18000000

19000000

163000000

103000000

28000000

15000000

17000000

217000000

103000000

71000000

26000000

5000000

12000000

120000000

155000000

1000000

931000000

4000000

1314000000

3000000

1826000000

9000000

348000000

151000000

197000000

754000000

276000000

478000000

48000000

842000000

11000000

361000000

481000000

280000000

26000000

29000000

406000000

125000000

281000000

106000000

103000000

3000000

38000000

18000000

305000000

161000000

34000000

47000000

81000000

106000000

268000000

64000000

88000000

92000000

112000000

356000000

269000000

-26000000

457000000

-32000000

697000000

-9000000

162000000

261000000

358000000

1.49

0.30

0.41

0.69

0.90

2.30

0.54

0.74

0.77

0.94

2.99

1.43

0.29

0.39

0.67

0.87

2.23

0.52

0.72

0.75

0.91

2.89

4000000

-1000000

2000000

1000000

3000000

-1000000

1000000

-1000000

0.03

-0.01

0.01

0.03

-0.01

0.00

0.01

-0.01

0.04

-0.01

0.02

0.01

0.02

-0.01

0.00

0.01

-0.01

173000000

285000000

8000000

341000000

107000000

-15000000

196000000

-8000000

339000000

-26000000

359000000

686000000

94000000

162000000

244000000

12000000

1000000

2000000

-2000000

-3000000

3000000

6000000

15000000

85000000

237000000

328000000

152000000

506000000

39000000

3000000

129000000

-27000000

172000000

609000000

536000000

1000000

8000000

9000000

80000000

5000000

96000000

8000000

89000000

51000000

143000000

463000000

360000000

4241256

4014448

3965626

120000000

155000000

27000000

23000000

35000000

30000000

43000000

39000000

30000000

40000000

55000000

11000000

2000000

11000000

9000000

19000000

1000000

28000000

1000000

35000000

-5000000

1373000000

360000000

1013000000

2016000000

325000000

1691000000

2296000000

2749000000

46000000

50000000

47000000

52000000

48000000

3933000000

842000000

5015000000

1186000000

5824000000

2733000000

7339000000

3510000000

2900000000

24000000

3629000000

13000000

2000000

815000000

1112000000

1723000000

2298000000

79000000

7975000000

11122000000

15279000000

723000000

945000000

1467000000

8995000000

12678000000

17242000000

75000000

225000000

2018-06-01

500000000

-14000000

1223000000

-14000000

5000000

901000000

1239000000

553000000

5000000

4000000

228000000

429000000

874000000

815000000

1216000000

1147000000

1280000000

10000000

1927000000

6000000

On July 5, 2013, the Company's subsidiary, Kentucky Spirit Health Plan, Inc. (Kentucky Spirit), terminated its contract with the Commonwealth of Kentucky (the Commonwealth). Kentucky Spirit believes it had a contractual right to terminate the contract and filed a lawsuit in Franklin Circuit Court seeking a declaration of this right. The Commonwealth has alleged that Kentucky Spirit's exit constitutes a material breach of contract. The Commonwealth seeks to recover substantial damages and to enforce its rights under Kentucky Spirit's $25 million performance bond. The Commonwealth's attorneys have asserted that the Commonwealth's expenditures due to Kentucky Spirit's departure range from $28 million to $40 million plus interest, and that the associated CMS expenditures range from $92 million to $134 million. Kentucky Spirit disputes the Commonwealth's alleged damages, and filed a lawsuit in April 2013, amended in October 2014, in Franklin Circuit Court seeking damages against the Commonwealth for losses sustained due to the Commonwealth's alleged breaches. On February 6, 2015, the Kentucky Court of Appeals affirmed a Franklin Circuit Court ruling that Kentucky Spirit does not have a contractual right to terminate the contract early. The Court of Appeals also found that the contract’s liquidated damages provision “is applicable in the event of a premature termination of the Contract term.” On September 8, 2015, Kentucky Spirit filed a motion for discretionary review seeking Kentucky Supreme Court review of the finding that Kentucky Spirit's departure constituted a breach of contract. On October 9, 2015, the Commonwealth filed a response opposing discretionary review.

-1000000

11000000

1.00

0.51

0.95

0.00

1.00

0.51

0.95

0.68

0.75

0.51

0.95

0.68

85000000

40000000

67000000

40000000

67000000

0.0514

154000000

165000000

198000000

222000000

305000000

313000000

-342000000

-486000000

-848000000

-539000000

-813000000

-774000000

382000000

302000000

1223000000

317000000

658000000

462000000

165000000

33000000

49000000

82000000

107000000

271000000

63000000

88000000

93000000

111000000

355000000

1000000

-7000000

2000000

166000000

1000000

165000000

270000000

-1000000

271000000

355000000

7000000

11000000

277000000

198000000

79000000

464000000

353000000

111000000

705000000

513000000

192000000

315000000

58000000

33000000

45000000

50000000

59000000

70000000

31000000

46000000

64000000

252000000

-83000000

378000000

390000000

-102000000

711000000

174000000

83000000

-14000000

38000000

177000000

102000000

-14000000

35000000

-1000000

-5000000

-8000000

2000000

-9000000

1000000

-7000000

3000000

-4000000

1000000

3000000

159000000

3000000

170000000

26000000

70000000

67000000

100000000

115000000

75000000

190000000

12000000

8698000000

12067000000

16746000000

19000000

20000000

29000000

53000000

4000000

3000000

7000000

4000000

63000000

67000000

136000000

137000000

18000000

113000000

80000000

11000000

7000000

93000000

17000000

790000000

12000000

1015000000

32000000

1321000000

17000000

68000000

103000000

150000000

8995000000

12678000000

17242000000

0.001

10000000

912000000

1279000000

10153000000

14198000000

19389000000

1000000

5000000

10000000

3000000

8000000

12000000

3000000

4000000

7000000

180000000

1875000000

1925000000

15000000

8000000

6000000

11000000

579000000

10000000

406000000

14000000

669000000

9000000

7000000

9000000

8000000

13000000

166000000

162000000

264000000

261000000

357000000

358000000

733000000

88000000

70000000

208000000

198000000

87000000

82000000

869000000

105000000

92000000

223000000

237000000

104000000

108000000

445000000

7000000

518000000

6000000

P7Y

P2Y

P10Y

P3Y

P40Y

P3Y

P20Y

P1Y

148000000

156000000

139000000

22000000

31000000

41000000

30000000

1674000000

1650000000

1583000000

1575000000

1003000000

1358000000

10863000000

3460000000

4023000000

4352000000

4725000000

16560000000

5131000000

5506000000

5821000000

6302000000

22760000000

373000000

1469000000

1876000000

429000000

428000000

37000000

48000000

71000000

P5Y

P3Y

P10Y

P1Y

116470

34.10

1795359

58.38

4350014

4122003

36.86

48.65

1906900

49000000

82000000

112000000

31.81

0.008

0.000

0.481

0.000

2528371

11.78

13000000

17000000

28000000

1000

9.52

0.00

1267066

677408

12.18

11.88

37000000

670740

12.52

12.39

0.00

P10Y

P5Y1M20D

P0Y

36000000

P2Y

177000000

8000000

176000000

5000000

1699000000

2284000000

851000000

1195000000

4486434

1492738

3433380

4486434

-1492738

-247580

84168

76088

86819

1100000.0

685280

2549450

2442000

2580613

588658

75000000

190000000

170000000

20000000

12000000

8000000

4000000

15000000

10000000

9000000

12000000

8000000

3335448

1744000000

2157000000

954000000

5000000

451000000

1000000

567000000

-70000000

1243000000

-3000000

594000000

9000000

732000000

-89000000

1743000000

-1000000

840000000

-1000000

1003000000

-98000000

2168000000

-10000000

956000000

11000000

1358000000

-147000000

9073000000

12820000000

17471000000

78000000

142000000

26000000

229000000

47000000

5841448

6512496

688128

626234

918628

98000000

147000000

19000000

29000000

53000000

14000000

8000000

4000000

112494346

120360212

123066370

108253090

116345764

119100744

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Health Insurance Marketplace</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Affordable Care Act (ACA) established risk spreading premium stabilization programs effective January 1, 2014 for the Health Insurance Marketplace product. These programs, commonly referred to as the “three Rs,” include a permanent risk adjustment program, a transitional reinsurance program, and a temporary risk corridor program. The Company’s accounting policies for the programs are as follows: </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Risk Adjustment </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The permanent risk adjustment program established by the ACA transfers funds from qualified individual and small group insurance plans with below average risk scores to those plans with above average risk scores within each state. The Company estimates the receivable or payable under the risk adjustment program based on its estimated risk score compared to the state average risk score. The Company may record a receivable or payable as an adjustment to Premium revenue to reflect the year to date impact of the risk adjustment based on its best estimate. The Company expects to refine its estimate as new information becomes available. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, the Company recorded a payable of </font><font style="font-family:inherit;font-size:10pt;">$108 million</font><font style="font-family:inherit;font-size:10pt;"> associated with risk adjustment, and </font><font style="font-family:inherit;font-size:10pt;">$44 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">December 31, 2014</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Reinsurance </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The ACA established a transitional three-year reinsurance program whereby the Company’s claims costs incurred for qualified members will be reimbursed when they exceed a specific threshold. For the 2015 benefit year, qualified member claims that exceeded </font><font style="font-family:inherit;font-size:10pt;">$45,000</font><font style="font-family:inherit;font-size:10pt;"> entitled the Company to reimbursement from the programs at 50% coinsurance. The Company accounts for reinsurance recoveries as a reduction of Medical Costs based on each individual case that exceeds the reinsurance threshold established by the program. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, the Company recorded a receivable of </font><font style="font-family:inherit;font-size:10pt;">$24 million</font><font style="font-family:inherit;font-size:10pt;"> associated with reinsurance, and </font><font style="font-family:inherit;font-size:10pt;">$11 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">December 31, 2014</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Risk Corridor</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The temporary, three-year risk corridor program established by the ACA applies to qualified individual and small group health plans operating both inside and outside of the Health Insurance Marketplace. The risk corridor program limits the Company’s gains and losses in the Health Insurance Marketplace by comparing certain medical and administrative costs to a target amount and sharing the risk for allowable costs with the federal government. Allowable medical costs are adjusted for risk adjustment settlements, transitional reinsurance recoveries, and cost sharing reductions received from the federal government. The Company records a risk corridor receivable or payable as an adjustment to Premium Revenue on a year to date basis based on where its estimated annual costs fall within the risk corridor range. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, the Company recorded a payable of </font><font style="font-family:inherit;font-size:10pt;">$4 million</font><font style="font-family:inherit;font-size:10pt;"> associated with risk corridor, and </font><font style="font-family:inherit;font-size:10pt;">$9 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">December 31, 2014</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;text-decoration:underline;">Minimum Medical Loss Ratio</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additionally, the ACA established a minimum annual medical loss ratio for the Health Insurance Marketplace. Each of the three R programs described above are taken into consideration to determine if the Company’s estimated annual medical costs are less than the minimum loss ratio and require an adjustment to Premium revenue to meet the minimum medical loss ratio. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, the Company recorded a payable of </font><font style="font-family:inherit;font-size:10pt;">$15 million</font><font style="font-family:inherit;font-size:10pt;"> associated with minimum medical loss ratio, and </font><font style="font-family:inherit;font-size:10pt;">$6 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;">December 31, 2014</font><font style="font-family:inherit;font-size:10pt;">. </font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Health Insurance Marketplace</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Affordable Care Act (ACA) established risk spreading premium stabilization programs effective January 1, 2014 for the Health Insurance Marketplace product. These programs, commonly referred to as the “three Rs,” include a permanent risk adjustment program, a transitional reinsurance program, and a temporary risk corridor program. Additionally, the ACA established a minimum annual medical loss ratio for the Health Insurance Marketplace. Each of the three R programs are taken into consideration to determine if the Company’s estimated annual medical costs are less than the minimum loss ratio and require an adjustment to Premium revenue to meet the minimum medical loss ratio. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2015, CMS released final results on reinsurance and risk-adjustment for the 2014 plan year. In September 2015, the results on risk corridor and the minimum medical loss ratio were finalized for the 2014 plan year. These final results had an insignificant impact to the Company for the 2014 plan year.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's receivables (payables) for each of these programs are as follows at each year ended ($ in millions): </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:69.921875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="43%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="26%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="26%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(108</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(44</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reinsurance</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk corridor</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Minimum medical loss ratio</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Medical Claims Liability</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The change in medical claims liability is summarized as follows ($ in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:70.1171875%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="48%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, January 1,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,723</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,112</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">815</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisitions</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Incurred related to:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">          Current year</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,471</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,820</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,073</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">          Prior years</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(229</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(142</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(78</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">         Total incurred</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,242</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,678</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,995</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Paid related to:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">          Current year</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,279</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,122</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,975</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">          Prior years</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,467</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">945</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">723</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">         Total paid</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,746</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,067</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,698</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, December 31,</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,298</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,723</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,112</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes in estimates of incurred claims for prior years are primarily attributable to reserving under moderately adverse conditions. Additionally, as a result of minimum HBR and other return of premium programs, approximately </font><font style="font-family:inherit;font-size:10pt;">$47 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">$26 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$0 million</font><font style="font-family:inherit;font-size:10pt;"> of the “Incurred related to: Prior period” was recorded as a reduction to premium revenues in 2015, 2014 and 2013, respectively. Further, claims processing initiatives yielded increased claim payment recoveries and coordination of benefits related to prior year dates of service. Changes in medical utilization and cost trends and the effect of medical management initiatives may also contribute to changes in medical claim liability estimates.  While the Company has evidence that medical management initiatives are effective on a case by case basis, medical management initiatives primarily focus on events and behaviors prior to the incurrence of the medical event and generation of a claim. Accordingly, any change in behavior, leveling of care, or coordination of treatment occurs prior to claim generation and as a result, the costs prior to the medical management initiative are not known by the Company. Additionally, certain medical management initiatives are focused on member and provider education with the intent of influencing behavior to appropriately align the medical services provided with the member's acuity. In these cases, determining whether the medical management initiative changed the behavior cannot be determined. Because of the complexity of its business, the number of states in which it operates, and the volume of claims that it processes, the Company is unable to practically quantify the impact of these initiatives on its changes in estimates of IBNR. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company had reinsurance recoverables related to medical claims liability of </font><font style="font-family:inherit;font-size:10pt;">$31 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$22 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015 and 2014</font><font style="font-family:inherit;font-size:10pt;">, respectively, included in premium and related receivables. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company periodically reviews actual and anticipated experience compared to the assumptions used to establish medical costs. The Company establishes premium deficiency reserves if actual and anticipated experience indicates that existing policy liabilities together with the present value of future gross premiums will not be sufficient to cover the present value of future benefits, settlement and maintenance costs.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Premium and Related Receivables and Unearned Revenue</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Premium and service revenues collected in advance are recorded as unearned revenue. For performance-based contracts the Company does not recognize revenue subject to refund until data is sufficient to measure performance. Premiums and service revenues due to the Company are recorded as premium and related receivables and are recorded net of an allowance based on historical trends and management's judgment on the collectibility of these accounts. As the Company generally receives payments during the month in which services are provided, the allowance is typically not significant in comparison to total revenues and does not have a material impact on the presentation of the financial condition or results of operations.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Activity in the allowance for uncollectible accounts for the years ended December 31, is summarized below ($ in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:88.671875%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="71%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowances, beginning of year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts charged to expense</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Write-offs of uncollectible receivables</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Allowances, end of year</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets are amortized using the straight-line method over the following periods:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:50.78125%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td width="58%" rowspan="1" colspan="1"></td><td width="4%" rowspan="1" colspan="1"></td><td width="38%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Intangible Asset</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Amortization Period</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchased contract rights</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 - 15 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provider contracts</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4 - 15 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3 - 15 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7 - 20 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Developed technology</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 years</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Centene Corporation (Parent Company Only)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Condensed Balance Sheets</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(In millions, except share data)</font><font style="font-family:inherit;font-size:7pt;"> </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="75%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ASSETS</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short term investments, at fair value (amortized cost $5 and $8, respectively)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">711</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">378</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">720</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">389</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long term investments, at fair value (amortized cost $6 and $10, respectively)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investment in subsidiaries</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,749</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,296</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long term assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,510</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,733</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">LIABILITIES AND STOCKHOLDERS' EQUITY</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long term debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,147</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">815</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long term liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,186</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">842</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Redeemable noncontrolling interest</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">156</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">148</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stockholders' equity:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock, $.001 par value; authorized 400,000,000 shares; 126,855,477 issued and 120,342,981 outstanding at December 31, 2015, and 124,274,864 issued and 118,433,416 outstanding at December 31, 2014</font></div><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additional paid-in capital</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">956</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">840</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated other comprehensive loss</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Retained earnings</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,358</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,003</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Treasury stock, at cost (6,512,496 and 5,841,448 shares, respectively)</font></div><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(147</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(98</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Centene stockholders' equity</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,157</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,744</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncontrolling interest</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total stockholders' equity</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,168</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,743</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities and stockholders' equity</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,510</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,733</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Centene Corporation (Parent Company Only)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Condensed Statements of Cash Flows </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(In millions)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.0703125%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="68%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash flows from operating activities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash provided by operating activities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">462</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">317</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">302</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash flows from investing activities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net dividends from and capital contributions to subsidiaries</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(660</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(384</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(417</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase of investments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(32</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales and maturities of investments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Proceeds from asset sale</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisitions</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(113</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(137</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(67</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash used in investing activities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(774</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(539</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(486</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash flows from financing activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Proceeds from borrowings</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,925</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,875</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payment of long term debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,575</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,650</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(30</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Proceeds from exercise of stock options</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Proceeds from stock offering</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock repurchases</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(53</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(29</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(20</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt issue costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payment of contingent consideration obligation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(29</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contributions from noncontrolling interest</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Excess tax benefits from stock compensation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash provided by financing activities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">313</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">222</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">165</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net increase (decrease) in cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash and cash equivalents,</font><font style="font-family:inherit;font-size:10pt;"> beginning of period</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash and cash equivalents,</font><font style="font-family:inherit;font-size:10pt;"> end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Centene Corporation (Parent Company Only)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Condensed Statements of Operations</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(In millions, except share data)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.015625%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="59%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Expenses:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(44</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other income (expense):</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investment and other income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(39</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(30</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings (loss) before income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(32</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Income tax benefit</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings (loss) before equity in subsidiaries</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity in earnings from subsidiaries</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">341</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">285</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">173</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">358</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">261</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Earnings) loss attributable to noncontrolling interests</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net earnings attributable to Centene</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">356</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net earnings per share from continuing operations:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic earnings per common share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.99</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.30</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.49</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted earnings per common share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.89</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.23</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.43</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted average number of shares outstanding:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">119,100,744</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">116,345,764</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">108,253,090</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">123,066,370</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">120,360,212</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">112,494,346</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, software and equipment are depreciated over the following periods:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:52.5390625%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td width="59%" rowspan="1" colspan="1"></td><td width="4%" rowspan="1" colspan="1"></td><td width="37%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fixed Asset</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Depreciation Period</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Buildings and land improvements</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3 - 40 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer hardware and software</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2 - 7 years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and equipment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3 - 10 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1 - 20 years</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's receivables (payables) for each of these programs are as follows at each year ended ($ in millions): </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:69.921875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="43%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="26%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="26%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk adjustment</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(108</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(44</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reinsurance</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk corridor</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Minimum medical loss ratio</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short term and long term investments and restricted deposits by investment type consist of the following ($ in millions):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="32" rowspan="1"></td></tr><tr><td width="21%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Treasury securities and obligations of U.S. government corporations and agencies</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">431</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2</font></div></td><td style="vertical-align:top;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">429</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">393</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2</font></div></td><td style="vertical-align:top;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">392</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate securities</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">859</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">853</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">556</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">556</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted certificates of deposit</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted cash equivalents</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">78</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">78</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">79</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">79</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Municipal securities</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">496</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1</font></div></td><td style="vertical-align:top;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">497</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">174</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">175</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset backed securities</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">163</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">162</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">180</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">180</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Residential mortgage backed securities</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">66</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">67</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">84</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">85</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial mortgage backed securities</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost and equity method investments</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">71</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">71</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">68</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">68</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Life insurance contracts</font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,225</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,218</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,556</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,557</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Significant Customers </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Centene receives the majority of its revenues under contracts or subcontracts with state Medicaid managed care programs. The current contracts expire on various dates between April 30, 2016 and June 30, 2019. States where the aggregate annual contract value exceeded 10% of total annual revenues included Texas, where the percentage of the Company's total revenue was </font><font style="font-family:inherit;font-size:10pt;">22%</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">25%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">37%</font><font style="font-family:inherit;font-size:10pt;"> for the years ended December 31, 2015, 2014, and 2013, respectively, and Florida where the percentage of the Company's total revenue was </font><font style="font-family:inherit;font-size:10pt;">14%</font><font style="font-family:inherit;font-size:10pt;"> for the years ended December 31, 2015 and 2014.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> Condensed Financial Information of Registrant</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Centene Corporation (Parent Company Only)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Condensed Balance Sheets</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(In millions, except share data)</font><font style="font-family:inherit;font-size:7pt;"> </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="75%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">ASSETS</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short term investments, at fair value (amortized cost $5 and $8, respectively)</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">711</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">378</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">720</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">389</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long term investments, at fair value (amortized cost $6 and $10, respectively)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investment in subsidiaries</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,749</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,296</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long term assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,510</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,733</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">LIABILITIES AND STOCKHOLDERS' EQUITY</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Long term debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,147</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">815</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long term liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,186</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">842</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Redeemable noncontrolling interest</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">156</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">148</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Stockholders' equity:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock, $.001 par value; authorized 400,000,000 shares; 126,855,477 issued and 120,342,981 outstanding at December 31, 2015, and 124,274,864 issued and 118,433,416 outstanding at December 31, 2014</font></div><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additional paid-in capital</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">956</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">840</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated other comprehensive loss</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Retained earnings</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,358</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,003</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Treasury stock, at cost (6,512,496 and 5,841,448 shares, respectively)</font></div><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(147</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(98</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total Centene stockholders' equity</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,157</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,744</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Noncontrolling interest</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total stockholders' equity</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,168</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,743</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities and stockholders' equity</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,510</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,733</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">See notes to condensed financial information of registrant.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Centene Corporation (Parent Company Only)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Condensed Statements of Operations</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(In millions, except share data)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.015625%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="59%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Expenses:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General and administrative expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain on contingent consideration</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(44</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other income (expense):</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investment and other income</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(39</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(30</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(23</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings (loss) before income taxes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(32</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Income tax benefit</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(26</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(15</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings (loss) before equity in subsidiaries</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity in earnings from subsidiaries</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">341</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">285</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">173</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">358</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">261</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Earnings) loss attributable to noncontrolling interests</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net earnings attributable to Centene</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">356</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Net earnings per share from continuing operations:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic earnings per common share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.99</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.30</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.49</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted earnings per common share</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.89</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.23</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.43</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted average number of shares outstanding:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">119,100,744</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">116,345,764</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">108,253,090</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">123,066,370</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">120,360,212</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">112,494,346</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"> </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">See notes to condensed financial information of registrant.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Centene Corporation (Parent Company Only)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Condensed Statements of Cash Flows </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(In millions)</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:97.0703125%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="68%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash flows from operating activities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash provided by operating activities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">462</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">317</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">302</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash flows from investing activities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net dividends from and capital contributions to subsidiaries</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(660</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(384</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(417</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchase of investments</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(32</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Sales and maturities of investments</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Proceeds from asset sale</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisitions</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(113</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(137</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(67</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash used in investing activities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(774</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(539</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(486</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash flows from financing activities:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Proceeds from borrowings</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,925</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,875</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payment of long term debt</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,575</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,650</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(30</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Proceeds from exercise of stock options</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Proceeds from stock offering</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock repurchases</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(53</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(29</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(20</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt issue costs</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Payment of contingent consideration obligation</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(29</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Contributions from noncontrolling interest</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Excess tax benefits from stock compensation</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net cash provided by financing activities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">313</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">222</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">165</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net increase (decrease) in cash and cash equivalents</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash and cash equivalents,</font><font style="font-family:inherit;font-size:10pt;"> beginning of period</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Cash and cash equivalents,</font><font style="font-family:inherit;font-size:10pt;"> end of period</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">See notes to condensed financial information of registrant.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Notes to Condensed Financial Information of Registrant</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Note A - Basis of Presentation and Significant Accounting Policies</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The parent company only financial statements should be read in conjunction with Centene Corporation's audited consolidated financial statements and the notes to consolidated financial statements included in this Form 10-K.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">    </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The parent company's investment in subsidiaries is stated at cost plus equity in undistributed earnings of the subsidiaries. The parent company's share of net income of its unconsolidated subsidiaries is included in income using the equity method of accounting. Certain unrestricted subsidiaries receive monthly management fees from our restricted subsidiaries. The management and service fees received by our unrestricted subsidiaries are associated with all of the functions required to manage the restricted subsidiaries including but not limited to salaries and wages for all personnel, rent, utilities, medical management, provider contracting, compliance, member services, claims processing, information technology, cash management, finance and accounting, and other services. The management fees are based on a percentage of the restricted subsidiaries revenue. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Due to our centralized cash management function, all cash flows generated by our unrestricted subsidiaries, including management fees, are transferred to the parent company, primarily to repay borrowings on the parent company's revolving credit facility. The parent company may also utilize the cash flow to make acquisitions, fund capital contributions to subsidiaries and fund its operations. During the years ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015, 2014 and 2013</font><font style="font-family:inherit;font-size:10pt;">, cash flows received by the parent from unrestricted subsidiaries was </font><font style="font-family:inherit;font-size:10pt;">$445 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$341 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$313 million</font><font style="font-family:inherit;font-size:10pt;"> and was included in cash flows from operating activities.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain amounts presented in the parent company only financial statements are eliminated in the consolidated financial statements of Centene Corporation. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Note B - Dividends</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015, 2014 and 2013</font><font style="font-family:inherit;font-size:10pt;">, the Registrant received dividends from its subsidiaries totaling </font><font style="font-family:inherit;font-size:10pt;">$14 million</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$54 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$21 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Note C - Other Current Assets</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The parent company's other current assets include </font><font style="font-family:inherit;font-size:10pt;">$686 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$359 million</font><font style="font-family:inherit;font-size:10pt;"> of federal and state income tax receivables as of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2015 and 2014</font><font style="font-family:inherit;font-size:10pt;">, respectively, primarily due to tax sharing agreements with its subsidiaries.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net income attributable to Centene Corporation and transfers from (to) noncontrolling interest entities are as follows ($ in millions):</font></div><div style="line-height:120%;text-align:center;text-indent:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:96.29629629629629%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="68%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings attributable to Centene Corporation</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">356</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Transfers from (to) the noncontrolling interest:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Increase in equity for distributions from and consolidation of noncontrolling interest</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reclassification to redeemable noncontrolling interest</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net transfers from (to) noncontrolling interest</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes from net earnings attributable to Centene Corporation and net transfers from (to) the noncontrolling interest</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">368</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">259</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">168</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> Debt</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt consists of the following ($ in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:82.6171875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="57%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="19%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="19%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$425 million 5.75% Senior notes, due June 1, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">428</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">429</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$500 million 4.75% Senior notes, due May 15, 2022</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">300</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of interest rate swap agreements</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Senior notes</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">937</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">740</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Revolving credit agreement</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">225</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Mortgage notes payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capital leases</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt issuance costs</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total debt</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,221</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">879</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less current portion</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Long term debt</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,216</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">874</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Senior Notes</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2015, the Company issued an additional </font><font style="font-family:inherit;font-size:10pt;">$200</font><font style="font-family:inherit;font-size:10pt;"> million of </font><font style="font-family:inherit;font-size:10pt;">4.75%</font><font style="font-family:inherit;font-size:10pt;"> Senior Notes (</font><font style="font-family:inherit;font-size:10pt;">$200</font><font style="font-family:inherit;font-size:10pt;"> Million Add-on Notes) at par. The </font><font style="font-family:inherit;font-size:10pt;">$200</font><font style="font-family:inherit;font-size:10pt;"> Million Add-on Notes were offered as additional debt securities under the indenture governing the </font><font style="font-family:inherit;font-size:10pt;">$300 million</font><font style="font-family:inherit;font-size:10pt;"> of </font><font style="font-family:inherit;font-size:10pt;">4.75%</font><font style="font-family:inherit;font-size:10pt;"> Senior Notes issued in April 2014. In connection with the January 2015 issuance, the Company entered into interest rate swap agreements for a notional amount of </font><font style="font-family:inherit;font-size:10pt;">$200</font><font style="font-family:inherit;font-size:10pt;"> million at a floating rate of interest based on the three month LIBOR plus </font><font style="font-family:inherit;font-size:10pt;">2.88%</font><font style="font-family:inherit;font-size:10pt;">. Gains and losses due to changes in the fair value of the interest rate swap completely offset changes in the fair value of the hedged portion of the underlying debt and are recorded as an adjustment to the </font><font style="font-family:inherit;font-size:10pt;">$200</font><font style="font-family:inherit;font-size:10pt;"> Million Add-on Notes.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In April 2014, the Company issued </font><font style="font-family:inherit;font-size:10pt;">$300 million</font><font style="font-family:inherit;font-size:10pt;"> of </font><font style="font-family:inherit;font-size:10pt;">4.75%</font><font style="font-family:inherit;font-size:10pt;"> Senior Notes due </font><font style="font-family:inherit;font-size:10pt;">May 15, 2022</font><font style="font-family:inherit;font-size:10pt;"> ($300 Million Notes) at par. In connection with the April 2014 issuance, the Company entered into interest rate swap agreements for a notional amount of </font><font style="font-family:inherit;font-size:10pt;">$300 million</font><font style="font-family:inherit;font-size:10pt;">. Gains and losses due to changes in the fair value of the interest rate swap agreements offset changes in the fair value of the hedged portion of the underlying debt and are recorded as an adjustment to the $300 Million Notes. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The indentures governing both the </font><font style="font-family:inherit;font-size:10pt;">$425 million</font><font style="font-family:inherit;font-size:10pt;"> and the </font><font style="font-family:inherit;font-size:10pt;">$500 million</font><font style="font-family:inherit;font-size:10pt;"> notes contain non-financial and financial covenants, including requirements of a minimum fixed charge coverage ratio. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Interest Rate Swaps</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company uses interest rate swap agreements to convert a portion of its interest rate exposure from fixed rates to floating rates to more closely align interest expense with interest income received on its cash equivalent and variable rate investment balances. The Company has </font><font style="font-family:inherit;font-size:10pt;">$750 million</font><font style="font-family:inherit;font-size:10pt;"> of notional amount of interest rate swap agreements consisting of </font><font style="font-family:inherit;font-size:10pt;">$250 million</font><font style="font-family:inherit;font-size:10pt;"> which are scheduled to expire on June 1, 2017 and </font><font style="font-family:inherit;font-size:10pt;">$500 million</font><font style="font-family:inherit;font-size:10pt;"> that are scheduled to expire May 15, 2022. Under the Swap Agreements, the Company receives a fixed rate of interest and pays a variable rate of the three month LIBOR plus an average </font><font style="font-family:inherit;font-size:10pt;">2.85%</font><font style="font-family:inherit;font-size:10pt;"> adjusted quarterly. At December 31, 2015, the weighted average rate was </font><font style="font-family:inherit;font-size:10pt;">3.22%</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Swap Agreements are formally designated and qualify as fair value hedges and are recorded at fair value in the Consolidated Balance Sheet in other assets or other liabilities. Gains and losses due to changes in fair value of the interest rate swap agreements completely offset changes in the fair value of the hedged portion of the underlying debt. Therefore, no gain or loss has been recognized due to hedge ineffectiveness. Offsetting changes in fair value of both the interest rate swaps and the hedged portion of the underlying debt both were recognized in interest expense in the Consolidated Statement of Operations. The Company does not hold or issue any derivative instrument for trading or speculative purposes.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair values of the Swap Agreements as of December 31, 2015 were assets of </font><font style="font-family:inherit;font-size:10pt;">$11 million</font><font style="font-family:inherit;font-size:10pt;"> and liabilities of </font><font style="font-family:inherit;font-size:10pt;">$2 million</font><font style="font-family:inherit;font-size:10pt;">, and are included in other long term assets and other long term liabilities, respectively in the Consolidated Balance Sheet. The fair value of the Swap Agreements as of December 31, 2014 were assets of </font><font style="font-family:inherit;font-size:10pt;">$11 million</font><font style="font-family:inherit;font-size:10pt;"> and are included in other long term assets in the Consolidated Balance Sheet. The fair value of the Swap Agreements excludes accrued interest and takes into consideration current interest rates and current likelihood of the swap counterparties' compliance with its contractual obligations.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Revolving Credit Agreement</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has an unsecured </font><font style="font-family:inherit;font-size:10pt;">$500 million</font><font style="font-family:inherit;font-size:10pt;"> revolving credit facility. Borrowings under the agreement bear interest based upon LIBOR rates, the Federal Funds Rate or the Prime Rate. The agreement has a maturity date of </font><font style="font-family:inherit;font-size:10pt;">June 1, 2018</font><font style="font-family:inherit;font-size:10pt;">, provided it will mature </font><font style="font-family:inherit;font-size:10pt;">90 days</font><font style="font-family:inherit;font-size:10pt;"> prior to the maturity date of the Company's 5.75% Senior Notes due 2017 if such notes are not refinanced (or extended), certain financial conditions are not met, or the Company does not carry </font><font style="font-family:inherit;font-size:10pt;">$100 million</font><font style="font-family:inherit;font-size:10pt;"> of unrestricted cash. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, the Company had </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$225 million</font><font style="font-family:inherit;font-size:10pt;"> of borrowings outstanding under the agreement with a weighted average interest rate of </font><font style="font-family:inherit;font-size:10pt;">2.05%</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The agreement contains non-financial and financial covenants, including requirements of minimum fixed charge coverage ratios, maximum debt-to-EBITDA ratios and minimum tangible net worth. The Company is required to not exceed a maximum debt-to-EBITDA ratio of 3.0 to 1.0.</font><font style="font-family:inherit;font-size:10pt;"> As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> limitations on the availability under the revolving credit agreement as a result of the debt-to-EBITDA ratio.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Mortgage Notes Payable</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has a non-recourse mortgage note of </font><font style="font-family:inherit;font-size:10pt;">$67 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;"> collateralized by its corporate headquarters building. The mortgage note is due </font><font style="font-family:inherit;font-size:10pt;">January 1, 2021</font><font style="font-family:inherit;font-size:10pt;"> and bears a </font><font style="font-family:inherit;font-size:10pt;">5.14%</font><font style="font-family:inherit;font-size:10pt;"> interest rate. The collateralized property had a net book value of </font><font style="font-family:inherit;font-size:10pt;">$151 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Letters of Credit & Surety Bonds</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company had outstanding letters of credit of </font><font style="font-family:inherit;font-size:10pt;">$47 million</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, which were not part of the revolving credit facility.  As discussed in Note </font><font style="font-family:inherit;font-size:10pt;">4</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Acquisitions and Noncontrolling Interest</font><font style="font-family:inherit;font-size:10pt;">, the Company also had letters of credit for </font><font style="font-family:inherit;font-size:10pt;">$50 million</font><font style="font-family:inherit;font-size:10pt;"> (valued at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;"> conversion rate), or </font><font style="font-family:inherit;font-size:10pt;">€46 million</font><font style="font-family:inherit;font-size:10pt;">, representing its proportional share of the letters of credit issued to support Ribera Salud's outstanding debt which are a part of the revolving credit facility. Collectively, the letters of credit bore interest at </font><font style="font-family:inherit;font-size:10pt;">1.55%</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">. The Company had outstanding surety bonds of </font><font style="font-family:inherit;font-size:10pt;">$305 million</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Aggregate maturities for the Company's debt are as follows ($ in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:34.1796875%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td width="62%" rowspan="1" colspan="1"></td><td width="3%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="33%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">  </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">  </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">429</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">  </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">228</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">  </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">  </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">  </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">553</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,223</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of outstanding debt was approximately </font><font style="font-family:inherit;font-size:10pt;">$1,239 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$901 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015 and 2014</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Earnings Per Share</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth the calculation of basic and diluted net earnings per common share for the years ended December 31 ($ in millions, except per share data):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="62%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings attributable to Centene Corporation:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings from continuing operations, net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">356</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discontinued operations, net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">355</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">271</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">165</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares used in computing per share amounts:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average number of common shares outstanding</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">119,100,744</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">116,345,764</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">108,253,090</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock equivalents (as determined by applying the treasury stock method)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,965,626</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,014,448</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,241,256</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average number of common shares and potential dilutive common shares outstanding</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">123,066,370</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">120,360,212</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">112,494,346</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings per common share attributable to Centene Corporation:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic: </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Continuing operations</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.99</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.30</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.49</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discontinued operations</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.01</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.03</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.03</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic earnings per common share</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.98</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.33</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.52</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Continuing operations</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.89</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.23</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.43</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discontinued operations</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.01</font></div></td><td style="vertical-align:top;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.02</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.04</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted earnings per common share</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.88</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.25</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.47</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The calculation of diluted earnings per common share for </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2015, 2014 and 2013</font><font style="font-family:inherit;font-size:10pt;"> excludes the impact of </font><font style="font-family:inherit;font-size:10pt;">7,247</font><font style="font-family:inherit;font-size:10pt;"> shares, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">207,980</font><font style="font-family:inherit;font-size:10pt;"> shares and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">187,078</font><font style="font-family:inherit;font-size:10pt;"> shares, respectively, related to anti-dilutive stock options, restricted stock and restricted stock units.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value Measurements</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets and liabilities recorded at fair value in the consolidated balance sheets are categorized based upon observable or unobservable inputs used to estimate the fair value.  Level inputs are as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="3" rowspan="1"></td></tr><tr><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="87%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level Input:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Input Definition:</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level I</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level II</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Inputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Level III</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes fair value measurements by level at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, for assets and liabilities measured at fair value on a recurring basis ($ in millions):  </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level I</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level II</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level III</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,760</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,760</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments available for sale:</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Treasury securities and obligations of U.S. government corporations and agencies</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">325</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">397</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate securities</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">853</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">853</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Municipal securities</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">497</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">497</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset backed securities</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Residential mortgage backed securities</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial mortgage backed securities</font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total investments</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">325</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,691</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted deposits available for sale:</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certificates of deposit</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Treasury securities and obligations of U.S. government corporations and agencies</font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total restricted deposits</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long term assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets at fair value</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,200</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,702</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,902</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long term liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities at fair value</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes fair value measurements by level at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2014</font><font style="font-family:inherit;font-size:10pt;">, for assets and liabilities measured at fair value on a recurring basis ($ in millions):  </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level I</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level II</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level III</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,610</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,610</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments available for sale:</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Treasury securities and obligations of U.S. government corporations and agencies</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">360</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">377</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate securities</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">556</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">556</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Municipal securities</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">175</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">175</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset backed securities</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Residential mortgage backed securities</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial mortgage backed securities</font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total investments</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">360</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,013</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,373</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted deposits available for sale:</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certificates of deposit</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Treasury securities and obligations of U.S. government corporations and agencies</font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total restricted deposits</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long term assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets at fair value</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,070</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,024</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,094</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company periodically transfers U.S. Treasury securities and obligations of U.S. government corporations and agencies between Level I and Level II fair value measurements dependent upon the level of trading activity for the specific securities at the measurement date.  The Company’s policy regarding the timing of transfers between Level I and Level II is to measure and record the transfers at the end of the reporting period.  At </font><font style="font-family:inherit;font-size:10pt;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;">$53 million</font><font style="font-family:inherit;font-size:10pt;"> of transfers from Level I to Level II and </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> transfers from Level II to Level I.  The Company utilizes matrix pricing services to estimate fair value for securities which are not actively traded on the measurement date.  The Company designates these securities as Level II fair value measurements.  The aggregate carrying amount of the Company’s life insurance contracts and other non-majority owned investments, which approximates fair value, was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$87 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$84 million</font><font style="font-family:inherit;font-size:10pt;"> as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2014</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The contractual maturities of short term and long term investments and restricted deposits are as follows ($ in millions):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="32" rowspan="1"></td></tr><tr><td width="17%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">December 31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Restricted Deposits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Restricted Deposits</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">One year or less</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">176</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">176</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">176</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">177</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">One year through five years</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,662</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,654</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,121</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,121</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Five years through ten years</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">267</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">120</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Greater than ten years</font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,110</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,103</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,456</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,457</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> Short term and Long term Investments, Restricted Deposits</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Short term and long term investments and restricted deposits by investment type consist of the following ($ in millions):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="32" rowspan="1"></td></tr><tr><td width="21%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December 31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unrealized</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Gains</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Gross</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Treasury securities and obligations of U.S. government corporations and agencies</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">431</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2</font></div></td><td style="vertical-align:top;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">429</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">393</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2</font></div></td><td style="vertical-align:top;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">392</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate securities</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">859</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(8</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">853</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">556</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(2</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">556</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted certificates of deposit</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted cash equivalents</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">78</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">78</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">79</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">79</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Municipal securities</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">496</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1</font></div></td><td style="vertical-align:top;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">497</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">174</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">175</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset backed securities</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">163</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(1</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">162</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">180</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">180</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Residential mortgage backed securities</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">66</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">67</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">84</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">85</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial mortgage backed securities</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">40</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost and equity method investments</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">71</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">71</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">68</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">68</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Life insurance contracts</font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">16</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,225</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(12</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">2,218</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,556</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">5</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">(4</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">1,557</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s investments are classified as available-for-sale with the exception of life insurance contracts and certain cost and equity method investments.  The Company’s investment policies are designed to provide liquidity, preserve capital and maximize total return on invested assets with the focus on high credit quality securities.  The Company limits the size of investment in any single issuer other than U.S. treasury securities and obligations of U.S. government corporations and agencies.  The Company's mortgage backed securities are issued by the Federal National Mortgage Association and carry guarantees by the U.S. government. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">99%</font><font style="font-family:inherit;font-size:10pt;"> of the Company’s investments in rated securities carry an investment grade rating by S&P or Moody’s.  At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, the Company held certificates of deposit, life insurance contracts and cost and equity method investments which did not carry a credit rating.</font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of available-for-sale investments with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="32" rowspan="1"></td></tr><tr><td width="17%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">December 31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Less Than 12 Months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">12 Months or More</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Less Than 12 Months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">12 Months or More</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Treasury securities and obligations of U.S. government corporations and agencies</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:top;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">294</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:top;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate securities</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">561</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">311</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Municipal securities</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:top;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">208</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset backed securities</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Residential Mortgage backed securities</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial mortgage backed securities</font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,248</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">491</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">198</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, the gross unrealized losses were generated from </font><font style="font-family:inherit;font-size:10pt;">429</font><font style="font-family:inherit;font-size:10pt;"> positions out of a total of </font><font style="font-family:inherit;font-size:10pt;">733</font><font style="font-family:inherit;font-size:10pt;"> positions.  The change in fair value of fixed income securities is a result of movement in interest rates subsequent to the purchase of the security.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For each security in an unrealized loss position, the Company assesses whether it intends to sell the security or if it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual or regulatory purposes.  If the security meets this criterion, the decline in fair value is other-than-temporary and is recorded in earnings.  The Company does not intend to sell these securities prior to maturity and it is not likely that the Company will be required to sell these securities prior to maturity; therefore, there is no indication of other than temporary impairment for these securities.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, the company recognized </font><font style="font-family:inherit;font-size:10pt;">$8 million</font><font style="font-family:inherit;font-size:10pt;"> of income from equity method investments. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The contractual maturities of short term and long term investments and restricted deposits are as follows ($ in millions):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="32" rowspan="1"></td></tr><tr><td width="17%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">December 31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Restricted Deposits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Investments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Restricted Deposits</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Amortized</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">One year or less</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">176</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">176</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">176</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">177</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">One year through five years</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,662</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,654</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,121</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,121</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Five years through ten years</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">267</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">120</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Greater than ten years</font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">39</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,110</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,103</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,456</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,457</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Actual maturities may differ from contractual maturities due to call or prepayment options.  Asset backed and mortgage backed securities are included in the one year through five years category, while cost and equity method investments and life insurance contracts are included in the five years through ten years category.  The Company has an option to redeem at amortized cost substantially all of the securities included in the greater than ten years category listed above.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company continuously monitors investments for other-than-temporary impairment.  Certain investments have experienced a decline in fair value due to changes in credit quality, market interest rates and/or general economic conditions.  The Company recognizes an impairment loss for cost and equity method investments when evidence demonstrates that it is other-than-temporarily impaired.  Evidence of a loss in value that is other than temporary may include the absence of an ability to recover the carrying amount of the investment or the inability of the investee to sustain a level of earnings that would justify the carrying amount of the investment.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Contingencies</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 5, 2013, the Company's subsidiary, Kentucky Spirit Health Plan, Inc. (Kentucky Spirit), terminated its contract with the Commonwealth of Kentucky (the Commonwealth). Kentucky Spirit believes it had a contractual right to terminate the contract and filed a lawsuit in Franklin Circuit Court seeking a declaration of this right. The Commonwealth has alleged that Kentucky Spirit's exit constitutes a material breach of contract.  The Commonwealth seeks to recover substantial damages and to enforce its rights under Kentucky Spirit's </font><font style="font-family:inherit;font-size:10pt;">$25 million</font><font style="font-family:inherit;font-size:10pt;"> performance bond. The Commonwealth's attorneys have asserted that the Commonwealth's expenditures due to Kentucky Spirit's departure range from </font><font style="font-family:inherit;font-size:10pt;">$28 million</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">$40 million</font><font style="font-family:inherit;font-size:10pt;"> plus interest, and that the associated CMS expenditures range from </font><font style="font-family:inherit;font-size:10pt;">$92 million</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">$134 million</font><font style="font-family:inherit;font-size:10pt;">. Kentucky Spirit disputes the Commonwealth's alleged damages, and filed a lawsuit in April 2013, amended in October 2014, in Franklin Circuit Court seeking damages against the Commonwealth for losses sustained due to the Commonwealth's alleged breaches.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 6, 2015, the Kentucky Court of Appeals affirmed a Franklin Circuit Court ruling that Kentucky Spirit does not have a contractual right to terminate the contract early. The Court of Appeals also found that the contract’s liquidated damages provision “is applicable in the event of a premature termination of the Contract term.” On September 8, 2015, Kentucky Spirit filed a motion for discretionary review seeking Kentucky Supreme Court review of the finding that Kentucky Spirit's departure constituted a breach of contract. On October 9, 2015, the Commonwealth filed a response opposing discretionary review. </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 26, 2015, the Commonwealth issued a demand for indemnification to its actuarial firm, for "all defense costs, and any resultant monetary awards in favor of Kentucky Spirit, arising from or related to Kentucky Spirit's claims which are predicated upon the alleged omissions and errors in the Data Book and the certified actuarially sound rates." On August 19, 2015, the actuarial firm moved to intervene in the litigation. The Franklin Circuit Court granted the actuarial firm's motion on September 8, 2015 and ordered a </font><font style="font-family:inherit;font-size:10pt;">forty-five</font><font style="font-family:inherit;font-size:10pt;"> day stay of all pretrial proceedings in order for the firm to review the record. Also, on August 19, 2015, the actuarial firm filed a petition seeking a declaratory judgment that it is not liable to the Commonwealth for indemnification related to the claims asserted by Kentucky Spirit against the Commonwealth. On October 5, 2015, the Commonwealth filed an answer to the actuarial firm's petition and asserted counterclaims/cross-claims against the firm.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On March 9, 2015, the Secretary of the Kentucky Cabinet for Health and Family Services (CHFS) issued a determination letter finding that Kentucky Spirit owed the Commonwealth </font><font style="font-family:inherit;font-size:10pt;">$40 million</font><font style="font-family:inherit;font-size:10pt;"> in actual damages plus prejudgment interest at </font><font style="font-family:inherit;font-size:10pt;">8</font><font style="font-family:inherit;font-size:10pt;"> percent. On March 18, 2015, in a letter to the Kentucky Finance and Administration Cabinet (FAC), Kentucky Spirit contested CHFS' jurisdiction to make such a determination. The FAC did not issue a decision within the required </font><font style="font-family:inherit;font-size:10pt;">120</font><font style="font-family:inherit;font-size:10pt;"> days. On August 13, 2015, Kentucky Spirit filed a declaratory judgment action against the Commonwealth in Franklin Circuit Court seeking a declaration that the Commonwealth may not purport to issue a decision against Kentucky Spirit awarding damages to itself when the matter is already before the Kentucky courts, and that the Commonwealth has waived its claims against Kentucky Spirit for damages arising out of the contract. The Commonwealth filed counterclaims seeking a Declaration of Rights and Entry of Judgment on its determination letter. On December 1, 2015 the Franklin Circuit Court consolidated this declaratory judgment action with Kentucky Spirit’s other litigation claims against the Commonwealth. On December 15, 2015, the Franklin Circuit Court denied Kentucky Spirit’s motion to dismiss the Commonwealth’s counterclaim for Declaration of Rights and Entry of Judgment. Discovery is proceeding in the consolidated litigation matters.</font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The resolution of the Kentucky litigation matters may result in a range of possible outcomes.  If Kentucky Spirit prevails on its claims, it would be entitled to damages.  If the Commonwealth prevails, a liability to the Commonwealth could be recorded.  The Company is unable to estimate the ultimate outcome resulting from the Kentucky litigation.  As a result, the Company has not recorded any receivable or any liability for potential damages under the contract as of December 31, 2015.  While uncertain, the ultimate resolution of the pending litigation could have a material effect on the financial position, cash flow or results of operations of the Company in the period it is resolved or becomes known. </font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Excluding the Kentucky matters discussed above, the Company is also routinely subjected to legal proceedings in the normal course of business.  While the ultimate resolution of such matters in the normal course of business is uncertain, the Company does not expect the results of any of these matters individually, or in the aggregate, to have a material effect on its financial position, results of operations or cash flows.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Health Net Merger</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On July 2, 2015, the Company announced that the Company and </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> direct, newly formed subsidiaries of the Company had entered into a definitive merger agreement with Health Net, Inc. (Health Net) under which the Company will acquire all of the issued and outstanding shares of Health Net. Under the terms of the agreement, at the closing of the transaction, Health Net stockholders (with limited exceptions) would receive </font><font style="font-family:inherit;font-size:10pt;">0.622</font><font style="font-family:inherit;font-size:10pt;"> of a validly issued, fully paid, non-assessable share of Centene common stock and </font><font style="font-family:inherit;font-size:10pt;">$28.25</font><font style="font-family:inherit;font-size:10pt;"> in cash for each share of Health Net common stock. The transaction is valued at approximately </font><font style="font-family:inherit;font-size:10pt;">$5.5 billion</font><font style="font-family:inherit;font-size:10pt;"> (</font><font style="font-family:inherit;font-size:10pt;">based on the Centene closing stock price on </font><font style="font-family:inherit;font-size:10pt;">February 17, 2016</font><font style="font-family:inherit;font-size:10pt;">), including the assumption of debt. </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The transaction is expected to close in early 2016 and is subject to approvals by relevant state insurance and healthcare regulators and other customary closing conditions. In August 2015, the Company announced the early termination of the waiting period required under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended. In October 2015, the Company and Health Net announced the transaction was approved by both the Centene and Health Net stockholders. The Company expects to fund the cash portion of the acquisition through a combination of the debt financing completed in February 2016, borrowings on the Company's revolving credit facility and existing cash on hand.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has consolidated subsidiaries where it maintains less than 100% ownership.  The Company’s ownership interest for each subsidiary as of December 31, are as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:58.28460038986355%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td width="50%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Celtic Insurance Company</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Centurion</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Home State Health Plan</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">95</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Medical Management</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Annual non-cancelable minimum lease payments over the next five years and thereafter are as follows ($ in millions): </font></div><div style="line-height:120%;text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"> </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:56.25%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="78%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="20%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">58</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">315</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, software and equipment consist of the following as of December 31 ($ in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:68.5546875%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="60%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="17%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="2%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="17%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer software</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">237</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">198</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Building</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">223</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">208</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Land</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Computer hardware</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">105</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Furniture and office equipment</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Leasehold improvements</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">108</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">869</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">733</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less accumulated depreciation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(351</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(288</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Property, software and equipment, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">518</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">445</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A reconciliation of the changes in the Redeemable Noncontrolling Interest is as follows ($ in millions): </font></div><div style="line-height:120%;text-align:center;text-indent:24px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:426px;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="354px" rowspan="1" colspan="1"></td><td width="9px" rowspan="1" colspan="1"></td><td width="58px" rowspan="1" colspan="1"></td><td width="4px" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance, December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">148</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair value of noncontrolling interest sold</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reclassification to redeemable noncontrolling interest</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings attributable to noncontrolling interest</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance, December 31, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">156</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The consolidated income tax expense consists of the following for the years ended December 31 ($ in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.921875%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Current provision:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Federal</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">332</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">225</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State and local</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total current provision</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">358</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">238</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">127</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred provision</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(42</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(20</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total provision for income taxes</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">339</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">196</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The tax effects of temporary differences which give rise to deferred tax assets and liabilities are presented below for the years ended December 31 ($ in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:62.890625%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td width="71%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="12%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:4pt;"><font style="font-family:inherit;font-size:4pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax assets:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Medical claims liability</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accrued expenses</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net operating loss carryforward</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Compensation accruals</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">73</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition costs</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Premium and related receivables</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">191</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">156</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Valuation allowance</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net deferred tax assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">144</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">46</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prepaid assets</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Depreciation and amortization</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments in partnerships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Deferred tax liabilities</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net deferred tax assets</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">87</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">83</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table sets forth the calculation of basic and diluted net earnings per common share for the years ended December 31 ($ in millions, except per share data):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="62%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings attributable to Centene Corporation:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings from continuing operations, net of tax</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">356</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discontinued operations, net of tax</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">355</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">271</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">165</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Shares used in computing per share amounts:</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average number of common shares outstanding</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">119,100,744</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">116,345,764</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">108,253,090</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock equivalents (as determined by applying the treasury stock method)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,965,626</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,014,448</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,241,256</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted average number of common shares and potential dilutive common shares outstanding</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">123,066,370</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">120,360,212</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">112,494,346</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings per common share attributable to Centene Corporation:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic: </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Continuing operations</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.99</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.30</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.49</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discontinued operations</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.01</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.03</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.03</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic earnings per common share</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.98</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.33</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.52</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Continuing operations</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.89</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.23</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.43</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discontinued operations</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.01</font></div></td><td style="vertical-align:top;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.02</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.04</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted earnings per common share</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.88</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.25</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.47</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The reconciliation of the tax provision at the U.S. Federal Statutory Rate to the provision for income taxes for the years ended December 31 is as follows ($ in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.921875%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="65%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings from continuing operations, before income tax expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">697</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">457</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">269</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Earnings) loss attributable to flow through noncontrolling interest </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings from continuing operations, less noncontrolling interest, before income tax expense</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">698</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">461</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">268</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Tax provision at the U.S. federal statutory rate</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">244</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">94</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">State income taxes, net of federal income tax benefit</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Nondeductible compensation</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Benefit from reversal of prior years impact of 162(m)(6) regulations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ACA Health Insurer Fee</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other, net</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax expense</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">339</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">196</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes fair value measurements by level at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, for assets and liabilities measured at fair value on a recurring basis ($ in millions):  </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level I</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level II</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level III</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,760</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,760</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments available for sale:</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Treasury securities and obligations of U.S. government corporations and agencies</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">325</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">397</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate securities</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">853</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">853</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Municipal securities</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">497</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">497</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset backed securities</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">162</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Residential mortgage backed securities</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">67</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial mortgage backed securities</font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total investments</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">325</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,691</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,016</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted deposits available for sale:</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certificates of deposit</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Treasury securities and obligations of U.S. government corporations and agencies</font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total restricted deposits</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">115</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long term assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets at fair value</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,200</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,702</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,902</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long term liabilities:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities at fair value</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes fair value measurements by level at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2014</font><font style="font-family:inherit;font-size:10pt;">, for assets and liabilities measured at fair value on a recurring basis ($ in millions):  </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="9%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level I</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level II</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Level III</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,610</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,610</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Investments available for sale:</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Treasury securities and obligations of U.S. government corporations and agencies</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">360</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">377</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate securities</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">556</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">556</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Municipal securities</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">175</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">175</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset backed securities</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Residential mortgage backed securities</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">85</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial mortgage backed securities</font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total investments</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">360</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,013</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,373</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Restricted deposits available for sale:</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash and cash equivalents</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certificates of deposit</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Treasury securities and obligations of U.S. government corporations and agencies</font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total restricted deposits</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other long term assets:</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate swap agreements</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:36px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets at fair value</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,070</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,024</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,094</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;padding-left:49px;text-indent:-24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets at December 31, consist of the following ($ in millions):  </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="49%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="4" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted Average Life in Years</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchased contract rights</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.8</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provider contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13.1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Developed technology</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.0</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">217</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">163</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9.8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10.3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less accumulated amortization:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Purchased contract rights</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(21</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Provider contracts</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(24</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Customer relationships</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(14</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(12</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trade names</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Developed technology</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total accumulated amortization</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(62</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(43</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Intangible assets, net</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">155</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">120</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table summarizes the changes in goodwill by operating segment ($ in millions):</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:76.3671875%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="40%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="17%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="20%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> Managed Care</font><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Specialty Services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</font><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of December 31, 2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">151</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">197</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">348</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">125</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">281</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">406</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of December 31, 2014</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">276</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">478</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">754</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisition</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">103</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">106</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Impairment</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance as of December 31, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">361</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">481</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">842</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The change in medical claims liability is summarized as follows ($ in millions): </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:70.1171875%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="48%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="16%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, January 1,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,723</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,112</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">815</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Acquisitions</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Incurred related to:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">          Current year</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,471</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,820</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,073</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">          Prior years</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(229</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(142</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(78</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">         Total incurred</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17,242</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,678</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,995</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Paid related to:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">          Current year</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,279</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11,122</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,975</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">          Prior years</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,467</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">945</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">723</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">         Total paid</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,746</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12,067</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8,698</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance, December 31,</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,298</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,723</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,112</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="49%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Quarter Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">March 31,</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">June 30,</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">September 30,</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">December 31,</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,131</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,506</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,821</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,302</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="16" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts attributable to Centene Corporation common shareholders:</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings from continuing operations, net of income tax expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">92</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">112</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discontinued operations, net of income tax expense (benefit)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">93</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">111</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td colspan="16" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings (loss) per common share attributable to Centene Corporation:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic: </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.54</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.74</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.77</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.94</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.01</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.01</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.01</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic earnings per common share</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.53</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.74</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.78</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.93</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.52</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.72</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.75</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.91</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.01</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.01</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.01</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted earnings per common share</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.51</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.72</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.76</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.90</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="49%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="10%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">For the Quarter Ended</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">March 31,<br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">June 30,<br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">September 30,<br clear="none"/>2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">December 31,<br clear="none"/>2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,460</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,023</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,352</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,725</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td colspan="16" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amounts attributable to Centene Corporation common shareholders:</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings from continuing operations, net of income tax expense</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">47</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">81</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">106</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discontinued operations, net of income tax expense (benefit)</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">107</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td colspan="16" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings (loss) per common share attributable to Centene Corporation:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.30</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.41</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.69</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.90</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.01</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.01</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.01</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.01</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic earnings per common share</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.29</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.42</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.70</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.91</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted:</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Continuing operations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.29</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.39</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.67</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.87</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Discontinued operations</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(0.01</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.02</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.01</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.01</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Diluted earnings per common share</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.28</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.41</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.68</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.88</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Segment information as of and for the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, follows ($ in millions): </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.270955165692%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Managed Care</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Specialty</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Consolidated</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Premium and service revenues from external customers</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,054</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,211</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,265</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Premium and service revenues from internal customers</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">100</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,864</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,964</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total premium and service revenues</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,154</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,075</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(4,964</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,265</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings from operations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">513</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">192</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">705</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,202</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,137</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,339</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Segment information as of and for the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2014</font><font style="font-family:inherit;font-size:10pt;">, follows ($ in millions):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.270955165692%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Managed Care</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Specialty</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Consolidated</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Premium and service revenues from external customers</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,886</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,781</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,667</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Premium and service revenues from internal customers</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">60</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,019</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,079</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total premium and service revenues</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">13,946</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,800</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,079</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">15,667</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings from operations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">353</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">111</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">464</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,706</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,118</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,824</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Segment information as of and for the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2013</font><font style="font-family:inherit;font-size:10pt;">, follows ($ in millions):</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:97.270955165692%;border-collapse:collapse;text-align:left;"><tr><td colspan="16" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Managed Care</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Specialty</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Services</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Eliminations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Consolidated</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Premium and service revenues from external customers</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,741</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">785</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,526</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Premium and service revenues from internal customers</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,147</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,188</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total premium and service revenues</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9,782</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,932</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2,188</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10,526</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings from operations</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">198</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">79</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">277</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,921</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">598</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,519</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of the Company's non-vested restricted stock and restricted stock unit shares as of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, and changes during the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;">, is presented below:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:80.2734375%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td width="53%" rowspan="1" colspan="1"></td><td width="17%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="26%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted Average Grant Date Fair Value </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested balance as of December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,350,014</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36.86</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,795,359</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">58.38</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Vested</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,906,900</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.81</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(116,470</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34.10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-vested balance as of December 31, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,122,003</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.65</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Option activity for the year ended </font><font style="font-family:inherit;font-size:10pt;">December 31, 2015</font><font style="font-family:inherit;font-size:10pt;"> is summarized below: </font></div><div style="line-height:120%;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td width="37%" rowspan="1" colspan="1"></td><td width="14%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="13%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="15%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Shares</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted Average Exercise Price</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Aggregate Intrinsic Value </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">($ in millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted Average Remaining Contractual Term</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding as of December 31, 2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,267,066</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.18</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Granted</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercised</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(588,658</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.52</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Forfeited</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12.39</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Outstanding as of December 31, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">677,408</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.88</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">37</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exercisable as of December 31, 2015</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">670,740</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11.78</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of each option grant is estimated on the date of the grant using the Black-Scholes option-pricing model with the following weighted-average assumptions: </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:74.8046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="6" rowspan="1"></td></tr><tr><td width="45%" rowspan="1" colspan="1"></td><td width="17%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="17%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="19%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year Ended December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2015 </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2014 </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2013</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected life (in years)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5.1</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Risk-free interest rate</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">0.8%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected volatility</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">48.1%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected dividend yield</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td colspan="6" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1) No options were awarded in the years ended December 31, 2015 and 2014.</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of available-for-sale investments with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="32" rowspan="1"></td></tr><tr><td width="17%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="8%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="7%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">December 31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Less Than 12 Months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">12 Months or More</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Less Than 12 Months</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">12 Months or More</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Unrealized Losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Fair</font></div><div style="text-align:center;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;font-weight:bold;">Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Treasury securities and obligations of U.S. government corporations and agencies</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:top;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">294</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">72</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:top;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate securities</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">561</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">311</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Municipal securities</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:top;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">208</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset backed securities</font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(1</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">121</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">70</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Residential Mortgage backed securities</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Commercial mortgage backed securities</font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,248</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">68</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">491</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(2</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:top;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">198</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Estimated total amortization expense related to intangible assets for each of the five succeeding fiscal years is as follows ($ in millions):</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:32.2265625%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td width="47%" rowspan="1" colspan="1"></td><td width="5%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="46%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Year</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Expense</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22</font></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2019</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">18</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

No options were awarded in the years ended December 31, 2015 and 2014.

EX-101.SCH 15 cnc-20151231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2103100 - Disclosure - Acquisitions and Noncontrolling Interest link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - Acquisitions and Noncontrolling Interest Acquisitions (Details) link:presentationLink link:calculationLink link:definitionLink 2403403 - Disclosure - Acquisitions and Noncontrolling Interest Non Controlling Interest (Details) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - Acquisitions and Noncontrolling Interest (Tables) link:presentationLink link:calculationLink link:definitionLink 2121100 - Disclosure - Commitments link:presentationLink link:calculationLink link:definitionLink 2421402 - Disclosure - Commitments (Details) link:presentationLink link:calculationLink link:definitionLink 2321301 - Disclosure - Commitments (Tables) link:presentationLink link:calculationLink link:definitionLink 2128100 - Disclosure - Condensed Financial Information Of Registrant link:presentationLink link:calculationLink link:definitionLink 2428406 - Disclosure - Condensed Financial Information Of Registrant Basis of Presentation and Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 2428402 - Disclosure - Condensed Financial Information Of Registrant (Condensed Balance Sheets) (Details) link:presentationLink link:calculationLink link:definitionLink 2428403 - Disclosure - Condensed Financial Information Of Registrant Condensed Balance Sheets (Parenthetical) (Details) link:presentationLink link:calculationLink link:definitionLink 2428405 - Disclosure - Condensed Financial Information Of Registrant (Condensed Statements Of Cash Flows) (Details) link:presentationLink link:calculationLink link:definitionLink 2428404 - Disclosure - Condensed Financial Information Of Registrant (Condensed Statements Of Operations) (Details) link:presentationLink link:calculationLink link:definitionLink 2428407 - Disclosure - Condensed Financial Information Of Registrant Dividends (Details) link:presentationLink link:calculationLink link:definitionLink 2428408 - Disclosure - Condensed Financial Information Of Registrant Other Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2328301 - Disclosure - Condensed Financial Information Of Registrant (Tables) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1001501 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Consolidated Statement Of Comprehensive Earnings link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Consolidated Statement Of Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - Consolidated Statements Of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Consolidated Statements Of Operations link:presentationLink link:calculationLink link:definitionLink 1002501 - Statement - Consolidated Statements of Operations (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1004501 - Statement - Consolidated Statements Of Stockholders' Equity (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 2122100 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 2422401 - Disclosure - Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 2115100 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 2415403 - Disclosure - Debt (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2415404 - Disclosure - Debt (Schedule Of Aggregate Maturities Of Debt) (Details) link:presentationLink link:calculationLink link:definitionLink 2415402 - Disclosure - Debt (Schedule Of Debt) (Details) link:presentationLink link:calculationLink link:definitionLink 2315301 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink 2123100 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 2423402 - Disclosure - Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2323301 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Fair Value Measurements (Fair Value Measurements By Level For Assets Measured At Fair Value On A Recurring Basis) (Details) link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - Fair Value Measurements (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Goodwill And Intangible Assets link:presentationLink link:calculationLink link:definitionLink 2410403 - Disclosure - Goodwill And Intangible Assets (Schedule Of Changes In Goodwill By Operating Segment) (Details) link:presentationLink link:calculationLink link:definitionLink 2410405 - Disclosure - Goodwill And Intangible Assets (Schedule Of Future Amortization Expenses) (Details) link:presentationLink link:calculationLink link:definitionLink 2410404 - Disclosure - Goodwill And Intangible Assets (Schedule Of Intangible Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Goodwill And Intangible Assets (Tables) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Health Insurance Marketplace link:presentationLink link:calculationLink link:definitionLink 2412402 - Disclosure - Health Insurance Marketplace (Details) link:presentationLink link:calculationLink link:definitionLink 2312301 - Disclosure - Health Insurance Marketplace (Tables) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - Health Net Merger link:presentationLink link:calculationLink link:definitionLink 2402402 - Disclosure - Health Net Merger (Details) link:presentationLink link:calculationLink link:definitionLink 2302301 - Disclosure - Health Net Merger (Tables) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2418402 - Disclosure - Income Taxes (Consolidated Income Tax Expense) (Details) link:presentationLink link:calculationLink link:definitionLink 2318301 - Disclosure - Income Taxes Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 2418405 - Disclosure - Income Taxes (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2418403 - Disclosure - Income Taxes (Reconciliation Of The Tax Provision At The U.S. Federal Statutory Rate To The Provision For Income Taxes) (Details) link:presentationLink link:calculationLink link:definitionLink 2418404 - Disclosure - Income Taxes (Tax Effects Of Temporary Differences Which Give Rise To Deferred Tax Assets And Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - Medical Claims Liability link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - Medical Claims Liability (Schedule Of Change In Medical Claims Liability) (Details) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - Medical Claims Liability (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Organization And Operations link:presentationLink link:calculationLink link:definitionLink 2401401 - Disclosure - Organization And Operations (Details) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - Property, Software And Equipment link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - Property, Software And Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - Property, Software And Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 2125100 - Disclosure - Quarterly Selected Financial Information link:presentationLink link:calculationLink link:definitionLink 2425402 - Disclosure - Quarterly Selected Financial Information (Details) link:presentationLink link:calculationLink link:definitionLink 2325301 - Disclosure - Quarterly Selected Financial Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2120100 - Disclosure - Retirement Plan link:presentationLink link:calculationLink link:definitionLink 2420401 - Disclosure - Retirement Plan (Details) link:presentationLink link:calculationLink link:definitionLink 2124100 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 2424402 - Disclosure - Segment Information (Details) link:presentationLink link:calculationLink link:definitionLink 2324301 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Short-Term And Long-Term Investments And Restricted Deposits link:presentationLink link:calculationLink link:definitionLink 2405405 - Disclosure - Short-Term And Long-Term Investments And Restricted Deposits (Contractual Maturities Of Short-Term And Long-Term Investments And Restricted Deposits) (Details) link:presentationLink link:calculationLink link:definitionLink 2405404 - Disclosure - Short-Term And Long-Term Investments And Restricted Deposits (Fair Value Of Available-For-Sale Investments With Gross Unrealized Losses By Investment Type And Length Of Time) (Details) link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Short-Term And Long-Term Investments And Restricted Deposits (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2405403 - Disclosure - Short-Term And Long-Term Investments And Restricted Deposits (Short-Term And Long-Term Investments, Restricted Deposits) (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Short-Term And Long-Term Investments And Restricted Deposits (Tables) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Statutory Capital Requirements And Dividend Restrictions link:presentationLink link:calculationLink link:definitionLink 2417401 - Disclosure - Statutory Capital Requirements And Dividend Restrictions (Details) link:presentationLink link:calculationLink link:definitionLink 2119100 - Disclosure - Stock Incentive Plans link:presentationLink link:calculationLink link:definitionLink 2419402 - Disclosure - Stock Incentive Plans (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2419406 - Disclosure - Stock Incentive Plans (Non-Vested Restricted Stock And Restricted Stock) (Details) link:presentationLink link:calculationLink link:definitionLink 2419404 - Disclosure - Stock Incentive Plans (Option Pricing Assumptions) (Details) link:presentationLink link:calculationLink link:definitionLink 2419405 - Disclosure - Stock Incentive Plans (Schedule Of Other Information Pertaining To Option Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 2419403 - Disclosure - Stock Incentive Plans (Summary Of Stock Option Activity) (Details) link:presentationLink link:calculationLink link:definitionLink 2319301 - Disclosure - Stock Incentive Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 2416401 - Disclosure - Stockholders' Equity (Details) link:presentationLink link:calculationLink link:definitionLink 2129100 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 2429401 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Summary Of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2401409 - Disclosure - Summary Of Significant Accounting Policies (Health Insurance Marketplace) (Details) link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Summary Of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2401408 - Disclosure - Summary Of Significant Accounting Policies (Recent Accounting Pronouncements) (Details) link:presentationLink link:calculationLink link:definitionLink 2401405 - Disclosure - Summary Of Significant Accounting Policies (Schedule Of Allowance For Uncollectible Accounts) (Details) link:presentationLink link:calculationLink link:definitionLink 2401404 - Disclosure - Summary Of Significant Accounting Policies (Schedule Of Amortization Period For Intangible Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 2401407 - Disclosure - Summary Of Significant Accounting Policies (Schedule Of Percentage Of Company's Total Revenues) (Details) link:presentationLink link:calculationLink link:definitionLink 2401403 - Disclosure - Summary Of Significant Accounting Policies (Schedule Of Property, Software And Equipment Depreciation Periods) (Details) link:presentationLink link:calculationLink link:definitionLink 2401406 - Disclosure - Summary Of Significant Accounting Policies (Summary of Significant Accounting Policies) (Details) link:presentationLink link:calculationLink link:definitionLink 2301302 - Disclosure - Summary Of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 16 cnc-20151231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 17 cnc-20151231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 18 cnc-20151231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Fair Value Disclosures [Abstract] Fair Value Measurements By Level For Assets Measured At Fair Value On A Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Expected life (in years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Expected volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate Expected dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Condensed Financial Information of Registrant [Abstract] Condensed Financial Information of Registrant [Abstract] Basis Of Presentation And Significant Accounting Policies [Abstract] Basis Of Presentation And Significant Accounting Policies [Abstract] Statement [Table] Statement [Table] Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] Parent Company [Member] Parent Company [Member] Statement [Line Items] Statement [Line Items] Cash Flows Received By Parent From Unrestricted Subsidiaries Cash Flows Received By Parent From Unrestricted Subsidiaries Cash flows received by the parent from unrestricted subsidiaries. Debt Disclosure [Abstract] Schedule Of Debt Schedule of Debt [Table Text Block] Schedule Of Aggregate Maturities Of Debt Schedule of Maturities of Long-term Debt [Table Text Block] Quarterly Selected Financial Information [Abstract] Quarterly Selected Financial Information [Abstract] Total revenues Revenues Net earnings attributable to Centene Income (Loss) from Continuing Operations Attributable to Parent Discontinued operations, net of income tax expense (benefit) Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent Net earnings attributable to Centene Corporation Net Income (Loss) Attributable to Parent Continuing operations (in usd per share) Income (Loss) from Continuing Operations, Per Basic Share Discontinued operations, Basic (in usd per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share Basic earnings per common share (in usd per share) Earnings Per Share, Basic Continuing operations, Diluted (in usd per share) Income (Loss) from Continuing Operations, Per Diluted Share Discontinued operations, Diluted (in usd per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share Diluted earnings per common share (in usd per share) Earnings Per Share, Diluted Liability for Unpaid Claims and Claims Adjustment Expense, Activity in Liability [Abstract] Medical Claims Liability Medical Claims Liability [Text Block] Disclosure of medical costs and medical costs payables including estimates of obligations for medical care services that have been rendered on behalf of insured consumers but for which claims have not yet been received or processed. Income Statement [Abstract] Discontinued operations, income tax expense (benefit) Discontinued Operation, Tax Effect of Discontinued Operation Liability for Claims and Claims Adjustment Expense [Table] Liability for Claims and Claims Adjustment Expense [Table] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Medicaid Premium Revenue [Member] Medicaid Premium Revenue [Member] Medicaid Premium Revenue [Member] Liability for Claims and Claims Adjustment Expense [Line Items] Liability for Claims and Claims Adjustment Expense [Line Items] Incurred related to: Prior years Prior Year Claims and Claims Adjustment Expense Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward] Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward] Balance, January 1, Liability for Claims and Claims Adjustment Expense Acquisitions Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions Incurred related to: Current year Current Year Claims and Claims Adjustment Expense Incurred related to: Prior years Total incurred Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims Paid related to: Current year Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year Paid related to: Prior years Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years Total paid Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid Balance, December 31, Reinsurance recoverables Reinsurance Recoverables Award Type [Axis] Award Type [Axis] Award Type [Domain] Equity Award [Domain] Stock Options [Member] Employee Stock Option [Member] Restricted Stock Units Awards [Member] Restricted Stock Units (RSUs) [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum [Member] Minimum [Member] Maximum [Member] Maximum [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Length of time options exercisable, years Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Shares available for future awards Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Stock options vesting period, years Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Allocated share-based compensation expense Allocated Share-based Compensation Expense Income tax benefit recognized Employee Service Share-based Compensation, Tax Benefit from Compensation Expense Fair value of restricted stock and restricted stock units Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Unrecognized compensation cost related to non-vested share Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Weighted-average period Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Employee stock purchase plan issued Stock Issued During Period, Shares, Employee Stock Purchase Plans General and administrative expenses General and Administrative Expense Gain on contingent consideration Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Investment and other income Investment Income, Nonoperating Interest expense Interest Expense Earnings (loss) before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest Income tax benefit Income Tax Expense (Benefit) Net earnings (loss) before equity in subsidiaries net income (loss), including portion attributable to noncontrolling interest before equity in earnings from subsidiaries Net income (loss), including portion attributable to noncontrolling interest before equity in earnings from subsidiaries Income (Loss) from Equity Method Investments Income (Loss) from Equity Method Investments Net earnings Net Income (Loss), Including Portion Attributable to Noncontrolling Interest (Earnings) loss attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Net earnings attributable to Centene Basic earnings (loss) per common share (in dollars per share) Diluted earnings (loss) per common share (in dollars per share) Weighted average number of common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Weighted average number of common shares and potential dilutive common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted Business Combinations [Abstract] Acquisitions and noncontrolling interest Business Combination Disclosure [Text Block] Earnings Per Share [Abstract] Earnings from continuing operations, net of income tax expense Common stock equivalents (as determined by applying the treasury stock method, in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Weighted average number of common shares and potential dilutive common shares outstanding (in shares) Continuing operations, Basic (in usd per share) Anti-dilutive stock options, restricted stock and restricted stock units excluded from the calculation of diluted earnings per common share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Accounting Policies [Abstract] Schedule of Finite-Lived Intangible Assets by Major Class [Table] Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Purchased Contract Rights [Member] Contractual Rights [Member] Provider Contracts [Member] Provider Contracts [Member] Provider Contracts [Member] Customer Relationships [Member] Customer Relationships [Member] Trade Names [Member] Trade Names [Member] Developed Technology Rights [Member] Developed Technology Rights [Member] Finite-Lived Intangible Assets [Line Items] Intangible Assets, Amortization Period Finite-Lived Intangible Asset, Useful Life Organization And Operations [Abstract] Organization And Operations [Abstract] Organization and Operations Nature of Operations [Text Block] Fair Value Measurements Fair Value Disclosures [Text Block] Investments, Debt and Equity Securities [Abstract] Short-Term And Long-Term Investments And Restricted Deposits Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Condensed Financial Information of Registrant Condensed Financial Information of Parent Company Only Disclosure [Text Block] Statement of Comprehensive Income [Abstract] Net earnings Reclassification adjustment, net of tax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax Change in unrealized gain (loss) on investments, net of tax Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax Foreign currency translation adjustments, net of tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Other comprehensive earnings (loss) Other Comprehensive Income (Loss), Net of Tax Comprehensive earnings Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Comprehensive (earnings) loss attributable to the noncontrolling interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive earnings attributable to Centene Corporation Comprehensive Income (Loss), Net of Tax, Attributable to Parent Commitments [Abstract] Commitments [Abstract] Commitments Commitments Disclosure [Text Block] Statement of Stockholders' Equity [Abstract] Statement, Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Centene Stockholders' Equity - Common Stock [Member] Common Stock [Member] Centene Stockholders' Equity - Additional Paid-In Capital [Member] Additional Paid-in Capital [Member] Centene Stockholders' Equity - Accumulated Other Comprehensive Income [Member] AOCI Attributable to Parent [Member] Centene Stockholders' Equity - Retained Earnings [Member] Retained Earnings [Member] Centene Stockholders' Equity - Treasury Stock [Member] Treasury Stock [Member] Noncontrolling Interest [Member] Noncontrolling Interest [Member] Balance Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Balance (in shares) Common Stock, Shares, Outstanding Comprehensive Earnings: Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract] Net earnings Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest Other Comprehensive Income (Loss), Net of Tax Common stock issued for acquisitions Stock Issued During Period, Value, Acquisitions Common stock issued for acquisitions (in shares) Stock Issued During Period, Shares, Acquisitions Common stock issued for stock offering Stock Issued During Period, Value, New Issues Common stock issued for stock offering (in shares) Stock Issued During Period, Shares, New Issues Common stock issued for employee benefit plans Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Common stock issued for employee benefit plans (in shares) Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Common stock repurchases Treasury Stock, Value, Acquired, Cost Method Common stock repurchases (in shares) Treasury Stock, Shares, Acquired Stock compensation expense Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Excess tax benefit from stock compensation Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation Contribution from noncontrolling interest Noncontrolling Interest, Increase from Subsidiary Equity Issuance Reclassification to redeemable noncontrolling interest Reclassification to redeemable noncontrolling interest Reclassification to redeemable noncontrolling interest Balance Balance (in shares) Goodwill and Intangible Assets Disclosure [Abstract] Schedule Of Changes In Goodwill By Operating Segment Schedule of Goodwill [Table Text Block] Schedule Of Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Schedule Of Future Amortization Expenses Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Segment Reporting [Abstract] Number of reportable segments Number of Reportable Segments Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Operating Segments [Member] Operating Segments [Member] Intersegment Eliminations [Member] Intersegment Eliminations [Member] Segments [Axis] Segments [Axis] Segment [Domain] Segments [Domain] Managed Care [Member] Managed Care [Member] ManagedCareMember Specialty Services [Member] Specialty Services [Member] SpecialtyServicesMember Total premium and service revenues Premium and service revenues Premiums earned on the income statement for all insurance and reinsurance contracts after subtracting any amounts ceded to another insurer and adding premiums assumed from other insurers, plus aggregate revenue during the period from services rendered in the normal course of business, after deducting allowances and discounts. Premium and service revenues exclude Premium Tax Revenue. Earnings from operations Operating Income (Loss) Total assets Assets Condensed Balance Sheets [Abstract] Condensed Balance Sheets [Abstract] Short term investments, amortized cost Short-term investments, Amortized cost Short-term investments, at amortized cost. Long term investments, amortized cost Long-term investments, Amortized cost The total amount of investments that are intended to be held for an extended period of time, at amortized cost (longer than one operating cycle). Common stock, par value (in usd per share) Common Stock, Par or Stated Value Per Share Common stock, shares authorized Common Stock, Shares Authorized Common stock, shares issued Common Stock, Shares, Issued Common stock, shares outstanding Treasury stock, shares Treasury Stock, Shares Annual Non-Cancelable Minimum Lease Payments Operating Leases of Lessee Disclosure [Table Text Block] Schedule Of Property Software And Equipment Depreciation Periods [Table Text Block] Schedule Of Property Software And Equipment Depreciation Periods [Table Text Block] Schedule Of Property Software And Equipment Depreciation Periods [Table Text Block] Schedule Of Amortization Period For Intangible Assets [Table Text Block] Schedule Of Amortization Period For Intangible Assets [Table Text Block] Schedule Of Amortization Period For Intangible Assets [Table Text Block] Schedule Of Allowance For Uncollectible Accounts [Table Text Block] Schedule Of Allowance For Uncollectible Accounts [Table Text Block] Schedule Of Allowance For Uncollectible Accounts [Table Text Block] Revenues: Revenues [Abstract] Premium Premiums Earned, Net Service Sales Revenue, Services, Net Premium and service revenues Premium tax and health insurer fee Premium Tax Revenue Premium tax revenue, similar assessments and provider pass through payments. Total revenues Expenses: Operating Expenses [Abstract] Medical costs Policyholder Benefits and Claims Incurred, Net, Health Cost of services Cost of Services General and administrative expenses Premium tax expense Premium Tax Expense Premium tax expense, similar assessments and provider pass through payments. Health insurer fee expense Health Insurer Fee Expense Health Insurer Fee Expense Total operating expenses Costs and Expenses Earnings from operations Other income (expense): Nonoperating Income (Expense) [Abstract] EX-101.PRE 19 cnc-20151231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 20 stockgraph2015.jpg GRAPHIC begin 644 stockgraph2015.jpg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htm IDEA: XBRL DOCUMENT v3.3.1.900

Document And Entity Information - USD ($)
$ in Billions
12 Months Ended

Dec. 31, 2015

Feb. 17, 2016

Jun. 30, 2015

Document and Entity Information [Abstract]

Entity Registrant Name CENTENE CORP

Entity Central Index Key 0001071739

Current Fiscal Year End Date --12-31

Entity Filer Category Large Accelerated Filer

Document Type 10-K

Document Period End Date Dec. 31, 2015

Document Fiscal Year Focus 2015

Document Fiscal Period Focus FY

Amendment Flag false

Entity Public Float $ 9.6

Entity Well-known Seasoned Issuer Yes

Entity Voluntary Filers No

Entity Current Reporting Status Yes

Entity Common Stock, Shares Outstanding 121,654,923

X

- Definition
Document and Entity Information [Abstract]
+ References
No definition available.
+ Details

Name: cnc_DocumentAndEntityInformationAbstract

Namespace Prefix: cnc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
If the value is true, then the document is an amendment to previously-filed/accepted document.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12b
-Subsection 1
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.
+ References
No definition available.
+ Details

Name: dei_EntityPublicFloat

Namespace Prefix: dei_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12b
-Subsection 1
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
+ References
No definition available.
+ Details

Name: dei_EntityVoluntaryFilers

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.
+ References
No definition available.
+ Details

Name: dei_EntityWellKnownSeasonedIssuer

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

XML 22 R2.htm IDEA: XBRL DOCUMENT v3.3.1.900

Consolidated Balance Sheets - USD ($)
$ in Millions

Dec. 31, 2015

Dec. 31, 2014

Current assets:

Cash and cash equivalents $ 1,760 $ 1,610

Premium and related receivables 1,279 912

Short term investments 176 177

Other current assets 390 252

Total current assets 3,605 2,951

Long term investments 1,927 1,280

Restricted deposits 115 100

Property, software and equipment, net 518 445

Goodwill 842 754

Intangible assets, net 155 120

Other long term assets 177 174

Total assets 7,339 5,824

Current liabilities:

Medical claims liability 2,298 1,723

Accounts payable and accrued expenses 976 768

Return of premium payable 207 236

Unearned revenue 143 168

Current portion of long term debt 5 5

Total current liabilities 3,629 2,900

Long term debt 1,216 874

Other long term liabilities 170 159

Total liabilities $ 5,015 $ 3,933

Commitments and contingencies

Redeemable noncontrolling interest $ 156 $ 148

Stockholders’ equity:

Preferred stock, $0.001 par value; authorized 10,000,000 shares; no shares issued or outstanding at December 31, 2015 and December 31, 2014 0 0

Common stock, $.001 par value; authorized 400,000,000 shares; 126,855,477 issued and 120,342,981 outstanding at December 31, 2015, and 124,274,864 issued and 118,433,416 outstanding at December 31, 2014 0 0

Additional paid-in capital 956 840

Accumulated other comprehensive loss (10) (1)

Retained earnings 1,358 1,003

Treasury stock, at cost (6,512,496 and 5,841,448 shares, respectively) (147) (98)

Total Centene stockholders’ equity 2,157 1,744

Noncontrolling interest 11 (1)

Total stockholders’ equity 2,168 1,743

Total liabilities and stockholders’ equity $ 7,339 $ 5,824

X

- Definition
Return of premium payable
+ References
No definition available.
+ Details

Name: cnc_Returnofpremiumpayable

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e637-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e681-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14A
-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669686-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 31
-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3
+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.30(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 31
-Article 5
+ Details

Name: us-gaap_AdditionalPaidInCapitalCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.18)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 12
-Article 7
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.9)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765
+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash
-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash Equivalents
-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.(a),19)
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.17)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommitmentsAndContingencies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The carrying amount of consideration received or receivable as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 13.A.4(a).Q1)
-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 13
-Section A
+ Details

Name: us-gaap_DeferredRevenueCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266
+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph ((a)(1),(b))
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275
+ Details

Name: us-gaap_IntangibleAssetsNetExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19-26)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.32)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 25
-Article 7
+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.21)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 50
-Paragraph 3
-Subparagraph (a),(b),(c)
-URI http://asc.fasb.org/extlink&oid=6482485&loc=d3e14764-158437
+ Details

Name: us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt, after unamortized discount or premium, scheduled to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebtCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying amount of long-term debt, net of unamortized discount or premium, excluding amounts to be repaid within one year or the normal operating cycle, if longer (current maturities). Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebtNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.12)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 27
-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 20
-Article 7
+ Details

Name: us-gaap_MinorityInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate carrying amount, as of the balance sheet date, of current assets not separately disclosed in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.8)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.17)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherAssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.24)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Other long-term assets not otherwise listed in the existing taxonomy that are pledged or subject to withdrawal restrictions.
+ References
No definition available.
+ Details

Name: us-gaap_OtherRestrictedAssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29
-Article 5
+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying amount as of the balance sheet date, net of allowance for doubtful accounts, of all premiums and other types of receivables due from other persons or entities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.5)
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910
+ Details

Name: us-gaap_PremiumsAndOtherReceivablesNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 13
-Subparagraph a
-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 8
-Article 7
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 3A
-Subparagraph (12)(c)
-URI http://asc.fasb.org/extlink&oid=27011957&loc=SL6540498-122764

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 3A
-Subparagraph (16)(c)
-URI http://asc.fasb.org/extlink&oid=27011957&loc=SL6540498-122764

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 3A
-Subparagraph 15
-URI http://asc.fasb.org/extlink&oid=27011957&loc=SL6540498-122764

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 3A
-Subparagraph 14
-URI http://asc.fasb.org/extlink&oid=27011957&loc=SL6540498-122764
+ Details

Name: us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.31(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Investments which are intended to be sold in the short term (usually less than one year or the normal operating cycle, whichever is longer) including trading securities, available-for-sale securities, held-to-maturity securities, and other short-term investments not otherwise listed in the existing taxonomy.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.2)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 1
-Subparagraph g
-Article 7
+ Details

Name: us-gaap_ShortTermInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4I
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4590271-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4568740-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4568447-111683
+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656
+ Details

Name: us-gaap_TreasuryStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 23 R3.htm IDEA: XBRL DOCUMENT v3.3.1.900

Consolidated Balance Sheets (Parenthetical) - $ / shares

Dec. 31, 2015

Dec. 31, 2014

Stockholders' equity:

Preferred stock, par value (in usd per share) $ 0.001 $ 0.001

Preferred stock, shares authorized 10,000,000 10,000,000

Preferred stock, shares issued 0 0

Preferred stock, shares outstanding 0 0

Common stock, par value (in usd per share) $ 0.001 $ 0.001

Common stock, shares authorized 400,000,000

Common stock, shares issued 126,855,477 124,274,864

Common stock, shares outstanding 120,342,981 118,433,416

Treasury stock, at cost 6,512,496 5,841,448

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29
-Article 5
+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29
-Article 5
+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29
-Article 5
+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29
-Article 5
+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28,29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30
-Article 5
+ Details

Name: us-gaap_TreasuryStockShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 24 R4.htm IDEA: XBRL DOCUMENT v3.3.1.900

Consolidated Statements Of Operations - USD ($)
$ in Millions
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Revenues:

Premium $ 19,389 $ 14,198 $ 10,153

Service 1,876 1,469 373

Premium and service revenues 21,265 15,667 10,526

Premium tax and health insurer fee 1,495 893 337

Total revenues 22,760 16,560 10,863

Expenses:

Medical costs 17,242 12,678 8,995

Cost of services 1,621 1,280 327

General and administrative expenses 1,826 1,314 931

Premium tax expense 1,151 698 333

Health insurer fee expense 215 126 0

Total operating expenses 22,055 16,096 10,586

Earnings from operations 705 464 277

Other income (expense):

Investment and other income 35 28 19

Interest expense (43) (35) (27)

Earnings from continuing operations, before income tax expense 697 457 269

Income tax expense 339 196 107

Earnings from continuing operations, net of income tax expense 358 261 162

Discontinued operations, net of income tax expense (benefit) of $(1), $1, and $2, respectively (1) 3 4

Net earnings 357 264 166

(Earnings) loss attributable to noncontrolling interests (2) 7 (1)

Net earnings attributable to Centene Corporation 355 271 165

Amounts attributable to Centene Corporation common shareholders:

Earnings from continuing operations, net of income tax expense 356 268 161

Discontinued operations, net of income tax expense (benefit) (1) 3 4

Net earnings $ 355 $ 271 $ 165

Basic:

Continuing operations (in usd per share) $ 2.99 $ 2.30 $ 1.49

Discontinued operations (in usd per share) (0.01) 0.03 0.03

Basic earnings per common share (in usd per share) 2.98 2.33 1.52

Diluted:

Continuing operations (in usd per share) 2.89 2.23 1.43

Discontinued operations (in usd per share) (0.01) 0.02 0.04

Diluted earnings per common share (in usd per share) $ 2.88 $ 2.25 $ 1.47

Weighted average number of common shares outstanding:

Basic (in shares) 119,100,744 116,345,764 108,253,090

Diluted (in shares) 123,066,370 120,360,212 112,494,346

X

- Definition
Health Insurer Fee Expense
+ References
No definition available.
+ Details

Name: cnc_HealthInsurerFeeExpense

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Premiums earned on the income statement for all insurance and reinsurance contracts after subtracting any amounts ceded to another insurer and adding premiums assumed from other insurers, plus aggregate revenue during the period from services rendered in the normal course of business, after deducting allowances and discounts. Premium and service revenues exclude Premium Tax Revenue.
+ References
No definition available.
+ Details

Name: cnc_PremiumAndServiceRevenues

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Premium tax expense, similar assessments and provider pass through payments.
+ References
No definition available.
+ Details

Name: cnc_PremiumTaxExpense

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Premium tax revenue, similar assessments and provider pass through payments.
+ References
No definition available.
+ Details

Name: cnc_PremiumTaxRevenue

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total costs related to services rendered by an entity during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2(d))
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688
+ Details

Name: us-gaap_CostOfServices

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Total costs of sales and operating expenses for the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688
+ Details

Name: us-gaap_CostsAndExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.21)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.23)
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 18
-Article 7

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 20
-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 21
-Article 9
+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareBasicAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.21)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 18
-Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 20
-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 21
-Article 9
+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareDilutedAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.4)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688
+ Details

Name: us-gaap_GeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of income (loss) from continuing operations attributable to the parent. Also defined as revenue less expenses and taxes from ongoing operations before extraordinary items but after deduction of those portions of income or loss from continuing operations that are allocable to noncontrolling interests.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.13)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4613673-111683
+ Details

Name: us-gaap_IncomeLossFromContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(1)(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses and taxes from ongoing operations before extraordinary items, and noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.21)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.23)
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 20
-Article 5

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 18
-Article 7

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 21
-Article 9
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsPerBasicShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.21)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 20
-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 21
-Article 9

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 18
-Article 7
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5C
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721675-107760

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3B
-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721525-107759

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721523-107759

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51716988&loc=d3e957-107759

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=51716988&loc=d3e1012-107759

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1361-107760

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721673-107760

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683
+ Details

Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.23)
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.21)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1278-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 20
-Article 5

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 18
-Article 7

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 21
-Article 9
+ Details

Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1278-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 5
-Section E
-Paragraph Question 3
+ Details

Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Income Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6515339
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.9)
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882
+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.7)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688
+ Details

Name: us-gaap_InvestmentIncomeNonoperating

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.18)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.22)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 19
-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 20
-Article 9
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetIncomeLossAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of Net Income (Loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684
+ Details

Name: us-gaap_NetIncomeLossAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NonoperatingIncomeExpenseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OperatingExpensesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.5)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913
+ Details

Name: us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.1)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 605
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.13(c))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 235
-Section S99
-Paragraph 2
-Subparagraph (SX 210.12-17)
-URI http://asc.fasb.org/extlink&oid=34713774&loc=d3e574992-122915
+ Details

Name: us-gaap_PremiumsEarnedNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a),(c)
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688
+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_RevenuesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Aggregate revenue during the period from services rendered in the normal course of business, after deducting allowances and discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(d))
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688
+ Details

Name: us-gaap_SalesRevenueServicesNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1505-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Weighted-Average Number of Common Shares Outstanding
-URI http://asc.fasb.org/extlink&oid=6528421
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 25 R5.htm IDEA: XBRL DOCUMENT v3.3.1.900

Consolidated Statements of Operations (Parenthetical) - USD ($)
$ in Millions
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Income Statement [Abstract]

Discontinued operations, income tax expense (benefit) $ (1) $ 1 $ 2

X

- Definition
Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32672-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3B
-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721525-107759

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721523-107759

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1361-107760

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721673-107760

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=18498875&loc=d3e38679-109324

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5C
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721675-107760

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=51716988&loc=d3e1012-107759
+ Details

Name: us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeStatementAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 26 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900

Consolidated Statement Of Comprehensive Earnings - USD ($)
$ in Millions
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Statement of Comprehensive Income [Abstract]

Net earnings $ 357 $ 264 $ 166

Reclassification adjustment, net of tax 0 0 (1)

Change in unrealized gain (loss) on investments, net of tax (4) 3 (7)

Foreign currency translation adjustments, net of tax (5) (1) 0

Other comprehensive earnings (loss) (9) 2 (8)

Comprehensive earnings 348 266 158

Comprehensive (earnings) loss attributable to the noncontrolling interest (2) 7 (1)

Comprehensive earnings attributable to Centene Corporation $ 346 $ 273 $ 157

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831270

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831223

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e557-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=51831255
+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4613674-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569643-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686
+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686
+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 20
-Subparagraph (b,c)
-URI http://asc.fasb.org/extlink&oid=6915805&loc=d3e32211-110900

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669646-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments of other comprehensive income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 55
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=51821188&loc=d3e1436-108581
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27357-111563

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e637-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e689-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669646-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e637-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a),(c)
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 27 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900

Consolidated Statement Of Stockholders' Equity - USD ($)
$ in Millions

Total

Centene Stockholders' Equity - Common Stock [Member]

Centene Stockholders' Equity - Additional Paid-In Capital [Member]

Centene Stockholders' Equity - Accumulated Other Comprehensive Income [Member]

Centene Stockholders' Equity - Retained Earnings [Member]

Centene Stockholders' Equity - Treasury Stock [Member]

Noncontrolling Interest [Member]

Balance at Dec. 31, 2012 $ 954 $ 0 $ 451 $ 5 $ 567 $ (70) $ 1

Balance (in shares) at Dec. 31, 2012 110,678,320 6,019,824

Comprehensive Earnings:

Net earnings 166 165 1

Other Comprehensive Income (Loss), Net of Tax (8) (8)

Common stock issued for acquisitions 75 $ 0 75

Common stock issued for acquisitions (in shares) 3,433,380

Common stock issued for stock offering 15 $ 0 15

Common stock issued for stock offering (in shares) 685,280

Common stock issued for employee benefit plans 10 $ 0 10

Common stock issued for employee benefit plans (in shares) 2,549,450

Common stock repurchases (19) $ (19)

Common stock repurchases (in shares) 688,128

Stock compensation expense 37 37

Excess tax benefit from stock compensation 6 6

Contribution from noncontrolling interest 7 7

Reclassification to redeemable noncontrolling interest 0

Balance at Dec. 31, 2013 1,243 $ 0 594 (3) 732 $ (89) 9

Balance (in shares) at Dec. 31, 2013 117,346,430 6,707,952

Comprehensive Earnings:

Net earnings 270 271 (1)

Other Comprehensive Income (Loss), Net of Tax 2 2

Common stock issued for acquisitions 190 $ 0 170 $ 20

Common stock issued for acquisitions (in shares) 4,486,434 (1,492,738)

Common stock issued for employee benefit plans 9 $ 0 9

Common stock issued for employee benefit plans (in shares) 2,442,000

Common stock repurchases $ (29) $ (29)

Common stock repurchases (in shares) 626,234 626,234

Stock compensation expense $ 48 48

Excess tax benefit from stock compensation 19 19

Contribution from noncontrolling interest 0

Reclassification to redeemable noncontrolling interest (9) (9)

Balance at Dec. 31, 2014 $ 1,743 $ 0 840 (1) 1,003 $ (98) (1)

Balance (in shares) at Dec. 31, 2014 118,433,416 124,274,864 5,841,448

Comprehensive Earnings:

Net earnings $ 355 355 0

Other Comprehensive Income (Loss), Net of Tax (9) (9)

Common stock issued for acquisitions 12 $ 0 8 $ 4

Common stock issued for acquisitions (in shares) 0 (247,580)

Common stock issued for employee benefit plans 12 $ 0 12

Common stock issued for employee benefit plans (in shares) 2,580,613

Common stock repurchases $ (53) $ (53)

Common stock repurchases (in shares) 918,628 918,628

Stock compensation expense $ 71 71

Excess tax benefit from stock compensation 25 25

Contribution from noncontrolling interest 11 11

Reclassification to redeemable noncontrolling interest 1 1

Balance at Dec. 31, 2015 $ 2,168 $ 0 $ 956 $ (10) $ 1,358 $ (147) $ 11

Balance (in shares) at Dec. 31, 2015 120,342,981 126,855,477 6,512,496

X

- Definition
Reclassification to redeemable noncontrolling interest
+ References
No definition available.
+ Details

Name: cnc_Reclassificationtoredeemablenoncontrollinginterest

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
This element represents the amount of recognized equity-based compensation during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized). Alternate captions include the words "stock-based compensation".
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415241&loc=d3e4534-113899

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=32706628&loc=d3e11149-113907

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=32706628&loc=d3e11178-113907
+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase in additional paid in capital (APIC) resulting from a tax benefit associated with share-based compensation plan other than an employee stock ownership plan (ESOP). Includes, but is not limited to, excess tax benefit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 740
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6419406&loc=d3e23524-113945

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644
+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 3A
-Subparagraph (3)
-URI http://asc.fasb.org/extlink&oid=27011957&loc=SL6540498-122764

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a),(c)
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684
+ Details

Name: us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(2)
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 23
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569655-111683
+ Details

Name: us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments of other comprehensive income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 55
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=51821188&loc=d3e1436-108581
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of shares of stock issued during the period pursuant to acquisitions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28,29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30
-Article 5
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesAcquisitions

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of new stock issued during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30
-Article 5
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of any shares forfeited. Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30
-Article 5
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Value of stock issued pursuant to acquisitions during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueAcquisitions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30, 31
-Article 5
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of stock value of such awards forfeited. Stock issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30, 31
-Article 5
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4I
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4590271-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4568740-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4568447-111683
+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Number of shares that have been repurchased during the period and are being held in treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30
-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3
+ Details

Name: us-gaap_TreasuryStockSharesAcquired

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_TreasuryStockValueAcquiredCostMethod

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 28 R8.htm IDEA: XBRL DOCUMENT v3.3.1.900

Consolidated Statements Of Stockholders' Equity (Parenthetical) - USD ($)
$ in Millions
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Statement of Stockholders' Equity [Abstract]

Tax on unrealized investment gain $ 3 $ 1 $ (4)

X

- Definition
Amount of tax expense (benefit) before reclassification adjustments of unrealized holding gain (loss) on available-for-sale securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e640-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (e,f)
-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669646-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfStockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 29 R9.htm IDEA: XBRL DOCUMENT v3.3.1.900

Consolidated Statements Of Cash Flows - USD ($)
$ in Millions
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Cash flows from operating activities:

Net earnings $ 357 $ 264 $ 166

Adjustments to reconcile net earnings to net cash provided by operating activities

Depreciation and amortization 111 89 67

Stock compensation expense 71 48 37

Deferred income taxes (17) (42) (2)

Gain on contingent consideration (44) 0 0

Goodwill and intangible adjustment 38 0 0

Changes in assets and liabilities

Premium and related receivables (360) (463) (143)

Other current assets (96) (5) (80)

Other assets (9) (8) (1)

Medical claims liabilities 536 609 172

Unearned revenue (27) 129 3

Accounts payable and accrued expenses 39 506 152

Other long term liabilities 51 89 8

Other operating activities 8 7 3

Net cash provided by operating activities 658 1,223 382

Cash flows from investing activities:

Capital expenditures (150) (103) (68)

Purchases of investments (1,321) (1,015) (790)

Sales and maturities of investments 669 406 579

Proceeds from asset sale 7 0 0

Investments in acquisitions, net of cash acquired (18) (136) (63)

Net cash used in investing activities (813) (848) (342)

Cash flows from financing activities:

Proceeds from exercise of stock options 13 8 9

Proceeds from borrowings 1,925 1,875 180

Proceeds from stock offering 0 0 15

Payment of long term debt (1,583) (1,674) (41)

Excess tax benefits from stock compensation 25 19 6

Common stock repurchases (53) (29) (19)

Contribution from noncontrolling interest 11 6 8

Debt issue costs (4) (7) (4)

Payment of contingent consideration obligation (29) 0 0

Net cash provided by financing activities 305 198 154

Effect of exchange rate changes on cash and cash equivalents 0 (1) 0

Net increase in cash and cash equivalents 150 572 194

Cash and cash equivalents, beginning of period 1,610 1,038 844

Cash and cash equivalents, end of period 1,760 1,610 1,038

Supplemental disclosures of cash flow information:

Interest paid 55 40 30

Income taxes paid 328 237 85

Equity issued in connection with acquisitions $ 12 $ 190 $ 75

X

- Definition
Business Acquisition, Contingent Consideration, Cash Payment
+ References
No definition available.
+ Details

Name: cnc_BusinessAcquisitionContingentConsiderationCashPayment

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The sum of adjustments which are added to or deducted from net income or loss, including the portion attributable to noncontrolling interest, to reflect cash provided by or used in operating activities, in accordance with the indirect cash flow method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479
+ Details

Name: us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
For the entity and the disposal group, cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents.
+ References
No definition available.
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 230
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906
+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Deferred Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6510177

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 6
-Section I
-Subsection 7
+ Details

Name: us-gaap_DeferredIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585
+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 230
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906
+ Details

Name: us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow from realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=32706628&loc=d3e11374-113907
+ Details

Name: us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.
+ References
No definition available.
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetImpairment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586
+ Details

Name: us-gaap_IncomeTaxesPaidNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting revenue yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInDeferredRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) in health care insurance liability balances during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in other noncurrent operating assets not separately disclosed in the statement of cash flows.
+ References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOtherNoncurrentAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in other assets used in operating activities not separately disclosed in the statement of cash flows. May include changes in other current assets, other noncurrent assets, or a combination of other current and noncurrent assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInOtherOperatingAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in other liabilities used in operating activities not separately disclosed in the statement of cash flows. May include changes in other current liabilities, other noncurrent liabilities, or a combination of other current and noncurrent liabilities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInOtherOperatingLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The change in the premium receivable balance on the balance sheet.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInPremiumsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of cash paid for interest during the period net of cash paid for interest that is capitalized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586
+ Details

Name: us-gaap_InterestPaidNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The value of the noncash (or part noncash) consideration given (for example, liability, equity) in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4304-108586

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4332-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4313-108586
+ Details

Name: us-gaap_OtherSignificantNoncashTransactionValueOfConsiderationGiven1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow to reacquire common stock during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_PaymentsForRepurchaseOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsOfDebtIssuanceCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of a controlling interest in another entity or an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133
+ Details

Name: us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the purchase of all investments (debt, security, other) during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquireInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_ProceedsFromIssuanceOfLongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceOrSaleOfEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585
+ Details

Name: us-gaap_ProceedsFromPaymentsToMinorityShareholders

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3179-108585
+ Details

Name: us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow from the sale of other assets recognized in investing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585
+ Details

Name: us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (j)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_ProceedsFromStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a),(c)
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_RepaymentsOfLongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585
+ Details

Name: us-gaap_ShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 30 R10.htm IDEA: XBRL DOCUMENT v3.3.1.900

Organization And Operations
12 Months Ended

Dec. 31, 2015

Organization And Operations [Abstract]

Organization and Operations
Organization and Operations

Centene Corporation, or the Company, is a diversified, multi-national healthcare enterprise operating in two segments: Managed Care and Specialty Services. The Managed Care segment provides Medicaid and Medicaid-related health plan coverage to individuals through the government subsidized programs, including Medicaid, the State Children's Health Insurance Program (CHIP), Long Term Care (LTC), Foster Care, dual-eligible individuals (Duals) in Medicare Special Needs Plans and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program, or collectively ABD and the Health Insurance Marketplace. The Specialty Services segment consists of our specialty companies offering auxiliary healthcare services and products to state programs, healthcare organizations, employer groups and other commercial organizations, as well as to our own subsidiaries.

On February 2, 2015, the Board of Directors declared a two-for-one split of Centene's common stock in the form of a 100% stock dividend distributed February 19, 2015 to stockholders of record on February 12, 2015. All share and per share information presented in this Form 10-K has been adjusted for the two-for-one stock split.

X

- Definition
Organization And Operations [Abstract]
+ References
No definition available.
+ Details

Name: cnc_OrganizationAndOperationsAbstract

Namespace Prefix: cnc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6003-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 2A
-URI http://asc.fasb.org/extlink&oid=51801978&loc=SL51803626-108592
+ Details

Name: us-gaap_NatureOfOperations

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 31 R11.htm IDEA: XBRL DOCUMENT v3.3.1.900

Summary Of Significant Accounting Policies
12 Months Ended

Dec. 31, 2015

Accounting Policies [Abstract]

Summary of Significant Accounting Policies
Summary of Significant Accounting Policies

Principles of Consolidation

The accompanying consolidated financial statements include the accounts of Centene Corporation and all majority owned subsidiaries and subsidiaries over which the Company exercises the power and control to direct activities significantly impacting financial performance. All material intercompany balances and transactions have been eliminated. The assets, liabilities and results of operations of Kentucky Spirit Health Plan are classified as discontinued operations for all periods presented.

Certain amounts in the consolidated financial statements have been reclassified to conform to the 2015 presentation. These reclassifications have no effect on net earnings or stockholders' equity as previously reported.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles in the United States, or GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Future events and their effects cannot be predicted with certainty; accordingly, the accounting estimates require the exercise of judgment. The accounting estimates used in the preparation of the consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the operating environment changes. The Company evaluates and updates its assumptions and estimates on an ongoing basis and may employ outside experts to assist in our evaluation, as considered necessary. Actual results could differ from those estimates.

Cash and Cash Equivalents

Investments with original maturities of three months or less are considered to be cash equivalents. Cash equivalents consist of money market funds and bank certificates of deposit and savings accounts.

The Company maintains amounts on deposit with various financial institutions, which may exceed federally insured limits. However, management periodically evaluates the credit-worthiness of those institutions, and the Company has not experienced any losses on such deposits.

Investments

Short term investments include securities with maturities greater than three months to one year. Long term investments include securities with maturities greater than one year.

Short term and long term investments are generally classified as available for sale and are carried at fair value. Certain equity investments are recorded using the cost or equity method. Unrealized gains and losses on investments available for sale are excluded from earnings and reported in accumulated other comprehensive income, a separate component of stockholders' equity, net of income tax effects. Premiums and discounts are amortized or accreted over the life of the related security using the effective interest method. The Company monitors the difference between the cost and fair value of investments. Investments that experience a decline in value that is judged to be other than temporary are written down to fair value and a realized loss is recorded in investment and other income. To calculate realized gains and losses on the sale of investments, the Company uses the specific amortized cost of each investment sold. Realized gains and losses are recorded in investment and other income.

The Company uses the equity method to account for its investments in entities that it does not control but has the ability to exercise significant influence over operating and financial policies. These investments are recorded at the lower of their cost or fair value adjusted for the Company's proportionate share of earnings or losses.

Restricted Deposits

Restricted deposits consist of investments required by various state statutes to be deposited or pledged to state agencies. These investments are classified as long term, regardless of the contractual maturity date, due to the nature of the states' requirements. The Company is required to annually adjust the amount of the deposit pledged to certain states.

Fair Value Measurements

In the normal course of business, the Company invests in various financial assets and incurs various financial liabilities. Fair values are disclosed for all financial instruments, whether or not such values are recognized in the Consolidated Balance Sheets. Management obtains quoted market prices and other observable inputs for these disclosures. The carrying amounts reported in the Consolidated Balance Sheets for cash and cash equivalents, premium and related receivables, unearned revenue, accounts payable and accrued expenses, and certain other current liabilities are carried at cost, which approximates fair value because of their short term nature.

The following methods and assumptions were used to estimate the fair value of each financial instrument:
•
Available for sale investments and restricted deposits: The carrying amount is stated at fair value, based on quoted market prices, where available. For securities not actively traded, fair values were estimated using values obtained from independent pricing services or quoted market prices of comparable instruments.
•
Senior unsecured notes: Estimated based on third-party quoted market prices for the same or similar issues.
•
Variable rate debt: The carrying amount of our floating rate debt approximates fair value since the interest rates adjust based on market rate adjustments.
•
Interest rate swap: Estimated based on third-party market prices based on the forward 3-month LIBOR curve.
•
Contingent consideration: Estimate based on expected membership retained at contract commencement and per member purchase price in the acquisition agreement.

Property, Software and Equipment

Property, software and equipment are stated at cost less accumulated depreciation. Capitalized software includes certain costs incurred in the development of internal-use software, including external direct costs of materials and services and payroll costs of employees devoted to specific software development. Depreciation is calculated principally by the straight-line method over estimated useful lives. Leasehold improvements are depreciated using the straight-line method over the shorter of the expected useful life or the remaining term of the lease. Property, software and equipment are depreciated over the following periods:
Fixed Asset

Depreciation Period
Buildings and land improvements

3 - 40 years
Computer hardware and software

2 - 7 years
Furniture and equipment

3 - 10 years
Leasehold improvements

1 - 20 years

The carrying amounts of all long-lived assets are evaluated to determine if adjustment to the depreciation and amortization period or to the unamortized balance is warranted. Such evaluation is based principally on the expected utilization of the long-lived assets.

The Company retains fully depreciated assets in property and accumulated depreciation accounts until it removes them from service. In the case of sale, retirement, or disposal, the asset cost and related accumulated depreciation balance is removed from the respective account, and the resulting net amount, less any proceeds, is included as a component of earnings from operations in the consolidated statements of operations.

Goodwill and Intangible Assets

Intangible assets represent assets acquired in purchase transactions and consist primarily of customer relationships, purchased contract rights, provider contracts, trade names and goodwill. Intangible assets are amortized using the straight-line method over the following periods:
Intangible Asset

Amortization Period
Purchased contract rights

5 - 15 years
Provider contracts

4 - 15 years
Customer relationships

3 - 15 years
Trade names

7 - 20 years
Developed technology

5 years

The Company tests for impairment of intangible assets as well as long-lived assets whenever events or changes in circumstances indicate that the carrying value of an asset or asset group (hereinafter referred to as “asset group”) may not be recoverable by comparing the sum of the estimated undiscounted future cash flows expected to result from use of the asset group and its eventual disposition to the carrying value. Such factors include, but are not limited to, significant changes in membership, state funding, state contracts and provider networks and contracts. If the sum of the estimated undiscounted future cash flows is less than the carrying value, an impairment determination is required. The amount of impairment is calculated by subtracting the fair value of the asset group from the carrying value of the asset group. An impairment charge, if any, is recognized within earnings from operations.

The Company tests goodwill for impairment using a fair value approach. The Company is required to test for impairment at least annually, absent a triggering event including a significant decline in operating performance that would require an impairment assessment. Absent any impairment indicators, the Company performs its goodwill impairment testing during the fourth quarter of each year. The Company recognizes an impairment charge for any amount by which the carrying amount of goodwill exceeds its implied fair value.

The Company first assesses qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. The Company generally does not calculate the fair value of a reporting unit unless it determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. However, in certain circumstances, such as recent acquisitions, the Company may elect to perform a quantitative assessment without first assessing qualitative factors.

If the two-step quantitative test is deemed necessary, the Company determines an appropriate valuation technique to estimate a reporting unit's fair value as of the testing date. The Company utilizes either the income approach or the market approach, whichever is most appropriate for the respective reporting unit. The income approach is based on an internally developed discounted cash flow model that includes many assumptions related to future growth rates, discount factors, future tax rates, etc. The market approach is based on financial multiples of comparable companies derived from current market data. Changes in economic and operating conditions impacting assumptions used in our analyses could result in goodwill impairment in future periods.

Medical Claims Liability

Medical claims liability includes claims reported but not yet paid, or inventory, estimates for claims incurred but not reported, or IBNR, and estimates for the costs necessary to process unpaid claims at the end of each period.  The Company estimates its medical claims liability using actuarial methods that are commonly used by health insurance actuaries and meet Actuarial Standards of Practice.  These actuarial methods consider factors such as historical data for payment patterns, cost trends, product mix, seasonality, utilization of healthcare services and other relevant factors.

Actuarial Standards of Practice generally require that the medical claims liability estimates be adequate to cover obligations under moderately adverse conditions.  Moderately adverse conditions are situations in which the actual claims are expected to be higher than the otherwise estimated value of such claims at the time of estimate.  In many situations, the claims amounts ultimately settled will be different than the estimate that satisfies the Actuarial Standards of Practice. The Company includes in its IBNR an estimate for medical claims liability under moderately adverse conditions which represents the risk of adverse deviation of the estimates in its actuarial method of reserving.

The Company uses its judgment to determine the assumptions to be used in the calculation of the required estimates. The assumptions it considers when estimating IBNR include, without limitation, claims receipt and payment experience (and variations in that experience), changes in membership, provider billing practices, healthcare service utilization trends, cost trends, product mix, seasonality, prior authorization of medical services, benefit changes, known outbreaks of disease or increased incidence of illness such as influenza, provider contract changes, changes to fee schedules, and the incidence of high dollar or catastrophic claims.

The Company's development of the medical claims liability estimate is a continuous process which it monitors and refines on a monthly basis as additional claims receipts and payment information becomes available. As more complete claims information becomes available, the Company adjusts the amount of the estimates, and includes the changes in estimates in medical costs in the period in which the changes are identified. In every reporting period, the operating results include the effects of more completely developed medical claims liability estimates associated with previously reported periods. The Company consistently applies its reserving methodology from period to period. As additional information becomes known, it adjusts the actuarial model accordingly to establish medical claims liability estimates.

The Company periodically reviews actual and anticipated experience compared to the assumptions used to establish medical costs. The Company establishes premium deficiency reserves if actual and anticipated experience indicates that existing policy liabilities together with the present value of future gross premiums will not be sufficient to cover the present value of future benefits, settlement and maintenance costs.

Revenue Recognition

The Company's health plans generate revenues primarily from premiums received from the states in which it operates health plans. The Company receives a fixed premium per member per month pursuant to its state contracts. The Company generally receives premium payments during the month it provides services and recognizes premium revenue during the period in which it is obligated to provide services to its members. In some instances, the Company's base premiums are subject to an adjustment, or risk score, based on the acuity of its membership. Generally, the risk score is determined by the State analyzing submissions of processed claims data to determine the acuity of the Company's membership relative to the entire state's Medicaid membership. Some states enact premium taxes, similar assessments and provider pass-through payments, collectively premium taxes, and these taxes are recorded as a separate component of both revenues and operating expenses. Some contracts allow for additional premiums related to certain supplemental services provided such as maternity deliveries.

Revenues are recorded based on membership and eligibility data provided by the states, which is adjusted on a monthly basis by the states for retroactive additions or deletions to membership data. These eligibility adjustments are estimated monthly and subsequent adjustments are made in the period known. We continuously review and update those estimates as new information becomes available.  It is possible that new information could require us to make additional adjustments, which could be significant, to these estimates.

The Company's specialty companies generate revenues under contracts with state programs, individuals, healthcare organizations and other commercial organizations, as well as from the Company's own subsidiaries. Revenues are recognized when the related services are provided or as ratably earned over the covered period of service.

Health Insurance Marketplace

The Affordable Care Act (ACA) established risk spreading premium stabilization programs effective January 1, 2014 for the Health Insurance Marketplace product. These programs, commonly referred to as the “three Rs,” include a permanent risk adjustment program, a transitional reinsurance program, and a temporary risk corridor program. The Company’s accounting policies for the programs are as follows:

Risk Adjustment

The permanent risk adjustment program established by the ACA transfers funds from qualified individual and small group insurance plans with below average risk scores to those plans with above average risk scores within each state. The Company estimates the receivable or payable under the risk adjustment program based on its estimated risk score compared to the state average risk score. The Company may record a receivable or payable as an adjustment to Premium revenue to reflect the year to date impact of the risk adjustment based on its best estimate. The Company expects to refine its estimate as new information becomes available. As of December 31, 2015, the Company recorded a payable of $108 million associated with risk adjustment, and $44 million at December 31, 2014.

Reinsurance

The ACA established a transitional three-year reinsurance program whereby the Company’s claims costs incurred for qualified members will be reimbursed when they exceed a specific threshold. For the 2015 benefit year, qualified member claims that exceeded $45,000 entitled the Company to reimbursement from the programs at 50% coinsurance. The Company accounts for reinsurance recoveries as a reduction of Medical Costs based on each individual case that exceeds the reinsurance threshold established by the program. As of December 31, 2015, the Company recorded a receivable of $24 million associated with reinsurance, and $11 million at December 31, 2014.

Risk Corridor

The temporary, three-year risk corridor program established by the ACA applies to qualified individual and small group health plans operating both inside and outside of the Health Insurance Marketplace. The risk corridor program limits the Company’s gains and losses in the Health Insurance Marketplace by comparing certain medical and administrative costs to a target amount and sharing the risk for allowable costs with the federal government. Allowable medical costs are adjusted for risk adjustment settlements, transitional reinsurance recoveries, and cost sharing reductions received from the federal government. The Company records a risk corridor receivable or payable as an adjustment to Premium Revenue on a year to date basis based on where its estimated annual costs fall within the risk corridor range. As of December 31, 2015, the Company recorded a payable of $4 million associated with risk corridor, and $9 million at December 31, 2014.

Minimum Medical Loss Ratio

Additionally, the ACA established a minimum annual medical loss ratio for the Health Insurance Marketplace. Each of the three R programs described above are taken into consideration to determine if the Company’s estimated annual medical costs are less than the minimum loss ratio and require an adjustment to Premium revenue to meet the minimum medical loss ratio. As of December 31, 2015, the Company recorded a payable of $15 million associated with minimum medical loss ratio, and $6 million at December 31, 2014.

Premium and Related Receivables and Unearned Revenue

Premium and service revenues collected in advance are recorded as unearned revenue. For performance-based contracts the Company does not recognize revenue subject to refund until data is sufficient to measure performance. Premiums and service revenues due to the Company are recorded as premium and related receivables and are recorded net of an allowance based on historical trends and management's judgment on the collectibility of these accounts. As the Company generally receives payments during the month in which services are provided, the allowance is typically not significant in comparison to total revenues and does not have a material impact on the presentation of the financial condition or results of operations. Activity in the allowance for uncollectible accounts for the years ended December 31, is summarized below ($ in millions):

2015

2014

2013
Allowances, beginning of year
$
5

$
1

$
1

Amounts charged to expense
12

8

3

Write-offs of uncollectible receivables
(7
)

(4
)

(3
)
Allowances, end of year
$
10

$
5

$
1

Significant Customers

Centene receives the majority of its revenues under contracts or subcontracts with state Medicaid managed care programs. The current contracts expire on various dates between April 30, 2016 and June 30, 2019. States where the aggregate annual contract value exceeded 10% of total annual revenues included Texas, where the percentage of the Company's total revenue was 22%, 25% and 37% for the years ended December 31, 2015, 2014, and 2013, respectively, and Florida where the percentage of the Company's total revenue was 14% for the years ended December 31, 2015 and 2014.

Other Income (Expense)

Other income (expense) consists principally of investment income, interest expense and equity method earnings from investments. Investment income is derived from the Company's cash, cash equivalents, restricted deposits and investments. Interest expense relates to borrowings under the senior notes, interest rate swap, credit facilities, interest on capital leases and credit facility fees.

Income Taxes

Deferred tax assets and liabilities are recorded for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax law or tax rates is recognized in income in the period that includes the enactment date.

Valuation allowances are provided when it is considered more likely than not that deferred tax assets will not be realized. In determining if a deductible temporary difference or net operating loss can be realized, the Company considers future reversals of existing taxable temporary differences, future taxable income, taxable income in prior carryback periods and tax planning strategies.

Contingencies

The Company accrues for loss contingencies associated with outstanding litigation, claims and assessments for which it has determined it is probable that a loss contingency exists and the amount of loss can be reasonably estimated. The Company expenses professional fees associated with litigation claims and assessments as incurred.

Stock Based Compensation

The fair value of the Company's employee share options and similar instruments are estimated using the Black-Scholes option-pricing model. That cost is recognized over the period during which an employee is required to provide service in exchange for the award. Excess tax benefits related to stock compensation are presented as a cash inflow from financing activities.

Foreign Currency Translation

The Company is exposed to foreign currency exchange risk through its equity method investment in Ribera Salud S.A. (Ribera Salud), a Spanish health management group whose functional currency is the Euro. The assets and liabilities of the Company's investment are translated into United States dollars at the balance sheet date. The Company translates its proportionate share of earnings using average rates during the year. The resulting foreign currency translation adjustments are recorded as a separate component of accumulated other comprehensive income.

Recent Accounting Pronouncements

In November 2015, the Financial Accounting Standards Board (FASB) issued an Accounting Standards Update (ASU) which requires entities to present deferred tax assets and deferred tax liabilities as noncurrent in a classified balance sheet. The new standards simplifies the current guidance, which requires entities to separately present deferred tax assets and deferred tax liabilities as current and noncurrent in a classified balance sheet. It is effective for annual and interim periods beginning after December 15, 2016. Early adoption is permitted. The Company elected to adopt this guidance in the current fiscal year and applied the new standard retrospectively to all prior periods. The reclassification of deferred tax assets and deferred tax liabilities impacted the Consolidated Balance Sheets by decreasing Other Current Assets and increasing Other Long Term Assets by $102 million and $83 million at December 31, 2015 and December 31, 2014. These reclassifications have no effect on net earnings or stockholders' equity as previously reported.

In September 2015, the FASB issued an ASU which simplifies the accounting for measurement-period adjustments in business combinations. The new standard eliminates the requirement for an acquirer in a business combination to account for measurement-period adjustments retrospectively. Instead, acquirers must recognize measurement-period adjustments during the period in which they determine the amounts, including any amounts they would have recorded in previous periods if the accounting had been completed at the acquisition date. Additionally, the acquirer must disclose the portion of the amount that would have been recorded in previous reporting periods. It is effective for annual and interim periods beginning after December 15, 2016. Early adoption is permitted. The Company elected to adopt this guidance in the current fiscal year.

In May 2015, the FASB issued an ASU which expands the disclosure requirements for insurance companies that issue short-duration contracts. The new standard will increase the level of disclosure around the Company's Medical Claims Liability to include the following: claims development by year; claim frequency; a rollforward of the claims liability; and a description of methods and assumptions used for determining the liability. It is effective for annual periods beginning after December 15, 2015 and interim periods beginning after December 15, 2016. Early adoption is permitted. The Company is currently evaluating the effect of the new disclosure requirements.

In April 2015, the FASB issued an ASU which changes the presentation of debt issuance costs in financial statements. Under the new standard, debt issuance costs are presented in the balance sheet as a direct deduction of the related debt liability rather than as an asset. Amortization of the cost is reported as interest expense. The new standard is effective for annual and interim periods beginning after December 15, 2015 and early adoption is permitted. The Company elected to adopt this guidance beginning in the first quarter of 2015 and has applied the new standard retrospectively to all prior periods. The reclassification of debt issuance costs impacted the Consolidated Balance Sheets by decreasing both Other Long Term Assets and Long Term Debt by $14 million at December 31, 2015 and December 31, 2014. These reclassifications have no effect on net earnings or stockholders' equity as previously reported.

In May 2014, the FASB issued an ASU which supersedes existing revenue recognition standards with a single model unless those contracts are within the scope of other standards (e.g., an insurance entity's insurance contracts). Under the new standard, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. In addition, the standard requires disclosure of the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The new effective date is for annual and interim periods beginning after December 15, 2017. Early adoption is permitted. The Company is currently evaluating the effect of the new revenue recognition guidance.

The Company has determined that there are no other recently issued accounting pronouncements that will have a material impact on its consolidated financial position, results of operations and cash flows.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for all significant accounting policies of the reporting entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18861-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18726-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18743-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18854-107790
+ Details

Name: us-gaap_SignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 32 R12.htm IDEA: XBRL DOCUMENT v3.3.1.900

Health Net Merger
12 Months Ended

Dec. 31, 2015

Business Combination, Description [Abstract]

Health Net Merger
Health Net Merger

On July 2, 2015, the Company announced that the Company and two direct, newly formed subsidiaries of the Company had entered into a definitive merger agreement with Health Net, Inc. (Health Net) under which the Company will acquire all of the issued and outstanding shares of Health Net. Under the terms of the agreement, at the closing of the transaction, Health Net stockholders (with limited exceptions) would receive 0.622 of a validly issued, fully paid, non-assessable share of Centene common stock and $28.25 in cash for each share of Health Net common stock. The transaction is valued at approximately $5.5 billion (based on the Centene closing stock price on February 17, 2016), including the assumption of debt.

The transaction is expected to close in early 2016 and is subject to approvals by relevant state insurance and healthcare regulators and other customary closing conditions. In August 2015, the Company announced the early termination of the waiting period required under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended. In October 2015, the Company and Health Net announced the transaction was approved by both the Centene and Health Net stockholders. The Company expects to fund the cash portion of the acquisition through a combination of the debt financing completed in February 2016, borrowings on the Company's revolving credit facility and existing cash on hand.

X

- References
No definition available.
+ Details

Name: us-gaap_BusinessCombinationDescriptionAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.
+ References
No definition available.
+ Details

Name: us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 33 R13.htm IDEA: XBRL DOCUMENT v3.3.1.900

Acquisitions and Noncontrolling Interest
12 Months Ended

Dec. 31, 2015

Business Combinations [Abstract]

Acquisitions and noncontrolling interest
Acquisitions and Noncontrolling Interest

Acquisitions

Agate Resources, Inc. In September 2015, the Company completed the acquisition of Agate Resources, Inc. (Agate) for $109 million. Agate is a diversified holding company that offers primarily Medicaid and other healthcare products and services to Oregon residents. The fair value of consideration of $109 million consists of initial cash consideration of $93 million, the present value of future cash payments of $7 million to be paid out over a three year period, and the fair value of estimated contingent consideration of $9 million. A portion of the contingent consideration is based on the achievement of underwriting targets and will be paid in cash over a three year period; the remainder is based on the net proceeds of a retrospective rate adjustment to be settled in 2016.

The Company's preliminary allocation of fair value resulted in goodwill of $48 million and other identifiable intangible assets of $39 million. The Company has not finalized the allocation of the fair value of assets and liabilities. The goodwill is not deductible for income tax purposes. The acquisition is recorded in the Managed Care segment.

Community Health Solutions of America, Inc. In July 2014, the Company completed a transaction whereby Community Health Solutions of America, Inc. assigned its contract with the Louisiana Department of Health and Hospitals under the Bayou Health Shared Savings Program to the Company's subsidiary, Louisiana Healthcare Connections (LHC). The fair value of consideration transferred included the present value of the estimated contingent consideration, subject to membership retained by LHC in the first quarter of 2015. The fair value of contingent consideration was $18 million at December 31, 2014. During the first quarter of 2015, the Company determined the amount of the actual contingent consideration to be $8 million. A gain of $10 million related to the settlement of the obligation was recorded in General and Administrative expense.

Fidelis SecureCare of Michigan, Inc. In May 2015, the Company acquired 100% of Fidelis SecureCare of Michigan, Inc. (Fidelis) a subsidiary of Concerto Healthcare. Fidelis was previously selected by the Michigan Department of Community Health to provide integrated healthcare services to members who are dually eligible for Medicare and Medicaid in Macomb and Wayne counties. The fair value of consideration of $57 million consisted of initial cash consideration of $7 million and the fair value of estimated contingent consideration of $50 million. The contingent consideration is based on duals membership and revenue per member during the first year of the contract (July 2015 - June 2016), including reconciliation payments settled over a two year period. The contingent consideration fair value is estimated based on expected membership during the first year of the contract as well as estimated revenue per member reflecting both member mix and risk adjustment. The Company's allocation of fair value resulted in goodwill of $29 million and other identifiable intangible assets of $23 million. 100% of the goodwill is deductible for income tax purposes. The acquisition is recorded in the Managed Care segment.

During 2015, the Company experienced higher than anticipated opt-out rates and member attrition in the dual demonstration program, resulting in lower than expected membership and lower blended premium rates. As a result, the fair value of estimated contingent consideration was reduced from $50 million to $16 million, and the Company recorded a gain of $34 million in general and administrative expenses. In connection with the lower membership and revenue outlook, the Company conducted an impairment analysis of the identifiable intangible assets and goodwill, resulting in a reduction of goodwill and intangible assets of $38 million which was recorded in general and administrative expenses. At December 31, 2015, the Company had goodwill of $11 million and other identifiable intangible assets of $1 million, net of $2 million of amortization, remaining on the balance sheet.

LiveHealthier, Inc. In January 2015, the Company acquired the remaining 79% of LiveHealthier, Inc. (LiveHealthier) for $28 million , bringing its total ownership to 100%. LiveHealthier is a provider of technology and service-based health management solutions. The fair value of consideration of $28 million consists of cash paid of $11 million, Centene common stock issued at closing of $13 million, and the fair value of estimated contingent consideration of $4 million to be paid in cash over a three year period. The contingent consideration will not exceed $9 million.

The Company's allocation of fair value resulted in goodwill of $26 million and other identifiable intangible assets of $15 million. The goodwill is not deductible for income tax purposes. The acquisition is recorded in the Managed Care segment.

Ribera Salud, S.A. In July 2014, the Company purchased a noncontrolling interest in Ribera Salud S.A. (Ribera Salud), a Spanish health management group for $17 million. Centene is a 50% joint shareholder with Ribera Salud's remaining investor, Banco Sabadell S.A. The Company is accounting for its investment using the equity method of accounting. Any basis difference between the Company's share of underlying net assets and the purchase price will be attributable to certain intangible assets and will be accreted into earnings over their useful lives.

Upon closing, the Company executed letters of credit for $52 million (valued at the December 31, 2015 conversion rate), or €48 million, representing its proportional share of the letters of credit issued to support Ribera Salud’s outstanding debt. Refer to Note 11, Debt for outstanding balance as of December 31, 2015.

U.S. Medical Management. In January 2014, the Company acquired 68% of U.S. Medical Management, LLC (USMM), a management services organization and provider of in-home health services for high acuity populations, for $213 million in total consideration. The transaction consideration consisted of $133 million of Centene common stock and $80 million of cash.

The total fair value of 100% of USMM on the date of acquisition was $352 million ($213 million for the Company's interest and $139 million for the redeemable noncontrolling interest). The Company's allocation of fair value resulted in goodwill of $280 million and other identifiable intangible assets of $78 million. Approximately 45% of the goodwill is deductible for income tax purposes. The acquisition is recorded in the Specialty Services segment.

In connection with the acquisition, the Company entered into call and put agreements with the noncontrolling interest holder to purchase the noncontrolling interest at a later date. Under these agreements, the Company may purchase or be required to purchase up to the total remaining interests in USMM over a period beginning in 2015 and continuing through 2017. Under certain circumstances, the agreements may be extended through 2020. At the Company’s sole option, up to 50% of the consideration to be issued for the purchase of the additional interests under these agreements may be funded with shares of the Company's common stock.

Noncontrolling Interest

The Company has consolidated subsidiaries where it maintains less than 100% ownership. The Company’s ownership interest for each subsidiary as of December 31, are as follows:

2015

2014

2013
Celtic Insurance Company

75
%

100
%

100
%
Centurion

51
%

51
%

51
%
Home State Health Plan

95
%

95
%

95
%
U.S. Medical Management

68
%

68
%

—

Net income attributable to Centene Corporation and transfers from (to) noncontrolling interest entities are as follows ($ in millions):

Year Ended December 31,

2015

2014

2013
Net earnings attributable to Centene Corporation
$
356

$
268

$
161

Transfers from (to) the noncontrolling interest:

Increase in equity for distributions from and consolidation of noncontrolling interest
11

—

7

Reclassification to redeemable noncontrolling interest
1

(9
)

—

Net transfers from (to) noncontrolling interest
12

(9
)

7

Changes from net earnings attributable to Centene Corporation and net transfers from (to) the noncontrolling interest
$
368

$
259

$
168

Redeemable Noncontrolling Interest

As a result of put option agreements, noncontrolling interest is considered redeemable and is classified in the Redeemable Noncontrolling Interest section of the consolidated balance sheets. Noncontrolling interest is initially measured at fair value using the binomial lattice model as of the acquisition date. The Company has elected to accrete changes in the redemption value through additional paid-in capital over the period from the date of issuance to the earliest redemption date following the effective interest method.

A reconciliation of the changes in the Redeemable Noncontrolling Interest is as follows ($ in millions):
Balance, December 31, 2014
$
148

Fair value of noncontrolling interest sold
7

Reclassification to redeemable noncontrolling interest
(1
)
Net earnings attributable to noncontrolling interest
2

Balance, December 31, 2015
$
156

Ownership changes are described in more detail below.

Celtic Insurance Company In January 2015, the Company sold 25% of its ownership in Celtic Insurance Company for $7 million. No gain or loss was recognized on the sale of the ownership interest. Celtic Insurance Company is included in the Managed Care segment. In connection with the sale of the ownership interest, the Company entered into a put agreement with the noncontrolling interest holder, allowing the noncontrolling interest holder to put its interest back to the Company beginning in 2022. As a result of put option agreements, the noncontrolling interest is considered redeemable and is classified in the Redeemable Noncontrolling Interest section of the consolidated balance sheets.

Pro forma disclosures related to the acquisitions have been excluded as immaterial.

X

- Definition
The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1497-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1490-128463

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1486-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1500-128463

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1524-128463

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7000-128479

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4922-128472

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4934-128472

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4926-128472

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1383-128463

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6996-128479
+ Details

Name: us-gaap_BusinessCombinationDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_BusinessCombinationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 34 R14.htm IDEA: XBRL DOCUMENT v3.3.1.900

Short-Term And Long-Term Investments And Restricted Deposits
12 Months Ended

Dec. 31, 2015

Investments, Debt and Equity Securities [Abstract]

Short-Term And Long-Term Investments And Restricted Deposits
Short term and Long term Investments, Restricted Deposits

Short term and long term investments and restricted deposits by investment type consist of the following ($ in millions):

December 31, 2015

December 31, 2014

Amortized
Cost

Gross
Unrealized
Gains

Gross
Unrealized Losses

Fair
Value

Amortized
Cost

Gross
Unrealized
Gains

Gross
Unrealized Losses

Fair
Value
U.S. Treasury securities and obligations of U.S. government corporations and agencies
$
431

$
—

$
(2
)

$
429

$
393

$
1

$
(2
)

$
392

Corporate securities
859

2

(8
)

853

556

2

(2
)

556

Restricted certificates of deposit
5

—

—

5

6

—

—

6

Restricted cash equivalents
78

—

—

78

79

—

—

79

Municipal securities
496

2

(1
)

497

174

1

—

175

Asset backed securities
163

—

(1
)

162

180

—

—

180

Residential mortgage backed securities
66

1

—

67

84

1

—

85

Commercial mortgage backed securities
40

—

—

40

—

—

—

—

Cost and equity method investments
71

—

—

71

68

—

—

68

Life insurance contracts
16

—

—

16

16

—

—

16

Total
$
2,225

$
5

$
(12
)

$
2,218

$
1,556

$
5

$
(4
)

$
1,557

The Company’s investments are classified as available-for-sale with the exception of life insurance contracts and certain cost and equity method investments.  The Company’s investment policies are designed to provide liquidity, preserve capital and maximize total return on invested assets with the focus on high credit quality securities.  The Company limits the size of investment in any single issuer other than U.S. treasury securities and obligations of U.S. government corporations and agencies.  The Company's mortgage backed securities are issued by the Federal National Mortgage Association and carry guarantees by the U.S. government. As of December 31, 2015, 99% of the Company’s investments in rated securities carry an investment grade rating by S&P or Moody’s.  At December 31, 2015, the Company held certificates of deposit, life insurance contracts and cost and equity method investments which did not carry a credit rating.

The fair value of available-for-sale investments with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):

December 31, 2015

December 31, 2014

Less Than 12 Months

12 Months or More

Less Than 12 Months

12 Months or More

Unrealized Losses

Fair
Value

Unrealized Losses

Fair
Value

Unrealized Losses

Fair
Value

Unrealized Losses

Fair
Value
U.S. Treasury securities and obligations of U.S. government corporations and agencies
$
(2
)

$
294

$
—

$
14

$
—

$
72

$
(2
)

$
180

Corporate securities
(6
)

561

(2
)

41

(2
)

311

—

1

Municipal securities
(1
)

208

—

5

—

20

—

7

Asset backed securities
(1
)

121

—

8

—

70

—

10

Residential Mortgage backed securities
—

30

—

—

—

18

—

—

Commercial mortgage backed securities
—

34

—

—

—

—

—

—

Total
$
(10
)

$
1,248

$
(2
)

$
68

$
(2
)

$
491

$
(2
)

$
198

As of December 31, 2015, the gross unrealized losses were generated from 429 positions out of a total of 733 positions.  The change in fair value of fixed income securities is a result of movement in interest rates subsequent to the purchase of the security.

For each security in an unrealized loss position, the Company assesses whether it intends to sell the security or if it is more likely than not the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual or regulatory purposes.  If the security meets this criterion, the decline in fair value is other-than-temporary and is recorded in earnings.  The Company does not intend to sell these securities prior to maturity and it is not likely that the Company will be required to sell these securities prior to maturity; therefore, there is no indication of other than temporary impairment for these securities.

During the year ended December 31, 2015, the company recognized $8 million of income from equity method investments.

The contractual maturities of short term and long term investments and restricted deposits are as follows ($ in millions):

December 31, 2015

December 31, 2014

Investments

Restricted Deposits

Investments

Restricted Deposits

Amortized
Cost

Fair
Value

Amortized
Cost

Fair
Value

Amortized
Cost

Fair
Value

Amortized
Cost

Fair
Value
One year or less
$
176

$
176

$
93

$
93

$
176

$
177

$
92

$
92

One year through five years
1,662

1,654

22

22

1,121

1,121

8

8

Five years through ten years
267

268

—

—

121

120

—

—

Greater than ten years
5

5

—

—

38

39

—

—

Total
$
2,110

$
2,103

$
115

$
115

$
1,456

$
1,457

$
100

$
100

Actual maturities may differ from contractual maturities due to call or prepayment options.  Asset backed and mortgage backed securities are included in the one year through five years category, while cost and equity method investments and life insurance contracts are included in the five years through ten years category.  The Company has an option to redeem at amortized cost substantially all of the securities included in the greater than ten years category listed above.

The Company continuously monitors investments for other-than-temporary impairment.  Certain investments have experienced a decline in fair value due to changes in credit quality, market interest rates and/or general economic conditions.  The Company recognizes an impairment loss for cost and equity method investments when evidence demonstrates that it is other-than-temporarily impaired.  Evidence of a loss in value that is other than temporary may include the absence of an ability to recover the carrying amount of the investment or the inability of the investee to sustain a level of earnings that would justify the carrying amount of the investment.

X

- References
No definition available.
+ Details

Name: us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for investments in certain debt and equity securities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-Glossary Debt Security
-URI http://asc.fasb.org/extlink&oid=6509901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27290-111563

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6379141&loc=d3e15032-111544

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27232-111563

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-Glossary Equity Security
-URI http://asc.fasb.org/extlink&oid=6511694

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 320
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6957658&loc=d3e62557-112803

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27357-111563

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27405-111563
+ Details

Name: us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 35 R15.htm IDEA: XBRL DOCUMENT v3.3.1.900

Fair Value Measurements
12 Months Ended

Dec. 31, 2015

Fair Value Disclosures [Abstract]

Fair Value Measurements
Fair Value Measurements

Assets and liabilities recorded at fair value in the consolidated balance sheets are categorized based upon observable or unobservable inputs used to estimate the fair value.  Level inputs are as follows:

Level Input:

Input Definition:
Level I

Inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.

Level II

Inputs other than quoted prices included in Level I that are observable for the asset or liability through corroboration with market data at the measurement date.

Level III

Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.

The following table summarizes fair value measurements by level at December 31, 2015, for assets and liabilities measured at fair value on a recurring basis ($ in millions):

Level I

Level II

Level III

Total
Assets

Cash and cash equivalents
$
1,760

$
—

$
—

$
1,760

Investments available for sale:

U.S. Treasury securities and obligations of U.S. government corporations and agencies
$
325

$
72

$
—

$
397

Corporate securities
—

853

—

853

Municipal securities
—

497

—

497

Asset backed securities
—

162

—

162

Residential mortgage backed securities
—

67

—

67

Commercial mortgage backed securities
—

40

—

40

Total investments
$
325

$
1,691

$
—

$
2,016

Restricted deposits available for sale:

Cash and cash equivalents
$
78

$
—

$
—

$
78

Certificates of deposit
5

—

—

5

U.S. Treasury securities and obligations of U.S. government corporations and agencies
32

—

—

32

Total restricted deposits
$
115

$
—

$
—

$
115

Other long term assets:

Interest rate swap agreements
$
—

$
11

$
—

$
11

Total assets at fair value
$
2,200

$
1,702

$
—

$
3,902

Liabilities

Other long term liabilities:

Interest rate swap agreements
$
—

$
2

$
—

$
2

Total liabilities at fair value
$
—

$
2

$
—

$
2

The following table summarizes fair value measurements by level at December 31, 2014, for assets and liabilities measured at fair value on a recurring basis ($ in millions):

Level I

Level II

Level III

Total
Assets

Cash and cash equivalents
$
1,610

$
—

$
—

$
1,610

Investments available for sale:

U.S. Treasury securities and obligations of U.S. government corporations and agencies
$
360

$
17

$
—

$
377

Corporate securities
—

556

—

556

Municipal securities
—

175

—

175

Asset backed securities
—

180

—

180

Residential mortgage backed securities
—

85

—

85

Commercial mortgage backed securities
—

—

—

—

Total investments
$
360

$
1,013

$
—

$
1,373

Restricted deposits available for sale:

Cash and cash equivalents
$
79

$
—

$
—

$
79

Certificates of deposit
6

—

—

6

U.S. Treasury securities and obligations of U.S. government corporations and agencies
15

—

—

15

Total restricted deposits
$
100

$
—

$
—

$
100

Other long term assets:

Interest rate swap agreements
$
—

$
11

$
—

$
11

Total assets at fair value
$
2,070

$
1,024

$
—

$
3,094

The Company periodically transfers U.S. Treasury securities and obligations of U.S. government corporations and agencies between Level I and Level II fair value measurements dependent upon the level of trading activity for the specific securities at the measurement date.  The Company’s policy regarding the timing of transfers between Level I and Level II is to measure and record the transfers at the end of the reporting period.  At December 31, 2015, there were $53 million of transfers from Level I to Level II and no transfers from Level II to Level I.  The Company utilizes matrix pricing services to estimate fair value for securities which are not actively traded on the measurement date.  The Company designates these securities as Level II fair value measurements.  The aggregate carrying amount of the Company’s life insurance contracts and other non-majority owned investments, which approximates fair value, was $87 million and $84 million as of December 31, 2015 and December 31, 2014, respectively.

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13537-108611

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13504-108611

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611
+ Details

Name: us-gaap_FairValueDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 36 R16.htm IDEA: XBRL DOCUMENT v3.3.1.900

Property, Software And Equipment
12 Months Ended

Dec. 31, 2015

Property, Software and Equipment [Abstract]

Property, Software and Equipment
Property, Software and Equipment

Property, software and equipment consist of the following as of December 31 ($ in millions):

2015

2014
Computer software
$
237

$
198

Building
223

208

Land
104

87

Computer hardware
105

88

Furniture and office equipment
92

70

Leasehold improvements
108

82

869

733

Less accumulated depreciation
(351
)

(288
)
Property, software and equipment, net
$
518

$
445

As of December 31, 2015 and 2014, the Company had assets acquired under capital leases included above of $6 million and $7 million, net of accumulated amortization of $4 million and $3 million, respectively. Amortization on assets under capital leases charged to expense is included in depreciation expense. Depreciation expense for the years ended December 31, 2015, 2014 and 2013 was $78 million, $65 million and $52 million, respectively.

X

- Definition
Property, Software and Equipment [Abstract]
+ References
No definition available.
+ Details

Name: cnc_PropertySoftwareAndEquipmentAbstract

Namespace Prefix: cnc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13-14)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1361-107760

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=51719941&loc=d3e2921-110230

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details

Name: us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 37 R17.htm IDEA: XBRL DOCUMENT v3.3.1.900

Goodwill And Intangible Assets
12 Months Ended

Dec. 31, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets Disclosure
Goodwill and Intangible Assets

The following table summarizes the changes in goodwill by operating segment ($ in millions):

Managed Care

Specialty Services

Total
Balance as of December 31, 2013
$
151

$
197

$
348

Acquisition
125

281

406

Balance as of December 31, 2014
276

478

754

Acquisition
103

3

106

Impairment
(18
)

—

(18
)
Balance as of December 31, 2015
$
361

$
481

$
842

Goodwill acquisitions were related to the acquisitions and finalization of fair value allocations discussed in Note 4, Acquisitions and Noncontrolling Interest.

Intangible assets at December 31, consist of the following ($ in millions):

Weighted Average Life in Years

2015

2014

2015

2014
Purchased contract rights
$
71

$
28

8.8

7.5

Provider contracts
103

103

11.1

11.1

Customer relationships
26

15

8.1

7.1

Trade names
12

17

7.3

13.1

Developed technology
5

—

5.0

—

Intangible assets
217

163

9.8

10.3

Less accumulated amortization:

Purchased contract rights
(21
)

(14
)

Provider contracts
(24
)

(14
)

Customer relationships
(14
)

(12
)

Trade names
(2
)

(3
)

Developed technology
(1
)

—

Total accumulated amortization
(62
)

(43
)

Intangible assets, net
$
155

$
120

Amortization expense was $24 million, $16 million and $6 million for the years ended December 31, 2015, 2014 and 2013, respectively. Estimated total amortization expense related to intangible assets for each of the five succeeding fiscal years is as follows ($ in millions):
Year

Expense
2016

$
22

2017

19

2018

18

2019

18

2020

16

X

- References
No definition available.
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16373-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 38 R18.htm IDEA: XBRL DOCUMENT v3.3.1.900

Medical Claims Liability
12 Months Ended

Dec. 31, 2015

Liability for Unpaid Claims and Claims Adjustment Expense, Activity in Liability [Abstract]

Medical Claims Liability
Medical Claims Liability

The change in medical claims liability is summarized as follows ($ in millions):

Year Ended December 31,

2015

2014

2013
Balance, January 1,
$
1,723

$
1,112

$
815

Acquisitions
79

—

—

Incurred related to:

          Current year
17,471

12,820

9,073

          Prior years
(229
)

(142
)

(78
)
         Total incurred
17,242

12,678

8,995

Paid related to:

          Current year
15,279

11,122

7,975

          Prior years
1,467

945

723

         Total paid
16,746

12,067

8,698

Balance, December 31,
$
2,298

$
1,723

$
1,112

Changes in estimates of incurred claims for prior years are primarily attributable to reserving under moderately adverse conditions. Additionally, as a result of minimum HBR and other return of premium programs, approximately $47 million, $26 million, and $0 million of the “Incurred related to: Prior period” was recorded as a reduction to premium revenues in 2015, 2014 and 2013, respectively. Further, claims processing initiatives yielded increased claim payment recoveries and coordination of benefits related to prior year dates of service. Changes in medical utilization and cost trends and the effect of medical management initiatives may also contribute to changes in medical claim liability estimates.  While the Company has evidence that medical management initiatives are effective on a case by case basis, medical management initiatives primarily focus on events and behaviors prior to the incurrence of the medical event and generation of a claim. Accordingly, any change in behavior, leveling of care, or coordination of treatment occurs prior to claim generation and as a result, the costs prior to the medical management initiative are not known by the Company. Additionally, certain medical management initiatives are focused on member and provider education with the intent of influencing behavior to appropriately align the medical services provided with the member's acuity. In these cases, determining whether the medical management initiative changed the behavior cannot be determined. Because of the complexity of its business, the number of states in which it operates, and the volume of claims that it processes, the Company is unable to practically quantify the impact of these initiatives on its changes in estimates of IBNR.

The Company had reinsurance recoverables related to medical claims liability of $31 million and $22 million at December 31, 2015 and 2014, respectively, included in premium and related receivables.

The Company periodically reviews actual and anticipated experience compared to the assumptions used to establish medical costs. The Company establishes premium deficiency reserves if actual and anticipated experience indicates that existing policy liabilities together with the present value of future gross premiums will not be sufficient to cover the present value of future benefits, settlement and maintenance costs.

X

- Definition
Disclosure of medical costs and medical costs payables including estimates of obligations for medical care services that have been rendered on behalf of insured consumers but for which claims have not yet been received or processed.
+ References
No definition available.
+ Details

Name: cnc_MedicalClaimsLiabilityTextBlock

Namespace Prefix: cnc_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 39 R19.htm IDEA: XBRL DOCUMENT v3.3.1.900

Health Insurance Marketplace
12 Months Ended

Dec. 31, 2015

Health Insurance Marketplace [Abstract]

Health Insurance Marketplace
Health Insurance Marketplace

The Affordable Care Act (ACA) established risk spreading premium stabilization programs effective January 1, 2014 for the Health Insurance Marketplace product. These programs, commonly referred to as the “three Rs,” include a permanent risk adjustment program, a transitional reinsurance program, and a temporary risk corridor program. Additionally, the ACA established a minimum annual medical loss ratio for the Health Insurance Marketplace. Each of the three R programs are taken into consideration to determine if the Company’s estimated annual medical costs are less than the minimum loss ratio and require an adjustment to Premium revenue to meet the minimum medical loss ratio.

In June 2015, CMS released final results on reinsurance and risk-adjustment for the 2014 plan year. In September 2015, the results on risk corridor and the minimum medical loss ratio were finalized for the 2014 plan year. These final results had an insignificant impact to the Company for the 2014 plan year.

The Company's receivables (payables) for each of these programs are as follows at each year ended ($ in millions):

December 31, 2015

December 31, 2014
Risk adjustment
$
(108
)

$
(44
)
Reinsurance
24

11

Risk corridor
(4
)

(9
)
Minimum medical loss ratio
(15
)

(6
)

X

- Definition
Health Insurance Marketplace [Abstract]
+ References
No definition available.
+ Details

Name: cnc_HealthInsuranceMarketplaceAbstract

Namespace Prefix: cnc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Health Insurance Marketplace Disclosure [Text Block]
+ References
No definition available.
+ Details

Name: cnc_HealthInsuranceMarketplaceDisclosureTextBlock

Namespace Prefix: cnc_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 40 R20.htm IDEA: XBRL DOCUMENT v3.3.1.900

Debt
12 Months Ended

Dec. 31, 2015

Debt Disclosure [Abstract]

Debt
Debt

Debt consists of the following ($ in millions):

December 31, 2015

December 31, 2014
$425 million 5.75% Senior notes, due June 1, 2017
$
428

$
429

$500 million 4.75% Senior notes, due May 15, 2022
500

300

Fair value of interest rate swap agreements
9

11

Senior notes
937

740

Revolving credit agreement
225

75

Mortgage notes payable
67

70

Capital leases
6

8

Debt issuance costs
(14
)

(14
)
Total debt
1,221

879

Less current portion
(5
)

(5
)
Long term debt
$
1,216

$
874

Senior Notes

In January 2015, the Company issued an additional $200 million of 4.75% Senior Notes ($200 Million Add-on Notes) at par. The $200 Million Add-on Notes were offered as additional debt securities under the indenture governing the $300 million of 4.75% Senior Notes issued in April 2014. In connection with the January 2015 issuance, the Company entered into interest rate swap agreements for a notional amount of $200 million at a floating rate of interest based on the three month LIBOR plus 2.88%. Gains and losses due to changes in the fair value of the interest rate swap completely offset changes in the fair value of the hedged portion of the underlying debt and are recorded as an adjustment to the $200 Million Add-on Notes.

In April 2014, the Company issued $300 million of 4.75% Senior Notes due May 15, 2022 ($300 Million Notes) at par. In connection with the April 2014 issuance, the Company entered into interest rate swap agreements for a notional amount of $300 million. Gains and losses due to changes in the fair value of the interest rate swap agreements offset changes in the fair value of the hedged portion of the underlying debt and are recorded as an adjustment to the $300 Million Notes.

The indentures governing both the $425 million and the $500 million notes contain non-financial and financial covenants, including requirements of a minimum fixed charge coverage ratio.

Interest Rate Swaps

The Company uses interest rate swap agreements to convert a portion of its interest rate exposure from fixed rates to floating rates to more closely align interest expense with interest income received on its cash equivalent and variable rate investment balances. The Company has $750 million of notional amount of interest rate swap agreements consisting of $250 million which are scheduled to expire on June 1, 2017 and $500 million that are scheduled to expire May 15, 2022. Under the Swap Agreements, the Company receives a fixed rate of interest and pays a variable rate of the three month LIBOR plus an average 2.85% adjusted quarterly. At December 31, 2015, the weighted average rate was 3.22%.

The Swap Agreements are formally designated and qualify as fair value hedges and are recorded at fair value in the Consolidated Balance Sheet in other assets or other liabilities. Gains and losses due to changes in fair value of the interest rate swap agreements completely offset changes in the fair value of the hedged portion of the underlying debt. Therefore, no gain or loss has been recognized due to hedge ineffectiveness. Offsetting changes in fair value of both the interest rate swaps and the hedged portion of the underlying debt both were recognized in interest expense in the Consolidated Statement of Operations. The Company does not hold or issue any derivative instrument for trading or speculative purposes.

The fair values of the Swap Agreements as of December 31, 2015 were assets of $11 million and liabilities of $2 million, and are included in other long term assets and other long term liabilities, respectively in the Consolidated Balance Sheet. The fair value of the Swap Agreements as of December 31, 2014 were assets of $11 million and are included in other long term assets in the Consolidated Balance Sheet. The fair value of the Swap Agreements excludes accrued interest and takes into consideration current interest rates and current likelihood of the swap counterparties' compliance with its contractual obligations.

Revolving Credit Agreement

The Company has an unsecured $500 million revolving credit facility. Borrowings under the agreement bear interest based upon LIBOR rates, the Federal Funds Rate or the Prime Rate. The agreement has a maturity date of June 1, 2018, provided it will mature 90 days prior to the maturity date of the Company's 5.75% Senior Notes due 2017 if such notes are not refinanced (or extended), certain financial conditions are not met, or the Company does not carry $100 million of unrestricted cash. As of December 31, 2015, the Company had $225 million of borrowings outstanding under the agreement with a weighted average interest rate of 2.05%.

The agreement contains non-financial and financial covenants, including requirements of minimum fixed charge coverage ratios, maximum debt-to-EBITDA ratios and minimum tangible net worth. The Company is required to not exceed a maximum debt-to-EBITDA ratio of 3.0 to 1.0. As of December 31, 2015, there were no limitations on the availability under the revolving credit agreement as a result of the debt-to-EBITDA ratio.

Mortgage Notes Payable

The Company has a non-recourse mortgage note of $67 million at December 31, 2015 collateralized by its corporate headquarters building. The mortgage note is due January 1, 2021 and bears a 5.14% interest rate. The collateralized property had a net book value of $151 million at December 31, 2015.

Letters of Credit & Surety Bonds

The Company had outstanding letters of credit of $47 million as of December 31, 2015, which were not part of the revolving credit facility.  As discussed in Note 4, Acquisitions and Noncontrolling Interest, the Company also had letters of credit for $50 million (valued at December 31, 2015 conversion rate), or €46 million, representing its proportional share of the letters of credit issued to support Ribera Salud's outstanding debt which are a part of the revolving credit facility. Collectively, the letters of credit bore interest at 1.55% as of December 31, 2015. The Company had outstanding surety bonds of $305 million as of December 31, 2015.

Aggregate maturities for the Company's debt are as follows ($ in millions):
2016

$
5

2017

429

2018

228

2019

4

2020

4

Thereafter

553

Total

$
1,223

The fair value of outstanding debt was approximately $1,239 million and $901 million at December 31, 2015 and 2014, respectively.

X

- References
No definition available.
+ Details

Name: us-gaap_DebtDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20,22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 41 R21.htm IDEA: XBRL DOCUMENT v3.3.1.900

Stockholders' Equity
12 Months Ended

Dec. 31, 2015

Stockholders' Equity Note [Abstract]

Stockholders' Equity
Stockholders' Equity

The Company has 10,000,000 authorized shares of preferred stock at $.001 par value. At December 31, 2015, there were no preferred shares outstanding.

The Company's Board of Directors has authorized a stock repurchase program for up to 8,000,000 shares of the Company's common stock from time to time on the open market or through privately negotiated transactions. No duration has been placed on the repurchase program. The Company has 3,335,448 available shares remaining under the program for repurchases as of December 31, 2015. The Company reserves the right to discontinue the repurchase program at any time. During the year ended December 31, 2015, the Company did not repurchase any shares through this publicly announced program.

As a component of the employee stock compensation plan, employees can use shares of stock which have vested to satisfy minimum statutory tax withholding obligations. As part of this plan, the Company repurchased 918,628 shares at an aggregate cost of $53 million in 2015 and 626,234 shares at an aggregate cost of $29 million in 2014. These shares are included in the Company's treasury stock.

In January 2014, the Company completed the acquisition of 68% of USMM and as a result, issued 4,486,434 shares of Centene common stock to the selling stockholders. Additionally, in July 2014, the Company completed a transaction whereby CHS assigned its contract with the Louisiana Department of Health and Hospitals to Centene's wholly owned subsidiary, LHC. The closing resulted in the issuance of 1,492,738 shares of Centene common stock.

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityNoteAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(d),(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB TOPIC 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section C
+ Details

Name: us-gaap_StockholdersEquityNoteDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 42 R22.htm IDEA: XBRL DOCUMENT v3.3.1.900

Statutory Capital Requirements And Dividend Restrictions
12 Months Ended

Dec. 31, 2015

Statutory Capital Requirements And Dividend Restrictions [Abstract]

Statutory Capital Requirements and Dividend Restriction
Statutory Capital Requirements and Dividend Restrictions

Various state laws require Centene's regulated subsidiaries to maintain minimum capital levels specified by each state and restrict the amount of dividends that may be paid without prior regulatory approval. At December 31, 2015 and 2014, Centene's subsidiaries, including Kentucky Spirit Health Plan, had aggregate statutory capital and surplus of $2,284 million and $1,699 million, respectively, compared with the required minimum aggregate statutory capital and surplus of $1,195 million and $851 million, respectively.

X

- Definition
Statutory capital requirements and dividend restrictions [Abstract]
+ References
No definition available.
+ Details

Name: cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract

Namespace Prefix: cnc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of how the entity's reporting under GAAP as of the balance sheet date differs from the results based on prescribed and permitted accounting practices of the state or country of domicile in which a relevant statutory filing is made, or differences in results based on the National Association of Insurance Commissioners (NAIC) prescribed practices, or a combination thereof. Describes the accounting practices used and the related monetary effect on statutory surplus, net income, and risk-based capital. If an insurance enterprise's risk-based capital would have triggered a regulatory event had it not used a permitted practice, that fact is disclosed in the financial statements. Permitted statutory accounting practices include practices not prescribed but allowed by the domiciliary state insurance department regulatory authority.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 505
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6486098&loc=d3e24746-158529

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.23(c))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 505
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6486098&loc=d3e24790-158529

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 505
-Section 55
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6588579&loc=d3e24938-158530

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 505
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6486098&loc=d3e24708-158529

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 505
-Section 55
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6588579&loc=d3e24959-158530
+ Details

Name: us-gaap_StatutoryAccountingPracticesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 43 R23.htm IDEA: XBRL DOCUMENT v3.3.1.900

Income Taxes
12 Months Ended

Dec. 31, 2015

Income Tax Disclosure [Abstract]

Income Taxes
Income Taxes

The consolidated income tax expense consists of the following for the years ended December 31 ($ in millions):

2015

2014

2013
Current provision:

Federal
$
332

$
225

$
121

State and local
26

13

6

Total current provision
358

238

127

Deferred provision
(19
)

(42
)

(20
)
Total provision for income taxes
$
339

$
196

$
107

The reconciliation of the tax provision at the U.S. Federal Statutory Rate to the provision for income taxes for the years ended December 31 is as follows ($ in millions):

2015

2014

2013
Earnings from continuing operations, before income tax expense
$
697

$
457

$
269

(Earnings) loss attributable to flow through noncontrolling interest
1

4

(1
)
Earnings from continuing operations, less noncontrolling interest, before income tax expense
698

461

268

Tax provision at the U.S. federal statutory rate
244

162

94

State income taxes, net of federal income tax benefit
15

6

3

Nondeductible compensation
2

1

12

Benefit from reversal of prior years impact of 162(m)(6) regulations
—

(14
)

—

ACA Health Insurer Fee
75

44

—

Other, net
3

(3
)

(2
)
Income tax expense
$
339

$
196

$
107

The tax effects of temporary differences which give rise to deferred tax assets and liabilities are presented below for the years ended December 31 ($ in millions):

2015

2014
Deferred tax assets:

Medical claims liability
$
27

$
27

Accrued expenses
9

11

Net operating loss carryforward
20

21

Compensation accruals
73

53

Acquisition costs
10

—

Premium and related receivables
34

35

Other
18

9

Deferred tax assets
191

156

Valuation allowance
(11
)

(12
)
Net deferred tax assets
$
180

$
144

Deferred tax liabilities:

Intangible assets
$
46

$
25

Prepaid assets
8

6

Depreciation and amortization
31

26

Investments in partnerships
7

—

Other
1

4

Deferred tax liabilities
93

61

Net deferred tax assets
$
87

$
83

The Company's deferred tax assets include federal and state net operating losses, or NOLs. Accordingly, the total and annual deduction for those NOLs is limited by tax law. Federal and State NOLs of $6 million were all acquired in business combinations. The Company's federal NOLs expire between the years 2020 and 2033 and the state NOLs expire between the years 2016 and 2035. Valuation allowances are recorded for those NOLs the Company believes are more likely than not to expire unused. During 2015 and 2014, the Company recorded valuation allowance additions in the tax provision of $1 million and $5 million, respectively. The Company recorded valuation allowance reductions of $2 million and $1 million during the years ended December 31, 2015 and 2014.

As of December 31, 2015 and 2014, the Company maintained reserves for uncertain tax positions that may be challenged by a tax authority of $4 million. The unrecognized federal tax benefits are related to returns open from 2012 to 2015. The Company files in numerous state jurisdictions with varying statutes of limitation. The unrecognized state tax benefits are related to returns open from 2010 to 2015.

In September 2014, the Internal Revenue Service issued final regulations related to the compensation deduction limitation applicable to certain health insurance issuers. The new regulations provided additional information regarding the definition of a health insurance issuer. Based on the final regulations, the Company believes it is not subject to the compensation deduction limitation. As a result of this change in regulation, tax benefits of $14 million related to 2013 were recorded during the 2014 period.

As of December 31, 2015, the Company had $8 million of undistributed earnings from non-U.S. subsidiaries that are intended to be reinvested in non-U.S. operations. Because these earnings are considered permanently reinvested, no U.S. tax provision has been accrued related to the repatriation of these earnings. The amount of U.S. tax that would be payable on the eventual remittance of such earnings is not material to the Company’s financial statements.

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319
+ Details

Name: us-gaap_IncomeTaxDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 44 R24.htm IDEA: XBRL DOCUMENT v3.3.1.900

Stock Incentive Plans
12 Months Ended

Dec. 31, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock Incentive Plans
Stock Incentive Plans

The Company's stock incentive plans allow for the granting of restricted stock or restricted stock unit awards and options to purchase common stock. Both incentive stock options and nonqualified stock options can be awarded under the plans. No option will be exercisable for longer than ten years after the date of grant. The plans have 2,528,371 shares available for future awards. Compensation expense for stock options and restricted stock unit awards is recognized on a straight-line basis over the vesting period, generally three to five years for stock options and 1 to 10 years for restricted stock or restricted stock unit awards. Certain restricted stock unit awards contain performance-based as well as service-based provisions. Certain awards provide for accelerated vesting if there is a change in control as defined in the plans. The total compensation cost that has been charged against income for the stock incentive plans was $71 million, $48 million and $36 million for the years ended December 31, 2015, 2014 and 2013, respectively. The total income tax benefit recognized in the income statement for stock-based compensation arrangements was $24 million, $17 million and $8 million for the years ended December 31, 2015, 2014 and 2013, respectively.

Option activity for the year ended December 31, 2015 is summarized below:

Shares

Weighted Average Exercise Price

Aggregate Intrinsic Value
($ in millions)

Weighted Average Remaining Contractual Term
Outstanding as of December 31, 2014
1,267,066

$
12.18

Granted
—

—

Exercised
(588,658
)

12.52

Forfeited
(1,000
)

12.39

Outstanding as of December 31, 2015
677,408

$
11.88

$
37

2.0

Exercisable as of December 31, 2015
670,740

$
11.78

$
36

2.0

The fair value of each option grant is estimated on the date of the grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:

Year Ended December 31,

2015 ⁽¹⁾

2014 ⁽¹⁾

2013
Expected life (in years)
—

—

5.1
Risk-free interest rate
—

—

0.8%
Expected volatility
—

—

48.1%
Expected dividend yield
—

—

—

(1) No options were awarded in the years ended December 31, 2015 and 2014.

For the year ended December 31, 2013, the Company used a projected expected life for each award granted based on historical experience of employees' exercise behavior. The expected volatility is primarily based on historical volatility levels. The risk-free interest rates are based on the implied yield currently available on U.S. Treasury instruments with a remaining term equal to the expected life.

Other information pertaining to option activity is as follows:

Year Ended December 31,

2015 ⁽¹⁾

2014 ⁽¹⁾

2013
Weighted-average fair value of options granted
$
—

$
—

$
9.52

Total intrinsic value of stock options exercised ($ in millions)
$
28

$
17

$
13

(1) No options were awarded in the years ended December 31, 2015 and 2014.

A summary of the Company's non-vested restricted stock and restricted stock unit shares as of December 31, 2015, and changes during the year ended December 31, 2015, is presented below:

Shares

Weighted Average Grant Date Fair Value
Non-vested balance as of December 31, 2014
4,350,014

$
36.86

Granted
1,795,359

58.38

Vested
(1,906,900
)

31.81

Forfeited
(116,470
)

34.10

Non-vested balance as of December 31, 2015
4,122,003

$
48.65

The total fair value of restricted stock and restricted stock units vested during the years ended December 31, 2015, 2014 and 2013, was $112 million, $82 million and $49 million, respectively.

As of December 31, 2015, there was $191 million of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the plans; that cost is expected to be recognized over a weighted-average period of 1.3 years.

The Company maintains an employee stock purchase plan and has issued 86,819 shares, 76,088 shares, and 84,168 shares in 2015, 2014 and 2013, respectively.

X

- Definition
The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 40
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=51659978&loc=d3e25284-112666

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 14
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 45 R25.htm IDEA: XBRL DOCUMENT v3.3.1.900

Retirement Plan
12 Months Ended

Dec. 31, 2015

Retirement Plan [Abstract]

Retirement Plan
Retirement Plan

Centene has a defined contribution plan which covers substantially all employees who are at least twenty-one years of age. Under the plan, eligible employees may contribute a percentage of their base salary, subject to certain limitations. Centene may elect to match a portion of the employee's contribution. Company expense related to matching contributions to the plan was $19 million, $12 million and $9 million during the years ended December 31, 2015, 2014 and 2013, respectively.

X

- Definition
Retirement Plan [Abstract]
+ References
No definition available.
+ Details

Name: cnc_RetirementPlanAbstract

Namespace Prefix: cnc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.
+ References
No definition available.
+ Details

Name: us-gaap_CompensationAndEmployeeBenefitPlansTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 46 R26.htm IDEA: XBRL DOCUMENT v3.3.1.900

Commitments
12 Months Ended

Dec. 31, 2015

Commitments [Abstract]

Commitments
Commitments

Centene and its subsidiaries lease office facilities and various equipment under non-cancelable operating leases which may contain escalation provisions. The rental expense related to these leases is recorded on a straight-line basis over the lease term, including rent holidays. Tenant improvement allowances are recorded as a liability and amortized against rent expense over the term of the lease. Rent expense was $64 million, $46 million and $31 million for the years ended December 31, 2015, 2014 and 2013, respectively. Annual non-cancelable minimum lease payments over the next five years and thereafter are as follows ($ in millions):

2016
$
58

2017
59

2018
50

2019
45

2020
33

Thereafter
70

$
315

X

- Definition
Commitments [Abstract]
+ References
No definition available.
+ Details

Name: cnc_CommitmentsAbstract

Namespace Prefix: cnc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.17)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.(a)(19))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommitmentsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 47 R27.htm IDEA: XBRL DOCUMENT v3.3.1.900

Contingencies
12 Months Ended

Dec. 31, 2015

Commitments and Contingencies Disclosure [Abstract]

Contingencies
Contingencies
On July 5, 2013, the Company's subsidiary, Kentucky Spirit Health Plan, Inc. (Kentucky Spirit), terminated its contract with the Commonwealth of Kentucky (the Commonwealth). Kentucky Spirit believes it had a contractual right to terminate the contract and filed a lawsuit in Franklin Circuit Court seeking a declaration of this right. The Commonwealth has alleged that Kentucky Spirit's exit constitutes a material breach of contract. The Commonwealth seeks to recover substantial damages and to enforce its rights under Kentucky Spirit's $25 million performance bond. The Commonwealth's attorneys have asserted that the Commonwealth's expenditures due to Kentucky Spirit's departure range from $28 million to $40 million plus interest, and that the associated CMS expenditures range from $92 million to $134 million. Kentucky Spirit disputes the Commonwealth's alleged damages, and filed a lawsuit in April 2013, amended in October 2014, in Franklin Circuit Court seeking damages against the Commonwealth for losses sustained due to the Commonwealth's alleged breaches.

On February 6, 2015, the Kentucky Court of Appeals affirmed a Franklin Circuit Court ruling that Kentucky Spirit does not have a contractual right to terminate the contract early. The Court of Appeals also found that the contract’s liquidated damages provision “is applicable in the event of a premature termination of the Contract term.” On September 8, 2015, Kentucky Spirit filed a motion for discretionary review seeking Kentucky Supreme Court review of the finding that Kentucky Spirit's departure constituted a breach of contract. On October 9, 2015, the Commonwealth filed a response opposing discretionary review.

On May 26, 2015, the Commonwealth issued a demand for indemnification to its actuarial firm, for "all defense costs, and any resultant monetary awards in favor of Kentucky Spirit, arising from or related to Kentucky Spirit's claims which are predicated upon the alleged omissions and errors in the Data Book and the certified actuarially sound rates." On August 19, 2015, the actuarial firm moved to intervene in the litigation. The Franklin Circuit Court granted the actuarial firm's motion on September 8, 2015 and ordered a forty-five day stay of all pretrial proceedings in order for the firm to review the record. Also, on August 19, 2015, the actuarial firm filed a petition seeking a declaratory judgment that it is not liable to the Commonwealth for indemnification related to the claims asserted by Kentucky Spirit against the Commonwealth. On October 5, 2015, the Commonwealth filed an answer to the actuarial firm's petition and asserted counterclaims/cross-claims against the firm.

On March 9, 2015, the Secretary of the Kentucky Cabinet for Health and Family Services (CHFS) issued a determination letter finding that Kentucky Spirit owed the Commonwealth $40 million in actual damages plus prejudgment interest at 8 percent. On March 18, 2015, in a letter to the Kentucky Finance and Administration Cabinet (FAC), Kentucky Spirit contested CHFS' jurisdiction to make such a determination. The FAC did not issue a decision within the required 120 days. On August 13, 2015, Kentucky Spirit filed a declaratory judgment action against the Commonwealth in Franklin Circuit Court seeking a declaration that the Commonwealth may not purport to issue a decision against Kentucky Spirit awarding damages to itself when the matter is already before the Kentucky courts, and that the Commonwealth has waived its claims against Kentucky Spirit for damages arising out of the contract. The Commonwealth filed counterclaims seeking a Declaration of Rights and Entry of Judgment on its determination letter. On December 1, 2015 the Franklin Circuit Court consolidated this declaratory judgment action with Kentucky Spirit’s other litigation claims against the Commonwealth. On December 15, 2015, the Franklin Circuit Court denied Kentucky Spirit’s motion to dismiss the Commonwealth’s counterclaim for Declaration of Rights and Entry of Judgment. Discovery is proceeding in the consolidated litigation matters.

The resolution of the Kentucky litigation matters may result in a range of possible outcomes. If Kentucky Spirit prevails on its claims, it would be entitled to damages. If the Commonwealth prevails, a liability to the Commonwealth could be recorded. The Company is unable to estimate the ultimate outcome resulting from the Kentucky litigation. As a result, the Company has not recorded any receivable or any liability for potential damages under the contract as of December 31, 2015. While uncertain, the ultimate resolution of the pending litigation could have a material effect on the financial position, cash flow or results of operations of the Company in the period it is resolved or becomes known.

Excluding the Kentucky matters discussed above, the Company is also routinely subjected to legal proceedings in the normal course of business. While the ultimate resolution of such matters in the normal course of business is uncertain, the Company does not expect the results of any of these matters individually, or in the aggregate, to have a material effect on its financial position, results of operations or cash flows.

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.
+ References
No definition available.
+ Details

Name: us-gaap_LegalMattersAndContingenciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 48 R28.htm IDEA: XBRL DOCUMENT v3.3.1.900

Earnings Per Share
12 Months Ended

Dec. 31, 2015

Earnings Per Share [Abstract]

Earnings Per Share
Earnings Per Share

The following table sets forth the calculation of basic and diluted net earnings per common share for the years ended December 31 ($ in millions, except per share data):

2015

2014

2013
Earnings attributable to Centene Corporation:

Earnings from continuing operations, net of tax
$
356

$
268

$
161

Discontinued operations, net of tax
(1
)

3

4

Net earnings
$
355

$
271

$
165

Shares used in computing per share amounts:

Weighted average number of common shares outstanding
119,100,744

116,345,764

108,253,090

Common stock equivalents (as determined by applying the treasury stock method)
3,965,626

4,014,448

4,241,256

Weighted average number of common shares and potential dilutive common shares outstanding
123,066,370

120,360,212

112,494,346

Net earnings per common share attributable to Centene Corporation:

Basic:

Continuing operations
$
2.99

$
2.30

$
1.49

Discontinued operations
(0.01
)

0.03

0.03

Basic earnings per common share
$
2.98

$
2.33

$
1.52

Diluted:

Continuing operations
$
2.89

$
2.23

$
1.43

Discontinued operations
(0.01
)

0.02

0.04

Diluted earnings per common share
$
2.88

$
2.25

$
1.47

The calculation of diluted earnings per common share for 2015, 2014 and 2013 excludes the impact of 7,247 shares, 207,980 shares and 187,078 shares, respectively, related to anti-dilutive stock options, restricted stock and restricted stock units.

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for earnings per share.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1278-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.21)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688
+ Details

Name: us-gaap_EarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 49 R29.htm IDEA: XBRL DOCUMENT v3.3.1.900

Segment Information
12 Months Ended

Dec. 31, 2015

Segment Reporting [Abstract]

Segment Information
Segment Information

Centene operates in two segments: Managed Care and Specialty Services.  The Managed Care segment consists of Centene’s health plans including all of the functions needed to operate them.  The Specialty Services segment consists of Centene’s specialty companies offering auxiliary healthcare services and products.

Factors used in determining the reportable business segments include the nature of operating activities, existence of separate senior management teams, and the type of information presented to the Company's chief operating decision maker to evaluate all results of operations.

Segment information as of and for the year ended December 31, 2015, follows ($ in millions):

Managed Care

Specialty
Services

Eliminations

Consolidated
Total
Premium and service revenues from external customers
$
19,054

$
2,211

$
—

$
21,265

Premium and service revenues from internal customers
100

4,864

(4,964
)

—

Total premium and service revenues
19,154

7,075

(4,964
)

21,265

Earnings from operations
513

192

—

705

Total assets
6,202

1,137

—

7,339

Segment information as of and for the year ended December 31, 2014, follows ($ in millions):

Managed Care

Specialty
Services

Eliminations

Consolidated
Total
Premium and service revenues from external customers
$
13,886

$
1,781

$
—

$
15,667

Premium and service revenues from internal customers
60

3,019

(3,079
)

—

Total premium and service revenues
13,946

4,800

(3,079
)

15,667

Earnings from operations
353

111

—

464

Total assets
4,706

1,118

—

5,824

Segment information as of and for the year ended December 31, 2013, follows ($ in millions):

Managed Care

Specialty
Services

Eliminations

Consolidated
Total
Premium and service revenues from external customers
$
9,741

$
785

$
—

$
10,526

Premium and service revenues from internal customers
41

2,147

(2,188
)

—

Total premium and service revenues
9,782

2,932

(2,188
)

10,526

Earnings from operations
198

79

—

277

Total assets
2,921

598

—

3,519

X

- References
No definition available.
+ Details

Name: us-gaap_SegmentReportingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8906-108599
+ Details

Name: us-gaap_SegmentReportingDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 50 R30.htm IDEA: XBRL DOCUMENT v3.3.1.900

Quarterly Selected Financial Information
12 Months Ended

Dec. 31, 2015

Quarterly Selected Financial Information [Abstract]

Quarterly Selected Financial Information
Quarterly Selected Financial Information
(In millions, except share data)
(Unaudited)

For the Quarter Ended

March 31,
2015

June 30,
2015

September 30,
2015

December 31,
2015
Total revenues
$
5,131

$
5,506

$
5,821

$
6,302

Amounts attributable to Centene Corporation common shareholders:
Earnings from continuing operations, net of income tax expense
$
64

$
88

$
92

$
112

Discontinued operations, net of income tax expense (benefit)
(1
)

—

1

(1
)
Net earnings
$
63

$
88

$
93

$
111

Net earnings (loss) per common share attributable to Centene Corporation:
Basic:

Continuing operations
$
0.54

$
0.74

$
0.77

$
0.94

Discontinued operations
(0.01
)

—

0.01

(0.01
)
Basic earnings per common share
$
0.53

$
0.74

$
0.78

$
0.93

Diluted:

Continuing operations
$
0.52

$
0.72

$
0.75

$
0.91

Discontinued operations
(0.01
)

—

0.01

(0.01
)
Diluted earnings per common share
$
0.51

$
0.72

$
0.76

$
0.90

For the Quarter Ended

March 31,
2014

June 30,
2014

September 30,
2014

December 31,
2014
Total revenues
$
3,460

$
4,023

$
4,352

$
4,725

Amounts attributable to Centene Corporation common shareholders:
Earnings from continuing operations, net of income tax expense
$
34

$
47

$
81

$
106

Discontinued operations, net of income tax expense (benefit)
(1
)

2

1

1

Net earnings
$
33

$
49

$
82

$
107

Net earnings (loss) per common share attributable to Centene Corporation:
Basic:

Continuing operations
$
0.30

$
0.41

$
0.69

$
0.90

Discontinued operations
(0.01
)

0.01

0.01

0.01

Basic earnings per common share
$
0.29

$
0.42

$
0.70

$
0.91

Diluted:

Continuing operations
$
0.29

$
0.39

$
0.67

$
0.87

Discontinued operations
(0.01
)

0.02

0.01

0.01

Diluted earnings per common share
$
0.28

$
0.41

$
0.68

$
0.88

X

- Definition
Quarterly Selected Financial Information [Abstract]
+ References
No definition available.
+ Details

Name: cnc_QuarterlySelectedFinancialInformationAbstract

Namespace Prefix: cnc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the quarterly financial data in the annual financial statements. The disclosure may include a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income or loss before extraordinary items and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=51655806&loc=d3e765-108305

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)-(j)
-URI http://asc.fasb.org/extlink&oid=51825399&loc=d3e1280-108306

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=51655806&loc=d3e725-108305

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 6
-Section G
-Subsection 1

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-K (SK)
-Number 229
-Section 302
-Paragraph a
+ Details

Name: us-gaap_QuarterlyFinancialInformationTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 51 R31.htm IDEA: XBRL DOCUMENT v3.3.1.900

Condensed Financial Information Of Registrant
12 Months Ended

Dec. 31, 2015

Condensed Financial Information of Registrant [Abstract]

Condensed Financial Information of Registrant
Condensed Financial Information of Registrant

Centene Corporation (Parent Company Only)
Condensed Balance Sheets
(In millions, except share data)

December 31,

2015

2014
ASSETS

Current assets:

Cash and cash equivalents
$
4

$
3

Short term investments, at fair value (amortized cost $5 and $8, respectively)
5

8

Other current assets
711

378

Total current assets
720

389

Long term investments, at fair value (amortized cost $6 and $10, respectively)
6

10

Investment in subsidiaries
2,749

2,296

Other long term assets
35

38

Total assets
$
3,510

$
2,733

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities
$
13

$
24

Long term debt
1,147

815

Other long term liabilities
26

3

Total liabilities
1,186

842

Redeemable noncontrolling interest
156

148

Stockholders' equity:

Common stock, $.001 par value; authorized 400,000,000 shares; 126,855,477 issued and 120,342,981 outstanding at December 31, 2015, and 124,274,864 issued and 118,433,416 outstanding at December 31, 2014

—

—

Additional paid-in capital
956

840

Accumulated other comprehensive loss
(10
)

(1
)
Retained earnings
1,358

1,003

Treasury stock, at cost (6,512,496 and 5,841,448 shares, respectively)

(147
)

(98
)
Total Centene stockholders' equity
2,157

1,744

Noncontrolling interest
11

(1
)
Total stockholders' equity
2,168

1,743

Total liabilities and stockholders' equity
$
3,510

$
2,733

See notes to condensed financial information of registrant.

Centene Corporation (Parent Company Only)
Condensed Statements of Operations
(In millions, except share data)

Year Ended December 31,

2015

2014

2013
Expenses:

General and administrative expenses
$
9

$
3

$
4

Gain on contingent consideration
(44
)

—

—

Other income (expense):

Investment and other income
(5
)

1

1

Interest expense
(39
)

(30
)

(23
)
Earnings (loss) before income taxes
(9
)

(32
)

(26
)
Income tax benefit
(26
)

(8
)

(15
)
Net earnings (loss) before equity in subsidiaries
17

(24
)

(11
)
Equity in earnings from subsidiaries
341

285

173

Net earnings
358

261

162

(Earnings) loss attributable to noncontrolling interests
(2
)

7

(1
)
Net earnings attributable to Centene
$
356

$
268

$
161

Net earnings per share from continuing operations:

Basic earnings per common share
$
2.99

$
2.30

$
1.49

Diluted earnings per common share
$
2.89

$
2.23

$
1.43

Weighted average number of shares outstanding:

Basic
119,100,744

116,345,764

108,253,090

Diluted
123,066,370

120,360,212

112,494,346

See notes to condensed financial information of registrant.

Centene Corporation (Parent Company Only)
Condensed Statements of Cash Flows
(In millions)

Year Ended December 31,

2015

2014

2013
Cash flows from operating activities:

Cash provided by operating activities
$
462

$
317

$
302

Cash flows from investing activities:

Net dividends from and capital contributions to subsidiaries
(660
)

(384
)

(417
)
Purchase of investments
(17
)

(32
)

(12
)
Sales and maturities of investments
9

14

10

Proceeds from asset sale
7

—

—

Acquisitions
(113
)

(137
)

(67
)
Net cash used in investing activities
(774
)

(539
)

(486
)
Cash flows from financing activities:

Proceeds from borrowings
1,925

1,875

180

Payment of long term debt
(1,575
)

(1,650
)

(30
)
Proceeds from exercise of stock options
13

8

9

Proceeds from stock offering
—

—

15

Common stock repurchases
(53
)

(29
)

(20
)
Debt issue costs
(4
)

(7
)

(3
)
Payment of contingent consideration obligation
(29
)

—

—

Contributions from noncontrolling interest
11

6

8

Excess tax benefits from stock compensation
25

19

6

Net cash provided by financing activities
313

222

165

Net increase (decrease) in cash and cash equivalents
1

—

(19
)
Cash and cash equivalents, beginning of period
3

3

22

Cash and cash equivalents, end of period
$
4

$
3

$
3

See notes to condensed financial information of registrant.

Notes to Condensed Financial Information of Registrant

Note A - Basis of Presentation and Significant Accounting Policies

The parent company only financial statements should be read in conjunction with Centene Corporation's audited consolidated financial statements and the notes to consolidated financial statements included in this Form 10-K.

The parent company's investment in subsidiaries is stated at cost plus equity in undistributed earnings of the subsidiaries. The parent company's share of net income of its unconsolidated subsidiaries is included in income using the equity method of accounting. Certain unrestricted subsidiaries receive monthly management fees from our restricted subsidiaries. The management and service fees received by our unrestricted subsidiaries are associated with all of the functions required to manage the restricted subsidiaries including but not limited to salaries and wages for all personnel, rent, utilities, medical management, provider contracting, compliance, member services, claims processing, information technology, cash management, finance and accounting, and other services. The management fees are based on a percentage of the restricted subsidiaries revenue.

Due to our centralized cash management function, all cash flows generated by our unrestricted subsidiaries, including management fees, are transferred to the parent company, primarily to repay borrowings on the parent company's revolving credit facility. The parent company may also utilize the cash flow to make acquisitions, fund capital contributions to subsidiaries and fund its operations. During the years ended December 31, 2015, 2014 and 2013, cash flows received by the parent from unrestricted subsidiaries was $445 million, $341 million, and $313 million and was included in cash flows from operating activities.

Certain amounts presented in the parent company only financial statements are eliminated in the consolidated financial statements of Centene Corporation.

Note B - Dividends

During 2015, 2014 and 2013, the Registrant received dividends from its subsidiaries totaling $14 million, $54 million and $21 million, respectively.

Note C - Other Current Assets

The parent company's other current assets include $686 million and $359 million of federal and state income tax receivables as of December 31, 2015 and 2014, respectively, primarily due to tax sharing agreements with its subsidiaries.

X

- Definition
Condensed Financial Information of Registrant [Abstract]
+ References
No definition available.
+ Details

Name: cnc_CondensedFinancialInformationOfRegistrantAbstract

Namespace Prefix: cnc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=51664549&loc=d3e5283-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04)
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph c
-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 06
-Article 9

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 05
-Paragraph c
-Article 7
+ Details

Name: us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 52 R32.htm IDEA: XBRL DOCUMENT v3.3.1.900

Subsequent Events
12 Months Ended

Dec. 31, 2015

Subsequent Events [Abstract]

Subsequent Event
Subsequent Events

In January 2016, the Company completed an approximate 19% investment in a data analytics business and as a result, issued 1.1 million shares of Centene common stock to the selling stockholders. The investment will be accounted for using the equity method of accounting.

In February 2016, a wholly owned unrestricted subsidiary of the Company (Escrow Issuer) issued $1,400 million of 5.625% Senior Notes ($1,400 million Notes) at par due 2021 and $1,000 million of 6.125% Senior Notes ($1,000 million Notes) at par due 2024. The Company intends to use the net proceeds of the offering, together with borrowings under the Company's $1,000 million revolving credit facility and cash on hand, to fund the cash consideration for the Health Net merger, to pay merger and offering related fees and expenses, and for general corporate purposes. The proceeds of the debt issuance will be held in escrow until the closing of the Health Net merger. If the Health Net merger is not consummated, the Escrow Issuer will be required to redeem each series of Notes at a redemption price equal to 100% of the principal amount of such series of Notes, plus accrued and unpaid interest to the redemption date.

X

- References
No definition available.
+ Details

Name: us-gaap_SubsequentEventsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
+ References
No definition available.
+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 53 R33.htm IDEA: XBRL DOCUMENT v3.3.1.900

Summary Of Significant Accounting Policies (Policies)
12 Months Ended

Dec. 31, 2015

Accounting Policies [Abstract]

Principles of Consolidation
Principles of Consolidation

The accompanying consolidated financial statements include the accounts of Centene Corporation and all majority owned subsidiaries and subsidiaries over which the Company exercises the power and control to direct activities significantly impacting financial performance. All material intercompany balances and transactions have been eliminated. The assets, liabilities and results of operations of Kentucky Spirit Health Plan are classified as discontinued operations for all periods presented.

Certain amounts in the consolidated financial statements have been reclassified to conform to the 2015 presentation. These reclassifications have no effect on net earnings or stockholders' equity as previously reported.

Use of Estimates
Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles in the United States, or GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Future events and their effects cannot be predicted with certainty; accordingly, the accounting estimates require the exercise of judgment. The accounting estimates used in the preparation of the consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the operating environment changes. The Company evaluates and updates its assumptions and estimates on an ongoing basis and may employ outside experts to assist in our evaluation, as considered necessary. Actual results could differ from those estimates.

Cash and Cash Equivalents
Cash and Cash Equivalents

Investments with original maturities of three months or less are considered to be cash equivalents. Cash equivalents consist of money market funds and bank certificates of deposit and savings accounts.

The Company maintains amounts on deposit with various financial institutions, which may exceed federally insured limits. However, management periodically evaluates the credit-worthiness of those institutions, and the Company has not experienced any losses on such deposits.

Investments
Investments

Short term investments include securities with maturities greater than three months to one year. Long term investments include securities with maturities greater than one year.

Short term and long term investments are generally classified as available for sale and are carried at fair value. Certain equity investments are recorded using the cost or equity method. Unrealized gains and losses on investments available for sale are excluded from earnings and reported in accumulated other comprehensive income, a separate component of stockholders' equity, net of income tax effects. Premiums and discounts are amortized or accreted over the life of the related security using the effective interest method. The Company monitors the difference between the cost and fair value of investments. Investments that experience a decline in value that is judged to be other than temporary are written down to fair value and a realized loss is recorded in investment and other income. To calculate realized gains and losses on the sale of investments, the Company uses the specific amortized cost of each investment sold. Realized gains and losses are recorded in investment and other income.

The Company uses the equity method to account for its investments in entities that it does not control but has the ability to exercise significant influence over operating and financial policies. These investments are recorded at the lower of their cost or fair value adjusted for the Company's proportionate share of earnings or losses.

Restricted Deposits
Restricted Deposits

Restricted deposits consist of investments required by various state statutes to be deposited or pledged to state agencies. These investments are classified as long term, regardless of the contractual maturity date, due to the nature of the states' requirements. The Company is required to annually adjust the amount of the deposit pledged to certain states.

Fair Value Measurements
Fair Value Measurements

In the normal course of business, the Company invests in various financial assets and incurs various financial liabilities. Fair values are disclosed for all financial instruments, whether or not such values are recognized in the Consolidated Balance Sheets. Management obtains quoted market prices and other observable inputs for these disclosures. The carrying amounts reported in the Consolidated Balance Sheets for cash and cash equivalents, premium and related receivables, unearned revenue, accounts payable and accrued expenses, and certain other current liabilities are carried at cost, which approximates fair value because of their short term nature.

The following methods and assumptions were used to estimate the fair value of each financial instrument:
•
Available for sale investments and restricted deposits: The carrying amount is stated at fair value, based on quoted market prices, where available. For securities not actively traded, fair values were estimated using values obtained from independent pricing services or quoted market prices of comparable instruments.
•
Senior unsecured notes: Estimated based on third-party quoted market prices for the same or similar issues.
•
Variable rate debt: The carrying amount of our floating rate debt approximates fair value since the interest rates adjust based on market rate adjustments.
•
Interest rate swap: Estimated based on third-party market prices based on the forward 3-month LIBOR curve.
•
Contingent consideration: Estimate based on expected membership retained at contract commencement and per member purchase price in the acquisition agreement.

Property, Software and Equipment
Property, Software and Equipment

Property, software and equipment are stated at cost less accumulated depreciation. Capitalized software includes certain costs incurred in the development of internal-use software, including external direct costs of materials and services and payroll costs of employees devoted to specific software development. Depreciation is calculated principally by the straight-line method over estimated useful lives. Leasehold improvements are depreciated using the straight-line method over the shorter of the expected useful life or the remaining term of the lease. Property, software and equipment are depreciated over the following periods:
Fixed Asset

Depreciation Period
Buildings and land improvements

3 - 40 years
Computer hardware and software

2 - 7 years
Furniture and equipment

3 - 10 years
Leasehold improvements

1 - 20 years

The carrying amounts of all long-lived assets are evaluated to determine if adjustment to the depreciation and amortization period or to the unamortized balance is warranted. Such evaluation is based principally on the expected utilization of the long-lived assets.

The Company retains fully depreciated assets in property and accumulated depreciation accounts until it removes them from service. In the case of sale, retirement, or disposal, the asset cost and related accumulated depreciation balance is removed from the respective account, and the resulting net amount, less any proceeds, is included as a component of earnings from operations in the consolidated statements of operations.

Goodwill and Intangible Assets
Goodwill and Intangible Assets

Intangible assets represent assets acquired in purchase transactions and consist primarily of customer relationships, purchased contract rights, provider contracts, trade names and goodwill. Intangible assets are amortized using the straight-line method over the following periods:
Intangible Asset

Amortization Period
Purchased contract rights

5 - 15 years
Provider contracts

4 - 15 years
Customer relationships

3 - 15 years
Trade names

7 - 20 years
Developed technology

5 years

The Company tests for impairment of intangible assets as well as long-lived assets whenever events or changes in circumstances indicate that the carrying value of an asset or asset group (hereinafter referred to as “asset group”) may not be recoverable by comparing the sum of the estimated undiscounted future cash flows expected to result from use of the asset group and its eventual disposition to the carrying value. Such factors include, but are not limited to, significant changes in membership, state funding, state contracts and provider networks and contracts. If the sum of the estimated undiscounted future cash flows is less than the carrying value, an impairment determination is required. The amount of impairment is calculated by subtracting the fair value of the asset group from the carrying value of the asset group. An impairment charge, if any, is recognized within earnings from operations.

The Company tests goodwill for impairment using a fair value approach. The Company is required to test for impairment at least annually, absent a triggering event including a significant decline in operating performance that would require an impairment assessment. Absent any impairment indicators, the Company performs its goodwill impairment testing during the fourth quarter of each year. The Company recognizes an impairment charge for any amount by which the carrying amount of goodwill exceeds its implied fair value.

The Company first assesses qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. The Company generally does not calculate the fair value of a reporting unit unless it determines, based on a qualitative assessment, that it is more likely than not that its fair value is less than its carrying amount. However, in certain circumstances, such as recent acquisitions, the Company may elect to perform a quantitative assessment without first assessing qualitative factors.

If the two-step quantitative test is deemed necessary, the Company determines an appropriate valuation technique to estimate a reporting unit's fair value as of the testing date. The Company utilizes either the income approach or the market approach, whichever is most appropriate for the respective reporting unit. The income approach is based on an internally developed discounted cash flow model that includes many assumptions related to future growth rates, discount factors, future tax rates, etc. The market approach is based on financial multiples of comparable companies derived from current market data. Changes in economic and operating conditions impacting assumptions used in our analyses could result in goodwill impairment in future periods.

Medical Claims Liability
Medical Claims Liability

Medical claims liability includes claims reported but not yet paid, or inventory, estimates for claims incurred but not reported, or IBNR, and estimates for the costs necessary to process unpaid claims at the end of each period.  The Company estimates its medical claims liability using actuarial methods that are commonly used by health insurance actuaries and meet Actuarial Standards of Practice.  These actuarial methods consider factors such as historical data for payment patterns, cost trends, product mix, seasonality, utilization of healthcare services and other relevant factors.

Actuarial Standards of Practice generally require that the medical claims liability estimates be adequate to cover obligations under moderately adverse conditions.  Moderately adverse conditions are situations in which the actual claims are expected to be higher than the otherwise estimated value of such claims at the time of estimate.  In many situations, the claims amounts ultimately settled will be different than the estimate that satisfies the Actuarial Standards of Practice. The Company includes in its IBNR an estimate for medical claims liability under moderately adverse conditions which represents the risk of adverse deviation of the estimates in its actuarial method of reserving.

The Company uses its judgment to determine the assumptions to be used in the calculation of the required estimates. The assumptions it considers when estimating IBNR include, without limitation, claims receipt and payment experience (and variations in that experience), changes in membership, provider billing practices, healthcare service utilization trends, cost trends, product mix, seasonality, prior authorization of medical services, benefit changes, known outbreaks of disease or increased incidence of illness such as influenza, provider contract changes, changes to fee schedules, and the incidence of high dollar or catastrophic claims.

The Company's development of the medical claims liability estimate is a continuous process which it monitors and refines on a monthly basis as additional claims receipts and payment information becomes available. As more complete claims information becomes available, the Company adjusts the amount of the estimates, and includes the changes in estimates in medical costs in the period in which the changes are identified. In every reporting period, the operating results include the effects of more completely developed medical claims liability estimates associated with previously reported periods. The Company consistently applies its reserving methodology from period to period. As additional information becomes known, it adjusts the actuarial model accordingly to establish medical claims liability estimates.

The Company periodically reviews actual and anticipated experience compared to the assumptions used to establish medical costs. The Company establishes premium deficiency reserves if actual and anticipated experience indicates that existing policy liabilities together with the present value of future gross premiums will not be sufficient to cover the present value of future benefits, settlement and maintenance costs.

Revenue Recognition
Revenue Recognition

The Company's health plans generate revenues primarily from premiums received from the states in which it operates health plans. The Company receives a fixed premium per member per month pursuant to its state contracts. The Company generally receives premium payments during the month it provides services and recognizes premium revenue during the period in which it is obligated to provide services to its members. In some instances, the Company's base premiums are subject to an adjustment, or risk score, based on the acuity of its membership. Generally, the risk score is determined by the State analyzing submissions of processed claims data to determine the acuity of the Company's membership relative to the entire state's Medicaid membership. Some states enact premium taxes, similar assessments and provider pass-through payments, collectively premium taxes, and these taxes are recorded as a separate component of both revenues and operating expenses. Some contracts allow for additional premiums related to certain supplemental services provided such as maternity deliveries.

Revenues are recorded based on membership and eligibility data provided by the states, which is adjusted on a monthly basis by the states for retroactive additions or deletions to membership data. These eligibility adjustments are estimated monthly and subsequent adjustments are made in the period known. We continuously review and update those estimates as new information becomes available.  It is possible that new information could require us to make additional adjustments, which could be significant, to these estimates.

The Company's specialty companies generate revenues under contracts with state programs, individuals, healthcare organizations and other commercial organizations, as well as from the Company's own subsidiaries. Revenues are recognized when the related services are provided or as ratably earned over the covered period of service.

Health Insurance Marketplace
Health Insurance Marketplace

The Affordable Care Act (ACA) established risk spreading premium stabilization programs effective January 1, 2014 for the Health Insurance Marketplace product. These programs, commonly referred to as the “three Rs,” include a permanent risk adjustment program, a transitional reinsurance program, and a temporary risk corridor program. The Company’s accounting policies for the programs are as follows:

Risk Adjustment

The permanent risk adjustment program established by the ACA transfers funds from qualified individual and small group insurance plans with below average risk scores to those plans with above average risk scores within each state. The Company estimates the receivable or payable under the risk adjustment program based on its estimated risk score compared to the state average risk score. The Company may record a receivable or payable as an adjustment to Premium revenue to reflect the year to date impact of the risk adjustment based on its best estimate. The Company expects to refine its estimate as new information becomes available. As of December 31, 2015, the Company recorded a payable of $108 million associated with risk adjustment, and $44 million at December 31, 2014.

Reinsurance

The ACA established a transitional three-year reinsurance program whereby the Company’s claims costs incurred for qualified members will be reimbursed when they exceed a specific threshold. For the 2015 benefit year, qualified member claims that exceeded $45,000 entitled the Company to reimbursement from the programs at 50% coinsurance. The Company accounts for reinsurance recoveries as a reduction of Medical Costs based on each individual case that exceeds the reinsurance threshold established by the program. As of December 31, 2015, the Company recorded a receivable of $24 million associated with reinsurance, and $11 million at December 31, 2014.

Risk Corridor

The temporary, three-year risk corridor program established by the ACA applies to qualified individual and small group health plans operating both inside and outside of the Health Insurance Marketplace. The risk corridor program limits the Company’s gains and losses in the Health Insurance Marketplace by comparing certain medical and administrative costs to a target amount and sharing the risk for allowable costs with the federal government. Allowable medical costs are adjusted for risk adjustment settlements, transitional reinsurance recoveries, and cost sharing reductions received from the federal government. The Company records a risk corridor receivable or payable as an adjustment to Premium Revenue on a year to date basis based on where its estimated annual costs fall within the risk corridor range. As of December 31, 2015, the Company recorded a payable of $4 million associated with risk corridor, and $9 million at December 31, 2014.

Minimum Medical Loss Ratio

Additionally, the ACA established a minimum annual medical loss ratio for the Health Insurance Marketplace. Each of the three R programs described above are taken into consideration to determine if the Company’s estimated annual medical costs are less than the minimum loss ratio and require an adjustment to Premium revenue to meet the minimum medical loss ratio. As of December 31, 2015, the Company recorded a payable of $15 million associated with minimum medical loss ratio, and $6 million at December 31, 2014.

Premium And Related Receivables And Unearned Revenue
Premium and Related Receivables and Unearned Revenue

Premium and service revenues collected in advance are recorded as unearned revenue. For performance-based contracts the Company does not recognize revenue subject to refund until data is sufficient to measure performance. Premiums and service revenues due to the Company are recorded as premium and related receivables and are recorded net of an allowance based on historical trends and management's judgment on the collectibility of these accounts. As the Company generally receives payments during the month in which services are provided, the allowance is typically not significant in comparison to total revenues and does not have a material impact on the presentation of the financial condition or results of operations.

Significant Customers
Significant Customers

Centene receives the majority of its revenues under contracts or subcontracts with state Medicaid managed care programs. The current contracts expire on various dates between April 30, 2016 and June 30, 2019. States where the aggregate annual contract value exceeded 10% of total annual revenues included Texas, where the percentage of the Company's total revenue was 22%, 25% and 37% for the years ended December 31, 2015, 2014, and 2013, respectively, and Florida where the percentage of the Company's total revenue was 14% for the years ended December 31, 2015 and 2014.

Other Income (Expense)
Other Income (Expense)

Other income (expense) consists principally of investment income, interest expense and equity method earnings from investments. Investment income is derived from the Company's cash, cash equivalents, restricted deposits and investments. Interest expense relates to borrowings under the senior notes, interest rate swap, credit facilities, interest on capital leases and credit facility fees.

Income Taxes
Income Taxes

Deferred tax assets and liabilities are recorded for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax law or tax rates is recognized in income in the period that includes the enactment date.

Valuation allowances are provided when it is considered more likely than not that deferred tax assets will not be realized. In determining if a deductible temporary difference or net operating loss can be realized, the Company considers future reversals of existing taxable temporary differences, future taxable income, taxable income in prior carryback periods and tax planning strategies.

Contingencies
Contingencies

The Company accrues for loss contingencies associated with outstanding litigation, claims and assessments for which it has determined it is probable that a loss contingency exists and the amount of loss can be reasonably estimated. The Company expenses professional fees associated with litigation claims and assessments as incurred.

Stock Based Compensation
Stock Based Compensation

The fair value of the Company's employee share options and similar instruments are estimated using the Black-Scholes option-pricing model. That cost is recognized over the period during which an employee is required to provide service in exchange for the award. Excess tax benefits related to stock compensation are presented as a cash inflow from financing activities.

Foreign Currency Transactions and Translations
Foreign Currency Translation

The Company is exposed to foreign currency exchange risk through its equity method investment in Ribera Salud S.A. (Ribera Salud), a Spanish health management group whose functional currency is the Euro. The assets and liabilities of the Company's investment are translated into United States dollars at the balance sheet date. The Company translates its proportionate share of earnings using average rates during the year. The resulting foreign currency translation adjustments are recorded as a separate component of accumulated other comprehensive income.

New Accounting Pronouncements
Recent Accounting Pronouncements

In November 2015, the Financial Accounting Standards Board (FASB) issued an Accounting Standards Update (ASU) which requires entities to present deferred tax assets and deferred tax liabilities as noncurrent in a classified balance sheet. The new standards simplifies the current guidance, which requires entities to separately present deferred tax assets and deferred tax liabilities as current and noncurrent in a classified balance sheet. It is effective for annual and interim periods beginning after December 15, 2016. Early adoption is permitted. The Company elected to adopt this guidance in the current fiscal year and applied the new standard retrospectively to all prior periods. The reclassification of deferred tax assets and deferred tax liabilities impacted the Consolidated Balance Sheets by decreasing Other Current Assets and increasing Other Long Term Assets by $102 million and $83 million at December 31, 2015 and December 31, 2014. These reclassifications have no effect on net earnings or stockholders' equity as previously reported.

In September 2015, the FASB issued an ASU which simplifies the accounting for measurement-period adjustments in business combinations. The new standard eliminates the requirement for an acquirer in a business combination to account for measurement-period adjustments retrospectively. Instead, acquirers must recognize measurement-period adjustments during the period in which they determine the amounts, including any amounts they would have recorded in previous periods if the accounting had been completed at the acquisition date. Additionally, the acquirer must disclose the portion of the amount that would have been recorded in previous reporting periods. It is effective for annual and interim periods beginning after December 15, 2016. Early adoption is permitted. The Company elected to adopt this guidance in the current fiscal year.

In May 2015, the FASB issued an ASU which expands the disclosure requirements for insurance companies that issue short-duration contracts. The new standard will increase the level of disclosure around the Company's Medical Claims Liability to include the following: claims development by year; claim frequency; a rollforward of the claims liability; and a description of methods and assumptions used for determining the liability. It is effective for annual periods beginning after December 15, 2015 and interim periods beginning after December 15, 2016. Early adoption is permitted. The Company is currently evaluating the effect of the new disclosure requirements.

In April 2015, the FASB issued an ASU which changes the presentation of debt issuance costs in financial statements. Under the new standard, debt issuance costs are presented in the balance sheet as a direct deduction of the related debt liability rather than as an asset. Amortization of the cost is reported as interest expense. The new standard is effective for annual and interim periods beginning after December 15, 2015 and early adoption is permitted. The Company elected to adopt this guidance beginning in the first quarter of 2015 and has applied the new standard retrospectively to all prior periods. The reclassification of debt issuance costs impacted the Consolidated Balance Sheets by decreasing both Other Long Term Assets and Long Term Debt by $14 million at December 31, 2015 and December 31, 2014. These reclassifications have no effect on net earnings or stockholders' equity as previously reported.

In May 2014, the FASB issued an ASU which supersedes existing revenue recognition standards with a single model unless those contracts are within the scope of other standards (e.g., an insurance entity's insurance contracts). Under the new standard, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration which the entity expects to receive in exchange for those goods or services. In addition, the standard requires disclosure of the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The new effective date is for annual and interim periods beginning after December 15, 2017. Early adoption is permitted. The Company is currently evaluating the effect of the new revenue recognition guidance.

The Company has determined that there are no other recently issued accounting pronouncements that will have a material impact on its consolidated financial position, results of operations and cash flows.

X

- Definition
Health Insurance Marketplace Disclosure [Policy Text Block]
+ References
No definition available.
+ Details

Name: cnc_HealthInsuranceMarketplaceDisclosurePolicyTextBlock

Namespace Prefix: cnc_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Premium And Related Receivables And Unearned Revenue [Policy Text Block]
+ References
No definition available.
+ Details

Name: cnc_PremiumAndRelatedReceivablesAndUnearnedRevenuePolicyTextBlock

Namespace Prefix: cnc_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Significant Customers [Policy Text Block]
+ References
No definition available.
+ Details

Name: cnc_SignificantCustomersPolicyTextBlock

Namespace Prefix: cnc_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 305
-SubTopic 10
-Section 05
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6375392&loc=d3e26790-107797

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4273-108586

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash
-URI http://asc.fasb.org/extlink&oid=6506951

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash Equivalents
-URI http://asc.fasb.org/extlink&oid=6507016

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Financial Reporting Release (FRR)
-Number 203
-Paragraph 02-03

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 1
-Article 5
+ Details

Name: us-gaap_CashAndCashEquivalentsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.1(a))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 305
-SubTopic 10
-Section 05
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6375392&loc=d3e26790-107797

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4273-108586

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 1
-Article 5

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Financial Reporting Release (FRR)
-Number 203
-Paragraph 02-03
+ Details

Name: us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 954
-SubTopic 450
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6491354&loc=d3e6052-115624

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 954
-SubTopic 450
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=51674963&loc=d3e12565-110249
+ Details

Name: us-gaap_CommitmentsAndContingenciesPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=18733093&loc=d3e5614-111684

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.3A-02)
-URI http://asc.fasb.org/extlink&oid=27015204&loc=d3e355033-122828

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph k
-Article 1

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02, 03
-Article 3A
+ Details

Name: us-gaap_ConsolidationPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for determining the fair value of financial instruments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13279-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 60
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260
+ Details

Name: us-gaap_FairValueOfFinancialInstrumentsPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895
+ Details

Name: us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32840-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 05
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6423966&loc=d3e40913-109327

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 954
-SubTopic 740
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32809-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e32247-109318

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=37586315&loc=d3e32280-109318
+ Details

Name: us-gaap_IncomeTaxPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for investments in financial assets, including marketable securities (debt and equity securities with readily determinable fair values), investments accounted for under the equity method and cost method, securities borrowed and loaned, and repurchase and resale agreements. For marketable securities, the disclosure may include the entity's accounting treatment for transfers between investment categories and how the fair values for such securities are determined. Also, for all investments, an entity may describe its policy for assessing, recognizing and measuring impairment of the investment.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 6
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27290-111563

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.2,12)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 325
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6872867&loc=d3e40691-111596

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 5
-Section M
+ Details

Name: us-gaap_InvestmentPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.3,6,7,9)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688
+ Details

Name: us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18823-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18726-107790

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 13.B.Q1)
-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 13
-Section B
-Paragraph Question 1
+ Details

Name: us-gaap_RevenueRecognitionPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b),(f)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for estimating the ultimate cost of settling insurance claims relating to insured events that have occurred on or before a particular date (ordinarily, the statement of financial position date). The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claims adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51655414&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.13(b))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6482485&loc=d3e14754-158437
+ Details

Name: us-gaap_UnpaidPolicyClaimsAndClaimsAdjustmentExpensePolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6061-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6143-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6132-108592
+ Details

Name: us-gaap_UseOfEstimates

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 54 R34.htm IDEA: XBRL DOCUMENT v3.3.1.900

Summary Of Significant Accounting Policies (Tables)
12 Months Ended

Dec. 31, 2015

Accounting Policies [Abstract]

Schedule Of Property Software And Equipment Depreciation Periods [Table Text Block]
Property, software and equipment are depreciated over the following periods:
Fixed Asset

Depreciation Period
Buildings and land improvements

3 - 40 years
Computer hardware and software

2 - 7 years
Furniture and equipment

3 - 10 years
Leasehold improvements

1 - 20 years

Schedule Of Amortization Period For Intangible Assets [Table Text Block]
Intangible assets are amortized using the straight-line method over the following periods:
Intangible Asset

Amortization Period
Purchased contract rights

5 - 15 years
Provider contracts

4 - 15 years
Customer relationships

3 - 15 years
Trade names

7 - 20 years
Developed technology

5 years

Schedule Of Allowance For Uncollectible Accounts [Table Text Block]
Activity in the allowance for uncollectible accounts for the years ended December 31, is summarized below ($ in millions):

2015

2014

2013
Allowances, beginning of year
$
5

$
1

$
1

Amounts charged to expense
12

8

3

Write-offs of uncollectible receivables
(7
)

(4
)

(3
)
Allowances, end of year
$
10

$
5

$
1

X

- Definition
Schedule Of Allowance For Uncollectible Accounts [Table Text Block]
+ References
No definition available.
+ Details

Name: cnc_ScheduleOfAllowanceForUncollectibleAccountsTableTextBlock

Namespace Prefix: cnc_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Schedule Of Amortization Period For Intangible Assets [Table Text Block]
+ References
No definition available.
+ Details

Name: cnc_ScheduleOfAmortizationPeriodForIntangibleAssetsTableTextBlock

Namespace Prefix: cnc_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Schedule Of Property Software And Equipment Depreciation Periods [Table Text Block]
+ References
No definition available.
+ Details

Name: cnc_ScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsTableTextBlock

Namespace Prefix: cnc_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 55 R35.htm IDEA: XBRL DOCUMENT v3.3.1.900

Acquisitions and Noncontrolling Interest (Tables)
12 Months Ended

Dec. 31, 2015

Noncontrolling Interest [Abstract]

Noncontrolling Interest Disclosure
The Company has consolidated subsidiaries where it maintains less than 100% ownership. The Company’s ownership interest for each subsidiary as of December 31, are as follows:

2015

2014

2013
Celtic Insurance Company

75
%

100
%

100
%
Centurion

51
%

51
%

51
%
Home State Health Plan

95
%

95
%

95
%
U.S. Medical Management

68
%

68
%

—

Schedule of Net Income Attributable to Parent and Transfers from and to Non-controlling Interest Entities
Net income attributable to Centene Corporation and transfers from (to) noncontrolling interest entities are as follows ($ in millions):

Year Ended December 31,

2015

2014

2013
Net earnings attributable to Centene Corporation
$
356

$
268

$
161

Transfers from (to) the noncontrolling interest:

Increase in equity for distributions from and consolidation of noncontrolling interest
11

—

7

Reclassification to redeemable noncontrolling interest
1

(9
)

—

Net transfers from (to) noncontrolling interest
12

(9
)

7

Changes from net earnings attributable to Centene Corporation and net transfers from (to) the noncontrolling interest
$
368

$
259

$
168

Redeemable Noncontrolling Interest
A reconciliation of the changes in the Redeemable Noncontrolling Interest is as follows ($ in millions):
Balance, December 31, 2014
$
148

Fair value of noncontrolling interest sold
7

Reclassification to redeemable noncontrolling interest
(1
)
Net earnings attributable to noncontrolling interest
2

Balance, December 31, 2015
$
156

X

- Definition
The tabular disclosure of the effects of any changes in a parent's ownership interest in a subsidiary on the equity attributable to the parent if the ownership interests in a subsidiary changes during the period. The changes represented by this element did not result in the deconsolidation of the subsidiary.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4M
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591554-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684
+ Details

Name: us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestEffectsOfChangesNetTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684
+ Details

Name: us-gaap_MinorityInterestDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NoncontrollingInterestAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of redeemable noncontrolling interest (as defined) included in the statement of financial position as either a liability or temporary equity. As of the date of the statement of financial position, such redeemable noncontrolling interest is currently redeemable, as defined, for cash or other assets of the entity at (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the entity.
+ References
No definition available.
+ Details

Name: us-gaap_RedeemableNoncontrollingInterestTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 56 R36.htm IDEA: XBRL DOCUMENT v3.3.1.900

Short-Term And Long-Term Investments And Restricted Deposits (Tables)
12 Months Ended

Dec. 31, 2015

Investments, Debt and Equity Securities [Abstract]

Short-Term And Long-Term Investments And Restricted Deposits By Investment Type
Short term and long term investments and restricted deposits by investment type consist of the following ($ in millions):

December 31, 2015

December 31, 2014

Amortized
Cost

Gross
Unrealized
Gains

Gross
Unrealized Losses

Fair
Value

Amortized
Cost

Gross
Unrealized
Gains

Gross
Unrealized Losses

Fair
Value
U.S. Treasury securities and obligations of U.S. government corporations and agencies
$
431

$
—

$
(2
)

$
429

$
393

$
1

$
(2
)

$
392

Corporate securities
859

2

(8
)

853

556

2

(2
)

556

Restricted certificates of deposit
5

—

—

5

6

—

—

6

Restricted cash equivalents
78

—

—

78

79

—

—

79

Municipal securities
496

2

(1
)

497

174

1

—

175

Asset backed securities
163

—

(1
)

162

180

—

—

180

Residential mortgage backed securities
66

1

—

67

84

1

—

85

Commercial mortgage backed securities
40

—

—

40

—

—

—

—

Cost and equity method investments
71

—

—

71

68

—

—

68

Life insurance contracts
16

—

—

16

16

—

—

16

Total
$
2,225

$
5

$
(12
)

$
2,218

$
1,556

$
5

$
(4
)

$
1,557

Schedule Of Available-For-Sale Investments In A Continuous Unrealized Loss Position
The fair value of available-for-sale investments with gross unrealized losses by investment type and length of time that individual securities have been in a continuous unrealized loss position were as follows ($ in millions):

December 31, 2015

December 31, 2014

Less Than 12 Months

12 Months or More

Less Than 12 Months

12 Months or More

Unrealized Losses

Fair
Value

Unrealized Losses

Fair
Value

Unrealized Losses

Fair
Value

Unrealized Losses

Fair
Value
U.S. Treasury securities and obligations of U.S. government corporations and agencies
$
(2
)

$
294

$
—

$
14

$
—

$
72

$
(2
)

$
180

Corporate securities
(6
)

561

(2
)

41

(2
)

311

—

1

Municipal securities
(1
)

208

—

5

—

20

—

7

Asset backed securities
(1
)

121

—

8

—

70

—

10

Residential Mortgage backed securities
—

30

—

—

—

18

—

—

Commercial mortgage backed securities
—

34

—

—

—

—

—

—

Total
$
(10
)

$
1,248

$
(2
)

$
68

$
(2
)

$
491

$
(2
)

$
198

Contractual Maturities Of Short-Term And Long-Term Investments And Restricted Deposits
The contractual maturities of short term and long term investments and restricted deposits are as follows ($ in millions):

December 31, 2015

December 31, 2014

Investments

Restricted Deposits

Investments

Restricted Deposits

Amortized
Cost

Fair
Value

Amortized
Cost

Fair
Value

Amortized
Cost

Fair
Value

Amortized
Cost

Fair
Value
One year or less
$
176

$
176

$
93

$
93

$
176

$
177

$
92

$
92

One year through five years
1,662

1,654

22

22

1,121

1,121

8

8

Five years through ten years
267

268

—

—

121

120

—

—

Greater than ten years
5

5

—

—

38

39

—

—

Total
$
2,110

$
2,103

$
115

$
115

$
1,456

$
1,457

$
100

$
100

X

- Definition
Short-term and long-term investments and restricted deposits by investment type
+ References
No definition available.
+ Details

Name: cnc_ShortTermAndLongTermInvestmentsAndRestrictedDepositsByInvestmentTypeTableTextBlockTableTextBlock

Namespace Prefix: cnc_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.
+ References
No definition available.
+ Details

Name: us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
For all investments in an unrealized loss position, including those for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), a tabular disclosure of the aggregate related fair value of investments with unrealized losses and the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27290-111563
+ Details

Name: us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 57 R37.htm IDEA: XBRL DOCUMENT v3.3.1.900

Fair Value Measurements (Tables)
12 Months Ended

Dec. 31, 2015

Fair Value Disclosures [Abstract]

Fair Value Measurements By Level For Assets Measured At Fair Value On A Recurring Basis
The following table summarizes fair value measurements by level at December 31, 2015, for assets and liabilities measured at fair value on a recurring basis ($ in millions):

Level I

Level II

Level III

Total
Assets

Cash and cash equivalents
$
1,760

$
—

$
—

$
1,760

Investments available for sale:

U.S. Treasury securities and obligations of U.S. government corporations and agencies
$
325

$
72

$
—

$
397

Corporate securities
—

853

—

853

Municipal securities
—

497

—

497

Asset backed securities
—

162

—

162

Residential mortgage backed securities
—

67

—

67

Commercial mortgage backed securities
—

40

—

40

Total investments
$
325

$
1,691

$
—

$
2,016

Restricted deposits available for sale:

Cash and cash equivalents
$
78

$
—

$
—

$
78

Certificates of deposit
5

—

—

5

U.S. Treasury securities and obligations of U.S. government corporations and agencies
32

—

—

32

Total restricted deposits
$
115

$
—

$
—

$
115

Other long term assets:

Interest rate swap agreements
$
—

$
11

$
—

$
11

Total assets at fair value
$
2,200

$
1,702

$
—

$
3,902

Liabilities

Other long term liabilities:

Interest rate swap agreements
$
—

$
2

$
—

$
2

Total liabilities at fair value
$
—

$
2

$
—

$
2

The following table summarizes fair value measurements by level at December 31, 2014, for assets and liabilities measured at fair value on a recurring basis ($ in millions):

Level I

Level II

Level III

Total
Assets

Cash and cash equivalents
$
1,610

$
—

$
—

$
1,610

Investments available for sale:

U.S. Treasury securities and obligations of U.S. government corporations and agencies
$
360

$
17

$
—

$
377

Corporate securities
—

556

—

556

Municipal securities
—

175

—

175

Asset backed securities
—

180

—

180

Residential mortgage backed securities
—

85

—

85

Commercial mortgage backed securities
—

—

—

—

Total investments
$
360

$
1,013

$
—

$
1,373

Restricted deposits available for sale:

Cash and cash equivalents
$
79

$
—

$
—

$
79

Certificates of deposit
6

—

—

6

U.S. Treasury securities and obligations of U.S. government corporations and agencies
15

—

—

15

Total restricted deposits
$
100

$
—

$
—

$
100

Other long term assets:

Interest rate swap agreements
$
—

$
11

$
—

$
11

Total assets at fair value
$
2,070

$
1,024

$
—

$
3,094

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19190-110258
+ Details

Name: us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 58 R38.htm IDEA: XBRL DOCUMENT v3.3.1.900

Property, Software And Equipment (Tables)
12 Months Ended

Dec. 31, 2015

Property, Software and Equipment [Abstract]

Property, Software and Equipment
Property, software and equipment consist of the following as of December 31 ($ in millions):

2015

2014
Computer software
$
237

$
198

Building
223

208

Land
104

87

Computer hardware
105

88

Furniture and office equipment
92

70

Leasehold improvements
108

82

869

733

Less accumulated depreciation
(351
)

(288
)
Property, software and equipment, net
$
518

$
445

X

- Definition
Property, Software and Equipment [Abstract]
+ References
No definition available.
+ Details

Name: cnc_PropertySoftwareAndEquipmentAbstract

Namespace Prefix: cnc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 13
-Subparagraph b
-Article 5
+ Details

Name: us-gaap_PropertyPlantAndEquipmentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 59 R39.htm IDEA: XBRL DOCUMENT v3.3.1.900

Goodwill And Intangible Assets (Tables)
12 Months Ended

Dec. 31, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule Of Changes In Goodwill By Operating Segment
The following table summarizes the changes in goodwill by operating segment ($ in millions):

Managed Care

Specialty Services

Total
Balance as of December 31, 2013
$
151

$
197

$
348

Acquisition
125

281

406

Balance as of December 31, 2014
276

478

754

Acquisition
103

3

106

Impairment
(18
)

—

(18
)
Balance as of December 31, 2015
$
361

$
481

$
842

Schedule Of Intangible Assets
Intangible assets at December 31, consist of the following ($ in millions):

Weighted Average Life in Years

2015

2014

2015

2014
Purchased contract rights
$
71

$
28

8.8

7.5

Provider contracts
103

103

11.1

11.1

Customer relationships
26

15

8.1

7.1

Trade names
12

17

7.3

13.1

Developed technology
5

—

5.0

—

Intangible assets
217

163

9.8

10.3

Less accumulated amortization:

Purchased contract rights
(21
)

(14
)

Provider contracts
(24
)

(14
)

Customer relationships
(14
)

(12
)

Trade names
(2
)

(3
)

Developed technology
(1
)

—

Total accumulated amortization
(62
)

(43
)

Intangible assets, net
$
155

$
120

Schedule Of Future Amortization Expenses
Estimated total amortization expense related to intangible assets for each of the five succeeding fiscal years is as follows ($ in millions):
Year

Expense
2016

$
22

2017

19

2018

18

2019

18

2020

16

X

- References
No definition available.
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275
+ Details

Name: us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267
+ Details

Name: us-gaap_ScheduleOfGoodwillTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275
+ Details

Name: us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 60 R40.htm IDEA: XBRL DOCUMENT v3.3.1.900

Medical Claims Liability (Tables)
12 Months Ended

Dec. 31, 2015

Liability for Unpaid Claims and Claims Adjustment Expense, Activity in Liability [Abstract]

Schedule Of Change In Medical Claims Liability
The change in medical claims liability is summarized as follows ($ in millions):

Year Ended December 31,

2015

2014

2013
Balance, January 1,
$
1,723

$
1,112

$
815

Acquisitions
79

—

—

Incurred related to:

          Current year
17,471

12,820

9,073

          Prior years
(229
)

(142
)

(78
)
         Total incurred
17,242

12,678

8,995

Paid related to:

          Current year
15,279

11,122

7,975

          Prior years
1,467

945

723

         Total paid
16,746

12,067

8,698

Balance, December 31,
$
2,298

$
1,723

$
1,112

X

- References
No definition available.
+ Details

Name: us-gaap_RollForwardInLiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 50
-Paragraph 3
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6482485&loc=d3e14764-158437
+ Details

Name: us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 61 R41.htm IDEA: XBRL DOCUMENT v3.3.1.900

Health Insurance Marketplace (Tables)
12 Months Ended

Dec. 31, 2015

Health Insurance Marketplace [Abstract]

Schedule of receivables (payables) related to the Health Insurance Marketplace programs
The Company's receivables (payables) for each of these programs are as follows at each year ended ($ in millions):

December 31, 2015

December 31, 2014
Risk adjustment
$
(108
)

$
(44
)
Reinsurance
24

11

Risk corridor
(4
)

(9
)
Minimum medical loss ratio
(15
)

(6
)

X

- Definition
Health Insurance Marketplace [Abstract]
+ References
No definition available.
+ Details

Name: cnc_HealthInsuranceMarketplaceAbstract

Namespace Prefix: cnc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
[Table Text Block] for Schedule of receivables (payables) related to the Health Insurance Marketplace programs [Table]
+ References
No definition available.
+ Details

Name: cnc_ScheduleofreceivablespayablesrelatedtotheHealthInsuranceMarketplaceprogramsTableTextBlock

Namespace Prefix: cnc_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 62 R42.htm IDEA: XBRL DOCUMENT v3.3.1.900

Debt (Tables)
12 Months Ended

Dec. 31, 2015

Debt Disclosure [Abstract]

Schedule Of Debt
Debt consists of the following ($ in millions):

December 31, 2015

December 31, 2014
$425 million 5.75% Senior notes, due June 1, 2017
$
428

$
429

$500 million 4.75% Senior notes, due May 15, 2022
500

300

Fair value of interest rate swap agreements
9

11

Senior notes
937

740

Revolving credit agreement
225

75

Mortgage notes payable
67

70

Capital leases
6

8

Debt issuance costs
(14
)

(14
)
Total debt
1,221

879

Less current portion
(5
)

(5
)
Long term debt
$
1,216

$
874

Schedule Of Aggregate Maturities Of Debt
Aggregate maturities for the Company's debt are as follows ($ in millions):
2016

$
5

2017

429

2018

228

2019

4

2020

4

Thereafter

553

Total

$
1,223

X

- References
No definition available.
+ Details

Name: us-gaap_DebtDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfDebtTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the combined aggregate amount of maturities and sinking fund requirements for all long-term borrowings for each of the five years following the date of the latest balance sheet date presented.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601
+ Details

Name: us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 63 R43.htm IDEA: XBRL DOCUMENT v3.3.1.900

Income Taxes Income Taxes (Tables)
12 Months Ended

Dec. 31, 2015

Income Tax Disclosure [Abstract]

Consolidated Income Tax Expense
The consolidated income tax expense consists of the following for the years ended December 31 ($ in millions):

2015

2014

2013
Current provision:

Federal
$
332

$
225

$
121

State and local
26

13

6

Total current provision
358

238

127

Deferred provision
(19
)

(42
)

(20
)
Total provision for income taxes
$
339

$
196

$
107

Reconciliation Of The Tax Provision At The U.S. Federal Statutory Rate To The Provision For Income Taxes
The reconciliation of the tax provision at the U.S. Federal Statutory Rate to the provision for income taxes for the years ended December 31 is as follows ($ in millions):

2015

2014

2013
Earnings from continuing operations, before income tax expense
$
697

$
457

$
269

(Earnings) loss attributable to flow through noncontrolling interest
1

4

(1
)
Earnings from continuing operations, less noncontrolling interest, before income tax expense
698

461

268

Tax provision at the U.S. federal statutory rate
244

162

94

State income taxes, net of federal income tax benefit
15

6

3

Nondeductible compensation
2

1

12

Benefit from reversal of prior years impact of 162(m)(6) regulations
—

(14
)

—

ACA Health Insurer Fee
75

44

—

Other, net
3

(3
)

(2
)
Income tax expense
$
339

$
196

$
107

Tax Effects Of Temporary Differences Which Give Rise To Deferred Tax Assets And Liabilities
The tax effects of temporary differences which give rise to deferred tax assets and liabilities are presented below for the years ended December 31 ($ in millions):

2015

2014
Deferred tax assets:

Medical claims liability
$
27

$
27

Accrued expenses
9

11

Net operating loss carryforward
20

21

Compensation accruals
73

53

Acquisition costs
10

—

Premium and related receivables
34

35

Other
18

9

Deferred tax assets
191

156

Valuation allowance
(11
)

(12
)
Net deferred tax assets
$
180

$
144

Deferred tax liabilities:

Intangible assets
$
46

$
25

Prepaid assets
8

6

Depreciation and amortization
31

26

Investments in partnerships
7

—

Other
1

4

Deferred tax liabilities
93

61

Net deferred tax assets
$
87

$
83

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319
+ Details

Name: us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319
+ Details

Name: us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319
+ Details

Name: us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 64 R44.htm IDEA: XBRL DOCUMENT v3.3.1.900

Stock Incentive Plans (Tables)
12 Months Ended

Dec. 31, 2015

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Summary Of Stock Option Activity
Option activity for the year ended December 31, 2015 is summarized below:

Shares

Weighted Average Exercise Price

Aggregate Intrinsic Value
($ in millions)

Weighted Average Remaining Contractual Term
Outstanding as of December 31, 2014
1,267,066

$
12.18

Granted
—

—

Exercised
(588,658
)

12.52

Forfeited
(1,000
)

12.39

Outstanding as of December 31, 2015
677,408

$
11.88

$
37

2.0

Exercisable as of December 31, 2015
670,740

$
11.78

$
36

2.0

Option Pricing Assumptions
The fair value of each option grant is estimated on the date of the grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:

Year Ended December 31,

2015 ⁽¹⁾

2014 ⁽¹⁾

2013
Expected life (in years)
—

—

5.1
Risk-free interest rate
—

—

0.8%
Expected volatility
—

—

48.1%
Expected dividend yield
—

—

—

(1) No options were awarded in the years ended December 31, 2015 and 2014.

Stock Option Awards
Other information pertaining to option activity is as follows:

Year Ended December 31,

2015 ⁽¹⁾

2014 ⁽¹⁾

2013
Weighted-average fair value of options granted
$
—

$
—

$
9.52

Total intrinsic value of stock options exercised ($ in millions)
$
28

$
17

$
13

(1) No options were awarded in the years ended December 31, 2015 and 2014.

Non-Vested Restricted Stock And Restricted Stock
A summary of the Company's non-vested restricted stock and restricted stock unit shares as of December 31, 2015, and changes during the year ended December 31, 2015, is presented below:

Shares

Weighted Average Grant Date Fair Value
Non-vested balance as of December 31, 2014
4,350,014

$
36.86

Granted
1,795,359

58.38

Vested
(1,906,900
)

31.81

Forfeited
(116,470
)

34.10

Non-vested balance as of December 31, 2015
4,122,003

$
48.65

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 65 R45.htm IDEA: XBRL DOCUMENT v3.3.1.900

Commitments (Tables)
12 Months Ended

Dec. 31, 2015

Commitments [Abstract]

Annual Non-Cancelable Minimum Lease Payments
Annual non-cancelable minimum lease payments over the next five years and thereafter are as follows ($ in millions):

2016
$
58

2017
59

2018
50

2019
45

2020
33

Thereafter
70

$
315

X

- Definition
Commitments [Abstract]
+ References
No definition available.
+ Details

Name: cnc_CommitmentsAbstract

Namespace Prefix: cnc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of a lessee's leasing arrangements including: (1) the basis on which contingent rental payments are determined, (2) the existence and terms of renewal or purchase options and escalation clauses, (3) restrictions imposed by lease arrangements, such as those concerning dividends, additional debt, and further leasing, (4) rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions. Disclosure may also include the specific period used to amortize material leasehold improvements made at the inception of the lease or during the lease term. Additionally, for operating leases having initial or remaining noncancelable lease terms in excess of one year: (a) future minimum rental payments required as of the date of the latest balance sheet presented, in the aggregate and for each of the five succeeding fiscal years, (b) the total of minimum rentals to be received in the future under noncancelable subleases as of the date of the latest balance sheet presented, and (c) for all operating leases, rental expense for each period for which an income statement is presented, with separate amounts for minimum rentals, contingent rentals, and sublease rentals. Rental payments under leases with terms of a month or less that were not renewed need not be included.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 1,3)
-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6452660&loc=d3e36991-112694

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41499-112717

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6851643&loc=d3e12069-110248
+ Details

Name: us-gaap_OperatingLeasesOfLesseeDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 66 R46.htm IDEA: XBRL DOCUMENT v3.3.1.900

Earnings Per Share (Tables)
12 Months Ended

Dec. 31, 2015

Earnings Per Share [Abstract]

Calculation Of Basic And Diluted Net Earnings Per Common Share
The following table sets forth the calculation of basic and diluted net earnings per common share for the years ended December 31 ($ in millions, except per share data):

2015

2014

2013
Earnings attributable to Centene Corporation:

Earnings from continuing operations, net of tax
$
356

$
268

$
161

Discontinued operations, net of tax
(1
)

3

4

Net earnings
$
355

$
271

$
165

Shares used in computing per share amounts:

Weighted average number of common shares outstanding
119,100,744

116,345,764

108,253,090

Common stock equivalents (as determined by applying the treasury stock method)
3,965,626

4,014,448

4,241,256

Weighted average number of common shares and potential dilutive common shares outstanding
123,066,370

120,360,212

112,494,346

Net earnings per common share attributable to Centene Corporation:

Basic:

Continuing operations
$
2.99

$
2.30

$
1.49

Discontinued operations
(0.01
)

0.03

0.03

Basic earnings per common share
$
2.98

$
2.33

$
1.52

Diluted:

Continuing operations
$
2.89

$
2.23

$
1.43

Discontinued operations
(0.01
)

0.02

0.04

Diluted earnings per common share
$
2.88

$
2.25

$
1.47

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 67 R47.htm IDEA: XBRL DOCUMENT v3.3.1.900

Segment Information (Tables)
12 Months Ended

Dec. 31, 2015

Segment Reporting [Abstract]

Segment Information

Segment information as of and for the year ended December 31, 2015, follows ($ in millions):

Managed Care

Specialty
Services

Eliminations

Consolidated
Total
Premium and service revenues from external customers
$
19,054

$
2,211

$
—

$
21,265

Premium and service revenues from internal customers
100

4,864

(4,964
)

—

Total premium and service revenues
19,154

7,075

(4,964
)

21,265

Earnings from operations
513

192

—

705

Total assets
6,202

1,137

—

7,339

Segment information as of and for the year ended December 31, 2014, follows ($ in millions):

Managed Care

Specialty
Services

Eliminations

Consolidated
Total
Premium and service revenues from external customers
$
13,886

$
1,781

$
—

$
15,667

Premium and service revenues from internal customers
60

3,019

(3,079
)

—

Total premium and service revenues
13,946

4,800

(3,079
)

15,667

Earnings from operations
353

111

—

464

Total assets
4,706

1,118

—

5,824

Segment information as of and for the year ended December 31, 2013, follows ($ in millions):

Managed Care

Specialty
Services

Eliminations

Consolidated
Total
Premium and service revenues from external customers
$
9,741

$
785

$
—

$
10,526

Premium and service revenues from internal customers
41

2,147

(2,188
)

—

Total premium and service revenues
9,782

2,932

(2,188
)

10,526

Earnings from operations
198

79

—

277

Total assets
2,921

598

—

3,519

X

- Definition
Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8813-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=51669610&loc=d3e8736-108599
+ Details

Name: us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SegmentReportingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 68 R48.htm IDEA: XBRL DOCUMENT v3.3.1.900

Quarterly Selected Financial Information (Tables)
12 Months Ended

Dec. 31, 2015

Quarterly Selected Financial Information [Abstract]

Quarterly Selected Financial Information

For the Quarter Ended

March 31,
2015

June 30,
2015

September 30,
2015

December 31,
2015
Total revenues
$
5,131

$
5,506

$
5,821

$
6,302

Amounts attributable to Centene Corporation common shareholders:
Earnings from continuing operations, net of income tax expense
$
64

$
88

$
92

$
112

Discontinued operations, net of income tax expense (benefit)
(1
)

—

1

(1
)
Net earnings
$
63

$
88

$
93

$
111

Net earnings (loss) per common share attributable to Centene Corporation:
Basic:

Continuing operations
$
0.54

$
0.74

$
0.77

$
0.94

Discontinued operations
(0.01
)

—

0.01

(0.01
)
Basic earnings per common share
$
0.53

$
0.74

$
0.78

$
0.93

Diluted:

Continuing operations
$
0.52

$
0.72

$
0.75

$
0.91

Discontinued operations
(0.01
)

—

0.01

(0.01
)
Diluted earnings per common share
$
0.51

$
0.72

$
0.76

$
0.90

For the Quarter Ended

March 31,
2014

June 30,
2014

September 30,
2014

December 31,
2014
Total revenues
$
3,460

$
4,023

$
4,352

$
4,725

Amounts attributable to Centene Corporation common shareholders:
Earnings from continuing operations, net of income tax expense
$
34

$
47

$
81

$
106

Discontinued operations, net of income tax expense (benefit)
(1
)

2

1

1

Net earnings
$
33

$
49

$
82

$
107

Net earnings (loss) per common share attributable to Centene Corporation:
Basic:

Continuing operations
$
0.30

$
0.41

$
0.69

$
0.90

Discontinued operations
(0.01
)

0.01

0.01

0.01

Basic earnings per common share
$
0.29

$
0.42

$
0.70

$
0.91

Diluted:

Continuing operations
$
0.29

$
0.39

$
0.67

$
0.87

Discontinued operations
(0.01
)

0.02

0.01

0.01

Diluted earnings per common share
$
0.28

$
0.41

$
0.68

$
0.88

X

- Definition
Quarterly Selected Financial Information [Abstract]
+ References
No definition available.
+ Details

Name: cnc_QuarterlySelectedFinancialInformationAbstract

Namespace Prefix: cnc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the quarterly financial data in the annual financial statements. The disclosure includes financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income (loss) before extraordinary items and cumulative effect of a change in accounting principle and earnings per share data.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)-(j)
-URI http://asc.fasb.org/extlink&oid=51825399&loc=d3e1280-108306
+ Details

Name: us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 69 R49.htm IDEA: XBRL DOCUMENT v3.3.1.900

Condensed Financial Information Of Registrant (Tables) - Parent Company [Member]
12 Months Ended

Dec. 31, 2015

Condensed Balance Sheets
Centene Corporation (Parent Company Only)
Condensed Balance Sheets
(In millions, except share data)

December 31,

2015

2014
ASSETS

Current assets:

Cash and cash equivalents
$
4

$
3

Short term investments, at fair value (amortized cost $5 and $8, respectively)
5

8

Other current assets
711

378

Total current assets
720

389

Long term investments, at fair value (amortized cost $6 and $10, respectively)
6

10

Investment in subsidiaries
2,749

2,296

Other long term assets
35

38

Total assets
$
3,510

$
2,733

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities
$
13

$
24

Long term debt
1,147

815

Other long term liabilities
26

3

Total liabilities
1,186

842

Redeemable noncontrolling interest
156

148

Stockholders' equity:

Common stock, $.001 par value; authorized 400,000,000 shares; 126,855,477 issued and 120,342,981 outstanding at December 31, 2015, and 124,274,864 issued and 118,433,416 outstanding at December 31, 2014

—

—

Additional paid-in capital
956

840

Accumulated other comprehensive loss
(10
)

(1
)
Retained earnings
1,358

1,003

Treasury stock, at cost (6,512,496 and 5,841,448 shares, respectively)

(147
)

(98
)
Total Centene stockholders' equity
2,157

1,744

Noncontrolling interest
11

(1
)
Total stockholders' equity
2,168

1,743

Total liabilities and stockholders' equity
$
3,510

$
2,733

Condensed Statements Of Operations
Centene Corporation (Parent Company Only)
Condensed Statements of Operations
(In millions, except share data)

Year Ended December 31,

2015

2014

2013
Expenses:

General and administrative expenses
$
9

$
3

$
4

Gain on contingent consideration
(44
)

—

—

Other income (expense):

Investment and other income
(5
)

1

1

Interest expense
(39
)

(30
)

(23
)
Earnings (loss) before income taxes
(9
)

(32
)

(26
)
Income tax benefit
(26
)

(8
)

(15
)
Net earnings (loss) before equity in subsidiaries
17

(24
)

(11
)
Equity in earnings from subsidiaries
341

285

173

Net earnings
358

261

162

(Earnings) loss attributable to noncontrolling interests
(2
)

7

(1
)
Net earnings attributable to Centene
$
356

$
268

$
161

Net earnings per share from continuing operations:

Basic earnings per common share
$
2.99

$
2.30

$
1.49

Diluted earnings per common share
$
2.89

$
2.23

$
1.43

Weighted average number of shares outstanding:

Basic
119,100,744

116,345,764

108,253,090

Diluted
123,066,370

120,360,212

112,494,346

Condensed Statements Of Cash Flows
Centene Corporation (Parent Company Only)
Condensed Statements of Cash Flows
(In millions)

Year Ended December 31,

2015

2014

2013
Cash flows from operating activities:

Cash provided by operating activities
$
462

$
317

$
302

Cash flows from investing activities:

Net dividends from and capital contributions to subsidiaries
(660
)

(384
)

(417
)
Purchase of investments
(17
)

(32
)

(12
)
Sales and maturities of investments
9

14

10

Proceeds from asset sale
7

—

—

Acquisitions
(113
)

(137
)

(67
)
Net cash used in investing activities
(774
)

(539
)

(486
)
Cash flows from financing activities:

Proceeds from borrowings
1,925

1,875

180

Payment of long term debt
(1,575
)

(1,650
)

(30
)
Proceeds from exercise of stock options
13

8

9

Proceeds from stock offering
—

—

15

Common stock repurchases
(53
)

(29
)

(20
)
Debt issue costs
(4
)

(7
)

(3
)
Payment of contingent consideration obligation
(29
)

—

—

Contributions from noncontrolling interest
11

6

8

Excess tax benefits from stock compensation
25

19

6

Net cash provided by financing activities
313

222

165

Net increase (decrease) in cash and cash equivalents
1

—

(19
)
Cash and cash equivalents, beginning of period
3

3

22

Cash and cash equivalents, end of period
$
4

$
3

$
3

X

- Definition
Schedule of condensed balance sheets [Table Text Block].
+ References
No definition available.
+ Details

Name: cnc_ScheduleOfCondensedBalanceSheetsTableTextBlock

Namespace Prefix: cnc_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Condensed Statements of Cash Flows
+ References
No definition available.
+ Details

Name: cnc_ScheduleOfCondensedStatementsOfCashFlowsTableTextBlock

Namespace Prefix: cnc_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Condensed Statements of Operations
+ References
No definition available.
+ Details

Name: cnc_ScheduleOfCondensedStatementsOfOperationsTableTextBlock

Namespace Prefix: cnc_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: dei_LegalEntityAxis=us-gaap_ParentCompanyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 70 R50.htm IDEA: XBRL DOCUMENT v3.3.1.900

Organization And Operations (Details)
12 Months Ended

Feb. 02, 2015

Dec. 31, 2015

segment

Organization And Operations [Abstract]

Stockholders' Equity Note, Stock Split, Conversion Ratio 2

Number of reportable segments 2

X

- Definition
Organization And Operations [Abstract]
+ References
No definition available.
+ Details

Name: cnc_OrganizationAndOperationsAbstract

Namespace Prefix: cnc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.
+ References
No definition available.
+ Details

Name: us-gaap_NumberOfReportableSegments

Namespace Prefix: us-gaap_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB TOPIC 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Stock Split
-URI http://asc.fasb.org/extlink&oid=6525746
+ Details

Name: us-gaap_StockholdersEquityNoteStockSplitConversionRatio1

Namespace Prefix: us-gaap_

Data Type: xbrli:pureItemType

Balance Type: na

Period Type: duration

XML 71 R51.htm IDEA: XBRL DOCUMENT v3.3.1.900

Summary Of Significant Accounting Policies (Schedule Of Property, Software And Equipment Depreciation Periods) (Details)
12 Months Ended

Dec. 31, 2015

Minimum [Member] | Buildings And Land Improvements [Member]

Property, Plant and Equipment [Line Items]

Fixed Asset - Depreciation Period 3 years

Minimum [Member] | Computer Hardware And Software [Member]

Property, Plant and Equipment [Line Items]

Fixed Asset - Depreciation Period 2 years

Minimum [Member] | Furniture And Equipment [Member]

Property, Plant and Equipment [Line Items]

Fixed Asset - Depreciation Period 3 years

Minimum [Member] | Leasehold Improvements [Member]

Property, Plant and Equipment [Line Items]

Fixed Asset - Depreciation Period 1 year

Maximum [Member] | Buildings And Land Improvements [Member]

Property, Plant and Equipment [Line Items]

Fixed Asset - Depreciation Period 40 years

Maximum [Member] | Computer Hardware And Software [Member]

Property, Plant and Equipment [Line Items]

Fixed Asset - Depreciation Period 7 years

Maximum [Member] | Furniture And Equipment [Member]

Property, Plant and Equipment [Line Items]

Fixed Asset - Depreciation Period 10 years

Maximum [Member] | Leasehold Improvements [Member]

Property, Plant and Equipment [Line Items]

Fixed Asset - Depreciation Period 20 years

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.
+ References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandBuildingsAndImprovementsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 72 R52.htm IDEA: XBRL DOCUMENT v3.3.1.900

Summary Of Significant Accounting Policies (Schedule Of Amortization Period For Intangible Assets) (Details)
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Finite-Lived Intangible Assets [Line Items]

Intangible Assets, Amortization Period 9 years 9 months 10 years 3 months

Purchased Contract Rights [Member]

Finite-Lived Intangible Assets [Line Items]

Intangible Assets, Amortization Period 8 years 9 months 7 years 6 months

Provider Contracts [Member]

Finite-Lived Intangible Assets [Line Items]

Intangible Assets, Amortization Period 11 years 1 month 11 years 1 month

Customer Relationships [Member]

Finite-Lived Intangible Assets [Line Items]

Intangible Assets, Amortization Period 8 years 1 month 7 years 1 month

Trade Names [Member]

Finite-Lived Intangible Assets [Line Items]

Intangible Assets, Amortization Period 7 years 4 months 13 years 1 month

Developed Technology Rights [Member]

Finite-Lived Intangible Assets [Line Items]

Intangible Assets, Amortization Period 5 years

Minimum [Member] | Purchased Contract Rights [Member]

Finite-Lived Intangible Assets [Line Items]

Intangible Assets, Amortization Period 5 years

Minimum [Member] | Provider Contracts [Member]

Finite-Lived Intangible Assets [Line Items]

Intangible Assets, Amortization Period 4 years

Minimum [Member] | Customer Relationships [Member]

Finite-Lived Intangible Assets [Line Items]

Intangible Assets, Amortization Period 3 years

Minimum [Member] | Trade Names [Member]

Finite-Lived Intangible Assets [Line Items]

Intangible Assets, Amortization Period 7 years

Maximum [Member] | Purchased Contract Rights [Member]

Finite-Lived Intangible Assets [Line Items]

Intangible Assets, Amortization Period 15 years

Maximum [Member] | Provider Contracts [Member]

Finite-Lived Intangible Assets [Line Items]

Intangible Assets, Amortization Period 15 years

Maximum [Member] | Customer Relationships [Member]

Finite-Lived Intangible Assets [Line Items]

Intangible Assets, Amortization Period 15 years

Maximum [Member] | Trade Names [Member]

Finite-Lived Intangible Assets [Line Items]

Intangible Assets, Amortization Period 20 years

X

- Definition
Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnc_ProviderContractsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 73 R53.htm IDEA: XBRL DOCUMENT v3.3.1.900

Summary Of Significant Accounting Policies (Schedule Of Allowance For Uncollectible Accounts) (Details) - USD ($)
$ in Millions
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Allowance for Doubtful Accounts Receivable [Roll Forward]

Allowances, beginning of year $ 5 $ 1 $ 1

Amounts charged to expense 12 8 3

Write-offs of uncollectible receivables (7) (4) (3)

Allowances, end of year $ 10 $ 5 $ 1

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The carrying value as of the balance sheet date of the estimated valuation allowance to reduce gross premiums receivable to net realizable value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=49124121&loc=d3e5074-111524

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SX 210.12-09)
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.5)
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910
+ Details

Name: us-gaap_PremiumsReceivableAllowanceForDoubtfulAccounts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of expense for known and estimated loss on collection of premiums receivable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SX 210.12-09)
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690
+ Details

Name: us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsProvisionChargedToExpense1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of decrease during the period to the valuation allowance account representing portions of such account associated with premium receivables that have been determined to be absolutely uncollectible or that were sold or transferred, and which receivables were simultaneously written off.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SX 210.12-09)
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690
+ Details

Name: us-gaap_PremiumsReceivableAllowanceForDoubtfulAccountsWriteOffsAgainstAllowance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 74 R54.htm IDEA: XBRL DOCUMENT v3.3.1.900

Summary Of Significant Accounting Policies (Schedule Of Percentage Of Company's Total Revenues) (Details)
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

TEXAS [Member]

Percentage of revenues under contracts or subcontracts 22.00% 25.00% 37.00%

FLORIDA [Member]

Percentage of revenues under contracts or subcontracts 14.00% 14.00%

X

- Definition
Percentage of revenues under contracts or subcontracts.
+ References
No definition available.
+ Details

Name: cnc_PercentageOfRevenuesUnderContractsOrSubcontracts

Namespace Prefix: cnc_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementGeographicalAxis=stpr_TX

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=stpr_FL

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 75 R55.htm IDEA: XBRL DOCUMENT v3.3.1.900

Summary Of Significant Accounting Policies (Recent Accounting Pronouncements) (Details) - USD ($)
$ in Millions

Dec. 31, 2015

Dec. 31, 2014

New Accounting Pronouncement, Early Adoption [Line Items]

Other Assets, Current $ 390 $ 252

Other long term assets 177 174

Long-term debt 1,223

ASU on presentation of debt issuance costs [Member] | New Accounting Pronouncement, Early Adoption, Effect [Member]

New Accounting Pronouncement, Early Adoption [Line Items]

Other long term assets (14) (14)

Long-term debt (14) (14)

ASU on presentation of deferred tax assets and liabilities as noncurrent [Member] | New Accounting Pronouncement, Early Adoption, Effect [Member]

New Accounting Pronouncement, Early Adoption [Line Items]

Other Assets, Current (102) (83)

Other long term assets $ 102 $ 83

X

- Definition
Carrying amount of long-term debt, net of unamortized discount or premium, including current and noncurrent amounts. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.16)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.16)
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 20, 22
-Article 5
+ Details

Name: us-gaap_LongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementEarlyAdoptionLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Aggregate carrying amount, as of the balance sheet date, of current assets not separately disclosed in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.8)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.17)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherAssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: cnc_ASUAxis=cnc_ASUonclassificationofdebtissuancecostsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_NewAccountingPronouncementEarlyAdoptionAxis=us-gaap_NewAccountingPronouncementEarlyAdoptionEffectMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: cnc_ASUAxis=cnc_ASUASUonpresentationofdeferredtaxassetsandliabilitiesasnoncurrentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 76 R56.htm IDEA: XBRL DOCUMENT v3.3.1.900

Summary Of Significant Accounting Policies (Health Insurance Marketplace) (Details) - USD ($)
$ in Millions
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Accounting Policies [Abstract]

Health Insurance Marketplace Risk Adjustment Payable $ 108 $ 44

Reinsurance reimbursement threshold $45,000 entitled the Company to reimbursement from the programs at 50% coinsurance

Health Insurance Marketplace Reinsurance Receivable $ 24 11

Health Insurance Marketplace Risk Corridor Payable 4 9

Health Insurance Marketplace Minimum Medical Loss Ratio Payable $ 15 $ 6

X

- Definition
Health Insurance Marketplace Minimum Medical Loss Ratio
+ References
No definition available.
+ Details

Name: cnc_HealthInsuranceMarketplaceMinimumMedicalLossRatio

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Health Insurance Marketplace Reinsurance
+ References
No definition available.
+ Details

Name: cnc_HealthInsuranceMarketplaceReinsurance

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Health Insurance Marketplace Risk Adjustment
+ References
No definition available.
+ Details

Name: cnc_HealthInsuranceMarketplaceRiskAdjustment

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Health Insurance Marketplace Risk Corridor
+ References
No definition available.
+ Details

Name: cnc_HealthInsuranceMarketplaceRiskCorridor

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Reinsurance reimbursement threshold
+ References
No definition available.
+ Details

Name: cnc_Reinsurancereimbursementthreshold

Namespace Prefix: cnc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 77 R57.htm IDEA: XBRL DOCUMENT v3.3.1.900

Health Net Merger (Details)
$ / shares in Units, $ in Millions

Jul. 02, 2015

USD ($)

subsidiary

$ / shares

shares

Business Combination, Description [Abstract]

Number of subsidiaries created | subsidiary 2

Share exchange, per share | shares 0.622

Cash consideration for each share due to merger | $ / shares $ 28.25

Total value of merger transaction | $ $ 5,513

X

- Definition
Business Combination, Share Exchange, Per Share
+ References
No definition available.
+ Details

Name: cnc_BusinessCombinationShareExchangePerShare

Namespace Prefix: cnc_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of Subsidiaries Created
+ References
No definition available.
+ Details

Name: cnc_NumberofSubsidiariesCreated

Namespace Prefix: cnc_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.
+ References
No definition available.
+ Details

Name: us-gaap_BusinessAcquisitionSharePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 30
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6578-128477

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 30
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6613-128477
+ Details

Name: us-gaap_BusinessCombinationConsiderationTransferred1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_BusinessCombinationDescriptionAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 78 R58.htm IDEA: XBRL DOCUMENT v3.3.1.900

Acquisitions and Noncontrolling Interest Acquisitions (Details)
€ in Millions, $ in Millions
1 Months Ended 3 Months Ended 12 Months Ended

Jul. 02, 2015

USD ($)

Sep. 30, 2015

USD ($)

May. 31, 2015

USD ($)

Jan. 31, 2015

USD ($)

Jul. 31, 2014

USD ($)

shares

Jan. 31, 2014

USD ($)

shares

Mar. 31, 2015

USD ($)

Dec. 31, 2015

USD ($)

shares

Dec. 31, 2014

USD ($)

shares

Dec. 31, 2013

USD ($)

Dec. 31, 2015

EUR (€)

shares

Dec. 31, 2015

USD ($)

shares

Jul. 01, 2014

EUR (€)

Jul. 01, 2014

USD ($)

Business Acquisition [Line Items]

Acquisition consideration $ 5,513

Goodwill $ 754 $ 348 $ 842

Business Acquisition, Contingent Consideration, Cash Payment $ 29 0 0

Gain on contingent consideration (44) 0 0

Goodwill and intangible adjustment $ 38 0 0

Net intangible assets 120 155

Finite-Lived Intangible Assets, Accumulated Amortization $ 43 $ 62

Common stock, shares authorized to repurchase (in shares) | shares 8,000,000 8,000,000

Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased | shares 3,335,448 3,335,448

Treasury Stock, Shares, Acquired | shares 918,628 626,234

Payments for Repurchase of Common Stock $ 53 $ 29 19

Redeemable noncontrolling interest 148 $ 156

Ribera Salud [Member]

Business Acquisition [Line Items]

Outstanding balance € 46 50 € 48 $ 52

Payments to Acquire Interest in Joint Venture $ 17

Equity Method Investment, Ownership Percentage 50.00%

Community Health Solutions [Member]

Business Acquisition [Line Items]

Contingent liability 18

Business Acquisition, Contingent Consideration, Cash Payment $ 8

Gain on contingent consideration $ (10)

Stock Issued During Period, Shares, Acquisitions | shares 1,492,738

U.S. Medical Management [Member]

Business Acquisition [Line Items]

Redeemable noncontrolling interest 156

Stock Issued During Period, Shares, Acquisitions | shares 4,486,434

Celtic Insurance Company [Member]

Business Acquisition [Line Items]

Ownership percentage sold by parent 25.00%

Proceeds from Divestiture of Businesses $ 7

Managed Care [Member]

Business Acquisition [Line Items]

Goodwill 276 151 361

Managed Care [Member] | Agate Resources, Inc. [Member]

Business Acquisition [Line Items]

Acquisition consideration $ 109

Business acquisition, cash paid 93

Business Combination, Consideration Transfered, Present Value of Future Consideration $ 7

Business Combination, Deferred Payment, Period of Payments 3 years

Contingent liability $ 9

Business Combination, Contingent Consideration Arrangement Based on Achievement of Underwriting Targets, Duration of Cash Payment 3 years

Goodwill $ 48

Recognized identifiable intangible assets $ 39

Description of contingent consideration arrangements A portion of the contingent consideration is based on the achievement of underwriting targets and will be paid in cash over a three year period; the remainder is based on the net proceeds of a retrospective rate adjustment to be settled in 2016.

Managed Care [Member] | LiveHealthier, Inc. [Member]

Business Acquisition [Line Items]

Acquisition consideration 28

Business acquisition, cash paid 11

Contingent liability 4

Goodwill 26

Recognized identifiable intangible assets $ 15

Percentage of voting interests acquired 79.00%

Business Combination, Step Acquisition, Equity Interest in Acquiree, Including Subsequent Acquisition, Percentage 100.00%

Business Combination, Consideration Transferred, Equity Interests Issued and Issuable $ 13

Business Combination, Contingent Consideration Arrangement, Duration of Payment 3 years

Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High $ 9

Managed Care [Member] | Fidelis [Member]

Business Acquisition [Line Items]

Acquisition consideration $ 57

Business acquisition, cash paid 7

Contingent liability 50 16

Goodwill 29 11

Recognized identifiable intangible assets $ 23

Percentage of voting interests acquired 100.00%

Description of contingent consideration arrangements duals membership and revenue per member during the first year of the contract (July 2015 - June 2016), including reconciliation payments settled over a two year period

Business Combination, Goodwill, Deductible for Income Tax , Percentage 100.00%

Net intangible assets 1

Finite-Lived Intangible Assets, Accumulated Amortization 2

Contingent consideration, period of reconciliation payments settled 2 years

Managed Care [Member] | General and Administrative Expense [Member] | Fidelis [Member]

Business Acquisition [Line Items]

Gain on contingent consideration $ (34)

Goodwill and intangible adjustment $ 38

Specialty Services [Member]

Business Acquisition [Line Items]

Goodwill $ 478 $ 197 $ 481

Specialty Services [Member] | U.S. Medical Management [Member]

Business Acquisition [Line Items]

Acquisition consideration $ 213

Business acquisition, cash paid 80

Goodwill 280

Recognized identifiable intangible assets $ 78

Percentage of voting interests acquired 68.00%

Business Combination, Consideration Transferred, Equity Interests Issued and Issuable $ 133

Business Combination, Total Fair Value 352

Redeemable Noncontrolling Interest, Equity, Fair Value $ 139

Percent of goodwill deductible for tax purposes 45.00%

Percent of future consideration issuable in shares 50.00%

X

- Definition
Business Acquisition, Contingent Consideration, Cash Payment
+ References
No definition available.
+ Details

Name: cnc_BusinessAcquisitionContingentConsiderationCashPayment

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Business Combination, Consideration Transfered, Present Value of Future Consideration
+ References
No definition available.
+ Details

Name: cnc_BusinessCombinationConsiderationTransferedPresentValueofFutureConsideration

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Business Combination, Contingent Consideration Arrangement Based on Achievement of Underwriting Targets, Duration of Cash Payment
+ References
No definition available.
+ Details

Name: cnc_BusinessCombinationContingentConsiderationArrangementBasedonAchievementofUnderwritingTargetsDurationofCashPayment

Namespace Prefix: cnc_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Business Combination, Contingent Consideration Arrangement, Duration of Payment
+ References
No definition available.
+ Details

Name: cnc_BusinessCombinationContingentConsiderationArrangementDurationofPayment

Namespace Prefix: cnc_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Business Combination, Deferred Payment, Period of Payments
+ References
No definition available.
+ Details

Name: cnc_BusinessCombinationDeferredPaymentPeriodofPayments

Namespace Prefix: cnc_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Business Combination, Goodwill, Deductible for Income Tax , Percentage
+ References
No definition available.
+ Details

Name: cnc_BusinessCombinationGoodwillDeductibleforIncomeTaxPercentage

Namespace Prefix: cnc_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Business Combination, Total Fair Value
+ References
No definition available.
+ Details

Name: cnc_BusinessCombinationTotalFairValue

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Contingent consideration, period of reconciliation payments settled
+ References
No definition available.
+ Details

Name: cnc_Contingentconsiderationperiodofreconciliationpaymentssettled

Namespace Prefix: cnc_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Ownership percentage sold by parent
+ References
No definition available.
+ Details

Name: cnc_Ownershippercentagesoldbyparent

Namespace Prefix: cnc_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Percent of future consideration issuable in shares
+ References
No definition available.
+ Details

Name: cnc_Percentoffutureconsiderationissuableinshares

Namespace Prefix: cnc_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
The percent of goodwill arising from a business combination that is expected to be deductible for tax purposes.
+ References
No definition available.
+ Details

Name: cnc_Percentofgoodwilldeductiblefortaxpurposes

Namespace Prefix: cnc_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_BusinessAcquisitionLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of voting equity interests acquired at the acquisition date in the business combination.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463
+ Details

Name: us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 30
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6578-128477

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 30
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6613-128477
+ Details

Name: us-gaap_BusinessCombinationConsiderationTransferred1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 30
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6578-128477

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 30
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6911251&loc=d3e6613-128477
+ Details

Name: us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479
+ Details

Name: us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
For contingent consideration arrangements recognized in connection with a business combination, this element represents a description of such arrangements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (c)(2)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479
+ Details

Name: us-gaap_BusinessCombinationContingentConsiderationArrangementsDescription

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (c)(3)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479
+ Details

Name: us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liability recognized arising from contingent consideration in a business combination.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 35
-Paragraph 1
-Subparagraph b
-URI http://asc.fasb.org/extlink&oid=6911338&loc=d3e6819-128478

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 25
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476
+ Details

Name: us-gaap_BusinessCombinationContingentConsiderationLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of identifiable intangible assets recognized as of the acquisition date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 55
-Paragraph 37
-URI http://asc.fasb.org/extlink&oid=35744172&loc=d3e2207-128464

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=56956791&loc=d3e4845-128472
+ Details

Name: us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Percentage of voting equity interests acquired in a business combination achieved in stages, including equity interests in the acquiree held by the acquirer immediately before the acquisition date and acquired at the acquisition date.
+ References
No definition available.
+ Details

Name: us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeIncludingSubsequentAcquisitionPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571
+ Details

Name: us-gaap_EquityMethodInvestmentOwnershipPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266
+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.
+ References
No definition available.
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetImpairment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.
+ References
No definition available.
+ Details

Name: us-gaap_LettersOfCreditOutstandingAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The cash outflow to reacquire common stock during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_PaymentsForRepurchaseOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquireBusinessesGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquireInterestInJointVenture

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3179-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133
+ Details

Name: us-gaap_ProceedsFromDivestitureOfBusinesses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 3A
-Subparagraph (12)(c)
-URI http://asc.fasb.org/extlink&oid=27011957&loc=SL6540498-122764

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 3A
-Subparagraph (16)(c)
-URI http://asc.fasb.org/extlink&oid=27011957&loc=SL6540498-122764

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 3A
-Subparagraph 15
-URI http://asc.fasb.org/extlink&oid=27011957&loc=SL6540498-122764

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 3A
-Subparagraph 14
-URI http://asc.fasb.org/extlink&oid=27011957&loc=SL6540498-122764
+ Details

Name: us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 3A
-Subparagraph 14
-URI http://asc.fasb.org/extlink&oid=27011957&loc=SL6540498-122764

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 3A
-Subparagraph 15
-URI http://asc.fasb.org/extlink&oid=27011957&loc=SL6540498-122764

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 3A
-Subparagraph (16)(c)
-URI http://asc.fasb.org/extlink&oid=27011957&loc=SL6540498-122764

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 3A
-Subparagraph (12)(c)
-URI http://asc.fasb.org/extlink&oid=27011957&loc=SL6540498-122764
+ Details

Name: us-gaap_RedeemableNoncontrollingInterestEquityFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Number of shares of stock issued during the period pursuant to acquisitions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28,29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30
-Article 5
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesAcquisitions

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.
+ References
No definition available.
+ Details

Name: us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.
+ References
No definition available.
+ Details

Name: us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares that have been repurchased during the period and are being held in treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30
-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3
+ Details

Name: us-gaap_TreasuryStockSharesAcquired

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: dei_LegalEntityAxis=cnc_RiberaSaludMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=cnc_CommunityHealthSolutionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=cnc_U.S.MedicalManagementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=cnc_CelticInsuranceCompanyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=cnc_ManagedCareMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=cnc_AgateResourcesInc.Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=cnc_LiveHealthierInc.Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=cnc_FidelisMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=cnc_SpecialtyServicesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 79 R59.htm IDEA: XBRL DOCUMENT v3.3.1.900

Acquisitions and Noncontrolling Interest Non Controlling Interest (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended

Dec. 31, 2015

Sep. 30, 2015

Jun. 30, 2015

Mar. 31, 2015

Dec. 31, 2014

Sep. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Net [Abstract]

Net earnings attributable to Centene $ 112 $ 92 $ 88 $ 64 $ 106 $ 81 $ 47 $ 34 $ 356 $ 268 $ 161

Increase in equity for distributions from and consolidation of noncontrolling interest 11 7

Reclassification to redeemable noncontrolling interest 1 (9) 0

Net transfers from (to) noncontrolling interest 12 (9) 7

Changes from net earnings attributable to Centene Corporation and net transfers from (to) the noncontrolling interest 368 259 168

Reconciliation of Changes in the Redeemable Noncontrolling Interest [Roll Forward]

Redeemable noncontrolling interest, beginning balance $ 148 148

Reclassification to redeemable noncontrolling interest (1) 9 $ 0

Net earnings attributable to noncontrolling interest 2

Redeemable noncontrolling interest, ending balance $ 156 $ 148 $ 156 $ 148

Celtic Insurance Company [Member]

Noncontrolling Interest [Line Items]

Ownership percentage by parent 75.00% 100.00% 75.00% 100.00% 100.00%

Centurion [Member]

Noncontrolling Interest [Line Items]

Ownership percentage by parent 51.00% 51.00% 51.00% 51.00% 51.00%

Home State Health Plan [Member]

Noncontrolling Interest [Line Items]

Ownership percentage by parent 95.00% 95.00% 95.00% 95.00% 95.00%

U.S. Medical Management [Member]

Noncontrolling Interest [Line Items]

Ownership percentage by parent 68.00% 68.00% 68.00% 68.00% 0.00%

Noncontrolling Interest [Member]

Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Net [Abstract]

Increase in equity for distributions from and consolidation of noncontrolling interest $ 11 $ 0 $ 7

Reclassification to redeemable noncontrolling interest 1 (9)

Reconciliation of Changes in the Redeemable Noncontrolling Interest [Roll Forward]

Reclassification to redeemable noncontrolling interest (1) $ 9

U.S. Medical Management [Member]

Reconciliation of Changes in the Redeemable Noncontrolling Interest [Roll Forward]

Fair value of noncontrolling interest sold 7

Redeemable noncontrolling interest, ending balance $ 156 $ 156

X

- Definition
Reclassification to redeemable noncontrolling interest
+ References
No definition available.
+ Details

Name: cnc_Reclassificationtoredeemablenoncontrollinginterest

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Reconciliation of Changes in the Redeemable Noncontrolling Interest [Roll Forward]
+ References
No definition available.
+ Details

Name: cnc_ReconciliationofChangesintheRedeemableNoncontrollingInterestRollForward

Namespace Prefix: cnc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
This element represents the total net income attributable to the parent for the period and the effect of net changes during the period impacting the parent's ownership interest in a subsidiary as it relates to the total (consolidated) equity attributable to the parent. The changes to the parent's ownership interest in a subsidiary represented by this element did not result in a deconsolidation of the subsidiary from the consolidated financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4M
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591554-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the period impacting the parent's ownership interest in a subsidiary as it relates to the total (consolidated) equity attributable to the parent. The changes to the parent's ownership interest in a subsidiary represented by this element did not arise in a deconsolidation of the subsidiary from the consolidated financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4M
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591554-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesNetAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of income (loss) from continuing operations attributable to the parent. Also defined as revenue less expenses and taxes from ongoing operations before extraordinary items but after deduction of those portions of income or loss from continuing operations that are allocable to noncontrolling interests.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.13)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4613673-111683
+ Details

Name: us-gaap_IncomeLossFromContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_MinorityInterestLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The parent entity's interest in net assets of the subsidiary, expressed as a percentage.
+ References
No definition available.
+ Details

Name: us-gaap_MinorityInterestOwnershipPercentageByParent

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.19)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688
+ Details

Name: us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(2)
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 23
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569655-111683
+ Details

Name: us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(2)
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 23
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569655-111683
+ Details

Name: us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 3A
-Subparagraph (12)(c)
-URI http://asc.fasb.org/extlink&oid=27011957&loc=SL6540498-122764

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 3A
-Subparagraph (16)(c)
-URI http://asc.fasb.org/extlink&oid=27011957&loc=SL6540498-122764

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 3A
-Subparagraph 15
-URI http://asc.fasb.org/extlink&oid=27011957&loc=SL6540498-122764

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 3A
-Subparagraph 14
-URI http://asc.fasb.org/extlink&oid=27011957&loc=SL6540498-122764
+ Details

Name: us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: dei_LegalEntityAxis=cnc_CelticInsuranceCompanyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=cnc_CenturionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=cnc_HomeStateHealthPlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=cnc_U.S.MedicalManagementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=cnc_U.S.MedicalManagementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 80 R60.htm IDEA: XBRL DOCUMENT v3.3.1.900

Short-Term And Long-Term Investments And Restricted Deposits (Narrative) (Details)
$ in Millions
12 Months Ended

Dec. 31, 2015

USD ($)

position

Investments, Debt and Equity Securities [Abstract]

Percentage of Investment Grade Investments Rated by S&P or Moody's 99.00%

Positions from which gross unrealized losses were generated 429

Total number of positions 733

Income (Loss) from Equity Method Investments | $ $ 8

X

- Definition
Percentage of Investment Grade Investments Rated by S&P or Moody's
+ References
No definition available.
+ Details

Name: cnc_PercentageofInvestmentGradeInvestmentsRatedbySPorMoodys

Namespace Prefix: cnc_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Positions from which gross unrealized losses were generated
+ References
No definition available.
+ Details

Name: cnc_PositionsFromWhichGrossUnrealizedLossesWereGenerated

Namespace Prefix: cnc_

Data Type: xbrli:decimalItemType

Balance Type: na

Period Type: instant

X

- Definition
Total Unrealized Investment Positions
+ References
No definition available.
+ Details

Name: cnc_Totalunrealizedinvestmentpositions

Namespace Prefix: cnc_

Data Type: xbrli:decimalItemType

Balance Type: na

Period Type: instant

X

- Definition
This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35755396&loc=d3e33749-111570

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.12)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 9
-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 11
-Article 7
+ Details

Name: us-gaap_IncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 81 R61.htm IDEA: XBRL DOCUMENT v3.3.1.900

Short-Term And Long-Term Investments And Restricted Deposits (Short-Term And Long-Term Investments, Restricted Deposits) (Details) - USD ($)
$ in Millions

Dec. 31, 2015

Dec. 31, 2014

Schedule Of Investments And Restricted Deposits By Type [Line Items]

Amortized Cost $ 2,225 $ 1,556

Available For Sale Securities Gross Unrealized Gain Accumulated In Investments 5 5

Available For Sale Securities Gross Unrealized Loss Accumulated In Investments (12) (4)

Fair Value 2,218 1,557

US Treasury and Government [Member]

Schedule Of Investments And Restricted Deposits By Type [Line Items]

Amortized Cost 431 393

Available For Sale Securities Gross Unrealized Gain Accumulated In Investments 0 1

Available For Sale Securities Gross Unrealized Loss Accumulated In Investments (2) (2)

Fair Value 429 392

Corporate Debt Securities [Member]

Schedule Of Investments And Restricted Deposits By Type [Line Items]

Amortized Cost 859 556

Available For Sale Securities Gross Unrealized Gain Accumulated In Investments 2 2

Available For Sale Securities Gross Unrealized Loss Accumulated In Investments (8) (2)

Fair Value 853 556

Restricted Certificates Of Deposit [Member]

Schedule Of Investments And Restricted Deposits By Type [Line Items]

Amortized Cost 5 6

Available For Sale Securities Gross Unrealized Gain Accumulated In Investments 0 0

Available For Sale Securities Gross Unrealized Loss Accumulated In Investments 0 0

Fair Value 5 6

Restricted Cash Equivalents [Member]

Schedule Of Investments And Restricted Deposits By Type [Line Items]

Amortized Cost 78 79

Available For Sale Securities Gross Unrealized Gain Accumulated In Investments 0 0

Available For Sale Securities Gross Unrealized Loss Accumulated In Investments 0 0

Fair Value 78 79

Municipal Bonds [Member]

Schedule Of Investments And Restricted Deposits By Type [Line Items]

Amortized Cost 496 174

Available For Sale Securities Gross Unrealized Gain Accumulated In Investments 2 1

Available For Sale Securities Gross Unrealized Loss Accumulated In Investments (1) 0

Fair Value 497 175

Asset-backed Securities [Member]

Schedule Of Investments And Restricted Deposits By Type [Line Items]

Amortized Cost 163 180

Available For Sale Securities Gross Unrealized Gain Accumulated In Investments 0 0

Available For Sale Securities Gross Unrealized Loss Accumulated In Investments (1) 0

Fair Value 162 180

Residential Mortgage Backed Securities [Member]

Schedule Of Investments And Restricted Deposits By Type [Line Items]

Amortized Cost 66 84

Available For Sale Securities Gross Unrealized Gain Accumulated In Investments 1 1

Available For Sale Securities Gross Unrealized Loss Accumulated In Investments 0 0

Fair Value 67 85

Commercial Mortgage Backed Securities [Member]

Schedule Of Investments And Restricted Deposits By Type [Line Items]

Amortized Cost 40 0

Available For Sale Securities Gross Unrealized Gain Accumulated In Investments 0 0

Available For Sale Securities Gross Unrealized Loss Accumulated In Investments 0 0

Fair Value 40 0

Cost Method Investments And Equity Method Securities [Member]

Schedule Of Investments And Restricted Deposits By Type [Line Items]

Amortized Cost 71 68

Available For Sale Securities Gross Unrealized Gain Accumulated In Investments 0 0

Available For Sale Securities Gross Unrealized Loss Accumulated In Investments 0 0

Fair Value 71 68

Life Insurance Contracts [Member]

Schedule Of Investments And Restricted Deposits By Type [Line Items]

Amortized Cost 16 16

Available For Sale Securities Gross Unrealized Gain Accumulated In Investments 0 0

Available For Sale Securities Gross Unrealized Loss Accumulated In Investments 0 0

Fair Value $ 16 $ 16

X

- Definition
Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 25
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=51813488&loc=d3e22054-111558

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 5
-Subparagraph (aa)
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27232-111563

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49167202&loc=d3e26610-111562
+ Details

Name: us-gaap_AvailableForSaleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before tax of unrealized gain in accumulated other comprehensive income (AOCI) on investments in debt and equity securities classified as available-for-sale.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563
+ Details

Name: us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before tax of unrealized loss in accumulated other comprehensive income (AOCI) on investments in debt and equity securities classified as available-for-sale.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27161-111563
+ Details

Name: us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.2)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AvailableForSaleSecuritiesAmortizedCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_USTreasuryAndGovernmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_CorporateDebtSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=cnc_RestrictedCertificatesOfDepositMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=cnc_RestrictedCashEquivalentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_MunicipalBondsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_AssetBackedSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_CommercialMortgageBackedSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=cnc_CostMethodInvestmentsAndEquityMethodSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=cnc_LifeInsuranceContractsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 82 R62.htm IDEA: XBRL DOCUMENT v3.3.1.900

Short-Term And Long-Term Investments And Restricted Deposits (Fair Value Of Available-For-Sale Investments With Gross Unrealized Losses By Investment Type And Length Of Time) (Details) - USD ($)
$ in Millions

Dec. 31, 2015

Dec. 31, 2014

Schedule of Available-for-sale Securities [Line Items]

Available For Sale Securities Continuous Unrealized Loss Position Less Than 12 Months Aggregate Losses Accumulated In Investments $ (10) $ (2)

Less Than 12 Months, Fair Value 1,248 491

Available For Sale Securities Continuous Unrealized Loss Position 12 Months Or Longer Aggregate Losses Accumulated In Investments (2) (2)

12 Months or More, Fair Value 68 198

U.S. Treasury Securities And Obligations Of U.S. Government Corporations And Agencies [Member]

Schedule of Available-for-sale Securities [Line Items]

Available For Sale Securities Continuous Unrealized Loss Position Less Than 12 Months Aggregate Losses Accumulated In Investments (2) 0

Less Than 12 Months, Fair Value 294 72

Available For Sale Securities Continuous Unrealized Loss Position 12 Months Or Longer Aggregate Losses Accumulated In Investments 0 (2)

12 Months or More, Fair Value 14 180

Corporate Securities [Member]

Schedule of Available-for-sale Securities [Line Items]

Available For Sale Securities Continuous Unrealized Loss Position Less Than 12 Months Aggregate Losses Accumulated In Investments (6) (2)

Less Than 12 Months, Fair Value 561 311

Available For Sale Securities Continuous Unrealized Loss Position 12 Months Or Longer Aggregate Losses Accumulated In Investments (2) 0

12 Months or More, Fair Value 41 1

Municipal Securities, General Obligation [Member]

Schedule of Available-for-sale Securities [Line Items]

Available For Sale Securities Continuous Unrealized Loss Position Less Than 12 Months Aggregate Losses Accumulated In Investments (1) 0

Less Than 12 Months, Fair Value 208 20

Available For Sale Securities Continuous Unrealized Loss Position 12 Months Or Longer Aggregate Losses Accumulated In Investments 0 0

12 Months or More, Fair Value 5 7

Asset-backed Securities [Member]

Schedule of Available-for-sale Securities [Line Items]

Available For Sale Securities Continuous Unrealized Loss Position Less Than 12 Months Aggregate Losses Accumulated In Investments (1) 0

Less Than 12 Months, Fair Value 121 70

Available For Sale Securities Continuous Unrealized Loss Position 12 Months Or Longer Aggregate Losses Accumulated In Investments 0 0

12 Months or More, Fair Value 8 10

Residential Mortgage Backed Securities [Member]

Schedule of Available-for-sale Securities [Line Items]

Available For Sale Securities Continuous Unrealized Loss Position Less Than 12 Months Aggregate Losses Accumulated In Investments 0 0

Less Than 12 Months, Fair Value 30 18

Available For Sale Securities Continuous Unrealized Loss Position 12 Months Or Longer Aggregate Losses Accumulated In Investments 0 0

12 Months or More, Fair Value 0 0

Commercial Mortgage Backed Securities [Member]

Schedule of Available-for-sale Securities [Line Items]

Available For Sale Securities Continuous Unrealized Loss Position Less Than 12 Months Aggregate Losses Accumulated In Investments 0 0

Less Than 12 Months, Fair Value 34 0

Available For Sale Securities Continuous Unrealized Loss Position 12 Months Or Longer Aggregate Losses Accumulated In Investments 0 0

12 Months or More, Fair Value $ 0 $ 0

X

- Definition
Amount of accumulated unrealized loss on investments in debt and equity securities classified as available-for-sale that have been in a continuous loss position for twelve months or longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 6
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27290-111563

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27337-111563
+ Details

Name: us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of accumulated unrealized loss on investments in debt and equity securities classified as available-for-sale that have been in a continuous loss position for less than twelve months.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 6
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27290-111563

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27337-111563
+ Details

Name: us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This item represents the aggregate fair value of investments in debt and equity securities categorized neither as held-to-maturity nor trading securities that have been in a continuous unrealized loss position for less than twelve months.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27337-111563

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 6
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27290-111563
+ Details

Name: us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This item represents the aggregate fair value of investments in debt and equity securities categorized neither as held-to-maturity nor trading securities that have been in a continuous unrealized loss position for twelve months or longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 6
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27290-111563

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27337-111563
+ Details

Name: us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_USTreasuryAndGovernmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_CorporateDebtSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_MunicipalBondsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_AssetBackedSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_CommercialMortgageBackedSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 83 R63.htm IDEA: XBRL DOCUMENT v3.3.1.900

Short-Term And Long-Term Investments And Restricted Deposits (Contractual Maturities Of Short-Term And Long-Term Investments And Restricted Deposits) (Details) - USD ($)
$ in Millions

Dec. 31, 2015

Dec. 31, 2014

Investments [Member]

Schedule of Available-for-sale Securities [Line Items]

One year or less, Amortized Cost $ 176 $ 176

One year through five years, Amortized Cost 1,662 1,121

Five years through ten years, Amortized Cost 267 121

Greater than ten years, Amortized Cost 5 38

Total, Amortized Cost 2,110 1,456

One year or less, Fair Value 176 177

One year through five years, Fair Value 1,654 1,121

Five years through ten years, Fair Value 268 120

Greater than ten years, Fair Value 5 39

Total, Fair Value 2,103 1,457

Restricted Deposits [Member]

Schedule of Available-for-sale Securities [Line Items]

One year or less, Amortized Cost 93 92

One year through five years, Amortized Cost 22 8

Five years through ten years, Amortized Cost 0 0

Greater than ten years, Amortized Cost 0 0

Total, Amortized Cost 115 100

One year or less, Fair Value 93 92

One year through five years, Fair Value 22 8

Five years through ten years, Fair Value 0 0

Greater than ten years, Fair Value 0 0

Total, Fair Value $ 115 $ 100

X

- Definition
Investments and restricted deposits contractual maturities after five through ten years amortized cost
+ References
No definition available.
+ Details

Name: cnc_InvestmentsAndRestrictedDepositsContractualMaturitiesAfterFiveThroughTenYearsAmortizedCost

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Investments and restricted deposits contractual maturities after five through ten years fair value
+ References
No definition available.
+ Details

Name: cnc_InvestmentsAndRestrictedDepositsContractualMaturitiesAfterFiveThroughTenYearsFairValue

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Investments and restricted deposits contractual maturities after one through five years amortized cost
+ References
No definition available.
+ Details

Name: cnc_InvestmentsAndRestrictedDepositsContractualMaturitiesAfterOneThroughFiveYearsAmortizedCost

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Investments and restricted deposits contractual maturities after one through five years fair value
+ References
No definition available.
+ Details

Name: cnc_InvestmentsAndRestrictedDepositsContractualMaturitiesAfterOneThroughFiveYearsFairValue

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
InvestmentsAndRestrictedDepositsContractualMaturitiesAfterTenYearsAmortizedCost
+ References
No definition available.
+ Details

Name: cnc_InvestmentsAndRestrictedDepositsContractualMaturitiesAfterTenYearsAmortizedCost

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Investments and restricted deposits contractual maturities after ten years fair value
+ References
No definition available.
+ Details

Name: cnc_InvestmentsAndRestrictedDepositsContractualMaturitiesAfterTenYearsFairValue

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Investments and restricted deposits contractual maturities amortized cost
+ References
No definition available.
+ Details

Name: cnc_InvestmentsAndRestrictedDepositsContractualMaturitiesAmortizedCost

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Investments and restricted deposits contractual maturities fair value
+ References
No definition available.
+ Details

Name: cnc_InvestmentsAndRestrictedDepositsContractualMaturitiesFairValue

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Investments and restricted deposits contractual maturities within one year amortized cost
+ References
No definition available.
+ Details

Name: cnc_InvestmentsAndRestrictedDepositsContractualMaturitiesWithinOneYearAmortizedCost

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Investments and restricted deposits contractual maturities within one year fair value
+ References
No definition available.
+ Details

Name: cnc_InvestmentsAndRestrictedDepositsContractualMaturitiesWithinOneYearFairValue

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: cnc_ScheduleOfContractualMaturitiesOfInvestmentsAndRestrictedDepositsAxis=us-gaap_InvestmentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: cnc_ScheduleOfContractualMaturitiesOfInvestmentsAndRestrictedDepositsAxis=us-gaap_DepositsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 84 R64.htm IDEA: XBRL DOCUMENT v3.3.1.900

Fair Value Measurements (Fair Value Measurements By Level For Assets Measured At Fair Value On A Recurring Basis) (Details) - USD ($)
$ in Millions

Dec. 31, 2015

Dec. 31, 2014

Cash and cash equivalents $ 1,760 $ 1,610

U.S. Treasury securities and obligations of U.S. government corporations and agencies 397 377

Corporate securities 853 556

Municipal securities 497 175

Asset backed securities 162 180

Total investments 2,016 1,373

Cash and cash equivalents 78 79

Certificates of deposit 5 6

U.S. Treasury securities and obligations of U.S. government corporations and agencies 32 15

Total restricted deposits 115 100

Interest rate swap agreements 11 11

Total assets at fair value 3,902 3,094

Interest rate swap agreements 2

Total liabilities at fair value 2

Level I [Member]

Cash and cash equivalents 1,760 1,610

U.S. Treasury securities and obligations of U.S. government corporations and agencies 325 360

Corporate securities 0 0

Municipal securities 0 0

Asset backed securities 0 0

Total investments 325 360

Cash and cash equivalents 78 79

Certificates of deposit 5 6

U.S. Treasury securities and obligations of U.S. government corporations and agencies 32 15

Total restricted deposits 115 100

Interest rate swap agreements 0 0

Total assets at fair value 2,200 2,070

Interest rate swap agreements 0

Total liabilities at fair value 0

Level II [Member]

Cash and cash equivalents 0 0

U.S. Treasury securities and obligations of U.S. government corporations and agencies 72 17

Corporate securities 853 556

Municipal securities 497 175

Asset backed securities 162 180

Total investments 1,691 1,013

Cash and cash equivalents 0 0

Certificates of deposit 0 0

U.S. Treasury securities and obligations of U.S. government corporations and agencies 0 0

Total restricted deposits 0 0

Interest rate swap agreements 11 11

Total assets at fair value 1,702 1,024

Interest rate swap agreements 2

Total liabilities at fair value 2

Level III [Member]

Cash and cash equivalents 0 0

U.S. Treasury securities and obligations of U.S. government corporations and agencies 0 0

Corporate securities 0 0

Municipal securities 0 0

Asset backed securities 0 0

Total investments 0 0

Cash and cash equivalents 0 0

Certificates of deposit 0 0

U.S. Treasury securities and obligations of U.S. government corporations and agencies 0 0

Total restricted deposits 0 0

Interest rate swap agreements 0 0

Total assets at fair value 0 0

Interest rate swap agreements 0

Total liabilities at fair value 0

Residential Mortgage Backed Securities [Member]

Residential mortgage backed securities 67 85

Commercial mortgage backed securities 67 85

Residential Mortgage Backed Securities [Member] | Level I [Member]

Residential mortgage backed securities 0 0

Commercial mortgage backed securities 0 0

Residential Mortgage Backed Securities [Member] | Level II [Member]

Residential mortgage backed securities 67 85

Commercial mortgage backed securities 67 85

Residential Mortgage Backed Securities [Member] | Level III [Member]

Residential mortgage backed securities 0 0

Commercial mortgage backed securities 0 0

Commercial Mortgage Backed Securities [Member]

Residential mortgage backed securities 40 0

Commercial mortgage backed securities 40 0

Commercial Mortgage Backed Securities [Member] | Level I [Member]

Residential mortgage backed securities 0

Commercial mortgage backed securities 0

Commercial Mortgage Backed Securities [Member] | Level II [Member]

Residential mortgage backed securities 40 0

Commercial mortgage backed securities 40 0

Commercial Mortgage Backed Securities [Member] | Level III [Member]

Residential mortgage backed securities 0 0

Commercial mortgage backed securities $ 0 $ 0

X

- Definition
This element represents asset backed securities reported on the balance sheet at period end measured at fair value by the entity. This element is intended to be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements.
+ References
No definition available.
+ Details

Name: cnc_AssetBackedSecuritiesFairValueDisclosure

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This element represents restricted cash and cash equivalents reported on the balance sheet at period end measured at fair value by the entity. This element is intended to be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements.
+ References
No definition available.
+ Details

Name: cnc_CashAndCashEquivalentsRestrictedFairValueDisclosure

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This element represents restricted certificates of deposit reported on the balance sheet at period end measured at fair value by the entity. This element is intended to be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements.
+ References
No definition available.
+ Details

Name: cnc_CertificatesOfDepositRestrictedFairValueDisclosure

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Corporate securities
+ References
No definition available.
+ Details

Name: cnc_CorporateSecuritiesFairValueDisclosure

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Municipal Securities Fair Value Disclosure
+ References
No definition available.
+ Details

Name: cnc_MunicipalSecuritiesFairValueDisclosure

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This element represents total restricted deposits reported on the balance sheet at period end measured at fair value by the entity. This element is intended to be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements.
+ References
No definition available.
+ Details

Name: cnc_TotalRestrictedDepositsFairValueDisclosure

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This element represents U.S. Treasury securities and obligations of U.S. government corporations and agencies reported on the balance sheet at period end measured at fair value by the entity. This element is intended to be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements.
+ References
No definition available.
+ Details

Name: cnc_UsTreasurySecuritiesAndObligationsOfUsGovernmentCorporationsAndAgenciesFairValueDisclosure

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This element represents restricted U.S. Treasury securities and obligations of U.S. government corporations and agencies reported on the balance sheet at period end measured at fair value by the entity. This element is intended to be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements.
+ References
No definition available.
+ Details

Name: cnc_UsTreasurySecuritiesAndObligationsOfUsGovernmentCorporationsAndAgenciesRestrictedFairValueDisclosure

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258
+ Details

Name: us-gaap_AssetsFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash
-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash Equivalents
-URI http://asc.fasb.org/extlink&oid=6507016
+ Details

Name: us-gaap_CashAndCashEquivalentsFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value as of the balance sheet date of interest rate derivative assets, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611
+ Details

Name: us-gaap_InterestRateDerivativeAssetsAtFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value as of the balance sheet date of interest rate derivative liabilities, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as liabilities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611
+ Details

Name: us-gaap_InterestRateDerivativeLiabilitiesAtFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Trading Securities
-URI http://asc.fasb.org/extlink&oid=6526789

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 35
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=27723805&loc=d3e24584-111560

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 320
-SubTopic 10
-Section 25
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=51813488&loc=d3e22054-111558

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Available-for-Sale Securities
-URI http://asc.fasb.org/extlink&oid=6505594

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 1
-Subparagraph a, f, g
-Article 7
+ Details

Name: us-gaap_InvestmentsFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value of financial and nonfinancial obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258
+ Details

Name: us-gaap_LiabilitiesFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Fair value of securitized, pay-through debt securities collateralized by real estate mortgage loans classified as available-for-sale.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Mortgage-Backed Securities
-URI http://asc.fasb.org/extlink&oid=6517959
+ Details

Name: us-gaap_MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_CommercialMortgageBackedSecuritiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 85 R65.htm IDEA: XBRL DOCUMENT v3.3.1.900

Fair Value Measurements (Narrative) (Details) - USD ($)
$ in Millions

Dec. 31, 2015

Dec. 31, 2014

Fair Value Disclosures [Abstract]

Transfers from Level I to Level II $ 53

Transfers from Level II to Level I 0

Life insurance contracts and cost-method investments $ 87 $ 84

X

- Definition
Life insurance contracts and cost method investments fair value disclosure
+ References
No definition available.
+ Details

Name: cnc_LifeInsuranceContractsAndCostMethodInvestmentsFairValueDisclosure

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of transfers of assets measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bb)
-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueAssetsLevel1ToLevel2TransfersAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of transfers of assets measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bb)
-URI http://asc.fasb.org/extlink&oid=36462937&loc=d3e19207-110258
+ Details

Name: us-gaap_FairValueAssetsLevel2ToLevel1TransfersAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 86 R66.htm IDEA: XBRL DOCUMENT v3.3.1.900

Property, Software And Equipment (Details) - USD ($)
$ in Millions
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Property, Plant and Equipment [Line Items]

Property, software and equipment, gross $ 869 $ 733

Less accumulated depreciation (351) (288)

Property, software and equipment, net 518 445

Depreciation expense 78 65 $ 52

Computer Software [Member]

Property, Plant and Equipment [Line Items]

Property, software and equipment, gross 237 198

Buildings [Member]

Property, Plant and Equipment [Line Items]

Property, software and equipment, gross 223 208

Land [Member]

Property, Plant and Equipment [Line Items]

Property, software and equipment, gross 104 87

Computer Hardware [Member]

Property, Plant and Equipment [Line Items]

Property, software and equipment, gross 105 88

Furniture And Office Equipment [Member]

Property, Plant and Equipment [Line Items]

Property, software and equipment, gross 92 70

Leasehold Improvements [Member]

Property, Plant and Equipment [Line Items]

Property, software and equipment, gross 108 82

Assets Held Under Capital Leases [Member]

Property, Plant and Equipment [Line Items]

Less accumulated depreciation (4) (3)

Property, software and equipment, net $ 6 $ 7

X

- Definition
Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.14)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585
+ Details

Name: us-gaap_Depreciation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 13
-Subparagraph a
-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 8
-Article 7
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerSoftwareIntangibleAssetMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=cnc_ComputerHardwareMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=cnc_FurnitureAndOfficeEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AssetsHeldUnderCapitalLeasesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 87 R67.htm IDEA: XBRL DOCUMENT v3.3.1.900

Goodwill And Intangible Assets (Schedule Of Changes In Goodwill By Operating Segment) (Details) - USD ($)
$ in Millions
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Goodwill [Roll Forward]

Goodwill, beginning $ 754 $ 348

Acquisition 106 406

Impairment 18

Goodwill, ending 842 754

Managed Care [Member]

Goodwill [Roll Forward]

Goodwill, beginning 276 151

Acquisition 103 125

Impairment 18

Goodwill, ending 361 276

Specialty Services [Member]

Goodwill [Roll Forward]

Goodwill, beginning 478 197

Acquisition 3 281

Impairment 0

Goodwill, ending $ 481 $ 478

X

- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266
+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267
+ Details

Name: us-gaap_GoodwillAcquiredDuringPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13777-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267
+ Details

Name: us-gaap_GoodwillImpairmentLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_GoodwillRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=cnc_ManagedCareMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=cnc_SpecialtyServicesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 88 R68.htm IDEA: XBRL DOCUMENT v3.3.1.900

Goodwill And Intangible Assets (Schedule Of Intangible Assets) (Details) - USD ($)
$ in Millions
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Finite-Lived Intangible Assets [Line Items]

Amortization expenses $ 24 $ 16 $ 6

Intangible assets $ 217 $ 163

Weighted Average Life in Years 9 years 9 months 10 years 3 months

Total accumulated amortization $ (62) $ (43)

Intangible Assets, Net, Total 155 120

Purchased Contract Rights [Member]

Finite-Lived Intangible Assets [Line Items]

Intangible assets $ 71 $ 28

Weighted Average Life in Years 8 years 9 months 7 years 6 months

Total accumulated amortization $ (21) $ (14)

Provider Contracts [Member]

Finite-Lived Intangible Assets [Line Items]

Intangible assets $ 103 $ 103

Weighted Average Life in Years 11 years 1 month 11 years 1 month

Total accumulated amortization $ (24) $ (14)

Customer Relationships [Member]

Finite-Lived Intangible Assets [Line Items]

Intangible assets $ 26 $ 15

Weighted Average Life in Years 8 years 1 month 7 years 1 month

Total accumulated amortization $ (14) $ (12)

Trade Names [Member]

Finite-Lived Intangible Assets [Line Items]

Intangible assets $ 12 $ 17

Weighted Average Life in Years 7 years 4 months 13 years 1 month

Total accumulated amortization $ (2) $ (3)

Developed Technology Rights [Member]

Finite-Lived Intangible Assets [Line Items]

Intangible assets $ 5 0

Weighted Average Life in Years 5 years

Total accumulated amortization $ (1) $ 0

X

- Definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275
+ Details

Name: us-gaap_AmortizationOfIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cnc_ProviderContractsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 89 R69.htm IDEA: XBRL DOCUMENT v3.3.1.900

Goodwill And Intangible Assets (Schedule Of Future Amortization Expenses) (Details)
$ in Millions

Dec. 31, 2015

USD ($)

Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]

2016 $ 22

2017 19

2018 18

2019 18

2020 $ 16

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 90 R70.htm IDEA: XBRL DOCUMENT v3.3.1.900

Medical Claims Liability (Schedule Of Change In Medical Claims Liability) (Details) - USD ($)
$ in Millions
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Liability for Claims and Claims Adjustment Expense [Line Items]

Incurred related to: Prior years $ (229) $ (142) $ (78)

Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]

Balance, January 1, 1,723 1,112 815

Acquisitions 79 0 0

Incurred related to: Current year 17,471 12,820 9,073

Incurred related to: Prior years (229) (142) (78)

Total incurred 17,242 12,678 8,995

Paid related to: Current year 15,279 11,122 7,975

Paid related to: Prior years (1,467) (945) (723)

Total paid 16,746 12,067 8,698

Balance, December 31, 2,298 1,723 1,112

Reinsurance recoverables 31 22

Medicaid Premium Revenue [Member]

Liability for Claims and Claims Adjustment Expense [Line Items]

Incurred related to: Prior years (47) (26) 0

Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]

Incurred related to: Prior years $ (47) $ (26) $ 0

X

- Definition
The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 50
-Paragraph 3
-Subparagraph (a),(b),(c)
-URI http://asc.fasb.org/extlink&oid=6482485&loc=d3e14764-158437
+ Details

Name: us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.
+ References
No definition available.
+ Details

Name: us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of payments to settle claims incurred in the current period and related claims settlement costs.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6482485&loc=d3e14764-158437
+ Details

Name: us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of payments to settle claims incurred in prior periods and related claims settlement costs.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6482485&loc=d3e14764-158437
+ Details

Name: us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of expense for claims incurred and costs incurred in the claim settlement process.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 50
-Paragraph 3
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6482485&loc=d3e14764-158437
+ Details

Name: us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of payments to settle insured claims and pay costs incurred in the claims settlement process.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585
+ Details

Name: us-gaap_PaymentsForLossesAndLossAdjustmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after valuation allowance recoverable including premium paid under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, premium paid, policy benefits and policy reserves.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 20
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6480758&loc=d3e6824-158387

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.(a),6)
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910
+ Details

Name: us-gaap_ReinsuranceRecoverables

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of expense for claims incurred in the current reporting period and related claims settlement costs.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 235
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-18)
-URI http://asc.fasb.org/extlink&oid=34713774&loc=d3e575016-122915
+ Details

Name: us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 235
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-18)
-URI http://asc.fasb.org/extlink&oid=34713774&loc=d3e575016-122915
+ Details

Name: us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=cnc_MedicaidPremiumRevenueMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 91 R71.htm IDEA: XBRL DOCUMENT v3.3.1.900

Health Insurance Marketplace (Details) - USD ($)
$ in Millions

Dec. 31, 2015

Dec. 31, 2014

Health Insurance Marketplace [Abstract]

Health Insurance Marketplace Risk adjustment Payable $ (108) $ (44)

Health Insurance Marketplace Reinsurance Receivable 24 11

Health Insurance Marketplace Risk Corridor Payable (4) (9)

Health Insurance Marketplace Minimum Medical Loss Ratio Payable $ (15) $ (6)

X

- Definition
Health Insurance Marketplace [Abstract]
+ References
No definition available.
+ Details

Name: cnc_HealthInsuranceMarketplaceAbstract

Namespace Prefix: cnc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Health Insurance Marketplace Minimum Medical Loss Ratio
+ References
No definition available.
+ Details

Name: cnc_HealthInsuranceMarketplaceMinimumMedicalLossRatio

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Health Insurance Marketplace Reinsurance
+ References
No definition available.
+ Details

Name: cnc_HealthInsuranceMarketplaceReinsurance

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Health Insurance Marketplace Risk Adjustment
+ References
No definition available.
+ Details

Name: cnc_HealthInsuranceMarketplaceRiskAdjustment

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Health Insurance Marketplace Risk Corridor
+ References
No definition available.
+ Details

Name: cnc_HealthInsuranceMarketplaceRiskCorridor

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 92 R72.htm IDEA: XBRL DOCUMENT v3.3.1.900

Debt (Schedule Of Debt) (Details) - USD ($)
$ in Millions

Dec. 31, 2015

Dec. 31, 2014

Debt Instrument [Line Items]

Fair value of interest rate swap agreements $ 9 $ 11

Senior Notes, Total 937 740

Revolving credit agreement 225 75

Mortgage notes payable 67 70

Capital leases 6 8

Debt issuance costs (14) (14)

Total debt 1,221 879

Less current portion (5) (5)

Long term debt 1,216 874

5.75% Senior notes, due June 1, 2017 [Member]

Debt Instrument [Line Items]

Debt face amount $ 425 $ 425

Interest rate stated, percentage 5.75% 5.75%

4.75% Senior Notes, due May 15, 2022 [Member]

Debt Instrument [Line Items]

Debt face amount $ 500 $ 500

Interest rate stated, percentage 4.75% 4.75%

Senior Notes [Member] | 5.75% Senior notes, due June 1, 2017 [Member]

Debt Instrument [Line Items]

$425 million 5.75% Senior notes, due June 1, 2017 $ 428 $ 429

Senior Notes [Member] | 4.75% Senior Notes, due May 15, 2022 [Member]

Debt Instrument [Line Items]

$500 million 4.75% Senior notes, due May 15, 2022 $ 500 $ 300

X

- Definition
Senior Notes At Par
+ References
No definition available.
+ Details

Name: cnc_SeniorNotesAtPar

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Senior Notes, Total
+ References
No definition available.
+ Details

Name: cnc_SeniorNotesTotal

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal through the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 16
-Article 7
+ Details

Name: us-gaap_CapitalLeaseObligations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying values as of the balance sheet date of all debt, including all short-term borrowings, long-term debt, and capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.13,16)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.16)
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910
+ Details

Name: us-gaap_DebtAndCapitalLeaseObligations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Face (par) amount of debt instrument at time of issuance.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399
+ Details

Name: us-gaap_DebtInstrumentFaceAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Fair value as of the balance sheet date of interest rate derivative assets, net of interest rate derivative liabilities, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized on the balance sheet.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13495-108611
+ Details

Name: us-gaap_InterestRateDerivativesAtFairValueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.16)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.16)
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 19, 20, 22
-Article 5
+ Details

Name: us-gaap_LineOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt, after unamortized discount or premium, scheduled to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebtCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying amount of long-term debt, net of unamortized discount or premium, excluding amounts to be repaid within one year or the normal operating cycle, if longer (current maturities). Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebtNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Including the current and noncurrent portions, the carrying value of notes payable which were initially due after one year or beyond the normal operating cycle, if longer, and which are not otherwise defined in the taxonomy.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.16)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.16(a))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 20, 22
-Article 5
+ Details

Name: us-gaap_OtherNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.16(a))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.16)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_SeniorNotes

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.17)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_UnamortizedDebtIssuanceExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_DebtInstrumentAxis=cnc_FivePointSevenFivePercentSeniorNotesDueJuneFirstTwentySeventeenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=cnc_FourPointSevenFivePercentSeniorNotesDueonMayFifteenTwentyTwentyTwoMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 93 R73.htm IDEA: XBRL DOCUMENT v3.3.1.900

Debt (Narrative) (Details)
€ in Millions, $ in Millions
12 Months Ended

Dec. 31, 2015

EUR (€)

Dec. 31, 2015

USD ($)

Jan. 31, 2015

USD ($)

Dec. 31, 2014

USD ($)

Jul. 01, 2014

EUR (€)

Jul. 01, 2014

USD ($)

Apr. 30, 2014

USD ($)

Debt Instrument [Line Items]

Derivative, notional amount $ 200

Fair value of swap agreements, assets $ 11 $ 11

Fair value of swap agreements, liabilities 2

Revolving credit facility, maximum borrowing capacity 500

Revolving credit facility, due date Jun. 01, 2018

Line of credit, minimum carrying amount of unrestricted cash 100

Revolving credit agreement $ 225 75

Weighted average interest rate of outstanding borrowings 2.05% 2.05%

Covenant terms The agreement contains non-financial and financial covenants, including requirements of minimum fixed charge coverage ratios, maximum debt-to-EBITDA ratios and minimum tangible net worth. The Company is required to not exceed a maximum debt-to-EBITDA ratio of 3.0 to 1.0.

Ratio of debt to EBITDA 3.0

Mortgage notes payable $ 67 70

Senior notes, effective yield 1.55% 1.55%

Surety Bonds $ 305

Fair Value of Outstanding Debt 1,239 $ 901

Interest Rate Swap [Member]

Debt Instrument [Line Items]

Derivative, notional amount $ 750

Variable rate of swap, percentage 2.85% 2.85%

Weighted average interest rate, interest rate swap agreements 3.22% 3.22%

4.75% Senior Notes, due May 15, 2022 [Member]

Debt Instrument [Line Items]

Senior notes, at par $ 200 $ 300

Interest rate stated, percentage 4.75% 4.75%

Maturity date May 15, 2022

4.75% Senior Notes, due May 15, 2022 [Member] | Interest Rate Swap [Member]

Debt Instrument [Line Items]

Derivative, notional amount $ 300

5.75% Senior notes, due June 1, 2017 [Member]

Debt Instrument [Line Items]

Senior notes, at par $ 425

Maturity date Jun. 01, 2017

Non-recourse Mortgage Note Due January 1, 2021 [Member]

Debt Instrument [Line Items]

Maturity date Jan. 01, 2021

Mortgage notes payable 67

Mortgage note non-recourse interest rate 5.14%

Net book value of collateralized properties 151

Ribera Salud [Member]

Debt Instrument [Line Items]

Outstanding balance € 46 50 € 48 $ 52

Non Revolver Letter of Credit [Member]

Debt Instrument [Line Items]

Outstanding balance $ 47

$200 Million Interest Rate Swap [Member]

Debt Instrument [Line Items]

Variable rate of swap, percentage 2.88% 2.88%

June 1, 2017 Expiration [Member] | Interest Rate Swap [Member]

Debt Instrument [Line Items]

Derivative, notional amount $ 250

May 15, 2022 Expiration [Member] | Interest Rate Swap [Member]

Debt Instrument [Line Items]

Derivative, notional amount $ 500

5.75% Senior notes, due June 1, 2017 [Member]

Debt Instrument [Line Items]

Interest rate stated, percentage 5.75% 5.75% 5.75%

4.75% Senior Notes, due May 15, 2022 [Member]

Debt Instrument [Line Items]

Interest rate stated, percentage 4.75% 4.75% 4.75%

4.75% Senior Notes, due May 15, 2022 [Member] | Senior Notes [Member]

Debt Instrument [Line Items]

Senior notes, at par $ 500 $ 300

X

- Definition
Line of Credit Facility, Covenant Terms, Ratio Of Debt To Earnings Before Interest Taxes Depreciation And Amortization
+ References
No definition available.
+ Details

Name: cnc_LineofCreditFacilityCovenantTermsRatioOfDebtToEarningsBeforeInterestTaxesDepreciationandAmortization

Namespace Prefix: cnc_

Data Type: xbrli:pureItemType

Balance Type: na

Period Type: duration

X

- Definition
Line of Credit, Minimum carrying amount of unrestricted cash
+ References
No definition available.
+ Details

Name: cnc_LineofCreditMinimumcarryingamountofunrestrictedcash

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Net book value of collateralized properties
+ References
No definition available.
+ Details

Name: cnc_NetBookValueOfCollateralizedProperties

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Senior Notes At Par
+ References
No definition available.
+ Details

Name: cnc_SeniorNotesAtPar

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
weighted average interest rate, interest rate swap agreements
+ References
No definition available.
+ Details

Name: cnc_Weightedaverageinterestrateinterestrateswapagreements

Namespace Prefix: cnc_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate notional amount specified by the derivative(s). Expressed as an absolute value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 12
-Section 13
-Sentence Column B
+ Details

Name: invest_DerivativeNotionalAmount

Namespace Prefix: invest_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: instant

X

- Definition
Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399
+ Details

Name: us-gaap_DebtInstrumentInterestRateEffectivePercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(2))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentMaturityDate

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average interest rate of debt outstanding.
+ References
No definition available.
+ Details

Name: us-gaap_DebtWeightedAverageInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.
+ References
No definition available.
+ Details

Name: us-gaap_DerivativeVariableInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (b)(1)
-URI http://asc.fasb.org/extlink&oid=6851643&loc=d3e12069-110248
+ Details

Name: us-gaap_GuaranteeObligationsMaximumExposure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Fair value as of the balance sheet date of interest rate derivative assets, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611
+ Details

Name: us-gaap_InterestRateDerivativeAssetsAtFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value as of the balance sheet date of interest rate derivative liabilities, which includes all such derivative instruments in hedging and nonhedging relationships that are recognized as liabilities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13433-108611
+ Details

Name: us-gaap_InterestRateDerivativeLiabilitiesAtFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.
+ References
No definition available.
+ Details

Name: us-gaap_LettersOfCreditOutstandingAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.16)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.16)
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 19, 20, 22
-Article 5
+ Details

Name: us-gaap_LineOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Description of the conditions for borrowing under the credit facility including the nature of any restrictions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(b),22(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LineOfCreditFacilityCovenantTerms

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Date the credit facility terminates, in CCYY-MM-DD format.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(b),22(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LineOfCreditFacilityExpirationDate1

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(b),22(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.
+ References
No definition available.
+ Details

Name: us-gaap_LongTermDebtFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The stated interest rate on the mortgage loan receivable or the weighted average interest rate on a group of loans.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 948
-SubTopic 310
-Section S99
-Paragraph 1
-Subparagraph (SX 210.12-29)
-URI http://asc.fasb.org/extlink&oid=6589523&loc=d3e617274-123014

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-Section S99
-Paragraph 6
-Subparagraph (SX 210.5-04.(c) Schedule IV)
-URI http://asc.fasb.org/extlink&oid=27047687&loc=d3e5864-122674
+ Details

Name: us-gaap_MortgageLoansOnRealEstateInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Including the current and noncurrent portions, the carrying value of notes payable which were initially due after one year or beyond the normal operating cycle, if longer, and which are not otherwise defined in the taxonomy.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.16)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.16(a))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 20, 22
-Article 5
+ Details

Name: us-gaap_OtherNotesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=cnc_FourPointSevenFivePercentSeniorNotesDueonMayFifteenTwentyTwentyTwoMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=cnc_FivePointSevenFivePercentSeniorNotesDueJuneFirstTwentySeventeenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=cnc_NonRecourseMortgageNoteDueJanuary12021Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=cnc_RiberaSaludMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CreditFacilityAxis=cnc_NonRevolverLetterofCreditMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_VariableRateAxis=cnc_A200MillionInterestRateSwapMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeByNatureAxis=cnc_June12017ExpirationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeByNatureAxis=cnc_May152022ExpirationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=cnc_FivePointSevenFivePercentSeniorNotesDueJuneFirstTwentySeventeenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=cnc_FourPointSevenFivePercentSeniorNotesDueonMayFifteenTwentyTwentyTwoMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 94 R74.htm IDEA: XBRL DOCUMENT v3.3.1.900

Debt (Schedule Of Aggregate Maturities Of Debt) (Details)
$ in Millions

Dec. 31, 2015

USD ($)

Debt Disclosure [Abstract]

2016 $ 5

2017 429

2018 228

2019 4

2020 4

Thereafter 553

Total $ 1,223

X

- References
No definition available.
+ Details

Name: us-gaap_DebtDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Carrying amount of long-term debt, net of unamortized discount or premium, including current and noncurrent amounts. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.16)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.16)
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 20, 22
-Article 5
+ Details

Name: us-gaap_LongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04.(a))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690
+ Details

Name: us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04.(a))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601
+ Details

Name: us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04.(a))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690
+ Details

Name: us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04.(a))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601
+ Details

Name: us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04.(a))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690
+ Details

Name: us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04.(a))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690
+ Details

Name: us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 95 R75.htm IDEA: XBRL DOCUMENT v3.3.1.900

Stockholders' Equity (Details) - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended 12 Months Ended

Jul. 31, 2014

Jan. 31, 2014

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Class of Stock [Line Items]

Preferred stock, shares authorized 10,000,000 10,000,000

Preferred stock, par value (in usd per share) $ 0.001 $ 0.001

Common stock, shares authorized to repurchase 8,000,000

Remaining number of shares available to be repurchased 3,335,448

Treasury Stock, Shares, Acquired 918,628 626,234

Payments for repurchase of common stock (in usd) $ 53 $ 29 $ 19

U.S. Medical Management [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, Acquisitions 4,486,434

Community Health Solutions [Member]

Class of Stock [Line Items]

Stock Issued During Period, Shares, Acquisitions 1,492,738

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ClassOfStockLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash outflow to reacquire common stock during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_PaymentsForRepurchaseOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29
-Article 5
+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29
-Article 5
+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of stock issued during the period pursuant to acquisitions.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28,29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30
-Article 5
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesAcquisitions

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.
+ References
No definition available.
+ Details

Name: us-gaap_StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The remaining number of shares authorized to be repurchased by an entity's Board of Directors under a stock repurchase plan.
+ References
No definition available.
+ Details

Name: us-gaap_StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares that have been repurchased during the period and are being held in treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30
-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3
+ Details

Name: us-gaap_TreasuryStockSharesAcquired

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=cnc_U.S.MedicalManagementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BusinessAcquisitionAxis=cnc_CommunityHealthSolutionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 96 R76.htm IDEA: XBRL DOCUMENT v3.3.1.900

Statutory Capital Requirements And Dividend Restrictions (Details) - USD ($)
$ in Millions

Dec. 31, 2015

Dec. 31, 2014

Statutory Capital Requirements And Dividend Restrictions [Abstract]

Statutory capital and surplus $ 2,284 $ 1,699

Required minimum aggregate statutory capital and surplus $ 1,195 $ 851

X

- Definition
Statutory capital requirements and dividend restrictions [Abstract]
+ References
No definition available.
+ Details

Name: cnc_StatutoryCapitalRequirementsAndDividendRestrictionsAbstract

Namespace Prefix: cnc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of statutory capital and surplus (stockholders' equity) as of the balance sheet date using prescribed or permitted statutory accounting practices (rather than GAAP, if different) of the state or country.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.23(c))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 505
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6486098&loc=d3e24708-158529

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 24
-Subparagraph c
-Article 7
+ Details

Name: us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of statutory capital required to be maintained as of the balance sheet date under prescribed or permitted statutory accounting practices.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 505
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6486098&loc=d3e24708-158529
+ Details

Name: us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 97 R77.htm IDEA: XBRL DOCUMENT v3.3.1.900

Income Taxes (Consolidated Income Tax Expense) (Details) - USD ($)
$ in Millions
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Income Tax Disclosure [Abstract]

Federal $ 332 $ 225 $ 121

State and local 26 13 6

Total current provision 358 238 127

Deferred provision (19) (42) (20)

Income tax expense $ 339 $ 196 $ 107

X

- Definition
Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6509736

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 6
-Section I
-Paragraph Question 1-7
+ Details

Name: us-gaap_CurrentFederalTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6509736

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 6
-Section I
-Subsection 7
+ Details

Name: us-gaap_CurrentIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6509736

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 6
-Section I
-Subsection 7
+ Details

Name: us-gaap_CurrentStateAndLocalTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of other deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. For example, but not limited to, acquisition-date income tax benefits or expenses recognized from changes in the acquirer's valuation allowance for its previously existing deferred tax assets resulting from a business combination and adjustments to beginning-of-year balance of a valuation allowance because of a change in circumstance causing a change in judgment about the realizability of the related deferred tax asset in future periods.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (g),(h)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Deferred Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6510177

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 6
-Section I
-Subsection 7
+ Details

Name: us-gaap_DeferredOtherTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Income Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6515339
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 98 R78.htm IDEA: XBRL DOCUMENT v3.3.1.900

Income Taxes (Reconciliation Of The Tax Provision At The U.S. Federal Statutory Rate To The Provision For Income Taxes) (Details) - USD ($)
$ in Millions
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Income Tax Disclosure [Abstract]

Earnings from continuing operations, before income tax expense $ 697 $ 457 $ 269

(Earnings) loss attributable to flow through noncontrolling interest 1 4 (1)

Earnings from continuing operations, less noncontrolling interest, before income tax expense 698 461 268

Tax provision at the U.S. federal statutory rate 244 162 94

State income taxes, net of federal income tax benefit 15 6 3

Nondeductible compensation 2 1 12

Benefit from reversal of prior years impact of 162(m)(6) regulations 0 (14) 0

ACA Health Insurer Fee 75 44 0

Other, net 3 (3) (2)

Income tax expense $ 339 $ 196 $ 107

X

- Definition
ACA Health Insurer Fee
+ References
No definition available.
+ Details

Name: cnc_ACAHealthInsurerFee

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Benefit from reversal of prior years impact of 162(m)(6) regulations
+ References
No definition available.
+ Details

Name: cnc_Benefitfromreversalofprioryearsimpactof162m6regulations

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Less Noncontrolling Interest
+ References
No definition available.
+ Details

Name: cnc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsLessNoncontrollingInterest

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Less flow through noncontrolling interest
+ References
No definition available.
+ Details

Name: cnc_LessFlowThroughNoncontrollingInterest

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(1)(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Income Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6515339
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Subparagraph 2
-Article 4
+ Details

Name: us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible equity-based compensation costs.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319
+ Details

Name: us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319
+ Details

Name: us-gaap_IncomeTaxReconciliationOtherReconcilingItems

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Subparagraph 1
-Article 4
+ Details

Name: us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 99 R79.htm IDEA: XBRL DOCUMENT v3.3.1.900

Income Taxes (Tax Effects Of Temporary Differences Which Give Rise To Deferred Tax Assets And Liabilities) (Details) - USD ($)
$ in Millions

Dec. 31, 2015

Dec. 31, 2014

Income Tax Disclosure [Abstract]

Medical claims liability $ 27 $ 27

Accrued expenses 9 11

Net operating loss carryforward 20 21

Compensation accruals 73 53

Acquisition costs 10 0

Premium and related receivables 34 35

Other 18 9

Deferred tax assets 191 156

Valuation allowance (11) (12)

Net deferred tax assets 180 144

Intangible assets 46 25

Prepaid assets 8 6

Depreciation and amortization 31 26

Investments in partnerships 7 0

Other 1 4

Deferred tax liabilities 93 61

Net deferred tax assets $ 87 $ 83

X

- Definition
Deferred Tax Assets, Tax Deferred Expense, Acquisition Costs
+ References
No definition available.
+ Details

Name: cnc_DeferredTaxAssetsTaxDeferredExpenseAcquisitionCosts

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Deferred tax liabilities, Depreciation and amortization, Noncurrent
+ References
No definition available.
+ Details

Name: cnc_DeferredTaxLiabilitiesDepreciationAndAmortizationNoncurrent

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Deferred Tax Liabilities, Investment In Subsidiaries
+ References
No definition available.
+ Details

Name: cnc_DeferredTaxLiabilitiesInvestmentInSubsidiaries

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Deferred tax liabilities, Prepaid assets and other, current
+ References
No definition available.
+ Details

Name: cnc_DeferredTaxLiabilitiesPrepaidAssetsAndOtherCurrent

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Premium and related receivables
+ References
No definition available.
+ Details

Name: cnc_Premiumandrelatedreceivables

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of deferred tax liability attributable to taxable temporary differences.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Deferred Tax Liability
-URI http://asc.fasb.org/extlink&oid=6510232

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 15
-Subparagraph b(2)
-Article 7
+ Details

Name: us-gaap_DeferredIncomeTaxLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Deferred Tax Asset
-URI http://asc.fasb.org/extlink&oid=6510090
+ Details

Name: us-gaap_DeferredTaxAssetsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, before jurisdictional netting.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsLiabilitiesNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b),(c)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=51675352&loc=d3e28680-109314
+ Details

Name: us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences not separately disclosed.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=51675352&loc=d3e28680-109314
+ Details

Name: us-gaap_DeferredTaxAssetsOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=51675352&loc=d3e28680-109314

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319
+ Details

Name: us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=51675352&loc=d3e28680-109314
+ Details

Name: us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=51675352&loc=d3e28680-109314

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319
+ Details

Name: us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsValuationAllowance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=51675352&loc=d3e28680-109314

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319
+ Details

Name: us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of deferred tax liability attributable to taxable temporary differences not separately disclosed.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32632-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=51675352&loc=d3e28680-109314

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32621-109319
+ Details

Name: us-gaap_DeferredTaxLiabilitiesOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 100 R80.htm IDEA: XBRL DOCUMENT v3.3.1.900

Income Taxes (Narrative) (Details) - USD ($)
$ in Millions
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Operating Loss Carryforwards [Line Items]

Federal and state net operating losses acquired in business combinations $ 6

Valuation allowance additions in the tax provision 1 $ 5

Valuation allowance reductions 2 1

Unrecognized Tax Benefits 4 4

Tax Benefit Related to 2013 $ 14

Undistributed earnings from non-US subsidiaries $ 8

Minimum [Member]

Operating Loss Carryforwards [Line Items]

Federal Net Operating Losses Expire Period 2020

State Net Operating Losses Expire Period 2016

Maximum [Member]

Operating Loss Carryforwards [Line Items]

Federal Net Operating Losses Expire Period 2033

State Net Operating Losses Expire Period 2035

X

- Definition
Federal net operating losses expire period.
+ References
No definition available.
+ Details

Name: cnc_FederalNetOperatingLossesExpirePeriod

Namespace Prefix: cnc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Net Operating Losses Acquired In Business Combinations
+ References
No definition available.
+ Details

Name: cnc_NetOperatingLossesAcquiredInBusinessCombinations

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
State net operating losses expire period.
+ References
No definition available.
+ Details

Name: cnc_StateNetOperatingLossesExpirePeriod

Namespace Prefix: cnc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tax benefit recognized for new regulations on compensation deduction limitation in 2013 and 2014, related to 2013.
+ References
No definition available.
+ Details

Name: cnc_TaxBenefitRelatedto2013

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Valuation allowance additions.
+ References
No definition available.
+ Details

Name: cnc_ValuationAllowanceAdditions

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Valuation allowance reductions.
+ References
No definition available.
+ Details

Name: cnc_ValuationAllowanceReductions

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingLossCarryforwardsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 740
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 740
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6479915&loc=d3e66715-112838

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 995
-SubTopic 740
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6503627&loc=d3e59836-110443

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 3
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=51675352&loc=d3e28200-109314

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (b)(c)
-URI http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331
+ Details

Name: us-gaap_UndistributedEarningsOfForeignSubsidiaries

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of unrecognized tax benefits pertaining to uncertain tax positions taken in tax returns.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=SL6600010-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Unrecognized Tax Benefit
-URI http://asc.fasb.org/extlink&oid=6527854
+ Details

Name: us-gaap_UnrecognizedTaxBenefits

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 101 R81.htm IDEA: XBRL DOCUMENT v3.3.1.900

Stock Incentive Plans (Narrative) (Details) - USD ($)
$ in Millions
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Length of time options exercisable, years 10 years

Shares available for future awards 2,528,371

Allocated share-based compensation expense $ 71 $ 48 $ 36

Income tax benefit recognized 24 17 8

Fair value of restricted stock and restricted stock units 112 $ 82 $ 49

Unrecognized compensation cost related to non-vested share $ 191

Weighted-average period 1 year 3 months

Employee stock purchase plan issued 86,819 76,088 84,168

Stock Options [Member] | Minimum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock options vesting period, years 3 years

Stock Options [Member] | Maximum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock options vesting period, years 5 years

Restricted Stock Units Awards [Member] | Minimum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock options vesting period, years 1 year

Restricted Stock Units Awards [Member] | Maximum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock options vesting period, years 10 years

X

- Definition
Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 14.F)
-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)(i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 14
-Section F
+ Details

Name: us-gaap_AllocatedShareBasedCompensationExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Unrecognized cost of unvested share-based compensation awards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The total recognized tax benefit related to compensation cost for equity-based payment arrangements recognized in income during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)(i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares issued during the period as a result of an employee stock purchase plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30
-Article 5
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 102 R82.htm IDEA: XBRL DOCUMENT v3.3.1.900

Stock Incentive Plans (Summary Of Stock Option Activity) (Details)
$ / shares in Units, $ in Millions
12 Months Ended

Dec. 31, 2015

USD ($)

$ / shares

shares

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Shares outstanding as of December 31, 2014 | shares 1,267,066

Shares granted | shares 0

Shares exercised | shares 588,658

Shares forfeited | shares (1,000)

Shares outstanding as of December 31, 2015 | shares 677,408

Shares exercisable as of December 31, 2015 | shares 670,740

Weighted Average Exercise Price Outstanding as of December 31, 2014 (usd per share) | $ / shares $ 12.18

Weighted Average Exercise Price Granted (usd per share) | $ / shares 0.00

Weighted Average Exercise Price Exercised (usd per share) | $ / shares 12.52

Weighted Average Exercise Price Forfeited (usd per share) | $ / shares 12.39

Weighted Average Exercise Price Outstanding as of December 31, 2015 (usd per share) | $ / shares 11.88

Weighted Average Exercise Price Exercisable as of December 31, 2015 (usd per share) | $ / shares $ 11.78

Aggregate Intrinsic Value Outstanding as of December 31, 2015 | $ $ 37

Aggreggate Intrinsic Value Exercisable as of December 31, 2015 | $ $ 36

Weighted Average Remaining Contractual Term Outstanding as of December 31, 2015 2 years

Weighted Average Remaining Contractual Term Exercisable as of December 31, 2015 2 years

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(3)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of options outstanding, including both vested and non-vested options.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount by which the current fair value of the underlying stock exceeds the exercise price of fully vested and expected to vest options outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
As of the balance sheet date, the number of shares into which fully vested and expected to vest stock options outstanding can be converted under the option plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which option holders acquired shares when converting their stock options into shares.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28,29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30
-Article 5
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 103 R83.htm IDEA: XBRL DOCUMENT v3.3.1.900

Stock Incentive Plans (Option Pricing Assumptions) (Details)
12 Months Ended

Dec. 31, 2015
^[1]
Dec. 31, 2014
^[1]
Dec. 31, 2013

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Expected life (in years) 0 years 0 years 5 years 1 month 20 days

Risk-free interest rate 0.00% 0.00% 0.80%

Expected volatility 0.00% 0.00% 48.10%

Expected dividend yield 0.00% 0.00% 0.00%

[1] No options were awarded in the years ended December 31, 2015 and 2014.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The risk-free interest rate assumption that is used in valuing an option on its own shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average expected volatility rate of share-based compensation awards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 14.D.2)
-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 14
-Section D
-Subsection 2
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

XML 104 R84.htm IDEA: XBRL DOCUMENT v3.3.1.900

Stock Incentive Plans (Schedule Of Other Information Pertaining To Option Activity) (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended

Dec. 31, 2015
^[1]
Dec. 31, 2014
^[1]
Dec. 31, 2013

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Weighted-average fair value of options granted (usd per share) $ 0.00 $ 0.00 $ 9.52

Total intrinsic value of stock options exercised $ 28 $ 17 $ 13

[1] No options were awarded in the years ended December 31, 2015 and 2014.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

XML 105 R85.htm IDEA: XBRL DOCUMENT v3.3.1.900

Stock Incentive Plans (Non-Vested Restricted Stock And Restricted Stock) (Details)
12 Months Ended

Dec. 31, 2015

$ / shares

shares

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Non-vested balance as of December 31, 2014 | shares 4,350,014

Shares Granted | shares 1,795,359

Shares Vested | shares (1,906,900)

Shares Forfeited | shares (116,470)

Non-vested balance as of December 31, 2015 | shares 4,122,003

Weighted Average Grant Date Fair Value, Non-vested balance as of December 31, 2014 (usd per share) | $ / shares $ 36.86

Weighted Average Grant Date Fair Value, Granted (usd per share) | $ / shares 58.38

Weighted Average Grant Date Fair Value, Vested (usd per share) | $ / shares 31.81

Weighted Average Grant Date Fair Value, Forfeited (usd per share) | $ / shares 34.10

Weighted Average Grant Date Fair Value, Non-vested balance as of December 31, 2015 (usd per share) | $ / shares $ 48.65

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(3)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(3)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

XML 106 R86.htm IDEA: XBRL DOCUMENT v3.3.1.900

Retirement Plan (Details) - USD ($)
$ in Millions
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Retirement Plan [Abstract]

Defined contribution plan, matching contributions $ 19 $ 12 $ 9

X

- Definition
Retirement Plan [Abstract]
+ References
No definition available.
+ Details

Name: cnc_RetirementPlanAbstract

Namespace Prefix: cnc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of the cost recognized during the period for defined contribution plans.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 70
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942
+ Details

Name: us-gaap_DefinedContributionPlanCostRecognized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 107 R87.htm IDEA: XBRL DOCUMENT v3.3.1.900

Commitments (Details) - USD ($)
$ in Millions
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Commitments [Abstract]

Rent expense $ 64 $ 46 $ 31

2016 58

2017 59

2018 50

2019 45

2020 33

Thereafter 70

Annual non-cancelable minimum lease payments, Total $ 315

X

- Definition
Commitments [Abstract]
+ References
No definition available.
+ Details

Name: cnc_CommitmentsAbstract

Namespace Prefix: cnc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 10
-Section 55
-Paragraph 40
-Subparagraph (Note 3)
-URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717
+ Details

Name: us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41499-112717
+ Details

Name: us-gaap_OperatingLeasesRentExpenseNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 108 R88.htm IDEA: XBRL DOCUMENT v3.3.1.900

Contingencies (Details) - USD ($)
$ in Millions
12 Months Ended

Dec. 31, 2015

Mar. 09, 2015

Commitments and Contingencies Disclosure [Abstract]

Contingencies allegations, description On July 5, 2013, the Company's subsidiary, Kentucky Spirit Health Plan, Inc. (Kentucky Spirit), terminated its contract with the Commonwealth of Kentucky (the Commonwealth). Kentucky Spirit believes it had a contractual right to terminate the contract and filed a lawsuit in Franklin Circuit Court seeking a declaration of this right. The Commonwealth has alleged that Kentucky Spirit's exit constitutes a material breach of contract. The Commonwealth seeks to recover substantial damages and to enforce its rights under Kentucky Spirit's $25 million performance bond. The Commonwealth's attorneys have asserted that the Commonwealth's expenditures due to Kentucky Spirit's departure range from $28 million to $40 million plus interest, and that the associated CMS expenditures range from $92 million to $134 million. Kentucky Spirit disputes the Commonwealth's alleged damages, and filed a lawsuit in April 2013, amended in October 2014, in Franklin Circuit Court seeking damages against the Commonwealth for losses sustained due to the Commonwealth's alleged breaches. On February 6, 2015, the Kentucky Court of Appeals affirmed a Franklin Circuit Court ruling that Kentucky Spirit does not have a contractual right to terminate the contract early. The Court of Appeals also found that the contract’s liquidated damages provision “is applicable in the event of a premature termination of the Contract term.” On September 8, 2015, Kentucky Spirit filed a motion for discretionary review seeking Kentucky Supreme Court review of the finding that Kentucky Spirit's departure constituted a breach of contract. On October 9, 2015, the Commonwealth filed a response opposing discretionary review.

Kentucky Spirit Performance Bond $ 25

Commonwealth of Kentucky Alleged Increased Program Costs - Low End of Range 28

Commonwealth of Kentucky Alleged Increased Program Costs - High End of Range 40

Commonwealth of Kentucky Alleged Associated CMS Expenditures - Low End of Range 92

Commonwealth of Kentucky Alleged Associated CMS Expenditures - High End of Range $ 134

Secretary of the Kentucky Cabinet for Health and Family Services Determination Letter Damages $ 40

Secretary of the Kentucky Cabinet for Health and Family Services Determination Letter Damages Letter Damages Prejudgment Interest Rate 8.00%

Inestimable loss contingency, description The resolution of the Kentucky litigation matters may result in a range of possible outcomes. If Kentucky Spirit prevails on its claims, it would be entitled to damages. If the Commonwealth prevails, a liability to the Commonwealth could be recorded. The Company is unable to estimate the ultimate outcome resulting from the Kentucky litigation. As a result, the Company has not recorded any receivable or any liability for potential damages under the contract as of December 31, 2015. While uncertain, the ultimate resolution of the pending litigation could have a material effect on the financial position, cash flow or results of operations of the Company in the period it is resolved or becomes known.

X

- Definition
Commonwealth of Kentucky Alleged Associated CMS Expenditures - High End of Range
+ References
No definition available.
+ Details

Name: cnc_CommonwealthofKentuckyAllegedAssociatedCMSExpendituresHighEndofRange

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Commonwealth of Kentucky Alleged Associated CMS Expenditures - Low End of Range
+ References
No definition available.
+ Details

Name: cnc_CommonwealthofKentuckyAllegedAssociatedCMSExpendituresLowEndofRange

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Commonwealth of Kentucky Alleged Increased Program Costs - High End of Range
+ References
No definition available.
+ Details

Name: cnc_CommonwealthofKentuckyAllegedIncreasedProgramCostsHighEndofRange

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Commonwealth of Kentucky Alleged Increased Program Costs - Low End of Range
+ References
No definition available.
+ Details

Name: cnc_CommonwealthofKentuckyAllegedIncreasedProgramCostsLowEndofRange

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Kentucky Spirit Performance Bond
+ References
No definition available.
+ Details

Name: cnc_KentuckySpiritPerformanceBond

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Secretary of the Kentucky Cabinet for Health and Family Services determination letter damages
+ References
No definition available.
+ Details

Name: cnc_SecretaryoftheKentuckyCabinetforHealthandFamilyServicesDeterminationLetterDamages

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Secretary of the Kentucky Cabinet for Health and Family Services determination letter damages letter damages prejudgment interest rate
+ References
No definition available.
+ Details

Name: cnc_SecretaryoftheKentuckyCabinetforHealthandFamilyServicesDeterminationLetterDamagesLetterDamagesPrejudgmentInterestRate

Namespace Prefix: cnc_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Presents an assertion of a fact by a plaintiff in a pleading or complaint, which the plaintiff claims it will prove upon presentation of evidence at the proceeding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14557-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349
+ Details

Name: us-gaap_LossContingencyAllegations

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Explanation as to why an estimate of a specified contingent loss cannot be made, resulting in disclosure without accrual.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 9
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14557-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349
+ Details

Name: us-gaap_LossContingencyInestimableLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 109 R89.htm IDEA: XBRL DOCUMENT v3.3.1.900

Earnings Per Share (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended

Dec. 31, 2015

Sep. 30, 2015

Jun. 30, 2015

Mar. 31, 2015

Dec. 31, 2014

Sep. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Earnings Per Share [Abstract]

Earnings from continuing operations, net of income tax expense $ 112 $ 92 $ 88 $ 64 $ 106 $ 81 $ 47 $ 34 $ 356 $ 268 $ 161

Discontinued operations, net of income tax expense (benefit) (1) 1 0 (1) 1 1 2 (1) (1) 3 4

Net earnings attributable to Centene Corporation $ 111 $ 93 $ 88 $ 63 $ 107 $ 82 $ 49 $ 33 $ 355 $ 271 $ 165

Weighted average number of common shares outstanding (in shares) 119,100,744 116,345,764 108,253,090

Common stock equivalents (as determined by applying the treasury stock method, in shares) 3,965,626 4,014,448 4,241,256

Weighted average number of common shares and potential dilutive common shares outstanding (in shares) 123,066,370 120,360,212 112,494,346

Continuing operations, Basic (in usd per share) $ 0.94 $ 0.77 $ 0.74 $ 0.54 $ 0.90 $ 0.69 $ 0.41 $ 0.30 $ 2.99 $ 2.30 $ 1.49

Discontinued operations, Basic (in usd per share) (0.01) 0.01 0.00 (0.01) 0.01 0.01 0.01 (0.01) (0.01) 0.03 0.03

Basic earnings per common share (in usd per share) 0.93 0.78 0.74 0.53 0.91 0.70 0.42 0.29 2.98 2.33 1.52

Continuing operations, Diluted (in usd per share) 0.91 0.75 0.72 0.52 0.87 0.67 0.39 0.29 2.89 2.23 1.43

Discontinued operations, Diluted (in usd per share) (0.01) 0.01 0.00 (0.01) 0.01 0.01 0.02 (0.01) (0.01) 0.02 0.04

Diluted earnings per common share (in usd per share) $ 0.90 $ 0.76 $ 0.72 $ 0.51 $ 0.88 $ 0.68 $ 0.41 $ 0.28 $ 2.88 $ 2.25 $ 1.47

Anti-dilutive stock options, restricted stock and restricted stock units excluded from the calculation of diluted earnings per common share 7,247 207,980 187,078

X

- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Antidilution
-URI http://asc.fasb.org/extlink&oid=6505113

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Diluted Earnings Per Share
-URI http://asc.fasb.org/extlink&oid=6510752

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Contingent Stock Agreement
-URI http://asc.fasb.org/extlink&oid=6508534

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.21)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.23)
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 18
-Article 7

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 20
-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 21
-Article 9
+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.21)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 18
-Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 20
-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 21
-Article 9
+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of income (loss) from continuing operations attributable to the parent. Also defined as revenue less expenses and taxes from ongoing operations before extraordinary items but after deduction of those portions of income or loss from continuing operations that are allocable to noncontrolling interests.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.13)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4613673-111683
+ Details

Name: us-gaap_IncomeLossFromContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.21)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.23)
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 20
-Article 5

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 18
-Article 7

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 21
-Article 9
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsPerBasicShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.21)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 20
-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 21
-Article 9

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 18
-Article 7
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5C
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721675-107760

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3B
-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721525-107759

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721523-107759

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51716988&loc=d3e957-107759

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=51716988&loc=d3e1012-107759

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1361-107760

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721673-107760

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683
+ Details

Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.23)
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.21)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1278-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 20
-Article 5

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 18
-Article 7

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 21
-Article 9
+ Details

Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1278-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 5
-Section E
-Paragraph Question 3
+ Details

Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 28A
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1500-109256
+ Details

Name: us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.18)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.22)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 19
-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 20
-Article 9
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1505-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Weighted-Average Number of Common Shares Outstanding
-URI http://asc.fasb.org/extlink&oid=6528421
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 110 R90.htm IDEA: XBRL DOCUMENT v3.3.1.900

Segment Information (Details)
$ in Millions
12 Months Ended

Dec. 31, 2015

USD ($)

segment

Dec. 31, 2014

USD ($)

Dec. 31, 2013

USD ($)

Segment Reporting [Abstract]

Number of reportable segments | segment 2

Total premium and service revenues $ 21,265 $ 15,667 $ 10,526

Earnings from operations 705 464 277

Total assets 7,339 5,824 3,519

Managed Care [Member]

Total premium and service revenues 19,054 13,886 9,741

Specialty Services [Member]

Total premium and service revenues 2,211 1,781 785

Operating Segments [Member] | Managed Care [Member]

Total premium and service revenues 19,154 13,946 9,782

Earnings from operations 513 353 198

Total assets 6,202 4,706 2,921

Operating Segments [Member] | Specialty Services [Member]

Total premium and service revenues 7,075 4,800 2,932

Earnings from operations 192 111 79

Total assets 1,137 1,118 598

Intersegment Eliminations [Member]

Total premium and service revenues (4,964) (3,079) (2,188)

Earnings from operations 0 0 0

Total assets 0 0 0

Intersegment Eliminations [Member] | Managed Care [Member]

Total premium and service revenues 100 60 41

Intersegment Eliminations [Member] | Specialty Services [Member]

Total premium and service revenues $ 4,864 $ 3,019 $ 2,147

X

- Definition
Premiums earned on the income statement for all insurance and reinsurance contracts after subtracting any amounts ceded to another insurer and adding premiums assumed from other insurers, plus aggregate revenue during the period from services rendered in the normal course of business, after deducting allowances and discounts. Premium and service revenues exclude Premium Tax Revenue.
+ References
No definition available.
+ Details

Name: cnc_PremiumAndServiceRevenues

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.18)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 12
-Article 7
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.
+ References
No definition available.
+ Details

Name: us-gaap_NumberOfReportableSegments

Namespace Prefix: us-gaap_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SegmentReportingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=cnc_ManagedCareMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementBusinessSegmentsAxis=cnc_SpecialtyServicesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 111 R91.htm IDEA: XBRL DOCUMENT v3.3.1.900

Quarterly Selected Financial Information (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended

Dec. 31, 2015

Sep. 30, 2015

Jun. 30, 2015

Mar. 31, 2015

Dec. 31, 2014

Sep. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Quarterly Selected Financial Information [Abstract]

Total revenues $ 6,302 $ 5,821 $ 5,506 $ 5,131 $ 4,725 $ 4,352 $ 4,023 $ 3,460 $ 22,760 $ 16,560 $ 10,863

Net earnings attributable to Centene 112 92 88 64 106 81 47 34 356 268 161

Discontinued operations, net of income tax expense (benefit) (1) 1 0 (1) 1 1 2 (1) (1) 3 4

Net earnings attributable to Centene Corporation $ 111 $ 93 $ 88 $ 63 $ 107 $ 82 $ 49 $ 33 $ 355 $ 271 $ 165

Continuing operations (in usd per share) $ 0.94 $ 0.77 $ 0.74 $ 0.54 $ 0.90 $ 0.69 $ 0.41 $ 0.30 $ 2.99 $ 2.30 $ 1.49

Discontinued operations, Basic (in usd per share) (0.01) 0.01 0.00 (0.01) 0.01 0.01 0.01 (0.01) (0.01) 0.03 0.03

Basic earnings per common share (in usd per share) 0.93 0.78 0.74 0.53 0.91 0.70 0.42 0.29 2.98 2.33 1.52

Continuing operations, Diluted (in usd per share) 0.91 0.75 0.72 0.52 0.87 0.67 0.39 0.29 2.89 2.23 1.43

Discontinued operations, Diluted (in usd per share) (0.01) 0.01 0.00 (0.01) 0.01 0.01 0.02 (0.01) (0.01) 0.02 0.04

Diluted earnings per common share (in usd per share) $ 0.90 $ 0.76 $ 0.72 $ 0.51 $ 0.88 $ 0.68 $ 0.41 $ 0.28 $ 2.88 $ 2.25 $ 1.47

X

- Definition
Quarterly Selected Financial Information [Abstract]
+ References
No definition available.
+ Details

Name: cnc_QuarterlySelectedFinancialInformationAbstract

Namespace Prefix: cnc_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.21)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.23)
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 18
-Article 7

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 20
-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 21
-Article 9
+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.21)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 18
-Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 20
-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 21
-Article 9
+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of income (loss) from continuing operations attributable to the parent. Also defined as revenue less expenses and taxes from ongoing operations before extraordinary items but after deduction of those portions of income or loss from continuing operations that are allocable to noncontrolling interests.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.13)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4613673-111683
+ Details

Name: us-gaap_IncomeLossFromContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.21)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.23)
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 20
-Article 5

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 18
-Article 7

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 21
-Article 9
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsPerBasicShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.21)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 20
-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 21
-Article 9

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 18
-Article 7
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5C
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721675-107760

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3B
-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721525-107759

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3A
-URI http://asc.fasb.org/extlink&oid=51716988&loc=SL51721523-107759

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51716988&loc=d3e957-107759

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=51716988&loc=d3e1012-107759

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=51717284&loc=d3e1361-107760

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=51717284&loc=SL51721673-107760

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683
+ Details

Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.23)
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.21)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1278-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 20
-Article 5

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 18
-Article 7

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 21
-Article 9
+ Details

Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1278-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 5
-Section E
-Paragraph Question 3
+ Details

Name: us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.18)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.22)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831270

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 19
-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 20
-Article 9
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688
+ Details

Name: us-gaap_Revenues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 112 R92.htm IDEA: XBRL DOCUMENT v3.3.1.900

Condensed Financial Information Of Registrant (Condensed Balance Sheets) (Details) - USD ($)
$ in Millions

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Cash and cash equivalents $ 1,760 $ 1,610

Short term investments 176 177

Other current assets 390 252

Total current assets 3,605 2,951

Long term investments 1,927 1,280

Other long term assets 177 174

Total assets 7,339 5,824 $ 3,519

Current liabilities 3,629 2,900

Long term debt 1,216 874

Other long term liabilities 170 159

Total liabilities 5,015 3,933

Redeemable noncontrolling interest 156 148

Common stock, $.001 par value; authorized 400,000,000 shares; 126,855,477 issued and 120,342,981 outstanding at December 31, 2015, and 124,274,864 issued and 118,433,416 outstanding at December 31, 2014 0 0

Additional paid-in capital 956 840

Accumulated other comprehensive loss (10) (1)

Retained earnings 1,358 1,003

Treasury stock, at cost (6,512,496 and 5,841,448 shares, respectively) (147) (98)

Total Centene stockholders’ equity 2,157 1,744

Noncontrolling interest 11 (1)

Total stockholders’ equity 2,168 1,743 $ 1,243 $ 954

Total liabilities and stockholders’ equity 7,339 5,824

Parent Company [Member]

Cash and cash equivalents 4 3

Short term investments 5 8

Other current assets 711 378

Total current assets 720 389

Long term investments 6 10

Investment in subsidiaries 2,749 2,296

Other long term assets 35 38

Total assets 3,510 2,733

Current liabilities 13 24

Long term debt 1,147 815

Other long term liabilities 26 3

Total liabilities 1,186 842

Redeemable noncontrolling interest 156 148

Common stock, $.001 par value; authorized 400,000,000 shares; 126,855,477 issued and 120,342,981 outstanding at December 31, 2015, and 124,274,864 issued and 118,433,416 outstanding at December 31, 2014 0 0

Additional paid-in capital 956 840

Accumulated other comprehensive loss (10) (1)

Retained earnings 1,358 1,003

Treasury stock, at cost (6,512,496 and 5,841,448 shares, respectively) (147) (98)

Total Centene stockholders’ equity 2,157 1,744

Noncontrolling interest 11 (1)

Total stockholders’ equity 2,168 1,743

Total liabilities and stockholders’ equity $ 3,510 $ 2,733

X

- Definition
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e637-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=36458714&loc=d3e681-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14A
-URI http://asc.fasb.org/extlink&oid=36458714&loc=SL7669686-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 31
-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3
+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.30(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 31
-Article 5
+ Details

Name: us-gaap_AdditionalPaidInCapitalCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.18)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 12
-Article 7
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.9)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765
+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash
-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash Equivalents
-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total investments in (A) an entity in which the entity has significant influence, but does not have control, (B) subsidiaries that are not required to be consolidated and are accounted for using the equity and or cost method, and (C) an entity in which the reporting entity shares control of the entity with another party or group. Includes long-term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.12)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19-26)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.32)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 25
-Article 7
+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.21)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying amount of long-term debt, net of unamortized discount or premium, excluding amounts to be repaid within one year or the normal operating cycle, if longer (current maturities). Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebtNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.12)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 27
-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 20
-Article 7
+ Details

Name: us-gaap_MinorityInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate carrying amount, as of the balance sheet date, of current assets not separately disclosed in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.8)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.17)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherAssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.24)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 3A
-Subparagraph (12)(c)
-URI http://asc.fasb.org/extlink&oid=27011957&loc=SL6540498-122764

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 3A
-Subparagraph (16)(c)
-URI http://asc.fasb.org/extlink&oid=27011957&loc=SL6540498-122764

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 3A
-Subparagraph 15
-URI http://asc.fasb.org/extlink&oid=27011957&loc=SL6540498-122764

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 3A
-Subparagraph 14
-URI http://asc.fasb.org/extlink&oid=27011957&loc=SL6540498-122764
+ Details

Name: us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.31(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Investments which are intended to be sold in the short term (usually less than one year or the normal operating cycle, whichever is longer) including trading securities, available-for-sale securities, held-to-maturity securities, and other short-term investments not otherwise listed in the existing taxonomy.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.2)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 1
-Subparagraph g
-Article 7
+ Details

Name: us-gaap_ShortTermInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4I
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4590271-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4568740-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4568447-111683
+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656
+ Details

Name: us-gaap_TreasuryStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: dei_LegalEntityAxis=us-gaap_ParentCompanyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 113 R93.htm IDEA: XBRL DOCUMENT v3.3.1.900

Condensed Financial Information Of Registrant Condensed Balance Sheets (Parenthetical) (Details) - USD ($)
$ / shares in Units, $ in Millions

Dec. 31, 2015

Dec. 31, 2014

Common stock, par value (in usd per share) $ 0.001 $ 0.001

Common stock, shares authorized 400,000,000

Common stock, shares issued 126,855,477 124,274,864

Common stock, shares outstanding 120,342,981 118,433,416

Treasury stock, shares 6,512,496 5,841,448

Parent Company [Member]

Short term investments, amortized cost $ 5 $ 8

Long term investments, amortized cost $ 6 $ 10

Common stock, par value (in usd per share) $ 0.001 $ 0.001

Common stock, shares authorized 400,000,000 200,000,000

Common stock, shares issued 126,855,477 124,274,864

Common stock, shares outstanding 120,342,981 118,433,416

Treasury stock, shares 6,512,496 5,841,448

X

- Definition
The total amount of investments that are intended to be held for an extended period of time, at amortized cost (longer than one operating cycle).
+ References
No definition available.
+ Details

Name: cnc_LongTermInvestmentsAmortizedCost

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Short-term investments, at amortized cost.
+ References
No definition available.
+ Details

Name: cnc_ShortTermInvestmentsAmortizedCost

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 30
-Article 5
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.28,29)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30
-Article 5
+ Details

Name: us-gaap_TreasuryStockShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: dei_LegalEntityAxis=us-gaap_ParentCompanyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 114 R94.htm IDEA: XBRL DOCUMENT v3.3.1.900

Condensed Financial Information Of Registrant (Condensed Statements Of Operations) (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended

Dec. 31, 2015

Sep. 30, 2015

Jun. 30, 2015

Mar. 31, 2015

Dec. 31, 2014

Sep. 30, 2014

Jun. 30, 2014

Mar. 31, 2014

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

General and administrative expenses $ 1,826 $ 1,314 $ 931

Gain on contingent consideration (44) 0 0

Investment and other income 35 28 19

Interest expense (43) (35) (27)

Earnings (loss) before income taxes 697 457 269

Income tax benefit 339 196 107

Income (Loss) from Equity Method Investments 8

Net earnings 357 264 166

(Earnings) loss attributable to noncontrolling interests (2) 7 (1)

Net earnings attributable to Centene $ 112 $ 92 $ 88 $ 64 $ 106 $ 81 $ 47 $ 34 $ 356 $ 268 $ 161

Basic earnings (loss) per common share (in dollars per share) $ 0.93 $ 0.78 $ 0.74 $ 0.53 $ 0.91 $ 0.70 $ 0.42 $ 0.29 $ 2.98 $ 2.33 $ 1.52

Diluted earnings (loss) per common share (in dollars per share) $ 0.90 $ 0.76 $ 0.72 $ 0.51 $ 0.88 $ 0.68 $ 0.41 $ 0.28 $ 2.88 $ 2.25 $ 1.47

Weighted average number of common shares outstanding (in shares) 119,100,744 116,345,764 108,253,090

Weighted average number of common shares and potential dilutive common shares outstanding (in shares) 123,066,370 120,360,212 112,494,346

Parent Company [Member]

General and administrative expenses $ 9 $ 3 $ 4

Gain on contingent consideration (44) 0 0

Investment and other income (5) 1 1

Interest expense (39) (30) (23)

Earnings (loss) before income taxes (9) (32) (26)

Income tax benefit (26) (8) (15)

Net earnings (loss) before equity in subsidiaries 17 (24) (11)

Income (Loss) from Equity Method Investments 341 285 173

Net earnings 358 261 162

(Earnings) loss attributable to noncontrolling interests (2) 7 (1)

Net earnings attributable to Centene $ 356 $ 268 $ 161

Basic earnings (loss) per common share (in dollars per share) $ 2.99 $ 2.30 $ 1.49

Diluted earnings (loss) per common share (in dollars per share) $ 2.89 $ 2.23 $ 1.43

Weighted average number of common shares outstanding (in shares) 119,100,744 116,345,764 108,253,090

Weighted average number of common shares and potential dilutive common shares outstanding (in shares) 123,066,370 120,360,212 112,494,346

X

- Definition
Net income (loss), including portion attributable to noncontrolling interest before equity in earnings from subsidiaries
+ References
No definition available.
+ Details

Name: cnc_Netincomelossincludingportionattributabletononcontrollinginterestbeforeequityinearningsfromsubsidiaries

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 4
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479
+ Details

Name: us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.21)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.19)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.23)
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 18
-Article 7

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 20
-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 21
-Article 9
+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.21)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 18
-Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 20
-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 21
-Article 9
+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.4)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688
+ Details

Name: us-gaap_GeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of income (loss) from continuing operations attributable to the parent. Also defined as revenue less expenses and taxes from ongoing operations before extraordinary items but after deduction of those portions of income or loss from continuing operations that are allocable to noncontrolling interests.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.13)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4613673-111683
+ Details

Name: us-gaap_IncomeLossFromContinuingOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Sum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(1)(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35755396&loc=d3e33749-111570

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.12)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 9
-Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 11
-Article 7
+ Details

Name: us-gaap_IncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Income Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6515339
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.9)
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882
+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.7)
-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688
+ Details

Name: us-gaap_InvestmentIncomeNonoperating

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of Net Income (Loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684
+ Details

Name: us-gaap_NetIncomeLossAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=51664549&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591552-111686

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a),(c)
-URI http://asc.fasb.org/extlink&oid=18733093&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=35736750&loc=SL4591551-111686
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1505-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Weighted-Average Number of Common Shares Outstanding
-URI http://asc.fasb.org/extlink&oid=6528421
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: dei_LegalEntityAxis=us-gaap_ParentCompanyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 115 R95.htm IDEA: XBRL DOCUMENT v3.3.1.900

Condensed Financial Information Of Registrant (Condensed Statements Of Cash Flows) (Details) - USD ($)
$ in Millions
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Cash provided by operating activities $ 658 $ 1,223 $ 382

Purchases of investments (1,321) (1,015) (790)

Sales and maturities of investments 669 406 579

Proceeds from asset sale 7 0 0

Acquisitions, net of cash acquired (18) (136) (63)

Net cash used in investing activities (813) (848) (342)

Proceeds from borrowings 1,925 1,875 180

Payment of long-term debt and notes payable (1,583) (1,674) (41)

Proceeds from exercise of stock options 13 8 9

Common stock offering 0 0 15

Common stock repurchases (53) (29) (19)

Debt issue costs (4) (7) (4)

Payment of contingent consideration obligation (29) 0 0

Contribution from noncontrolling interest 11 6 8

Excess tax benefits from stock compensation 25 19 6

Net cash provided by financing activities 305 198 154

Net increase in cash and cash equivalents 150 572 194

Cash and cash equivalents, beginning of period 1,610 1,038 844

Cash and cash equivalents, end of period 1,760 1,610 1,038

Parent Company [Member]

Cash provided by operating activities 462 317 302

Net dividends from and capital contributions to subsidiaries (660) (384) (417)

Purchases of investments (17) (32) (12)

Sales and maturities of investments 9 14 10

Proceeds from asset sale 7 0 0

Acquisitions, net of cash acquired (113) (137) (67)

Net cash used in investing activities (774) (539) (486)

Proceeds from borrowings 1,925 1,875 180

Payment of long-term debt and notes payable (1,575) (1,650) (30)

Proceeds from exercise of stock options 13 8 9

Common stock offering 0 0 15

Common stock repurchases (53) (29) (20)

Debt issue costs (4) (7) (3)

Payment of contingent consideration obligation (29) 0 0

Contribution from noncontrolling interest 11 6 8

Excess tax benefits from stock compensation 25 19 6

Net cash provided by financing activities 313 222 165

Net increase in cash and cash equivalents 1 0 (19)

Cash and cash equivalents, beginning of period 3 3 22

Cash and cash equivalents, end of period $ 4 $ 3 $ 3

X

- Definition
Business Acquisition, Contingent Consideration, Cash Payment
+ References
No definition available.
+ Details

Name: cnc_BusinessAcquisitionContingentConsiderationCashPayment

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Net dividends from and capital contributions to subsidiaries
+ References
No definition available.
+ Details

Name: cnc_NetDividendsFromAndCapitalContributionsToSubsidiaries

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
For the entity and the disposal group, cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents.
+ References
No definition available.
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 230
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906
+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow from realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=32706628&loc=d3e11374-113907
+ Details

Name: us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3574-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash outflow to reacquire common stock during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_PaymentsForRepurchaseOfCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsOfDebtIssuanceCosts

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of a controlling interest in another entity or an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133
+ Details

Name: us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the purchase of all investments (debt, security, other) during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquireInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_ProceedsFromIssuanceOfLongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceOrSaleOfEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585
+ Details

Name: us-gaap_ProceedsFromPaymentsToMinorityShareholders

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3179-108585
+ Details

Name: us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow from the sale of other assets recognized in investing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585
+ Details

Name: us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow associated with the amount received from holders exercising their stock options. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (j)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_ProceedsFromStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_RepaymentsOfLongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: dei_LegalEntityAxis=us-gaap_ParentCompanyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 116 R96.htm IDEA: XBRL DOCUMENT v3.3.1.900

Condensed Financial Information Of Registrant Basis of Presentation and Significant Accounting Policies (Details) - USD ($)
$ in Millions
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Parent Company [Member]

Cash Flows Received By Parent From Unrestricted Subsidiaries $ 445 $ 341 $ 313

X

- Definition
Cash flows received by the parent from unrestricted subsidiaries.
+ References
No definition available.
+ Details

Name: cnc_CashFlowsReceivedByParentFromUnrestrictedSubsidiaries

Namespace Prefix: cnc_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: dei_LegalEntityAxis=us-gaap_ParentCompanyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 117 R97.htm IDEA: XBRL DOCUMENT v3.3.1.900

Condensed Financial Information Of Registrant Dividends (Details) - USD ($)
$ in Millions
12 Months Ended

Dec. 31, 2015

Dec. 31, 2014

Dec. 31, 2013

Parent Company [Member]

Cash Dividends Paid to Parent Company by Unconsolidated Subsidiaries $ 14 $ 54 $ 21

X

- Definition
This element represents disclosure of the aggregate cash dividends paid to the entity by unconsolidated subsidiaries.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 2
-Subparagraph (SX 210.9-06)
-URI http://asc.fasb.org/extlink&oid=6882215&loc=d3e537971-122884

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(b))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690
+ Details

Name: us-gaap_CashDividendsPaidToParentCompanyByUnconsolidatedSubsidiaries

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: dei_LegalEntityAxis=us-gaap_ParentCompanyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 118 R98.htm IDEA: XBRL DOCUMENT v3.3.1.900

Condensed Financial Information Of Registrant Other Current Assets (Details) - USD ($)
$ in Millions

Dec. 31, 2015

Dec. 31, 2014

Parent Company [Member]

Income Taxes Receivable $ 686 $ 359

X

- Definition
Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.8)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 03
-Paragraph 5
-Subparagraph c
-Article 7
+ Details

Name: us-gaap_IncomeTaxReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: dei_LegalEntityAxis=us-gaap_ParentCompanyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 119 R99.htm IDEA: XBRL DOCUMENT v3.3.1.900

Subsequent Events (Details) - Subsequent Event [Member] - USD ($)
$ in Millions
1 Months Ended

Jan. 31, 2016

Feb. 19, 2016

Subsequent Event [Line Items]

Percentage of voting interests acquired 19.00%

Stock issued 1,100,000.0

Five Point Six Two Five Percent Senior Notes, Due in Twenty Twenty One [Member]

Subsequent Event [Line Items]

Debt face amount $ 1,400

Interest rate stated, percentage 5.625%

Six Point One Two Five Percent Senior Notes, Due in Twenty Twenty Four [Member]

Subsequent Event [Line Items]

Debt face amount $ 1,000

Interest rate stated, percentage 6.125%

X

- Definition
Percentage of voting equity interests acquired at the acquisition date in the business combination.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=56956515&loc=d3e1392-128463
+ Details

Name: us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Face (par) amount of debt instrument at time of issuance.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=34725769&loc=d3e28878-108400

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28551-108399
+ Details

Name: us-gaap_DebtInstrumentFaceAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of new stock issued during the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30
-Article 5
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.
+ References
No definition available.
+ Details

Name: us-gaap_SubsequentEventLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=cnc_FivePointSixTwoFivePercentSeniorNotesDueinTwentyTwentyOneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=cnc_SixPointOneTwoFivePercentSeniorNotesDueinTwentyTwentyFourMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

EXCEL 120 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 121 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 122 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 124 FilingSummary.xml IDEA: XBRL DOCUMENT 3.3.1.900 html 275 464 1 true 77 0 false 8 false false R1.htm 0001000 - Document - Document And Entity Information Sheet http://www.centene.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 1001000 - Statement - Consolidated Balance Sheets Sheet http://www.centene.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 1001501 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.centene.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - Consolidated Statements Of Operations Sheet http://www.centene.com/role/ConsolidatedStatementsOfOperations Consolidated Statements Of Operations Statements 4 false false R5.htm 1002501 - Statement - Consolidated Statements of Operations (Parenthetical) Sheet http://www.centene.com/role/ConsolidatedStatementsOfOperationsParenthetical Consolidated Statements of Operations (Parenthetical) Statements 5 false false R6.htm 1003000 - Statement - Consolidated Statement Of Comprehensive Earnings Sheet http://www.centene.com/role/ConsolidatedStatementOfComprehensiveEarnings Consolidated Statement Of Comprehensive Earnings Statements 6 false false R7.htm 1004000 - Statement - Consolidated Statement Of Stockholders' Equity Sheet http://www.centene.com/role/ConsolidatedStatementOfStockholdersEquity Consolidated Statement Of Stockholders' Equity Statements 7 false false R8.htm 1004501 - Statement - Consolidated Statements Of Stockholders' Equity (Parenthetical) Sheet http://www.centene.com/role/ConsolidatedStatementsOfStockholdersEquityParenthetical Consolidated Statements Of Stockholders' Equity (Parenthetical) Statements 8 false false R9.htm 1005000 - Statement - Consolidated Statements Of Cash Flows Sheet http://www.centene.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements Of Cash Flows Statements 9 false false R10.htm 2101100 - Disclosure - Organization And Operations Sheet http://www.centene.com/role/OrganizationAndOperations Organization And Operations Notes 10 false false R11.htm 2101100 - Disclosure - Summary Of Significant Accounting Policies Sheet http://www.centene.com/role/SummaryOfSignificantAccountingPolicies Summary Of Significant Accounting Policies Notes 11 false false R12.htm 2102100 - Disclosure - Health Net Merger Sheet http://www.centene.com/role/HealthNetMerger Health Net Merger Notes 12 false false R13.htm 2103100 - Disclosure - Acquisitions and Noncontrolling Interest Sheet http://www.centene.com/role/AcquisitionsAndNoncontrollingInterest Acquisitions and Noncontrolling Interest Notes 13 false false R14.htm 2105100 - Disclosure - Short-Term And Long-Term Investments And Restricted Deposits Sheet http://www.centene.com/role/ShortTermAndLongTermInvestmentsAndRestrictedDeposits Short-Term And Long-Term Investments And Restricted Deposits Notes 14 false false R15.htm 2106100 - Disclosure - Fair Value Measurements Sheet http://www.centene.com/role/FairValueMeasurements Fair Value Measurements Notes 15 false false R16.htm 2109100 - Disclosure - Property, Software And Equipment Sheet http://www.centene.com/role/PropertySoftwareAndEquipment Property, Software And Equipment Notes 16 false false R17.htm 2110100 - Disclosure - Goodwill And Intangible Assets Sheet http://www.centene.com/role/GoodwillAndIntangibleAssets Goodwill And Intangible Assets Notes 17 false false R18.htm 2111100 - Disclosure - Medical Claims Liability Sheet http://www.centene.com/role/MedicalClaimsLiability Medical Claims Liability Notes 18 false false R19.htm 2112100 - Disclosure - Health Insurance Marketplace Sheet http://www.centene.com/role/HealthInsuranceMarketplace Health Insurance Marketplace Notes 19 false false R20.htm 2115100 - Disclosure - Debt Sheet http://www.centene.com/role/Debt Debt Notes 20 false false R21.htm 2116100 - Disclosure - Stockholders' Equity Sheet http://www.centene.com/role/StockholdersEquity Stockholders' Equity Notes 21 false false R22.htm 2117100 - Disclosure - Statutory Capital Requirements And Dividend Restrictions Sheet http://www.centene.com/role/StatutoryCapitalRequirementsAndDividendRestrictions Statutory Capital Requirements And Dividend Restrictions Notes 22 false false R23.htm 2118100 - Disclosure - Income Taxes Sheet http://www.centene.com/role/IncomeTaxes Income Taxes Notes 23 false false R24.htm 2119100 - Disclosure - Stock Incentive Plans Sheet http://www.centene.com/role/StockIncentivePlans Stock Incentive Plans Notes 24 false false R25.htm 2120100 - Disclosure - Retirement Plan Sheet http://www.centene.com/role/RetirementPlan Retirement Plan Notes 25 false false R26.htm 2121100 - Disclosure - Commitments Sheet http://www.centene.com/role/Commitments Commitments Notes 26 false false R27.htm 2122100 - Disclosure - Contingencies Sheet http://www.centene.com/role/Contingencies Contingencies Notes 27 false false R28.htm 2123100 - Disclosure - Earnings Per Share Sheet http://www.centene.com/role/EarningsPerShare Earnings Per Share Notes 28 false false R29.htm 2124100 - Disclosure - Segment Information Sheet http://www.centene.com/role/SegmentInformation Segment Information Notes 29 false false R30.htm 2125100 - Disclosure - Quarterly Selected Financial Information Sheet http://www.centene.com/role/QuarterlySelectedFinancialInformation Quarterly Selected Financial Information Notes 30 false false R31.htm 2128100 - Disclosure - Condensed Financial Information Of Registrant Sheet http://www.centene.com/role/CondensedFinancialInformationOfRegistrant Condensed Financial Information Of Registrant Notes 31 false false R32.htm 2129100 - Disclosure - Subsequent Events Sheet http://www.centene.com/role/SubsequentEvents Subsequent Events Notes 32 false false R33.htm 2201201 - Disclosure - Summary Of Significant Accounting Policies (Policies) Sheet http://www.centene.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary Of Significant Accounting Policies (Policies) Policies http://www.centene.com/role/SummaryOfSignificantAccountingPolicies 33 false false R34.htm 2301302 - Disclosure - Summary Of Significant Accounting Policies (Tables) Sheet http://www.centene.com/role/SummaryOfSignificantAccountingPoliciesTables Summary Of Significant Accounting Policies (Tables) Tables http://www.centene.com/role/SummaryOfSignificantAccountingPolicies 34 false false R35.htm 2303301 - Disclosure - Acquisitions and Noncontrolling Interest (Tables) Sheet http://www.centene.com/role/AcquisitionsAndNoncontrollingInterestTables Acquisitions and Noncontrolling Interest (Tables) Tables http://www.centene.com/role/AcquisitionsAndNoncontrollingInterest 35 false false R36.htm 2305301 - Disclosure - Short-Term And Long-Term Investments And Restricted Deposits (Tables) Sheet http://www.centene.com/role/ShortTermAndLongTermInvestmentsAndRestrictedDepositsTables Short-Term And Long-Term Investments And Restricted Deposits (Tables) Tables http://www.centene.com/role/ShortTermAndLongTermInvestmentsAndRestrictedDeposits 36 false false R37.htm 2306301 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.centene.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.centene.com/role/FairValueMeasurements 37 false false R38.htm 2309301 - Disclosure - Property, Software And Equipment (Tables) Sheet http://www.centene.com/role/PropertySoftwareAndEquipmentTables Property, Software And Equipment (Tables) Tables http://www.centene.com/role/PropertySoftwareAndEquipment 38 false false R39.htm 2310301 - Disclosure - Goodwill And Intangible Assets (Tables) Sheet http://www.centene.com/role/GoodwillAndIntangibleAssetsTables Goodwill And Intangible Assets (Tables) Tables http://www.centene.com/role/GoodwillAndIntangibleAssets 39 false false R40.htm 2311301 - Disclosure - Medical Claims Liability (Tables) Sheet http://www.centene.com/role/MedicalClaimsLiabilityTables Medical Claims Liability (Tables) Tables http://www.centene.com/role/MedicalClaimsLiability 40 false false R41.htm 2312301 - Disclosure - Health Insurance Marketplace (Tables) Sheet http://www.centene.com/role/HealthInsuranceMarketplaceTables Health Insurance Marketplace (Tables) Tables http://www.centene.com/role/HealthInsuranceMarketplace 41 false false R42.htm 2315301 - Disclosure - Debt (Tables) Sheet http://www.centene.com/role/DebtTables Debt (Tables) Tables http://www.centene.com/role/Debt 42 false false R43.htm 2318301 - Disclosure - Income Taxes Income Taxes (Tables) Sheet http://www.centene.com/role/IncomeTaxesIncomeTaxesTables Income Taxes Income Taxes (Tables) Tables 43 false false R44.htm 2319301 - Disclosure - Stock Incentive Plans (Tables) Sheet http://www.centene.com/role/StockIncentivePlansTables Stock Incentive Plans (Tables) Tables http://www.centene.com/role/StockIncentivePlans 44 false false R45.htm 2321301 - Disclosure - Commitments (Tables) Sheet http://www.centene.com/role/CommitmentsTables Commitments (Tables) Tables http://www.centene.com/role/Commitments 45 false false R46.htm 2323301 - Disclosure - Earnings Per Share (Tables) Sheet http://www.centene.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.centene.com/role/EarningsPerShare 46 false false R47.htm 2324301 - Disclosure - Segment Information (Tables) Sheet http://www.centene.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.centene.com/role/SegmentInformation 47 false false R48.htm 2325301 - Disclosure - Quarterly Selected Financial Information (Tables) Sheet http://www.centene.com/role/QuarterlySelectedFinancialInformationTables Quarterly Selected Financial Information (Tables) Tables http://www.centene.com/role/QuarterlySelectedFinancialInformation 48 false false R49.htm 2328301 - Disclosure - Condensed Financial Information Of Registrant (Tables) Sheet http://www.centene.com/role/CondensedFinancialInformationOfRegistrantTables Condensed Financial Information Of Registrant (Tables) Tables http://www.centene.com/role/CondensedFinancialInformationOfRegistrant 49 false false R50.htm 2401401 - Disclosure - Organization And Operations (Details) Sheet http://www.centene.com/role/OrganizationAndOperationsDetails Organization And Operations (Details) Details http://www.centene.com/role/OrganizationAndOperations 50 false false R51.htm 2401403 - Disclosure - Summary Of Significant Accounting Policies (Schedule Of Property, Software And Equipment Depreciation Periods) (Details) Sheet http://www.centene.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPropertySoftwareAndEquipmentDepreciationPeriodsDetails Summary Of Significant Accounting Policies (Schedule Of Property, Software And Equipment Depreciation Periods) (Details) Details http://www.centene.com/role/SummaryOfSignificantAccountingPoliciesTables 51 false false R52.htm 2401404 - Disclosure - Summary Of Significant Accounting Policies (Schedule Of Amortization Period For Intangible Assets) (Details) Sheet http://www.centene.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAmortizationPeriodForIntangibleAssetsDetails Summary Of Significant Accounting Policies (Schedule Of Amortization Period For Intangible Assets) (Details) Details http://www.centene.com/role/SummaryOfSignificantAccountingPoliciesTables 52 false false R53.htm 2401405 - Disclosure - Summary Of Significant Accounting Policies (Schedule Of Allowance For Uncollectible Accounts) (Details) Sheet http://www.centene.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfAllowanceForUncollectibleAccountsDetails Summary Of Significant Accounting Policies (Schedule Of Allowance For Uncollectible Accounts) (Details) Details http://www.centene.com/role/SummaryOfSignificantAccountingPoliciesTables 53 false false R54.htm 2401407 - Disclosure - Summary Of Significant Accounting Policies (Schedule Of Percentage Of Company's Total Revenues) (Details) Sheet http://www.centene.com/role/SummaryOfSignificantAccountingPoliciesScheduleOfPercentageOfCompanysTotalRevenuesDetails Summary Of Significant Accounting Policies (Schedule Of Percentage Of Company's Total Revenues) (Details) Details http://www.centene.com/role/SummaryOfSignificantAccountingPoliciesTables 54 false false R55.htm 2401408 - Disclosure - Summary Of Significant Accounting Policies (Recent Accounting Pronouncements) (Details) Sheet http://www.centene.com/role/SummaryOfSignificantAccountingPoliciesRecentAccountingPronouncementsDetails Summary Of Significant Accounting Policies (Recent Accounting Pronouncements) (Details) Details http://www.centene.com/role/SummaryOfSignificantAccountingPoliciesTables 55 false false R56.htm 2401409 - Disclosure - Summary Of Significant Accounting Policies (Health Insurance Marketplace) (Details) Sheet http://www.centene.com/role/SummaryOfSignificantAccountingPoliciesHealthInsuranceMarketplaceDetails Summary Of Significant Accounting Policies (Health Insurance Marketplace) (Details) Details http://www.centene.com/role/SummaryOfSignificantAccountingPoliciesTables 56 false false R57.htm 2402402 - Disclosure - Health Net Merger (Details) Sheet http://www.centene.com/role/HealthNetMergerDetails Health Net Merger (Details) Details http://www.centene.com/role/HealthNetMerger 57 false false R58.htm 2403402 - Disclosure - Acquisitions and Noncontrolling Interest Acquisitions (Details) Sheet http://www.centene.com/role/AcquisitionsAndNoncontrollingInterestAcquisitionsDetails Acquisitions and Noncontrolling Interest Acquisitions (Details) Details 58 false false R59.htm 2403403 - Disclosure - Acquisitions and Noncontrolling Interest Non Controlling Interest (Details) Sheet http://www.centene.com/role/AcquisitionsAndNoncontrollingInterestNonControllingInterestDetails Acquisitions and Noncontrolling Interest Non Controlling Interest (Details) Details 59 false false R60.htm 2405402 - Disclosure - Short-Term And Long-Term Investments And Restricted Deposits (Narrative) (Details) Sheet http://www.centene.com/role/ShortTermAndLongTermInvestmentsAndRestrictedDepositsNarrativeDetails Short-Term And Long-Term Investments And Restricted Deposits (Narrative) (Details) Details http://www.centene.com/role/ShortTermAndLongTermInvestmentsAndRestrictedDepositsTables 60 false false R61.htm 2405403 - Disclosure - Short-Term And Long-Term Investments And Restricted Deposits (Short-Term And Long-Term Investments, Restricted Deposits) (Details) Sheet http://www.centene.com/role/ShortTermAndLongTermInvestmentsAndRestrictedDepositsShortTermAndLongTermInvestmentsRestrictedDepositsDetails Short-Term And Long-Term Investments And Restricted Deposits (Short-Term And Long-Term Investments, Restricted Deposits) (Details) Details http://www.centene.com/role/ShortTermAndLongTermInvestmentsAndRestrictedDepositsTables 61 false false R62.htm 2405404 - Disclosure - Short-Term And Long-Term Investments And Restricted Deposits (Fair Value Of Available-For-Sale Investments With Gross Unrealized Losses By Investment Type And Length Of Time) (Details) Sheet http://www.centene.com/role/ShortTermAndLongTermInvestmentsAndRestrictedDepositsFairValueOfAvailableForSaleInvestmentsWithGrossUnrealizedLossesByInvestmentTypeAndLengthOfTimeDetails Short-Term And Long-Term Investments And Restricted Deposits (Fair Value Of Available-For-Sale Investments With Gross Unrealized Losses By Investment Type And Length Of Time) (Details) Details http://www.centene.com/role/ShortTermAndLongTermInvestmentsAndRestrictedDepositsTables 62 false false R63.htm 2405405 - Disclosure - Short-Term And Long-Term Investments And Restricted Deposits (Contractual Maturities Of Short-Term And Long-Term Investments And Restricted Deposits) (Details) Sheet http://www.centene.com/role/ShortTermAndLongTermInvestmentsAndRestrictedDepositsContractualMaturitiesOfShortTermAndLongTermInvestmentsAndRestrictedDepositsDetails Short-Term And Long-Term Investments And Restricted Deposits (Contractual Maturities Of Short-Term And Long-Term Investments And Restricted Deposits) (Details) Details http://www.centene.com/role/ShortTermAndLongTermInvestmentsAndRestrictedDepositsTables 63 false false R64.htm 2406402 - Disclosure - Fair Value Measurements (Fair Value Measurements By Level For Assets Measured At Fair Value On A Recurring Basis) (Details) Sheet http://www.centene.com/role/FairValueMeasurementsFairValueMeasurementsByLevelForAssetsMeasuredAtFairValueOnRecurringBasisDetails Fair Value Measurements (Fair Value Measurements By Level For Assets Measured At Fair Value On A Recurring Basis) (Details) Details http://www.centene.com/role/FairValueMeasurementsTables 64 false false R65.htm 2406403 - Disclosure - Fair Value Measurements (Narrative) (Details) Sheet http://www.centene.com/role/FairValueMeasurementsNarrativeDetails Fair Value Measurements (Narrative) (Details) Details http://www.centene.com/role/FairValueMeasurementsTables 65 false false R66.htm 2409402 - Disclosure - Property, Software And Equipment (Details) Sheet http://www.centene.com/role/PropertySoftwareAndEquipmentDetails Property, Software And Equipment (Details) Details http://www.centene.com/role/PropertySoftwareAndEquipmentTables 66 false false R67.htm 2410403 - Disclosure - Goodwill And Intangible Assets (Schedule Of Changes In Goodwill By Operating Segment) (Details) Sheet http://www.centene.com/role/GoodwillAndIntangibleAssetsScheduleOfChangesInGoodwillByOperatingSegmentDetails Goodwill And Intangible Assets (Schedule Of Changes In Goodwill By Operating Segment) (Details) Details http://www.centene.com/role/GoodwillAndIntangibleAssetsTables 67 false false R68.htm 2410404 - Disclosure - Goodwill And Intangible Assets (Schedule Of Intangible Assets) (Details) Sheet http://www.centene.com/role/GoodwillAndIntangibleAssetsScheduleOfIntangibleAssetsDetails Goodwill And Intangible Assets (Schedule Of Intangible Assets) (Details) Details http://www.centene.com/role/GoodwillAndIntangibleAssetsTables 68 false false R69.htm 2410405 - Disclosure - Goodwill And Intangible Assets (Schedule Of Future Amortization Expenses) (Details) Sheet http://www.centene.com/role/GoodwillAndIntangibleAssetsScheduleOfFutureAmortizationExpensesDetails Goodwill And Intangible Assets (Schedule Of Future Amortization Expenses) (Details) Details http://www.centene.com/role/GoodwillAndIntangibleAssetsTables 69 false false R70.htm 2411402 - Disclosure - Medical Claims Liability (Schedule Of Change In Medical Claims Liability) (Details) Sheet http://www.centene.com/role/MedicalClaimsLiabilityScheduleOfChangeInMedicalClaimsLiabilityDetails Medical Claims Liability (Schedule Of Change In Medical Claims Liability) (Details) Details http://www.centene.com/role/MedicalClaimsLiabilityTables 70 false false R71.htm 2412402 - Disclosure - Health Insurance Marketplace (Details) Sheet http://www.centene.com/role/HealthInsuranceMarketplaceDetails Health Insurance Marketplace (Details) Details http://www.centene.com/role/HealthInsuranceMarketplaceTables 71 false false R72.htm 2415402 - Disclosure - Debt (Schedule Of Debt) (Details) Sheet http://www.centene.com/role/DebtScheduleOfDebtDetails Debt (Schedule Of Debt) (Details) Details http://www.centene.com/role/DebtTables 72 false false R73.htm 2415403 - Disclosure - Debt (Narrative) (Details) Sheet http://www.centene.com/role/DebtNarrativeDetails Debt (Narrative) (Details) Details http://www.centene.com/role/DebtTables 73 false false R74.htm 2415404 - Disclosure - Debt (Schedule Of Aggregate Maturities Of Debt) (Details) Sheet http://www.centene.com/role/DebtScheduleOfAggregateMaturitiesOfDebtDetails Debt (Schedule Of Aggregate Maturities Of Debt) (Details) Details http://www.centene.com/role/DebtTables 74 false false R75.htm 2416401 - Disclosure - Stockholders' Equity (Details) Sheet http://www.centene.com/role/StockholdersEquityDetails Stockholders' Equity (Details) Details http://www.centene.com/role/StockholdersEquity 75 false false R76.htm 2417401 - Disclosure - Statutory Capital Requirements And Dividend Restrictions (Details) Sheet http://www.centene.com/role/StatutoryCapitalRequirementsAndDividendRestrictionsDetails Statutory Capital Requirements And Dividend Restrictions (Details) Details http://www.centene.com/role/StatutoryCapitalRequirementsAndDividendRestrictions 76 false false R77.htm 2418402 - Disclosure - Income Taxes (Consolidated Income Tax Expense) (Details) Sheet http://www.centene.com/role/IncomeTaxesConsolidatedIncomeTaxExpenseDetails Income Taxes (Consolidated Income Tax Expense) (Details) Details http://www.centene.com/role/IncomeTaxesIncomeTaxesTables 77 false false R78.htm 2418403 - Disclosure - Income Taxes (Reconciliation Of The Tax Provision At The U.S. Federal Statutory Rate To The Provision For Income Taxes) (Details) Sheet http://www.centene.com/role/IncomeTaxesReconciliationOfTaxProvisionAtUSFederalStatutoryRateToProvisionForIncomeTaxesDetails Income Taxes (Reconciliation Of The Tax Provision At The U.S. Federal Statutory Rate To The Provision For Income Taxes) (Details) Details http://www.centene.com/role/IncomeTaxesIncomeTaxesTables 78 false false R79.htm 2418404 - Disclosure - Income Taxes (Tax Effects Of Temporary Differences Which Give Rise To Deferred Tax Assets And Liabilities) (Details) Sheet http://www.centene.com/role/IncomeTaxesTaxEffectsOfTemporaryDifferencesWhichGiveRiseToDeferredTaxAssetsAndLiabilitiesDetails Income Taxes (Tax Effects Of Temporary Differences Which Give Rise To Deferred Tax Assets And Liabilities) (Details) Details http://www.centene.com/role/IncomeTaxesIncomeTaxesTables 79 false false R80.htm 2418405 - Disclosure - Income Taxes (Narrative) (Details) Sheet http://www.centene.com/role/IncomeTaxesNarrativeDetails Income Taxes (Narrative) (Details) Details http://www.centene.com/role/IncomeTaxesIncomeTaxesTables 80 false false R81.htm 2419402 - Disclosure - Stock Incentive Plans (Narrative) (Details) Sheet http://www.centene.com/role/StockIncentivePlansNarrativeDetails Stock Incentive Plans (Narrative) (Details) Details http://www.centene.com/role/StockIncentivePlansTables 81 false false R82.htm 2419403 - Disclosure - Stock Incentive Plans (Summary Of Stock Option Activity) (Details) Sheet http://www.centene.com/role/StockIncentivePlansSummaryOfStockOptionActivityDetails Stock Incentive Plans (Summary Of Stock Option Activity) (Details) Details http://www.centene.com/role/StockIncentivePlansTables 82 false false R83.htm 2419404 - Disclosure - Stock Incentive Plans (Option Pricing Assumptions) (Details) Sheet http://www.centene.com/role/StockIncentivePlansOptionPricingAssumptionsDetails Stock Incentive Plans (Option Pricing Assumptions) (Details) Details http://www.centene.com/role/StockIncentivePlansTables 83 false false R84.htm 2419405 - Disclosure - Stock Incentive Plans (Schedule Of Other Information Pertaining To Option Activity) (Details) Sheet http://www.centene.com/role/StockIncentivePlansScheduleOfOtherInformationPertainingToOptionActivityDetails Stock Incentive Plans (Schedule Of Other Information Pertaining To Option Activity) (Details) Details http://www.centene.com/role/StockIncentivePlansTables 84 false false R85.htm 2419406 - Disclosure - Stock Incentive Plans (Non-Vested Restricted Stock And Restricted Stock) (Details) Sheet http://www.centene.com/role/StockIncentivePlansNonVestedRestrictedStockAndRestrictedStockDetails Stock Incentive Plans (Non-Vested Restricted Stock And Restricted Stock) (Details) Details http://www.centene.com/role/StockIncentivePlansTables 85 false false R86.htm 2420401 - Disclosure - Retirement Plan (Details) Sheet http://www.centene.com/role/RetirementPlanDetails Retirement Plan (Details) Details http://www.centene.com/role/RetirementPlan 86 false false R87.htm 2421402 - Disclosure - Commitments (Details) Sheet http://www.centene.com/role/CommitmentsDetails Commitments (Details) Details http://www.centene.com/role/CommitmentsTables 87 false false R88.htm 2422401 - Disclosure - Contingencies (Details) Sheet http://www.centene.com/role/ContingenciesDetails Contingencies (Details) Details http://www.centene.com/role/Contingencies 88 false false R89.htm 2423402 - Disclosure - Earnings Per Share (Details) Sheet http://www.centene.com/role/EarningsPerShareDetails Earnings Per Share (Details) Details http://www.centene.com/role/EarningsPerShareTables 89 false false R90.htm 2424402 - Disclosure - Segment Information (Details) Sheet http://www.centene.com/role/SegmentInformationDetails Segment Information (Details) Details http://www.centene.com/role/SegmentInformationTables 90 false false R91.htm 2425402 - Disclosure - Quarterly Selected Financial Information (Details) Sheet http://www.centene.com/role/QuarterlySelectedFinancialInformationDetails Quarterly Selected Financial Information (Details) Details http://www.centene.com/role/QuarterlySelectedFinancialInformationTables 91 false false R92.htm 2428402 - Disclosure - Condensed Financial Information Of Registrant (Condensed Balance Sheets) (Details) Sheet http://www.centene.com/role/CondensedFinancialInformationOfRegistrantCondensedBalanceSheetsDetails Condensed Financial Information Of Registrant (Condensed Balance Sheets) (Details) Details http://www.centene.com/role/CondensedFinancialInformationOfRegistrantTables 92 false false R93.htm 2428403 - Disclosure - Condensed Financial Information Of Registrant Condensed Balance Sheets (Parenthetical) (Details) Sheet http://www.centene.com/role/CondensedFinancialInformationOfRegistrantCondensedBalanceSheetsParentheticalDetails Condensed Financial Information Of Registrant Condensed Balance Sheets (Parenthetical) (Details) Details 93 false false R94.htm 2428404 - Disclosure - Condensed Financial Information Of Registrant (Condensed Statements Of Operations) (Details) Sheet http://www.centene.com/role/CondensedFinancialInformationOfRegistrantCondensedStatementsOfOperationsDetails Condensed Financial Information Of Registrant (Condensed Statements Of Operations) (Details) Details http://www.centene.com/role/CondensedFinancialInformationOfRegistrantTables 94 false false R95.htm 2428405 - Disclosure - Condensed Financial Information Of Registrant (Condensed Statements Of Cash Flows) (Details) Sheet http://www.centene.com/role/CondensedFinancialInformationOfRegistrantCondensedStatementsOfCashFlowsDetails Condensed Financial Information Of Registrant (Condensed Statements Of Cash Flows) (Details) Details http://www.centene.com/role/CondensedFinancialInformationOfRegistrantTables 95 false false R96.htm 2428406 - Disclosure - Condensed Financial Information Of Registrant Basis of Presentation and Significant Accounting Policies (Details) Sheet http://www.centene.com/role/CondensedFinancialInformationOfRegistrantBasisOfPresentationAndSignificantAccountingPoliciesDetails Condensed Financial Information Of Registrant Basis of Presentation and Significant Accounting Policies (Details) Details 96 false false R97.htm 2428407 - Disclosure - Condensed Financial Information Of Registrant Dividends (Details) Sheet http://www.centene.com/role/CondensedFinancialInformationOfRegistrantDividendsDetails Condensed Financial Information Of Registrant Dividends (Details) Details http://www.centene.com/role/CondensedFinancialInformationOfRegistrantTables 97 false false R98.htm 2428408 - Disclosure - Condensed Financial Information Of Registrant Other Current Assets (Details) Sheet http://www.centene.com/role/CondensedFinancialInformationOfRegistrantOtherCurrentAssetsDetails Condensed Financial Information Of Registrant Other Current Assets (Details) Details 98 false false R99.htm 2429401 - Disclosure - Subsequent Events (Details) Sheet http://www.centene.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.centene.com/role/SubsequentEvents 99 false false All Reports Book All Reports cnc-20151231.xml cnc-20151231.xsd cnc-20151231_cal.xml cnc-20151231_def.xml cnc-20151231_lab.xml cnc-20151231_pre.xml true true ZIP 126 0001071739-16-000192-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001071739-16-000192-xbrl.zip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`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
OA0/R1LYXY;*>6P)Q198+1P$ED>S M+CW1UM/H,%J N4;G]E=J88YER=S3(A"76 B0C#]0;X4'"K\0+S>HYM*M0V.M M[W4J3H%YR+O/>K4H9\5BL1W?QQ)9'FP7M$(IM3=5S&A,!92.LUK,='_@:MAT MLI[WW6[N -8AV+.=#(XE('KU7"!$Q 5V](XQ1\2:*($6.W PR2VZ,4)V=*/- M'SER I@9=_DFL\E#<6>BP'L3;+SY7'"68F"]3)&H<3FD%-6D[AEB*O.&WAC5 MG*>0JCOPVJOURU.1DO.EC'_S;^7M@2R*!YX.WCACO:7<"X<%,]114_>2@-R, M3B/<$#]=Q=U .(!-KR>RWQLD0_GIV>"P-C(Z2DA[@)SUG*@=;ZWEF4=R8V1$ MQS/_J5 .R(S/U3156/AK,C]4_.V-IP./LUQ<_P(#B4!&Q67P\Y2'/+J>M.8G M:',/+_)A') 9#>@0H(X#@0@&@!:0I;O#=@>$=&XH#CP5\[*ZBQ[:?#D($[+T MMX<++3$?\/]_53,%L4YJWJ=YWP"6QQ'+J=.&D/B2*76 M <^15US$-:DZ3Z%/7\[*9?%[^:WX282]JFL26'+":X,R'DD@G;?0:8A\*F>U M!8H(#&"V_SF&\XK&+/@Q-F\X1(>(#=TOS1MR?(AFX>:O8OJM>%_-EE\/EG8X MZ<4!<,4QE)9+K"B+ICIJ:PL4Y5IFNBDC7/X.0Z?F'.Y>.:-C\7\7D_G-7U5G MY-V^+VBKK) >2* 99%$7.KJ#6UBPTN1J5F$7P-D\G8R3JO'S!ZMYYKTQQ$4M MPR1ZOY8I *%AU*,:&@II)EU'N!*\%+IF:&64A/75ZF!M@:P7!LDTH%)[(FD< MS=3'/_%NTE&YM79&F,7T0NB:H91QLC4^VRU;X[-!P>@7&6JP5.FZIS ([H8Q MB\N+/+:.\"[VI;"UO5+.O&'STQ+V5]NF4=A000R!1A,OK?;>*[6NA,*8DD=W M'WJ_]K*?@\TC2X^])#"4A@:S-B5=8MQ::7T- K*YV4A'N [NB1O[;[!TB_QY MIS;]?5VFU$PGBV/1J"W>$HQA2GN,$?>"*PB5TK"&0!!_/86L^Z!%\RGK1-S/ M2[WGKG^8/!;'ZVNV>U-@WAF#J,"0<$U=2J^X@SO=$[D:"O;"C^8<[ #\ 7A8 MWU1>3::?RX>ORR8%K=]L$41<90.E);72>PTBF'('(5)'[ZA<4B6HWK3^4QWK M+J!N'Y_[:5Y]*R/\NVOL!^-S]SP=G+1*0.@]C4M:Y86!7NS&% 37$XW9-QVZ M WD(@[):+*O'8OZYF&X2I'XMGQH8E?VM@N.*Q/4L((IS*A&QDNU$]-1=44Z* MH;^>2N2$(?)]&/CP:'F'/<.ZJ(=BGNE<9IOAX<6F=:H,O:X.R4 M.2OC?T:XZT#)C@B)GB@&@@N&50&;(3%9#K M*>HT%)FZ!?R\:[;?&]Q7:=(\VE^9'+HHJ780:26YI3O[*W-79R-TFLZ[09 + M^ L>[G=_O.>]0%^'6X8L%942&(5P%9P)I%\%A0K=3V7[+M5^X\9D[L$^;PV MZ[?YX7#W8TV#IUHX[1WR$%,)K6+&;H7EP,K,J]0CM%6],JICF,_*J3\6Q?UJ MFE+A9?'JN7D@C"L@M4[YM!RQ<22Y>O*/?_>_1"A-G]S*AOK,$0>WMZO'55RV M%G%8@-@U 0*0F<)I1H2U*0/*X%1=YG)JEHOZ3LO63%N1C6'N2S MA*B<+[GJ>>)0H".""Y#PA]3B./$ F/+1":"Q _ \.>3?R*G0*IGJ3ZV"<( X MK!V#U!MED,.4UF)JIZXOX4#'VC^>UBP3ZB&24S7>WFB9LK?IVP*S%A,HM> I MCSEA$#BW@\3GGL>.<'4V-/OZ4L& K*P.";$WR+0U7;OX3,!6*$LI%0*J(3W M7J*=PJS/S,0PPI7@L#P^@V[Z\ZW^JYA,EU]WZ???3^;_*I9/T\EMTC,: M8O_+#SA&S1H&*0$T *6[?D 8RHV7; ,@!^F:2DM/J&7_FZ5\;OV.=!&8&2R- M9E00#0U+]_JW4G%P5*KQ.SY=:[<:!NES#,"L(/O!QR'"RG*EL$<\+C^9-PA0 M$->(W$-OF&L;&=^R_Y_+Q;_4W?^L-L5!6DOQNGG TD&H4.PX))(@PB&4M2R MTMXO>K_>OCKG^&NLU4;C[R28VP?A'>A(4=:_;<^5Y[;!08\YB8X#Q]89[X60 MN): D,'.FON,V#P/4;(Q[I0ED:ZFFL_+NVI?Y&:SQH%@3SGQL=N8$N:TI'C' M=*]L9K7OYA[X-1N43)"[),K[N YX7#V^+^[*V\DTI>'ZG'35FC-[WA.XL-Q1 MI"$U@BFOF""JEDQ;E)GS)OY_ )<_:[!W<)L91>*ZH5)$I!!2DR M1+E4$UL:8H^F]6O4_^?%^+RX+)M_7_YT7ZZ.Q9;7\6NSO[].\>IA/ M'H_O)?;ZO8 X PX3!!&'!/M!0,U6L;ZRZ^&VC5KJO%II6]3\*%8OB_F#\]1 MN$.>=-55$$SU^&S%X0(;US<&P>,CPP %"/*UY S M+#ERQP9"/$O8%^L\[(NRG7,OYK=V7+Q5&W_^J*H79,=WKP7!BM5DLS+Q(\\<>A^! BR E(BS M%,2?]:PU6?>#;?L7WAEA?OD9 W-^WZQ)[GXKY^N][ MJ-&T>;0IU%LLM:? 6(WBRD.Y6@ZCQ?4DZ>N1)SV!/<"1?YN6; MVY.-V@6IM0!13&2%D5(*A2"IQ=109@8OC/#0MR=.]8'R@&1Z@8:)KDRZ^+S^ MRTU<]RPV^H/MIN2]KPE$1K_'(*DU!]K?>S>*/Q^X^WRJT\T"KP!V@D@AJL(H>BV<22+TY M?HZJQ:3M'EEO8C99TAYJ%AB//AHF3J>2:]Q2 SBN!14J=SX:H2_U1G#IL.MP_)2U+6,^,1\1 )BIVLQ1:8 M9QYNCG#QVR.G.H5X.&;].#4TIM2>AH$SP;T7RDO%-(.<0LLW@AJ@B!DLTKGW MZV ]9,L&73W7W M]\7MLOQ6["3Y'-WQS\5M-;LMI^5FY[8].=N_-FCBJ2 8QUF6,.8 9)QM0:+Q M'S*C0RYL+74Z.WM'?E!ZUBY9%&.;-20N%,O)GU&295GD7*%N]<;@B2<($NZ= M%DY@P/E.'U1SE%DD:80GD?V2LD_0!W&?RFCT_K \/90XII-Q'W[_>; M-'R\ <:1D8@@H"H[EQFF# M-(&H%A<3\&L=4GN -,(I]3Y,R1XBV[9T*<\[0UA@,M"1,.*4AHW7WB M!=L FM]=DCJB^U?/!8)2I O2-O&=((N%V0T!IWVFTS=6[;?5W8^AZ"= M-P0#)G\W8\#+YX(SRKAUQ5@IL=!2,VQVDR04F0P8X5JT$P:< -T #-@_X?W> M(&U[@];!&J(90\P Q;&'B,8E2RVR-TZ*L M(U^R:-*@93 $>BP8#EQ::A WD=D6;<9\:)C="GZ%+UW0$Z MB)FX*Z.)%TN?SCRW:1EMSP M553Z]Q3'^?I]R)^/_KX-U_GU>KAZX=HME(A]FH:&S[4O=WC2C5J&[Q5PJ72VY(Y MQJSR2/L=RI;V7JYCZ*)C73*N+Y3;\R2#\^[O*'145SF;S+^OUZ))E%8,Z_FK M@2.%A# ("JP\M<@30FK4(,V]4W1A%]-R2#DNQ0QY(>FU:[%+4%.F^;/HXKS,?K5G>4W\KHT MY^R^-P6)* ($I8J7"E)*!-&NAL+Z*]J>'9"5'8%]/M[%B>!NL\?\Y[38#JUU M1B\]611WZ6)2_,TV]=*;_D*G[P^.:^@9IQ)X''7#TRV!&C9E3&;L ONE.=JK M"C+22&X,=X)D7GR+0$^FU?W3O(RFNYC,%^7C4\2@NH<,/;)Y\9#J^1XXD,I\ M6Y!"$:TU-P372RE&C,C+C_4WQ^%3-)_/OMHR_BN#=%HM_?BUOO_Y6?DLU MGHJ;ZLCMUZLZNH)<"Z@Y@9B8.+$HA0'T<>UNXH**0W LRUX_8OZD@-3W[>^V M;/L<63'_5B35J-O;^6HR7:S_6[S4U %,NOI$B+,P=H9+ RP!&F$/4KKO!& T MG!+_&I=4&[-H3P:G@;4P8,*P=I)U3MB@?)RZL2".<^QP7&/"Z"UN@,%8VU\C MX^&P]&R)^3G(N#_$\M666QLZ-GQEX)X1SIS /#H%1C,)%:_!<9QD1B->6$A: M9X3L!_5QV,>7>V=1D#KT,FO_M(_/!0H,U$Y+JYF-OJ[%UOH:5(MS[Q%>V$%4 MC[:U;XVTWP9KT.D7M3M2E_;MK&:\*3B6;FL*)JEV.$XM3@FUE8Y8[3)W52_L MB*DMWX8!NSV5/LV+QW+U.)G=;6M&OJ@FN87 M&Y-IC"[L;">''!VB>A97+NW:M7+44H,@%<6LMI0$:I@9QWUA M)S3=N6$9F)Z#++_-HYO8ABSK!L$IQ@QU1$;/T4M&%".B%LQKE$F6]N@RP_WY=KPYR?6X>4=IL2 :$'C$KCHNBV%AE3F7D;J?FAS0"EY0. 1(:6B,,)JZED4S*.M4#1"E^GW7MHY36>T:0_IL#QY ML:_[6U7=_55.I^N;!)N7=[@QP[>5M*Y<<7]8W?%$0E"N@L7&$ M*&B$H1K(6C;%>&9R&'CE6_2#@-T5D6P157%;UAM9ZK&:+\M_U^&#MQF,:O3& M@)1%'@%EO/4,42 8(K6TEI/=^] G\TQ:['K]&.KB&)<\%H)H6 P_6&%KU>^ ME$*6FZ[URO>QNT=V0/+L@&@7G/-6L^"BRV>,X]!P;F$TK:G>TU9(050N?=KO M=%_T:K #:,^Q>_"BMRTW$EZW#-YB+PS!2#F*G"31R.X<02[1L6*Z^UC4?@/\ MHEG4#;K]Q8"^+^[*V\G43"?EXZZ/W\\1N?FYFD[])C3CW6S7D_B;/V9IM;+I M8?0IMS_<_<]JXQ[4QY/'HSP[^D*PTGA!(7:&*BF 1M*B5.*;.\RP]<<"=!JY ML&_KY5!AH :M@F=8(28\QU)RC:&(:[UMS[FS*G=,C\^O&%S555]*&'KHOZ@* M]S6E4G\W>_NY,\9X7XZEP,P0R(V*%EX)X:*>*0-$>RRCXW \]+D?^%[*($PAB[EIB3."\FLEUM(J*,F\Z3TBDU08PY5PZIFL(M,ZSC-U-D4 MJ+G6^^$22 =:!1WM+L;1B>/$G+3]ZC]-V\Y=0'W^1AEJ\=) M.6O/J4V[(./P=%A[QE$*?8/<,E^+"97+S$(]0E9UHNMF_,F"MOU6\<:Y*>^V M,6Z?BV_%;+6_M-:Q)@$("F)G#>56"2!BSPFH^VLTS;Q-*L<9TK719A#XZRDQ/-Q\-H0B!N#GE]73 MTW0]-%-BH/MJ_KC6J@M!.1O-0C0#%"'IB'2&H1I\!_JO.#1TKLF>*?ICT>-Q MJG%@&]]LU?:A6#;87CCIO8%RC+G!W",+9,H.ZW&](&11L==3K6!,*^B^U30R MCZ4C1R4PZ@2(5H=0S'G*T4ZMJ4$PD Y5=O9I7=LH.JOSY6"&N4?&G."QM-3( M*(UL70/OQ8VTIIYU_@?BDH8CBQ20SFLH."&(NAHX!'AFC/4(S>[Y23R8EL;O MAV_#,L_KB;?H1$""(.AL.MS6.-T.A4)O%<"]5)G#I'5 Y;=B_F=UE0-EM+H< M_V"ZJ$4M-59QK+VW4G.I-*.1*%OPA?*]ES8<\"[810ZDOC0Y2I?KW29V>_O/ ML%-OZX=W!V,T(T!#;0&@WF($1*U/S@7(C*0>8?#KI3A:IREHE'S>_/I3>O)Y M/NR6UF]_(FCOE!& 6J<=PAP09W;&P$"1N2)N'9M[O?[1F30U; M7PA1;8Y8)215$C@6YSUJGF<\?BQGYLFY,Z[>=SF/H@;@^*?)]W4%M"C7ICCY M.D';HI6+WO@=@2!.N%844:<%12JN=VKXXTI'9-Z4&&':CO.PM"]%7.EFN50$ M&&64-$AS8@P5JHZ@$5+2S*V3UBG;-YOE;G;M=K-C?0Q RL]%6:]$4Q;ZZ,/M M2X9VI$7 Q%M$@37KZ!RFM1 [T51VQ-HH=^G.?8K8C0J&O@9P\XI9_XGN?XL1 M#$0"0.4]I@Q&QTD;[M-%#@&XL.1HI>^>MDAW]S?:2W9HV_.$UP8%J$:>.:0X MD,C$J1WL@&* _N?:43:S?MS2'$Y+_1FDC_.'R6R;-")E)]G5%FUGC=X,]]W[ M[@-FHU&[(!2RAE+@D;?<2$X07=\4$Q ![?2QU&W]&(,/D^5J'MGP,X9O#/&? M'PX2*^T$%8 8QAV34118"X58;J'A8^U6'6-ZAF&6=;-OX-%&+!/( M&\^QP0 #[S@6%A*C%3+*FV,S2D]3[[*Z_=?7:AI)OM@4=O]0+8OU;[\\15ML MJEDJ6!<%^9S$.;01U_95@5K-(P9(,,@DQXX)CA,@GE$K_-$J->.?8COFQ8\3 M9[]X#[ V_+!*]R0^WG\NGJKY,GGO7XJ']>[+(9._MU' UDFF(HS:4PU(= "0 MWB+I#!"7'V7:+Z$Z0[:_": ^Y?Y2W2^CQYI*823J/Z5>=F#\#[W^B/UOTC0H MQ(U&T5T5G%N-@!5(;J[1?II/8U1?=?DXMR1 1YCIBQ4B@A- MB+.;12?1EN@S.7*[9?1>9AQ+C-#T%0%X:AAF!G-I#=$ XG4JUS4 4.>6R+G$ MT=N8"GLW/3J%>HC#SGW]U=]O8A^.Y#EHT#I8+S4%5#&&@4',*@1WF(+HOEX\ MN_HC0=,Y(AOMJ_*;>R M@1Z 6ZFTV"KB7MOT'U*2[TVAT*I]*@+BK8PN"?&:&BYPQ& W7#'[!?B5PX&J M?Z@'8)A>1<3*V<-1*KU^,' 2+;NQ:1@:):/!YX+MAJ')S5PYHJV+(3AS$J9# M!.A,9G='B?'\4%#4,\507+8A(9PCV'A3"T"9S(R['6&B]SY)D8UG^\0\MN\,US;Z]ZOYK,R M'9RE/=G[^_*VV ETD 9'VP6+A$,*0T\QIYREY+ND[KG0*+/>PPCOEO3%B*XA M'F*F*":+(IWMO'M\FE??UC>^%L>GCOVM I!$":F]$93*M)A$B)C(S>FZ$ ME41[G4LZ W@ #FUR>/]7,;U;7P$TDZ8*PEI@2;6\FK70 M^38 <\$^)[N.E;D]W#!H)9B'CFEC.;0.4*#X3E GADJC.T3X>)=J;\JH')"' MF 1O;U>/JW4%\)=UON+/T^*-@E][Q3LT57;TB>"-IR2BIUST'YR-/@/R-7@, MYEYP:&[W!KR!V"-#SZ2.1D&4*>)0O7EB%+"9=TY;;TI= M^-QY J3G">8,V[H=$D=HCZT8AC[(/B6:[CFH M*WI6) K,M-,<:(8L\:06&E$S5)[*$43A-%9_XS/L3)#[&Z;__VHRCTA/OW\I MIL5M]&U\.9O,HC%YF0:J@Y':Z#M'AFRK=P2O( ': AD1UEQ2*[!8QR9:%17* MR%G&[DZ$M[K>9/PV>T'@6&D$"<$.1C(AI0% M? FKO&O8@SWQ(=J ,3//*"[ MBXD]P[B&G *F$+9.4XZX8R8:Y^CM,&ZI%.>)DMT6Z#BVAT M__1XXT"AUY9@S9VP#A+CE'*UP("RRR]W,AR).D=[<'JERQF;;A5R7OZY6E^]NJDVU["B>"XV>*YO>Y2%)WPC2"VTP!Q+CIA)L75"\1H^ MZ4GFO9Q1Y5@Y%UV'4\L0-S>+Y;-T!YCYZKF@G=*2M4X =Q:3ZJ9CKR:*\_?(U(GK2#/OJ3<%H[3R&%EOC7/0ON+=@ MYU\0E!F5,*)HJ3%-MZ= /[*Y-X^/+=X9M-'<*&^IIE0(KIQCHH;'QD7O0!%8 MO][<>HH:!F"IF\QG<52EP;3NX;JO!QCXYO,!,H2@T$QJ8P5CQ$NX6U<1K#*# M9MI'8UW!W-H%P&.98VTY746<.IEE7[XK0.*5@@P38AWEG%H!=@LM#'1FFJ76 M:6BOT9IU#__XYMHL7K9Z:U@GI91,DNB/*"@E(V+GCD@L,N?;UJEIKY&A?2KB M##/NMKAZ*O13,2Y":; _^9=G,Q/O.)36U'H".=]N>[_HLEX;?.:P WG"&KIB?,<&J8EE340QJ#,_'\C&Z:GDN"-/ L] M 3S4,.PN2J*+T9@,HP HVD0MM?8"6K^-7S$^9=X]RVBT49FSXBZM+-?'3"GP M/7;:5(ME2O#_,"O_?=#_;=0^6*8HEI+J%%>#6;33Q.]$=_JJQU]CM?\4%-P] MLOT-O&U"T.R8PXZD#>HG[&N2%J=42NDX!E)RP](6\"8UHH\6C1X+ M;1]&P':9.!NT#DI;19WE0*0-<**H5K 66QEU3;?A3E?]CRYLY_@..6"S9LOQ MC5O/H ?"8&@T%Y8Y9T6*XU3$QT4!/U/8<-<)K8F' )",#8<0^J$P[(6TA-Z M^8DVNU-S\US6[4 =8#OR>4G\(PPOAJW^OOW'YEE<&[\M:"E8]%:0=W'E[I%3 MVH$:$B)EYC;FB&(4>^-9_V@/DA9QMJBFY=VZL^L[;D?2N+[=($3PH%-I2Y_$ MR0XZPY0K68 .P);MJ>'LH9Z6CV8DVM,B.(.M,U)C#HQ(=4P@ MI+5HBN7&UU\$5]HJM^H#T4%B"];HKCOIIN5C.5MC<)0R!]L%02),*DK'XD"S M7K*4M&DKIC4F,]/B")V>SHG3):Y#^-=12>L-.[U:E+-BL:CY?L3+.=@N (+3 MPMY+;024@H,(9"VF #XSF'V$]!G2V>D2\B&8M>G=44?GU7.!2&)%1(=8:!W$ M*BCMS+)WO3\\%X*B6T@+,#5-Q M8:D,W(T!CV5F1.X8U9RGD*H[\-JK]#8("DH%=(3 MN?.>C?"9Z9I'F+3]+'Y!+L[M+<2G>?%8KA[5[&[+V .Y PX^'R"*\YR%@$6> M"X"I0V+74Q89?ST3P0E:JKI'76=V/L"&S0/!1@BPT1X QSV#!!.JZXYC+3)]B#'.%]T1 M( NZ(0_9<\+ QW?&3N/2#&)%L&)88@0< W03=:0)4/C8Q#6*T])6,>&MWACI M!Z%GC"ML")%"6ZY(#8_&N5?@QCBOGTR0TTY-,Q'O<;)1_F]FCVD M']_-OA6+Y69[8W;W.?X\+V\W28BK1;D\BS%XT2=;_%FG.$QKL-O5O%R6Q:*! M>6C^DD -)<0 BI$E@C@)HD'?9$M4CC%WGBLD+_K_;K:5X/UD_J]B'1;RDRRS M.U/,EW&9>S.?I&)BF[FF701>7Y\,6 HE!6=QTF1$<^N]P37 SK.A(FR'"-OK M@W8_G6.,0DWCLE/K2.2(ZFHR?3]9;F6/ACKC56<,-1S:\FF&'/(6 >&81=08 MC+BQ0E@H!.;F/%'_S].L^A85D4CMJ_F720J&JR5H'DYVY!T!,BB\L9&^:XG>PS#,2.PYY"ULW<'Q+W$T= KKI61 M&$M)0(T BX[IU?"N!U)4YU7&&>BX]ZRVP[<'!;"!R&J+.-4 $26EWZ% W>7' M;9^!,%U2-4M-@P0Z[?K=(+CIAV>#@*$BF%UEM!G(1'5^_C/XH8 W].PGS0 MRRC[G8Q&)^-MWA.HEIX2:Y1BT4EFPF *:QBPS2U#U9IZ@UQ'[,V+&P+Z]AY; MUG[#/\OEUW+V<5;\=S&9;\NUI4O2BWV7\3O^2B"&2JK$.INNBK H"5"-"C,T M,XIC1'-ISV2IQJ*:@0BK[J.J8G=OOLZKU<-77WY;]WS1&W<;?3 =L!(5?6ND M"=9,QJG&UMZU\R2W1O.(IO21T[@/+0W)Z-3A;=]OBMD C#[VP1082@#5$29D MI<404<%JK("2F8P>8[C$B!G=L9:&9/0P-'X;%2&UM1 KPY'4@",GN*A1@5QE M[E2VKW_P2W.W"]4,1=C>./I*=D,!]LRE2DR8>&>=X_52UBD",V]0MB^9T'L- MX+'2\@1MG&,]YB?E_!^3Z>JM8\..OQ!23@8"7-HC)M! B""T-1H&P\Q+-*V+ M)ORR)K,3M9QY#=8+7X]^+&AG-"*IP 2 CI$(EMKY0%RZS%B=]A49?E7J=JVA M,Z^[^F/QH8\%8K0G*>$G459J2("0N[4IPV*H.@^_-HL[U- YUEK]4?=G-)R2 M#%/L)"06*$>!!3OW21J6>=FJ==6'7YNOIZIE()+VPLMGF8WEF,6.4J#3C4>( MO=AA[C3,#8@;47&(D7,Q5Q7C"LC=2?$SNB^:)D?]MWFU6/PQFQ>3:5I.IGMQ MQ4)_?W[J)HJ7OES,'I9?/][?E(_%+Q2CRSE*] )$8@R4C>:#((4A-1)R$IGX M"\3H.H2H!!9KI7VTNQ)@2G<0&',]L9)]T"([1K<=Z@,$>;R?_$\U3\9@\?%^ M'SR'@!&F6K^ M5,TGRR*A\0S"448=;!>,1((9B*&USA@>QREQM9@&Y!X)CS+PL7]&=0GU$+/B M:E;>ED^3J:YF=\>)]-;CP3G(/710 >6LC>M9[V4ME"6Y=3Q:A\-!8TP>&0(UZH7 MS*_V0E.$ *??4(_A,.VM]/IU*J? 6K=LS\,>J^W(3?,GA4/J4LW(SMG;TR^'_W&D>CK(H;#S5_%]%NQ$??0 M&7[/7PS&27X[T6M]\) MX> 7 Z"4&L0TT@P1DE*C[G9XI/ @T^L?X4;:V,= EVH:5S38A\D\Y3[_]BL% M;GFDO=*46:"HY I03(UC*.H.6.#(L9W#1@&DGXIYTL_DH:A>I(#Y;3ZY>QEE M]SE9T3^_?_E4S=]7U=WWO<4@\MX6!*$VY4 7C#*'#;21GEM)'0;\>@I?]J'] M:FC\VXQC%<%(*6%7$(6+:#& MU EE=2V?<_CR4SP-Q:_^P6]/KIL4Y[W:=:'<0?!4]W8/E8XW#)8CQY1!'E.L MF,!<>%CWG;K@\*(<>'BR(G^'!-<&H]K"!#/S7LURD#-/HB1?=.A M'>[CB#SOZ*8#X-&,:FH]0@[X.&%B+#YG^]>XY-.9#]CV'=I!?[CT'B"2T&$GD!-4VE58$ MM9A F>O9ANI!\^UN.;0"^F)O.7 N**72>40-,HPS)VPMIL%'"PE>SK93_WSJ M$NCV6TS/ZZI4"JN\+Z.F-K*N5UD'BZ@W:AL(!AHZ PQ#C$@!#6"FE@ [FIDU M:80;3?U1I2^P3Z++9/$UB?,2,[?"*/[-?\%9!+H6Z@_GJ;DMIS.+HL5X2:!F4FG+B:_$%<)F3 MW BS1_;/LKY O[+;4M1HI:C25'"D!,4I7\16>(NRRYF/,-/C$(NT7C!O[X"G MC-(_'?SMY-W\2P,NY;XJ..08L$1HQ95C)-T\J-T!RY#)#(@<83;&?EWU ;!O MSZW?R_OBW6RQFD]FMT6=?^\PAPXU"0Z+Z#]?'"L^D;+ M-P0(B522,D\P]Q"RZ&;"G3V6<+"BP"/+!MN8$8TO!YP"^WD9]WQ3YX=PTM_B M9*"+^VI>W$S^SN-BLW<'H)@PVA& -8((8, K>$"# V5D&H6IU- R[LQNG%(JKR>)UKD9UQ+I<<4MKWWM7R(*&6%,%53(Q?6KE7'1 M2:(GA@07@%,MV+$\(8VV('(T\&,^_+5&;J(.=/SDOU[_;<\V1M^?#9P);+UC MAN-H,"'A4(D:.P7!8$N%,=V%:,RG:K2*&G0[Y?5$_''V0NZC)#_A;0$ C8G' MFEE.!"4""NMK2#Q6F?F!1KB Z)&[P^$_R/6Q75?-=+)8E/=E<:>__URQY;N- M7F1C;I[RVF I$T)S9 S66&MD,03/XY9DDG2$468#D'1 1?3HR\4VJZCC[V;R M5"XGT\]%A&E>U-.$+;^E(^3==/'R,FTS)^YM_Z7]5P\X:2>^,3C#HSN=2GMJ M)#0"@G.9=,&M$M+"8X=U/4UHM4!QH5FM4M:/AT^IM^5ML;#EXG9:+5;S9I-9 MNS<%@E- M@60",F4!I S7L-A!;C\ZQ6#\>7'6:U718S*1F3=.KT 4^$ET78V!C>5/PH;!3PRVK^-%TM]&2:#DHS#6 M 8DQYI89:PFN@3)$9&ZHCV@]=UG\S=1+G[-BG*/?S=+ORV_%ISBZSK*]^>PX M?+PWU>-3,5NL9?E!$C5<<8@- M56&K_X7Y4+2JSJF?0:W.&#(CCM4*&0PHC7J#""(GA&<<$>FCYBS6%,*V&12[ M\WC64^S1O"^O'@P &>NQD4 J[2U#GGE1"^-T[M6(Z[,1C97^AF.2#?<0)_=_ M3>9WZ6CF2.:65\\%CRFU*"7?<^FL)G8=T%H,Q7)#/D?(FESU_7@ ?P)Z0RR7 M=I/4RY&AXA0P>]CX[?K[3Q/96J9GP69W:>+X,'DLCF9EZ>-S02F@*()"6>"9 MA@ YHVM0F337DS(HDTL_VJ7SZV 8KO'IVGUO2C6'L['IR3BT3M>>]L$XQ$0 M#&.'K:.0*1=7JEOQ#!6Y]2%'2+'SDJ/J1Q_#W&K=!D"L._O'K%PN/G_YH\E- MUOWM E4&&0< (TI"0"& $M=B6I);@GM$FT:CI%V7.AF">@FC(S[<[IF ,"-. M,85INHIK%?;.UMT7&F8FAADCI;KQWW*1&TKQQRW,\U,1!.DT=3*ET$:1J])R M5HN B/QW"TOGPL84\\$<5Y8P[ C6G"Z M$\/+WDO.#:O]MKK[,2W+"= -DB+S[V8,>/E<0%9X&4>!]MBFRZO*1(NX%<-! M>CV5UCIAP G0C6'EOL]C^KW)->"37QXXPA$Q:HG23CJ$.:0[PXLTR4Q6.,+8 MP(X4"I9IQ M1'=&7B%]/?M(0U+M+9:?05MC-L@?5FF&^7B__M?%RQM;O\6VAXZS^OIDT$9Y M:K1CD@"CF<=>H!VX#%Q18H]^4"1\#I"AOB?'6Z9D5Q][:8<4*+/QXLK]KH M!8$#X+7PRAEM0,0>^^>]RY"J' M^^PS@/8N>7!L;$-MB/!T3C_*T6$0Y:EHHC4UX&R%MFCT=&7 MD_GZ&H=1%RH=Y'I?NK"P6*R*.[N:[Y;_FZVP5_%BGU;SVZ\1F5=7J=Z,BL]Z M8\#*,8B4384ZHO8T)KO NLYRTPN-,*LU[=,#I)D1<]BEYO M5(U@&S1XZ['7%GD,)&#<6$*?P>>H]Z/:H7-57]U@.DF?%SV8XGK[OBC//9Y^ MZD6PB @A)891#2+5>\!.U2KP0/=>&_8_0^K,*KWH437&=1,45@$J(7(8"D:, M=Z:&7Q(,,R>IUB?:ONB)^M3+'>9$;3C& )7WD7] ,@NC"@6! I7J8UXD'F .\,I_=!.U M6TU?]$2]]YVCKE?#G*5-!AAX)!JSKG@<'5J/F';>E(H3*K7P\ #C%$8W13M4 M\T7/S_%XI-Q;S"3UWA$#O-8,"[<_1E @T2-M_E;[[U.A86FZUXBDG3#OE[/I M;'&K5JO-W4ZZW_%'OU"0(^.+0.8HDG&9W2ZR7!MM#*Y*L1A8D84].Q\I MOZN7.XJ#[ ,0U]D;*L$0]NJ M&[(1\I*L'V:KO_PRR][$-362;/TA:JD+"Z/N=P>OG88<>^284%)ASJ0KX882 M)1Z3C2]\Z*29,B -7MJ$>686_3./VIK-HTW5Y\PY.H@ (**2::0< YX)8:"! MI0(8)N,I\S"&*=2F*B]M+I4;[?X-I1ZGT$O?'03"A$>'AC%@O3$2.+1?ND1T M:493=F(,,Z<%#?;JDSZ\V+SUN=\L;O+EW;;G]]DRNJ6+Z*I>Y3O/54UCL^)9 MW-_^ZG/N2<^@%Y1$=4)JJ3:V?%.-1WV[JD<3![8L#N?"._&RDU!,B2-"&F"D M<1(2X/;J$'X\!0;[HFU;2V8O^ARRQ?&NW":RY72VRE9/ZE!$CV4Y6ZQFTZ[G M4YVO#\P[Q*2([I+ AAL$;0EZ *G5ND3Y<]W-X]> M'?EM8ARD&1%(0\$ -)0Z#8&("G4,>:D0=UQ>6$KN/8??;=:K]61Q':W,[D+( M#WU74#[""0'"3"B&*!(N[BOWD&*,^C(3+B1.M38!6U[G3M7;!9@#3^VA?RSS M52X\,E]@KAW )"+6I)1/&=\:<3.*N57(!2_6C6+$N4TD/?UL0 M6A05^86VHLB!YT@054+J/4Q\(G&T*:/G6K%/5]T%S(;SVN_"&26TH0@P9*EP MTL.]'>B42#1:QIGJ.1SKO9G6+F 2["+\U>)Z'Z.3%[_J2(VN( MB9J(/P*V7\M8ZCGL^)(;.YM*9]/E)4RG7^[9SC6C&@TD2"ZQL18[J0V*BYPW M!):*@!S+W^F(9YY47:KS$N;5"P#TJ M\P+FT;UXQ;NO9YI'-4<0D'620.^IP#0"KAU!I>4=US69^ X\_'V'/VQ%7L < MJC[45+>WR^U]8F\AL,EC"EXAHRFA42T08(*\$>7)JR HV?C['69P::KM:^9] M3D@A_W7)>2IJ)R4'*K\T"( 4$P(ACB1R2A/ ]DN;8JD5Y.'XDME.FCM#T-T% M3([#-NV'[&Z7^F;RQ58?F\F\*+R .IPU":,)FKAH7WL.45'?QG%N)"U5PJQ7 MB=-I@,\Y7^ATZEZI%S#/#MN]AT#H:7>J.YH0[6XI@*-1*QX9&I7!]UZM]R[5 MM?H=-G$Y2NTU->JJ$.1W]M/C)#MDE"6,:A!U XV6=O=Z&C<04$^K;K,Z6ACW MR?,ONRR/0Z++S+:M:J^B,G4I3 M&"-,@ZY+KN>K5M\JZF.S?T&FQPON8YD*QV#'CH<"&"?Q._V+HG="M^NYI-P8 MP)S#BI9 F,2@[+&=_C9)M=[4]<%G'$V+&E0?YJ<GQ2SJH("C=>NJX3<%"*#6V^*" M#CEJA:; [/=Q*1)-K?&=:W9E:G6KKXZ=OR_Y/*I[M2N#?0ZO[]=1_)FOLQI> MW?&& 6OHH.1QIR?*"^DDI$1)9C2VQ55FU:LE?0K[P.M:RT?=/@(Q%%$.E/'6 M.H.CU$;N(4 V\56( ?I@;5'AI9SC#I#NN?9CY9[3R/>J; \U;!6J&T5,PIB#FDG!FN2C$A]JD' MOQVNK^_"V?2*V/5B?>K.:+;+52DTC *O95FD_9L@W[P+4,_&E^.LRRVQ>W#HT9,Z3MD%#J F6$B)K M(1066+X7ETN76,QD@!PZ6=\U^',*M$>9-%U,M_2 Z)X<\1?AT]\^_NV/['HV MG.-@F;*.0(%]\8"; DB%)5C MEH".IRQG-W1H%=T>-IGMAGJ_O48W)'NSSNZ.F20O?CY(+"$O2I-B):3R#ECC M2[&X3'U]88"DZ<(@:0/2'ICROE3%=J"[HEQJL_Z2+V?_/EII[7C#$%D/GZVYN#]]ER*T)M&AWJ M($!FE!9&4X45=112P'4IN(TFWVB6HB[IU!*Z?=6$_)!]W2RG7R9%ADM^NYS< M[8K8W!_F/YH65[G.'CY<61XRM=_ H*.&6:2%Y5$'C")J2IA(5'5/]YK?LN7G M_*)HV"?L9V/G/F:P*YHV_8)@A"'(8$NQPM@HA../)7 ,@L1B#HVO%\?"UX[Q M[X&X5\MLLMHL?SXV+G;.T3$V'FD5M"*Z.&_!F$F#.)%0L[TO;'4BQ1JG$EP> MQ=H#M0\K[_Y"WN?+!WYO;_+O[N,5CUEXE8V#D@0+R32)XD%7%"R!4SG'76I[0. W?:2J0P])#Z^"=C MVMT#(PFM##-HJR#?I;D4O:!][K+SCX0[^J9"W3Z"+V*UO5(<2ZZ=0%H!58KO M.4F\VQM@L;H.#+$. .XPCF/S>97]WR;^VGTK5N:SA&\\&T.=P(T#38+FC/'H M<2$DB+$0$TUVKU!Z+ VMK+/3CX"U@J\.M0D6( \Y*2KA DJA%4#Y4L3XTWBN MRDY7\O/IV1*F_4W'[01S!& PGFN#TU5[?"ZFP-F#U?4V7]Q&<.]L M]GE]%;^T(E3JI8]'4](C3@$5TEAB%%,2\5(H1M%X8EQ.4VG>.I1GX$=E2-3+ M#0)5EAI#XI[&$*02(LA@*1B%LBK2]'(X^7 HUU7I^+LR;,RT.:SN\^(WUA^?SS?(HTT[L-8@X5Z-# M[)$NXA6=(W':WDM-#>")AP,#O-QND6G]8M['>=2SS;[:.#K0(BC!@,52(RF MI]IPP.1>-&,3_=D!TJE5^Z@=-,]#E$HKZ6";0(1'1,HBM8H@93G#@);B:<]3 MZU(.GRR-]5O-ER1(^V?,P;WLZ.<#UM&&)$!:B+1"BD#F52F6@VI$.8FG:_8X M5Y( [9\G;VL$#A]J$H0DTGMA#8&20ZH,<[X4C@F@ MX(Q#SBSCV'FI]S@KPT>4#=$VTSH!N =F%6[JF\5JO=P4039^,LW47;Y9'"U8 M>*!)$''A5]:K(NK!"&"E8WR_V0,XGII(K;.G)4A[YTNY='Z8K+-=T/W#\EJ; M0<I=Q'!>KS7*RF&9_3)9_9>NO\[@-GC&6I>TI;P GWG'DE:=< M*LT%A("(J&]K$!:^X91_\>[G,) ?9JN_U/6_-JMUL1L_)/R0S=-!++XXG5LLRJJ M'1U@2&6[8!76!%JL(1. (RTH!.7(;?1Y1N-"MDR-MI%MSHDCY'P86_.5XZ%M MD(9+83".'K!$DFSK2.PE,'8\#F)_RT8RNJWR(RY>)E\N9]?YH?B!>HV#1)!9 MX+36B!##L+#"EC) HL93+;;7C241WC8I\L=L,;O;W-W7&WJ;KU8?"BTU9LN! M?@(CFA%)G*<,2>,UD1./@/'DJ)E^LXD"OMPK<#OEGG:."8\U"Y%5TB8F# @A-"<=6 MBE)0ANQXHI_;4/;SFDSM =O#Y\I3Z9#K8)'$-L MBQ="((?0640-TJ5X7*"J\[Q1N"JI!&H+U;.M1@^O:AR;"XT7J7K=!D@BXIAY M+3&PDCJ"+2I!0M'4?PW.3KMK5R? ]\#._0-&[V[\;!$]N-ED_G#I6TW#6NV# M%40;YAUQB!;AG(7UN,?:Z\1 QP$^\MH!W[I N(]R2,O\:[9<_RQ>75W'^5#, MA:_-MLZZ780H(-8\8BL1XQ8*9A$IA5<8)>8&#;!*30?TZ@CD'ACVCSR__CZ; MS^.@WT3M+6YGG^>96JVR)K9^_4Z"+^Y(F!90XSC7>'%NJ4H -&:)4;0#+$_3 M C=,,Y_,[E;%]K[[R_["U?TH'DS+*O?+YIV%N)ICS+"B MUA%+5;0;&"\!H4HEIFG+5\&[SN'N@7\?LF_98I-]R*;Y[6+6[)2TLFWP6&$E MHSD:/6U&2!%:O%_6F7*)%=X@>!7T:AO>-B_,'AYRJZ9+8D\!<2^+VQRD*+): M<&1(Q$TPJCDU1*>>LX_[H+T?L)M3Z?TRNYMM[N(">?_B:*1U%OW7N%,7J^:G M1399+HK?;CE?CU0G]1F(U(@!B:)PPFDHL(#@'EE) $LM4#+N4_J^84\I,+&_ M;S5Q"\[O(KSUZ%2C9< && <1D985-3.YE0Z7HZ?6)U9;AN,^F.\&W!Z,HW?K M+]GRS6(:1QN)O?WIWIQK]NQLHWY"]'U97'EY<8R'$,4, E/"$,>9^GCEZSB[ M[Q+J7BZ!BI%?37XTN0-ZN4EP!'L)D8DS!P(<_5NK9"F<9\GVT^LXB&\)U3ZN M@/*[N]EZ]UQ[=#_S+0[98A]>5#/@I6XGH4CRHZAX;1U0R!R&3K']*JU!JD_W M.L[;.\.YCS3O(EM8%^]J1"F*)76KPW=?MYHLCMZ*(+BB#-1\LJB^VTGH+1A' M+4'.8<") P@S9/>06&Y24[->QUE\]X#W<:.8+[-H29I-U-4BSI;HX*XB*$4! M\BC#]L?Y5JX&:U]RG\5C<#CN!@P[A+6T$2BW-Q\,,ZFEFU['J7U?L/? RC^S M[X\ 6N:+^-=I]N@&M3X9FW85:/'0,C* (@^88$6F]&,P4LNOO(X3_([1/G=X M>7$P\^3W3R0<4?:J,G$-B.J7%&'D/,>8":^YL90QKW%5N&3?JX*;+.<_U76^ MW7NKJK0WZ29@0RFQ!GKJG2=4>:AI"43\\5CW/.;ZWNH MUY,?DVW0PF1Q/9]-/L_FLW7D]62UR!?3K96T/EAFM*VN P?%T1=VPEB-I('8 M>E7*SSF\_.26)&7G9T4YD673XB&HK6U0#O/S>K9:;8H[P6F^6J^.EM1NTD5 MW@./">)4:*>T85#X>WDXDO#R:]CVK_GGE.M&%6D;TTE 5+&NC=Z#51ZCZ!T* MB9!$-FK:ZA(%Z5/S9P9TMWMN0IY!2V=UY)^8&15EX1OT$HR,N[F)IM6UZY/Z"T PXEC#'+H!90<"PGQ MWF@1RHZ5BJW0)&T-/ '_X5#R;8T"^4V["A0* *AR4'IMD5,(4?4 !A]/':@A M;"<3W1S\R;NVO;>,ZG2PGP'ONN]^/TR_9 M]6:>O;M1\WG^O3@F]/GRTV*:S^?1\-NF2.X:C>DBN'AHM3A00@@!!PW73#CG M%?> &<0K7YWM2,A'"K#YYO/Z9C,OL7_(G?@0%7.3+[]/EL<>Z6G<5^!4(".Y M,GADK?UG0S.&+_ MSW*VCL;9S4K=3F:+U7K_V=9X?? ;@N><(DL%95!"9@GQLMP.+04H,9+=%^NBK)'9;RAD 4T7(/A/>)P6V-TR!W%H1; MO$Z>-M3"@+S>NWRYGOU[: 1>;Z*.:(0@M&\0YI["#V5C@&+ MK"LR6ZM"L#I*&=NKP\\6<<%[._N6_5*CJ2H NGXG 6C%F33"\H*VP%KC1 F" M9W(\5]IM$.%Y?EA7,/=1Q2@.,JN(RME_)@#FB80"$,>9=588#4 Y?*Q\:N6/ MX;&D"Y4^+U*4B&I?I*@,5WCTJ8")1\ K81E%3!7!D]&EN!?! )48-3A 8B1H M[26])\'6@^;WCX-4Z/[)YZ*EPR$ C&A,L(BH2$-@*89V?#SWM$FZR]N#K@\& M3'[48\#CSP6-M3*,0(*TE2*N?X3S4@R%Q7AN6UMAP G0]9$I?GC'TS__F/PK M7YHBHK[":&C02X"2.8XI)-ARYB/K&<+W$'"K1A3*VX-9T1WNYZ7>P]#_G-QE M!].Y$GL*V$F"B53<(>"ZD,M-BZA)O)_,/L M]LN1A*^*%H$9J9#5%L,H(D?2,[X7S6J86F2@*:^^9 YYL))35"<3UAZ&+?\^U$*#<5X+L:ZID-[(/>Q MH-Q7;MS6_2PJLWR9?:VQJ!QN%3P$4GA@-98\.I^LX'TI(@8TL9[F $/6>EM6 M6@.[!SY=+2?762%T-8F>?S0@0X'&@CKDB++$*^I4*8S$(C%E9(!%,OMBSHD( M]T 7FWW+YOG7[/HJFWY9Y//\]F=-NZ:B94 ,>8"9Q09##!"##+-25!:7WC0R M#;!29E]D:A?P\_IL;VLD&=5I'JA7"D# F8+.2D.0UFB__K+**[K#F]T8W?Q4 MV,[*E4^K[&8S?SN[.7:?6:=YH,X2J"0C0FF(*? ,F5)HZFE?E7W.['$ED* V MPY+!'DZ,P_ML6?0QN8U_+XIZ3A8_5U?Y.GJ4N]K[8XIOP XH"+6W1!N(HRF+ MC*1*&"6H@D95'6UU%-\0E;S-.ZF,87CRP> LP!!"$AQ3(Z4]3KESB-YQ77# ?;!(2_K]9?EP5?X/9O!4_@(YX4OPM7__L"&^[_ M)1I%&B , 8LK*"I> (M3HQR>Q7H\93-:T%!^"G1=:-:_/:19_S80;Q&2%I#H M)'NC *=,E<.CW":&J WP?+UES3:&KD^#H,Y!PJ\?#AQXPR7!CA.A*41 <5X* MI(Q//#88(A=:-@%2(4RX5'ODB)6^UZ?%XRN==\N/F\_3\J=#MVT-NPG81 &T M$9Q@+A404C^L8B2:U^/9 $[0:=X;P ,Z&;A_>/MC?K/^'A%^_/:VS>(PIK-' MF1%C.B<02,NBH"^DPA6// /N 6'(02^4Q+3*)NHZ#^+@B^CULR".=Q$TQ@P8 MJ2-U@061M-A[0CVC'')B4DN?#G!-:(,$!W,@6@5Y%4<.1A4=?0 MPW+X5*B^XGGZ#%5L2Z$'\Q^:83K(_ ?CD,:0J>A&&RJHQ$2 4@1OW'@28Q*T M=B3_H1EL@\U_T-)9J9 WUJ@HD32(X7LQA %H/,ES2;H[FO_0#+K!YC\@@ST3 MEB+'A;<<,V%<*49TJA,O'0?H:;;"@!.@ZR5K_\!^IW]>Q3%4F HU6@8&^M98PJ">.<UIUXR \ ML*.9TPH:0R#G<"\@2"U!,<"\AR[9TQJ^?>QHV625?RPZV"-,X" M;K'GW&]=C.(5VA(U01,I-, $B$[WL-8 /J?%7>=BN;IQ4)@H;*V@7&@BH*? MB%)@#DWB;6(/\>E]NV6ID)V3([5"TVNT#H80*>)<<)))C9"G4K']20<#?44D M]A&9WB8!ZG(K&>ES7SYOY]HHKI"Y!@0!1CC22'H4/6V^O3TDE@/G>=-2>B]& MC"1?U6]AWC](?R"0I*7> [= ..Z1_TDGE4] M1M*48\WZ"T9S;Z!EI 34$Z=X*6D3)+$D.D!.M[=\:M3Q(];,?_Y]^*CGZ// M]E__\?]02P$"% ,4 " #5%9(Y^!)D4>+ @"O;C$ $ M@ $ 8VYC+3(P,34Q,C,Q+GAM;%!+ 0(4 Q0 ( -45DBA1ID37AP M !Q3 0 0 " 76+ @!C;F,M,C Q-3$R,S$N>'-D4$L! A0# M% @ U162#AL[; 4-0 9CT" !0 ( ! :@" &-N8RTR M,#$U,3(S,5]C86PN>&UL4$L! A0#% @ U162$;F->YQ;0 8A % !0 M ( !1]T" &-N8RTR,#$U,3(S,5]D968N>&UL4$L! A0#% M @ U162/0]R$[/* $ 8;@/ !0 ( !ZDH# &-N8RTR,#$U M,3(S,5]L86(N>&UL4$L! A0#% @ U162&4V.J2KPP =HH) !0 M ( !ZW,$ &-N8RTR,#$U,3(S,5]P&UL4$L%!@ & 8 *A $ ,@W!0 $! end

Document And Entity Information - USD ($) $ in Billions	12 Months Ended
Document And Entity Information - USD ($) $ in Billions	Dec. 31, 2015	Feb. 17, 2016	Jun. 30, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	CENTENE CORP
Entity Central Index Key	0001071739
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-K
Document Period End Date	Dec. 31, 2015
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Public Float			$ 9.6
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Common Stock, Shares Outstanding		121,654,923

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 1,760	$ 1,610
Premium and related receivables	1,279	912
Short term investments	176	177
Other current assets	390	252
Total current assets	3,605	2,951
Long term investments	1,927	1,280
Restricted deposits	115	100
Property, software and equipment, net	518	445
Goodwill	842	754
Intangible assets, net	155	120
Other long term assets	177	174
Total assets	7,339	5,824
Current liabilities:
Medical claims liability	2,298	1,723
Accounts payable and accrued expenses	976	768
Return of premium payable	207	236
Unearned revenue	143	168
Current portion of long term debt	5	5
Total current liabilities	3,629	2,900
Long term debt	1,216	874
Other long term liabilities	170	159
Total liabilities	$ 5,015	$ 3,933
Commitments and contingencies
Redeemable noncontrolling interest	$ 156	$ 148
Stockholders’ equity:
Preferred stock, $0.001 par value; authorized 10,000,000 shares; no shares issued or outstanding at December 31, 2015 and December 31, 2014	0	0
Common stock, $.001 par value; authorized 400,000,000 shares; 126,855,477 issued and 120,342,981 outstanding at December 31, 2015, and 124,274,864 issued and 118,433,416 outstanding at December 31, 2014	0	0
Additional paid-in capital	956	840
Accumulated other comprehensive loss	(10)	(1)
Retained earnings	1,358	1,003
Treasury stock, at cost (6,512,496 and 5,841,448 shares, respectively)	(147)	(98)
Total Centene stockholders’ equity	2,157	1,744
Noncontrolling interest	11	(1)
Total stockholders’ equity	2,168	1,743
Total liabilities and stockholders’ equity	$ 7,339	$ 5,824

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2015	Dec. 31, 2014
Stockholders' equity:
Preferred stock, par value (in usd per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in usd per share)	$ 0.001	$ 0.001
Common stock, shares authorized	400,000,000
Common stock, shares issued	126,855,477	124,274,864
Common stock, shares outstanding	120,342,981	118,433,416
Treasury stock, at cost	6,512,496	5,841,448

Consolidated Statements Of Operations - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Revenues:
Premium	$ 19,389	$ 14,198	$ 10,153
Service	1,876	1,469	373
Premium and service revenues	21,265	15,667	10,526
Premium tax and health insurer fee	1,495	893	337
Total revenues	22,760	16,560	10,863
Expenses:
Medical costs	17,242	12,678	8,995
Cost of services	1,621	1,280	327
General and administrative expenses	1,826	1,314	931
Premium tax expense	1,151	698	333
Health insurer fee expense	215	126	0
Total operating expenses	22,055	16,096	10,586
Earnings from operations	705	464	277
Other income (expense):
Investment and other income	35	28	19
Interest expense	(43)	(35)	(27)
Earnings from continuing operations, before income tax expense	697	457	269
Income tax expense	339	196	107
Earnings from continuing operations, net of income tax expense	358	261	162
Discontinued operations, net of income tax expense (benefit) of $(1), $1, and $2, respectively	(1)	3	4
Net earnings	357	264	166
(Earnings) loss attributable to noncontrolling interests	(2)	7	(1)
Net earnings attributable to Centene Corporation	355	271	165
Amounts attributable to Centene Corporation common shareholders:
Earnings from continuing operations, net of income tax expense	356	268	161
Discontinued operations, net of income tax expense (benefit)	(1)	3	4
Net earnings	$ 355	$ 271	$ 165
Basic:
Continuing operations (in usd per share)	$ 2.99	$ 2.30	$ 1.49
Discontinued operations (in usd per share)	(0.01)	0.03	0.03
Basic earnings per common share (in usd per share)	2.98	2.33	1.52
Diluted:
Continuing operations (in usd per share)	2.89	2.23	1.43
Discontinued operations (in usd per share)	(0.01)	0.02	0.04
Diluted earnings per common share (in usd per share)	$ 2.88	$ 2.25	$ 1.47
Weighted average number of common shares outstanding:
Basic (in shares)	119,100,744	116,345,764	108,253,090
Diluted (in shares)	123,066,370	120,360,212	112,494,346

Consolidated Statement Of Stockholders' Equity - USD ($) $ in Millions	Total	Centene Stockholders' Equity - Common Stock [Member]	Centene Stockholders' Equity - Additional Paid-In Capital [Member]	Centene Stockholders' Equity - Accumulated Other Comprehensive Income [Member]	Centene Stockholders' Equity - Retained Earnings [Member]	Centene Stockholders' Equity - Treasury Stock [Member]	Noncontrolling Interest [Member]
Balance at Dec. 31, 2012	$ 954	$ 0	$ 451	$ 5	$ 567	$ (70)	$ 1
Balance (in shares) at Dec. 31, 2012		110,678,320				6,019,824
Comprehensive Earnings:
Net earnings	166				165		1
Other Comprehensive Income (Loss), Net of Tax	(8)			(8)
Common stock issued for acquisitions	75	$ 0	75
Common stock issued for acquisitions (in shares)		3,433,380
Common stock issued for stock offering	15	$ 0	15
Common stock issued for stock offering (in shares)		685,280
Common stock issued for employee benefit plans	10	$ 0	10
Common stock issued for employee benefit plans (in shares)		2,549,450
Common stock repurchases	(19)					$ (19)
Common stock repurchases (in shares)						688,128
Stock compensation expense	37		37
Excess tax benefit from stock compensation	6		6
Contribution from noncontrolling interest	7						7
Reclassification to redeemable noncontrolling interest	0
Balance at Dec. 31, 2013	1,243	$ 0	594	(3)	732	$ (89)	9
Balance (in shares) at Dec. 31, 2013		117,346,430				6,707,952
Comprehensive Earnings:
Net earnings	270				271		(1)
Other Comprehensive Income (Loss), Net of Tax	2			2
Common stock issued for acquisitions	190	$ 0	170			$ 20
Common stock issued for acquisitions (in shares)		4,486,434				(1,492,738)
Common stock issued for employee benefit plans	9	$ 0	9
Common stock issued for employee benefit plans (in shares)		2,442,000
Common stock repurchases	$ (29)					$ (29)
Common stock repurchases (in shares)	626,234					626,234
Stock compensation expense	$ 48		48
Excess tax benefit from stock compensation	19		19
Contribution from noncontrolling interest							0
Reclassification to redeemable noncontrolling interest	(9)						(9)
Balance at Dec. 31, 2014	$ 1,743	$ 0	840	(1)	1,003	$ (98)	(1)
Balance (in shares) at Dec. 31, 2014	118,433,416	124,274,864				5,841,448
Comprehensive Earnings:
Net earnings	$ 355				355		0
Other Comprehensive Income (Loss), Net of Tax	(9)			(9)
Common stock issued for acquisitions	12	$ 0	8			$ 4
Common stock issued for acquisitions (in shares)		0				(247,580)
Common stock issued for employee benefit plans	12	$ 0	12
Common stock issued for employee benefit plans (in shares)		2,580,613
Common stock repurchases	$ (53)					$ (53)
Common stock repurchases (in shares)	918,628					918,628
Stock compensation expense	$ 71		71
Excess tax benefit from stock compensation	25		25
Contribution from noncontrolling interest	11						11
Reclassification to redeemable noncontrolling interest	1						1
Balance at Dec. 31, 2015	$ 2,168	$ 0	$ 956	$ (10)	$ 1,358	$ (147)	$ 11
Balance (in shares) at Dec. 31, 2015	120,342,981	126,855,477				6,512,496

Organization And Operations	12 Months Ended
Organization And Operations	Dec. 31, 2015
Organization And Operations [Abstract]
Organization and Operations	Organization and Operations Centene Corporation, or the Company, is a diversified, multi-national healthcare enterprise operating in two segments: Managed Care and Specialty Services. The Managed Care segment provides Medicaid and Medicaid-related health plan coverage to individuals through the government subsidized programs, including Medicaid, the State Children's Health Insurance Program (CHIP), Long Term Care (LTC), Foster Care, dual-eligible individuals (Duals) in Medicare Special Needs Plans and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program, or collectively ABD and the Health Insurance Marketplace. The Specialty Services segment consists of our specialty companies offering auxiliary healthcare services and products to state programs, healthcare organizations, employer groups and other commercial organizations, as well as to our own subsidiaries. On February 2, 2015, the Board of Directors declared a two-for-one split of Centene's common stock in the form of a 100% stock dividend distributed February 19, 2015 to stockholders of record on February 12, 2015. All share and per share information presented in this Form 10-K has been adjusted for the two-for-one stock split.

Health Net Merger	12 Months Ended
Health Net Merger	Dec. 31, 2015
Business Combination, Description [Abstract]
Health Net Merger	Health Net Merger On July 2, 2015, the Company announced that the Company and two direct, newly formed subsidiaries of the Company had entered into a definitive merger agreement with Health Net, Inc. (Health Net) under which the Company will acquire all of the issued and outstanding shares of Health Net. Under the terms of the agreement, at the closing of the transaction, Health Net stockholders (with limited exceptions) would receive 0.622 of a validly issued, fully paid, non-assessable share of Centene common stock and $28.25 in cash for each share of Health Net common stock. The transaction is valued at approximately $5.5 billion (based on the Centene closing stock price on February 17, 2016), including the assumption of debt. The transaction is expected to close in early 2016 and is subject to approvals by relevant state insurance and healthcare regulators and other customary closing conditions. In August 2015, the Company announced the early termination of the waiting period required under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended. In October 2015, the Company and Health Net announced the transaction was approved by both the Centene and Health Net stockholders. The Company expects to fund the cash portion of the acquisition through a combination of the debt financing completed in February 2016, borrowings on the Company's revolving credit facility and existing cash on hand.

Stockholders' Equity	12 Months Ended
Stockholders' Equity	Dec. 31, 2015
Stockholders' Equity Note [Abstract]
Stockholders' Equity	Stockholders' Equity The Company has 10,000,000 authorized shares of preferred stock at $.001 par value. At December 31, 2015, there were no preferred shares outstanding. The Company's Board of Directors has authorized a stock repurchase program for up to 8,000,000 shares of the Company's common stock from time to time on the open market or through privately negotiated transactions. No duration has been placed on the repurchase program. The Company has 3,335,448 available shares remaining under the program for repurchases as of December 31, 2015. The Company reserves the right to discontinue the repurchase program at any time. During the year ended December 31, 2015, the Company did not repurchase any shares through this publicly announced program. As a component of the employee stock compensation plan, employees can use shares of stock which have vested to satisfy minimum statutory tax withholding obligations. As part of this plan, the Company repurchased 918,628 shares at an aggregate cost of $53 million in 2015 and 626,234 shares at an aggregate cost of $29 million in 2014. These shares are included in the Company's treasury stock. In January 2014, the Company completed the acquisition of 68% of USMM and as a result, issued 4,486,434 shares of Centene common stock to the selling stockholders. Additionally, in July 2014, the Company completed a transaction whereby CHS assigned its contract with the Louisiana Department of Health and Hospitals to Centene's wholly owned subsidiary, LHC. The closing resulted in the issuance of 1,492,738 shares of Centene common stock.

Statutory Capital Requirements And Dividend Restrictions	12 Months Ended
	Dec. 31, 2015
Statutory Capital Requirements And Dividend Restrictions [Abstract]
Statutory Capital Requirements and Dividend Restriction	Statutory Capital Requirements and Dividend Restrictions Various state laws require Centene's regulated subsidiaries to maintain minimum capital levels specified by each state and restrict the amount of dividends that may be paid without prior regulatory approval. At December 31, 2015 and 2014, Centene's subsidiaries, including Kentucky Spirit Health Plan, had aggregate statutory capital and surplus of $2,284 million and $1,699 million, respectively, compared with the required minimum aggregate statutory capital and surplus of $1,195 million and $851 million, respectively.

Retirement Plan	12 Months Ended
Retirement Plan	Dec. 31, 2015
Retirement Plan [Abstract]
Retirement Plan	Retirement Plan Centene has a defined contribution plan which covers substantially all employees who are at least twenty-one years of age. Under the plan, eligible employees may contribute a percentage of their base salary, subject to certain limitations. Centene may elect to match a portion of the employee's contribution. Company expense related to matching contributions to the plan was $19 million, $12 million and $9 million during the years ended December 31, 2015, 2014 and 2013, respectively.

Contingencies	12 Months Ended
Contingencies	Dec. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
Contingencies	Contingencies On July 5, 2013, the Company's subsidiary, Kentucky Spirit Health Plan, Inc. (Kentucky Spirit), terminated its contract with the Commonwealth of Kentucky (the Commonwealth). Kentucky Spirit believes it had a contractual right to terminate the contract and filed a lawsuit in Franklin Circuit Court seeking a declaration of this right. The Commonwealth has alleged that Kentucky Spirit's exit constitutes a material breach of contract. The Commonwealth seeks to recover substantial damages and to enforce its rights under Kentucky Spirit's $25 million performance bond. The Commonwealth's attorneys have asserted that the Commonwealth's expenditures due to Kentucky Spirit's departure range from $28 million to $40 million plus interest, and that the associated CMS expenditures range from $92 million to $134 million. Kentucky Spirit disputes the Commonwealth's alleged damages, and filed a lawsuit in April 2013, amended in October 2014, in Franklin Circuit Court seeking damages against the Commonwealth for losses sustained due to the Commonwealth's alleged breaches. On February 6, 2015, the Kentucky Court of Appeals affirmed a Franklin Circuit Court ruling that Kentucky Spirit does not have a contractual right to terminate the contract early. The Court of Appeals also found that the contract’s liquidated damages provision “is applicable in the event of a premature termination of the Contract term.” On September 8, 2015, Kentucky Spirit filed a motion for discretionary review seeking Kentucky Supreme Court review of the finding that Kentucky Spirit's departure constituted a breach of contract. On October 9, 2015, the Commonwealth filed a response opposing discretionary review. On May 26, 2015, the Commonwealth issued a demand for indemnification to its actuarial firm, for "all defense costs, and any resultant monetary awards in favor of Kentucky Spirit, arising from or related to Kentucky Spirit's claims which are predicated upon the alleged omissions and errors in the Data Book and the certified actuarially sound rates." On August 19, 2015, the actuarial firm moved to intervene in the litigation. The Franklin Circuit Court granted the actuarial firm's motion on September 8, 2015 and ordered a forty-five day stay of all pretrial proceedings in order for the firm to review the record. Also, on August 19, 2015, the actuarial firm filed a petition seeking a declaratory judgment that it is not liable to the Commonwealth for indemnification related to the claims asserted by Kentucky Spirit against the Commonwealth. On October 5, 2015, the Commonwealth filed an answer to the actuarial firm's petition and asserted counterclaims/cross-claims against the firm. On March 9, 2015, the Secretary of the Kentucky Cabinet for Health and Family Services (CHFS) issued a determination letter finding that Kentucky Spirit owed the Commonwealth $40 million in actual damages plus prejudgment interest at 8 percent. On March 18, 2015, in a letter to the Kentucky Finance and Administration Cabinet (FAC), Kentucky Spirit contested CHFS' jurisdiction to make such a determination. The FAC did not issue a decision within the required 120 days. On August 13, 2015, Kentucky Spirit filed a declaratory judgment action against the Commonwealth in Franklin Circuit Court seeking a declaration that the Commonwealth may not purport to issue a decision against Kentucky Spirit awarding damages to itself when the matter is already before the Kentucky courts, and that the Commonwealth has waived its claims against Kentucky Spirit for damages arising out of the contract. The Commonwealth filed counterclaims seeking a Declaration of Rights and Entry of Judgment on its determination letter. On December 1, 2015 the Franklin Circuit Court consolidated this declaratory judgment action with Kentucky Spirit’s other litigation claims against the Commonwealth. On December 15, 2015, the Franklin Circuit Court denied Kentucky Spirit’s motion to dismiss the Commonwealth’s counterclaim for Declaration of Rights and Entry of Judgment. Discovery is proceeding in the consolidated litigation matters. The resolution of the Kentucky litigation matters may result in a range of possible outcomes. If Kentucky Spirit prevails on its claims, it would be entitled to damages. If the Commonwealth prevails, a liability to the Commonwealth could be recorded. The Company is unable to estimate the ultimate outcome resulting from the Kentucky litigation. As a result, the Company has not recorded any receivable or any liability for potential damages under the contract as of December 31, 2015. While uncertain, the ultimate resolution of the pending litigation could have a material effect on the financial position, cash flow or results of operations of the Company in the period it is resolved or becomes known. Excluding the Kentucky matters discussed above, the Company is also routinely subjected to legal proceedings in the normal course of business. While the ultimate resolution of such matters in the normal course of business is uncertain, the Company does not expect the results of any of these matters individually, or in the aggregate, to have a material effect on its financial position, results of operations or cash flows.

Subsequent Events	12 Months Ended
Subsequent Events	Dec. 31, 2015
Subsequent Events [Abstract]
Subsequent Event	Subsequent Events In January 2016, the Company completed an approximate 19% investment in a data analytics business and as a result, issued 1.1 million shares of Centene common stock to the selling stockholders. The investment will be accounted for using the equity method of accounting. In February 2016, a wholly owned unrestricted subsidiary of the Company (Escrow Issuer) issued $1,400 million of 5.625% Senior Notes ($1,400 million Notes) at par due 2021 and $1,000 million of 6.125% Senior Notes ($1,000 million Notes) at par due 2024. The Company intends to use the net proceeds of the offering, together with borrowings under the Company's $1,000 million revolving credit facility and cash on hand, to fund the cash consideration for the Health Net merger, to pay merger and offering related fees and expenses, and for general corporate purposes. The proceeds of the debt issuance will be held in escrow until the closing of the Health Net merger. If the Health Net merger is not consummated, the Escrow Issuer will be required to redeem each series of Notes at a redemption price equal to 100% of the principal amount of such series of Notes, plus accrued and unpaid interest to the redemption date.

Organization And Operations (Details)		12 Months Ended
Organization And Operations (Details)	Feb. 02, 2015	Dec. 31, 2015 segment
Organization And Operations [Abstract]
Stockholders' Equity Note, Stock Split, Conversion Ratio	2
Number of reportable segments		2

Summary Of Significant Accounting Policies (Schedule Of Property, Software And Equipment Depreciation Periods) (Details)	12 Months Ended
	Dec. 31, 2015
Minimum [Member] \| Buildings And Land Improvements [Member]
Property, Plant and Equipment [Line Items]
Fixed Asset - Depreciation Period	3 years
Minimum [Member] \| Computer Hardware And Software [Member]
Property, Plant and Equipment [Line Items]
Fixed Asset - Depreciation Period	2 years
Minimum [Member] \| Furniture And Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed Asset - Depreciation Period	3 years
Minimum [Member] \| Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Fixed Asset - Depreciation Period	1 year
Maximum [Member] \| Buildings And Land Improvements [Member]
Property, Plant and Equipment [Line Items]
Fixed Asset - Depreciation Period	40 years
Maximum [Member] \| Computer Hardware And Software [Member]
Property, Plant and Equipment [Line Items]
Fixed Asset - Depreciation Period	7 years
Maximum [Member] \| Furniture And Equipment [Member]
Property, Plant and Equipment [Line Items]
Fixed Asset - Depreciation Period	10 years
Maximum [Member] \| Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Fixed Asset - Depreciation Period	20 years

Summary Of Significant Accounting Policies (Schedule Of Amortization Period For Intangible Assets) (Details)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Amortization Period	9 years 9 months	10 years 3 months
Purchased Contract Rights [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Amortization Period	8 years 9 months	7 years 6 months
Provider Contracts [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Amortization Period	11 years 1 month	11 years 1 month
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Amortization Period	8 years 1 month	7 years 1 month
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Amortization Period	7 years 4 months	13 years 1 month
Developed Technology Rights [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Amortization Period	5 years
Minimum [Member] \| Purchased Contract Rights [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Amortization Period	5 years
Minimum [Member] \| Provider Contracts [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Amortization Period	4 years
Minimum [Member] \| Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Amortization Period	3 years
Minimum [Member] \| Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Amortization Period	7 years
Maximum [Member] \| Purchased Contract Rights [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Amortization Period	15 years
Maximum [Member] \| Provider Contracts [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Amortization Period	15 years
Maximum [Member] \| Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Amortization Period	15 years
Maximum [Member] \| Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible Assets, Amortization Period	20 years

Summary Of Significant Accounting Policies (Recent Accounting Pronouncements) (Details) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
New Accounting Pronouncement, Early Adoption [Line Items]
Other Assets, Current	$ 390	$ 252
Other long term assets	177	174
Long-term debt	1,223
ASU on presentation of debt issuance costs [Member] \| New Accounting Pronouncement, Early Adoption, Effect [Member]
New Accounting Pronouncement, Early Adoption [Line Items]
Other long term assets	(14)	(14)
Long-term debt	(14)	(14)
ASU on presentation of deferred tax assets and liabilities as noncurrent [Member] \| New Accounting Pronouncement, Early Adoption, Effect [Member]
New Accounting Pronouncement, Early Adoption [Line Items]
Other Assets, Current	(102)	(83)
Other long term assets	$ 102	$ 83

Summary Of Significant Accounting Policies (Health Insurance Marketplace) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Accounting Policies [Abstract]
Health Insurance Marketplace Risk Adjustment Payable	$ 108	$ 44
Reinsurance reimbursement threshold	$45,000 entitled the Company to reimbursement from the programs at 50% coinsurance
Health Insurance Marketplace Reinsurance Receivable	$ 24	11
Health Insurance Marketplace Risk Corridor Payable	4	9
Health Insurance Marketplace Minimum Medical Loss Ratio Payable	$ 15	$ 6

Health Net Merger (Details) $ / shares in Units, $ in Millions	Jul. 02, 2015 USD ($) subsidiary $ / shares shares
Business Combination, Description [Abstract]
Number of subsidiaries created \| subsidiary	2
Share exchange, per share \| shares	0.622
Cash consideration for each share due to merger \| $ / shares	$ 28.25
Total value of merger transaction \| $	$ 5,513

Acquisitions and Noncontrolling Interest Acquisitions (Details) € in Millions, $ in Millions		1 Months Ended					3 Months Ended	12 Months Ended
	Jul. 02, 2015 USD ($)	Sep. 30, 2015 USD ($)	May. 31, 2015 USD ($)	Jan. 31, 2015 USD ($)	Jul. 31, 2014 USD ($) shares	Jan. 31, 2014 USD ($) shares	Mar. 31, 2015 USD ($)	Dec. 31, 2015 USD ($) shares	Dec. 31, 2014 USD ($) shares	Dec. 31, 2013 USD ($)	Dec. 31, 2015 EUR (€) shares	Dec. 31, 2015 USD ($) shares	Jul. 01, 2014 EUR (€)	Jul. 01, 2014 USD ($)
Business Acquisition [Line Items]
Acquisition consideration	$ 5,513
Goodwill									$ 754	$ 348		$ 842
Business Acquisition, Contingent Consideration, Cash Payment								$ 29	0	0
Gain on contingent consideration								(44)	0	0
Goodwill and intangible adjustment								$ 38	0	0
Net intangible assets									120			155
Finite-Lived Intangible Assets, Accumulated Amortization									$ 43			$ 62
Common stock, shares authorized to repurchase (in shares) \| shares											8,000,000	8,000,000
Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased \| shares											3,335,448	3,335,448
Treasury Stock, Shares, Acquired \| shares								918,628	626,234
Payments for Repurchase of Common Stock								$ 53	$ 29	19
Redeemable noncontrolling interest									148			$ 156
Ribera Salud [Member]
Business Acquisition [Line Items]
Outstanding balance											€ 46	50	€ 48	$ 52
Payments to Acquire Interest in Joint Venture					$ 17
Equity Method Investment, Ownership Percentage					50.00%
Community Health Solutions [Member]
Business Acquisition [Line Items]
Contingent liability									18
Business Acquisition, Contingent Consideration, Cash Payment							$ 8
Gain on contingent consideration							$ (10)
Stock Issued During Period, Shares, Acquisitions \| shares					1,492,738
U.S. Medical Management [Member]
Business Acquisition [Line Items]
Redeemable noncontrolling interest												156
Stock Issued During Period, Shares, Acquisitions \| shares						4,486,434
Celtic Insurance Company [Member]
Business Acquisition [Line Items]
Ownership percentage sold by parent				25.00%
Proceeds from Divestiture of Businesses				$ 7
Managed Care [Member]
Business Acquisition [Line Items]
Goodwill									276	151		361
Managed Care [Member] \| Agate Resources, Inc. [Member]
Business Acquisition [Line Items]
Acquisition consideration		$ 109
Business acquisition, cash paid		93
Business Combination, Consideration Transfered, Present Value of Future Consideration		$ 7
Business Combination, Deferred Payment, Period of Payments		3 years
Contingent liability		$ 9
Business Combination, Contingent Consideration Arrangement Based on Achievement of Underwriting Targets, Duration of Cash Payment		3 years
Goodwill		$ 48
Recognized identifiable intangible assets		$ 39
Description of contingent consideration arrangements		A portion of the contingent consideration is based on the achievement of underwriting targets and will be paid in cash over a three year period; the remainder is based on the net proceeds of a retrospective rate adjustment to be settled in 2016.
Managed Care [Member] \| LiveHealthier, Inc. [Member]
Business Acquisition [Line Items]
Acquisition consideration				28
Business acquisition, cash paid				11
Contingent liability				4
Goodwill				26
Recognized identifiable intangible assets				$ 15
Percentage of voting interests acquired				79.00%
Business Combination, Step Acquisition, Equity Interest in Acquiree, Including Subsequent Acquisition, Percentage				100.00%
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable				$ 13
Business Combination, Contingent Consideration Arrangement, Duration of Payment				3 years
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High				$ 9
Managed Care [Member] \| Fidelis [Member]
Business Acquisition [Line Items]
Acquisition consideration			$ 57
Business acquisition, cash paid			7
Contingent liability			50									16
Goodwill			29									11
Recognized identifiable intangible assets			$ 23
Percentage of voting interests acquired			100.00%
Description of contingent consideration arrangements			duals membership and revenue per member during the first year of the contract (July 2015 - June 2016), including reconciliation payments settled over a two year period
Business Combination, Goodwill, Deductible for Income Tax , Percentage			100.00%
Net intangible assets												1
Finite-Lived Intangible Assets, Accumulated Amortization												2
Contingent consideration, period of reconciliation payments settled								2 years
Managed Care [Member] \| General and Administrative Expense [Member] \| Fidelis [Member]
Business Acquisition [Line Items]
Gain on contingent consideration								$ (34)
Goodwill and intangible adjustment								$ 38
Specialty Services [Member]
Business Acquisition [Line Items]
Goodwill									$ 478	$ 197		$ 481
Specialty Services [Member] \| U.S. Medical Management [Member]
Business Acquisition [Line Items]
Acquisition consideration						$ 213
Business acquisition, cash paid						80
Goodwill						280
Recognized identifiable intangible assets						$ 78
Percentage of voting interests acquired						68.00%
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable						$ 133
Business Combination, Total Fair Value						352
Redeemable Noncontrolling Interest, Equity, Fair Value						$ 139
Percent of goodwill deductible for tax purposes						45.00%
Percent of future consideration issuable in shares						50.00%

Acquisitions and Noncontrolling Interest Non Controlling Interest (Details) - USD ($) $ in Millions	3 Months Ended								12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Net [Abstract]
Net earnings attributable to Centene	$ 112	$ 92	$ 88	$ 64	$ 106	$ 81	$ 47	$ 34	$ 356	$ 268	$ 161
Increase in equity for distributions from and consolidation of noncontrolling interest									11		7
Reclassification to redeemable noncontrolling interest									1	(9)	0
Net transfers from (to) noncontrolling interest									12	(9)	7
Changes from net earnings attributable to Centene Corporation and net transfers from (to) the noncontrolling interest									368	259	168
Reconciliation of Changes in the Redeemable Noncontrolling Interest [Roll Forward]
Redeemable noncontrolling interest, beginning balance				$ 148					148
Reclassification to redeemable noncontrolling interest									(1)	9	$ 0
Net earnings attributable to noncontrolling interest									2
Redeemable noncontrolling interest, ending balance	$ 156				$ 148				$ 156	$ 148
Celtic Insurance Company [Member]
Noncontrolling Interest [Line Items]
Ownership percentage by parent	75.00%				100.00%				75.00%	100.00%	100.00%
Centurion [Member]
Noncontrolling Interest [Line Items]
Ownership percentage by parent	51.00%				51.00%				51.00%	51.00%	51.00%
Home State Health Plan [Member]
Noncontrolling Interest [Line Items]
Ownership percentage by parent	95.00%				95.00%				95.00%	95.00%	95.00%
U.S. Medical Management [Member]
Noncontrolling Interest [Line Items]
Ownership percentage by parent	68.00%				68.00%				68.00%	68.00%	0.00%
Noncontrolling Interest [Member]
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Changes, Net [Abstract]
Increase in equity for distributions from and consolidation of noncontrolling interest									$ 11	$ 0	$ 7
Reclassification to redeemable noncontrolling interest									1	(9)
Reconciliation of Changes in the Redeemable Noncontrolling Interest [Roll Forward]
Reclassification to redeemable noncontrolling interest									(1)	$ 9
U.S. Medical Management [Member]
Reconciliation of Changes in the Redeemable Noncontrolling Interest [Roll Forward]
Fair value of noncontrolling interest sold									7
Redeemable noncontrolling interest, ending balance	$ 156								$ 156

Short-Term And Long-Term Investments And Restricted Deposits (Narrative) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2015 USD ($) position
Investments, Debt and Equity Securities [Abstract]
Percentage of Investment Grade Investments Rated by S&P or Moody's	99.00%
Positions from which gross unrealized losses were generated	429
Total number of positions	733
Income (Loss) from Equity Method Investments \| $	$ 8

Short-Term And Long-Term Investments And Restricted Deposits (Short-Term And Long-Term Investments, Restricted Deposits) (Details) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Schedule Of Investments And Restricted Deposits By Type [Line Items]
Amortized Cost	$ 2,225	$ 1,556
Available For Sale Securities Gross Unrealized Gain Accumulated In Investments	5	5
Available For Sale Securities Gross Unrealized Loss Accumulated In Investments	(12)	(4)
Fair Value	2,218	1,557
US Treasury and Government [Member]
Schedule Of Investments And Restricted Deposits By Type [Line Items]
Amortized Cost	431	393
Available For Sale Securities Gross Unrealized Gain Accumulated In Investments	0	1
Available For Sale Securities Gross Unrealized Loss Accumulated In Investments	(2)	(2)
Fair Value	429	392
Corporate Debt Securities [Member]
Schedule Of Investments And Restricted Deposits By Type [Line Items]
Amortized Cost	859	556
Available For Sale Securities Gross Unrealized Gain Accumulated In Investments	2	2
Available For Sale Securities Gross Unrealized Loss Accumulated In Investments	(8)	(2)
Fair Value	853	556
Restricted Certificates Of Deposit [Member]
Schedule Of Investments And Restricted Deposits By Type [Line Items]
Amortized Cost	5	6
Available For Sale Securities Gross Unrealized Gain Accumulated In Investments	0	0
Available For Sale Securities Gross Unrealized Loss Accumulated In Investments	0	0
Fair Value	5	6
Restricted Cash Equivalents [Member]
Schedule Of Investments And Restricted Deposits By Type [Line Items]
Amortized Cost	78	79
Available For Sale Securities Gross Unrealized Gain Accumulated In Investments	0	0
Available For Sale Securities Gross Unrealized Loss Accumulated In Investments	0	0
Fair Value	78	79
Municipal Bonds [Member]
Schedule Of Investments And Restricted Deposits By Type [Line Items]
Amortized Cost	496	174
Available For Sale Securities Gross Unrealized Gain Accumulated In Investments	2	1
Available For Sale Securities Gross Unrealized Loss Accumulated In Investments	(1)	0
Fair Value	497	175
Asset-backed Securities [Member]
Schedule Of Investments And Restricted Deposits By Type [Line Items]
Amortized Cost	163	180
Available For Sale Securities Gross Unrealized Gain Accumulated In Investments	0	0
Available For Sale Securities Gross Unrealized Loss Accumulated In Investments	(1)	0
Fair Value	162	180
Residential Mortgage Backed Securities [Member]
Schedule Of Investments And Restricted Deposits By Type [Line Items]
Amortized Cost	66	84
Available For Sale Securities Gross Unrealized Gain Accumulated In Investments	1	1
Available For Sale Securities Gross Unrealized Loss Accumulated In Investments	0	0
Fair Value	67	85
Commercial Mortgage Backed Securities [Member]
Schedule Of Investments And Restricted Deposits By Type [Line Items]
Amortized Cost	40	0
Available For Sale Securities Gross Unrealized Gain Accumulated In Investments	0	0
Available For Sale Securities Gross Unrealized Loss Accumulated In Investments	0	0
Fair Value	40	0
Cost Method Investments And Equity Method Securities [Member]
Schedule Of Investments And Restricted Deposits By Type [Line Items]
Amortized Cost	71	68
Available For Sale Securities Gross Unrealized Gain Accumulated In Investments	0	0
Available For Sale Securities Gross Unrealized Loss Accumulated In Investments	0	0
Fair Value	71	68
Life Insurance Contracts [Member]
Schedule Of Investments And Restricted Deposits By Type [Line Items]
Amortized Cost	16	16
Available For Sale Securities Gross Unrealized Gain Accumulated In Investments	0	0
Available For Sale Securities Gross Unrealized Loss Accumulated In Investments	0	0
Fair Value	$ 16	$ 16

Short-Term And Long-Term Investments And Restricted Deposits (Fair Value Of Available-For-Sale Investments With Gross Unrealized Losses By Investment Type And Length Of Time) (Details) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Schedule of Available-for-sale Securities [Line Items]
Available For Sale Securities Continuous Unrealized Loss Position Less Than 12 Months Aggregate Losses Accumulated In Investments	$ (10)	$ (2)
Less Than 12 Months, Fair Value	1,248	491
Available For Sale Securities Continuous Unrealized Loss Position 12 Months Or Longer Aggregate Losses Accumulated In Investments	(2)	(2)
12 Months or More, Fair Value	68	198
U.S. Treasury Securities And Obligations Of U.S. Government Corporations And Agencies [Member]
Schedule of Available-for-sale Securities [Line Items]
Available For Sale Securities Continuous Unrealized Loss Position Less Than 12 Months Aggregate Losses Accumulated In Investments	(2)	0
Less Than 12 Months, Fair Value	294	72
Available For Sale Securities Continuous Unrealized Loss Position 12 Months Or Longer Aggregate Losses Accumulated In Investments	0	(2)
12 Months or More, Fair Value	14	180
Corporate Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Available For Sale Securities Continuous Unrealized Loss Position Less Than 12 Months Aggregate Losses Accumulated In Investments	(6)	(2)
Less Than 12 Months, Fair Value	561	311
Available For Sale Securities Continuous Unrealized Loss Position 12 Months Or Longer Aggregate Losses Accumulated In Investments	(2)	0
12 Months or More, Fair Value	41	1
Municipal Securities, General Obligation [Member]
Schedule of Available-for-sale Securities [Line Items]
Available For Sale Securities Continuous Unrealized Loss Position Less Than 12 Months Aggregate Losses Accumulated In Investments	(1)	0
Less Than 12 Months, Fair Value	208	20
Available For Sale Securities Continuous Unrealized Loss Position 12 Months Or Longer Aggregate Losses Accumulated In Investments	0	0
12 Months or More, Fair Value	5	7
Asset-backed Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Available For Sale Securities Continuous Unrealized Loss Position Less Than 12 Months Aggregate Losses Accumulated In Investments	(1)	0
Less Than 12 Months, Fair Value	121	70
Available For Sale Securities Continuous Unrealized Loss Position 12 Months Or Longer Aggregate Losses Accumulated In Investments	0	0
12 Months or More, Fair Value	8	10
Residential Mortgage Backed Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Available For Sale Securities Continuous Unrealized Loss Position Less Than 12 Months Aggregate Losses Accumulated In Investments	0	0
Less Than 12 Months, Fair Value	30	18
Available For Sale Securities Continuous Unrealized Loss Position 12 Months Or Longer Aggregate Losses Accumulated In Investments	0	0
12 Months or More, Fair Value	0	0
Commercial Mortgage Backed Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Available For Sale Securities Continuous Unrealized Loss Position Less Than 12 Months Aggregate Losses Accumulated In Investments	0	0
Less Than 12 Months, Fair Value	34	0
Available For Sale Securities Continuous Unrealized Loss Position 12 Months Or Longer Aggregate Losses Accumulated In Investments	0	0
12 Months or More, Fair Value	$ 0	$ 0

Short-Term And Long-Term Investments And Restricted Deposits (Contractual Maturities Of Short-Term And Long-Term Investments And Restricted Deposits) (Details) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Investments [Member]
Schedule of Available-for-sale Securities [Line Items]
One year or less, Amortized Cost	$ 176	$ 176
One year through five years, Amortized Cost	1,662	1,121
Five years through ten years, Amortized Cost	267	121
Greater than ten years, Amortized Cost	5	38
Total, Amortized Cost	2,110	1,456
One year or less, Fair Value	176	177
One year through five years, Fair Value	1,654	1,121
Five years through ten years, Fair Value	268	120
Greater than ten years, Fair Value	5	39
Total, Fair Value	2,103	1,457
Restricted Deposits [Member]
Schedule of Available-for-sale Securities [Line Items]
One year or less, Amortized Cost	93	92
One year through five years, Amortized Cost	22	8
Five years through ten years, Amortized Cost	0	0
Greater than ten years, Amortized Cost	0	0
Total, Amortized Cost	115	100
One year or less, Fair Value	93	92
One year through five years, Fair Value	22	8
Five years through ten years, Fair Value	0	0
Greater than ten years, Fair Value	0	0
Total, Fair Value	$ 115	$ 100

Fair Value Measurements (Narrative) (Details) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Transfers from Level I to Level II	$ 53
Transfers from Level II to Level I	0
Life insurance contracts and cost-method investments	$ 87	$ 84

Goodwill And Intangible Assets (Schedule Of Changes In Goodwill By Operating Segment) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Goodwill [Roll Forward]
Goodwill, beginning	$ 754	$ 348
Acquisition	106	406
Impairment	18
Goodwill, ending	842	754
Managed Care [Member]
Goodwill [Roll Forward]
Goodwill, beginning	276	151
Acquisition	103	125
Impairment	18
Goodwill, ending	361	276
Specialty Services [Member]
Goodwill [Roll Forward]
Goodwill, beginning	478	197
Acquisition	3	281
Impairment	0
Goodwill, ending	$ 481	$ 478

Goodwill And Intangible Assets (Schedule Of Future Amortization Expenses) (Details) $ in Millions	Dec. 31, 2015 USD ($)
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2016	$ 22
2017	19
2018	18
2019	18
2020	$ 16

Health Insurance Marketplace (Details) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Health Insurance Marketplace [Abstract]
Health Insurance Marketplace Risk adjustment Payable	$ (108)	$ (44)
Health Insurance Marketplace Reinsurance Receivable	24	11
Health Insurance Marketplace Risk Corridor Payable	(4)	(9)
Health Insurance Marketplace Minimum Medical Loss Ratio Payable	$ (15)	$ (6)

Debt (Schedule Of Debt) (Details) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Fair value of interest rate swap agreements	$ 9	$ 11
Senior Notes, Total	937	740
Revolving credit agreement	225	75
Mortgage notes payable	67	70
Capital leases	6	8
Debt issuance costs	(14)	(14)
Total debt	1,221	879
Less current portion	(5)	(5)
Long term debt	1,216	874
5.75% Senior notes, due June 1, 2017 [Member]
Debt Instrument [Line Items]
Debt face amount	$ 425	$ 425
Interest rate stated, percentage	5.75%	5.75%
4.75% Senior Notes, due May 15, 2022 [Member]
Debt Instrument [Line Items]
Debt face amount	$ 500	$ 500
Interest rate stated, percentage	4.75%	4.75%
Senior Notes [Member] \| 5.75% Senior notes, due June 1, 2017 [Member]
Debt Instrument [Line Items]
$425 million 5.75% Senior notes, due June 1, 2017	$ 428	$ 429
Senior Notes [Member] \| 4.75% Senior Notes, due May 15, 2022 [Member]
Debt Instrument [Line Items]
$500 million 4.75% Senior notes, due May 15, 2022	$ 500	$ 300

Debt (Narrative) (Details) € in Millions, $ in Millions	12 Months Ended
Debt (Narrative) (Details) € in Millions, $ in Millions	Dec. 31, 2015 EUR (€)	Dec. 31, 2015 USD ($)	Jan. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)	Jul. 01, 2014 EUR (€)	Jul. 01, 2014 USD ($)	Apr. 30, 2014 USD ($)
Debt Instrument [Line Items]
Derivative, notional amount			$ 200
Fair value of swap agreements, assets		$ 11		$ 11
Fair value of swap agreements, liabilities		2
Revolving credit facility, maximum borrowing capacity		500
Revolving credit facility, due date	Jun. 01, 2018
Line of credit, minimum carrying amount of unrestricted cash		100
Revolving credit agreement		$ 225		75
Weighted average interest rate of outstanding borrowings	2.05%	2.05%
Covenant terms	The agreement contains non-financial and financial covenants, including requirements of minimum fixed charge coverage ratios, maximum debt-to-EBITDA ratios and minimum tangible net worth. The Company is required to not exceed a maximum debt-to-EBITDA ratio of 3.0 to 1.0.
Ratio of debt to EBITDA	3.0
Mortgage notes payable		$ 67		70
Senior notes, effective yield	1.55%	1.55%
Surety Bonds		$ 305
Fair Value of Outstanding Debt		1,239		$ 901
Interest Rate Swap [Member]
Debt Instrument [Line Items]
Derivative, notional amount		$ 750
Variable rate of swap, percentage	2.85%	2.85%
Weighted average interest rate, interest rate swap agreements	3.22%	3.22%
4.75% Senior Notes, due May 15, 2022 [Member]
Debt Instrument [Line Items]
Senior notes, at par			$ 200				$ 300
Interest rate stated, percentage			4.75%				4.75%
Maturity date	May 15, 2022
4.75% Senior Notes, due May 15, 2022 [Member] \| Interest Rate Swap [Member]
Debt Instrument [Line Items]
Derivative, notional amount							$ 300
5.75% Senior notes, due June 1, 2017 [Member]
Debt Instrument [Line Items]
Senior notes, at par		$ 425
Maturity date	Jun. 01, 2017
Non-recourse Mortgage Note Due January 1, 2021 [Member]
Debt Instrument [Line Items]
Maturity date	Jan. 01, 2021
Mortgage notes payable		67
Mortgage note non-recourse interest rate	5.14%
Net book value of collateralized properties		151
Ribera Salud [Member]
Debt Instrument [Line Items]
Outstanding balance	€ 46	50			€ 48	$ 52
Non Revolver Letter of Credit [Member]
Debt Instrument [Line Items]
Outstanding balance		$ 47
$200 Million Interest Rate Swap [Member]
Debt Instrument [Line Items]
Variable rate of swap, percentage	2.88%	2.88%
June 1, 2017 Expiration [Member] \| Interest Rate Swap [Member]
Debt Instrument [Line Items]
Derivative, notional amount		$ 250
May 15, 2022 Expiration [Member] \| Interest Rate Swap [Member]
Debt Instrument [Line Items]
Derivative, notional amount		$ 500
5.75% Senior notes, due June 1, 2017 [Member]
Debt Instrument [Line Items]
Interest rate stated, percentage	5.75%	5.75%		5.75%
4.75% Senior Notes, due May 15, 2022 [Member]
Debt Instrument [Line Items]
Interest rate stated, percentage	4.75%	4.75%		4.75%
4.75% Senior Notes, due May 15, 2022 [Member] \| Senior Notes [Member]
Debt Instrument [Line Items]
Senior notes, at par		$ 500		$ 300